{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "qbWd5IyrGmek",
        "outputId": "a1ce41c2-1d67-4bec-fb3a-6fab4d0d4247"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "Requirement already satisfied: neo4j in /usr/local/lib/python3.11/dist-packages (5.28.1)\n",
            "Requirement already satisfied: pytz in /usr/local/lib/python3.11/dist-packages (from neo4j) (2025.1)\n"
          ]
        }
      ],
      "source": [
        "!pip install neo4j\n",
        "from neo4j import GraphDatabase\n",
        "driver = GraphDatabase.driver(\"uri\", auth=(\"neo4j\", \"password\"))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "50mzb-SEbAMq"
      },
      "outputs": [],
      "source": [
        "uri =       \"uri\"\n",
        "username =  \"username\"\n",
        "password =  \"password\""
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "_-QVByPNphdY"
      },
      "outputs": [],
      "source": [
        "A=['PGM1-CDG','Cerebral cavernous malformations 3',\"CLOVES syndrome\",\"STT3B-CDG\",\"Thoracolaryngopelvic dysplasia\",\"Actinic prurigo\",\"Non-syndromic polydactyly\",\"Genitopatellar syndrome\",\"Diaphanospondylodysostosis\"]\n",
        "B=['GARD0004329','GARD0018314',\"GARD0010939\",\"GARD0017603\",\"GARD0005184\", \"GARD0017510\",\"GARD0004410\",\"GARD0010994\",\"GARD0016674\"]\n",
        "for n in range(len(A)):\n",
        "  disease= A[n]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "  diseaseid=B[n] #'GARD0017510'\n",
        "  #event_properties = {'GARDID': diseaseid ,'GARDname':disease }\n",
        "  #create_Gard_node(event_properties)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "MtvQ2y21RMiw"
      },
      "source": [
        "# First part"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "02sRLIbSHfPA",
        "outputId": "60c6929c-5513-48fd-8213-f6a886acf7b3"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "0 4 111\n"
          ]
        }
      ],
      "source": [
        "import pandas as pd\n",
        "ClinicalTrial = pd.DataFrame()#pd.read_csv('/content/ClinicalTrial.csv')\n",
        "Grant = pd.read_csv('/content/Grants.csv')#,  error_bad_lines=False)\n",
        "Pubmed=pd.read_csv('/content/Pubmed.csv')\n",
        "\n",
        "'''\n",
        "data1=pd.read_csv('/content/pubmed1.csv')\n",
        "data2=pd.read_csv('/content/pubmed2.csv')\n",
        "data3=pd.read_csv('/content/pubmed3.csv')\n",
        "data4=pd.read_csv('/content/Pubmed.csv')\n",
        "data=pd.concat([data1,data2,data3,data4], ignore_index=True)\n",
        "Pubmed = data.drop_duplicates()\n",
        "Pubmed.index= range(Pubmed.shape[0])\n",
        "'''\n",
        "ClinicalTrial = ClinicalTrial.replace('\"', '', regex=True)\n",
        "Grant = Grant.replace('\"', '', regex=True)\n",
        "Pubmed = Pubmed.replace('\"', '', regex=True)\n",
        "print(ClinicalTrial.shape[0], Grant.shape[0], Pubmed.shape[0])"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "j7HkwoEDZksr"
      },
      "outputs": [],
      "source": [
        "A=['PGM1-CDG','Cerebral cavernous malformations 3',\"CLOVES syndrome\",\"STT3B-CDG\",\"Thoracolaryngopelvic dysplasia\",\"Actinic prurigo\",\"Non-syndromic polydactyly\",\"Genitopatellar syndrome\",\"Diaphanospondylodysostosis\"]\n",
        "B=['GARD0004329','GARD0018314',\"GARD0010939\",\"GARD0017603\",\"GARD0005184\", \"GARD0017510\",\"GARD0004410\",\"GARD0010994\",\"GARD0016674\"]\n",
        "\n",
        "\n",
        "disease= 'Diaphanospondylodysostosis'   #'Cystic fibrosis'\n",
        "diseaseid='GARD0016674'\n",
        "#ClinicalTrial['GARDname']= disease\n",
        "Grant['GARDname']= disease\n",
        "Pubmed['GARDname']= disease"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "xtton6tKAzG3",
        "outputId": "e02280ed-8649-4b74-ad0e-bf70b19ec0a6"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "RangeIndex(start=0, stop=0, step=1)\n",
            "Index(['pi.pi_name', 'pi.org_name', 'p.title', 'p.funding_year',\n",
            "       'p.application_id', 'p.abstract', 'p.terms'],\n",
            "      dtype='object')\n",
            "Index(['ar.title', 'ar.pubmed_id', 'ar.abstractText', 'ar.publicationYear',\n",
            "       'Keywords', 'a.fullName', 'a.affiliation'],\n",
            "      dtype='object')\n"
          ]
        }
      ],
      "source": [
        "print(ClinicalTrial.columns)\n",
        "print(Grant.columns)\n",
        "print(Pubmed.columns)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "uNw8Y7IPZuoM",
        "outputId": "f8e0adac-d746-44ea-a78f-985e120e60ad"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "DF1 columns: Index([], dtype='object')\n",
            "DF2 columns: Index(['pi_name', 'org_name', 'title', 'year', 'application_id', 'abstract',\n",
            "       'terms'],\n",
            "      dtype='object')\n",
            "DF3 columns: Index(['title', 'pubmed_id', 'abstractText', 'year', 'concatenatedKeywords',\n",
            "       'fullName', 'affiliation'],\n",
            "      dtype='object')\n"
          ]
        }
      ],
      "source": [
        "rename_dict_1 = {\n",
        "    'i.OfficialName':         'OfficialName',\n",
        "    'i.OfficialAffiliation':  'OfficialAffiliation',\n",
        "    'c. BriefTitle':       'BriefTitle',\n",
        "    'c.OfficialTitle':    'OfficialTitle',\n",
        "    'c.BriefSummary':     'BriefSummary',\n",
        "    'c.NCTId':            'NCTId',\n",
        "    'l.LocationCity':     'LocationCity',\n",
        "    'l. LocationState':   'LocationState',\n",
        "    'l.LocationCountry':  'LocationCountry',\n",
        "    'l.LocationFacility': 'LocationFacility',\n",
        "     'c.StartDate':     'StartDate' }\n",
        "\n",
        "rename_dict_2 = {\n",
        "    'pi.pi_name':           'pi_name',\n",
        "    'pi.org_name':          'org_name',\n",
        "    'p.title':              'title',\n",
        "    'p.application_id':     'application_id',\n",
        "    'p.abstract':           'abstract',\n",
        "    'p.terms':              'terms',\n",
        "    'p.funding_year':     'year'\n",
        "}\n",
        "\n",
        "rename_dict_3 = {\n",
        "    'AuthorFullName':            'fullName'        ,\n",
        "    'Title':              'title'       ,\n",
        "    'AuthorAffiliation':        'affiliation'       ,\n",
        "    'PubMedID':          'pubmed_id'      ,\n",
        "    'Abstract':       'abstractText'     ,\n",
        "    'Keywords':  'concatenatedKeywords',\n",
        "    'ar.publicationYear':   'year'\n",
        "}\n",
        "\n",
        "rename_dict_3 = {\n",
        "    'a.fullName':            'fullName'        ,\n",
        "    'ar.title':              'title'       ,\n",
        "    'a.affiliation':        'affiliation'       ,\n",
        "    'ar.pubmed_id':          'pubmed_id'      ,\n",
        "    'ar.abstractText':       'abstractText'     ,\n",
        "    'Keywords':  'concatenatedKeywords',\n",
        "    'ar.publicationYear':   'year'\n",
        "}\n",
        "\n",
        "\n",
        "# Rename the columns of each DataFrame\n",
        "ClinicalTrial.rename(columns=rename_dict_1, inplace=True)\n",
        "Grant.rename(columns=rename_dict_2, inplace=True)\n",
        "\n",
        "Pubmed.rename(columns=rename_dict_3, inplace=True)\n",
        "\n",
        "# Check the renamed columns\n",
        "print(\"DF1 columns:\", ClinicalTrial.columns)\n",
        "print(\"DF2 columns:\", Grant.columns)\n",
        "print(\"DF3 columns:\", Pubmed.columns)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Dmj7YHdkOtuZ"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "iYSueaVwZyva"
      },
      "outputs": [],
      "source": [
        "def create_Gard_node(properties):\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            query = (\n",
        "                \"create (ga:Gard {\"\n",
        "                'GARDID: $GARDID,'\n",
        "                'GARDname: $GARDname'\n",
        "                \"})\"\n",
        "            )\n",
        "            session.run(query, **properties)\n",
        "def create_ClinicalTrial_node(properties):\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            query = (\n",
        "                \"create (CT:ClinicalTrial {\"\n",
        "                'OfficialName: $OfficialName,'\n",
        "                'OfficialAffiliation: $OfficialAffiliation,'\n",
        "                'BriefTitle: $BriefTitle,'\n",
        "                'OfficialTitle: $OfficialTitle,'\n",
        "                'BriefSummary: $BriefSummary,'\n",
        "                'NCTId: $NCTId,'\n",
        "                'LocationCity: $LocationCity,'\n",
        "                'LocationState: $LocationState,'\n",
        "                'LocationCountry: $LocationCountry,'\n",
        "                'LocationFacility: $LocationFacility,'\n",
        "                'Interventions: $Interventions,'\n",
        "                'GARDname: $GARDname,'\n",
        "                 'year: $StartDate'\n",
        "                \"})\"\n",
        "            )\n",
        "            session.run(query, **properties)\n",
        "\n",
        "def create_ClinicalTrial_node(properties):\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            query = (\n",
        "                \"MERGE (CT:ClinicalTrial {\"\n",
        "                'NCTId: $NCTId'  # Unique identifier for the ClinicalTrial\n",
        "                \"}) \"\n",
        "                \"ON CREATE SET \"\n",
        "                'CT.OfficialName = $OfficialName, '\n",
        "                'CT.OfficialAffiliation = $OfficialAffiliation, '\n",
        "                'CT.BriefTitle = $BriefTitle, '\n",
        "                'CT.OfficialTitle = $OfficialTitle, '\n",
        "                'CT.BriefSummary = $BriefSummary, '\n",
        "                'CT.LocationCity = $LocationCity, '\n",
        "                'CT.LocationState = $LocationState, '\n",
        "                'CT.LocationCountry = $LocationCountry, '\n",
        "                'CT.LocationFacility = $LocationFacility, '\n",
        "                'CT.Interventions = $Interventions, '\n",
        "                'CT.GARDname = $GARDname'\n",
        "            )\n",
        "            session.run(query, **properties)\n",
        "\n",
        "def create_Grant_node(properties):\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            query = (\n",
        "                \"create (gr:Grant {\"\n",
        "    'pi_name: $pi_name,'\n",
        "    'org_name: $org_name,'\n",
        "    'title: $title,'\n",
        "    'application_id: $application_id,'\n",
        "    'abstract: $abstract,'\n",
        "    'terms: $terms,'\n",
        "    'GARDname: $GARDname,'\n",
        "    'year: $year'\n",
        "                \"})\"\n",
        "            )\n",
        "            session.run(query, **properties)\n",
        "def create_Pubmed_node(properties):\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            query = (\n",
        "                \"create (pm:Pubmed {\"\n",
        "    'fullName: $fullName,'\n",
        "    'ar_title: $ar_title,'\n",
        "    'ar_affiliation: $ar_affiliation,'\n",
        "    'pubmed_id: $pubmed_id,'\n",
        "    'abstractText: $abstractText,'\n",
        "    'concatenatedKeywords: $concatenatedKeywords,'\n",
        "    'GARDname: $GARDname,'\n",
        "     'year: $year'\n",
        "                \"})\"\n",
        "            )\n",
        "            session.run(query, **properties)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 35
        },
        "id": "9Z_okbN_DolV",
        "outputId": "377d5fcd-6055-4814-9c52-d4ab98f11c4f"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'2018'"
            ]
          },
          "execution_count": 11,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "ClinicalTrial['StartDate'][2][-4:]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "OdNBjM7CZ2iY",
        "outputId": "af1287ac-6055-452d-c9ef-0a845ff858d5"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "CT: finished\n",
            "Grant: finished\n",
            "Pubmed: finished\n"
          ]
        }
      ],
      "source": [
        "for i in range(len(ClinicalTrial)):\n",
        "      event_properties = {\n",
        "                'OfficialName': ClinicalTrial['OfficialName'][i],\n",
        "                'OfficialAffiliation': ClinicalTrial['OfficialAffiliation'][i],\n",
        "                'BriefTitle': ClinicalTrial['BriefTitle'][i],\n",
        "                'OfficialTitle':ClinicalTrial['OfficialTitle'][i],\n",
        "                'BriefSummary': ClinicalTrial['BriefSummary'][i],\n",
        "                'NCTId': ClinicalTrial['NCTId'][i],\n",
        "                'LocationCity': ClinicalTrial['LocationCity'][i],\n",
        "                 'LocationState': ClinicalTrial['LocationState'][i],\n",
        "                'LocationCountry': ClinicalTrial['LocationCountry'][i],\n",
        "                'LocationFacility': ClinicalTrial['LocationFacility'][i],\n",
        "                'Interventions': ClinicalTrial['Interventions'][i],\n",
        "                'GARDname': ClinicalTrial['GARDname'][i],\n",
        "                'year': ClinicalTrial['StartDate'][i][-4:]\n",
        "        }\n",
        "      create_ClinicalTrial_node(event_properties)\n",
        "print('CT: finished')\n",
        "\n",
        "for i in range(len(Grant)):\n",
        "    event_properties = {\n",
        "        'pi_name': str(Grant['pi_name'][i]),\n",
        "        'org_name': str(Grant['org_name'][i]),\n",
        "        'title': str(Grant['title'][i]),\n",
        "        'application_id': str(Grant['application_id'][i]),\n",
        "        'abstract': str(Grant['abstract'][i]),\n",
        "        'terms': str(Grant['terms'][i]),\n",
        "        'GARDname': Grant['GARDname'][i],\n",
        "        'year': Grant['year'][i]\n",
        "    }\n",
        "    create_Grant_node(event_properties)\n",
        "print('Grant: finished')\n",
        "\n",
        "for i in range(len(Pubmed)):\n",
        "    event_properties = {\n",
        "        'fullName': Pubmed['fullName'][i],  # Convert to string\n",
        "        'ar_title': Pubmed['title'][i],  # Convert to string\n",
        "        'ar_affiliation': Pubmed['affiliation'][i],  # Convert to string\n",
        "        'pubmed_id': Pubmed['pubmed_id'][i],  # Convert to string (or other appropriate type)\n",
        "        'abstractText': Pubmed['abstractText'][i],  # Convert to string\n",
        "        'concatenatedKeywords': Pubmed['concatenatedKeywords'][i],  # Convert to string\n",
        "        'GARDname': Pubmed['GARDname'][i],  # Convert to string\n",
        "        'year': Pubmed['year'][i]\n",
        "    }\n",
        "    create_Pubmed_node(event_properties)\n",
        "\n",
        "print('Pubmed: finished')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "RrdViy25geUw",
        "outputId": "7801c095-827a-4e7c-98bf-c0b9676a2e38"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Pubmed: finished\n"
          ]
        }
      ],
      "source": [
        "for i in range(len(Pubmed)):\n",
        "    event_properties = {\n",
        "        'fullName': Pubmed['fullName'][i],  # Convert to string\n",
        "        'ar_title': Pubmed['title'][i],  # Convert to string\n",
        "        'ar_affiliation': Pubmed['affiliation'][i],  # Convert to string\n",
        "        'pubmed_id': Pubmed['pubmed_id'][i],  # Convert to string (or other appropriate type)\n",
        "        'abstractText': Pubmed['abstractText'][i],  # Convert to string\n",
        "        'concatenatedKeywords': Pubmed['concatenatedKeywords'][i],  # Convert to string\n",
        "        'GARDname': Pubmed['GARDname'][i],  # Convert to string\n",
        "        'year': Pubmed['year'][i]\n",
        "    }\n",
        "    create_Pubmed_node(event_properties)\n",
        "\n",
        "print('Pubmed: finished')\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "KqMETCMLpPAZ"
      },
      "outputs": [],
      "source": [
        "#event_properties = {'GARDID': 'GARD0006233' ,'GARDname': 'Cystic fibrosis'}\n",
        "event_properties = {'GARDID': diseaseid ,'GARDname': disease }\n",
        "create_Gard_node(event_properties)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "FcvfwyaqpX2L"
      },
      "outputs": [],
      "source": [
        "def create_relationship_between_nodes(node1_label, node2_label, relationship_type):\n",
        "    with driver.session() as session:\n",
        "        query = (\n",
        "        f\"MATCH (n1:{node1_label}), (n2:{node2_label}) \"\n",
        "         f\"WHERE n1.GARDname = n2.GARDname \"\n",
        "       f\"CREATE (n1)-[:{relationship_type}]->(n2)\"\n",
        "        )\n",
        "        session.run(query)\n",
        "\n",
        "\n",
        "create_relationship_between_nodes('ClinicalTrial','Gard',  \"RELATED_GARD\")\n",
        "create_relationship_between_nodes('Grant','Gard',  \"RELATED_GARD\")\n",
        "create_relationship_between_nodes('Pubmed','Gard',  \"RELATED_GARD\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "XguH4zvYpbgd"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "fips_finding=pd.read_csv('/content/uscities.csv')\n",
        "fips_finding_dict=dict()\n",
        "for i in fips_finding.index:\n",
        "     fips_finding_dict[(fips_finding['city'][i].lower().strip(),fips_finding['state_name'][i].lower().strip() )]= ['{:0>5}'.format(fips_finding['county_fips'][i]),fips_finding['county_name'][i]]\n",
        "     fips_finding_dict[fips_finding['city'][i].lower().strip()]= ['{:0>5}'.format(fips_finding['county_fips'][i]),fips_finding['county_name'][i]]\n",
        "\n",
        "def find_fip(x,y):\n",
        " if y != None:\n",
        "  try:\n",
        "    return (fips_finding_dict[ (x.lower().strip(),y.lower().strip())][0]), fips_finding_dict[ (x.lower(),y.lower())][1]\n",
        "  except:\n",
        "    return  '',''\n",
        " else:\n",
        "    try:\n",
        "      return (fips_finding_dict[x.lower().strip()][0]),fips_finding_dict[ x.lower()][1]\n",
        "    except:\n",
        "      return  '',''"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Efx9h6uepdnh"
      },
      "outputs": [],
      "source": [
        "def create_Researcher_node(properties):\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            query = (\n",
        "                \"MERGE (Re:Researcher {\"\n",
        "                    'Name: $Name,'\n",
        "                    'Aff_name: $Aff_name'\n",
        "                \"}) \"\n",
        "                \"ON CREATE SET \"\n",
        "                    \"Re.Contact_info= $Contact_info,\"\n",
        "                    \"Re.Aff_Zip = $Aff_Zip \"\n",
        "\n",
        "            )\n",
        "            result = session.run(query, **properties)\n",
        "\n",
        "\n",
        "def create_Location_node(properties, Name, Aff_name):\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            query = (\n",
        "                \"MERGE (Loc:Location {Aff_country: $Aff_country, Aff_state: $Aff_state, Aff_county: $Aff_county}) \"\n",
        "                \"ON CREATE SET \"\n",
        "                \"Loc.Aff_city = $Aff_city, \"\n",
        "                \"Loc.Aff_FIPS = $Aff_FIPS \"\n",
        "                \"WITH Loc \"\n",
        "                \"MATCH (Re:Researcher {Name: $Name, Aff_name: $Aff_name}) \"\n",
        "                \"CREATE (Re)-[:Researcher_location]->(Loc)\"\n",
        "            )\n",
        "            # Execute the query, passing the properties dictionary and other parameters\n",
        "            result = session.run(query, **properties, Name=Name, Aff_name=Aff_name)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "P-BQN0LjpjJ5",
        "outputId": "050923ea-b02a-4c16-c532-d5e4174f4b54"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: spacy in /usr/local/lib/python3.10/dist-packages (3.7.5)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (1.0.11)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.0.10)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.3.0,>=8.2.2 in /usr/local/lib/python3.10/dist-packages (from spacy) (8.2.5)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy) (1.1.3)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.5.0)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.5.0,>=0.1.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (0.4.1)\n",
            "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (0.15.1)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (4.67.1)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.32.3)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.10.3)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy) (3.1.4)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy) (75.1.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (3.5.0)\n",
            "Requirement already satisfied: numpy>=1.19.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (1.26.4)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.10/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy) (1.3.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.1 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (2.27.1)\n",
            "Requirement already satisfied: typing-extensions>=4.12.2 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (3.4.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2.2.3)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2024.12.14)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy) (0.1.5)\n",
            "Requirement already satisfied: click>=8.0.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (8.1.7)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (1.5.4)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (13.9.4)\n",
            "Requirement already satisfied: cloudpathlib<1.0.0,>=0.7.0 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy) (0.20.0)\n",
            "Requirement already satisfied: smart-open<8.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy) (7.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy) (3.0.2)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.10/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy) (1.2.1)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (2.18.0)\n",
            "Requirement already satisfied: wrapt in /usr/local/lib/python3.10/dist-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy) (1.17.0)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.10/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (0.1.2)\n",
            "Collecting en-core-web-sm==3.7.1\n",
            "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_sm-3.7.1/en_core_web_sm-3.7.1-py3-none-any.whl (12.8 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m12.8/12.8 MB\u001b[0m \u001b[31m100.0 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: spacy<3.8.0,>=3.7.2 in /usr/local/lib/python3.10/dist-packages (from en-core-web-sm==3.7.1) (3.7.5)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.0.11)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.0.10)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.3.0,>=8.2.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (8.2.5)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.1.3)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.5.0)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.5.0,>=0.1.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.4.1)\n",
            "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.15.1)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (4.67.1)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.32.3)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.10.3)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.1.4)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (75.1.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.5.0)\n",
            "Requirement already satisfied: numpy>=1.19.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.26.4)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.10/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.3.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.1 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.27.1)\n",
            "Requirement already satisfied: typing-extensions>=4.12.2 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.4.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.2.3)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2024.12.14)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.1.5)\n",
            "Requirement already satisfied: click>=8.0.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (8.1.7)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.5.4)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (13.9.4)\n",
            "Requirement already satisfied: cloudpathlib<1.0.0,>=0.7.0 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.20.0)\n",
            "Requirement already satisfied: smart-open<8.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (7.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.2)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.10/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.2.1)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.18.0)\n",
            "Requirement already satisfied: wrapt in /usr/local/lib/python3.10/dist-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.17.0)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.10/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.1.2)\n",
            "\u001b[38;5;2m✔ Download and installation successful\u001b[0m\n",
            "You can now load the package via spacy.load('en_core_web_sm')\n",
            "\u001b[38;5;3m⚠ Restart to reload dependencies\u001b[0m\n",
            "If you are in a Jupyter or Colab notebook, you may need to restart Python in\n",
            "order to load all the package's dependencies. You can do this by selecting the\n",
            "'Restart kernel' or 'Restart runtime' option.\n"
          ]
        },
        {
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "text/plain": [
              "False"
            ]
          },
          "execution_count": 21,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "!pip install spacy\n",
        "!python -m spacy download en_core_web_sm\n",
        "import spacy\n",
        "nlp = spacy.load(\"en_core_web_sm\")\n",
        "\n",
        "\n",
        "def classify_entity(text):\n",
        "    if not isinstance(text, str):  # Check if the input is a string\n",
        "        return False\n",
        "    doc = nlp(text)\n",
        "    for ent in doc.ents:\n",
        "        if ent.label_ == \"PERSON\":\n",
        "            return True\n",
        "    return False\n",
        "\n",
        "display(classify_entity('Devon Leadman'))\n",
        "classify_entity('NIH')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "jLLchFucpm56"
      },
      "outputs": [],
      "source": [
        "def extract_and_create_researcher_location_nodes_CT():\n",
        " with driver.session() as session:\n",
        "  query = \"MATCH (i:ClinicalTrial) where i.GARDname= $disease RETURN i.OfficialName AS OfficialName, i.OfficialAffiliation AS OfficialAffiliation, i.LocationCountry as LocationCountry, i.LocationCity as LocationCity,i.LocationState as LocationState\"\n",
        "  results = session.run(query, disease=disease)\n",
        "  for ClinicalTrial in results:\n",
        "   Name=  ClinicalTrial['OfficialName']\n",
        "   Aff_name=   str(ClinicalTrial['OfficialAffiliation'])\n",
        "   if  classify_entity(Name)==True and (Name, Aff_name) not in current_names:\n",
        "    event_properties = {\n",
        "        'Name': Name,\n",
        "        'Contact_info': '',#str(ClinicalTrial['i.OfficialAffiliation'][i]),\n",
        "        'Aff_name':Aff_name,\n",
        "        'Aff_Zip': ''#str(ClinicalTrial['LocationZip'][i]),\n",
        "    }\n",
        "    create_Researcher_node(event_properties)\n",
        "    city_  = str(ClinicalTrial['LocationCity']).lower().strip()\n",
        "    State_ = str(ClinicalTrial['LocationState']).lower().strip()\n",
        "    event_properties = {\n",
        "        'Aff_country': str(ClinicalTrial['LocationCountry']),\n",
        "        'Aff_state': State_,\n",
        "        'Aff_county': find_fip(city_, State_ )[1] ,\n",
        "        'Aff_city': city_,\n",
        "        'Aff_FIPS': find_fip(city_, State_ )[0]\n",
        "    }\n",
        "    create_Location_node(event_properties, Name, Aff_name)\n",
        "    current_names[(Name, Aff_name)] =1\n",
        "\n",
        "current_names={}\n",
        "extract_and_create_researcher_location_nodes_CT()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "bEPpuWpCOI7p"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "hxU49BG1pqU4",
        "outputId": "53d25872-d3aa-477c-9d74-c82b82cb054c"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting locationtagger\n",
            "  Downloading locationtagger-0.0.1-py3-none-any.whl.metadata (6.2 kB)\n",
            "Requirement already satisfied: nltk in /usr/local/lib/python3.10/dist-packages (from locationtagger) (3.9.1)\n",
            "Requirement already satisfied: spacy in /usr/local/lib/python3.10/dist-packages (from locationtagger) (3.7.5)\n",
            "Collecting newspaper3k (from locationtagger)\n",
            "  Downloading newspaper3k-0.2.8-py3-none-any.whl.metadata (11 kB)\n",
            "Collecting pycountry (from locationtagger)\n",
            "  Downloading pycountry-24.6.1-py3-none-any.whl.metadata (12 kB)\n",
            "Requirement already satisfied: beautifulsoup4>=4.4.1 in /usr/local/lib/python3.10/dist-packages (from newspaper3k->locationtagger) (4.12.3)\n",
            "Requirement already satisfied: Pillow>=3.3.0 in /usr/local/lib/python3.10/dist-packages (from newspaper3k->locationtagger) (11.0.0)\n",
            "Requirement already satisfied: PyYAML>=3.11 in /usr/local/lib/python3.10/dist-packages (from newspaper3k->locationtagger) (6.0.2)\n",
            "Collecting cssselect>=0.9.2 (from newspaper3k->locationtagger)\n",
            "  Downloading cssselect-1.2.0-py2.py3-none-any.whl.metadata (2.2 kB)\n",
            "Requirement already satisfied: lxml>=3.6.0 in /usr/local/lib/python3.10/dist-packages (from newspaper3k->locationtagger) (5.3.0)\n",
            "Requirement already satisfied: requests>=2.10.0 in /usr/local/lib/python3.10/dist-packages (from newspaper3k->locationtagger) (2.32.3)\n",
            "Collecting feedparser>=5.2.1 (from newspaper3k->locationtagger)\n",
            "  Downloading feedparser-6.0.11-py3-none-any.whl.metadata (2.4 kB)\n",
            "Collecting tldextract>=2.0.1 (from newspaper3k->locationtagger)\n",
            "  Downloading tldextract-5.1.3-py3-none-any.whl.metadata (11 kB)\n",
            "Collecting feedfinder2>=0.0.4 (from newspaper3k->locationtagger)\n",
            "  Downloading feedfinder2-0.0.4.tar.gz (3.3 kB)\n",
            "  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Collecting jieba3k>=0.35.1 (from newspaper3k->locationtagger)\n",
            "  Downloading jieba3k-0.35.1.zip (7.4 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m7.4/7.4 MB\u001b[0m \u001b[31m85.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: python-dateutil>=2.5.3 in /usr/local/lib/python3.10/dist-packages (from newspaper3k->locationtagger) (2.8.2)\n",
            "Collecting tinysegmenter==0.3 (from newspaper3k->locationtagger)\n",
            "  Downloading tinysegmenter-0.3.tar.gz (16 kB)\n",
            "  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: click in /usr/local/lib/python3.10/dist-packages (from nltk->locationtagger) (8.1.7)\n",
            "Requirement already satisfied: joblib in /usr/local/lib/python3.10/dist-packages (from nltk->locationtagger) (1.4.2)\n",
            "Requirement already satisfied: regex>=2021.8.3 in /usr/local/lib/python3.10/dist-packages (from nltk->locationtagger) (2024.11.6)\n",
            "Requirement already satisfied: tqdm in /usr/local/lib/python3.10/dist-packages (from nltk->locationtagger) (4.67.1)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (1.0.11)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (2.0.10)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.3.0,>=8.2.2 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (8.2.5)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (1.1.3)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (2.5.0)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.5.0,>=0.1.0 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (0.4.1)\n",
            "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (0.15.1)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (2.10.3)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (3.1.4)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (75.1.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (3.5.0)\n",
            "Requirement already satisfied: numpy>=1.19.0 in /usr/local/lib/python3.10/dist-packages (from spacy->locationtagger) (1.26.4)\n",
            "Requirement already satisfied: soupsieve>1.2 in /usr/local/lib/python3.10/dist-packages (from beautifulsoup4>=4.4.1->newspaper3k->locationtagger) (2.6)\n",
            "Requirement already satisfied: six in /usr/local/lib/python3.10/dist-packages (from feedfinder2>=0.0.4->newspaper3k->locationtagger) (1.17.0)\n",
            "Collecting sgmllib3k (from feedparser>=5.2.1->newspaper3k->locationtagger)\n",
            "  Downloading sgmllib3k-1.0.0.tar.gz (5.8 kB)\n",
            "  Preparing metadata (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.10/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy->locationtagger) (1.3.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy->locationtagger) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.1 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy->locationtagger) (2.27.1)\n",
            "Requirement already satisfied: typing-extensions>=4.12.2 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy->locationtagger) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests>=2.10.0->newspaper3k->locationtagger) (3.4.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests>=2.10.0->newspaper3k->locationtagger) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests>=2.10.0->newspaper3k->locationtagger) (2.2.3)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests>=2.10.0->newspaper3k->locationtagger) (2024.12.14)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy->locationtagger) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy->locationtagger) (0.1.5)\n",
            "Collecting requests-file>=1.4 (from tldextract>=2.0.1->newspaper3k->locationtagger)\n",
            "  Downloading requests_file-2.1.0-py2.py3-none-any.whl.metadata (1.7 kB)\n",
            "Requirement already satisfied: filelock>=3.0.8 in /usr/local/lib/python3.10/dist-packages (from tldextract>=2.0.1->newspaper3k->locationtagger) (3.16.1)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy->locationtagger) (1.5.4)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy->locationtagger) (13.9.4)\n",
            "Requirement already satisfied: cloudpathlib<1.0.0,>=0.7.0 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy->locationtagger) (0.20.0)\n",
            "Requirement already satisfied: smart-open<8.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy->locationtagger) (7.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy->locationtagger) (3.0.2)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.10/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy->locationtagger) (1.2.1)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy->locationtagger) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy->locationtagger) (2.18.0)\n",
            "Requirement already satisfied: wrapt in /usr/local/lib/python3.10/dist-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy->locationtagger) (1.17.0)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.10/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy->locationtagger) (0.1.2)\n",
            "Downloading locationtagger-0.0.1-py3-none-any.whl (1.6 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m1.6/1.6 MB\u001b[0m \u001b[31m54.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading newspaper3k-0.2.8-py3-none-any.whl (211 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m211.1/211.1 kB\u001b[0m \u001b[31m18.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pycountry-24.6.1-py3-none-any.whl (6.3 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m6.3/6.3 MB\u001b[0m \u001b[31m100.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading cssselect-1.2.0-py2.py3-none-any.whl (18 kB)\n",
            "Downloading feedparser-6.0.11-py3-none-any.whl (81 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m81.3/81.3 kB\u001b[0m \u001b[31m7.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading tldextract-5.1.3-py3-none-any.whl (104 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m104.9/104.9 kB\u001b[0m \u001b[31m9.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading requests_file-2.1.0-py2.py3-none-any.whl (4.2 kB)\n",
            "Building wheels for collected packages: tinysegmenter, feedfinder2, jieba3k, sgmllib3k\n",
            "  Building wheel for tinysegmenter (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for tinysegmenter: filename=tinysegmenter-0.3-py3-none-any.whl size=13539 sha256=45ef9d13fb1df74d0d81473dadbaabf6e2ca305ea57b3a776adc8affd38d45d7\n",
            "  Stored in directory: /root/.cache/pip/wheels/c8/d6/6c/384f58df48c00b9a31d638005143b5b3ac62c3d25fb1447f23\n",
            "  Building wheel for feedfinder2 (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for feedfinder2: filename=feedfinder2-0.0.4-py3-none-any.whl size=3342 sha256=e8f618bd44ca707e5cd0964468f4a7066cfd9e2a5ebd2ce013c7cee0c94fd0e6\n",
            "  Stored in directory: /root/.cache/pip/wheels/97/02/e7/a1ff1760e12bdbaab0ac824fae5c1bc933e41c4ccd6a8f8edb\n",
            "  Building wheel for jieba3k (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for jieba3k: filename=jieba3k-0.35.1-py3-none-any.whl size=7398379 sha256=b45b539634c3b77b7f7eac9c006619df2c27ffe5ba03e4651467c3662868136e\n",
            "  Stored in directory: /root/.cache/pip/wheels/7a/c4/0c/12a9a314ecac499456c4c3b2fcc2f635a3b45a39dfbd240299\n",
            "  Building wheel for sgmllib3k (setup.py) ... \u001b[?25l\u001b[?25hdone\n",
            "  Created wheel for sgmllib3k: filename=sgmllib3k-1.0.0-py3-none-any.whl size=6047 sha256=40cec6f0d8e9433429538d422b574f85de378cc91b09992fcffe37a22f87ddab\n",
            "  Stored in directory: /root/.cache/pip/wheels/f0/69/93/a47e9d621be168e9e33c7ce60524393c0b92ae83cf6c6e89c5\n",
            "Successfully built tinysegmenter feedfinder2 jieba3k sgmllib3k\n",
            "Installing collected packages: tinysegmenter, sgmllib3k, jieba3k, pycountry, feedparser, cssselect, requests-file, feedfinder2, tldextract, newspaper3k, locationtagger\n",
            "Successfully installed cssselect-1.2.0 feedfinder2-0.0.4 feedparser-6.0.11 jieba3k-0.35.1 locationtagger-0.0.1 newspaper3k-0.2.8 pycountry-24.6.1 requests-file-2.1.0 sgmllib3k-1.0.0 tinysegmenter-0.3 tldextract-5.1.3\n",
            "Requirement already satisfied: spacy in /usr/local/lib/python3.10/dist-packages (3.7.5)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (1.0.11)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.0.10)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.3.0,>=8.2.2 in /usr/local/lib/python3.10/dist-packages (from spacy) (8.2.5)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy) (1.1.3)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.5.0)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.5.0,>=0.1.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (0.4.1)\n",
            "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (0.15.1)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (4.67.1)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.32.3)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy) (2.10.3)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy) (3.1.4)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy) (75.1.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (3.5.0)\n",
            "Requirement already satisfied: numpy>=1.19.0 in /usr/local/lib/python3.10/dist-packages (from spacy) (1.26.4)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.10/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy) (1.3.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.1 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (2.27.1)\n",
            "Requirement already satisfied: typing-extensions>=4.12.2 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (3.4.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2.2.3)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy) (2024.12.14)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy) (0.1.5)\n",
            "Requirement already satisfied: click>=8.0.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (8.1.7)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (1.5.4)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy) (13.9.4)\n",
            "Requirement already satisfied: cloudpathlib<1.0.0,>=0.7.0 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy) (0.20.0)\n",
            "Requirement already satisfied: smart-open<8.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy) (7.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy) (3.0.2)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.10/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy) (1.2.1)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (2.18.0)\n",
            "Requirement already satisfied: wrapt in /usr/local/lib/python3.10/dist-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy) (1.17.0)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.10/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy) (0.1.2)\n",
            "Collecting en-core-web-sm==3.7.1\n",
            "  Downloading https://github.com/explosion/spacy-models/releases/download/en_core_web_sm-3.7.1/en_core_web_sm-3.7.1-py3-none-any.whl (12.8 MB)\n",
            "\u001b[2K     \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m12.8/12.8 MB\u001b[0m \u001b[31m98.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hRequirement already satisfied: spacy<3.8.0,>=3.7.2 in /usr/local/lib/python3.10/dist-packages (from en-core-web-sm==3.7.1) (3.7.5)\n",
            "Requirement already satisfied: spacy-legacy<3.1.0,>=3.0.11 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.12)\n",
            "Requirement already satisfied: spacy-loggers<2.0.0,>=1.0.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.0.5)\n",
            "Requirement already satisfied: murmurhash<1.1.0,>=0.28.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.0.11)\n",
            "Requirement already satisfied: cymem<2.1.0,>=2.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.0.10)\n",
            "Requirement already satisfied: preshed<3.1.0,>=3.0.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.9)\n",
            "Requirement already satisfied: thinc<8.3.0,>=8.2.2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (8.2.5)\n",
            "Requirement already satisfied: wasabi<1.2.0,>=0.9.1 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.1.3)\n",
            "Requirement already satisfied: srsly<3.0.0,>=2.4.3 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.5.0)\n",
            "Requirement already satisfied: catalogue<2.1.0,>=2.0.6 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.0.10)\n",
            "Requirement already satisfied: weasel<0.5.0,>=0.1.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.4.1)\n",
            "Requirement already satisfied: typer<1.0.0,>=0.3.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.15.1)\n",
            "Requirement already satisfied: tqdm<5.0.0,>=4.38.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (4.67.1)\n",
            "Requirement already satisfied: requests<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.32.3)\n",
            "Requirement already satisfied: pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.10.3)\n",
            "Requirement already satisfied: jinja2 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.1.4)\n",
            "Requirement already satisfied: setuptools in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (75.1.0)\n",
            "Requirement already satisfied: packaging>=20.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (24.2)\n",
            "Requirement already satisfied: langcodes<4.0.0,>=3.2.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.5.0)\n",
            "Requirement already satisfied: numpy>=1.19.0 in /usr/local/lib/python3.10/dist-packages (from spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.26.4)\n",
            "Requirement already satisfied: language-data>=1.2 in /usr/local/lib/python3.10/dist-packages (from langcodes<4.0.0,>=3.2.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.3.0)\n",
            "Requirement already satisfied: annotated-types>=0.6.0 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.7.0)\n",
            "Requirement already satisfied: pydantic-core==2.27.1 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.27.1)\n",
            "Requirement already satisfied: typing-extensions>=4.12.2 in /usr/local/lib/python3.10/dist-packages (from pydantic!=1.8,!=1.8.1,<3.0.0,>=1.7.4->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (4.12.2)\n",
            "Requirement already satisfied: charset-normalizer<4,>=2 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.4.0)\n",
            "Requirement already satisfied: idna<4,>=2.5 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.10)\n",
            "Requirement already satisfied: urllib3<3,>=1.21.1 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.2.3)\n",
            "Requirement already satisfied: certifi>=2017.4.17 in /usr/local/lib/python3.10/dist-packages (from requests<3.0.0,>=2.13.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2024.12.14)\n",
            "Requirement already satisfied: blis<0.8.0,>=0.7.8 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.7.11)\n",
            "Requirement already satisfied: confection<1.0.0,>=0.0.1 in /usr/local/lib/python3.10/dist-packages (from thinc<8.3.0,>=8.2.2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.1.5)\n",
            "Requirement already satisfied: click>=8.0.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (8.1.7)\n",
            "Requirement already satisfied: shellingham>=1.3.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.5.4)\n",
            "Requirement already satisfied: rich>=10.11.0 in /usr/local/lib/python3.10/dist-packages (from typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (13.9.4)\n",
            "Requirement already satisfied: cloudpathlib<1.0.0,>=0.7.0 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.20.0)\n",
            "Requirement already satisfied: smart-open<8.0.0,>=5.2.1 in /usr/local/lib/python3.10/dist-packages (from weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (7.1.0)\n",
            "Requirement already satisfied: MarkupSafe>=2.0 in /usr/local/lib/python3.10/dist-packages (from jinja2->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.2)\n",
            "Requirement already satisfied: marisa-trie>=1.1.0 in /usr/local/lib/python3.10/dist-packages (from language-data>=1.2->langcodes<4.0.0,>=3.2.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.2.1)\n",
            "Requirement already satisfied: markdown-it-py>=2.2.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (3.0.0)\n",
            "Requirement already satisfied: pygments<3.0.0,>=2.13.0 in /usr/local/lib/python3.10/dist-packages (from rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (2.18.0)\n",
            "Requirement already satisfied: wrapt in /usr/local/lib/python3.10/dist-packages (from smart-open<8.0.0,>=5.2.1->weasel<0.5.0,>=0.1.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (1.17.0)\n",
            "Requirement already satisfied: mdurl~=0.1 in /usr/local/lib/python3.10/dist-packages (from markdown-it-py>=2.2.0->rich>=10.11.0->typer<1.0.0,>=0.3.0->spacy<3.8.0,>=3.7.2->en-core-web-sm==3.7.1) (0.1.2)\n",
            "\u001b[38;5;2m✔ Download and installation successful\u001b[0m\n",
            "You can now load the package via spacy.load('en_core_web_sm')\n",
            "\u001b[38;5;3m⚠ Restart to reload dependencies\u001b[0m\n",
            "If you are in a Jupyter or Colab notebook, you may need to restart Python in\n",
            "order to load all the package's dependencies. You can do this by selecting the\n",
            "'Restart kernel' or 'Restart runtime' option.\n",
            "Requirement already satisfied: lxml[html_clean] in /usr/local/lib/python3.10/dist-packages (5.3.0)\n",
            "Collecting lxml-html-clean (from lxml[html_clean])\n",
            "  Downloading lxml_html_clean-0.4.1-py3-none-any.whl.metadata (2.4 kB)\n",
            "Downloading lxml_html_clean-0.4.1-py3-none-any.whl (14 kB)\n",
            "Installing collected packages: lxml-html-clean\n",
            "Successfully installed lxml-html-clean-0.4.1\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "[nltk_data] Downloading package maxent_ne_chunker to\n",
            "[nltk_data]     /root/nltk_data...\n",
            "[nltk_data]   Unzipping chunkers/maxent_ne_chunker.zip.\n",
            "[nltk_data] Downloading package words to /root/nltk_data...\n",
            "[nltk_data]   Unzipping corpora/words.zip.\n",
            "[nltk_data] Downloading package treebank to /root/nltk_data...\n",
            "[nltk_data]   Unzipping corpora/treebank.zip.\n",
            "[nltk_data] Downloading package maxent_treebank_pos_tagger to\n",
            "[nltk_data]     /root/nltk_data...\n",
            "[nltk_data]   Unzipping taggers/maxent_treebank_pos_tagger.zip.\n",
            "[nltk_data] Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]   Unzipping tokenizers/punkt.zip.\n",
            "[nltk_data] Downloading package averaged_perceptron_tagger to\n",
            "[nltk_data]     /root/nltk_data...\n",
            "[nltk_data]   Unzipping taggers/averaged_perceptron_tagger.zip.\n"
          ]
        }
      ],
      "source": [
        "#!pip install torch torchvision torchaudio\n",
        "!pip install locationtagger\n",
        "!pip install spacy\n",
        "!python -m spacy download en_core_web_sm\n",
        "!pip install lxml[html_clean]\n",
        "import nltk\n",
        "import spacy\n",
        "# essential entity models downloads\n",
        "nltk.downloader.download('maxent_ne_chunker')\n",
        "nltk.downloader.download('words')\n",
        "nltk.downloader.download('treebank')\n",
        "nltk.downloader.download('maxent_treebank_pos_tagger')\n",
        "nltk.downloader.download('punkt')\n",
        "nltk.download('averaged_perceptron_tagger')\n",
        "import locationtagger"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "MDz7hV9YptgQ",
        "outputId": "cfc5dba8-df0f-48e6-88ae-821d2e98548e"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "[nltk_data] Downloading collection 'all'\n",
            "[nltk_data]    | \n",
            "[nltk_data]    | Downloading package abc to /root/nltk_data...\n",
            "[nltk_data]    |   Package abc is already up-to-date!\n",
            "[nltk_data]    | Downloading package alpino to /root/nltk_data...\n",
            "[nltk_data]    |   Package alpino is already up-to-date!\n",
            "[nltk_data]    | Downloading package averaged_perceptron_tagger to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package averaged_perceptron_tagger is already up-\n",
            "[nltk_data]    |       to-date!\n",
            "[nltk_data]    | Downloading package averaged_perceptron_tagger_eng to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package averaged_perceptron_tagger_eng is already\n",
            "[nltk_data]    |       up-to-date!\n",
            "[nltk_data]    | Downloading package averaged_perceptron_tagger_ru to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package averaged_perceptron_tagger_ru is already\n",
            "[nltk_data]    |       up-to-date!\n",
            "[nltk_data]    | Downloading package averaged_perceptron_tagger_rus to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package averaged_perceptron_tagger_rus is already\n",
            "[nltk_data]    |       up-to-date!\n",
            "[nltk_data]    | Downloading package basque_grammars to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package basque_grammars is already up-to-date!\n",
            "[nltk_data]    | Downloading package bcp47 to /root/nltk_data...\n",
            "[nltk_data]    |   Package bcp47 is already up-to-date!\n",
            "[nltk_data]    | Downloading package biocreative_ppi to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package biocreative_ppi is already up-to-date!\n",
            "[nltk_data]    | Downloading package bllip_wsj_no_aux to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package bllip_wsj_no_aux is already up-to-date!\n",
            "[nltk_data]    | Downloading package book_grammars to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package book_grammars is already up-to-date!\n",
            "[nltk_data]    | Downloading package brown to /root/nltk_data...\n",
            "[nltk_data]    |   Package brown is already up-to-date!\n",
            "[nltk_data]    | Downloading package brown_tei to /root/nltk_data...\n",
            "[nltk_data]    |   Package brown_tei is already up-to-date!\n",
            "[nltk_data]    | Downloading package cess_cat to /root/nltk_data...\n",
            "[nltk_data]    |   Package cess_cat is already up-to-date!\n",
            "[nltk_data]    | Downloading package cess_esp to /root/nltk_data...\n",
            "[nltk_data]    |   Package cess_esp is already up-to-date!\n",
            "[nltk_data]    | Downloading package chat80 to /root/nltk_data...\n",
            "[nltk_data]    |   Package chat80 is already up-to-date!\n",
            "[nltk_data]    | Downloading package city_database to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package city_database is already up-to-date!\n",
            "[nltk_data]    | Downloading package cmudict to /root/nltk_data...\n",
            "[nltk_data]    |   Package cmudict is already up-to-date!\n",
            "[nltk_data]    | Downloading package comparative_sentences to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package comparative_sentences is already up-to-\n",
            "[nltk_data]    |       date!\n",
            "[nltk_data]    | Downloading package comtrans to /root/nltk_data...\n",
            "[nltk_data]    |   Package comtrans is already up-to-date!\n",
            "[nltk_data]    | Downloading package conll2000 to /root/nltk_data...\n",
            "[nltk_data]    |   Package conll2000 is already up-to-date!\n",
            "[nltk_data]    | Downloading package conll2002 to /root/nltk_data...\n",
            "[nltk_data]    |   Package conll2002 is already up-to-date!\n",
            "[nltk_data]    | Downloading package conll2007 to /root/nltk_data...\n",
            "[nltk_data]    |   Package conll2007 is already up-to-date!\n",
            "[nltk_data]    | Downloading package crubadan to /root/nltk_data...\n",
            "[nltk_data]    |   Package crubadan is already up-to-date!\n",
            "[nltk_data]    | Downloading package dependency_treebank to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package dependency_treebank is already up-to-date!\n",
            "[nltk_data]    | Downloading package dolch to /root/nltk_data...\n",
            "[nltk_data]    |   Package dolch is already up-to-date!\n",
            "[nltk_data]    | Downloading package europarl_raw to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package europarl_raw is already up-to-date!\n",
            "[nltk_data]    | Downloading package extended_omw to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package extended_omw is already up-to-date!\n",
            "[nltk_data]    | Downloading package floresta to /root/nltk_data...\n",
            "[nltk_data]    |   Package floresta is already up-to-date!\n",
            "[nltk_data]    | Downloading package framenet_v15 to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package framenet_v15 is already up-to-date!\n",
            "[nltk_data]    | Downloading package framenet_v17 to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package framenet_v17 is already up-to-date!\n",
            "[nltk_data]    | Downloading package gazetteers to /root/nltk_data...\n",
            "[nltk_data]    |   Package gazetteers is already up-to-date!\n",
            "[nltk_data]    | Downloading package genesis to /root/nltk_data...\n",
            "[nltk_data]    |   Package genesis is already up-to-date!\n",
            "[nltk_data]    | Downloading package gutenberg to /root/nltk_data...\n",
            "[nltk_data]    |   Package gutenberg is already up-to-date!\n",
            "[nltk_data]    | Downloading package ieer to /root/nltk_data...\n",
            "[nltk_data]    |   Package ieer is already up-to-date!\n",
            "[nltk_data]    | Downloading package inaugural to /root/nltk_data...\n",
            "[nltk_data]    |   Package inaugural is already up-to-date!\n",
            "[nltk_data]    | Downloading package indian to /root/nltk_data...\n",
            "[nltk_data]    |   Package indian is already up-to-date!\n",
            "[nltk_data]    | Downloading package jeita to /root/nltk_data...\n",
            "[nltk_data]    |   Package jeita is already up-to-date!\n",
            "[nltk_data]    | Downloading package kimmo to /root/nltk_data...\n",
            "[nltk_data]    |   Package kimmo is already up-to-date!\n",
            "[nltk_data]    | Downloading package knbc to /root/nltk_data...\n",
            "[nltk_data]    |   Package knbc is already up-to-date!\n",
            "[nltk_data]    | Downloading package large_grammars to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package large_grammars is already up-to-date!\n",
            "[nltk_data]    | Downloading package lin_thesaurus to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package lin_thesaurus is already up-to-date!\n",
            "[nltk_data]    | Downloading package mac_morpho to /root/nltk_data...\n",
            "[nltk_data]    |   Package mac_morpho is already up-to-date!\n",
            "[nltk_data]    | Downloading package machado to /root/nltk_data...\n",
            "[nltk_data]    |   Package machado is already up-to-date!\n",
            "[nltk_data]    | Downloading package masc_tagged to /root/nltk_data...\n",
            "[nltk_data]    |   Package masc_tagged is already up-to-date!\n",
            "[nltk_data]    | Downloading package maxent_ne_chunker to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package maxent_ne_chunker is already up-to-date!\n",
            "[nltk_data]    | Downloading package maxent_ne_chunker_tab to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package maxent_ne_chunker_tab is already up-to-\n",
            "[nltk_data]    |       date!\n",
            "[nltk_data]    | Downloading package maxent_treebank_pos_tagger to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package maxent_treebank_pos_tagger is already up-\n",
            "[nltk_data]    |       to-date!\n",
            "[nltk_data]    | Downloading package maxent_treebank_pos_tagger_tab to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package maxent_treebank_pos_tagger_tab is already\n",
            "[nltk_data]    |       up-to-date!\n",
            "[nltk_data]    | Downloading package moses_sample to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package moses_sample is already up-to-date!\n",
            "[nltk_data]    | Downloading package movie_reviews to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package movie_reviews is already up-to-date!\n",
            "[nltk_data]    | Downloading package mte_teip5 to /root/nltk_data...\n",
            "[nltk_data]    |   Package mte_teip5 is already up-to-date!\n",
            "[nltk_data]    | Downloading package mwa_ppdb to /root/nltk_data...\n",
            "[nltk_data]    |   Package mwa_ppdb is already up-to-date!\n",
            "[nltk_data]    | Downloading package names to /root/nltk_data...\n",
            "[nltk_data]    |   Package names is already up-to-date!\n",
            "[nltk_data]    | Downloading package nombank.1.0 to /root/nltk_data...\n",
            "[nltk_data]    |   Package nombank.1.0 is already up-to-date!\n",
            "[nltk_data]    | Downloading package nonbreaking_prefixes to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package nonbreaking_prefixes is already up-to-date!\n",
            "[nltk_data]    | Downloading package nps_chat to /root/nltk_data...\n",
            "[nltk_data]    |   Package nps_chat is already up-to-date!\n",
            "[nltk_data]    | Downloading package omw to /root/nltk_data...\n",
            "[nltk_data]    |   Package omw is already up-to-date!\n",
            "[nltk_data]    | Downloading package omw-1.4 to /root/nltk_data...\n",
            "[nltk_data]    |   Package omw-1.4 is already up-to-date!\n",
            "[nltk_data]    | Downloading package opinion_lexicon to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package opinion_lexicon is already up-to-date!\n",
            "[nltk_data]    | Downloading package panlex_swadesh to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package panlex_swadesh is already up-to-date!\n",
            "[nltk_data]    | Downloading package paradigms to /root/nltk_data...\n",
            "[nltk_data]    |   Package paradigms is already up-to-date!\n",
            "[nltk_data]    | Downloading package pe08 to /root/nltk_data...\n",
            "[nltk_data]    |   Package pe08 is already up-to-date!\n",
            "[nltk_data]    | Downloading package perluniprops to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package perluniprops is already up-to-date!\n",
            "[nltk_data]    | Downloading package pil to /root/nltk_data...\n",
            "[nltk_data]    |   Package pil is already up-to-date!\n",
            "[nltk_data]    | Downloading package pl196x to /root/nltk_data...\n",
            "[nltk_data]    |   Package pl196x is already up-to-date!\n",
            "[nltk_data]    | Downloading package porter_test to /root/nltk_data...\n",
            "[nltk_data]    |   Package porter_test is already up-to-date!\n",
            "[nltk_data]    | Downloading package ppattach to /root/nltk_data...\n",
            "[nltk_data]    |   Package ppattach is already up-to-date!\n",
            "[nltk_data]    | Downloading package problem_reports to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package problem_reports is already up-to-date!\n",
            "[nltk_data]    | Downloading package product_reviews_1 to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package product_reviews_1 is already up-to-date!\n",
            "[nltk_data]    | Downloading package product_reviews_2 to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package product_reviews_2 is already up-to-date!\n",
            "[nltk_data]    | Downloading package propbank to /root/nltk_data...\n",
            "[nltk_data]    |   Package propbank is already up-to-date!\n",
            "[nltk_data]    | Downloading package pros_cons to /root/nltk_data...\n",
            "[nltk_data]    |   Package pros_cons is already up-to-date!\n",
            "[nltk_data]    | Downloading package ptb to /root/nltk_data...\n",
            "[nltk_data]    |   Package ptb is already up-to-date!\n",
            "[nltk_data]    | Downloading package punkt to /root/nltk_data...\n",
            "[nltk_data]    |   Package punkt is already up-to-date!\n",
            "[nltk_data]    | Downloading package punkt_tab to /root/nltk_data...\n",
            "[nltk_data]    |   Package punkt_tab is already up-to-date!\n",
            "[nltk_data]    | Downloading package qc to /root/nltk_data...\n",
            "[nltk_data]    |   Package qc is already up-to-date!\n",
            "[nltk_data]    | Downloading package reuters to /root/nltk_data...\n",
            "[nltk_data]    |   Package reuters is already up-to-date!\n",
            "[nltk_data]    | Downloading package rslp to /root/nltk_data...\n",
            "[nltk_data]    |   Package rslp is already up-to-date!\n",
            "[nltk_data]    | Downloading package rte to /root/nltk_data...\n",
            "[nltk_data]    |   Package rte is already up-to-date!\n",
            "[nltk_data]    | Downloading package sample_grammars to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package sample_grammars is already up-to-date!\n",
            "[nltk_data]    | Downloading package semcor to /root/nltk_data...\n",
            "[nltk_data]    |   Package semcor is already up-to-date!\n",
            "[nltk_data]    | Downloading package senseval to /root/nltk_data...\n",
            "[nltk_data]    |   Package senseval is already up-to-date!\n",
            "[nltk_data]    | Downloading package sentence_polarity to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package sentence_polarity is already up-to-date!\n",
            "[nltk_data]    | Downloading package sentiwordnet to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package sentiwordnet is already up-to-date!\n",
            "[nltk_data]    | Downloading package shakespeare to /root/nltk_data...\n",
            "[nltk_data]    |   Package shakespeare is already up-to-date!\n",
            "[nltk_data]    | Downloading package sinica_treebank to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package sinica_treebank is already up-to-date!\n",
            "[nltk_data]    | Downloading package smultron to /root/nltk_data...\n",
            "[nltk_data]    |   Package smultron is already up-to-date!\n",
            "[nltk_data]    | Downloading package snowball_data to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package snowball_data is already up-to-date!\n",
            "[nltk_data]    | Downloading package spanish_grammars to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package spanish_grammars is already up-to-date!\n",
            "[nltk_data]    | Downloading package state_union to /root/nltk_data...\n",
            "[nltk_data]    |   Package state_union is already up-to-date!\n",
            "[nltk_data]    | Downloading package stopwords to /root/nltk_data...\n",
            "[nltk_data]    |   Package stopwords is already up-to-date!\n",
            "[nltk_data]    | Downloading package subjectivity to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package subjectivity is already up-to-date!\n",
            "[nltk_data]    | Downloading package swadesh to /root/nltk_data...\n",
            "[nltk_data]    |   Package swadesh is already up-to-date!\n",
            "[nltk_data]    | Downloading package switchboard to /root/nltk_data...\n",
            "[nltk_data]    |   Package switchboard is already up-to-date!\n",
            "[nltk_data]    | Downloading package tagsets to /root/nltk_data...\n",
            "[nltk_data]    |   Package tagsets is already up-to-date!\n",
            "[nltk_data]    | Downloading package tagsets_json to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package tagsets_json is already up-to-date!\n",
            "[nltk_data]    | Downloading package timit to /root/nltk_data...\n",
            "[nltk_data]    |   Package timit is already up-to-date!\n",
            "[nltk_data]    | Downloading package toolbox to /root/nltk_data...\n",
            "[nltk_data]    |   Package toolbox is already up-to-date!\n",
            "[nltk_data]    | Downloading package treebank to /root/nltk_data...\n",
            "[nltk_data]    |   Package treebank is already up-to-date!\n",
            "[nltk_data]    | Downloading package twitter_samples to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package twitter_samples is already up-to-date!\n",
            "[nltk_data]    | Downloading package udhr to /root/nltk_data...\n",
            "[nltk_data]    |   Package udhr is already up-to-date!\n",
            "[nltk_data]    | Downloading package udhr2 to /root/nltk_data...\n",
            "[nltk_data]    |   Package udhr2 is already up-to-date!\n",
            "[nltk_data]    | Downloading package unicode_samples to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package unicode_samples is already up-to-date!\n",
            "[nltk_data]    | Downloading package universal_tagset to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package universal_tagset is already up-to-date!\n",
            "[nltk_data]    | Downloading package universal_treebanks_v20 to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package universal_treebanks_v20 is already up-to-\n",
            "[nltk_data]    |       date!\n",
            "[nltk_data]    | Downloading package vader_lexicon to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package vader_lexicon is already up-to-date!\n",
            "[nltk_data]    | Downloading package verbnet to /root/nltk_data...\n",
            "[nltk_data]    |   Package verbnet is already up-to-date!\n",
            "[nltk_data]    | Downloading package verbnet3 to /root/nltk_data...\n",
            "[nltk_data]    |   Package verbnet3 is already up-to-date!\n",
            "[nltk_data]    | Downloading package webtext to /root/nltk_data...\n",
            "[nltk_data]    |   Package webtext is already up-to-date!\n",
            "[nltk_data]    | Downloading package wmt15_eval to /root/nltk_data...\n",
            "[nltk_data]    |   Package wmt15_eval is already up-to-date!\n",
            "[nltk_data]    | Downloading package word2vec_sample to\n",
            "[nltk_data]    |     /root/nltk_data...\n",
            "[nltk_data]    |   Package word2vec_sample is already up-to-date!\n",
            "[nltk_data]    | Downloading package wordnet to /root/nltk_data...\n",
            "[nltk_data]    |   Package wordnet is already up-to-date!\n",
            "[nltk_data]    | Downloading package wordnet2021 to /root/nltk_data...\n",
            "[nltk_data]    |   Package wordnet2021 is already up-to-date!\n",
            "[nltk_data]    | Downloading package wordnet2022 to /root/nltk_data...\n",
            "[nltk_data]    |   Package wordnet2022 is already up-to-date!\n",
            "[nltk_data]    | Downloading package wordnet31 to /root/nltk_data...\n",
            "[nltk_data]    |   Package wordnet31 is already up-to-date!\n",
            "[nltk_data]    | Downloading package wordnet_ic to /root/nltk_data...\n",
            "[nltk_data]    |   Package wordnet_ic is already up-to-date!\n",
            "[nltk_data]    | Downloading package words to /root/nltk_data...\n",
            "[nltk_data]    |   Package words is already up-to-date!\n",
            "[nltk_data]    | Downloading package ycoe to /root/nltk_data...\n",
            "[nltk_data]    |   Package ycoe is already up-to-date!\n",
            "[nltk_data]    | \n",
            "[nltk_data]  Done downloading collection all\n"
          ]
        }
      ],
      "source": [
        "import nltk\n",
        "nltk.download('all')\n",
        "\n",
        "states = [\n",
        "    \"Alabama\", \"Alaska\", \"Arizona\", \"Arkansas\", \"California\", \"Colorado\", \"Connecticut\", \"Delaware\", \"Florida\",\n",
        "    \"Georgia\", \"Hawaii\", \"Idaho\", \"Illinois\", \"Indiana\", \"Iowa\", \"Kansas\", \"Kentucky\", \"Louisiana\", \"Maine\",\n",
        "    \"Maryland\", \"Massachusetts\", \"Michigan\", \"Minnesota\", \"Mississippi\", \"Missouri\", \"Montana\", \"Nebraska\",\n",
        "    \"Nevada\", \"New Hampshire\", \"New Jersey\", \"New Mexico\", \"New York\", \"North Carolina\", \"North Dakota\", \"Ohio\",\n",
        "    \"Oklahoma\", \"Oregon\", \"Pennsylvania\", \"Rhode Island\", \"South Carolina\", \"South Dakota\", \"Tennessee\", \"Texas\",\n",
        "    \"Utah\", \"Vermont\", \"Virginia\", \"Washington\", \"West Virginia\", \"Wisconsin\", \"Wyoming\"\n",
        "]\n",
        "states_lower = [state.lower() for state in states]\n",
        "states_lower_set = set(state.lower() for state in states)\n",
        "\n",
        "def location_information(j):\n",
        " if j:\n",
        "    place_entity = locationtagger.find_locations(text=j)\n",
        "    if place_entity.countries and place_entity.countries[0] != 'United States':\n",
        "       if place_entity.countries:country = place_entity.countries[0]\n",
        "       else:country = None  # or some default value\n",
        "       if place_entity.regions:region = place_entity.regions[0]\n",
        "       else: region = None  # or some default value\n",
        "       if place_entity.cities: city = place_entity.cities[0]\n",
        "       else:city = None  # or some default value\n",
        "       return country, region, city\n",
        "    else:\n",
        "     if place_entity.countries or (place_entity.regions and place_entity.regions[0].lower() in states_lower_set):\n",
        "        # If country is specified as US or region matches a state, proceed\n",
        "        city_lower=None\n",
        "        for i in reversed(place_entity.cities):\n",
        "            city_lower = i.lower()\n",
        "            if city_lower in fips_finding_dict and city_lower not in ['hospital', 'university']:\n",
        "                   break\n",
        "        if place_entity.countries:country = place_entity.countries[0]\n",
        "        else:country = None  # or some default value\n",
        "        if place_entity.regions:region = place_entity.regions[0]\n",
        "        else: region = None  # or some default value\n",
        "        if city_lower: city = city_lower\n",
        "        else:city = None  # or some default value\n",
        "        return country, region, city\n",
        "    return None, None, None\n",
        " return None, None, None\n",
        "\n",
        "def extract_and_create_researcher_location_nodes_PubMed():\n",
        " with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "\n",
        "  with driver.session() as session:\n",
        "   query = \"MATCH (i:Pubmed)  where i.GARDname= $disease RETURN i.fullName AS fullName, i.ar_affiliation AS affiliation\"\n",
        "   results = session.run(query, disease=disease)\n",
        "   for Pubmed in results:\n",
        "    A,B=Pubmed['fullName'], str(Pubmed['affiliation'])\n",
        "    if  (A, B) not in current_names:\n",
        "     if B in pubmed_institution:\n",
        "        place_entity=pubmed_institution[B]\n",
        "     else:\n",
        "       place_entity =location_information(B)\n",
        "       pubmed_institution[B]= place_entity\n",
        "\n",
        "     event_properties = {\n",
        "        'Name': str(A),\n",
        "        'Contact_info': '',#str(Pubmed['i.OfficialAffiliation'][i]),\n",
        "        'Aff_name': B,\n",
        "        'Aff_Zip': ''  }\n",
        "     create_Researcher_node(event_properties)\n",
        "     current_names[(A, B)] =1\n",
        "     if place_entity[0] != None and place_entity[1] !=  None and place_entity[2] !=  None:\n",
        "      event_properties = {\n",
        "         'Aff_country': place_entity[0],\n",
        "        'Aff_state':   place_entity[1],\n",
        "        'Aff_county': find_fip(place_entity[2], place_entity[1] )[1],\n",
        "        'Aff_city': place_entity[2],\n",
        "        'Aff_FIPS': find_fip(place_entity[2], place_entity[1] )[0]  }\n",
        "      create_Location_node(event_properties, A, B)\n",
        "\n",
        "pubmed_institution={}\n",
        "current_names={}\n",
        "extract_and_create_researcher_location_nodes_PubMed()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "lWb6uDG5pu1l"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "organ_address=pd.read_csv('/content/Grant_org1.csv')\n",
        "organ_address['n.org_name']=organ_address.apply(lambda x: x['n.org_name'].replace('\"','').lower().strip(),axis=1)\n",
        "\n",
        "def extract_and_create_researcher_location_nodes_Grant():\n",
        " with driver.session() as session:\n",
        "  query = \"MATCH (i:Grant)  where i.GARDname= $disease RETURN i.org_name AS org_name, i.pi_name AS pi_name\"\n",
        "  results = session.run(query, disease=disease)\n",
        "  for Grant in results:\n",
        "   Name= Grant['pi_name']\n",
        "   Aff_name= str(Grant['org_name'])\n",
        "   if (Name, Aff_name) not in current_names:\n",
        "     data=organ_address[organ_address['n.org_name'] == Grant['org_name'].lower().strip()]\n",
        "     '''\n",
        "      or\n",
        "      from geopy.geocoders import Nominatim\n",
        "      geolocator = Nominatim(user_agent=\"GetLoc\", timeout=30)  # You can adjust the timeout value as needed\n",
        "      location = geolocator.geocode('NIH')\n",
        "      if location:\n",
        "              address = location.address.split(\", \")\n",
        "              data={}\n",
        "              data['Country'] = address[-1]\n",
        "              data['zip_code'] = address[-2]\n",
        "              data['state']  = address[-3]  # Massachusetts (state)\n",
        "              data['County'] = address[-4]  # Massachusetts (state)\n",
        "              data['city'] = address[-5]  # Boston (city)\n",
        "     '''\n",
        "     if len(data) >0 :\n",
        "       event_properties = {\n",
        "        'Name': Name,\n",
        "        'Contact_info': '',\n",
        "        'Aff_name': Aff_name,\n",
        "        'Aff_Zip':  data.iloc[0]['zip_code']\n",
        "       }\n",
        "       create_Researcher_node(event_properties)\n",
        "       A,B,C=data.iloc[0]['Country'], data.iloc[0]['state'], data.iloc[0]['County']\n",
        "       if  type(A)==str and type(B)==str and type(C) == str:\n",
        "        event_properties = {\n",
        "        'Aff_country': A ,\n",
        "        'Aff_state': B,\n",
        "        'Aff_county': C,\n",
        "        'Aff_city': data.iloc[0]['city'],\n",
        "        'Aff_FIPS': find_fip(data.iloc[0]['city'], data.iloc[0]['state'] )[0]\n",
        "        }\n",
        "        create_Location_node(event_properties, Name, Aff_name)\n",
        "     else:\n",
        "         event_properties = {'Name': Name,'Contact_info': '', 'Aff_name': Aff_name, 'Aff_Zip': ''    }\n",
        "         create_Researcher_node(event_properties)\n",
        "     current_names[(Name, Aff_name)] =1\n",
        "\n",
        "current_names={}\n",
        "extract_and_create_researcher_location_nodes_Grant()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "HsMIka1_N2rK"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "MdzHYt00p0j7"
      },
      "outputs": [],
      "source": [
        "def create_relationship_between_nodes_1(node1_label, node2_label, relationship_type):\n",
        "    with driver.session() as session:\n",
        "        query = (\n",
        "            f\"MATCH (n1:{node1_label}), (n2:{node2_label}) \"\n",
        "            f\"WHERE n1.Name = n2.OfficialName AND n1.Aff_name = n2.OfficialAffiliation \"\n",
        "            f\"CREATE (n1)-[:{relationship_type}]->(n2)\"\n",
        "        )\n",
        "        session.run(query)\n",
        "def create_relationship_between_nodes_2(node1_label, node2_label, relationship_type):\n",
        "    with driver.session() as session:\n",
        "        query = (\n",
        "        f\"MATCH (n1:{node1_label}), (n2:{node2_label}) \"\n",
        "        f\"WHERE n1.Name = n2.pi_name and  n1.Aff_name= n2.org_name \"\n",
        "       f\"CREATE (n1)-[:{relationship_type}]->(n2)\"\n",
        "        )\n",
        "        session.run(query)\n",
        "def create_relationship_between_nodes_3(node1_label, node2_label, relationship_type):\n",
        "  with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "    with driver.session() as session:\n",
        "        query = (\n",
        "        f\"MATCH (n1:{node1_label}), (n2:{node2_label}) \"\n",
        "        f\"WHERE n1.Name = n2.fullName and  n1.Aff_name= n2.ar_affiliation \"\n",
        "       f\"CREATE (n1)-[:{relationship_type}]->(n2)\"\n",
        "        )\n",
        "        session.run(query)\n",
        "\n",
        "create_relationship_between_nodes_1('Researcher','ClinicalTrial',  \"Involves_Researcher_ct\")\n",
        "\n",
        "create_relationship_between_nodes_2('Researcher','Grant',  \"Involves_Researcher_g\")\n",
        "create_relationship_between_nodes_3('Researcher','Pubmed',  \"Involves_Researcher_p\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "dh4RGbGfNp2y"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "4VvnB2Zyp52_",
        "outputId": "5d839456-091a-409e-9b34-53a76c135f76"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "--- start ---\n",
            "--- 0.014131784439086914 seconds ---\n",
            "--- 0.005818605422973633 seconds ---\n",
            "--- 0.5867185592651367 seconds ---\n"
          ]
        }
      ],
      "source": [
        "#faster way\n",
        "def find_coauthors(df, name, affiliation, title):\n",
        "    coauthors_dict = {}\n",
        "    connection = {}\n",
        "    # Group rows by title\n",
        "    grouped = df.groupby(title)\n",
        "    for title_value, group in grouped:\n",
        "        author_affiliation_set = set()\n",
        "\n",
        "        for _, row in group.iterrows():\n",
        "            author = (row[name], row[affiliation])\n",
        "\n",
        "            # Skip if author name or affiliation is empty\n",
        "            if not all(author):\n",
        "                continue\n",
        "\n",
        "            # If the author is not already seen for this title\n",
        "            if author not in author_affiliation_set:\n",
        "                author_affiliation_set.add(author)\n",
        "            else:\n",
        "                # This author has already been considered for this title\n",
        "                continue\n",
        "\n",
        "            # Add author to coauthors_dict if not already present\n",
        "            if author not in coauthors_dict:\n",
        "                coauthors_dict[author] = []\n",
        "\n",
        "            # Find co-authors within the same title group\n",
        "            coauthors = group[(group[name] != row[name]) | (group[affiliation] != row[affiliation])]\n",
        "            for _, coauthor_row in coauthors.iterrows():\n",
        "                coauthor = (coauthor_row[name], coauthor_row[affiliation])\n",
        "\n",
        "                # Skip if coauthor name or affiliation is empty\n",
        "                if not all(coauthor):\n",
        "                    continue\n",
        "\n",
        "                # Avoid duplicates\n",
        "                if coauthor not in coauthors_dict[author]:\n",
        "                    coauthors_dict[author].append(coauthor)\n",
        "\n",
        "                # Update connection count\n",
        "                connection[(author, coauthor)] = connection.get((author, coauthor), 0) + 1\n",
        "\n",
        "    return coauthors_dict, connection\n",
        "import time\n",
        "from collections import defaultdict\n",
        "\n",
        "def merge_dicts(d1, d2):\n",
        "    combined_dict = defaultdict(set)\n",
        "    for key, values in d1.items():\n",
        "        combined_dict[key].update(values)\n",
        "    for key, values in d2.items():\n",
        "        combined_dict[key].update(values)\n",
        "    return combined_dict\n",
        "\n",
        "\n",
        "\n",
        "def sum_dicts(dict1, dict2):\n",
        "    result_dict = {}\n",
        "    all_keys = set(dict1.keys()) | set(dict2.keys())\n",
        "    for key in all_keys:\n",
        "        value1 = dict1.get(key, 0)\n",
        "        value2 = dict2.get(key, 0)\n",
        "        result_dict[key] = value1 + value2\n",
        "    return result_dict\n",
        "def extract_and_create_researcher_connection(disease):\n",
        " with driver.session() as session:\n",
        "  query = \"MATCH (i:ClinicalTrial)--(g:Gard) where g.GARDname= $disease  RETURN i.OfficialName AS OfficialName, i.OfficialAffiliation AS OfficialAffiliation, i.NCTId as NCTId \"\n",
        "  results = session.run(query, disease=disease)\n",
        "  data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "  ClinicalTrial = pd.DataFrame(data)\n",
        "  print(\"--- start ---\")\n",
        "  start_time = time.time()\n",
        "  a,a1=find_coauthors(ClinicalTrial,'OfficialName','OfficialAffiliation','NCTId')\n",
        "  print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "  ######   Grant\n",
        "  query = \"MATCH (i:Grant)--(g:Gard) where g.GARDname= $disease  RETURN i.pi_name AS pi_name, i.org_name AS org_name, i.application_id as application_id \"\n",
        "  results = session.run(query, disease=disease)\n",
        "  data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "  Grant = pd.DataFrame(data)\n",
        "  start_time = time.time()\n",
        "  b,b1=find_coauthors(Grant,'pi_name','org_name','application_id')\n",
        "  print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "  ##################### pubmed\n",
        "  query = \"MATCH (i:Pubmed)--(g:Gard) where g.GARDname= $disease  RETURN i.fullName AS fullName, i.ar_affiliation AS affiliation, i.pubmed_id as pubmed_id \"\n",
        "  results = session.run(query, disease=disease)\n",
        "  data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "  Pubmed = pd.DataFrame(data)\n",
        "  start_time = time.time()\n",
        "  c,c1=find_coauthors(Pubmed,'fullName','affiliation','pubmed_id')\n",
        "  print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "  ###################\n",
        "  combined_dict = merge_dicts(a, b)\n",
        "  combined_dict = merge_dicts(combined_dict, c)\n",
        "  ###########\n",
        "  combined_dict1 = sum_dicts(a1, b1)\n",
        "  result_dict1 = sum_dicts(combined_dict1, c1)\n",
        "  for key in result_dict1:\n",
        "    result_dict1[key] = result_dict1[key] %1000\n",
        "  ###########\n",
        "  result_dict = {key: list(values) for key, values in combined_dict.items()}\n",
        "  return combined_dict, result_dict1, a,a1,b,b1,c,c1\n",
        "result_dict, result_dict1, a,a1,b,b1,c,c1=extract_and_create_researcher_connection(disease)\n"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Figures"
      ],
      "metadata": {
        "id": "6Z8JNdZGe_Jw"
      }
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 500
        },
        "id": "OZPqyinm82PU",
        "outputId": "dfc6c87c-286e-4bae-87af-5ed3d2c7abbf"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "--- start ---\n",
            "--- 0.0035042762756347656 seconds ---\n",
            "--- 0.0071222782135009766 seconds ---\n",
            "--- 0.5973477363586426 seconds ---\n"
          ]
        },
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import pandas as pd\n",
        "import matplotlib.pyplot as plt\n",
        "A=['PGM1-CDG','Cerebral cavernous malformations 3',\"CLOVES syndrome\",\"STT3B-CDG\",\"Thoracolaryngopelvic dysplasia\",\"Actinic prurigo\",\"Non-syndromic polydactyly\",\"Genitopatellar syndrome\",\"Diaphanospondylodysostosis\"]\n",
        "B=['GARD0004329','GARD0018314',\"GARD0010939\",\"GARD0017603\",\"GARD0005184\", \"GARD0017510\",\"GARD0004410\",\"GARD0010994\",\"GARD0016674\"]\n",
        "#for n in range(len(A)):\n",
        "n=0\n",
        "disease= A[n]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid=B[n] #'GARD0017510'\n",
        "result_dict, result_dict1, a,a1,b,b1,c,c1=extract_and_create_researcher_connection(disease)\n",
        "import networkx as nx\n",
        "layout_algorithms = [\n",
        "    nx.circular_layout,\n",
        "    nx.random_layout,\n",
        "    nx.spring_layout,\n",
        "    nx.spectral_layout,\n",
        "    nx.shell_layout,\n",
        "    nx.bipartite_layout,\n",
        "    nx.planar_layout,\n",
        "    nx.fruchterman_reingold_layout,\n",
        "    nx.kamada_kawai_layout\n",
        "]\n",
        "data= dict(list(result_dict.items()))\n",
        "G = nx.DiGraph()\n",
        "\n",
        "# Add nodes and edges from the dictionary\n",
        "for nodes, edges in data.items():\n",
        "    G.add_node(nodes[0], institution=nodes[1])\n",
        "    for edge in edges:\n",
        "        G.add_node(edge[0], institution=edge[1])\n",
        "        G.add_edge(nodes[0], edge[0])\n",
        "\n",
        "# Determine connected components\n",
        "components = list(nx.strongly_connected_components(G))\n",
        "# Assign colors to nodes based on connected components\n",
        "color_map = {}\n",
        "for i, component in enumerate(components):\n",
        "    for node in component:\n",
        "        color_map[node] = plt.cm.Set1(i / len(components))  # Set1 colormap for variety\n",
        "\n",
        "# Draw the graph with enhanced styling\n",
        "#fig, ax = plt.subplots(figsize=(10, 6))  # Adjust the figure size\n",
        "\n",
        "#pos = nx.spring_layout(G, seed=42, k=1, iterations=1)\n",
        "pos = nx.kamada_kawai_layout(G)\n",
        "\n",
        "# Node styling with specified colors\n",
        "node_colors = [color_map[node] for node in G.nodes]\n",
        "nx.draw_networkx_nodes(G, pos, node_size=100, node_color=node_colors, alpha=0.8)\n",
        "# Edge styling\n",
        "nx.draw_networkx_edges(G, pos, edge_color='gray', width=0.5, alpha=0.5, arrowsize=1)\n",
        "# Label styling\n",
        "#labels = {node: f\"{node[:10]}\\n{G.nodes[node]['institution'][-25:]}\" for node in G.nodes}\n",
        "#nx.draw_networkx_labels(G, pos,  font_size=6, font_color='black')\n",
        "# Add a title\n",
        "plt.title(\"Social Network for Rare Disease-Based Research Collaboration Recommendation\")\n",
        "# Show the plot\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 717
        },
        "id": "6tbJqy809hUv",
        "outputId": "29534546-a2e5-4739-c24b-7342bd6c061a"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: python-louvain in /usr/local/lib/python3.10/dist-packages (0.16)\n",
            "Requirement already satisfied: networkx in /usr/local/lib/python3.10/dist-packages (from python-louvain) (3.4.2)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.10/dist-packages (from python-louvain) (1.26.4)\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "<ipython-input-16-93c7e8736fc9>:24: MatplotlibDeprecationWarning: The get_cmap function was deprecated in Matplotlib 3.7 and will be removed in 3.11. Use ``matplotlib.colormaps[name]`` or ``matplotlib.colormaps.get_cmap()`` or ``pyplot.get_cmap()`` instead.\n",
            "  cmap = plt.cm.get_cmap('viridis', max(partition.values()) + 1)  # Set color map\n",
            "<ipython-input-16-93c7e8736fc9>:27: UserWarning: \n",
            "\n",
            "The arrowsize keyword argument is not applicable when drawing edges\n",
            "with LineCollection.\n",
            "\n",
            "To make this warning go away, either specify `arrows=True` to\n",
            "force FancyArrowPatches or use the default values.\n",
            "Note that using FancyArrowPatches may be slow for large graphs.\n",
            "\n",
            "  nx.draw_networkx_edges(G, pos, edge_color='gray', width=0.5, alpha=0.5, arrowsize=0.02)\n"
          ]
        },
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "!pip install python-louvain\n",
        "import networkx as nx\n",
        "import community\n",
        "from community import community_louvain\n",
        "import matplotlib.pyplot as plt\n",
        "\n",
        "\n",
        "# Create a directed graph\n",
        "G = nx.Graph()\n",
        "\n",
        "# Add nodes and edges from the dictionary\n",
        "for nodes, edges in result_dict.items():\n",
        "    G.add_node(nodes[0], institution=nodes[1])\n",
        "    #G.add_node(nodes[0], institution=nodes[1])\n",
        "    for edge in edges:\n",
        "        G.add_node(edge[0], institution=edge[1])\n",
        "        G.add_edge(nodes[0], edge[0])\n",
        "\n",
        "# Detect communities using Louvain method\n",
        "partition = community_louvain.best_partition(G)\n",
        "\n",
        "# Draw the graph with nodes colored by their community\n",
        "pos = nx.kamada_kawai_layout(G)\n",
        "cmap = plt.cm.get_cmap('viridis', max(partition.values()) + 1)  # Set color map\n",
        "#nx.draw(G, pos, node_color=[cmap(partition[node]) for node in G.nodes()], with_labels=None)\n",
        "nx.draw_networkx_nodes(G, pos, node_size=20, node_color=[cmap(partition[node]) for node in G.nodes()], alpha=0.8)\n",
        "nx.draw_networkx_edges(G, pos, edge_color='gray', width=0.5, alpha=0.5, arrowsize=0.02)\n",
        "plt.title(\"Social Network for Rare Disease-Based Research Collaboration Recommendation\")\n",
        "\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 663
        },
        "id": "275k56CHDcYG",
        "outputId": "91984db2-ac31-486b-f4db-e969454e7b3c"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "<ipython-input-17-aa36fe27ad45>:21: MatplotlibDeprecationWarning: The get_cmap function was deprecated in Matplotlib 3.7 and will be removed in 3.11. Use ``matplotlib.colormaps[name]`` or ``matplotlib.colormaps.get_cmap()`` or ``pyplot.get_cmap()`` instead.\n",
            "  cmap = plt.cm.get_cmap('viridis', max(partition.values()) + 1)  # Set color map\n",
            "<ipython-input-17-aa36fe27ad45>:23: UserWarning: \n",
            "\n",
            "The arrowsize keyword argument is not applicable when drawing edges\n",
            "with LineCollection.\n",
            "\n",
            "To make this warning go away, either specify `arrows=True` to\n",
            "force FancyArrowPatches or use the default values.\n",
            "Note that using FancyArrowPatches may be slow for large graphs.\n",
            "\n",
            "  nx.draw_networkx_edges(G, pos, edge_color='gray', width=0.5, alpha=0.5, arrowsize=0.02)\n"
          ]
        },
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import networkx as nx\n",
        "import community\n",
        "from community import community_louvain\n",
        "import matplotlib.pyplot as plt\n",
        "\n",
        "# Create a directed graph\n",
        "G = nx.Graph()\n",
        "\n",
        "# Add nodes and edges from the dictionary\n",
        "for nodes, edges in result_dict.items():\n",
        "    G.add_node(nodes[0], institution=nodes[1])\n",
        "    for edge in edges:\n",
        "        G.add_node(edge[0], institution=edge[1])\n",
        "        G.add_edge(nodes[0], edge[0])\n",
        "\n",
        "# Detect communities using Louvain method\n",
        "partition = community_louvain.best_partition(G)\n",
        "\n",
        "# Draw the graph with nodes colored by their community\n",
        "pos = nx.kamada_kawai_layout(G)\n",
        "cmap = plt.cm.get_cmap('viridis', max(partition.values()) + 1)  # Set color map\n",
        "nx.draw_networkx_nodes(G, pos, node_size=20, node_color=[cmap(partition[node]) for node in G.nodes()], alpha=0.8)\n",
        "nx.draw_networkx_edges(G, pos, edge_color='gray', width=0.5, alpha=0.5, arrowsize=0.02)\n",
        "\n",
        "# Label one node per community with its community partition value near its community\n",
        "community_labels = {}\n",
        "for node, community_id in partition.items():\n",
        "    if community_id not in community_labels:\n",
        "        community_labels[community_id] = node\n",
        "\n",
        "for community_id, node in community_labels.items():\n",
        "    x, y = pos[node]\n",
        "    plt.text(x, y, str(community_id), fontsize=12, color='red')\n",
        "\n",
        "plt.title(\"Social Network for Rare Disease-Based Research Collaboration Recommendation\")\n",
        "plt.show()\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 302
        },
        "id": "szVEQd_QD-yg",
        "outputId": "e651371f-7589-4336-9b16-4de739efc5a4"
      },
      "outputs": [
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "import networkx as nx\n",
        "import matplotlib.pyplot as plt\n",
        "\n",
        "# Your provided dictionary\n",
        "data= dict(list(result_dict.items())[:6])\n",
        "\n",
        "# Create a directed graph\n",
        "G = nx.DiGraph()\n",
        "\n",
        "# Add nodes and edges from the dictionary\n",
        "for nodes, edges in data.items():\n",
        "    G.add_node(nodes[0], institution=nodes[1])\n",
        "    for edge in edges:\n",
        "        G.add_node(edge[0], institution=edge[1])\n",
        "        G.add_edge(nodes[0], edge[0])\n",
        "\n",
        "unique_institutions = set(nx.get_node_attributes(G, 'institution').values())\n",
        "\n",
        "# Assign colors to nodes based on institutions\n",
        "color_map = {}\n",
        "for i, institution in enumerate(unique_institutions):\n",
        "    nodes_with_institution = [node for node, data in G.nodes(data=True) if data['institution'] == institution]\n",
        "    for node in nodes_with_institution:\n",
        "        color_map[node] = plt.cm.Set1(i / len(unique_institutions))\n",
        "# Draw the graph with enhanced styling\n",
        "#fig, ax = plt.subplots(figsize=(10, 8))  # Adjust the figure size\n",
        "\n",
        "# Draw the graph with enhanced styling\n",
        "#pos = nx.spring_layout(G , seed=42, k=1, iterations=1)\n",
        "pos = layout_algorithms[0](G)\n",
        "\n",
        "# Node styling with specified colors\n",
        "node_colors = [color_map[node] for node in G.nodes]\n",
        "nodes = nx.draw_networkx_nodes(G, pos, node_size=100, node_color=node_colors, alpha=0.8)\n",
        "# Rest of the code remains the same\n",
        "nx.draw_networkx_edges(G, pos, edge_color='gray', width=0.5, alpha=0.5, arrowsize=1)\n",
        "\n",
        "# Create a legend\n",
        "legend_handles = [plt.Line2D([0], [0], marker='o', color='w', markerfacecolor=plt.cm.Set1(i / len(unique_institutions)), markersize=10, label=institution) for i, institution in enumerate(unique_institutions)]\n",
        "plt.legend(handles=legend_handles, title='Institutions', bbox_to_anchor=(1.05, 1), loc='upper left', fontsize=5)\n",
        "\n",
        "# Label styling without displaying the institution names\n",
        "#labels = {node: node for node in G.nodes}\n",
        "#nx.draw_networkx_labels(G, pos, labels=labels, font_size=5, font_color='black')\n",
        "\n",
        "# Show the plot\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 173
        },
        "id": "UEN4MoyoERHg",
        "outputId": "fdd24347-7708-42e3-b7d1-2d09a9e7da7e"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "<ipython-input-19-68fd65e7945f>:2: MatplotlibDeprecationWarning: The get_cmap function was deprecated in Matplotlib 3.7 and will be removed in 3.11. Use ``matplotlib.colormaps[name]`` or ``matplotlib.colormaps.get_cmap()`` or ``pyplot.get_cmap()`` instead.\n",
            "  cmap = plt.cm.get_cmap('tab20', len(unique_institutions))\n"
          ]
        },
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 640x480 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "\n",
        "# Define a colormap with enough distinct colors\n",
        "cmap = plt.cm.get_cmap('tab20', len(unique_institutions))\n",
        "\n",
        "# Assign colors to nodes based on institutions\n",
        "color_map = {}\n",
        "for i, institution in enumerate(unique_institutions):\n",
        "    nodes_with_institution = [node for node, data in G.nodes(data=True) if data['institution'] == institution]\n",
        "    for node in nodes_with_institution:\n",
        "        color_map[node] = cmap(i)\n",
        "\n",
        "# Draw the graph with enhanced styling\n",
        "#pos = nx.spring_layout(G, seed=42, k=1, iterations=1)\n",
        "pos=layout_algorithms[0](G)\n",
        "# Node styling with specified colors\n",
        "node_colors = [color_map[node] for node in G.nodes]\n",
        "nodes = nx.draw_networkx_nodes(G, pos, node_size=100, node_color=node_colors, alpha=0.8)\n",
        "\n",
        "# Rest of the code remains the same\n",
        "nx.draw_networkx_edges(G, pos, edge_color='gray', width=0.5, alpha=0.5, arrowsize=1)\n",
        "\n",
        "# Create a legend\n",
        "legend_handles = [plt.Line2D([0], [0], marker='o', color='w', markerfacecolor=cmap(i), markersize=10, label=institution) for i, institution in enumerate(unique_institutions)]\n",
        "plt.legend(handles=legend_handles, title='Institutions', bbox_to_anchor=(1.05, 1), loc='upper left', fontsize=5)\n",
        "\n",
        "# Show the plot\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "s7m88QS4p9Qk"
      },
      "outputs": [],
      "source": [
        "def create_relationship_between_Researchers(n1_Name, n1_Aff_name, n2_Name, n2_Aff_name, num_colab):\n",
        "    with driver.session() as session:\n",
        "        # Check if the relationship already exists in either direction\n",
        "        check_query = (\n",
        "            \"MATCH (n1:Researcher)-[r:Collaborated_With]->(n2:Researcher) \"\n",
        "            \"WHERE (n1.Name = $n1_Name AND n1.Aff_name = $n1_Aff_name AND n2.Name = $n2_Name AND n2.Aff_name = $n2_Aff_name) \"\n",
        "            \"OR (n2.Name = $n1_Name AND n2.Aff_name = $n1_Aff_name AND n1.Name = $n2_Name AND n1.Aff_name = $n2_Aff_name) \"\n",
        "            \"RETURN COUNT(r) AS relationship_count\"\n",
        "        )\n",
        "\n",
        "        result = session.run(check_query, n1_Name=n1_Name, n1_Aff_name=n1_Aff_name, n2_Name=n2_Name, n2_Aff_name=n2_Aff_name)\n",
        "        relationship_count = result.single()[\"relationship_count\"]\n",
        "\n",
        "        # If the relationship doesn't exist, create it\n",
        "        if relationship_count == 0:\n",
        "            create_query = (\n",
        "                \"MATCH (n1:Researcher), (n2:Researcher) \"\n",
        "                \"WHERE n1.Name = $n1_Name AND n1.Aff_name = $n1_Aff_name \"\n",
        "                \"AND n2.Name = $n2_Name AND n2.Aff_name = $n2_Aff_name \"\n",
        "                \"CREATE (n1)-[:Collaborated_With {num_colab: $num_colab}]->(n2)\"\n",
        "            )\n",
        "            session.run(create_query, n1_Name=n1_Name, n1_Aff_name=n1_Aff_name, n2_Name=n2_Name, n2_Aff_name=n2_Aff_name, num_colab=num_colab)\n",
        "\n",
        "\n",
        "for key in result_dict1:\n",
        "    create_relationship_between_Researchers(key[0][0], key[0][1], key[1][0], key[1][1], result_dict1[key])"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "afOyadXzFFpU"
      },
      "source": [
        "# Us map"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "mRF8437c-1of"
      },
      "outputs": [],
      "source": [
        "A=['PGM1-CDG','Cerebral cavernous malformations 3',\"CLOVES syndrome\",\"STT3B-CDG\",\"Thoracolaryngopelvic dysplasia\",\"Actinic prurigo\",\"Non-syndromic polydactyly\",\"Genitopatellar syndrome\",\"Diaphanospondylodysostosis\"]\n",
        "B=['GARD0004329','GARD0018314',\"GARD0010939\",\"GARD0017603\",\"GARD0005184\", \"GARD0017510\",\"GARD0004410\",\"GARD0010994\",\"GARD0016674\"]\n",
        "disease= A[0]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid=B[0] #'GARD0017510'"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "T1ynT3IGC75G",
        "outputId": "15a927cb-3de9-4da3-c231-a888a5276b38"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: python-louvain in /usr/local/lib/python3.10/dist-packages (0.16)\n",
            "Requirement already satisfied: networkx in /usr/local/lib/python3.10/dist-packages (from python-louvain) (3.4.2)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.10/dist-packages (from python-louvain) (1.26.4)\n"
          ]
        }
      ],
      "source": [
        "!pip install python-louvain\n",
        "import networkx as nx\n",
        "layout_algorithms = [\n",
        "    nx.circular_layout,\n",
        "    nx.random_layout,\n",
        "    nx.spring_layout,\n",
        "    nx.spectral_layout,\n",
        "    nx.shell_layout,\n",
        "    nx.bipartite_layout,\n",
        "    nx.planar_layout,\n",
        "    nx.fruchterman_reingold_layout,\n",
        "    nx.kamada_kawai_layout\n",
        "]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "WTfQC-yE9qZg",
        "outputId": "fe2ef53b-0570-42c0-8285-f089b7c2eff8"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "--- start ---\n",
            "--- 0.0020461082458496094 seconds ---\n",
            "--- 0.009773492813110352 seconds ---\n",
            "--- 0.004009723663330078 seconds ---\n",
            "6\n"
          ]
        }
      ],
      "source": [
        "#faster way\n",
        "import pandas as pd\n",
        "def find_coauthors(df, name, affiliation, title):\n",
        "    coauthors_dict = {}\n",
        "    connection = {}\n",
        "    # Group rows by title\n",
        "    grouped = df.groupby(title)\n",
        "    for title_value, group in grouped:\n",
        "        author_affiliation_set = set()\n",
        "\n",
        "        for _, row in group.iterrows():\n",
        "            author = (row[name], row[affiliation])\n",
        "\n",
        "            # Skip if author name or affiliation is empty\n",
        "            if not all(author):\n",
        "                continue\n",
        "\n",
        "            # If the author is not already seen for this title\n",
        "            if author not in author_affiliation_set:\n",
        "                author_affiliation_set.add(author)\n",
        "            else:\n",
        "                # This author has already been considered for this title\n",
        "                continue\n",
        "\n",
        "            # Add author to coauthors_dict if not already present\n",
        "            if author not in coauthors_dict:\n",
        "                coauthors_dict[author] = []\n",
        "\n",
        "            # Find co-authors within the same title group\n",
        "            coauthors = group[(group[name] != row[name]) | (group[affiliation] != row[affiliation])]\n",
        "            for _, coauthor_row in coauthors.iterrows():\n",
        "                coauthor = (coauthor_row[name], coauthor_row[affiliation])\n",
        "\n",
        "                # Skip if coauthor name or affiliation is empty\n",
        "                if not all(coauthor):\n",
        "                    continue\n",
        "\n",
        "                # Avoid duplicates\n",
        "                if coauthor not in coauthors_dict[author]:\n",
        "                    coauthors_dict[author].append(coauthor)\n",
        "\n",
        "                # Update connection count\n",
        "                connection[(author, coauthor)] = connection.get((author, coauthor), 0) + 1\n",
        "\n",
        "    return coauthors_dict, connection\n",
        "import time\n",
        "from collections import defaultdict\n",
        "\n",
        "def merge_dicts(d1, d2):\n",
        "    combined_dict = defaultdict(set)\n",
        "    for key, values in d1.items():\n",
        "        combined_dict[key].update(values)\n",
        "    for key, values in d2.items():\n",
        "        combined_dict[key].update(values)\n",
        "    return combined_dict\n",
        "\n",
        "\n",
        "\n",
        "def sum_dicts(dict1, dict2):\n",
        "    result_dict = {}\n",
        "    all_keys = set(dict1.keys()) | set(dict2.keys())\n",
        "    for key in all_keys:\n",
        "        value1 = dict1.get(key, 0)\n",
        "        value2 = dict2.get(key, 0)\n",
        "        result_dict[key] = value1 + value2\n",
        "    return result_dict\n",
        "def extract_and_create_researcher_connection(disease):\n",
        " with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "  with driver.session() as session:\n",
        "   query = \"MATCH (l:Location)--(r:Researcher)--(i:ClinicalTrial)--(g:Gard) where g.GARDname= $disease and COALESCE(size(l.Aff_FIPS), 0) > 3    RETURN i.OfficialName AS OfficialName, i.OfficialAffiliation AS OfficialAffiliation, i.NCTId as NCTId, l.Aff_FIPS as FIPS \"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   ClinicalTrial = pd.DataFrame(data)\n",
        "   print(\"--- start ---\")\n",
        "   start_time = time.time()\n",
        "   if ClinicalTrial.shape[0]>0: a,a1=find_coauthors(ClinicalTrial,'OfficialName','OfficialAffiliation','NCTId')\n",
        "   else: a,a1=pd.DataFrame(),pd.DataFrame()\n",
        "   print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "   ######   Grant\n",
        "   query = \"MATCH (l:Location)--(r:Researcher)--(i:Grant)--(g:Gard) where g.GARDname= $disease and COALESCE(size(l.Aff_FIPS), 0) > 3    RETURN i.pi_name AS pi_name, i.org_name AS org_name, i.application_id as application_id , l.Aff_FIPS as FIPS \"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   Grant = pd.DataFrame(data)\n",
        "   start_time = time.time()\n",
        "   if Grant.shape[0]>0:b,b1=find_coauthors(Grant,'pi_name','org_name','application_id')\n",
        "   else: b,b1=pd.DataFrame(),pd.DataFrame()\n",
        "   print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "   ##################### pubmed\n",
        "   query = \"MATCH (l:Location)--(r:Researcher)--(i:Pubmed)--(g:Gard) where g.GARDname= $disease and COALESCE(size(l.Aff_FIPS), 0) > 3   RETURN i.fullName AS fullName, i.ar_affiliation AS affiliation, i.pubmed_id as pubmed_id, l.Aff_FIPS as FIPS \"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   Pubmed = pd.DataFrame(data)\n",
        "   start_time = time.time()\n",
        "   if Pubmed.shape[0]>0:c,c1=find_coauthors(Pubmed,'fullName','affiliation','pubmed_id')\n",
        "   else: c,c1=pd.DataFrame(),pd.DataFrame()\n",
        "   print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "   ###################\n",
        "   combined_dict = merge_dicts(a, b)\n",
        "   combined_dict = merge_dicts(combined_dict, c)\n",
        "   ###########\n",
        "   combined_dict1 = sum_dicts(a1, b1)\n",
        "   result_dict1 = sum_dicts(combined_dict1, c1)\n",
        "   for key in result_dict1:\n",
        "    result_dict1[key] = result_dict1[key] %1000\n",
        "   ###########\n",
        "   result_dict = {key: list(values) for key, values in combined_dict.items()}\n",
        "   return combined_dict, result_dict1, a,a1,b,b1,c,c1\n",
        "disease= A[0]\n",
        "result_dict, result_dict1, a,a1,b,b1,c,c1=extract_and_create_researcher_connection(disease)\n",
        "print(len(result_dict))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "QOv0tX6nDD5O"
      },
      "outputs": [],
      "source": [
        "import networkx as nx\n",
        "import community\n",
        "from community import community_louvain\n",
        "import matplotlib.pyplot as plt\n",
        "# Create a directed graph\n",
        "G = nx.Graph()\n",
        "# Add nodes and edges from the dictionary\n",
        "for nodes, edges in result_dict.items():\n",
        "    G.add_node(nodes)\n",
        "    for edge in edges:\n",
        "        G.add_node(edge)\n",
        "        G.add_edge(nodes, edge)\n",
        "\n",
        "# Detect communities using Louvain method\n",
        "partition = community_louvain.best_partition(G)\n",
        "data_table = pd.DataFrame(partition.items(), columns=['name', 'Community'])\n",
        "data_table['network']=data_table.apply(lambda x: result_dict[x['name']] ,axis=1)\n",
        "index_community_detection= list(set(data_table[data_table['network']!=set()]['Community'].values))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 237
        },
        "id": "f1XDDxVPN0YO",
        "outputId": "be57b57e-24ff-441d-9d61-cef7487d8d5a"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"data_table\",\n  \"rows\": 6,\n  \"fields\": [\n    {\n      \"column\": \"name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          [\n            \"Eva Morava-Kozicz\",\n            \"Mayo Clinic\"\n          ],\n          [\n            \"FREEZE, HUDSON H.\",\n            \"MAYO CLINIC ROCHESTER\"\n          ],\n          [\n            \"Morava E\",\n            \"[Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biophysics, University of P\\u00e9cs Medical School, 7624 P\\u00e9cs, Hungary. Electronic address: eva.morava@mssm.edu.]\"\n          ]\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": 0,\n        \"max\": 5,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          0,\n          1,\n          5\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"network\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "data_table"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-503991af-fbc2-4a7a-8e5f-e63f7fdae328\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>name</th>\n",
              "      <th>Community</th>\n",
              "      <th>network</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>(Eva Morava-Kozicz, Mayo Clinic)</td>\n",
              "      <td>0</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>(FREEZE, HUDSON H., MAYO CLINIC ROCHESTER)</td>\n",
              "      <td>1</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>(MORAVA-KOZICZ, EVA, MAYO CLINIC ROCHESTER)</td>\n",
              "      <td>2</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>(Ackermann AM, [Division of Endocrinology and ...</td>\n",
              "      <td>3</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>(Kronn D, [Department of Pediatrics, New York ...</td>\n",
              "      <td>4</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>(Morava E, [Department of Clinical Genomics, M...</td>\n",
              "      <td>5</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-503991af-fbc2-4a7a-8e5f-e63f7fdae328')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-503991af-fbc2-4a7a-8e5f-e63f7fdae328 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-503991af-fbc2-4a7a-8e5f-e63f7fdae328');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-e32b4772-e744-40a7-9608-43de54928b94\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-e32b4772-e744-40a7-9608-43de54928b94')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-e32b4772-e744-40a7-9608-43de54928b94 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_70687756-bc00-450f-ad5a-e2f83241ceac\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('data_table')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_70687756-bc00-450f-ad5a-e2f83241ceac button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('data_table');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                                                name  Community network\n",
              "0                   (Eva Morava-Kozicz, Mayo Clinic)          0      {}\n",
              "1         (FREEZE, HUDSON H., MAYO CLINIC ROCHESTER)          1      {}\n",
              "2        (MORAVA-KOZICZ, EVA, MAYO CLINIC ROCHESTER)          2      {}\n",
              "3  (Ackermann AM, [Division of Endocrinology and ...          3      {}\n",
              "4  (Kronn D, [Department of Pediatrics, New York ...          4      {}\n",
              "5  (Morava E, [Department of Clinical Genomics, M...          5      {}"
            ]
          },
          "execution_count": 81,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "data_table"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ig5edKbFDyzC"
      },
      "outputs": [],
      "source": [
        "def merge_community_detection_and_researchers_info(disease):\n",
        " with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "  with driver.session() as session:\n",
        "   query = \"MATCH (l:Location)--(r:Researcher)--(i:ClinicalTrial)--(g:Gard) WHERE g.GARDname= $disease and COALESCE(size(l.Aff_FIPS), 0) > 3 RETURN i.OfficialName as OfficialName , i.OfficialAffiliation as OfficialAffiliation, i.OfficialTitle as OfficialTitle  ,i.Interventions as concatenatedInterventions, i.BriefSummary as BriefSummary, l.Aff_FIPS as FIPS\"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   if data==[]:  ClinicalTrial = pd.DataFrame(columns=[\"OfficialName\", \"OfficialAffiliation\", \"OfficialTitle\", \"concatenatedInterventions\", \"BriefSummary,FIPS\"])\n",
        "   else: ClinicalTrial = pd.DataFrame(data)\n",
        "   ######   Grant\n",
        "   query = \"MATCH (l:Location)--(r:Researcher)--(i:Grant)--(g:Gard) WHERE g.GARDname= $disease and COALESCE(size(l.Aff_FIPS), 0) > 3 RETURN i.pi_name as pi_name,i.org_name as org_name,i.title as title ,i.terms as terms,i.abstract as abstract, l.Aff_FIPS as FIPS\"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "\n",
        "   if data==[]:  Grant = pd.DataFrame(columns=[\"pi_name\", \"org_name\", \"title\", \"terms\", \"abstract\",\"FIPS\"])\n",
        "   else: Grant = pd.DataFrame(data)\n",
        "   ##################### pubmed\n",
        "   query = \"MATCH (l:Location)--(r:Researcher)--(i:Pubmed)--(g:Gard) WHERE g.GARDname= $disease and COALESCE(size(l.Aff_FIPS), 0) > 3 RETURN i.fullName as fullName, i.ar_affiliation as affiliation, i.title as title, i.concatenatedKeywords as concatenatedKeywords,i.abstractText as abstractText, l.Aff_FIPS as FIPS \"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "\n",
        "   if data==[]:  Pubmed = pd.DataFrame(columns=[\"fullName\", \"affiliation\", \"title\", \"concatenatedKeywords\",\"abstractText\", \"FIPS\"])\n",
        "   else: Pubmed = pd.DataFrame(data)\n",
        "   ################\n",
        "   if ClinicalTrial.shape[0]>0:  ClinicalTrial['name'] = ClinicalTrial.apply(lambda row: (row['OfficialName'], row['OfficialAffiliation']), axis=1)\n",
        "   else: ClinicalTrial['name'] = None\n",
        "   if Grant.shape[0]>0:          Grant['name'] = Grant.apply(lambda row: (row['pi_name'], row['org_name']), axis=1)\n",
        "   else: Grant['name'] = None\n",
        "   if Pubmed.shape[0]>0:         Pubmed['name'] = Pubmed.apply(lambda row: (row['fullName'], row['affiliation']), axis=1)\n",
        "   else: Pubmed['name'] = None\n",
        "\n",
        "   ClinicalTrial['BriefSummary']=ClinicalTrial['OfficialTitle'].fillna(\"\").astype(str)+' '+ ClinicalTrial['BriefSummary'].fillna(\"\").astype(str)   #+ClinicalTrial['concatenatedInterventions'].fillna(\"\").astype(str)+\n",
        "   Grant['BriefSummary']=Grant['title'].fillna(\"\").astype(str)+' '+ Grant['abstract'].fillna(\"\").astype(str)                   #+Grant['terms'].fillna(\"\").astype(str)\n",
        "   Pubmed['abstractText']=Pubmed['title'].fillna(\"\").astype(str)+' '+ Pubmed['abstractText'].fillna(\"\").astype(str)    #+Pubmed['concatenatedKeywords'].fillna(\"\").astype(str)\n",
        "\n",
        "   ClinicalTrial['Terms']=ClinicalTrial['concatenatedInterventions']\n",
        "   Grant['Terms']=Grant['terms']\n",
        "   Pubmed['Terms']=Pubmed['concatenatedKeywords']\n",
        "   #df1=ClinicalTrial[['i.OfficialName',  'c.BriefSummary', 'i.OfficialAffiliation','name']]\n",
        "   df1=ClinicalTrial[['OfficialName',  'BriefSummary','OfficialAffiliation', 'name','Terms',\"FIPS\"]]\n",
        "   df2=Grant[['pi_name', 'abstract', 'org_name','name','Terms',\"FIPS\"]]\n",
        "   df3=Pubmed[['fullName',  'abstractText', 'affiliation','name','Terms',\"FIPS\"]]\n",
        "   # Rename columns to avoid conflicts\n",
        "   df1.columns = ['PI','Abstract', 'affiliation','name','Terms',\"FIPS\"]\n",
        "   df2.columns = ['PI','Abstract', 'affiliation','name','Terms',\"FIPS\"]\n",
        "   df3.columns = ['PI','Abstract', 'affiliation','name','Terms',\"FIPS\"]\n",
        "   #df2['Location']=  df2['locationCity'] +' , '+df2['Location']\n",
        "   result_df = pd.concat([df1  , df2, df3])\n",
        "   #result_df = pd.concat([df1,  df3])\n",
        "   result_df=result_df.drop_duplicates()\n",
        "   result_df.index= range(result_df.shape[0])\n",
        "   #################################################### merging with c\n",
        "\n",
        "   merged_data1 = pd.merge(result_df,data_table , on='name', how='outer')\n",
        "   concatenated_data = merged_data1.drop_duplicates(subset=['name'])\n",
        "   concatenated_data.reset_index(drop=True, inplace=True)\n",
        "   #concatenated_data=concatenated_data.drop(['name'],axis=1)\n",
        "   return concatenated_data\n",
        "   '''\n",
        "   #return result_df\n",
        "   '''\n",
        "concatenated_data=merge_community_detection_and_researchers_info(disease)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 587
        },
        "id": "4f2re2iAJ6vs",
        "outputId": "e3824fc5-bc9d-42c1-ec47-150f9f22f660"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"concatenated_data\",\n  \"rows\": 6,\n  \"fields\": [\n    {\n      \"column\": \"PI\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"Ackermann AM\",\n          \"Eva Morava-Kozicz\",\n          \"Morava E\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \" PurposePhosphoglucomutase-1 deficiency is a subtype of congenital disorders of glycosylation (PGM1-CDG). Previous casereports in PGM1-CDG patients receiving oral D-galactose (D-gal) showed clinical improvement. So far no systematic in vitro and clinical studies have assessed safety and benefits of D-gal supplementation. In a prospective pilot study, we evaluated the effects of oral D-gal in nine patients.MethodsD-gal supplementation was increased to 1.5\\u2009g/kg/day (maximum 50\\u2009g/day) in three increments over 18 weeks. Laboratory studies were performed before and during treatment to monitor safety and effect on serum transferrin-glycosylation, coagulation, and liver and endocrine function. Additionally, the effect of D-gal on cellular glycosylation was characterized in vitro.ResultsEight patients were compliant with D-gal supplementation. No adverse effects were reported. Abnormal baseline results (alanine transaminase, aspartate transaminase, activated partial thromboplastin time) improved or normalized already using 1\\u2009g/kg/day D-gal. Antithrombin-III levels and transferrin-glycosylation showed significant improvement, and increase in galactosylation and whole glycan content. In vitro studies before treatment showed N-glycan hyposialylation, altered O-linked glycans, abnormal lipid-linked oligosaccharide profile, and abnormal nucleotide sugars in patient fibroblasts. Most cellular abnormalities improved or normalized following D-gal treatment. D-gal increased both UDP-Glc and UDP-Gal levels and improved lipid-linked oligosaccharide fractions in concert with improved glycosylation in PGM1-CDG.ConclusionOral D-gal supplementation is a safe and effective treatment for PGM1-CDG in this pilot study. Transferrin glycosylation and ATIII levels were useful trial end points. Larger, longer-duration trials are ongoing.\",\n          \"A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG) You have been asked to take part in this research study because you have been diagnosed with PGM1-CDG and are currently taking D-galactose.\",\n          \" Phosphoglucomutase-1-congenital disorder of glycosylation (PGM1-CDG) is a rare genetic disorder caused by biallelic variants in the PGM1 gene, leading to the deficiency of the PGM1 enzyme. The most common clinical presentations include muscle involvement, failure to thrive, cleft palate, and cardiac involvement. Abnormal serum N-glycosylation, hypoglycemia, and liver function abnormalities including coagulation abnormalities are the most common laboratory abnormalities. While PGM1-CDG has been extensively studied, little is known about the extent of the coagulation abnormalities in individuals with PGM1-CDG. Unlike most CDG, some symptoms of PGM1-CDG are treatable with D-galactose (D-gal) supplementation, though reliable clinical endpoints are necessary to appropriately evaluate the potential improvement with D-gal in PGM1-CDG. Here, we aimed to describe the incidence of coagulation abnormalities in PGM1-CDG and their evolution, their relation to clinical events, and the ability of D-gal treatment to improve them. A retrospective analysis was conducted on 73 reported individuals. All individuals had a molecularly confirmed PGM1-CDG diagnosis. All incidences of antithrombin (AT), aPTT, PT, factor (F) XI, FX, FIX, FVII, protein C and protein S data and major clinical events related to coagulation abnormalities, were collected. Coagulation information was available for only 58.9 % of the reported individuals, out of which 67.4 % of PGM1-CDG individuals were reported to have abnormalities. The most frequently observed abnormality was AT (mean: 30.8% R:80-120 %) deficiency. Four individuals had major thrombotic events. Coagulation status on D-gal treatment, were reported in 19 individuals. Several factors showed improvement including AT (mean: 64.5 %), indicating galactose is beneficial in treating coagulation abnormalities in PGM1-CDG. Due to the scarcity of the reported data on coagulation parameters, we also evaluated data collected in sixteen PGM1-CDG individuals enrolled in the FCDGC Natural History Study. Longitudinal data showed improvements in several coagulant parameters and disease severity improved for almost all patients of whom we had multiple datapoints on D-gal. AT showed significant improvement on D-gal. We conclude that coagulation abnormalities are frequently present in PGM1-CDG and show improvement on D-gal. We recommend coagulation parameters should be routinely checked in individuals with PGM1-CDG or suspected of having PGM1-CDG. Finally, AT may be used as a primary or secondary clinical endpoint for upcoming clinical trials in PGM1-CDG individuals.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"affiliation\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"Mayo Clinic\",\n          \"[Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biophysics, University of P\\u00e9cs Medical School, 7624 P\\u00e9cs, Hungary. Electronic address: eva.morava@mssm.edu.]\",\n          \"MAYO CLINIC ROCHESTER\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          [\n            \"Ackermann AM\",\n            \"[Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, United States., Congenital Hyperinsulinism Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States., Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.]\"\n          ],\n          [\n            \"Eva Morava-Kozicz\",\n            \"Mayo Clinic\"\n          ],\n          [\n            \"Morava E\",\n            \"[Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biophysics, University of P\\u00e9cs Medical School, 7624 P\\u00e9cs, Hungary. Electronic address: eva.morava@mssm.edu.]\"\n          ]\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"[]\",\n          \"[AVTX-801]\",\n          \"[c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, d, (, ), f, y, p, h, -, 1]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"FIPS\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 4,\n        \"samples\": [\n          \"27109\",\n          \"36055\",\n          \"42101\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": 0,\n        \"max\": 5,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          3,\n          0,\n          5\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"network\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "concatenated_data"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-bfcf0e19-f4d1-4c87-b5d2-a39c11c6edad\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>PI</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>affiliation</th>\n",
              "      <th>name</th>\n",
              "      <th>Terms</th>\n",
              "      <th>FIPS</th>\n",
              "      <th>Community</th>\n",
              "      <th>network</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Ackermann AM</td>\n",
              "      <td>PurposePhosphoglucomutase-1 deficiency is a s...</td>\n",
              "      <td>[Division of Endocrinology and Diabetes, Child...</td>\n",
              "      <td>(Ackermann AM, [Division of Endocrinology and ...</td>\n",
              "      <td>[]</td>\n",
              "      <td>42101</td>\n",
              "      <td>3</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Eva Morava-Kozicz</td>\n",
              "      <td>A Phase 2b, Multicenter, Randomized, Double-bl...</td>\n",
              "      <td>Mayo Clinic</td>\n",
              "      <td>(Eva Morava-Kozicz, Mayo Clinic)</td>\n",
              "      <td>[AVTX-801]</td>\n",
              "      <td>27109</td>\n",
              "      <td>0</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>FREEZE, HUDSON H.</td>\n",
              "      <td>DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/P...</td>\n",
              "      <td>MAYO CLINIC ROCHESTER</td>\n",
              "      <td>(FREEZE, HUDSON H., MAYO CLINIC ROCHESTER)</td>\n",
              "      <td>[accurate diagnosis, Address, Affect, Affectiv...</td>\n",
              "      <td>27109</td>\n",
              "      <td>1</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Kronn D</td>\n",
              "      <td>Phosphoglucomutase 1 deficiency is a congenit...</td>\n",
              "      <td>[Department of Pediatrics, New York Medical Co...</td>\n",
              "      <td>(Kronn D, [Department of Pediatrics, New York ...</td>\n",
              "      <td>[exercise intolerance, dilated cardiomyopathy,...</td>\n",
              "      <td>36119</td>\n",
              "      <td>4</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>MORAVA-KOZICZ, EVA</td>\n",
              "      <td>CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMAR...</td>\n",
              "      <td>MAYO CLINIC ROCHESTER</td>\n",
              "      <td>(MORAVA-KOZICZ, EVA, MAYO CLINIC ROCHESTER)</td>\n",
              "      <td>[Address, Animal Model, Biochemical Genetics, ...</td>\n",
              "      <td>27109</td>\n",
              "      <td>2</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>Morava E</td>\n",
              "      <td>Phosphoglucomutase-1-congenital disorder of g...</td>\n",
              "      <td>[Department of Clinical Genomics, Mayo Clinic,...</td>\n",
              "      <td>(Morava E, [Department of Clinical Genomics, M...</td>\n",
              "      <td>[c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, ...</td>\n",
              "      <td>36055</td>\n",
              "      <td>5</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-bfcf0e19-f4d1-4c87-b5d2-a39c11c6edad')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-bfcf0e19-f4d1-4c87-b5d2-a39c11c6edad button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-bfcf0e19-f4d1-4c87-b5d2-a39c11c6edad');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-e9b3379c-e665-4a78-b380-ea2710c92d36\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-e9b3379c-e665-4a78-b380-ea2710c92d36')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-e9b3379c-e665-4a78-b380-ea2710c92d36 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_3a415beb-c581-4e48-8598-2a0c328d9b83\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('concatenated_data')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_3a415beb-c581-4e48-8598-2a0c328d9b83 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('concatenated_data');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                   PI                                           Abstract  \\\n",
              "0        Ackermann AM   PurposePhosphoglucomutase-1 deficiency is a s...   \n",
              "1   Eva Morava-Kozicz  A Phase 2b, Multicenter, Randomized, Double-bl...   \n",
              "2   FREEZE, HUDSON H.  DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/P...   \n",
              "3             Kronn D   Phosphoglucomutase 1 deficiency is a congenit...   \n",
              "4  MORAVA-KOZICZ, EVA  CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMAR...   \n",
              "5            Morava E   Phosphoglucomutase-1-congenital disorder of g...   \n",
              "\n",
              "                                         affiliation  \\\n",
              "0  [Division of Endocrinology and Diabetes, Child...   \n",
              "1                                        Mayo Clinic   \n",
              "2                              MAYO CLINIC ROCHESTER   \n",
              "3  [Department of Pediatrics, New York Medical Co...   \n",
              "4                              MAYO CLINIC ROCHESTER   \n",
              "5  [Department of Clinical Genomics, Mayo Clinic,...   \n",
              "\n",
              "                                                name  \\\n",
              "0  (Ackermann AM, [Division of Endocrinology and ...   \n",
              "1                   (Eva Morava-Kozicz, Mayo Clinic)   \n",
              "2         (FREEZE, HUDSON H., MAYO CLINIC ROCHESTER)   \n",
              "3  (Kronn D, [Department of Pediatrics, New York ...   \n",
              "4        (MORAVA-KOZICZ, EVA, MAYO CLINIC ROCHESTER)   \n",
              "5  (Morava E, [Department of Clinical Genomics, M...   \n",
              "\n",
              "                                               Terms   FIPS  Community network  \n",
              "0                                                 []  42101          3      {}  \n",
              "1                                         [AVTX-801]  27109          0      {}  \n",
              "2  [accurate diagnosis, Address, Affect, Affectiv...  27109          1      {}  \n",
              "3  [exercise intolerance, dilated cardiomyopathy,...  36119          4      {}  \n",
              "4  [Address, Animal Model, Biochemical Genetics, ...  27109          2      {}  \n",
              "5  [c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, ...  36055          5      {}  "
            ]
          },
          "execution_count": 83,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "concatenated_data"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 587
        },
        "id": "kX5ehh2wZ9HM",
        "outputId": "a8979a83-3b11-4015-a9be-88b4aab35683"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"concatenated_data\",\n  \"rows\": 6,\n  \"fields\": [\n    {\n      \"column\": \"PI\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"Ackermann AM\",\n          \"Eva Morava-Kozicz\",\n          \"Morava E\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \" PurposePhosphoglucomutase-1 deficiency is a subtype of congenital disorders of glycosylation (PGM1-CDG). Previous casereports in PGM1-CDG patients receiving oral D-galactose (D-gal) showed clinical improvement. So far no systematic in vitro and clinical studies have assessed safety and benefits of D-gal supplementation. In a prospective pilot study, we evaluated the effects of oral D-gal in nine patients.MethodsD-gal supplementation was increased to 1.5\\u2009g/kg/day (maximum 50\\u2009g/day) in three increments over 18 weeks. Laboratory studies were performed before and during treatment to monitor safety and effect on serum transferrin-glycosylation, coagulation, and liver and endocrine function. Additionally, the effect of D-gal on cellular glycosylation was characterized in vitro.ResultsEight patients were compliant with D-gal supplementation. No adverse effects were reported. Abnormal baseline results (alanine transaminase, aspartate transaminase, activated partial thromboplastin time) improved or normalized already using 1\\u2009g/kg/day D-gal. Antithrombin-III levels and transferrin-glycosylation showed significant improvement, and increase in galactosylation and whole glycan content. In vitro studies before treatment showed N-glycan hyposialylation, altered O-linked glycans, abnormal lipid-linked oligosaccharide profile, and abnormal nucleotide sugars in patient fibroblasts. Most cellular abnormalities improved or normalized following D-gal treatment. D-gal increased both UDP-Glc and UDP-Gal levels and improved lipid-linked oligosaccharide fractions in concert with improved glycosylation in PGM1-CDG.ConclusionOral D-gal supplementation is a safe and effective treatment for PGM1-CDG in this pilot study. Transferrin glycosylation and ATIII levels were useful trial end points. Larger, longer-duration trials are ongoing.\",\n          \"A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG) You have been asked to take part in this research study because you have been diagnosed with PGM1-CDG and are currently taking D-galactose.\",\n          \" Phosphoglucomutase-1-congenital disorder of glycosylation (PGM1-CDG) is a rare genetic disorder caused by biallelic variants in the PGM1 gene, leading to the deficiency of the PGM1 enzyme. The most common clinical presentations include muscle involvement, failure to thrive, cleft palate, and cardiac involvement. Abnormal serum N-glycosylation, hypoglycemia, and liver function abnormalities including coagulation abnormalities are the most common laboratory abnormalities. While PGM1-CDG has been extensively studied, little is known about the extent of the coagulation abnormalities in individuals with PGM1-CDG. Unlike most CDG, some symptoms of PGM1-CDG are treatable with D-galactose (D-gal) supplementation, though reliable clinical endpoints are necessary to appropriately evaluate the potential improvement with D-gal in PGM1-CDG. Here, we aimed to describe the incidence of coagulation abnormalities in PGM1-CDG and their evolution, their relation to clinical events, and the ability of D-gal treatment to improve them. A retrospective analysis was conducted on 73 reported individuals. All individuals had a molecularly confirmed PGM1-CDG diagnosis. All incidences of antithrombin (AT), aPTT, PT, factor (F) XI, FX, FIX, FVII, protein C and protein S data and major clinical events related to coagulation abnormalities, were collected. Coagulation information was available for only 58.9 % of the reported individuals, out of which 67.4 % of PGM1-CDG individuals were reported to have abnormalities. The most frequently observed abnormality was AT (mean: 30.8% R:80-120 %) deficiency. Four individuals had major thrombotic events. Coagulation status on D-gal treatment, were reported in 19 individuals. Several factors showed improvement including AT (mean: 64.5 %), indicating galactose is beneficial in treating coagulation abnormalities in PGM1-CDG. Due to the scarcity of the reported data on coagulation parameters, we also evaluated data collected in sixteen PGM1-CDG individuals enrolled in the FCDGC Natural History Study. Longitudinal data showed improvements in several coagulant parameters and disease severity improved for almost all patients of whom we had multiple datapoints on D-gal. AT showed significant improvement on D-gal. We conclude that coagulation abnormalities are frequently present in PGM1-CDG and show improvement on D-gal. We recommend coagulation parameters should be routinely checked in individuals with PGM1-CDG or suspected of having PGM1-CDG. Finally, AT may be used as a primary or secondary clinical endpoint for upcoming clinical trials in PGM1-CDG individuals.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"affiliation\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"Mayo Clinic\",\n          \"[Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biophysics, University of P\\u00e9cs Medical School, 7624 P\\u00e9cs, Hungary. Electronic address: eva.morava@mssm.edu.]\",\n          \"MAYO CLINIC ROCHESTER\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          [\n            \"Ackermann AM\",\n            \"[Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, United States., Congenital Hyperinsulinism Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States., Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.]\"\n          ],\n          [\n            \"Eva Morava-Kozicz\",\n            \"Mayo Clinic\"\n          ],\n          [\n            \"Morava E\",\n            \"[Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biophysics, University of P\\u00e9cs Medical School, 7624 P\\u00e9cs, Hungary. Electronic address: eva.morava@mssm.edu.]\"\n          ]\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"[]\",\n          \"[AVTX-801]\",\n          \"[c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, d, (, ), f, y, p, h, -, 1]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"FIPS\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 4,\n        \"samples\": [\n          \"27109\",\n          \"36055\",\n          \"42101\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": 0,\n        \"max\": 5,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          3,\n          0,\n          5\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"network\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "concatenated_data"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-778e2b52-400a-4f2f-80e2-564300ddaead\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>PI</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>affiliation</th>\n",
              "      <th>name</th>\n",
              "      <th>Terms</th>\n",
              "      <th>FIPS</th>\n",
              "      <th>Community</th>\n",
              "      <th>network</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Ackermann AM</td>\n",
              "      <td>PurposePhosphoglucomutase-1 deficiency is a s...</td>\n",
              "      <td>[Division of Endocrinology and Diabetes, Child...</td>\n",
              "      <td>(Ackermann AM, [Division of Endocrinology and ...</td>\n",
              "      <td>[]</td>\n",
              "      <td>42101</td>\n",
              "      <td>3</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Eva Morava-Kozicz</td>\n",
              "      <td>A Phase 2b, Multicenter, Randomized, Double-bl...</td>\n",
              "      <td>Mayo Clinic</td>\n",
              "      <td>(Eva Morava-Kozicz, Mayo Clinic)</td>\n",
              "      <td>[AVTX-801]</td>\n",
              "      <td>27109</td>\n",
              "      <td>0</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>FREEZE, HUDSON H.</td>\n",
              "      <td>DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/P...</td>\n",
              "      <td>MAYO CLINIC ROCHESTER</td>\n",
              "      <td>(FREEZE, HUDSON H., MAYO CLINIC ROCHESTER)</td>\n",
              "      <td>[accurate diagnosis, Address, Affect, Affectiv...</td>\n",
              "      <td>27109</td>\n",
              "      <td>1</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Kronn D</td>\n",
              "      <td>Phosphoglucomutase 1 deficiency is a congenit...</td>\n",
              "      <td>[Department of Pediatrics, New York Medical Co...</td>\n",
              "      <td>(Kronn D, [Department of Pediatrics, New York ...</td>\n",
              "      <td>[exercise intolerance, dilated cardiomyopathy,...</td>\n",
              "      <td>36119</td>\n",
              "      <td>4</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>MORAVA-KOZICZ, EVA</td>\n",
              "      <td>CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMAR...</td>\n",
              "      <td>MAYO CLINIC ROCHESTER</td>\n",
              "      <td>(MORAVA-KOZICZ, EVA, MAYO CLINIC ROCHESTER)</td>\n",
              "      <td>[Address, Animal Model, Biochemical Genetics, ...</td>\n",
              "      <td>27109</td>\n",
              "      <td>2</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>Morava E</td>\n",
              "      <td>Phosphoglucomutase-1-congenital disorder of g...</td>\n",
              "      <td>[Department of Clinical Genomics, Mayo Clinic,...</td>\n",
              "      <td>(Morava E, [Department of Clinical Genomics, M...</td>\n",
              "      <td>[c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, ...</td>\n",
              "      <td>36055</td>\n",
              "      <td>5</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-778e2b52-400a-4f2f-80e2-564300ddaead')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-778e2b52-400a-4f2f-80e2-564300ddaead button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-778e2b52-400a-4f2f-80e2-564300ddaead');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-92df3a84-3d1b-4ec5-92e8-a7fd2cab9c80\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-92df3a84-3d1b-4ec5-92e8-a7fd2cab9c80')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-92df3a84-3d1b-4ec5-92e8-a7fd2cab9c80 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_316bada0-969f-4b96-b147-8dc452f20370\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('concatenated_data')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_316bada0-969f-4b96-b147-8dc452f20370 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('concatenated_data');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                   PI                                           Abstract  \\\n",
              "0        Ackermann AM   PurposePhosphoglucomutase-1 deficiency is a s...   \n",
              "1   Eva Morava-Kozicz  A Phase 2b, Multicenter, Randomized, Double-bl...   \n",
              "2   FREEZE, HUDSON H.  DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/P...   \n",
              "3             Kronn D   Phosphoglucomutase 1 deficiency is a congenit...   \n",
              "4  MORAVA-KOZICZ, EVA  CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMAR...   \n",
              "5            Morava E   Phosphoglucomutase-1-congenital disorder of g...   \n",
              "\n",
              "                                         affiliation  \\\n",
              "0  [Division of Endocrinology and Diabetes, Child...   \n",
              "1                                        Mayo Clinic   \n",
              "2                              MAYO CLINIC ROCHESTER   \n",
              "3  [Department of Pediatrics, New York Medical Co...   \n",
              "4                              MAYO CLINIC ROCHESTER   \n",
              "5  [Department of Clinical Genomics, Mayo Clinic,...   \n",
              "\n",
              "                                                name  \\\n",
              "0  (Ackermann AM, [Division of Endocrinology and ...   \n",
              "1                   (Eva Morava-Kozicz, Mayo Clinic)   \n",
              "2         (FREEZE, HUDSON H., MAYO CLINIC ROCHESTER)   \n",
              "3  (Kronn D, [Department of Pediatrics, New York ...   \n",
              "4        (MORAVA-KOZICZ, EVA, MAYO CLINIC ROCHESTER)   \n",
              "5  (Morava E, [Department of Clinical Genomics, M...   \n",
              "\n",
              "                                               Terms   FIPS  Community network  \n",
              "0                                                 []  42101          3      {}  \n",
              "1                                         [AVTX-801]  27109          0      {}  \n",
              "2  [accurate diagnosis, Address, Affect, Affectiv...  27109          1      {}  \n",
              "3  [exercise intolerance, dilated cardiomyopathy,...  36119          4      {}  \n",
              "4  [Address, Animal Model, Biochemical Genetics, ...  27109          2      {}  \n",
              "5  [c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, ...  36055          5      {}  "
            ]
          },
          "execution_count": 84,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "concatenated_data"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "BD7WAD5s-pxf"
      },
      "outputs": [],
      "source": [
        "fip_finding=pd.read_csv('/content/uscities.csv')\n",
        "fip_finding_dict=dict()\n",
        "lat_finding_dict=dict()\n",
        "lon_finding_dict=dict()\n",
        "lon_lag_fip_info=dict()\n",
        "for i in fip_finding.index:\n",
        "     fip_finding_dict[fip_finding['city'][i].lower()]= fip_finding['county_fips'][i]\n",
        "     lat_finding_dict[fip_finding['city'][i].lower()]= fip_finding['lat'][i]\n",
        "     lon_finding_dict[fip_finding['city'][i].lower()]= fip_finding['lng'][i]\n",
        "     lon_lag_fip_info[( round(fip_finding['lat'][i]) ,round(fip_finding['lng'][i]) )]=fip_finding['city'][i]\n",
        "for i in concatenated_data.index:\n",
        "  concatenated_data.at[i,'lat']= fip_finding[fip_finding['county_fips'].astype(str)== concatenated_data['FIPS'][i] ]['lat'].iloc[0]\n",
        "  concatenated_data.at[i,'lng']= fip_finding[fip_finding['county_fips'].astype(str)== concatenated_data['FIPS'][i] ]['lng'].iloc[0]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 587
        },
        "id": "P0276Cx2FIDM",
        "outputId": "3092102e-1dc3-4bc7-ca17-89fce46c3c59"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"concatenated_data\",\n  \"rows\": 6,\n  \"fields\": [\n    {\n      \"column\": \"PI\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"Ackermann AM\",\n          \"Eva Morava-Kozicz\",\n          \"Morava E\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \" PurposePhosphoglucomutase-1 deficiency is a subtype of congenital disorders of glycosylation (PGM1-CDG). Previous casereports in PGM1-CDG patients receiving oral D-galactose (D-gal) showed clinical improvement. So far no systematic in vitro and clinical studies have assessed safety and benefits of D-gal supplementation. In a prospective pilot study, we evaluated the effects of oral D-gal in nine patients.MethodsD-gal supplementation was increased to 1.5\\u2009g/kg/day (maximum 50\\u2009g/day) in three increments over 18 weeks. Laboratory studies were performed before and during treatment to monitor safety and effect on serum transferrin-glycosylation, coagulation, and liver and endocrine function. Additionally, the effect of D-gal on cellular glycosylation was characterized in vitro.ResultsEight patients were compliant with D-gal supplementation. No adverse effects were reported. Abnormal baseline results (alanine transaminase, aspartate transaminase, activated partial thromboplastin time) improved or normalized already using 1\\u2009g/kg/day D-gal. Antithrombin-III levels and transferrin-glycosylation showed significant improvement, and increase in galactosylation and whole glycan content. In vitro studies before treatment showed N-glycan hyposialylation, altered O-linked glycans, abnormal lipid-linked oligosaccharide profile, and abnormal nucleotide sugars in patient fibroblasts. Most cellular abnormalities improved or normalized following D-gal treatment. D-gal increased both UDP-Glc and UDP-Gal levels and improved lipid-linked oligosaccharide fractions in concert with improved glycosylation in PGM1-CDG.ConclusionOral D-gal supplementation is a safe and effective treatment for PGM1-CDG in this pilot study. Transferrin glycosylation and ATIII levels were useful trial end points. Larger, longer-duration trials are ongoing.\",\n          \"A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG) You have been asked to take part in this research study because you have been diagnosed with PGM1-CDG and are currently taking D-galactose.\",\n          \" Phosphoglucomutase-1-congenital disorder of glycosylation (PGM1-CDG) is a rare genetic disorder caused by biallelic variants in the PGM1 gene, leading to the deficiency of the PGM1 enzyme. The most common clinical presentations include muscle involvement, failure to thrive, cleft palate, and cardiac involvement. Abnormal serum N-glycosylation, hypoglycemia, and liver function abnormalities including coagulation abnormalities are the most common laboratory abnormalities. While PGM1-CDG has been extensively studied, little is known about the extent of the coagulation abnormalities in individuals with PGM1-CDG. Unlike most CDG, some symptoms of PGM1-CDG are treatable with D-galactose (D-gal) supplementation, though reliable clinical endpoints are necessary to appropriately evaluate the potential improvement with D-gal in PGM1-CDG. Here, we aimed to describe the incidence of coagulation abnormalities in PGM1-CDG and their evolution, their relation to clinical events, and the ability of D-gal treatment to improve them. A retrospective analysis was conducted on 73 reported individuals. All individuals had a molecularly confirmed PGM1-CDG diagnosis. All incidences of antithrombin (AT), aPTT, PT, factor (F) XI, FX, FIX, FVII, protein C and protein S data and major clinical events related to coagulation abnormalities, were collected. Coagulation information was available for only 58.9 % of the reported individuals, out of which 67.4 % of PGM1-CDG individuals were reported to have abnormalities. The most frequently observed abnormality was AT (mean: 30.8% R:80-120 %) deficiency. Four individuals had major thrombotic events. Coagulation status on D-gal treatment, were reported in 19 individuals. Several factors showed improvement including AT (mean: 64.5 %), indicating galactose is beneficial in treating coagulation abnormalities in PGM1-CDG. Due to the scarcity of the reported data on coagulation parameters, we also evaluated data collected in sixteen PGM1-CDG individuals enrolled in the FCDGC Natural History Study. Longitudinal data showed improvements in several coagulant parameters and disease severity improved for almost all patients of whom we had multiple datapoints on D-gal. AT showed significant improvement on D-gal. We conclude that coagulation abnormalities are frequently present in PGM1-CDG and show improvement on D-gal. We recommend coagulation parameters should be routinely checked in individuals with PGM1-CDG or suspected of having PGM1-CDG. Finally, AT may be used as a primary or secondary clinical endpoint for upcoming clinical trials in PGM1-CDG individuals.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"affiliation\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 5,\n        \"samples\": [\n          \"Mayo Clinic\",\n          \"[Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biophysics, University of P\\u00e9cs Medical School, 7624 P\\u00e9cs, Hungary. Electronic address: eva.morava@mssm.edu.]\",\n          \"MAYO CLINIC ROCHESTER\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"name\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          [\n            \"Ackermann AM\",\n            \"[Division of Endocrinology and Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, United States., Congenital Hyperinsulinism Center, Children's Hospital of Philadelphia, Philadelphia, PA, United States., Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.]\"\n          ],\n          [\n            \"Eva Morava-Kozicz\",\n            \"Mayo Clinic\"\n          ],\n          [\n            \"Morava E\",\n            \"[Department of Clinical Genomics, Mayo Clinic, Rochester, MN, USA; Department of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Biophysics, University of P\\u00e9cs Medical School, 7624 P\\u00e9cs, Hungary. Electronic address: eva.morava@mssm.edu.]\"\n          ]\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"[]\",\n          \"[AVTX-801]\",\n          \"[c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, d, (, ), f, y, p, h, -, 1]\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": 0,\n        \"max\": 5,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          3,\n          0,\n          5\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"network\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"lat\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1.773842211415661,\n        \"min\": 40.0077,\n        \"max\": 44.0154,\n        \"num_unique_values\": 4,\n        \"samples\": [\n          44.0154,\n          43.168,\n          40.0077\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"lng\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 9.355867171067928,\n        \"min\": -92.478,\n        \"max\": -73.8673,\n        \"num_unique_values\": 4,\n        \"samples\": [\n          -92.478,\n          -77.6162,\n          -75.1339\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"fip\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 4,\n        \"samples\": [\n          \"27109\",\n          \"36055\",\n          \"42101\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "concatenated_data"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-9dbe5425-4499-4c08-902b-71e66ceeb63e\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>PI</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>affiliation</th>\n",
              "      <th>name</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Community</th>\n",
              "      <th>network</th>\n",
              "      <th>lat</th>\n",
              "      <th>lng</th>\n",
              "      <th>fip</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>Ackermann AM</td>\n",
              "      <td>PurposePhosphoglucomutase-1 deficiency is a s...</td>\n",
              "      <td>[Division of Endocrinology and Diabetes, Child...</td>\n",
              "      <td>(Ackermann AM, [Division of Endocrinology and ...</td>\n",
              "      <td>[]</td>\n",
              "      <td>3</td>\n",
              "      <td>{}</td>\n",
              "      <td>40.0077</td>\n",
              "      <td>-75.1339</td>\n",
              "      <td>42101</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>Eva Morava-Kozicz</td>\n",
              "      <td>A Phase 2b, Multicenter, Randomized, Double-bl...</td>\n",
              "      <td>Mayo Clinic</td>\n",
              "      <td>(Eva Morava-Kozicz, Mayo Clinic)</td>\n",
              "      <td>[AVTX-801]</td>\n",
              "      <td>0</td>\n",
              "      <td>{}</td>\n",
              "      <td>44.0154</td>\n",
              "      <td>-92.4780</td>\n",
              "      <td>27109</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>FREEZE, HUDSON H.</td>\n",
              "      <td>DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/P...</td>\n",
              "      <td>MAYO CLINIC ROCHESTER</td>\n",
              "      <td>(FREEZE, HUDSON H., MAYO CLINIC ROCHESTER)</td>\n",
              "      <td>[accurate diagnosis, Address, Affect, Affectiv...</td>\n",
              "      <td>1</td>\n",
              "      <td>{}</td>\n",
              "      <td>44.0154</td>\n",
              "      <td>-92.4780</td>\n",
              "      <td>27109</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>Kronn D</td>\n",
              "      <td>Phosphoglucomutase 1 deficiency is a congenit...</td>\n",
              "      <td>[Department of Pediatrics, New York Medical Co...</td>\n",
              "      <td>(Kronn D, [Department of Pediatrics, New York ...</td>\n",
              "      <td>[exercise intolerance, dilated cardiomyopathy,...</td>\n",
              "      <td>4</td>\n",
              "      <td>{}</td>\n",
              "      <td>40.9466</td>\n",
              "      <td>-73.8673</td>\n",
              "      <td>36119</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>MORAVA-KOZICZ, EVA</td>\n",
              "      <td>CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMAR...</td>\n",
              "      <td>MAYO CLINIC ROCHESTER</td>\n",
              "      <td>(MORAVA-KOZICZ, EVA, MAYO CLINIC ROCHESTER)</td>\n",
              "      <td>[Address, Animal Model, Biochemical Genetics, ...</td>\n",
              "      <td>2</td>\n",
              "      <td>{}</td>\n",
              "      <td>44.0154</td>\n",
              "      <td>-92.4780</td>\n",
              "      <td>27109</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>Morava E</td>\n",
              "      <td>Phosphoglucomutase-1-congenital disorder of g...</td>\n",
              "      <td>[Department of Clinical Genomics, Mayo Clinic,...</td>\n",
              "      <td>(Morava E, [Department of Clinical Genomics, M...</td>\n",
              "      <td>[c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, ...</td>\n",
              "      <td>5</td>\n",
              "      <td>{}</td>\n",
              "      <td>43.1680</td>\n",
              "      <td>-77.6162</td>\n",
              "      <td>36055</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-9dbe5425-4499-4c08-902b-71e66ceeb63e')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-9dbe5425-4499-4c08-902b-71e66ceeb63e button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-9dbe5425-4499-4c08-902b-71e66ceeb63e');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-36af2a7c-8c4c-4623-b233-ccf0b153ec03\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-36af2a7c-8c4c-4623-b233-ccf0b153ec03')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-36af2a7c-8c4c-4623-b233-ccf0b153ec03 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_05d7d883-ffe9-454d-84c1-5997e93a8025\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('concatenated_data')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_05d7d883-ffe9-454d-84c1-5997e93a8025 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('concatenated_data');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "                   PI                                           Abstract  \\\n",
              "0        Ackermann AM   PurposePhosphoglucomutase-1 deficiency is a s...   \n",
              "1   Eva Morava-Kozicz  A Phase 2b, Multicenter, Randomized, Double-bl...   \n",
              "2   FREEZE, HUDSON H.  DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/P...   \n",
              "3             Kronn D   Phosphoglucomutase 1 deficiency is a congenit...   \n",
              "4  MORAVA-KOZICZ, EVA  CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMAR...   \n",
              "5            Morava E   Phosphoglucomutase-1-congenital disorder of g...   \n",
              "\n",
              "                                         affiliation  \\\n",
              "0  [Division of Endocrinology and Diabetes, Child...   \n",
              "1                                        Mayo Clinic   \n",
              "2                              MAYO CLINIC ROCHESTER   \n",
              "3  [Department of Pediatrics, New York Medical Co...   \n",
              "4                              MAYO CLINIC ROCHESTER   \n",
              "5  [Department of Clinical Genomics, Mayo Clinic,...   \n",
              "\n",
              "                                                name  \\\n",
              "0  (Ackermann AM, [Division of Endocrinology and ...   \n",
              "1                   (Eva Morava-Kozicz, Mayo Clinic)   \n",
              "2         (FREEZE, HUDSON H., MAYO CLINIC ROCHESTER)   \n",
              "3  (Kronn D, [Department of Pediatrics, New York ...   \n",
              "4        (MORAVA-KOZICZ, EVA, MAYO CLINIC ROCHESTER)   \n",
              "5  (Morava E, [Department of Clinical Genomics, M...   \n",
              "\n",
              "                                               Terms  Community network  \\\n",
              "0                                                 []          3      {}   \n",
              "1                                         [AVTX-801]          0      {}   \n",
              "2  [accurate diagnosis, Address, Affect, Affectiv...          1      {}   \n",
              "3  [exercise intolerance, dilated cardiomyopathy,...          4      {}   \n",
              "4  [Address, Animal Model, Biochemical Genetics, ...          2      {}   \n",
              "5  [c, o, a, g, u, l, t, i, n,  , b, r, m, e, s, ...          5      {}   \n",
              "\n",
              "       lat      lng    fip  \n",
              "0  40.0077 -75.1339  42101  \n",
              "1  44.0154 -92.4780  27109  \n",
              "2  44.0154 -92.4780  27109  \n",
              "3  40.9466 -73.8673  36119  \n",
              "4  44.0154 -92.4780  27109  \n",
              "5  43.1680 -77.6162  36055  "
            ]
          },
          "execution_count": 86,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "concatenated_data ['fip']=concatenated_data ['FIPS']\n",
        "concatenated_data= concatenated_data.drop('FIPS' , axis=1)\n",
        "concatenated_data"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "R0tLlNUwFODU"
      },
      "outputs": [],
      "source": [
        "concatenated_data=pd.read_csv('/content/concatenated_data.csv')\n",
        "import ast\n",
        "import pandas as pd\n",
        "\n",
        "def safe_dict_conversion(x):\n",
        "    try:\n",
        "        # Try to evaluate if it's a valid string representation of a dictionary\n",
        "        if isinstance(x, str):\n",
        "            # Handle the specific case of 'set()' by replacing it with an empty dictionary\n",
        "            if x == 'set()' or x == '' or x.lower() == 'none':\n",
        "                return {}\n",
        "            else:\n",
        "                return ast.literal_eval(x) if isinstance(ast.literal_eval(x), dict) else {}\n",
        "        # If it's not a string, return an empty dictionary\n",
        "        return {}\n",
        "    except (ValueError, SyntaxError):\n",
        "        # If there's any error in eval, return an empty dictionary\n",
        "        return {}\n",
        "\n",
        "# Apply the function to the 'network' column\n",
        "concatenated_data['network'] = concatenated_data['network'].apply(safe_dict_conversion)\n",
        "concatenated_data['name'] = concatenated_data['name'].apply(ast.literal_eval)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "Fr0ttpMishgM",
        "outputId": "27b13b73-484d-4e8b-930b-8579895b0775"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "3542"
            ]
          },
          "execution_count": 149,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "concatenated_data.shape[0]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "tGnNGtX3FRTq"
      },
      "outputs": [],
      "source": [
        "concatenated_data1=concatenated_data\n",
        "Node=[]\n",
        "Edge=[]\n",
        "Node=list(set(list(concatenated_data1['fip'].values)))\n",
        "for i in concatenated_data1.index:\n",
        "     for j in concatenated_data1['network'][i]:\n",
        "           filtered_data = concatenated_data1[concatenated_data1['name'] == j]\n",
        "           if not filtered_data.empty:\n",
        "                  value = filtered_data['fip'].iloc[0]\n",
        "                  edge=( concatenated_data1['fip'][i],value )\n",
        "                  Edge.append(edge)\n",
        "           else: pass\n",
        "\n",
        "Edge=list(set(Edge))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "E5qYseuOFVsl"
      },
      "outputs": [],
      "source": [
        "import networkx as nx\n",
        "from networkx.algorithms import community #This part of networkx, for community detection, needs to be imported separately.\n",
        "#G = nx.Graph()\n",
        "G=nx.DiGraph()\n",
        "G.add_nodes_from(Node)\n",
        "G.add_edges_from(Edge)\n",
        "#nx.info(G)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "v97_E1j1FWSr"
      },
      "outputs": [],
      "source": [
        "Node_utility=Node\n",
        "Edge_utility=[]\n",
        "Fips_utlity=Node\n",
        "Lat_utlity=[]\n",
        "Log_utlity=[]\n",
        "n=0\n",
        "while n < len(Node_utility):\n",
        "      Lat_utlity.append(  concatenated_data1[concatenated_data1['fip']==Node[n]]['lat'].iloc[0] )\n",
        "      Log_utlity.append(  concatenated_data1[concatenated_data1['fip']==Node[n]]['lng'].iloc[0] )\n",
        "      n+=1\n",
        "      #Node_utility.append(Utility_County[0][i])\n",
        "\n",
        "G_utility=nx.DiGraph()\n",
        "G_utility.add_nodes_from(Node_utility)\n",
        "G_utility.add_edges_from(Edge_utility)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "uLeXnTn0FYyR"
      },
      "outputs": [],
      "source": [
        "import numpy as np\n",
        "Fips_latlong_utility=pd.DataFrame()\n",
        "Fips_latlong_utility['Utility Number']=Node_utility\n",
        "Fips_latlong_utility['fips']=Node_utility\n",
        "Fips_latlong_utility['Latitude']=Lat_utlity\n",
        "Fips_latlong_utility['Longitude']=Log_utlity\n",
        "\n",
        "\n",
        "data_G=pd.DataFrame()\n",
        "data_G['Node']=Node\n",
        "d = nx.degree(G)\n",
        "data_G['degree']=d\n",
        "\n",
        "data_G_utility=pd.DataFrame()\n",
        "data_G_utility['Node']=Fips_latlong_utility['Utility Number']\n",
        "data_G_utility['degree']=''\n",
        "for i in range(data_G_utility.shape[0]):\n",
        "    if Fips_latlong_utility['fips'][i] in data_G['Node'].values:\n",
        "        data_G_utility.at[i,'degree'] = data_G.loc[data_G['Node'] == Fips_latlong_utility['fips'][i]]['degree'].item()\n",
        "    else:\n",
        "        data_G_utility.at[i,'degree'] = 1"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "6DcMbRl8Fe4J"
      },
      "outputs": [],
      "source": [
        "for i in range(data_G_utility.shape[0]):\n",
        "     data_G_utility.at[i,'degree']=data_G_utility['degree'][i][1]\n",
        "List=np.array(data_G_utility['degree'].astype(float))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "eAPoWXYqFfhI",
        "outputId": "1d1c9d02-0478-43e9-f322-ea641ee2b3a0"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Collecting basemap\n",
            "  Downloading basemap-1.4.1-cp310-cp310-manylinux1_x86_64.whl.metadata (9.1 kB)\n",
            "Collecting basemap-data<1.4,>=1.3.2 (from basemap)\n",
            "  Downloading basemap_data-1.3.2-py2.py3-none-any.whl.metadata (2.7 kB)\n",
            "Requirement already satisfied: pyshp<2.4,>=1.2 in /usr/local/lib/python3.10/dist-packages (from basemap) (2.3.1)\n",
            "Collecting matplotlib<3.9,>=1.5 (from basemap)\n",
            "  Downloading matplotlib-3.8.4-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (5.8 kB)\n",
            "Collecting pyproj<3.7.0,>=1.9.3 (from basemap)\n",
            "  Downloading pyproj-3.6.1-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl.metadata (31 kB)\n",
            "Collecting packaging<24.0,>=16.0 (from basemap)\n",
            "  Downloading packaging-23.2-py3-none-any.whl.metadata (3.2 kB)\n",
            "Requirement already satisfied: numpy<1.27,>=1.21 in /usr/local/lib/python3.10/dist-packages (from basemap) (1.26.4)\n",
            "Requirement already satisfied: contourpy>=1.0.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib<3.9,>=1.5->basemap) (1.3.1)\n",
            "Requirement already satisfied: cycler>=0.10 in /usr/local/lib/python3.10/dist-packages (from matplotlib<3.9,>=1.5->basemap) (0.12.1)\n",
            "Requirement already satisfied: fonttools>=4.22.0 in /usr/local/lib/python3.10/dist-packages (from matplotlib<3.9,>=1.5->basemap) (4.55.3)\n",
            "Requirement already satisfied: kiwisolver>=1.3.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib<3.9,>=1.5->basemap) (1.4.8)\n",
            "Requirement already satisfied: pillow>=8 in /usr/local/lib/python3.10/dist-packages (from matplotlib<3.9,>=1.5->basemap) (11.1.0)\n",
            "Requirement already satisfied: pyparsing>=2.3.1 in /usr/local/lib/python3.10/dist-packages (from matplotlib<3.9,>=1.5->basemap) (3.2.1)\n",
            "Requirement already satisfied: python-dateutil>=2.7 in /usr/local/lib/python3.10/dist-packages (from matplotlib<3.9,>=1.5->basemap) (2.8.2)\n",
            "Requirement already satisfied: certifi in /usr/local/lib/python3.10/dist-packages (from pyproj<3.7.0,>=1.9.3->basemap) (2024.12.14)\n",
            "Requirement already satisfied: six>=1.5 in /usr/local/lib/python3.10/dist-packages (from python-dateutil>=2.7->matplotlib<3.9,>=1.5->basemap) (1.17.0)\n",
            "Downloading basemap-1.4.1-cp310-cp310-manylinux1_x86_64.whl (935 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m936.0/936.0 kB\u001b[0m \u001b[31m45.9 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading basemap_data-1.3.2-py2.py3-none-any.whl (30.5 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m30.5/30.5 MB\u001b[0m \u001b[31m26.1 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading matplotlib-3.8.4-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (11.6 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m11.6/11.6 MB\u001b[0m \u001b[31m43.4 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading packaging-23.2-py3-none-any.whl (53 kB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m53.0/53.0 kB\u001b[0m \u001b[31m5.6 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hDownloading pyproj-3.6.1-cp310-cp310-manylinux_2_17_x86_64.manylinux2014_x86_64.whl (8.3 MB)\n",
            "\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m8.3/8.3 MB\u001b[0m \u001b[31m107.7 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25hInstalling collected packages: pyproj, packaging, basemap-data, matplotlib, basemap\n",
            "  Attempting uninstall: pyproj\n",
            "    Found existing installation: pyproj 3.7.0\n",
            "    Uninstalling pyproj-3.7.0:\n",
            "      Successfully uninstalled pyproj-3.7.0\n",
            "  Attempting uninstall: packaging\n",
            "    Found existing installation: packaging 24.2\n",
            "    Uninstalling packaging-24.2:\n",
            "      Successfully uninstalled packaging-24.2\n",
            "  Attempting uninstall: matplotlib\n",
            "    Found existing installation: matplotlib 3.10.0\n",
            "    Uninstalling matplotlib-3.10.0:\n",
            "      Successfully uninstalled matplotlib-3.10.0\n",
            "Successfully installed basemap-1.4.1 basemap-data-1.3.2 matplotlib-3.8.4 packaging-23.2 pyproj-3.6.1\n"
          ]
        }
      ],
      "source": [
        "!python -m pip install basemap\n",
        "#!python -m pip install basemap-data-hires"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "w1RKlLc1syx1",
        "outputId": "509f5fe6-d039-4907-d83d-64b25ce35d16"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "181\n"
          ]
        }
      ],
      "source": [
        "n=0\n",
        "for node in G.nodes():\n",
        "  n+=1\n",
        "print(n)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 874
        },
        "id": "nuNhkqpUFhNV",
        "outputId": "2381c19b-97da-4977-9e73-528ffe077eaf"
      },
      "outputs": [
        {
          "ename": "NetworkXError",
          "evalue": "Node 29189 has no position.",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mKeyError\u001b[0m                                  Traceback (most recent call last)",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/networkx/drawing/nx_pylab.py\u001b[0m in \u001b[0;36mdraw_networkx_nodes\u001b[0;34m(G, pos, nodelist, node_size, node_color, node_shape, alpha, cmap, vmin, vmax, ax, linewidths, edgecolors, label, margins, hide_ticks)\u001b[0m\n\u001b[1;32m    444\u001b[0m     \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 445\u001b[0;31m         \u001b[0mxy\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mnp\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0masarray\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mpos\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mv\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mv\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mnodelist\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    446\u001b[0m     \u001b[0;32mexcept\u001b[0m \u001b[0mKeyError\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0merr\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/networkx/drawing/nx_pylab.py\u001b[0m in \u001b[0;36m<listcomp>\u001b[0;34m(.0)\u001b[0m\n\u001b[1;32m    444\u001b[0m     \u001b[0;32mtry\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 445\u001b[0;31m         \u001b[0mxy\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mnp\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0masarray\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mpos\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mv\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mv\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mnodelist\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    446\u001b[0m     \u001b[0;32mexcept\u001b[0m \u001b[0mKeyError\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0merr\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mKeyError\u001b[0m: 29189",
            "\nThe above exception was the direct cause of the following exception:\n",
            "\u001b[0;31mNetworkXError\u001b[0m                             Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-167-29786de4b035>\u001b[0m in \u001b[0;36m<cell line: 35>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     33\u001b[0m \u001b[0;31m# Now pass only the valid nodes to the draw function\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     34\u001b[0m \u001b[0;31m#d_valid = [(d[node]+1) * 2500 for node in valid_nodes]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 35\u001b[0;31m \u001b[0mnx\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdraw_networkx_nodes\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mG\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mpos\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mpos\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mnodelist\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mvalid_nodes\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mnode_color\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m'r'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0malpha\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m0.8\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     36\u001b[0m \u001b[0mnx\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdraw_networkx_edges\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mG\u001b[0m \u001b[0;34m,\u001b[0m \u001b[0mpos\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mpos\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0medge_color\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m'g'\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0malpha\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m0.2\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0marrows\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mFalse\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mwidth\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m2\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     37\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/networkx/drawing/nx_pylab.py\u001b[0m in \u001b[0;36mdraw_networkx_nodes\u001b[0;34m(G, pos, nodelist, node_size, node_color, node_shape, alpha, cmap, vmin, vmax, ax, linewidths, edgecolors, label, margins, hide_ticks)\u001b[0m\n\u001b[1;32m    445\u001b[0m         \u001b[0mxy\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mnp\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0masarray\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mpos\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mv\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mv\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mnodelist\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    446\u001b[0m     \u001b[0;32mexcept\u001b[0m \u001b[0mKeyError\u001b[0m \u001b[0;32mas\u001b[0m \u001b[0merr\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 447\u001b[0;31m         \u001b[0;32mraise\u001b[0m \u001b[0mnx\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mNetworkXError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34mf\"Node {err} has no position.\"\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mfrom\u001b[0m \u001b[0merr\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    448\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    449\u001b[0m     \u001b[0;32mif\u001b[0m \u001b[0misinstance\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0malpha\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mIterable\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mNetworkXError\u001b[0m: Node 29189 has no position."
          ]
        },
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 2000x900 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "from mpl_toolkits.basemap import Basemap as Basemap\n",
        "plt.figure(figsize = (20,9))\n",
        "m = Basemap(\n",
        "         #projection='merc',   'mill',  'cyl'\n",
        "         llcrnrlon=-130,    #-180,  left\n",
        "         llcrnrlat=25,         #   10,  south\n",
        "         urcrnrlon=-50,   #-50, right\n",
        "         urcrnrlat=50,    #70,  North\n",
        "         lat_ts=0,\n",
        "         resolution='l',     #   c - crude,  l - low,  h - high,  f - full\n",
        "         suppress_ticks=True)\n",
        "\n",
        "mx, my = m(pd.to_numeric(fip_finding['lng'].astype(str).str.replace('–', '-', regex=True), downcast='float').values,  pd.to_numeric(fip_finding['lat'], downcast='float').values)\n",
        "\n",
        "############ Counties\n",
        "#mx, my = m(pd.to_numeric(fip_finding['lng'].str.replace('–', '-', regex=True), downcast='float').values,  pd.to_numeric(fip_finding['lat'], downcast='float').values)\n",
        "pos = {}\n",
        "\n",
        "fip_finding['county_fips'] = fip_finding['county_fips'].astype(str)\n",
        "fip_finding['county_fips'] = fip_finding['county_fips'].apply(lambda x: '{0:0>5}'.format(x))\n",
        "\n",
        "for count, elem in enumerate (fip_finding['county_fips'].values):\n",
        "      pos[elem] = (mx[count], my[count])\n",
        "\n",
        "\n",
        "#pos=nx.spring_layout(G)\n",
        "d = nx.degree(G)\n",
        "d = [(d[node]+1) * 25 for node in G.nodes()]\n",
        "#nx.draw_networkx_nodes(G , pos = pos, node_color = 'r', alpha = 0.8, node_size=d) #node_size = 4)\n",
        "\n",
        "\n",
        "valid_nodes = [node for node in G.nodes() if str(node) in pos]\n",
        "# Now pass only the valid nodes to the draw function\n",
        "d_valid = [(d[node]+1) * 2500 for node in valid_nodes]\n",
        "nx.draw_networkx_nodes(G, pos=pos, nodelist=valid_nodes, node_color='r', alpha=0.8, node_size=d_valid)\n",
        "nx.draw_networkx_edges(G , pos = pos, edge_color='g',alpha=0.2, arrows = False, width=2)\n",
        "\n",
        "\n",
        "\n",
        "####### Utilities\n",
        "#mx1, my1 = m(pd.to_numeric(Fips_latlong_utility['Longitude'].str.replace('–', '-', regex=True), downcast='float').values,  pd.to_numeric(Fips_latlong_utility['Latitude'], downcast='float').values)\n",
        "pos1 = {}\n",
        "#for count, elem in enumerate (Fips_latlong_utility['Utility Number'].values):\n",
        "#       pos1[elem] = (mx[count], my[count])\n",
        "n=0\n",
        "while n<len(Node_utility):\n",
        "  pos1[Node_utility[n]] = (Log_utlity[n],Lat_utlity[n])\n",
        "  n+=1\n",
        "\n",
        "dd = List*1\n",
        "nx.draw_networkx_nodes(G_utility , pos = pos1,node_shape ='s' , node_color = 'k', alpha = 0.8,node_size=50) #node_size = 4,   node_shape  'so^>v<dph8'\n",
        "#filled_markers = ('o', 'v', '^', '<', '>', '8', 's', 'p', '*', 'h', 'H', 'D', 'd', 'P', 'X')\n",
        "\n",
        "\n",
        "m.drawcountries(linewidth = 3)\n",
        "m.drawstates(linewidth = 0.2)\n",
        "m.drawcoastlines(linewidth=3)\n",
        "#m.drawcounties(color='darkred')\n",
        "#m.bluemarble()\n",
        "#m.etopo()\n",
        "\n",
        "plt.tight_layout()\n",
        "#plt.savefig(\"/content/drive/Shareddrives/MY Files/Utility-based /map_1.png\", format = \"png\", dpi = 300)\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "AZqwGg_psUEH",
        "outputId": "05dddfe8-a569-48f5-d45c-758637631b62"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "[25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25,\n",
              " 25]"
            ]
          },
          "execution_count": 165,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "d"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "R8OQHY9uFn-M",
        "outputId": "1ebd59a6-476a-4532-fbcb-1328de4d3a87"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: python-louvain in /usr/local/lib/python3.10/dist-packages (0.16)\n",
            "Requirement already satisfied: networkx in /usr/local/lib/python3.10/dist-packages (from python-louvain) (3.4.2)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.10/dist-packages (from python-louvain) (1.26.4)\n"
          ]
        }
      ],
      "source": [
        "!pip install python-louvain"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "qB0Fhbg-ForF",
        "outputId": "e27edb76-628a-42ec-d108-5ff37f2d270b"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "[[24033], [26081], [2020], [27109], [44007], [44009], [48113], [27123], [29173], [5119]]\n",
            "5 Largest Cliques [[29189], [48135], [22033], [42003], [48167]]\n",
            "Top 10 county By Pagerank [(29189, 0.005524861878453028), (48135, 0.005524861878453028), (22033, 0.005524861878453028), (42003, 0.005524861878453028), (48167, 0.005524861878453028), (42027, 0.005524861878453028), (41003, 0.005524861878453028), (22061, 0.005524861878453028), (42029, 0.005524861878453028), (51760, 0.005524861878453028)]\n",
            "Top 10 Biggest Hubs [(29189, nan), (48135, nan), (22033, nan), (42003, nan), (48167, nan), (42027, nan), (41003, nan), (22061, nan), (42029, nan), (51760, nan)]\n",
            "\n",
            "Top 10 Biggest Authorities [(27109, 0.07904865125885929), (42129, 0.07689477663711461), (24021, 0.07436981815474722), (48215, 0.07322049348020351), (48167, 0.07145902244991588), (41051, 0.06871528205340763), (51760, 0.06820218290375027), (39061, 0.0661931969916058), (6059, 0.06558067703746177), (26081, 0.06307828577049855)]\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.10/dist-packages/networkx/algorithms/link_analysis/hits_alg.py:92: RuntimeWarning: invalid value encountered in divide\n",
            "  h /= h.sum()\n"
          ]
        }
      ],
      "source": [
        "G=nx.Graph()\n",
        "G.add_nodes_from(Node)\n",
        "G.add_edges_from(Edge)\n",
        "\n",
        "###########################################################  Cliques ###################################\n",
        "cl=nx.enumerate_all_cliques(G)\n",
        "#print last 10 cliques\n",
        "print([l for l in cl][-10:])\n",
        "#\"5 Largest Cliques\"\n",
        "print(\"5 Largest Cliques\",sorted([l for l in nx.find_cliques(G)],key=lambda x: len(x),reverse=True)[:5])\n",
        "\n",
        "##################################################### PAGERANK and HITS  ###################################\n",
        "pg_rank=sorted([l for l in nx.pagerank(G).items()],key=lambda x: x[1],reverse=True)\n",
        "print(\"Top 10 county By Pagerank\",pg_rank[:10])\n",
        "\n",
        "hubs,authorities=nx.hits(G)\n",
        "hubs=sorted([l for l in hubs.items()],key=lambda x: x[1],reverse=True)\n",
        "authorities=sorted([l for l in authorities.items()],key=lambda x: x[1],reverse=True)\n",
        "print(\"Top 10 Biggest Hubs\",hubs[:10])\n",
        "print(\"\\nTop 10 Biggest Authorities\",authorities[:10])\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_SAmW0mVriTF",
        "outputId": "287c63ae-2fda-4c51-ded0-4a1d8f87247c"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "0"
            ]
          },
          "execution_count": 133,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "len(valid_nodes)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 291
        },
        "id": "-PkDGl6-FtUh",
        "outputId": "eff57627-5f90-4d11-c437-0fa56accdae4"
      },
      "outputs": [
        {
          "data": {
            "image/png": "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\n",
            "text/plain": [
              "<Figure size 2000x900 with 1 Axes>"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "############################  Communty Detection  ######################\n",
        "import community #requires separate install -  pip install python-louvain\n",
        "from community import community_louvain\n",
        "import warnings\n",
        "\n",
        "plt.figure(figsize=(20,9))\n",
        "#pos = nx.spring_layout(Gc,iterations=50,k=2)\n",
        "partition = community_louvain.best_partition(G)\n",
        "values = [partition.get(node) for node in G.nodes()]\n",
        "\n",
        "\n",
        "#####################################################################\n",
        "\n",
        "\n",
        "plt.axis(\"off\")\n",
        "plt.title('Social Network'.format(len(set(partition.values()))))\n",
        "#nx.draw_networkx(Gc, pos = pos, cmap = plt.get_cmap(\"jet\"), node_color = values, node_size = 1, with_labels = False)\n",
        "\n",
        "valid_nodes = [node for node in G.nodes() if node in pos]\n",
        "# Now pass only the valid nodes to the draw function\n",
        "d_valid = [(d[node]+1) * 2500 for node in valid_nodes]\n",
        "nx.draw_networkx_nodes(G, pos=pos, nodelist=valid_nodes, node_color='r', alpha=0.8, node_size=d_valid)\n",
        "#nx.draw_networkx_nodes(G , pos = pos, cmap = plt.get_cmap(\"jet\"), node_color = values, alpha = 0.8, node_size=50) #node_size = 4)\n",
        "nx.draw_networkx_edges(G , pos = pos, edge_color='k',alpha=0.2, arrows = False,width=5)\n",
        "\n",
        "\n",
        "m.drawcountries(linewidth = 3)\n",
        "m.drawstates(linewidth = 0.2)\n",
        "m.drawcoastlines(linewidth=3)\n",
        "#m.drawcounties(color='darkred')\n",
        "#m.bluemarble()\n",
        "#m.etopo()\n",
        "\n",
        "plt.tight_layout()\n",
        "plt.show()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ckOuCP-PFzhM"
      },
      "outputs": [],
      "source": [
        "L = nx.laplacian_matrix(G)\n",
        "eig_values, eig_vectors = np.linalg.eigh(L.todense()) # Eigen values sorted from smallest to biggest\n",
        "f = eig_vectors[:,1] # use the second smallest Eigen vector for spectral clustering\n",
        "labels = np.ravel(np.sign(f)) # decides the label of each node\n",
        "\n",
        "\n",
        "#####################################################################\n",
        "\n",
        "fig = plt.figure(figsize=(9,6))\n",
        "plt.axis(\"off\")\n",
        "#nx.draw_networkx(Gc, pos,node_size=45, cmap = plt.get_cmap(\"jet\"), node_color=labels, with_labels = False)\n",
        "nx.draw_networkx_nodes(G , pos = pos, cmap = plt.get_cmap(\"jet\"), node_color = labels, alpha = 0.8, node_size=10) #node_size = 4)\n",
        "nx.draw_networkx_edges(G , pos = pos, edge_color='k',alpha=0.2, arrows = False)\n",
        "\n",
        "\n",
        "m.drawcountries(linewidth = 3)\n",
        "m.drawstates(linewidth = 0.2)\n",
        "m.drawcoastlines(linewidth=3)\n",
        "#m.drawcounties(color='darkred')\n",
        "#m.bluemarble()\n",
        "#m.etopo()\n",
        "\n",
        "plt.tight_layout()\n",
        "plt.show()\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "aGkqPTvrPCSt"
      },
      "source": [
        "# all codes in one section"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "38KwVA48NGpM",
        "outputId": "46250714-325c-409c-e909-f6eaec80597f"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0 7 734\n",
            "Grant: finished\n",
            "Pubmed: finished\n",
            "--- start ---\n",
            "--- 0.0005049705505371094 seconds ---\n",
            "--- 0.005098104476928711 seconds ---\n",
            "--- 0.3682534694671631 seconds ---\n"
          ]
        }
      ],
      "source": [
        "disease='Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid='GARD0017510'\n",
        "\n",
        "ClinicalTrial =pd.DataFrame()# pd.read_csv('/content/ClinicalTrial.csv')\n",
        "Grant = pd.read_csv('/content/Grants.csv')#,  error_bad_lines=False)\n",
        "Pubmed=pd.read_csv('/content/Pubmed.csv')\n",
        "\n",
        "\n",
        "ClinicalTrial = ClinicalTrial.replace('\"', '', regex=True)\n",
        "Grant = Grant.replace('\"', '', regex=True)\n",
        "Pubmed = Pubmed.replace('\"', '', regex=True)\n",
        "print(ClinicalTrial.shape[0], Grant.shape[0], Pubmed.shape[0])\n",
        "\n",
        "ClinicalTrial['GARDname']= disease\n",
        "Grant['GARDname']= disease\n",
        "Pubmed['GARDname']= disease\n",
        "\n",
        "\n",
        "# Rename the columns of each DataFrame\n",
        "ClinicalTrial.rename(columns=rename_dict_1, inplace=True)\n",
        "Grant.rename(columns=rename_dict_2, inplace=True)\n",
        "\n",
        "Pubmed.rename(columns=rename_dict_3, inplace=True)\n",
        "'''\n",
        "for i in range(len(ClinicalTrial)):\n",
        "      event_properties = {\n",
        "                'OfficialName': ClinicalTrial['OfficialName'][i],\n",
        "                'OfficialAffiliation': ClinicalTrial['OfficialAffiliation'][i],\n",
        "                'BriefTitle': ClinicalTrial['BriefTitle'][i],\n",
        "                'OfficialTitle':ClinicalTrial['OfficialTitle'][i],\n",
        "                'BriefSummary': ClinicalTrial['BriefSummary'][i],\n",
        "                'NCTId': ClinicalTrial['NCTId'][i],\n",
        "                'LocationCity': ClinicalTrial['LocationCity'][i],\n",
        "                 'LocationState': ClinicalTrial['LocationState'][i],\n",
        "                'LocationCountry': ClinicalTrial['LocationCountry'][i],\n",
        "                'LocationFacility': ClinicalTrial['LocationFacility'][i],\n",
        "                'Interventions': ClinicalTrial['Interventions'][i],\n",
        "                'GARDname': ClinicalTrial['GARDname'][i],\n",
        "                'year': ClinicalTrial['StartDate'][i][-4:]\n",
        "        }\n",
        "      create_ClinicalTrial_node(event_properties)\n",
        "print('CT: finished')\n",
        "'''\n",
        "for i in range(len(Grant)):\n",
        "    event_properties = {\n",
        "        'pi_name': str(Grant['pi_name'][i]),\n",
        "        'org_name': str(Grant['org_name'][i]),\n",
        "        'title': str(Grant['title'][i]),\n",
        "        'application_id': str(Grant['application_id'][i]),\n",
        "        'abstract': str(Grant['abstract'][i]),\n",
        "        'terms': str(Grant['terms'][i]),\n",
        "        'GARDname': Grant['GARDname'][i],\n",
        "        'year': Grant['year'][i]\n",
        "    }\n",
        "    create_Grant_node(event_properties)\n",
        "print('Grant: finished')\n",
        "\n",
        "for i in range(len(Pubmed)):\n",
        "    event_properties = {\n",
        "        'fullName': Pubmed['fullName'][i],  # Convert to string\n",
        "        'ar_title': Pubmed['title'][i],  # Convert to string\n",
        "        'ar_affiliation': Pubmed['affiliation'][i],  # Convert to string\n",
        "        'pubmed_id': Pubmed['pubmed_id'][i],  # Convert to string (or other appropriate type)\n",
        "        'abstractText': Pubmed['abstractText'][i],  # Convert to string\n",
        "        'concatenatedKeywords': Pubmed['concatenatedKeywords'][i],  # Convert to string\n",
        "        'GARDname': Pubmed['GARDname'][i],  # Convert to string\n",
        "        'year': Pubmed['year'][i]\n",
        "    }\n",
        "    create_Pubmed_node(event_properties)\n",
        "\n",
        "print('Pubmed: finished')\n",
        "\n",
        "\n",
        "\n",
        "event_properties = {'GARDID': diseaseid ,'GARDname':disease }\n",
        "create_Gard_node(event_properties)\n",
        "#create_relationship_between_nodes('ClinicalTrial','Gard',  \"RELATED_GARD\")\n",
        "create_relationship_between_nodes('Grant','Gard',  \"RELATED_GARD\")\n",
        "create_relationship_between_nodes('Pubmed','Gard',  \"RELATED_GARD\")\n",
        "'''\n",
        "def extract_and_create_researcher_location_nodes_CT():\n",
        " with driver.session() as session:\n",
        "  query = \"MATCH (i:ClinicalTrial) where i.GARDname= $disease RETURN i.OfficialName AS OfficialName, i.OfficialAffiliation AS OfficialAffiliation, i.LocationCountry as LocationCountry, i.LocationCity as LocationCity,i.LocationState as LocationState\"\n",
        "  results = session.run(query, disease=disease)\n",
        "  for ClinicalTrial in results:\n",
        "   Name=  ClinicalTrial['OfficialName']\n",
        "   Aff_name=   str(ClinicalTrial['OfficialAffiliation'])\n",
        "   if  classify_entity(Name)==True and (Name, Aff_name) not in current_names:\n",
        "    event_properties = {\n",
        "        'Name': Name,\n",
        "        'Contact_info': '',#str(ClinicalTrial['i.OfficialAffiliation'][i]),\n",
        "        'Aff_name':Aff_name,\n",
        "        'Aff_Zip': ''#str(ClinicalTrial['LocationZip'][i]),\n",
        "    }\n",
        "    create_Researcher_node(event_properties)\n",
        "    city_  = str(ClinicalTrial['LocationCity']).lower().strip()\n",
        "    State_ = str(ClinicalTrial['LocationState']).lower().strip()\n",
        "    event_properties = {\n",
        "        'Aff_country': str(ClinicalTrial['LocationCountry']),\n",
        "        'Aff_state': State_,\n",
        "        'Aff_county': find_fip(city_, State_ )[1] ,\n",
        "        'Aff_city': city_,\n",
        "        'Aff_FIPS': find_fip(city_, State_ )[0]\n",
        "    }\n",
        "    create_Location_node(event_properties, Name, Aff_name)\n",
        "    current_names[(Name, Aff_name)] =1\n",
        "\n",
        "current_names={}\n",
        "extract_and_create_researcher_location_nodes_CT()\n",
        "'''\n",
        "def extract_and_create_researcher_location_nodes_PubMed():\n",
        " with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "\n",
        "  with driver.session() as session:\n",
        "   query = \"MATCH (i:Pubmed)  where i.GARDname= $disease RETURN i.fullName AS fullName, i.ar_affiliation AS affiliation\"\n",
        "   results = session.run(query, disease=disease)\n",
        "   for Pubmed in results:\n",
        "    A,B=Pubmed['fullName'], str(Pubmed['affiliation'])\n",
        "    if  (A, B) not in current_names:\n",
        "     if B in pubmed_institution:\n",
        "        place_entity=pubmed_institution[B]\n",
        "     else:\n",
        "       place_entity =location_information(B)\n",
        "       pubmed_institution[B]= place_entity\n",
        "\n",
        "     event_properties = {\n",
        "        'Name': str(A),\n",
        "        'Contact_info': '',#str(Pubmed['i.OfficialAffiliation'][i]),\n",
        "        'Aff_name': B,\n",
        "        'Aff_Zip': ''  }\n",
        "     create_Researcher_node(event_properties)\n",
        "     current_names[(A, B)] =1\n",
        "     if place_entity[0] != None and place_entity[1] !=  None and place_entity[2] !=  None:\n",
        "      event_properties = {\n",
        "         'Aff_country': place_entity[0],\n",
        "        'Aff_state':   place_entity[1],\n",
        "        'Aff_county': find_fip(place_entity[2], place_entity[1] )[1],\n",
        "        'Aff_city': place_entity[2],\n",
        "        'Aff_FIPS': find_fip(place_entity[2], place_entity[1] )[0]  }\n",
        "      create_Location_node(event_properties, A, B)\n",
        "\n",
        "pubmed_institution={}\n",
        "current_names={}\n",
        "extract_and_create_researcher_location_nodes_PubMed()\n",
        "\n",
        "def extract_and_create_researcher_location_nodes_Grant():\n",
        " with driver.session() as session:\n",
        "  query = \"MATCH (i:Grant)  where i.GARDname= $disease RETURN i.org_name AS org_name, i.pi_name AS pi_name\"\n",
        "  results = session.run(query, disease=disease)\n",
        "  for Grant in results:\n",
        "   Name= Grant['pi_name']\n",
        "   Aff_name= str(Grant['org_name'])\n",
        "   if (Name, Aff_name) not in current_names:\n",
        "     data=organ_address[organ_address['n.org_name'] == Grant['org_name'].lower().strip()]\n",
        "     '''\n",
        "      or\n",
        "      from geopy.geocoders import Nominatim\n",
        "      geolocator = Nominatim(user_agent=\"GetLoc\", timeout=30)  # You can adjust the timeout value as needed\n",
        "      location = geolocator.geocode('NIH')\n",
        "      if location:\n",
        "              address = location.address.split(\", \")\n",
        "              data={}\n",
        "              data['Country'] = address[-1]\n",
        "              data['zip_code'] = address[-2]\n",
        "              data['state']  = address[-3]  # Massachusetts (state)\n",
        "              data['County'] = address[-4]  # Massachusetts (state)\n",
        "              data['city'] = address[-5]  # Boston (city)\n",
        "     '''\n",
        "     if len(data) >0 :\n",
        "       event_properties = {\n",
        "        'Name': Name,\n",
        "        'Contact_info': '',\n",
        "        'Aff_name': Aff_name,\n",
        "        'Aff_Zip':  data.iloc[0]['zip_code']\n",
        "       }\n",
        "       create_Researcher_node(event_properties)\n",
        "       A,B,C=data.iloc[0]['Country'], data.iloc[0]['state'], data.iloc[0]['County']\n",
        "       if  type(A)==str and type(B)==str and type(C) == str:\n",
        "        event_properties = {\n",
        "        'Aff_country': A ,\n",
        "        'Aff_state': B,\n",
        "        'Aff_county': C,\n",
        "        'Aff_city': data.iloc[0]['city'],\n",
        "        'Aff_FIPS': find_fip(data.iloc[0]['city'], data.iloc[0]['state'] )[0]\n",
        "        }\n",
        "        create_Location_node(event_properties, Name, Aff_name)\n",
        "     else:\n",
        "         event_properties = {'Name': Name,'Contact_info': '', 'Aff_name': Aff_name, 'Aff_Zip': ''    }\n",
        "         create_Researcher_node(event_properties)\n",
        "     current_names[(Name, Aff_name)] =1\n",
        "\n",
        "current_names={}\n",
        "extract_and_create_researcher_location_nodes_Grant()\n",
        "\n",
        "#create_relationship_between_nodes_1('Researcher','ClinicalTrial',  \"Involves_Researcher_ct\")\n",
        "create_relationship_between_nodes_2('Researcher','Grant',  \"Involves_Researcher_g\")\n",
        "create_relationship_between_nodes_3('Researcher','Pubmed',  \"Involves_Researcher_p\")\n",
        "\n",
        "def extract_and_create_researcher_connection():\n",
        " with driver.session() as session:\n",
        "  query = \"MATCH (i:ClinicalTrial) where i.GARDname= $disease  RETURN i.OfficialName AS OfficialName, i.OfficialAffiliation AS OfficialAffiliation, i.NCTId as NCTId \"\n",
        "  results = session.run(query, disease=disease)\n",
        "  data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "  ClinicalTrial = pd.DataFrame(data)\n",
        "  print(\"--- start ---\")\n",
        "  start_time = time.time()\n",
        "  a,a1=pd.DataFrame(),pd.DataFrame()#find_coauthors(ClinicalTrial,'OfficialName','OfficialAffiliation','NCTId')\n",
        "  print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "  ######   Grant\n",
        "  query = \"MATCH (i:Grant) where i.GARDname= $disease  RETURN i.pi_name AS pi_name, i.org_name AS org_name, i.application_id as application_id \"\n",
        "  results = session.run(query, disease=disease)\n",
        "  data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "  Grant = pd.DataFrame(data)\n",
        "  start_time = time.time()\n",
        "  b,b1=find_coauthors(Grant,'pi_name','org_name','application_id')\n",
        "  print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "  ##################### pubmed\n",
        "  query = \"MATCH (i:Pubmed) where i.GARDname= $disease  RETURN i.fullName AS fullName, i.ar_affiliation AS affiliation, i.pubmed_id as pubmed_id \"\n",
        "  results = session.run(query, disease=disease)\n",
        "  data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "  Pubmed = pd.DataFrame(data)\n",
        "  start_time = time.time()\n",
        "  c,c1=find_coauthors(Pubmed,'fullName','affiliation','pubmed_id')\n",
        "  print(\"--- %s seconds ---\" % (time.time() - start_time))\n",
        "  ###################\n",
        "  combined_dict = merge_dicts(a, b)\n",
        "  combined_dict = merge_dicts(combined_dict, c)\n",
        "  ###########\n",
        "  combined_dict1 = sum_dicts(a1, b1)\n",
        "  result_dict1 = sum_dicts(combined_dict1, c1)\n",
        "  for key in result_dict1:\n",
        "    result_dict1[key] = result_dict1[key] %1000\n",
        "  ###########\n",
        "  result_dict = {key: list(values) for key, values in combined_dict.items()}\n",
        "  return combined_dict, result_dict1, a,a1,b,b1,c,c1\n",
        "result_dict, result_dict1, a,a1,b,b1,c,c1=extract_and_create_researcher_connection()\n",
        "\n",
        "\n",
        "for key in result_dict1:\n",
        "    create_relationship_between_Researchers(key[0][0], key[0][1], key[1][0], key[1][1], result_dict1[key])\n",
        "\n",
        "\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "SIw2h0NXPHgF"
      },
      "source": [
        "# clustering"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "HfC74DQmBKAE",
        "outputId": "3652efb2-536d-4be0-f743-2c4308d196a6"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: python-louvain in /usr/local/lib/python3.11/dist-packages (0.16)\n",
            "Requirement already satisfied: networkx in /usr/local/lib/python3.11/dist-packages (from python-louvain) (3.4.2)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.11/dist-packages (from python-louvain) (1.26.4)\n"
          ]
        }
      ],
      "source": [
        "!pip install python-louvain\n",
        "import networkx as nx\n",
        "layout_algorithms = [\n",
        "    nx.circular_layout,\n",
        "    nx.random_layout,\n",
        "    nx.spring_layout,\n",
        "    nx.spectral_layout,\n",
        "    nx.shell_layout,\n",
        "    nx.bipartite_layout,\n",
        "    nx.planar_layout,\n",
        "    nx.fruchterman_reingold_layout,\n",
        "    nx.kamada_kawai_layout\n",
        "]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "Qm_IkZNTBN9v"
      },
      "outputs": [],
      "source": [
        "import networkx as nx\n",
        "import community\n",
        "from community import community_louvain\n",
        "import matplotlib.pyplot as plt\n",
        "# Create a directed graph\n",
        "G = nx.Graph()\n",
        "# Add nodes and edges from the dictionary\n",
        "for nodes, edges in result_dict.items():\n",
        "    G.add_node(nodes)\n",
        "    for edge in edges:\n",
        "        G.add_node(edge)\n",
        "        G.add_edge(nodes, edge)\n",
        "\n",
        "# Detect communities using Louvain method\n",
        "partition = community_louvain.best_partition(G)\n",
        "data_table = pd.DataFrame(partition.items(), columns=['Node', 'Community'])\n",
        "data_table['network']=data_table.apply(lambda x: result_dict[x['Node']] ,axis=1)\n",
        "index_community_detection= list(set(data_table[data_table['network']!=set()]['Community'].values))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "PhIR4CkyBU0a"
      },
      "outputs": [],
      "source": [
        "def merge_community_detection_and_researchers_info(disease):\n",
        " with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "  with driver.session() as session:\n",
        "   query = \"MATCH (i:ClinicalTrial)--(g:Gard) WHERE g.GARDname= $disease RETURN i.OfficialName as OfficialName , i.OfficialAffiliation as OfficialAffiliation, i.OfficialTitle as OfficialTitle  ,i.Interventions as concatenatedInterventions, i.BriefSummary as BriefSummary\"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   if data==[]:  ClinicalTrial = pd.DataFrame(columns=[\"OfficialName\", \"OfficialAffiliation\", \"OfficialTitle\", \"concatenatedInterventions\", \"BriefSummary\"])\n",
        "   else: ClinicalTrial = pd.DataFrame(data)\n",
        "   ######   Grant\n",
        "   query = \"MATCH (i:Grant)--(g:Gard) WHERE g.GARDname= $disease RETURN i.pi_name as pi_name,i.org_name as org_name,i.title as title ,i.terms as terms,i.abstract as abstract\"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   Grant = pd.DataFrame(data)\n",
        "   ##################### pubmed\n",
        "   query = \"MATCH (i:Pubmed)--(g:Gard) WHERE g.GARDname= $disease RETURN i.fullName as fullName, i.ar_affiliation as affiliation, i.title as title, i.concatenatedKeywords as concatenatedKeywords,i.abstractText as abstractText \"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   Pubmed = pd.DataFrame(data)\n",
        "   ################\n",
        "   ClinicalTrial['name'] = ClinicalTrial.apply(lambda row: (row['OfficialName'], row['OfficialAffiliation']), axis=1)\n",
        "   Grant['name'] = Grant.apply(lambda row: (row['pi_name'], row['org_name']), axis=1)\n",
        "   Pubmed['name'] = Pubmed.apply(lambda row: (row['fullName'], row['affiliation']), axis=1)\n",
        "\n",
        "   ClinicalTrial['BriefSummary']=ClinicalTrial['OfficialTitle'].fillna(\"\").astype(str)+' '+ ClinicalTrial['BriefSummary'].fillna(\"\").astype(str)   #+ClinicalTrial['concatenatedInterventions'].fillna(\"\").astype(str)+\n",
        "   Grant['BriefSummary']=Grant['title'].fillna(\"\").astype(str)+' '+ Grant['abstract'].fillna(\"\").astype(str)                   #+Grant['terms'].fillna(\"\").astype(str)\n",
        "   Pubmed['abstractText']=Pubmed['title'].fillna(\"\").astype(str)+' '+ Pubmed['abstractText'].fillna(\"\").astype(str)    #+Pubmed['concatenatedKeywords'].fillna(\"\").astype(str)\n",
        "\n",
        "   ClinicalTrial['Terms']=ClinicalTrial['concatenatedInterventions']\n",
        "   Grant['Terms']=Grant['terms']\n",
        "   Pubmed['Terms']=Pubmed['concatenatedKeywords']\n",
        "   #df1=ClinicalTrial[['i.OfficialName',  'c.BriefSummary', 'i.OfficialAffiliation','name']]\n",
        "   df1=ClinicalTrial[['OfficialName',  'BriefSummary','OfficialAffiliation', 'name','Terms']]\n",
        "   df2=Grant[['pi_name', 'abstract', 'org_name','name','Terms']]\n",
        "   df3=Pubmed[['fullName',  'abstractText', 'affiliation','name','Terms']]\n",
        "   # Rename columns to avoid conflicts\n",
        "   df1.columns = ['PI','Abstract', 'affiliation','name','Terms']\n",
        "   df2.columns = ['PI','Abstract', 'affiliation','name','Terms']\n",
        "   df3.columns = ['PI','Abstract', 'affiliation','name','Terms']\n",
        "   #df2['Location']=  df2['locationCity'] +' , '+df2['Location']\n",
        "   result_df = pd.concat([df1  , df2, df3])\n",
        "   #result_df = pd.concat([df1,  df3])\n",
        "   result_df=result_df.drop_duplicates()\n",
        "   result_df.index= range(result_df.shape[0])\n",
        "   #################################################### merging with c\n",
        "   '''\n",
        "  merged_data1 = pd.merge(result_df,data_table , left_on='name', right_on='Node', how='outer')\n",
        "  concatenated_data = merged_data1.drop_duplicates(subset=['name'])\n",
        "  concatenated_data.reset_index(drop=True, inplace=True)\n",
        "  concatenated_data=concatenated_data.drop(['name'],axis=1)\n",
        "  return concatenated_data\n",
        "   '''\n",
        "   return result_df\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "7qlBpbUuUlPd"
      },
      "outputs": [],
      "source": [
        "def merge_community_detection_and_researchers_info(disease):\n",
        " with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "  with driver.session() as session:\n",
        "   query = \"MATCH (i:ClinicalTrial)--(g:Gard) WHERE g.GARDname= $disease RETURN i.OfficialName as OfficialName , i.OfficialAffiliation as OfficialAffiliation, i.OfficialTitle as OfficialTitle  ,i.Interventions as concatenatedInterventions, i.BriefSummary as BriefSummary\"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   if data==[]:  ClinicalTrial = pd.DataFrame(columns=[\"OfficialName\", \"OfficialAffiliation\", \"OfficialTitle\", \"concatenatedInterventions\", \"BriefSummary\"])\n",
        "   else: ClinicalTrial = pd.DataFrame(data)\n",
        "   ######   Grant\n",
        "   query = \"MATCH (i:Grant)--(g:Gard) WHERE g.GARDname= $disease RETURN i.pi_name as pi_name,i.org_name as org_name,i.title as title ,i.terms as terms,i.abstract as abstract\"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   Grant = pd.DataFrame(data)\n",
        "   ##################### pubmed\n",
        "   query = \"MATCH (i:Pubmed)--(g:Gard) WHERE g.GARDname= $disease RETURN i.fullName as fullName, i.ar_affiliation as affiliation, i.title as title, i.concatenatedKeywords as concatenatedKeywords,i.abstractText as abstractText \"\n",
        "   results = session.run(query, disease=disease)\n",
        "   data = [record.data() for record in results]  # Convert result to a list of dictionaries\n",
        "   Pubmed = pd.DataFrame(data)\n",
        "   ################\n",
        "   ClinicalTrial['name'] = ClinicalTrial.apply(lambda row: (row['OfficialName'], row['OfficialAffiliation']), axis=1)\n",
        "   Grant['name'] = Grant.apply(lambda row: (row['pi_name'], row['org_name']), axis=1)\n",
        "   Pubmed['name'] = Pubmed.apply(lambda row: (row['fullName'], row['affiliation']), axis=1)\n",
        "\n",
        "   ClinicalTrial['BriefSummary']=ClinicalTrial['OfficialTitle'].fillna(\"\").astype(str)+' '+ ClinicalTrial['BriefSummary'].fillna(\"\").astype(str)   #+ClinicalTrial['concatenatedInterventions'].fillna(\"\").astype(str)+\n",
        "   Grant['BriefSummary']=Grant['title'].fillna(\"\").astype(str)+' '+ Grant['abstract'].fillna(\"\").astype(str)                   #+Grant['terms'].fillna(\"\").astype(str)\n",
        "   Pubmed['abstractText']=Pubmed['title'].fillna(\"\").astype(str)+' '+ Pubmed['abstractText'].fillna(\"\").astype(str)    #+Pubmed['concatenatedKeywords'].fillna(\"\").astype(str)\n",
        "\n",
        "   ClinicalTrial['Terms']=ClinicalTrial['concatenatedInterventions']\n",
        "   Grant['Terms']=Grant['terms']\n",
        "   Pubmed['Terms']=Pubmed['concatenatedKeywords']\n",
        "   #df1=ClinicalTrial[['i.OfficialName',  'c.BriefSummary', 'i.OfficialAffiliation','name']]\n",
        "   df1=ClinicalTrial[['OfficialName',  'BriefSummary','OfficialAffiliation', 'name','Terms']]\n",
        "   df2=Grant[['pi_name', 'abstract', 'org_name','name','Terms']]\n",
        "   df3=Pubmed[['fullName',  'abstractText', 'affiliation','name','Terms']]\n",
        "   # Rename columns to avoid conflicts\n",
        "   df1.columns = ['PI','Abstract', 'affiliation','name','Terms']\n",
        "   df2.columns = ['PI','Abstract', 'affiliation','name','Terms']\n",
        "   df3.columns = ['PI','Abstract', 'affiliation','name','Terms']\n",
        "   #df2['Location']=  df2['locationCity'] +' , '+df2['Location']\n",
        "   result_df = pd.concat([df1  , df2, df3])\n",
        "   #result_df = pd.concat([df1,  df3])\n",
        "   result_df=result_df.drop_duplicates()\n",
        "   result_df.index= range(result_df.shape[0])\n",
        "   #################################################### merging with c\n",
        "   '''\n",
        "  merged_data1 = pd.merge(result_df,data_table , left_on='name', right_on='Node', how='outer')\n",
        "  concatenated_data = merged_data1.drop_duplicates(subset=['name'])\n",
        "  concatenated_data.reset_index(drop=True, inplace=True)\n",
        "  concatenated_data=concatenated_data.drop(['name'],axis=1)\n",
        "  return concatenated_data\n",
        "   '''\n",
        "   return result_df\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "UE2wQKyYCJ4H"
      },
      "outputs": [],
      "source": [
        "import pandas as pd\n",
        "\n",
        "def sum_strings(series):\n",
        "    # Convert all items to string, handling NaNs, and remove duplicates by converting to a set\n",
        "    return ', '.join(sorted(set(str(item) for item in series if pd.notna(item))))\n",
        "\n",
        "# Function to clean and flatten terms\n",
        "def sum_terms(series):\n",
        "    result = []\n",
        "    for item in series:\n",
        "        if isinstance(item, list):  # Check if item is a list\n",
        "            for subitem in item:\n",
        "                if isinstance(subitem, str):  # Ensure it's a string\n",
        "                    subitem_cleaned = subitem.strip('[]')  # Remove surrounding brackets\n",
        "                    result.extend(subitem_cleaned.split(','))  # Split and add terms\n",
        "        elif pd.notna(item):  # Handle non-list, non-NaN values\n",
        "            item_cleaned = str(item).strip('[]')  # Convert to string and remove brackets\n",
        "            result.extend(item_cleaned.split(','))  # Split and add terms\n",
        "    # Remove extra whitespace from terms\n",
        "    return [term.strip() for term in result if term.strip()]\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "OqwFXXq8BhMl",
        "outputId": "bbaa1ee7-4fa6-4cd0-b2b1-f89bd5a236f2"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "18\n",
            "------------------\n",
            "6\n",
            "3\n",
            "9\n"
          ]
        }
      ],
      "source": [
        "from sklearn.feature_extraction.text import TfidfVectorizer\n",
        "from sklearn.cluster import MiniBatchKMeans  # Use MiniBatchKMeans for faster clustering\n",
        "import numpy as np\n",
        "import pandas as pd\n",
        "from sklearn.decomposition import TruncatedSVD  # Dimensionality reduction to speed up vectorization\n",
        "\n",
        "def name_clusters(df, text_column, cluster_column, num_clusters=5, n_components=100):\n",
        "    # Extract abstracts from the specified column and handle NaN values\n",
        "    abstracts = df[text_column].fillna(\"\").astype(str).tolist()\n",
        "\n",
        "    # TF-IDF vectorization with ngram_range (optimize based on your dataset)\n",
        "    vectorizer = TfidfVectorizer(stop_words='english', ngram_range=(1, 2))  # Bi-grams may help for better context\n",
        "    tfidf_matrix = vectorizer.fit_transform(abstracts)\n",
        "\n",
        "    # Optionally reduce dimensionality to speed up clustering\n",
        "    #if n_components:\n",
        "    #    svd = TruncatedSVD(n_components=n_components, random_state=42)\n",
        "    #    tfidf_matrix = svd.fit_transform(tfidf_matrix)\n",
        "\n",
        "    # MiniBatchKMeans clustering (faster than KMeans)\n",
        "    kmeans = MiniBatchKMeans(n_clusters=num_clusters, random_state=10, n_init=10, batch_size=1000)\n",
        "    clusters = kmeans.fit_predict(tfidf_matrix)\n",
        "\n",
        "    # Assign cluster labels to the DataFrame\n",
        "    df[cluster_column] = clusters\n",
        "\n",
        "    return df\n",
        "\n",
        "\n",
        "disease= A[8]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid=B[8] #'GARD0017510'\n",
        "\n",
        "concatenated_data= merge_community_detection_and_researchers_info(disease)\n",
        "# Assuming you have a DataFrame `clustering_2`\n",
        "clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', num_clusters=3, n_components=100)\n",
        "# Group by 'Community' and aggregate columns using sum_strings and sum_terms functions\n",
        "result = clustering_.groupby('Community').agg(\n",
        "    Abstract=('Abstract', sum_strings),\n",
        "    Terms=('Terms', sum_terms),\n",
        "    Size=('Community', 'size')  # Count of occurrences\n",
        ").reset_index()\n",
        "\n",
        "data=result\n",
        "\n",
        "print(len(clustering_['Abstract'].unique()))\n",
        "print('------------------')\n",
        "for i in clustering_['Community'].unique():\n",
        "    ASD= clustering_[clustering_['Community']==i]\n",
        "    print( ASD['Abstract'].drop_duplicates().shape[0] )"
      ]
    },
    {
      "cell_type": "code",
      "source": [
        "import matplotlib.pyplot as plt\n",
        "from sklearn.cluster import MiniBatchKMeans\n",
        "from sklearn.feature_extraction.text import TfidfVectorizer\n",
        "import numpy as np\n",
        "disease= A[3]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid=B[3] #'GARD0017510'\n",
        "\n",
        "concatenated_data= merge_community_detection_and_researchers_info(disease)\n",
        "# Function to calculate the Elbow plot\n",
        "def plot_elbow_method(df, text_column, min_clusters=1, max_clusters=10):\n",
        "    # Extract abstracts and handle NaN values\n",
        "    abstracts = df[text_column].fillna(\"\").astype(str).tolist()\n",
        "\n",
        "    # TF-IDF vectorization\n",
        "    vectorizer = TfidfVectorizer(stop_words='english', ngram_range=(1, 2))\n",
        "    tfidf_matrix = vectorizer.fit_transform(abstracts)\n",
        "\n",
        "    # List to store inertia values for each k\n",
        "    inertia_values = []\n",
        "\n",
        "    # Run MiniBatchKMeans for a range of cluster sizes\n",
        "    for k in range(min_clusters, max_clusters+1):\n",
        "        kmeans = MiniBatchKMeans(n_clusters=k, random_state=10, n_init=10, batch_size=1000)\n",
        "        kmeans.fit(tfidf_matrix)\n",
        "        inertia_values.append(kmeans.inertia_)\n",
        "\n",
        "    # Plotting the Elbow method\n",
        "    plt.figure(figsize=(4, 3))\n",
        "    plt.plot(range(min_clusters, max_clusters+1), inertia_values, marker='o', linestyle='-', color='b')\n",
        "    plt.title('Elbow Method for Optimal k')\n",
        "    plt.xlabel('Number of Clusters')\n",
        "    plt.ylabel('Inertia (Within-cluster sum of squares)')\n",
        "    #plt.xticks(range(min_clusters, max_clusters+1))\n",
        "    #plt.xticks(range(min_clusters, max_clusters+1), rotation=90)  # Rotate x-ticks by 90 degrees\n",
        "    ticks = range(min_clusters, max_clusters+1, 5)  # Every 5th tick\n",
        "    plt.xticks(ticks, rotation=0)\n",
        "    plt.grid(True)\n",
        "    plt.show()\n",
        "\n",
        "# Call the function with your dataframe to plot the elbow graph\n",
        "# Assuming 'concatenated_data' is your dataframe and 'Abstract' is the column with text data\n",
        "plot_elbow_method(concatenated_data, 'Abstract', min_clusters=1, max_clusters=30)"
      ],
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 333
        },
        "id": "v0grTh0K6zRs",
        "outputId": "90ef213e-fde0-44c0-bd35-74b639570dbe"
      },
      "execution_count": null,
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 400x300 with 1 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        }
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "86X0SqPDkHpb",
        "outputId": "80cca229-f4dd-4d11-8d03-94c870290af9"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "65\n",
            "------------------\n",
            "18\n",
            "36\n",
            "2\n",
            "4\n",
            "1\n",
            "1\n",
            "3\n"
          ]
        }
      ],
      "source": [
        "from sklearn.cluster import DBSCAN\n",
        "from sklearn.metrics.pairwise import cosine_distances\n",
        "\n",
        "def name_clusters(df, text_column, cluster_column, eps=0.5, min_samples=5, n_components=100):\n",
        "    # Extract abstracts from the specified column and handle NaN values\n",
        "    abstracts = df[text_column].fillna(\"\").astype(str).tolist()\n",
        "\n",
        "    # TF-IDF vectorization with ngram_range (optimize based on your dataset)\n",
        "    vectorizer = TfidfVectorizer(stop_words='english', ngram_range=(1, 2))  # Bi-grams may help for better context\n",
        "    tfidf_matrix = vectorizer.fit_transform(abstracts)\n",
        "\n",
        "    # Optionally reduce dimensionality to speed up clustering\n",
        "    # if n_components:\n",
        "    #     svd = TruncatedSVD(n_components=n_components, random_state=42)\n",
        "    #     tfidf_matrix = svd.fit_transform(tfidf_matrix)\n",
        "\n",
        "    # DBSCAN clustering\n",
        "    dbscan = DBSCAN(eps=eps, min_samples=min_samples, metric='cosine')  # Using cosine distance as the metric\n",
        "    clusters = dbscan.fit_predict(tfidf_matrix)\n",
        "\n",
        "    # Assign cluster labels to the DataFrame\n",
        "    df[cluster_column] = clusters\n",
        "\n",
        "    return df\n",
        "\n",
        "disease= A[0]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid=B[0] #'GARD0017510'\n",
        "\n",
        "concatenated_data= merge_community_detection_and_researchers_info(disease)\n",
        "# Assuming you have a DataFrame `clustering_2`\n",
        "clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', eps=0.9, min_samples=10, n_components=100)\n",
        "# Group by 'Community' and aggregate columns using sum_strings and sum_terms functions\n",
        "result = clustering_.groupby('Community').agg(\n",
        "    Abstract=('Abstract', sum_strings),\n",
        "    Terms=('Terms', sum_terms),\n",
        "    Size=('Community', 'size')  # Count of occurrences\n",
        ").reset_index()\n",
        "\n",
        "data=result\n",
        "\n",
        "print(len(clustering_['Abstract'].unique()))\n",
        "print('------------------')\n",
        "for i in clustering_['Community'].unique():\n",
        "    ASD= clustering_[clustering_['Community']==i]\n",
        "    print( ASD['Abstract'].drop_duplicates().shape[0] )"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "KUqf13c0Bo8N"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 217
        },
        "id": "dcGwARBJClr-",
        "outputId": "9771060b-b3f4-42c5-80b6-bd3b4d32a898"
      },
      "outputs": [
        {
          "ename": "TypeError",
          "evalue": "name_clusters() got an unexpected keyword argument 'num_clusters'",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-95-12a8b023e147>\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      7\u001b[0m \u001b[0mconcatenated_data\u001b[0m\u001b[0;34m=\u001b[0m \u001b[0mmerge_community_detection_and_researchers_info\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdisease\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      8\u001b[0m \u001b[0;31m# Assuming you have a DataFrame `clustering_2`\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 9\u001b[0;31m \u001b[0mclustering_\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mname_clusters\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mconcatenated_data\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'Abstract'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m'Community'\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mnum_clusters\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m9\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mn_components\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m100\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     10\u001b[0m \u001b[0;31m# Group by 'Community' and aggregate columns using sum_strings and sum_terms functions\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     11\u001b[0m result = clustering_.groupby('Community').agg(\n",
            "\u001b[0;31mTypeError\u001b[0m: name_clusters() got an unexpected keyword argument 'num_clusters'"
          ]
        }
      ],
      "source": [
        "A=['PGM1-CDG','Cerebral cavernous malformations 3',\"CLOVES syndrome\",\"STT3B-CDG\",\"Thoracolaryngopelvic dysplasia\",\"Actinic prurigo\",\"Non-syndromic polydactyly\",\"Genitopatellar syndrome\",\"Diaphanospondylodysostosis\"]\n",
        "B=['GARD0004329','GARD0018314',\"GARD0010939\",\"GARD0017603\",\"GARD0005184\", \"GARD0017510\",\"GARD0004410\",\"GARD0010994\",\"GARD0016674\"]\n",
        "#for n in range(len(A)):\n",
        "disease= A[0]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid=B[0] #'GARD0017510'\n",
        "\n",
        "concatenated_data= merge_community_detection_and_researchers_info(disease)\n",
        "# Assuming you have a DataFrame `clustering_2`\n",
        "clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', num_clusters=9, n_components=100)\n",
        "# Group by 'Community' and aggregate columns using sum_strings and sum_terms functions\n",
        "result = clustering_.groupby('Community').agg(\n",
        "    Abstract=('Abstract', sum_strings),\n",
        "    Terms=('Terms', sum_terms),\n",
        "    Size=('Community', 'size')  # Count of occurrences\n",
        ").reset_index()\n",
        "\n",
        "data=result\n",
        "\n",
        "print(len(clustering_['Abstract'].unique()))\n",
        "print('------------------')\n",
        "for i in data.index:\n",
        "    ASD= clustering_[clustering_['Community']==i]\n",
        "    print( ASD['Abstract'].drop_duplicates().shape[0] )"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "GJUSzw712TDN",
        "outputId": "3c6b7a7d-213c-4663-dc1d-9cd5a311fc8f"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "88251\n"
          ]
        },
        {
          "data": {
            "text/plain": [
              "0"
            ]
          },
          "execution_count": 16,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "print(len(result['Abstract'][0]))\n",
        "clustering_['Community'][0]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 981
        },
        "id": "6j9Cjb_4B4gY",
        "outputId": "3cdc3a89-368c-48d9-c3b4-d6a6564a28ea"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 113,\n  \"fields\": [\n    {\n      \"column\": \"Unnamed: 0.1\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 32,\n        \"min\": 0,\n        \"max\": 112,\n        \"num_unique_values\": 113,\n        \"samples\": [\n          80,\n          4,\n          40\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Unnamed: 0\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 32,\n        \"min\": 0,\n        \"max\": 112,\n        \"num_unique_values\": 113,\n        \"samples\": [\n          80,\n          4,\n          40\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 32,\n        \"min\": 1,\n        \"max\": 113,\n        \"num_unique_values\": 113,\n        \"samples\": [\n          81,\n          5,\n          41\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 112,\n        \"samples\": [\n          \"A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., A Randomised, Double-blind, Placebo-controlled Phase 2B Clinical Trial of Repeated Application of Gene Therapy in Patients With Cystic FibrosisPlacebo, pGM169/GL67ACystic fibrosis is a genetic condition where epithelial cells, including from the respiratory tract, have an abnormal function of a surface protein, the cystic fibrosis transmembrane conductance regulator (CFTR) protein resulting from abnormal gene expression. The trial will assess the clinical efficacy, safety & tolerability and gene expression following repeated nebulised doses of a gene product coding for a normal CFTR protein, with the primary outcome of the trial assessing lung function., Evaluation of Safety and Gene Expression With a Single Dose of pGM169/GL67A Administered to the Nose and Lung of Individuals With Cystic FibrosispGM169/GL67AThe study objectives are to assess safety, tolerability and gene expression after a single dose of non-viral CFTR gene therapy (pGM169/GL67A) administered to the nose and lungs of patients with cystic fibrosis., Evaluation of Safety and Gene Expression With a Single Dose of pGM169/GL67A Administered to the Nose and Lung of Individuals With Cystic FibrosispGM169/GL67AThe study objectives are to assess safety, tolerability and gene expression after a single dose of non-viral CFTR gene therapy (pGM169/GL67A) administered to the nose and lungs of patients with cystic fibrosis., Evaluation of Safety and Gene Expression With a Single Dose of pGM169/GL67A Administered to the Nose and Lung of Individuals With Cystic FibrosispGM169/GL67AThe study objectives are to assess safety, tolerability and gene expression after a single dose of non-viral CFTR gene therapy (pGM169/GL67A) administered to the nose and lungs of patients with cystic fibrosis., Evaluation of Safety and Gene Expression With a Single Dose of pGM169/GL67A Administered to the Nose and Lung of Individuals With Cystic FibrosispGM169/GL67AThe study objectives are to assess safety, tolerability and gene expression after a single dose of non-viral CFTR gene therapy (pGM169/GL67A) administered to the nose and lungs of patients with cystic fibrosis.\",\n          \"Early Intervention in Cystic Fibrosis ExacerbationHome lung function and symptom monitoringIndividuals with cystic fibrosis (CF) develop chronic lung infections and suffer intermittent acute exacerbations of their lung disease. Most exacerbations are not treated until they cause increased symptoms, and patients seek medical attention. This proposal details a study of home lung function and symptom monitoring. Subjects will be randomly assigned to one of two groups: 1) home monitoring, in which spirometry and symptoms are recorded; or 2) standard care. The home monitoring data will be transmitted electronically to the study center. If spirometry or symptoms have deteriorated substantially, treatment for a CF pulmonary exacerbation will be initiated. It is anticipated that use of home monitoring will lead to earlier, more reliable recognition and treatment of exacerbations, which will translate into better lung health., Early Intervention in Cystic Fibrosis ExacerbationHome lung function and symptom monitoringIndividuals with cystic fibrosis (CF) develop chronic lung infections and suffer intermittent acute exacerbations of their lung disease. Most exacerbations are not treated until they cause increased symptoms, and patients seek medical attention. This proposal details a study of home lung function and symptom monitoring. Subjects will be randomly assigned to one of two groups: 1) home monitoring, in which spirometry and symptoms are recorded; or 2) standard care. The home monitoring data will be transmitted electronically to the study center. If spirometry or symptoms have deteriorated substantially, treatment for a CF pulmonary exacerbation will be initiated. It is anticipated that use of home monitoring will lead to earlier, more reliable recognition and treatment of exacerbations, which will translate into better lung health.\",\n          \"Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb\\u00ae Compared to Placebo Control in Patients With Pancreatic InsufficiencyPancrelipaseThe purpose of this research study is to learn about the activity of oral Pancrecarb\\u00ae (a pancreatic enzyme preparation which contains proteins that help to digest food), administered by mouth as a capsule filled with specially coated granules in patients taking exogenous pancreatic enzyme therapy. Specific enzymes activities will be determined from samples of stomach and intestinal fluids after a standard liquid meal., Intraduodenal Aspiration Study to Assess the Bioavailability of Oral Pancrecarb\\u00ae Compared to Placebo Control in Patients With Pancreatic InsufficiencyPancrelipaseThe purpose of this research study is to learn about the activity of oral Pancrecarb\\u00ae (a pancreatic enzyme preparation which contains proteins that help to digest food), administered by mouth as a capsule filled with specially coated granules in patients taking exogenous pancreatic enzyme therapy. Specific enzymes activities will be determined from samples of stomach and intestinal fluids after a standard liquid meal.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 113,\n        \"samples\": [\n          \"['Placebo (Part 2 - MAD), CHF6333 (Part 2 - MAD), Placebo (Part 1 - SAD), CHF6333 (Part 1 - SAD)', 'Inhaled Placebo, Inhaled SNSP113', 'Placebo, AIR DNase', 'Placebo, Molgramostim', 'Placebo, GS-9411', 'Placebo, FDL169', 'Placebo, AZD5634 for infusion, AZD5634 for inhalation', 'FDL169', 'Placebo, Cavosonstat', 'Placebo multiple once daily doses, ETD001 multiple once daily doses, Placebo multiple twice daily doses, ETD001 multiple twice daily doses, Placebo single dose, ETD001 single dose', 'Placebo, BI 443651', 'FDL176 & FDL169 coadministration', 'Inhaled Placebo, Inhaled AR-501', 'Inhaled Placebo, Inhaled AR-501', 'Placebo, ARCT-032', 'Placebo, bLF, OSCN-, ALX-009', 'S-1226', 'Placebo, Roscovitine', 'PUR118', 'Placebo, ABCI', 'Placebo, GS-9411', 'Placebo, QR-010', 'Placebo, CTX-4430', 'Placebo, CR002 Liquid API', 'Placebos, CB-280', 'Placebo, QAU145']\",\n          \"['Pancrelipase', 'Pancrelipase']\",\n          \"['Placebo, pGM169/GL67A', 'Placebo, pGM169/GL67A', 'Placebo, pGM169/GL67A', 'Placebo, pGM169/GL67A', 'Placebo, pGM169/GL67A', 'Placebo, pGM169/GL67A', 'Placebo, pGM169/GL67A', 'Placebo, pGM169/GL67A', 'Placebo, pGM169/GL67A', 'pGM169/GL67A', 'pGM169/GL67A', 'pGM169/GL67A', 'pGM169/GL67A']\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1968,\n        \"min\": 2,\n        \"max\": 20907,\n        \"num_unique_values\": 40,\n        \"samples\": [\n          48,\n          12,\n          20907\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"frequent_words\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 113,\n        \"samples\": [\n          \"Placebo, GS-9411 , Inhaled Placebo, Inhaled AR-501 , Placebo (Part 2 - MAD), CHF6333 (Part 2 - MAD), Placebo (Part 1 - SAD), CHF6333 (Part 1 - SAD)\",\n          \"Pancrelipase\",\n          \"Placebo, pGM169/GL67A , pGM169/GL67A\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Mistral\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 112,\n        \"samples\": [\n          \"1. Gene therapy: The use of genes to treat or cure diseases by replacing, inactivating, or supplementing genes that are abnormal or nonfunctional.\\n2. Placebo-controlled trials: A type of clinical trial where participants receive either an active treatment or a placebo (a fake treatment) to evaluate the effectiveness of the treatment.\\n3. Cystic fibrosis: A genetic disorder that affects the lungs and digestive system and is caused by a mutation in the CFTR gene.<|end_of_text|>\",\n          \"1. Home Lung Function Monitoring\\n2. Symptom Monitoring\\n3. Cystic Fibrosis<|end_of_text|>\",\n          \"1. Pancreatic Enzyme Replacement Therapy (PERT)\\n2. Pancreatic Exocrine Function\\n3. Cystic Fibrosis<|end_of_text|>\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-840085b9-f8ed-4c5a-9c1e-821a93c3a067\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Unnamed: 0.1</th>\n",
              "      <th>Unnamed: 0</th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Mistral</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>0</td>\n",
              "      <td>0</td>\n",
              "      <td>1</td>\n",
              "      <td>Development of a New Tool for Dyspnea Measurem...</td>\n",
              "      <td>['Cross sectional psychometric evaluation of a...</td>\n",
              "      <td>2</td>\n",
              "      <td>Cross sectional psychometric evaluation of a s...</td>\n",
              "      <td>1. Psychometrics: The study focused on the psy...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>1</td>\n",
              "      <td>1</td>\n",
              "      <td>2</td>\n",
              "      <td>The Effects of a Low Glycemic Load Diet on Dys...</td>\n",
              "      <td>['Low Glycemic Load Diet', 'Low Glycemic Load ...</td>\n",
              "      <td>2</td>\n",
              "      <td>Low Glycemic Load Diet</td>\n",
              "      <td>1. Glycemic Control\\n2. Nutrition Management\\n...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>2</td>\n",
              "      <td>2</td>\n",
              "      <td>3</td>\n",
              "      <td>A Phase 1/2 Study to Evaluate the Safety, Tole...</td>\n",
              "      <td>['PTI-808, Placebo, PTI-428, PTI-801', 'PTI-80...</td>\n",
              "      <td>2</td>\n",
              "      <td>PTI-808, Placebo, PTI-428, PTI-801</td>\n",
              "      <td>1. Pharmacokinetics: The study will evaluate t...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>3</td>\n",
              "      <td>3</td>\n",
              "      <td>4</td>\n",
              "      <td>In Vitro Comparison of Continuous and Breath-s...</td>\n",
              "      <td>['Nebulization of Amikacin during NIV (RR: 25 ...</td>\n",
              "      <td>7</td>\n",
              "      <td>Nebulization of Amikacin during NIV (RR: 25 cy...</td>\n",
              "      <td>1. Nebulization\\n2. Inhaled and Lost Doses\\n3....</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>4</td>\n",
              "      <td>4</td>\n",
              "      <td>5</td>\n",
              "      <td>Intraduodenal Aspiration Study to Assess the B...</td>\n",
              "      <td>['Pancrelipase', 'Pancrelipase']</td>\n",
              "      <td>2</td>\n",
              "      <td>Pancrelipase</td>\n",
              "      <td>1. Pancreatic Enzyme Replacement Therapy (PERT...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>...</th>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "      <td>...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>108</th>\n",
              "      <td>108</td>\n",
              "      <td>108</td>\n",
              "      <td>109</td>\n",
              "      <td>Project Summary/Abstract Cilia dysfunction lea...</td>\n",
              "      <td>['[Actins,  Adaptor Signaling Protein,  Addres...</td>\n",
              "      <td>4</td>\n",
              "      <td>[Actins,  Adaptor Signaling Protein,  Address,...</td>\n",
              "      <td>1. Microtubule dynamics\\n2. Protein traffickin...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>109</th>\n",
              "      <td>109</td>\n",
              "      <td>109</td>\n",
              "      <td>110</td>\n",
              "      <td>...</td>\n",
              "      <td>['[bacteria infection mechanism, respiratory i...</td>\n",
              "      <td>7</td>\n",
              "      <td>[16S ribosomal RNA sequencing,  Adopted,  Adop...</td>\n",
              "      <td>1. Bioinformatics - The use of computational t...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>110</th>\n",
              "      <td>110</td>\n",
              "      <td>110</td>\n",
              "      <td>111</td>\n",
              "      <td>DESCRIPTION (provided by applicant): Cystic Fi...</td>\n",
              "      <td>['[absorption, Affect, Animal Model, Area, Bac...</td>\n",
              "      <td>11</td>\n",
              "      <td>[absorption, Affect, Animal Model, Area, Bacte...</td>\n",
              "      <td>1. Comparative Pathology: The study of the dif...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>111</th>\n",
              "      <td>111</td>\n",
              "      <td>111</td>\n",
              "      <td>112</td>\n",
              "      <td>This project will test the hypothesis that som...</td>\n",
              "      <td>['[lung disorder, chloride channels, protein d...</td>\n",
              "      <td>3</td>\n",
              "      <td>[lung disorder, chloride channels, protein deg...</td>\n",
              "      <td>1. Molecular biology: Genetic engineering, gen...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>112</th>\n",
              "      <td>112</td>\n",
              "      <td>112</td>\n",
              "      <td>113</td>\n",
              "      <td>The overall objective of this project is to de...</td>\n",
              "      <td>['[protein protein interaction, phosphoprotein...</td>\n",
              "      <td>4</td>\n",
              "      <td>[protein protein interaction, phosphoproteins,...</td>\n",
              "      <td>1. Bioinformatics\\n2. Protein structure and fu...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "<p>113 rows × 8 columns</p>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-840085b9-f8ed-4c5a-9c1e-821a93c3a067')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-840085b9-f8ed-4c5a-9c1e-821a93c3a067 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-840085b9-f8ed-4c5a-9c1e-821a93c3a067');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-9d08aeda-2289-4518-959c-27181e1ec05f\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-9d08aeda-2289-4518-959c-27181e1ec05f')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-9d08aeda-2289-4518-959c-27181e1ec05f button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_aa026261-6b91-482c-94f1-33a7d2dd3f89\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_aa026261-6b91-482c-94f1-33a7d2dd3f89 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "     Unnamed: 0.1  Unnamed: 0  Community  \\\n",
              "0               0           0          1   \n",
              "1               1           1          2   \n",
              "2               2           2          3   \n",
              "3               3           3          4   \n",
              "4               4           4          5   \n",
              "..            ...         ...        ...   \n",
              "108           108         108        109   \n",
              "109           109         109        110   \n",
              "110           110         110        111   \n",
              "111           111         111        112   \n",
              "112           112         112        113   \n",
              "\n",
              "                                              Abstract  \\\n",
              "0    Development of a New Tool for Dyspnea Measurem...   \n",
              "1    The Effects of a Low Glycemic Load Diet on Dys...   \n",
              "2    A Phase 1/2 Study to Evaluate the Safety, Tole...   \n",
              "3    In Vitro Comparison of Continuous and Breath-s...   \n",
              "4    Intraduodenal Aspiration Study to Assess the B...   \n",
              "..                                                 ...   \n",
              "108  Project Summary/Abstract Cilia dysfunction lea...   \n",
              "109                                                ...   \n",
              "110  DESCRIPTION (provided by applicant): Cystic Fi...   \n",
              "111  This project will test the hypothesis that som...   \n",
              "112  The overall objective of this project is to de...   \n",
              "\n",
              "                                                 Terms  Size  \\\n",
              "0    ['Cross sectional psychometric evaluation of a...     2   \n",
              "1    ['Low Glycemic Load Diet', 'Low Glycemic Load ...     2   \n",
              "2    ['PTI-808, Placebo, PTI-428, PTI-801', 'PTI-80...     2   \n",
              "3    ['Nebulization of Amikacin during NIV (RR: 25 ...     7   \n",
              "4                     ['Pancrelipase', 'Pancrelipase']     2   \n",
              "..                                                 ...   ...   \n",
              "108  ['[Actins,  Adaptor Signaling Protein,  Addres...     4   \n",
              "109  ['[bacteria infection mechanism, respiratory i...     7   \n",
              "110  ['[absorption, Affect, Animal Model, Area, Bac...    11   \n",
              "111  ['[lung disorder, chloride channels, protein d...     3   \n",
              "112  ['[protein protein interaction, phosphoprotein...     4   \n",
              "\n",
              "                                        frequent_words  \\\n",
              "0    Cross sectional psychometric evaluation of a s...   \n",
              "1                               Low Glycemic Load Diet   \n",
              "2                   PTI-808, Placebo, PTI-428, PTI-801   \n",
              "3    Nebulization of Amikacin during NIV (RR: 25 cy...   \n",
              "4                                         Pancrelipase   \n",
              "..                                                 ...   \n",
              "108  [Actins,  Adaptor Signaling Protein,  Address,...   \n",
              "109  [16S ribosomal RNA sequencing,  Adopted,  Adop...   \n",
              "110  [absorption, Affect, Animal Model, Area, Bacte...   \n",
              "111  [lung disorder, chloride channels, protein deg...   \n",
              "112  [protein protein interaction, phosphoproteins,...   \n",
              "\n",
              "                                               Mistral  \n",
              "0    1. Psychometrics: The study focused on the psy...  \n",
              "1    1. Glycemic Control\\n2. Nutrition Management\\n...  \n",
              "2    1. Pharmacokinetics: The study will evaluate t...  \n",
              "3    1. Nebulization\\n2. Inhaled and Lost Doses\\n3....  \n",
              "4    1. Pancreatic Enzyme Replacement Therapy (PERT...  \n",
              "..                                                 ...  \n",
              "108  1. Microtubule dynamics\\n2. Protein traffickin...  \n",
              "109  1. Bioinformatics - The use of computational t...  \n",
              "110  1. Comparative Pathology: The study of the dif...  \n",
              "111  1. Molecular biology: Genetic engineering, gen...  \n",
              "112  1. Bioinformatics\\n2. Protein structure and fu...  \n",
              "\n",
              "[113 rows x 8 columns]"
            ]
          },
          "execution_count": 37,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "result = pd.read_csv('/content/data_u4.csv')\n",
        "result"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "Jgt2sDwDNtL5"
      },
      "source": [
        "# LLM"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "NcbD4KElNy7Y"
      },
      "outputs": [],
      "source": [
        "%%capture\n",
        "!pip install unsloth\n",
        "# Also get the latest nightly Unsloth!\n",
        "!pip uninstall unsloth -y && pip install --upgrade --no-cache-dir --no-deps git+https://github.com/unslothai/unsloth.git"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "background_save": true,
          "referenced_widgets": [
            "f8bbcb14b44041c5ad0a84734dea8c79",
            "28c47044d4534419aabc6fb592e07d50",
            "5096ea3bb8bc4b9bbc1fd755eb631f07",
            "87e911487df746189a5dbb13b69d2acb",
            "6af1c4db114c499ab80840579b96f813"
          ]
        },
        "id": "uPhFXkhHN826",
        "outputId": "fdd9f805-26da-4f59-952f-eabe95950ff3"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "🦥 Unsloth: Will patch your computer to enable 2x faster free finetuning.\n",
            "🦥 Unsloth Zoo will now patch everything to make training faster!\n",
            "==((====))==  Unsloth 2025.1.6: Fast Llama patching. Transformers: 4.47.1.\n",
            "   \\\\   /|    GPU: Tesla T4. Max memory: 14.748 GB. Platform: Linux.\n",
            "O^O/ \\_/ \\    Torch: 2.5.1+cu121. CUDA: 7.5. CUDA Toolkit: 12.1. Triton: 3.1.0\n",
            "\\        /    Bfloat16 = FALSE. FA [Xformers = 0.0.29.post1. FA2 = False]\n",
            " \"-____-\"     Free Apache license: http://github.com/unslothai/unsloth\n",
            "Unsloth: Fast downloading is enabled - ignore downloading bars which are red colored!\n"
          ]
        },
        {
          "data": {
            "application/vnd.jupyter.widget-view+json": {
              "model_id": "f8bbcb14b44041c5ad0a84734dea8c79",
              "version_major": 2,
              "version_minor": 0
            },
            "text/plain": [
              "model.safetensors:   0%|          | 0.00/5.70G [00:00<?, ?B/s]"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.jupyter.widget-view+json": {
              "model_id": "28c47044d4534419aabc6fb592e07d50",
              "version_major": 2,
              "version_minor": 0
            },
            "text/plain": [
              "generation_config.json:   0%|          | 0.00/230 [00:00<?, ?B/s]"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.jupyter.widget-view+json": {
              "model_id": "5096ea3bb8bc4b9bbc1fd755eb631f07",
              "version_major": 2,
              "version_minor": 0
            },
            "text/plain": [
              "tokenizer_config.json:   0%|          | 0.00/50.6k [00:00<?, ?B/s]"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.jupyter.widget-view+json": {
              "model_id": "87e911487df746189a5dbb13b69d2acb",
              "version_major": 2,
              "version_minor": 0
            },
            "text/plain": [
              "tokenizer.json:   0%|          | 0.00/9.09M [00:00<?, ?B/s]"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.jupyter.widget-view+json": {
              "model_id": "6af1c4db114c499ab80840579b96f813",
              "version_major": 2,
              "version_minor": 0
            },
            "text/plain": [
              "special_tokens_map.json:   0%|          | 0.00/345 [00:00<?, ?B/s]"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "from unsloth import FastLanguageModel\n",
        "import torch\n",
        "max_seq_length = 10000 # Choose any! We auto support RoPE Scaling internally!\n",
        "dtype = None # None for auto detection. Float16 for Tesla T4, V100, Bfloat16 for Ampere+\n",
        "load_in_4bit = True # Use 4bit quantization to reduce memory usage. Can be False.\n",
        "\n",
        "# 4bit pre quantized models we support for 4x faster downloading + no OOMs.\n",
        "fourbit_models = [\n",
        "    \"unsloth/Meta-Llama-3.1-8B-bnb-4bit\",      # Llama-3.1 15 trillion tokens model 2x faster!\n",
        "    \"unsloth/Meta-Llama-3.1-8B-Instruct-bnb-4bit\",\n",
        "    \"unsloth/Meta-Llama-3.1-70B-bnb-4bit\",\n",
        "    \"unsloth/Meta-Llama-3.1-405B-bnb-4bit\",    # We also uploaded 4bit for 405b!\n",
        "    \"unsloth/Mistral-Nemo-Base-2407-bnb-4bit\", # New Mistral 12b 2x faster!\n",
        "    \"unsloth/Mistral-Nemo-Instruct-2407-bnb-4bit\",\n",
        "    \"unsloth/mistral-7b-v0.3-bnb-4bit\",        # Mistral v3 2x faster!\n",
        "    \"unsloth/mistral-7b-instruct-v0.3-bnb-4bit\",\n",
        "    \"unsloth/Phi-3.5-mini-instruct\",           # Phi-3.5 2x faster!\n",
        "    \"unsloth/Phi-3-medium-4k-instruct\",\n",
        "    \"unsloth/gemma-2-9b-bnb-4bit\",\n",
        "    \"unsloth/gemma-2-27b-bnb-4bit\",            # Gemma 2x faster!\n",
        "] # More models at https://huggingface.co/unsloth\n",
        "\n",
        "model, tokenizer = FastLanguageModel.from_pretrained(\n",
        "    model_name = \"unsloth/Meta-Llama-3.1-8B\",\n",
        "    max_seq_length = max_seq_length,\n",
        "    dtype = dtype,\n",
        "    load_in_4bit = load_in_4bit,\n",
        "    # token = \"hf_...\", # use one if using gated models like meta-llama/Llama-2-7b-hf\n",
        ")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ZCCsemOsN-85"
      },
      "outputs": [],
      "source": [
        "model = FastLanguageModel.get_peft_model(\n",
        "    model,\n",
        "    r = 16, # Choose any number > 0 ! Suggested 8, 16, 32, 64, 128\n",
        "    target_modules = [\"q_proj\", \"k_proj\", \"v_proj\", \"o_proj\",\n",
        "                      \"gate_proj\", \"up_proj\", \"down_proj\",],\n",
        "    lora_alpha = 16,\n",
        "    lora_dropout = 0, # Supports any, but = 0 is optimized\n",
        "    bias = \"none\",    # Supports any, but = \"none\" is optimized\n",
        "    # [NEW] \"unsloth\" uses 30% less VRAM, fits 2x larger batch sizes!\n",
        "    use_gradient_checkpointing = \"unsloth\", # True or \"unsloth\" for very long context\n",
        "    random_state = 3407,\n",
        "    use_rslora = False,  # We support rank stabilized LoRA\n",
        "    loftq_config = None, # And LoftQ\n",
        ")\n",
        "\n",
        "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
        "\n",
        "### Instruction:\n",
        "{}\n",
        "\n",
        "### Input:\n",
        "{}\n",
        "\n",
        "### Response:\n",
        "{}\"\"\"\n",
        "\n",
        "EOS_TOKEN = tokenizer.eos_token # Must add EOS_TOKEN\n",
        "def formatting_prompts_func(examples):\n",
        "    instructions = examples[\"instruction\"]\n",
        "    inputs       = examples[\"input\"]\n",
        "    outputs      = examples[\"output\"]\n",
        "    texts = []\n",
        "    for instruction, input, output in zip(instructions, inputs, outputs):\n",
        "        # Must add EOS_TOKEN, otherwise your generation will go on forever!\n",
        "        text = alpaca_prompt.format(instruction, input, output) + EOS_TOKEN\n",
        "        texts.append(text)\n",
        "    return { \"text\" : texts, }\n",
        "pass\n",
        "\n",
        "from datasets import load_dataset\n",
        "dataset = load_dataset(\"yahma/alpaca-cleaned\", split = \"train\")\n",
        "dataset = dataset.map(formatting_prompts_func, batched = True,)\n",
        "from trl import SFTTrainer\n",
        "from transformers import TrainingArguments\n",
        "from unsloth import is_bfloat16_supported\n",
        "\n",
        "trainer = SFTTrainer(\n",
        "    model = model,\n",
        "    tokenizer = tokenizer,\n",
        "    train_dataset = dataset,\n",
        "    dataset_text_field = \"text\",\n",
        "    max_seq_length = max_seq_length,\n",
        "    dataset_num_proc = 2,\n",
        "    packing = False, # Can make training 5x faster for short sequences.\n",
        "    args = TrainingArguments(\n",
        "        per_device_train_batch_size = 2,\n",
        "        gradient_accumulation_steps = 4,\n",
        "        warmup_steps = 5,\n",
        "        # num_train_epochs = 1, # Set this for 1 full training run.\n",
        "        max_steps = 60,\n",
        "        learning_rate = 2e-4,\n",
        "        fp16 = not is_bfloat16_supported(),\n",
        "        bf16 = is_bfloat16_supported(),\n",
        "        logging_steps = 1,\n",
        "        optim = \"adamw_8bit\",\n",
        "        weight_decay = 0.01,\n",
        "        lr_scheduler_type = \"linear\",\n",
        "        seed = 3407,\n",
        "        output_dir = \"outputs\",\n",
        "        report_to = \"none\", # Use this for WandB etc\n",
        "    ),\n",
        ")\n",
        "trainer_stats = trainer.train()\n",
        "# alpaca_prompt = Copied from above\n",
        "FastLanguageModel.for_inference(model) # Enable native 2x faster inference\n",
        "inputs = tokenizer(\n",
        "[\n",
        "    alpaca_prompt.format(\n",
        "        \"Continue the fibonnaci sequence.\", # instruction\n",
        "        \"1, 1, 2, 3, 5, 8\", # input\n",
        "        \"\", # output - leave this blank for generation!\n",
        "    )\n",
        "], return_tensors = \"pt\").to(\"cuda\")\n",
        "\n",
        "outputs = model.generate(**inputs, max_new_tokens = 64, use_cache = True)\n",
        "tokenizer.batch_decode(outputs)\n",
        "\n",
        "# alpaca_prompt = Copied from above\n",
        "FastLanguageModel.for_inference(model) # Enable native 2x faster inference\n",
        "inputs = tokenizer(\n",
        "[\n",
        "    alpaca_prompt.format(\n",
        "        \"Continue the fibonnaci sequence.\", # instruction\n",
        "        \"1, 1, 2, 3, 5, 8\", # input\n",
        "        \"\", # output - leave this blank for generation!\n",
        "    )\n",
        "], return_tensors = \"pt\").to(\"cuda\")\n",
        "\n",
        "from transformers import TextStreamer\n",
        "text_streamer = TextStreamer(tokenizer)\n",
        "_ = model.generate(**inputs, streamer = text_streamer, max_new_tokens = 128)\n",
        "\n",
        "\n",
        "model.save_pretrained(\"lora_model\") # Local saving\n",
        "tokenizer.save_pretrained(\"lora_model\")\n",
        "# model.push_to_hub(\"your_name/lora_model\", token = \"...\") # Online saving\n",
        "# tokenizer.push_to_hub(\"your_name/lora_model\", token = \"...\") # Online saving\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "zPgt6MDvQ5e9"
      },
      "source": [
        "# example"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "KkqNcCVpd8OB"
      },
      "outputs": [],
      "source": [
        "2. List 3 key research areas described from the below abstracts (the best one)\n",
        "\n",
        "\n",
        "Given the work of authors (or principal investigators) in the field of rare diseases, identify 3 key detailed research expertise areas they have contributed to. Follow these steps: 1-Research Contribution Summary: Based on their publications, clinical trials, or grant proposals, summarize the major contributions made by the researchers in the context of {}.\n",
        "    2- Identify Expertise Areas: Based on their contributions, identify 3 key detailed research expertise areas that emerge from their work. 3-Generate Keywords: Condense each expertise area into a clear keyword or phrase that best represents their contribution.\n",
        "\n",
        "   Identify Expertise Areas: From the contributions, identify the key research expertise areas that emerge from their work. These can be areas of disease research, treatment strategies, technology, or clinical trial methods."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "pAis6zks3f8_"
      },
      "outputs": [],
      "source": [
        "\n",
        "### Example 1:\n",
        "**Input**:\n",
        "'Cerebral cavernous malformations (CCM) are rare vascular anomalies affecting the central nervous system. Mutations in CCM1, CCM2, and CCM3 are implicated in disease. The study explores the molecular pathophysiology of CCM3, particularly through a mouse model, focusing on the interaction between neural and endothelial cells, and its effect on Akt signaling.'\n",
        "\n",
        "**Output**:\n",
        "'Research Contribution Summary: The researchers studying CCM3 have made important contributions to understanding its molecular pathophysiology, particularly the role of mutations in the CCM3 gene (PDCD10). They have identified how CCM3 interacts with Akt signaling and endothelial-neural cell interactions, which contribute to vascular lesions and neurological symptoms.\n",
        "\n",
        "Expertise Areas:\n",
        "1. **Molecular Signaling in CCM3**: The study investigates how CCM3 regulates key molecular pathways like Akt signaling, which impacts vascular pathology.\n",
        "2. **Neurovascular Pathology and Cell Interactions**: Focuses on how CCM3 modulates the interaction between neural and endothelial cells to drive vascular lesions in the brain.\n",
        "3. **Mouse Models in Disease Mechanism Study**: Advanced use of conditional knockout mouse models to study CCM3 expression and its effects on vascular health in vivo.'\n",
        "\n",
        "### Example 2:\n",
        "**Input**:\n",
        "'Polydactyly is a congenital limb deformity, which may occur as a syndrome or independently. The GLI3 gene is associated with both syndromic and non-syndromic polydactyly. This study examines GLI3 mutations in non-syndromic cases and explores the role of FGFR2 mutations in related syndromes.'\n",
        "\n",
        "**Output**:\n",
        "'Research Contribution Summary: The researchers have identified key mutations in the GLI3 gene, specifically in non-syndromic bilateral polydactyly cases. They also explored the role of FGFR2 mutations, particularly the S252W variant, in syndromic polydactyly, including Apert syndrome.\n",
        "\n",
        "Expertise Areas:\n",
        "1. **GLI3 Mutations in Non-Syndromic Polydactyly**: The study highlights how GLI3 mutations contribute to non-syndromic bilateral polydactyly.\n",
        "2. **FGFR2 and Osteoblastic Differentiation in Polydactyly Syndromes**: Investigates how FGFR2 mutations (S252W) impact osteoblastic differentiation in polydactyly-related bone anomalies.\n",
        "3. **Genetic Basis of Polydactyly Syndromes**: Explores the genetic factors, including GLI3 and FGFR2 mutations, that underlie various polydactyly syndromes and their clinical manifestations.'\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "5d0eh9iszBFQ"
      },
      "outputs": [],
      "source": [
        "Given the work of authors (or principal investigators) in the context of {} which is a rare disease, identify 3 key detailed research expertise areas they have contributed to. Follow these steps: 1-Research Contribution Summary: Based on their publications, clinical trials, or grant proposals, summarize the major contributions made by the researchers in the field.\n",
        "    2- Identify Expertise Areas: Based on their contributions, identify 3 key detailed research expertise areas that emerge from their work.\n",
        "\n",
        "Here are two examples:\n",
        "example1: if the input is: 'DESCRIPTION (provided by applicant): Cerebral cavernous malformations (CCM), characterized by dilated sinusoidal vascular spaces lined by a single layer of endothelium, affect the central nervous system and may lead to neurological problems including bleeding and seizures. Mutations in the three genes, CCM1 (KRIT1, Krev1/Rap1a Interaction Trapped 1), CCM2 (OSM, malcavernin) and CCM3 (PDCD10, Programmed Cell Death Protein 10) have been shown to cause CCM. While recent in vitro studies have begun to illuminate the nature of CCM signaling, an in vivo, mechanistic understanding of CCM pathophysiology is lacking. Based on our recent data from in vitro cell culture studies, in vivo data from our mouse conditional knock-out of Ccm3 in neural cells, and intriguing observations in animal models from various groups, we hypothesize that CCM3 is a negative modulator of Akt signaling via interactions with PP2A, and CCM lesions are the consequence of altered expression of Akt and its downstream effectors. We further hypothesize that CCM3 signaling mediates an interaction between neural and endothelial cells and alteration of this interaction caused by neural CCM3 loss, results in a vascular phenotype. We propose to test these hypotheses using in vitro and in vivo approaches aimed at elaborating this novel Ccm3 signaling pathway and to investigate its potential influence on the interactions among various cell types within the neurovascular unit in CCM lesion development. We will perform studies aimed at clarifying the nature of Ccm3 interactions with the Akt signaling pathway. We will comprehensively study the Emx1-Cre;Ccm3lox/lox mouse model that we have recently generated. Unlike other conditional Ccm3 knockouts, these mice survive long term and develop vascular pathology. The vascular pathology is characterized by dilated vessels throughout the brain and isolated lesions that are reminiscent of human CCM disease. We will take advantage of our findings to gain insight into CCM3 function and signaling. In addition, we propose to cross inducible VE-cadherin-CreER and GFAP-CreER to Ccm3lox/lox mice to study cell autonomous effects of CCM3 in endothelial cells and postnatal astrocytes. The proposed experiments are focused on identifying the molecular pathways relevant to CCM disease and on studying these pathways in vivo with a long-term goal of defining new and more effective therapies.       PUBLIC HEALTH RELEVANCE: Mutations in the gene Programmed Cell Death Protein 10 (PDCD10) cause Cerebral Cavernous Malformation 3 (CCM3), a vascular disorder mainly affecting the brain. The root causes of CCM are largely unknown. To study these causes, we propose to use a mouse model, Emx1-Cre;Ccm3lox/lox that we recently developed which leads, in part, to the same of abnormalities seen in humans suffering from CCM. These mice develop spontaneous vascular lesions identical to those in human CCM. By using a variety of assays, we plan to identify the molecular mechanisms that lead to the vascular pathology. We also propose to develop new models with inducible Cre lines that will allow us to modulate CCC3 expression in astrocytes or endothelial cells at postnatal stages to study cell specific effects of CCM3. A deeper understanding of the causes of CCM pathology at the cellular and molecular level in vivo will set the stage for efforts to define new and more effective therapies for this potentially debilitating and sometimes fatal disorder.'\n",
        "          its response is : 'Research_contribution_summary = The researchers studying Cerebral Cavernous Malformations 3 (CCM3) have made several major contributions to understanding the pathophysiology and molecular mechanisms behind this rare neurovascular disorder. Their work has focused on the genetic basis of CCM3, particularly the role of mutations in the PDCD10 gene (Programmed Cell Death Protein 10), which causes CCM3. This disease manifests in the brain as vascular lesions, leading to neurological complications such as bleeding and seizures.\\n A key area of their research involves the use of animal models, particularly the Emx1-Cre;Ccm3lox/lox mouse model, which replicates the vascular pathology found in human CCM3 patients. This model has been instrumental in studying the loss of CCM3 in neural cells, which results in altered vascular development and signaling. The researchers have also proposed hypotheses that CCM3 negatively modulates Akt signaling through interactions with PP2A, suggesting that alterations in these pathways contribute to the formation of CCM lesions.\\n Through both in vitro and in vivo experiments, they aim to elaborate on the molecular mechanisms behind CCM3 and its impact on the neurovascular unit, with a particular focus on the interaction between neural cells and endothelial cells. The long-term goal is to understand the fundamental biological pathways involved in CCM3, with an emphasis on discovering new therapeutic targets for treating this debilitating disease.   \\n\\n expertise_areas=\\n 1. Molecular Signaling Pathways in CCM3:\\n The researchers have focused on understanding the role of CCM3 in regulating key signaling pathways, particularly how it interacts with the Akt signaling pathway and its downstream effectors. Their hypothesis suggests that CCM3 may act as a negative modulator of Akt signaling via interactions with PP2A. This has significant implications for understanding how alterations in these molecular pathways contribute to the pathogenesis of CCM lesions. Detailed knowledge of these signaling mechanisms is essential for identifying potential therapeutic targets.\\n 2. Neurovascular Interactions and CCM Pathogenesis:\\n A core part of the researchers’ work is the study of the interactions between neural cells and endothelial cells within the neurovascular unit. By investigating how the loss of CCM3 in neural cells affects the development of vascular pathology, they aim to better understand the cellular interactions that contribute to the formation of vascular lesions seen in CCM3. Their use of conditional knockout mouse models, such as the Emx1-Cre;Ccm3lox/lox model, allows them to study these effects in a controlled in vivo environment, offering insights into how these cellular dynamics drive disease progression.\\n 3. Mouse Models and Disease Mechanisms:\\n The researchers have developed and utilized advanced mouse models to study CCM3. Specifically, they have created inducible models to manipulate CCM3 expression in postnatal stages of astrocytes and endothelial cells. These models are crucial for studying cell-specific effects and understanding the mechanisms that lead to vascular abnormalities. The ability to study the disease in these models is pivotal for defining the molecular underpinnings of CCM3 and for evaluating potential therapeutic strategies.'\n",
        "example2: if the input is: 'Polydactyly is a common congenital limb deformity. This anomaly may occur in isolation (non-syndromic) or as part of a syndrome. The glioma-associated oncogene family zinc finger 3 (GLI3) is known to be associated with both syndromic and non-syndromic polydactyly. GLI3 plays a predominant role in the pathogenesis of syndromic polydactyly: mutations have been identified in 68% of patients with Greig cephalopolysyndactyly syndrome and 91% of patients with Pallister-Hall syndrome. The knowledge regarding the contribution of GLI3 in non-syndromic polydactyly is currently very limited. In this study, we assembled a cohort of individuals of Chinese ethnicity with non-syndromic postaxial polydactyly. We presented the clinical features and molecular evaluations of 19 probands. GLI3 mutations were identified in 15.8% of probands (3/19) including two novel frame-shift mutations c.3855dupC (p.Met1286HisfsTer18) and c.4141delA (p.Arg1381GlyfsTer38) detected in sporadic cases and one previously reported nonsense mutation (c.1927C>T/p.Arg643Ter) in a familial case. Of note, GLI3 mutations were exclusively detected in patients with bilateral polydactyly affecting both hands and feet. Three out of five (60%) probands with bilateral polydactyly on both hands and feet carried pathogenic mutations in GLI3. Our study demonstrated the role of GLI3 in a significant fraction of patients with non-syndromic bilateral polydactyly affecting both hands and feet. Apert syndrome is an autosomal dominant disease characterized by craniosynostosis and bony syndactyly associated with point mutations (S252W and P253R) in the fibroblast growth factor receptor (FGFR) 2 that cause FGFR2 activation. Here we investigated the role of the S252W mutation of FGFR2 on osteoblastic differentiation. Osteoblastic cells derived from digital bone in two Apert patients with the S252W mutation showed more prominent alkaline phosphatase activity, osteocalcin and osteopontin mRNA expression, and mineralized nodule formation compared with the control osteoblastic cells derived from two independent non-syndromic polydactyly patients. Stable clones of the human MG63 osteosarcoma cells (MG63-Ap and MG63-IIIc) overexpressing a splice variant form of FGFR2 with or without the S252W mutation (FGFR2IIIcS252W and FGFR2IIIc) showed a higher RUNX2 mRNA expression than parental MG63 cells. Furthermore MG63-Ap exhibited a higher osteopontin mRNA expression than did MG63-IIIc. The enhanced osteoblastic marker gene expression and mineralized nodule formation of the MG63-Ap was inhibited by the conditioned medium from the COS-1 cells overexpressing the soluble FGFR2IIIcS252W. Furthermore the FGF2-induced osteogenic response in the mouse calvarial organ culture system was blocked by the soluble FGFR2IIIcS252W. These results show that the S252W mutation in the FGFR2 gene enhances the osteoblast phenotype in human osteoblasts and that a soluble FGFR2 with the S252W mutation controls osteoblast differentiation induced by the S252W mutation through a dominant negative effect on FGFR2 signaling in Apert syndrome. Acrocallosal syndrome is characterized by postaxial polydactyly, macrocephaly, agenesis of the corpus callosum, and severe developmental delay. In a few patients with this disorder, a mutation in the KIF7 gene has been reported, which was associated with impaired GLI3 processing and dysregulaton of GLI3 transcription factors. A single patient with acrocallosal syndrome and a de novo p.Ala934Pro mutation in GLI3 has been reported, whereas diverse and numerous GLI3 mutations have also been described in syndromes with overlapping clinical manifestations, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, trigonocephaly with craniosynostosis and polydactyly, oral-facial-digital syndrome, and non-syndromic polydactyly. Here, we describe a second patient with acrocallosal syndrome, who has a de novo, novel c.2786T>C mutation in GLI3, which predicts p.Leu929Pro. This mutation is in the same domain as the mutation in the previously reported patient. These data confirm that mutations in GLI3 are a cause of the acrocallosal phenotype. Human GLI3 gene mutations have been identified in several phenotypes of digital abnormality such as Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type-IV (PPD-IV) and postaxial polydactyly. However, the different phenotypes resulting from GLI3 mutations have not yet been properly defined. We have experienced two types of digital abnormality without other complicating developmental defects; a family with foot PPD-IV with syndactyly of the third and fourth fingers, and four sporadic cases with biphalangeal thumb polydactyly (PPD-I). The genes responsible for syndactyly of the third and fourth fingers (syndactyly type-I) and PPD-I have not yet been identified; we therefore examined the involvement of the GLI3 gene in these subtypes of digital abnormality. We found a non-sense mutation in the GLI3 gene in the family with foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers, but no mutations were detected in the GLI3 gene in the four other cases with PPD-I alone. Thus, the phenotype of foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers may result from a GLI3 mutation, whereas the PPD-I phenotype alone is not caused by GLI3 gene defect. These results will help to define the phenotypic spectrum of GLI3 morphopathies, which have been recently proposed.'\n",
        "          its response is: 'Research_contribution_summary = Polydactyly is a common congenital limb deformity. This anomaly may occur in isolation (non-syndromic) or as part of a syndrome. The glioma-associated oncogene family zinc finger 3 (GLI3) is known to be associated with both syndromic and non-syndromic polydactyly. GLI3 plays a predominant role in the pathogenesis of syndromic polydactyly: mutations have been identified in 68% of patients with Greig cephalopolysyndactyly syndrome and 91% of patients with Pallister-Hall syndrome. The knowledge regarding the contribution of GLI3 in non-syndromic polydactyly is currently very limited. In this study, we assembled a cohort of individuals of Chinese ethnicity with non-syndromic postaxial polydactyly. We presented the clinical features and molecular evaluations of 19 probands. GLI3 mutations were identified in 15.8% of probands (3/19) including two novel frame-shift mutations c.3855dupC (p.Met1286HisfsTer18) and c.4141delA (p.Arg1381GlyfsTer38) detected in sporadic cases and one previously reported nonsense mutation (c.1927C>T/p.Arg643Ter) in a familial case. Of note, GLI3 mutations were exclusively detected in patients with bilateral polydactyly affecting both hands and feet. Three out of five (60%) probands with bilateral polydactyly on both hands and feet carried pathogenic mutations in GLI3. Our study demonstrated the role of GLI3 in a significant fraction of patients with non-syndromic bilateral polydactyly affecting both hands and feet.\\n Apert syndrome is an autosomal dominant disease characterized by craniosynostosis and bony syndactyly associated with point mutations (S252W and P253R) in the fibroblast growth factor receptor (FGFR) 2 that cause FGFR2 activation. Here we investigated the role of the S252W mutation of FGFR2 on osteoblastic differentiation. Osteoblastic cells derived from digital bone in two Apert patients with the S252W mutation showed more prominent alkaline phosphatase activity, osteocalcin and osteopontin mRNA expression, and mineralized nodule formation compared with the control osteoblastic cells derived from two independent non-syndromic polydactyly patients. Stable clones of the human MG63 osteosarcoma cells (MG63-Ap and MG63-IIIc) overexpressing a splice variant form of FGFR2 with or without the S252W mutation (FGFR2IIIcS252W and FGFR2IIIc) showed a higher RUNX2 mRNA expression than parental MG63 cells. Furthermore MG63-Ap exhibited a higher osteopontin mRNA expression than did MG63-IIIc. The enhanced osteoblastic marker gene expression and mineralized nodule formation of the MG63-Ap was inhibited by the conditioned medium from the COS-1 cells overexpressing the soluble FGFR2IIIcS252W. Furthermore the FGF2-induced osteogenic response in the mouse calvarial organ culture system was blocked by the soluble FGFR2IIIcS252W. These results show that the S252W mutation in the FGFR2 gene enhances the osteoblast phenotype in human osteoblasts and that a soluble FGFR2 with the S252W mutation controls osteoblast differentiation induced by the S252W mutation through a dominant negative effect on FGFR2 signaling in Apert syndrome.\\n Acrocallosal syndrome is characterized by postaxial polydactyly, macrocephaly, agenesis of the corpus callosum, and severe developmental delay. In a few patients with this disorder, a mutation in the KIF7 gene has been reported, which was associated with impaired GLI3 processing and dysregulation of GLI3 transcription factors. A single patient with acrocallosal syndrome and a de novo p.Ala934Pro mutation in GLI3 has been reported, whereas diverse and numerous GLI3 mutations have also been described in syndromes with overlapping clinical manifestations, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, trigonocephaly with craniosynostosis and polydactyly, oral-facial-digital syndrome, and non-syndromic polydactyly. Here, we describe a second patient with acrocallosal syndrome, who has a de novo, novel c.2786T>C mutation in GLI3, which predicts p.Leu929Pro. This mutation is in the same domain as the mutation in the previously reported patient. These data confirm that mutations in GLI3 are a cause of the acrocallosal phenotype. Human GLI3 gene mutations have been identified in several phenotypes of digital abnormality such as Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type-IV (PPD-IV) and postaxial polydactyly. However, the different phenotypes resulting from GLI3 mutations have not yet been properly defined. We have experienced two types of digital abnormality without other complicating developmental defects; a family with foot PPD-IV with syndactyly of the third and fourth fingers, and four sporadic cases with biphalangeal thumb polydactyly (PPD-I). The genes responsible for syndactyly of the third and fourth fingers (syndactyly type-I) and PPD-I have not yet been identified; we therefore examined the involvement of the GLI3 gene in these subtypes of digital abnormality. We found a non-sense mutation in the GLI3 gene in the family with foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers, but no mutations were detected in the GLI3 gene in the four other cases with PPD-I alone. Thus, the phenotype of foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers may result from a GLI3 mutation, whereas the PPD-I phenotype alone is not caused by GLI3 gene defect. These results will help to define the phenotypic spectrum of GLI3 morphopathies, which have been recently proposed. \\n\\n expertise_areas = \\n 1. Molecular Genetics of Non-Syndromic Polydactyly and GLI3 Mutations:\\n The researchers have made significant contributions in understanding the genetic basis of non-syndromic postaxial polydactyly, specifically the role of **GLI3 mutations**. Their study identified **novel frame-shift mutations** and **previously reported mutations** in **GLI3**, demonstrating its involvement in **bilateral polydactyly** affecting both hands and feet. Their findings underscore the role of GLI3 as a genetic modifier in non-syndromic polydactyly, specifically in cases with bilateral manifestations.\\n 2. Role of FGFR2 Mutations in Osteoblastic Differentiation in Polydactyly-Related Syndromes:\\n The research has also focused on understanding how mutations in the **FGFR2 gene**, particularly the **S252W mutation**, contribute to osteoblastic differentiation in conditions like **Apert syndrome**, which overlaps with polydactyly phenotypes. They demonstrated that the **S252W mutation** in FGFR2 enhances osteoblastic activity, leading to higher expression of osteoblastic markers. Their study provides insights into the molecular mechanisms affecting **bone differentiation** and its potential impact on polydactyly-related syndromes.\\n 3. GLI3 Mutations in Acrocallosal Syndrome and Digital Abnormalities:\\n The researchers also contributed to the understanding of **GLI3 mutations** in rare conditions like **Acrocallosal syndrome** and other digital abnormalities such as **preaxial and postaxial polydactyly**. They identified novel mutations in GLI3 that contribute to **impaired GLI3 processing**, which impacts the development of polydactyly and other associated features. This work highlights how **GLI3 mutations** contribute to different polydactyly subtypes and how these mutations expand the phenotypic spectrum of **GLI3 morphopathies**.'\n",
        "\n",
        "\n",
        "example1: if the input is: 'DESCRIPTION (provided by applicant): Cerebral cavernous malformations (CCM), characterized by dilated sinusoidal vascular spaces lined by a single layer of endothelium, affect the central nervous system and may lead to neurological problems including bleeding and seizures. Mutations in the three genes, CCM1 (KRIT1, Krev1/Rap1a Interaction Trapped 1), CCM2 (OSM, malcavernin) and CCM3 (PDCD10, Programmed Cell Death Protein 10) have been shown to cause CCM. While recent in vitro studies have begun to illuminate the nature of CCM signaling, an in vivo, mechanistic understanding of CCM pathophysiology is lacking. Based on our recent data from in vitro cell culture studies, in vivo data from our mouse conditional knock-out of Ccm3 in neural cells, and intriguing observations in animal models from various groups, we hypothesize that CCM3 is a negative modulator of Akt signaling via interactions with PP2A, and CCM lesions are the consequence of altered expression of Akt and its downstream effectors. We further hypothesize that CCM3 signaling mediates an interaction between neural and endothelial cells and alteration of this interaction caused by neural CCM3 loss, results in a vascular phenotype. We propose to test these hypotheses using in vitro and in vivo approaches aimed at elaborating this novel Ccm3 signaling pathway and to investigate its potential influence on the interactions among various cell types within the neurovascular unit in CCM lesion development. We will perform studies aimed at clarifying the nature of Ccm3 interactions with the Akt signaling pathway. We will comprehensively study the Emx1-Cre;Ccm3lox/lox mouse model that we have recently generated. Unlike other conditional Ccm3 knockouts, these mice survive long term and develop vascular pathology. The vascular pathology is characterized by dilated vessels throughout the brain and isolated lesions that are reminiscent of human CCM disease. We will take advantage of our findings to gain insight into CCM3 function and signaling. In addition, we propose to cross inducible VE-cadherin-CreER and GFAP-CreER to Ccm3lox/lox mice to study cell autonomous effects of CCM3 in endothelial cells and postnatal astrocytes. The proposed experiments are focused on identifying the molecular pathways relevant to CCM disease and on studying these pathways in vivo with a long-term goal of defining new and more effective therapies.       PUBLIC HEALTH RELEVANCE: Mutations in the gene Programmed Cell Death Protein 10 (PDCD10) cause Cerebral Cavernous Malformation 3 (CCM3), a vascular disorder mainly affecting the brain. The root causes of CCM are largely unknown. To study these causes, we propose to use a mouse model, Emx1-Cre;Ccm3lox/lox that we recently developed which leads, in part, to the same of abnormalities seen in humans suffering from CCM. These mice develop spontaneous vascular lesions identical to those in human CCM. By using a variety of assays, we plan to identify the molecular mechanisms that lead to the vascular pathology. We also propose to develop new models with inducible Cre lines that will allow us to modulate CCC3 expression in astrocytes or endothelial cells at postnatal stages to study cell specific effects of CCM3. A deeper understanding of the causes of CCM pathology at the cellular and molecular level in vivo will set the stage for efforts to define new and more effective therapies for this potentially debilitating and sometimes fatal disorder.'\n",
        "          its response is : 'expertise_areas=\\n 1. Molecular Signaling Pathways in CCM3:\\n The researchers have focused on understanding the role of CCM3 in regulating key signaling pathways, particularly how it interacts with the Akt signaling pathway and its downstream effectors. Their hypothesis suggests that CCM3 may act as a negative modulator of Akt signaling via interactions with PP2A. This has significant implications for understanding how alterations in these molecular pathways contribute to the pathogenesis of CCM lesions. Detailed knowledge of these signaling mechanisms is essential for identifying potential therapeutic targets.\\n 2. Neurovascular Interactions and CCM Pathogenesis:\\n A core part of the researchers’ work is the study of the interactions between neural cells and endothelial cells within the neurovascular unit. By investigating how the loss of CCM3 in neural cells affects the development of vascular pathology, they aim to better understand the cellular interactions that contribute to the formation of vascular lesions seen in CCM3. Their use of conditional knockout mouse models, such as the Emx1-Cre;Ccm3lox/lox model, allows them to study these effects in a controlled in vivo environment, offering insights into how these cellular dynamics drive disease progression.\\n 3. Mouse Models and Disease Mechanisms:\\n The researchers have developed and utilized advanced mouse models to study CCM3. Specifically, they have created inducible models to manipulate CCM3 expression in postnatal stages of astrocytes and endothelial cells. These models are crucial for studying cell-specific effects and understanding the mechanisms that lead to vascular abnormalities. The ability to study the disease in these models is pivotal for defining the molecular underpinnings of CCM3 and for evaluating potential therapeutic strategies.'\n",
        "example2: if the input is: 'Polydactyly is a common congenital limb deformity. This anomaly may occur in isolation (non-syndromic) or as part of a syndrome. The glioma-associated oncogene family zinc finger 3 (GLI3) is known to be associated with both syndromic and non-syndromic polydactyly. GLI3 plays a predominant role in the pathogenesis of syndromic polydactyly: mutations have been identified in 68% of patients with Greig cephalopolysyndactyly syndrome and 91% of patients with Pallister-Hall syndrome. The knowledge regarding the contribution of GLI3 in non-syndromic polydactyly is currently very limited. In this study, we assembled a cohort of individuals of Chinese ethnicity with non-syndromic postaxial polydactyly. We presented the clinical features and molecular evaluations of 19 probands. GLI3 mutations were identified in 15.8% of probands (3/19) including two novel frame-shift mutations c.3855dupC (p.Met1286HisfsTer18) and c.4141delA (p.Arg1381GlyfsTer38) detected in sporadic cases and one previously reported nonsense mutation (c.1927C>T/p.Arg643Ter) in a familial case. Of note, GLI3 mutations were exclusively detected in patients with bilateral polydactyly affecting both hands and feet. Three out of five (60%) probands with bilateral polydactyly on both hands and feet carried pathogenic mutations in GLI3. Our study demonstrated the role of GLI3 in a significant fraction of patients with non-syndromic bilateral polydactyly affecting both hands and feet. Apert syndrome is an autosomal dominant disease characterized by craniosynostosis and bony syndactyly associated with point mutations (S252W and P253R) in the fibroblast growth factor receptor (FGFR) 2 that cause FGFR2 activation. Here we investigated the role of the S252W mutation of FGFR2 on osteoblastic differentiation. Osteoblastic cells derived from digital bone in two Apert patients with the S252W mutation showed more prominent alkaline phosphatase activity, osteocalcin and osteopontin mRNA expression, and mineralized nodule formation compared with the control osteoblastic cells derived from two independent non-syndromic polydactyly patients. Stable clones of the human MG63 osteosarcoma cells (MG63-Ap and MG63-IIIc) overexpressing a splice variant form of FGFR2 with or without the S252W mutation (FGFR2IIIcS252W and FGFR2IIIc) showed a higher RUNX2 mRNA expression than parental MG63 cells. Furthermore MG63-Ap exhibited a higher osteopontin mRNA expression than did MG63-IIIc. The enhanced osteoblastic marker gene expression and mineralized nodule formation of the MG63-Ap was inhibited by the conditioned medium from the COS-1 cells overexpressing the soluble FGFR2IIIcS252W. Furthermore the FGF2-induced osteogenic response in the mouse calvarial organ culture system was blocked by the soluble FGFR2IIIcS252W. These results show that the S252W mutation in the FGFR2 gene enhances the osteoblast phenotype in human osteoblasts and that a soluble FGFR2 with the S252W mutation controls osteoblast differentiation induced by the S252W mutation through a dominant negative effect on FGFR2 signaling in Apert syndrome. Acrocallosal syndrome is characterized by postaxial polydactyly, macrocephaly, agenesis of the corpus callosum, and severe developmental delay. In a few patients with this disorder, a mutation in the KIF7 gene has been reported, which was associated with impaired GLI3 processing and dysregulaton of GLI3 transcription factors. A single patient with acrocallosal syndrome and a de novo p.Ala934Pro mutation in GLI3 has been reported, whereas diverse and numerous GLI3 mutations have also been described in syndromes with overlapping clinical manifestations, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, trigonocephaly with craniosynostosis and polydactyly, oral-facial-digital syndrome, and non-syndromic polydactyly. Here, we describe a second patient with acrocallosal syndrome, who has a de novo, novel c.2786T>C mutation in GLI3, which predicts p.Leu929Pro. This mutation is in the same domain as the mutation in the previously reported patient. These data confirm that mutations in GLI3 are a cause of the acrocallosal phenotype. Human GLI3 gene mutations have been identified in several phenotypes of digital abnormality such as Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type-IV (PPD-IV) and postaxial polydactyly. However, the different phenotypes resulting from GLI3 mutations have not yet been properly defined. We have experienced two types of digital abnormality without other complicating developmental defects; a family with foot PPD-IV with syndactyly of the third and fourth fingers, and four sporadic cases with biphalangeal thumb polydactyly (PPD-I). The genes responsible for syndactyly of the third and fourth fingers (syndactyly type-I) and PPD-I have not yet been identified; we therefore examined the involvement of the GLI3 gene in these subtypes of digital abnormality. We found a non-sense mutation in the GLI3 gene in the family with foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers, but no mutations were detected in the GLI3 gene in the four other cases with PPD-I alone. Thus, the phenotype of foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers may result from a GLI3 mutation, whereas the PPD-I phenotype alone is not caused by GLI3 gene defect. These results will help to define the phenotypic spectrum of GLI3 morphopathies, which have been recently proposed.'\n",
        "          its response is: 'expertise_areas = \\n 1. Molecular Genetics of Non-Syndromic Polydactyly and GLI3 Mutations:\\n The researchers have made significant contributions in understanding the genetic basis of non-syndromic postaxial polydactyly, specifically the role of **GLI3 mutations**. Their study identified **novel frame-shift mutations** and **previously reported mutations** in **GLI3**, demonstrating its involvement in **bilateral polydactyly** affecting both hands and feet. Their findings underscore the role of GLI3 as a genetic modifier in non-syndromic polydactyly, specifically in cases with bilateral manifestations.\\n 2. Role of FGFR2 Mutations in Osteoblastic Differentiation in Polydactyly-Related Syndromes:\\n The research has also focused on understanding how mutations in the **FGFR2 gene**, particularly the **S252W mutation**, contribute to osteoblastic differentiation in conditions like **Apert syndrome**, which overlaps with polydactyly phenotypes. They demonstrated that the **S252W mutation** in FGFR2 enhances osteoblastic activity, leading to higher expression of osteoblastic markers. Their study provides insights into the molecular mechanisms affecting **bone differentiation** and its potential impact on polydactyly-related syndromes.\\n 3. GLI3 Mutations in Acrocallosal Syndrome and Digital Abnormalities:\\n The researchers also contributed to the understanding of **GLI3 mutations** in rare conditions like **Acrocallosal syndrome** and other digital abnormalities such as **preaxial and postaxial polydactyly**. They identified novel mutations in GLI3 that contribute to **impaired GLI3 processing**, which impacts the development of polydactyly and other associated features. This work highlights how **GLI3 mutations** contribute to different polydactyly subtypes and how these mutations expand the phenotypic spectrum of **GLI3 morphopathies**.'\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 377
        },
        "id": "yFd6m1LNQYK5",
        "outputId": "5edec2e1-feee-4507-c4a2-a8c8e4fcbef0"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'Expertise Areas:\\n1. BMPER Mutations and Polytopic Skeletal Dysostosis:\\n The researchers have made significant contributions in understanding the genetic basis of **polytopic skeletal dysostosis** conditions such as **ischiospinal dysostosis (ISD)** and **diaphanospondylodysostosis (DSD)**. They have identified **mutations in the BMPER gene** in patients with these conditions, demonstrating its role in the development of skeletal abnormalities. Their findings have helped to define the phenotypic spectrum of **BMPER-related skeletal disorders**, which are characterized by a range of skeletal abnormalities including spinal ossification, segmentation defects, and renal cystic dysplasia with nephrogenic rests.\\n 2. Novel Mutation in BMPER Gene and Importance of Respiratory Assessment:\\n The researchers have also contributed to the understanding of the **novel mutation c.1750delT (p.Cys584fs)** in the **BMPER gene** in a female adolescent patient. They highlighted the importance of **regular assessment of respiratory failure** for successful management of this condition, which is a common and fatal symptom for patients with BMPER gene mutation. This study provides valuable insights into the management of patients with BMPER-related skeletal disorders.\\n 3. Nephroblastomatosis in Diaphanospondylodysostosis:\\n The researchers have also contributed to the understanding of the **natural history of nephroblastomatosis** in patients with **DSD**, a rare skeletal dysplasia syndrome resulting from disordered mesenchymal differentiation. They described a patient with DSD who developed bilateral hyperplastic nephroblastomatosis that ultimately evolved into therapy-resistant anaplastic Wilms tumor (nephroblastoma). This study provides valuable insights into the management of patients with DSD and its associated renal abnormalities.\\n 4. Genetic Mapping and Prioritization of BMPER-Related Skeletal Disorders:\\n The researchers have also made significant contributions to the understanding of **genetic mapping** and **prioritization of BMPER-related skeletal disorders**. They identified a **novel deleterious mutation Q104X in the BMPER gene** in a female adolescent patient and highlighted the importance of the **shared 440 SNP haplotype** as evidence of an ancestral founder allele. This study provides valuable insights into the genetic basis of BMPER-related skeletal disorders and their associated clinical features.<|end_of_text|>'"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "---------------------------------------------------------------\n"
          ]
        }
      ],
      "source": [
        "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
        "\n",
        "### Instruction:\n",
        "Given the work of authors (or principal investigators) in the context of {} which is a rare disease, identify 3 key detailed research expertise areas they have contributed to. Follow these steps: 1-Research Contribution Summary: Based on their publications, clinical trials, or grant proposals, summarize the major contributions made by the researchers in the field.\n",
        "    2- Identify Expertise Areas: Based on their contributions, identify 3 key detailed research expertise areas that emerge from their work. Here are two examples:\n",
        "example1: if the input is: 'DESCRIPTION (provided by applicant): Cerebral cavernous malformations (CCM), characterized by dilated sinusoidal vascular spaces lined by a single layer of endothelium, affect the central nervous system and may lead to neurological problems including bleeding and seizures. Mutations in the three genes, CCM1 (KRIT1, Krev1/Rap1a Interaction Trapped 1), CCM2 (OSM, malcavernin) and CCM3 (PDCD10, Programmed Cell Death Protein 10) have been shown to cause CCM. While recent in vitro studies have begun to illuminate the nature of CCM signaling, an in vivo, mechanistic understanding of CCM pathophysiology is lacking. Based on our recent data from in vitro cell culture studies, in vivo data from our mouse conditional knock-out of Ccm3 in neural cells, and intriguing observations in animal models from various groups, we hypothesize that CCM3 is a negative modulator of Akt signaling via interactions with PP2A, and CCM lesions are the consequence of altered expression of Akt and its downstream effectors. We further hypothesize that CCM3 signaling mediates an interaction between neural and endothelial cells and alteration of this interaction caused by neural CCM3 loss, results in a vascular phenotype. We propose to test these hypotheses using in vitro and in vivo approaches aimed at elaborating this novel Ccm3 signaling pathway and to investigate its potential influence on the interactions among various cell types within the neurovascular unit in CCM lesion development. We will perform studies aimed at clarifying the nature of Ccm3 interactions with the Akt signaling pathway. We will comprehensively study the Emx1-Cre;Ccm3lox/lox mouse model that we have recently generated. Unlike other conditional Ccm3 knockouts, these mice survive long term and develop vascular pathology. The vascular pathology is characterized by dilated vessels throughout the brain and isolated lesions that are reminiscent of human CCM disease. We will take advantage of our findings to gain insight into CCM3 function and signaling. In addition, we propose to cross inducible VE-cadherin-CreER and GFAP-CreER to Ccm3lox/lox mice to study cell autonomous effects of CCM3 in endothelial cells and postnatal astrocytes. The proposed experiments are focused on identifying the molecular pathways relevant to CCM disease and on studying these pathways in vivo with a long-term goal of defining new and more effective therapies.       PUBLIC HEALTH RELEVANCE: Mutations in the gene Programmed Cell Death Protein 10 (PDCD10) cause Cerebral Cavernous Malformation 3 (CCM3), a vascular disorder mainly affecting the brain. The root causes of CCM are largely unknown. To study these causes, we propose to use a mouse model, Emx1-Cre;Ccm3lox/lox that we recently developed which leads, in part, to the same of abnormalities seen in humans suffering from CCM. These mice develop spontaneous vascular lesions identical to those in human CCM. By using a variety of assays, we plan to identify the molecular mechanisms that lead to the vascular pathology. We also propose to develop new models with inducible Cre lines that will allow us to modulate CCC3 expression in astrocytes or endothelial cells at postnatal stages to study cell specific effects of CCM3. A deeper understanding of the causes of CCM pathology at the cellular and molecular level in vivo will set the stage for efforts to define new and more effective therapies for this potentially debilitating and sometimes fatal disorder.'\n",
        "          its response is : 'expertise_areas=\\n 1. Molecular Signaling Pathways in CCM3:\\n The researchers have focused on understanding the role of CCM3 in regulating key signaling pathways, particularly how it interacts with the Akt signaling pathway and its downstream effectors. Their hypothesis suggests that CCM3 may act as a negative modulator of Akt signaling via interactions with PP2A. This has significant implications for understanding how alterations in these molecular pathways contribute to the pathogenesis of CCM lesions. Detailed knowledge of these signaling mechanisms is essential for identifying potential therapeutic targets.\\n 2. Neurovascular Interactions and CCM Pathogenesis:\\n A core part of the researchers’ work is the study of the interactions between neural cells and endothelial cells within the neurovascular unit. By investigating how the loss of CCM3 in neural cells affects the development of vascular pathology, they aim to better understand the cellular interactions that contribute to the formation of vascular lesions seen in CCM3. Their use of conditional knockout mouse models, such as the Emx1-Cre;Ccm3lox/lox model, allows them to study these effects in a controlled in vivo environment, offering insights into how these cellular dynamics drive disease progression.\\n 3. Mouse Models and Disease Mechanisms:\\n The researchers have developed and utilized advanced mouse models to study CCM3. Specifically, they have created inducible models to manipulate CCM3 expression in postnatal stages of astrocytes and endothelial cells. These models are crucial for studying cell-specific effects and understanding the mechanisms that lead to vascular abnormalities. The ability to study the disease in these models is pivotal for defining the molecular underpinnings of CCM3 and for evaluating potential therapeutic strategies.'\n",
        "example2: if the input is: 'Polydactyly is a common congenital limb deformity. This anomaly may occur in isolation (non-syndromic) or as part of a syndrome. The glioma-associated oncogene family zinc finger 3 (GLI3) is known to be associated with both syndromic and non-syndromic polydactyly. GLI3 plays a predominant role in the pathogenesis of syndromic polydactyly: mutations have been identified in 68% of patients with Greig cephalopolysyndactyly syndrome and 91% of patients with Pallister-Hall syndrome. The knowledge regarding the contribution of GLI3 in non-syndromic polydactyly is currently very limited. In this study, we assembled a cohort of individuals of Chinese ethnicity with non-syndromic postaxial polydactyly. We presented the clinical features and molecular evaluations of 19 probands. GLI3 mutations were identified in 15.8% of probands (3/19) including two novel frame-shift mutations c.3855dupC (p.Met1286HisfsTer18) and c.4141delA (p.Arg1381GlyfsTer38) detected in sporadic cases and one previously reported nonsense mutation (c.1927C>T/p.Arg643Ter) in a familial case. Of note, GLI3 mutations were exclusively detected in patients with bilateral polydactyly affecting both hands and feet. Three out of five (60%) probands with bilateral polydactyly on both hands and feet carried pathogenic mutations in GLI3. Our study demonstrated the role of GLI3 in a significant fraction of patients with non-syndromic bilateral polydactyly affecting both hands and feet. Apert syndrome is an autosomal dominant disease characterized by craniosynostosis and bony syndactyly associated with point mutations (S252W and P253R) in the fibroblast growth factor receptor (FGFR) 2 that cause FGFR2 activation. Here we investigated the role of the S252W mutation of FGFR2 on osteoblastic differentiation. Osteoblastic cells derived from digital bone in two Apert patients with the S252W mutation showed more prominent alkaline phosphatase activity, osteocalcin and osteopontin mRNA expression, and mineralized nodule formation compared with the control osteoblastic cells derived from two independent non-syndromic polydactyly patients. Stable clones of the human MG63 osteosarcoma cells (MG63-Ap and MG63-IIIc) overexpressing a splice variant form of FGFR2 with or without the S252W mutation (FGFR2IIIcS252W and FGFR2IIIc) showed a higher RUNX2 mRNA expression than parental MG63 cells. Furthermore MG63-Ap exhibited a higher osteopontin mRNA expression than did MG63-IIIc. The enhanced osteoblastic marker gene expression and mineralized nodule formation of the MG63-Ap was inhibited by the conditioned medium from the COS-1 cells overexpressing the soluble FGFR2IIIcS252W. Furthermore the FGF2-induced osteogenic response in the mouse calvarial organ culture system was blocked by the soluble FGFR2IIIcS252W. These results show that the S252W mutation in the FGFR2 gene enhances the osteoblast phenotype in human osteoblasts and that a soluble FGFR2 with the S252W mutation controls osteoblast differentiation induced by the S252W mutation through a dominant negative effect on FGFR2 signaling in Apert syndrome. Acrocallosal syndrome is characterized by postaxial polydactyly, macrocephaly, agenesis of the corpus callosum, and severe developmental delay. In a few patients with this disorder, a mutation in the KIF7 gene has been reported, which was associated with impaired GLI3 processing and dysregulaton of GLI3 transcription factors. A single patient with acrocallosal syndrome and a de novo p.Ala934Pro mutation in GLI3 has been reported, whereas diverse and numerous GLI3 mutations have also been described in syndromes with overlapping clinical manifestations, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, trigonocephaly with craniosynostosis and polydactyly, oral-facial-digital syndrome, and non-syndromic polydactyly. Here, we describe a second patient with acrocallosal syndrome, who has a de novo, novel c.2786T>C mutation in GLI3, which predicts p.Leu929Pro. This mutation is in the same domain as the mutation in the previously reported patient. These data confirm that mutations in GLI3 are a cause of the acrocallosal phenotype. Human GLI3 gene mutations have been identified in several phenotypes of digital abnormality such as Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type-IV (PPD-IV) and postaxial polydactyly. However, the different phenotypes resulting from GLI3 mutations have not yet been properly defined. We have experienced two types of digital abnormality without other complicating developmental defects; a family with foot PPD-IV with syndactyly of the third and fourth fingers, and four sporadic cases with biphalangeal thumb polydactyly (PPD-I). The genes responsible for syndactyly of the third and fourth fingers (syndactyly type-I) and PPD-I have not yet been identified; we therefore examined the involvement of the GLI3 gene in these subtypes of digital abnormality. We found a non-sense mutation in the GLI3 gene in the family with foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers, but no mutations were detected in the GLI3 gene in the four other cases with PPD-I alone. Thus, the phenotype of foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers may result from a GLI3 mutation, whereas the PPD-I phenotype alone is not caused by GLI3 gene defect. These results will help to define the phenotypic spectrum of GLI3 morphopathies, which have been recently proposed.'\n",
        "          its response is: 'expertise_areas = \\n 1. Molecular Genetics of Non-Syndromic Polydactyly and GLI3 Mutations:\\n The researchers have made significant contributions in understanding the genetic basis of non-syndromic postaxial polydactyly, specifically the role of **GLI3 mutations**. Their study identified **novel frame-shift mutations** and **previously reported mutations** in **GLI3**, demonstrating its involvement in **bilateral polydactyly** affecting both hands and feet. Their findings underscore the role of GLI3 as a genetic modifier in non-syndromic polydactyly, specifically in cases with bilateral manifestations.\\n 2. Role of FGFR2 Mutations in Osteoblastic Differentiation in Polydactyly-Related Syndromes:\\n The research has also focused on understanding how mutations in the **FGFR2 gene**, particularly the **S252W mutation**, contribute to osteoblastic differentiation in conditions like **Apert syndrome**, which overlaps with polydactyly phenotypes. They demonstrated that the **S252W mutation** in FGFR2 enhances osteoblastic activity, leading to higher expression of osteoblastic markers. Their study provides insights into the molecular mechanisms affecting **bone differentiation** and its potential impact on polydactyly-related syndromes.\\n 3. GLI3 Mutations in Acrocallosal Syndrome and Digital Abnormalities:\\n The researchers also contributed to the understanding of **GLI3 mutations** in rare conditions like **Acrocallosal syndrome** and other digital abnormalities such as **preaxial and postaxial polydactyly**. They identified novel mutations in GLI3 that contribute to **impaired GLI3 processing**, which impacts the development of polydactyly and other associated features. This work highlights how **GLI3 mutations** contribute to different polydactyly subtypes and how these mutations expand the phenotypic spectrum of **GLI3 morphopathies**.'\n",
        "\n",
        "\n",
        "### Input:\n",
        "{}\n",
        "\n",
        "### Response:\n",
        "{}\"\"\"\n",
        "\n",
        "\n",
        "def extract_response(text):\n",
        "    response_marker = \"### Response:\"\n",
        "    start = text.find(response_marker)\n",
        "\n",
        "    if start != -1:\n",
        "        start += len(response_marker)\n",
        "        response = text[start:].strip()\n",
        "        return response\n",
        "\n",
        "    return None\n",
        "\n",
        "def Costumized_question(user_query, system_query):\n",
        "  inputs = tokenizer(\n",
        "  [\n",
        "\n",
        "    alpaca_prompt.format(\n",
        "        user_query, # instruction\n",
        "        system_query, # input\n",
        "        \"\", # output - leave this blank for generation!\n",
        "    )\n",
        "  ], return_tensors = \"pt\").to(\"cuda\")\n",
        "  #print( alpaca_prompt.format(\n",
        "  #      user_query, # instruction\n",
        "  #      system_query, # input\n",
        "  #      \"\", # output - leave this blank for generation!\n",
        "  #  ))\n",
        "  #print('----------------------------------------')\n",
        "  outputs = model.generate(**inputs, max_new_tokens = 5000, use_cache = True)\n",
        "  ans=tokenizer.batch_decode(outputs)\n",
        "  return extract_response(ans[0])\n",
        "\n",
        "\n",
        "\n",
        "Text='''\n",
        " Ischiospinal dysostosis (ISD) is a polytopic dysostosis characterized by ischial hypoplasia, multiple segmental anomalies of the cervicothoracic spine, hypoplasia of the lumbrosacral spine and occasionally associated with nephroblastomatosis. ISD is similar to, but milder than the lethal/semilethal condition termed diaphanospondylodysostosis (DSD), which is associated with homozygous or compound heterozygous mutations of bone morphogenetic protein-binding endothelial regulator protein (BMPER) gene. Here we report for the first time biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. Our data supports and further extends the phenotypic variability of BMPER-related skeletal disorders. Bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) gene mutation presents a disease spectrum ranging from a mild type of ischiospinal dysostosis (ISD) to a more severe type of diaphanospondylodysostosis (DSD). It is known that BMPER gene mutations are very rare, and their resulting clinical manifestations, including musculoskeletal modifications, appear in a spectrum of various types and severity levels. With the development of genetic diagnosis, case reports of patients with specific mutations in the BMPER gene have been published. The most commonly known clinical features are kidney structural problems, including neuroblastoma and renal cysts. Meanwhile, respiratory failure is a common and fatal symptom for patients with BMPER gene mutation, but it does not appear to have been well evaluated or managed so far. We report a case of a confirmed novel mutation of c.1750delT (p.Cys584fs) in the BMPER gene in a female adolescent patient and highlight the importance of the regular assessment of respiratory failure for successful management of this condition. Diaphanospondylodysostosis (DSD) is a rare skeletal dysplasia syndrome resulting from disordered mesenchymal differentiation. Children with DSD generally die in utero or during the first month of life from severe thoracic insufficiency syndrome. An association of DSD with nephroblastomatosis has been observed, but the natural history of such nephroblastomatosis remains poorly characterized due to the rarity of the underlying condition. We describe a patient with DSD who developed bilateral hyperplastic nephroblastomatosis that ultimately evolved into therapy-resistant anaplastic Wilms tumor (nephroblastoma). Diaphanospondylodysostosis (DSD) is a rare, recessively inherited, perinatal lethal skeletal disorder. The low frequency and perinatal lethality of DSD makes assembling a large set of families for traditional linkage-based genetic approaches challenging. By searching for evidence of unknown ancestral consanguinity, we identified two autozygous intervals, comprising 34 Mbps, unique to a single case of DSD. Empirically testing for ancestral consanguinity was effective in localizing the causative variant, thereby reducing the genomic space within which the mutation resides. High-throughput sequence analysis of exons captured from these intervals demonstrated that the affected individual was homozygous for a null mutation in BMPER, which encodes the bone morphogenetic protein-binding endothelial cell precursor-derived regulator. Mutations in BMPER were subsequently found in three additional DSD cases, confirming that defects in BMPER produce DSD. Phenotypic similarities between DSD and Bmper null mice indicate that BMPER-mediated signaling plays an essential role in vertebral segmentation early in human development.Diaphonospondylodysostosis (DSD) is a rare, recessively inherited, lethal skeletal dysplasia, characterized by severe spinal ossification, segmentation defects, and renal cystic dysplasia with nephrogenic rests. We hereby present three affected individuals: two children and a fetus from two unrelated East Jerusalem Arab-Muslim families. Whereas most fetuses die in utero or perinatally, one of the children survived to 15 months. Homozygosity mapping in the two families demonstrated a single common 3.87 Mb region on chromosome 7, ruling out previously known spondylocostal/spondylothoracic dysostosis loci. The 15 protein coding genes in the region were prioritized, and some were sequenced. A single, novel deleterious mutation, Q104X, was detected in the bone morphogenetic protein-binding endothelial regulator protein (BMPER) gene, recently reported to be mutated in other DSD patients [Funari et al., 2010]. The novel mutation we identified is an ancestral founder allele, as evidenced by a shared 440 SNP haplotype, and its frequency in the general Arab population is estimated to be <1:123. Our findings confirm loss of BMPER function as a cause of axial versus appendicular skeletal defects, and suggest that less deleterious mutations may be involved in milder axial skeleton abnormalities. Diaphanospondylodysostosis (DSD) and ischiospinal dysostosis (ISD) are both rare skeletal dysplasias consisting of abnormal axial skeletal development but normal appendicular skeletal development. Both disorders recently have been found to result from mutations in the BMPER gene. We report a patient with one deletion and one mutation of the BMPER gene who has features most consistent with DSD but who has survived to age 9 years. Survival suggests that DSD and ISD reflect a spectrum of severity of one disease process.'''\n",
        "#display(Costumized_question(user_query='Diaphanospondylodysostosis',system_query=Text))\n",
        "tetx=Costumized_question(user_query='Diaphanospondylodysostosis',system_query=Text)\n",
        "display(tetx)\n",
        "print('---------------------------------------------------------------')\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "-Mb-zBLnLswR",
        "outputId": "db3fb844-6f83-4699-b55c-3563396fcb96"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "{'BMPER Mutations and Polytopic Skeletal Dysostosis': 'The researchers have made significant contributions in understanding the genetic basis of **polytopic skeletal dysostosis** conditions such as **ischiospinal dysostosis (ISD)** and **diaphanospondylodysostosis (DSD)**. They have identified **mutations in the BMPER gene** in patients with these conditions, demonstrating its role in the development of skeletal abnormalities. Their findings have helped to define the phenotypic spectrum of **BMPER-related skeletal disorders**, which are characterized by a range of skeletal abnormalities including spinal ossification, segmentation defects, and renal cystic dysplasia with nephrogenic rests.',\n",
              " 'Novel Mutation in BMPER Gene and Importance of Respiratory Assessment': 'The researchers have also contributed to the understanding of the **novel mutation c.1750delT (p.Cys584fs)** in the **BMPER gene** in a female adolescent patient. They highlighted the importance of **regular assessment of respiratory failure** for successful management of this condition, which is a common and fatal symptom for patients with BMPER gene mutation. This study provides valuable insights into the management of patients with BMPER-related skeletal disorders.',\n",
              " 'Nephroblastomatosis in Diaphanospondylodysostosis': 'The researchers have also contributed to the understanding of the **natural history of nephroblastomatosis** in patients with **DSD**, a rare skeletal dysplasia syndrome resulting from disordered mesenchymal differentiation. They described a patient with DSD who developed bilateral hyperplastic nephroblastomatosis that ultimately evolved into therapy-resistant anaplastic Wilms tumor (nephroblastoma). This study provides valuable insights into the management of patients with DSD and its associated renal abnormalities.',\n",
              " 'Genetic Mapping and Prioritization of BMPER-Related Skeletal Disorders': 'The researchers have also made significant contributions to the understanding of **genetic mapping** and **prioritization of BMPER-related skeletal disorders**. They identified a **novel deleterious mutation Q104X in the BMPER gene** in a female adolescent patient and highlighted the importance of the **shared 440 SNP haplotype** as evidence of an ancestral founder allele. This study provides valuable insights into the genetic basis of BMPER-related skeletal disorders and their associated clinical features.'}"
            ]
          },
          "execution_count": 86,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "import re\n",
        "\n",
        "def organize_research_expertise(text):\n",
        "    expertise_entries = re.split(r'[\\s|n]\\d+[\\.-]', text.strip())[1:]\n",
        "    research_expertise = {}\n",
        "    for idx, entry in enumerate(expertise_entries, start=1):\n",
        "        entry = entry.strip()\n",
        "        split_point = entry.split(\":\")\n",
        "        research_expertise[split_point[0].strip()]= split_point[1].strip().replace('<|end_of_text|>','')\n",
        "    return research_expertise\n",
        "organize_research_expertise(tetx)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "LCQ0o30JOpaC"
      },
      "source": [
        "# applying the fintunned model"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "c59F6i5NPdnS",
        "outputId": "ddf038d8-fa83-4d15-9e69-efbb78fbfca1"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "<|begin_of_text|>Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
            "\n",
            "### Instruction:\n",
            "What is a famous tall tower in Paris?\n",
            "\n",
            "### Input:\n",
            "\n",
            "\n",
            "### Response:\n",
            "One of the most famous tall towers in Paris is the Eiffel Tower. The Eiffel Tower is an iron lattice tower located on the Champ de Mars in Paris. It was built in 1889 as the entrance arch to the World's Fair and has become one of the most recognizable landmarks in the world. The Eiffel Tower stands at a height of 324 meters (1,063 feet) and has two observation decks, one on the first level and one on the second level, which offer stunning views of the city. It is the tallest structure in Paris and the most visited paid monument in the world, with over\n"
          ]
        }
      ],
      "source": [
        "if False:\n",
        "    from unsloth import FastLanguageModel\n",
        "    model, tokenizer = FastLanguageModel.from_pretrained(\n",
        "        model_name = \"lora_model\", # YOUR MODEL YOU USED FOR TRAINING\n",
        "        max_seq_length = max_seq_length,\n",
        "        dtype = dtype,\n",
        "        load_in_4bit = load_in_4bit,\n",
        "    )\n",
        "    FastLanguageModel.for_inference(model) # Enable native 2x faster inference\n",
        "\n",
        "# alpaca_prompt = You MUST copy from above!\n",
        "\n",
        "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
        "\n",
        "### Instruction:\n",
        "{}\n",
        "\n",
        "### Input:\n",
        "{}\n",
        "\n",
        "### Response:\n",
        "{}\"\"\"\n",
        "\n",
        "EOS_TOKEN = tokenizer.eos_token # Must add EOS_TOKEN\n",
        "def formatting_prompts_func(examples):\n",
        "    instructions = examples[\"instruction\"]\n",
        "    inputs       = examples[\"input\"]\n",
        "    outputs      = examples[\"output\"]\n",
        "    texts = []\n",
        "    for instruction, input, output in zip(instructions, inputs, outputs):\n",
        "        # Must add EOS_TOKEN, otherwise your generation will go on forever!\n",
        "        text = alpaca_prompt.format(instruction, input, output) + EOS_TOKEN\n",
        "        texts.append(text)\n",
        "    return { \"text\" : texts, }\n",
        "pass\n",
        "\n",
        "\n",
        "inputs = tokenizer(\n",
        "[\n",
        "    alpaca_prompt.format(\n",
        "        \"What is a famous tall tower in Paris?\", # instruction\n",
        "        \"\", # input\n",
        "        \"\", # output - leave this blank for generation!\n",
        "    )\n",
        "], return_tensors = \"pt\").to(\"cuda\")\n",
        "\n",
        "from transformers import TextStreamer\n",
        "text_streamer = TextStreamer(tokenizer)\n",
        "_ = model.generate(**inputs, streamer = text_streamer, max_new_tokens = 128)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_STxh1yKIekk",
        "outputId": "b54e6d54-4777-4fb7-83ac-c070cea01367"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "['AVTX-801',\n",
              " 'fucokinase',\n",
              " 'fcsk',\n",
              " 'crispr/cas9',\n",
              " 'congenital disorder of glycosylation',\n",
              " 'fucokinase',\n",
              " 'fcsk',\n",
              " 'crispr/cas9',\n",
              " 'congenital disorder of glycosylation',\n",
              " 'fucokinase',\n",
              " 'fcsk',\n",
              " 'crispr/cas9',\n",
              " 'congenital disorder of glycosylation',\n",
              " 'fucokinase',\n",
              " 'fcsk',\n",
              " 'crispr/cas9',\n",
              " 'congenital disorder of glycosylation',\n",
              " 'fucokinase',\n",
              " 'fcsk',\n",
              " 'crispr/cas9',\n",
              " 'congenital disorder of glycosylation',\n",
              " 'fucokinase',\n",
              " 'fcsk',\n",
              " 'crispr/cas9',\n",
              " 'congenital disorder of glycosylation',\n",
              " 'high performance liquid chromatography',\n",
              " 'alcohol abuse',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'dried blood spots',\n",
              " 'isoelectric focusing',\n",
              " 'high performance liquid chromatography',\n",
              " 'alcohol abuse',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'dried blood spots',\n",
              " 'isoelectric focusing',\n",
              " 'high performance liquid chromatography',\n",
              " 'alcohol abuse',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'dried blood spots',\n",
              " 'isoelectric focusing',\n",
              " 'high performance liquid chromatography',\n",
              " 'alcohol abuse',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'dried blood spots',\n",
              " 'isoelectric focusing',\n",
              " 'high performance liquid chromatography',\n",
              " 'alcohol abuse',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'dried blood spots',\n",
              " 'isoelectric focusing',\n",
              " 'high performance liquid chromatography',\n",
              " 'alcohol abuse',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'dried blood spots',\n",
              " 'isoelectric focusing',\n",
              " 'high performance liquid chromatography',\n",
              " 'alcohol abuse',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'dried blood spots',\n",
              " 'isoelectric focusing',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hepatopathy',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'hypoglycemia',\n",
              " 'glycosylation',\n",
              " 'central nervous system',\n",
              " 'cdg',\n",
              " 'seizures',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hypoglycemia',\n",
              " 'developmental delay',\n",
              " 'intellectual disability',\n",
              " 'glycosylation',\n",
              " 'central nervous system',\n",
              " 'cdg',\n",
              " 'seizures',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hypoglycemia',\n",
              " 'developmental delay',\n",
              " 'intellectual disability',\n",
              " 'glycosylation',\n",
              " 'central nervous system',\n",
              " 'cdg',\n",
              " 'seizures',\n",
              " 'phosphoglucomutase 1',\n",
              " 'hypoglycemia',\n",
              " 'developmental delay',\n",
              " 'intellectual disability',\n",
              " 'galactose',\n",
              " 'restrictive cardiomyopathy',\n",
              " 'pgm1‐cdg',\n",
              " 'galactose',\n",
              " 'restrictive cardiomyopathy',\n",
              " 'pgm1‐cdg',\n",
              " 'galactose',\n",
              " 'restrictive cardiomyopathy',\n",
              " 'pgm1‐cdg',\n",
              " 'galactose',\n",
              " 'restrictive cardiomyopathy',\n",
              " 'pgm1‐cdg',\n",
              " 'galactose',\n",
              " 'restrictive cardiomyopathy',\n",
              " 'pgm1‐cdg',\n",
              " 'galactose',\n",
              " 'restrictive cardiomyopathy',\n",
              " 'pgm1‐cdg',\n",
              " 'glycosylation',\n",
              " 'galactose',\n",
              " 'glycogen storage disease',\n",
              " 'cdg',\n",
              " 'neutrophil dysfunction',\n",
              " 'glycosylation',\n",
              " 'galactose',\n",
              " 'glycogen storage disease',\n",
              " 'cdg',\n",
              " 'neutrophil dysfunction',\n",
              " 'glycosylation',\n",
              " 'galactose',\n",
              " 'glycogen storage disease',\n",
              " 'cdg',\n",
              " 'neutrophil dysfunction',\n",
              " 'glycosylation',\n",
              " 'galactose',\n",
              " 'glycogen storage disease',\n",
              " 'cdg',\n",
              " 'neutrophil dysfunction',\n",
              " 'glycosylation',\n",
              " 'galactose',\n",
              " 'glycogen storage disease',\n",
              " 'cdg',\n",
              " 'neutrophil dysfunction',\n",
              " 'glycosylation',\n",
              " 'galactose',\n",
              " 'glycogen storage disease',\n",
              " 'cdg',\n",
              " 'neutrophil dysfunction',\n",
              " 'glycosylation',\n",
              " 'galactose',\n",
              " 'glycogen storage disease',\n",
              " 'cdg',\n",
              " 'neutrophil dysfunction',\n",
              " 'glycosylation',\n",
              " 'galactose',\n",
              " 'glycogen storage disease',\n",
              " 'cdg',\n",
              " 'neutrophil dysfunction',\n",
              " 'genetics',\n",
              " 's. cerevisiae',\n",
              " 'genomics',\n",
              " 'experimental evolution',\n",
              " 'evolutionary biology',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pmm2-cdg',\n",
              " 'humanized yeast',\n",
              " 'genetics',\n",
              " 's. cerevisiae',\n",
              " 'genomics',\n",
              " 'experimental evolution',\n",
              " 'evolutionary biology',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pmm2-cdg',\n",
              " 'humanized yeast',\n",
              " 'genetics',\n",
              " 's. cerevisiae',\n",
              " 'genomics',\n",
              " 'experimental evolution',\n",
              " 'evolutionary biology',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pmm2-cdg',\n",
              " 'humanized yeast',\n",
              " 'genetics',\n",
              " 's. cerevisiae',\n",
              " 'genomics',\n",
              " 'experimental evolution',\n",
              " 'evolutionary biology',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pmm2-cdg',\n",
              " 'humanized yeast',\n",
              " 'genetics',\n",
              " 's. cerevisiae',\n",
              " 'genomics',\n",
              " 'experimental evolution',\n",
              " 'evolutionary biology',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pmm2-cdg',\n",
              " 'humanized yeast',\n",
              " 'genetics',\n",
              " 's. cerevisiae',\n",
              " 'genomics',\n",
              " 'experimental evolution',\n",
              " 'evolutionary biology',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pmm2-cdg',\n",
              " 'humanized yeast',\n",
              " 'genetics',\n",
              " 's. cerevisiae',\n",
              " 'genomics',\n",
              " 'experimental evolution',\n",
              " 'evolutionary biology',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pmm2-cdg',\n",
              " 'humanized yeast',\n",
              " 'genetics',\n",
              " 's. cerevisiae',\n",
              " 'genomics',\n",
              " 'experimental evolution',\n",
              " 'evolutionary biology',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pmm2-cdg',\n",
              " 'humanized yeast',\n",
              " 'maldi–tof/ms',\n",
              " 'permethylation',\n",
              " 'n-glycan',\n",
              " 'o-glycan',\n",
              " 'lc–ms/ms',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'maldi–tof/ms',\n",
              " 'permethylation',\n",
              " 'n-glycan',\n",
              " 'o-glycan',\n",
              " 'lc–ms/ms',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'maldi–tof/ms',\n",
              " 'permethylation',\n",
              " 'n-glycan',\n",
              " 'o-glycan',\n",
              " 'lc–ms/ms',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'maldi–tof/ms',\n",
              " 'permethylation',\n",
              " 'n-glycan',\n",
              " 'o-glycan',\n",
              " 'lc–ms/ms',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'maldi–tof/ms',\n",
              " 'permethylation',\n",
              " 'n-glycan',\n",
              " 'o-glycan',\n",
              " 'lc–ms/ms',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'maldi–tof/ms',\n",
              " 'permethylation',\n",
              " 'n-glycan',\n",
              " 'o-glycan',\n",
              " 'lc–ms/ms',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'maldi–tof/ms',\n",
              " 'permethylation',\n",
              " 'n-glycan',\n",
              " 'o-glycan',\n",
              " 'lc–ms/ms',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'maldi–tof/ms',\n",
              " 'permethylation',\n",
              " 'n-glycan',\n",
              " 'o-glycan',\n",
              " 'lc–ms/ms',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'pgm1 mutation',\n",
              " 'secondary adrenal insufficiency',\n",
              " 'phosphoglucumutase 1 deficiency',\n",
              " 'pgm1 mutation',\n",
              " 'secondary adrenal insufficiency',\n",
              " 'phosphoglucumutase 1 deficiency',\n",
              " 'pgm1 mutation',\n",
              " 'secondary adrenal insufficiency',\n",
              " 'phosphoglucumutase 1 deficiency',\n",
              " 'pgm1 mutation',\n",
              " 'secondary adrenal insufficiency',\n",
              " 'phosphoglucumutase 1 deficiency',\n",
              " 'heart transplantation',\n",
              " 'ventricular non‐compaction',\n",
              " 'pgm1‐cdg',\n",
              " 'd‐galactose',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'heart transplantation',\n",
              " 'ventricular non‐compaction',\n",
              " 'pgm1‐cdg',\n",
              " 'd‐galactose',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'heart transplantation',\n",
              " 'ventricular non‐compaction',\n",
              " 'pgm1‐cdg',\n",
              " 'd‐galactose',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'heart transplantation',\n",
              " 'ventricular non‐compaction',\n",
              " 'pgm1‐cdg',\n",
              " 'd‐galactose',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'heart transplantation',\n",
              " 'ventricular non‐compaction',\n",
              " 'pgm1‐cdg',\n",
              " 'd‐galactose',\n",
              " 'congenital disorders of glycosylation',\n",
              " 'heart transplantation',\n",
              " 'ventricular non‐compaction',\n",
              " 'pgm1‐cdg',\n",
              " 'd‐galactose',\n",
              " 'congenital disorders of glycosylation']"
            ]
          },
          "execution_count": 98,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "import pandas as pd\n",
        "#data =result# pd.read_csv('/content/LLM_input.csv')\n",
        "import ast\n",
        "from collections import Counter\n",
        "data['Terms'][0]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "8zfodBJgSJBA",
        "outputId": "392a5f27-c8b7-474d-dde3-18a32dabc340"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Tobramycin for Inhalation , Tobramycin solution for inhalation (TOBI), Oral placebo, Oral ciprofloxacin\n"
          ]
        }
      ],
      "source": [
        "def three_most_frequent_terms(term_string):\n",
        "    # Convert the string representation of the list to an actual list\n",
        "    #term_list = ast.literal_eval(term_string)\n",
        "    # Count the frequency of each term in the list\n",
        "    term_counts = Counter(term_string)\n",
        "    # Get the three most common terms\n",
        "    most_common_terms = term_counts.most_common(5)\n",
        "\n",
        "    return ' , '.join([term  for term, count in most_common_terms])\n",
        "\n",
        "# Example usage\n",
        "terms = [\n",
        "    'Tobramycin for Inhalation',\n",
        "    'Tobramycin solution for inhalation (TOBI), Oral placebo, Oral ciprofloxacin',\n",
        "    'Tobramycin for Inhalation',\n",
        "    'Tobramycin for Inhalation',\n",
        "    'Tobramycin for Inhalation',\n",
        "    'Tobramycin for Inhalation',\n",
        "    'Tobramycin for Inhalation',\n",
        "    'Tobramycin for Inhalation',\n",
        "    'Tobramycin for Inhalation',\n",
        "    'Tobramycin solution for inhalation (TOBI), Oral placebo, Oral ciprofloxacin',\n",
        "    'Tobramycin solution for inhalation (TOBI), Oral placebo, Oral ciprofloxacin']\n",
        "\n",
        "print(three_most_frequent_terms(terms))\n",
        "data['frequent_words']  = data.apply(lambda x:  three_most_frequent_terms(x['Terms'])   , axis=1)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "FIKXi5YXIU_I"
      },
      "outputs": [],
      "source": [
        "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
        "\n",
        "### Instruction:\n",
        "List 5 technical expertise areas in the form of keywords that the authors\n",
        "have their work about {}. The response must be in the format of a Python list, like ['keyword1', 'keyword2', 'keyword3'], without any additional text, explanation, or context. Do not include disease name or any abbreviation in the final answer.\n",
        "\n",
        "### Input:\n",
        "{}\n",
        "\n",
        "### Response:\n",
        "{}\"\"\"\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 306
        },
        "id": "cCBSKpmrOtf9",
        "outputId": "8ed86cfc-a5dc-4cc9-905d-8ca7388dae16"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'Expertise Areas in Cystic Fibrosis Research:\\n1. Molecular Genetics: Understanding the genetic basis of CF, including the identification of the CFTR gene and the mutations that cause the disease.\\n2. Pathophysiology: Understanding the mechanisms by which the defective CFTR gene leads to the production of thick mucus and the resulting damage to the lungs and other organs.\\n3. Clinical Care: Providing comprehensive care for individuals with CF, including managing symptoms, treating complications, and improving health outcomes.\\n4. Gene Therapy: Developing and testing gene therapies to correct the defective CFTR gene and restore normal mucus production.\\n5. Drug Development: Developing and testing new drugs to treat the symptoms and complications of CF.\\n6. Epidemiology: Understanding the prevalence, incidence, and distribution of CF in different populations.\\n7. Psychosocial Support: Providing support to individuals with CF and their families to manage the physical and emotional challenges of living with the disease.\\n8. Transplantation: Providing care for individuals with end-stage lung disease and managing the challenges of lung transplantation.\\n9. Stem Cell Research: Using stem cells to develop new treatments for CF, including cell-based therapies and tissue engineering.\\n10. Clinical Trials: Participating in clinical trials to test new treatments and therapies for CF.<|end_of_text|>'"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "---------------------------------------------------------------\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "'Cystic fibrosis (CF) is a rare genetic disease that causes the body to produce thick mucus, which can block airways, damage the lungs, and lead to other health problems. Symptoms include a cough that produces thick mucus, wheezing, shortness of breath, frequent lung or sinus infections, and nasal polyps. Other affected organs include the pancreas, sweat glands, and reproductive system. Other health problems include diabetes, cirrhosis (liver disease), arthritis, reflux, hypersplenism (overactive spleen), and osteoporosis. Inheritance is autosomal recessive, meaning a person must inherit two defective genes, one from each parent. Most children with CF are diagnosed by age 2, but some are not detected until age 18 or older. Treatments can improve health outcomes and increase life expectancy.<|end_of_text|>'"
            ]
          },
          "execution_count": 88,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "alpaca_prompt = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
        "\n",
        "### Instruction:\n",
        "Given the work of authors (or principal investigators) in the context of {} which is a rare disease, identify 3 key detailed research expertise areas they have contributed to. Follow these steps: 1-Research Contribution Summary: Based on their publications, clinical trials, or grant proposals, summarize the major contributions made by the researchers in the field.\n",
        "    2- Identify Expertise Areas: Based on their contributions, identify 3 key detailed research expertise areas that emerge from their work. Here are two examples:\n",
        "example1: if the input is: 'DESCRIPTION (provided by applicant): Cerebral cavernous malformations (CCM), characterized by dilated sinusoidal vascular spaces lined by a single layer of endothelium, affect the central nervous system and may lead to neurological problems including bleeding and seizures. Mutations in the three genes, CCM1 (KRIT1, Krev1/Rap1a Interaction Trapped 1), CCM2 (OSM, malcavernin) and CCM3 (PDCD10, Programmed Cell Death Protein 10) have been shown to cause CCM. While recent in vitro studies have begun to illuminate the nature of CCM signaling, an in vivo, mechanistic understanding of CCM pathophysiology is lacking. Based on our recent data from in vitro cell culture studies, in vivo data from our mouse conditional knock-out of Ccm3 in neural cells, and intriguing observations in animal models from various groups, we hypothesize that CCM3 is a negative modulator of Akt signaling via interactions with PP2A, and CCM lesions are the consequence of altered expression of Akt and its downstream effectors. We further hypothesize that CCM3 signaling mediates an interaction between neural and endothelial cells and alteration of this interaction caused by neural CCM3 loss, results in a vascular phenotype. We propose to test these hypotheses using in vitro and in vivo approaches aimed at elaborating this novel Ccm3 signaling pathway and to investigate its potential influence on the interactions among various cell types within the neurovascular unit in CCM lesion development. We will perform studies aimed at clarifying the nature of Ccm3 interactions with the Akt signaling pathway. We will comprehensively study the Emx1-Cre;Ccm3lox/lox mouse model that we have recently generated. Unlike other conditional Ccm3 knockouts, these mice survive long term and develop vascular pathology. The vascular pathology is characterized by dilated vessels throughout the brain and isolated lesions that are reminiscent of human CCM disease. We will take advantage of our findings to gain insight into CCM3 function and signaling. In addition, we propose to cross inducible VE-cadherin-CreER and GFAP-CreER to Ccm3lox/lox mice to study cell autonomous effects of CCM3 in endothelial cells and postnatal astrocytes. The proposed experiments are focused on identifying the molecular pathways relevant to CCM disease and on studying these pathways in vivo with a long-term goal of defining new and more effective therapies.       PUBLIC HEALTH RELEVANCE: Mutations in the gene Programmed Cell Death Protein 10 (PDCD10) cause Cerebral Cavernous Malformation 3 (CCM3), a vascular disorder mainly affecting the brain. The root causes of CCM are largely unknown. To study these causes, we propose to use a mouse model, Emx1-Cre;Ccm3lox/lox that we recently developed which leads, in part, to the same of abnormalities seen in humans suffering from CCM. These mice develop spontaneous vascular lesions identical to those in human CCM. By using a variety of assays, we plan to identify the molecular mechanisms that lead to the vascular pathology. We also propose to develop new models with inducible Cre lines that will allow us to modulate CCC3 expression in astrocytes or endothelial cells at postnatal stages to study cell specific effects of CCM3. A deeper understanding of the causes of CCM pathology at the cellular and molecular level in vivo will set the stage for efforts to define new and more effective therapies for this potentially debilitating and sometimes fatal disorder.'\n",
        "          its response is : 'expertise_areas=\\n 1. Molecular Signaling Pathways in CCM3:\\n The researchers have focused on understanding the role of CCM3 in regulating key signaling pathways, particularly how it interacts with the Akt signaling pathway and its downstream effectors. Their hypothesis suggests that CCM3 may act as a negative modulator of Akt signaling via interactions with PP2A. This has significant implications for understanding how alterations in these molecular pathways contribute to the pathogenesis of CCM lesions. Detailed knowledge of these signaling mechanisms is essential for identifying potential therapeutic targets.\\n 2. Neurovascular Interactions and CCM Pathogenesis:\\n A core part of the researchers’ work is the study of the interactions between neural cells and endothelial cells within the neurovascular unit. By investigating how the loss of CCM3 in neural cells affects the development of vascular pathology, they aim to better understand the cellular interactions that contribute to the formation of vascular lesions seen in CCM3. Their use of conditional knockout mouse models, such as the Emx1-Cre;Ccm3lox/lox model, allows them to study these effects in a controlled in vivo environment, offering insights into how these cellular dynamics drive disease progression.\\n 3. Mouse Models and Disease Mechanisms:\\n The researchers have developed and utilized advanced mouse models to study CCM3. Specifically, they have created inducible models to manipulate CCM3 expression in postnatal stages of astrocytes and endothelial cells. These models are crucial for studying cell-specific effects and understanding the mechanisms that lead to vascular abnormalities. The ability to study the disease in these models is pivotal for defining the molecular underpinnings of CCM3 and for evaluating potential therapeutic strategies.'\n",
        "example2: if the input is: 'Polydactyly is a common congenital limb deformity. This anomaly may occur in isolation (non-syndromic) or as part of a syndrome. The glioma-associated oncogene family zinc finger 3 (GLI3) is known to be associated with both syndromic and non-syndromic polydactyly. GLI3 plays a predominant role in the pathogenesis of syndromic polydactyly: mutations have been identified in 68% of patients with Greig cephalopolysyndactyly syndrome and 91% of patients with Pallister-Hall syndrome. The knowledge regarding the contribution of GLI3 in non-syndromic polydactyly is currently very limited. In this study, we assembled a cohort of individuals of Chinese ethnicity with non-syndromic postaxial polydactyly. We presented the clinical features and molecular evaluations of 19 probands. GLI3 mutations were identified in 15.8% of probands (3/19) including two novel frame-shift mutations c.3855dupC (p.Met1286HisfsTer18) and c.4141delA (p.Arg1381GlyfsTer38) detected in sporadic cases and one previously reported nonsense mutation (c.1927C>T/p.Arg643Ter) in a familial case. Of note, GLI3 mutations were exclusively detected in patients with bilateral polydactyly affecting both hands and feet. Three out of five (60%) probands with bilateral polydactyly on both hands and feet carried pathogenic mutations in GLI3. Our study demonstrated the role of GLI3 in a significant fraction of patients with non-syndromic bilateral polydactyly affecting both hands and feet. Apert syndrome is an autosomal dominant disease characterized by craniosynostosis and bony syndactyly associated with point mutations (S252W and P253R) in the fibroblast growth factor receptor (FGFR) 2 that cause FGFR2 activation. Here we investigated the role of the S252W mutation of FGFR2 on osteoblastic differentiation. Osteoblastic cells derived from digital bone in two Apert patients with the S252W mutation showed more prominent alkaline phosphatase activity, osteocalcin and osteopontin mRNA expression, and mineralized nodule formation compared with the control osteoblastic cells derived from two independent non-syndromic polydactyly patients. Stable clones of the human MG63 osteosarcoma cells (MG63-Ap and MG63-IIIc) overexpressing a splice variant form of FGFR2 with or without the S252W mutation (FGFR2IIIcS252W and FGFR2IIIc) showed a higher RUNX2 mRNA expression than parental MG63 cells. Furthermore MG63-Ap exhibited a higher osteopontin mRNA expression than did MG63-IIIc. The enhanced osteoblastic marker gene expression and mineralized nodule formation of the MG63-Ap was inhibited by the conditioned medium from the COS-1 cells overexpressing the soluble FGFR2IIIcS252W. Furthermore the FGF2-induced osteogenic response in the mouse calvarial organ culture system was blocked by the soluble FGFR2IIIcS252W. These results show that the S252W mutation in the FGFR2 gene enhances the osteoblast phenotype in human osteoblasts and that a soluble FGFR2 with the S252W mutation controls osteoblast differentiation induced by the S252W mutation through a dominant negative effect on FGFR2 signaling in Apert syndrome. Acrocallosal syndrome is characterized by postaxial polydactyly, macrocephaly, agenesis of the corpus callosum, and severe developmental delay. In a few patients with this disorder, a mutation in the KIF7 gene has been reported, which was associated with impaired GLI3 processing and dysregulaton of GLI3 transcription factors. A single patient with acrocallosal syndrome and a de novo p.Ala934Pro mutation in GLI3 has been reported, whereas diverse and numerous GLI3 mutations have also been described in syndromes with overlapping clinical manifestations, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, trigonocephaly with craniosynostosis and polydactyly, oral-facial-digital syndrome, and non-syndromic polydactyly. Here, we describe a second patient with acrocallosal syndrome, who has a de novo, novel c.2786T>C mutation in GLI3, which predicts p.Leu929Pro. This mutation is in the same domain as the mutation in the previously reported patient. These data confirm that mutations in GLI3 are a cause of the acrocallosal phenotype. Human GLI3 gene mutations have been identified in several phenotypes of digital abnormality such as Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type-IV (PPD-IV) and postaxial polydactyly. However, the different phenotypes resulting from GLI3 mutations have not yet been properly defined. We have experienced two types of digital abnormality without other complicating developmental defects; a family with foot PPD-IV with syndactyly of the third and fourth fingers, and four sporadic cases with biphalangeal thumb polydactyly (PPD-I). The genes responsible for syndactyly of the third and fourth fingers (syndactyly type-I) and PPD-I have not yet been identified; we therefore examined the involvement of the GLI3 gene in these subtypes of digital abnormality. We found a non-sense mutation in the GLI3 gene in the family with foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers, but no mutations were detected in the GLI3 gene in the four other cases with PPD-I alone. Thus, the phenotype of foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers may result from a GLI3 mutation, whereas the PPD-I phenotype alone is not caused by GLI3 gene defect. These results will help to define the phenotypic spectrum of GLI3 morphopathies, which have been recently proposed.'\n",
        "          its response is: 'expertise_areas = \\n 1. Molecular Genetics of Non-Syndromic Polydactyly and GLI3 Mutations:\\n The researchers have made significant contributions in understanding the genetic basis of non-syndromic postaxial polydactyly, specifically the role of **GLI3 mutations**. Their study identified **novel frame-shift mutations** and **previously reported mutations** in **GLI3**, demonstrating its involvement in **bilateral polydactyly** affecting both hands and feet. Their findings underscore the role of GLI3 as a genetic modifier in non-syndromic polydactyly, specifically in cases with bilateral manifestations.\\n 2. Role of FGFR2 Mutations in Osteoblastic Differentiation in Polydactyly-Related Syndromes:\\n The research has also focused on understanding how mutations in the **FGFR2 gene**, particularly the **S252W mutation**, contribute to osteoblastic differentiation in conditions like **Apert syndrome**, which overlaps with polydactyly phenotypes. They demonstrated that the **S252W mutation** in FGFR2 enhances osteoblastic activity, leading to higher expression of osteoblastic markers. Their study provides insights into the molecular mechanisms affecting **bone differentiation** and its potential impact on polydactyly-related syndromes.\\n 3. GLI3 Mutations in Acrocallosal Syndrome and Digital Abnormalities:\\n The researchers also contributed to the understanding of **GLI3 mutations** in rare conditions like **Acrocallosal syndrome** and other digital abnormalities such as **preaxial and postaxial polydactyly**. They identified novel mutations in GLI3 that contribute to **impaired GLI3 processing**, which impacts the development of polydactyly and other associated features. This work highlights how **GLI3 mutations** contribute to different polydactyly subtypes and how these mutations expand the phenotypic spectrum of **GLI3 morphopathies**.'\n",
        "\n",
        "\n",
        "### Input:\n",
        "{}\n",
        "\n",
        "### Response:\n",
        "{}\"\"\"\n",
        "\n",
        "\n",
        "\n",
        "def extract_response(text):\n",
        "    response_marker = \"### Response:\"\n",
        "    start = text.find(response_marker)\n",
        "\n",
        "    if start != -1:\n",
        "        start += len(response_marker)\n",
        "        response = text[start:].strip()\n",
        "        return response\n",
        "\n",
        "    return None\n",
        "\n",
        "def Costumized_question(user_query, system_query):\n",
        "  inputs = tokenizer(\n",
        "  [\n",
        "\n",
        "    alpaca_prompt.format(\n",
        "        user_query, # instruction\n",
        "        system_query, # input\n",
        "        \"\", # output - leave this blank for generation!\n",
        "    )\n",
        "  ], return_tensors = \"pt\").to(\"cuda\")\n",
        "\n",
        "  outputs = model.generate(**inputs, max_new_tokens = 4000, use_cache = True)\n",
        "  ans=tokenizer.batch_decode(outputs)\n",
        "  return extract_response(ans[0])\n",
        "\n",
        "\n",
        "\n",
        "Text='''\n",
        "Cystic fibrosis (CF) is a genetic disease that causes the body to produce thick mucus that can block airways, damage the lungs, and lead to other health problems:\n",
        "Symptoms: A cough that produces thick mucus, wheezing, shortness of breath, frequent lung or sinus infections, and nasal polyps\n",
        "Organs affected: Lungs, pancreas, sweat glands, and reproductive system\n",
        "Other health problems: Diabetes, cirrhosis (liver disease), arthritis, reflux, hypersplenism (overactive spleen), and osteoporosis\n",
        "Inheritance: Inherited in an autosomal recessive manner, meaning a person must inherit two defective genes, one from each parent\n",
        "Diagnosis: Most children with CF are diagnosed by age 2, but some are not detected until age 18 or older\n",
        "Treatment: Treatments can improve health outcomes and increase life expectancy\n",
        "'''\n",
        "\n",
        "display(Costumized_question(user_query='Cystic fibrosis',system_query=Text))\n",
        "print('---------------------------------------------------------------')\n",
        "\n",
        "\n",
        "alpaca_prompt_summary = \"\"\"Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request.\n",
        "\n",
        "### Instruction:\n",
        "Summarize the following scientific text about {}, a rare disease, into a three paragarph less than 1000 tokens, preserving key technical details.\n",
        "### Input:\n",
        "{}\n",
        "### Response:\n",
        "{}\"\"\"\n",
        "\n",
        "\n",
        "\n",
        "def extract_response_summary(text):\n",
        "    response_marker = \"### Response:\"\n",
        "    start = text.find(response_marker)\n",
        "\n",
        "    if start != -1:\n",
        "        start += len(response_marker)\n",
        "        response = text[start:].strip()\n",
        "        return response\n",
        "\n",
        "    return None\n",
        "\n",
        "def Costumized_question_summary (user_query,system_query):\n",
        "  inputs = tokenizer(\n",
        "  [\n",
        "\n",
        "    alpaca_prompt_summary.format(\n",
        "        user_query, # instruction\n",
        "        system_query, # input\n",
        "        \"\", # output - leave this blank for generation!\n",
        "    )\n",
        "  ], return_tensors = \"pt\").to(\"cuda\")\n",
        "\n",
        "  outputs = model.generate(**inputs, max_new_tokens = 1400, use_cache = True)\n",
        "  ans=tokenizer.batch_decode(outputs)\n",
        "  return extract_response_summary(ans[0])\n",
        "user_query1='Summarize the following scientific text into one short sentence, preserving key technical details.'\n",
        "\n",
        "\n",
        "Text='''\n",
        "Cystic fibrosis (CF) is a genetic disease that causes the body to produce thick mucus that can block airways, damage the lungs, and lead to other health problems:\n",
        "Symptoms: A cough that produces thick mucus, wheezing, shortness of breath, frequent lung or sinus infections, and nasal polyps\n",
        "Organs affected: Lungs, pancreas, sweat glands, and reproductive system\n",
        "Other health problems: Diabetes, cirrhosis (liver disease), arthritis, reflux, hypersplenism (overactive spleen), and osteoporosis\n",
        "Inheritance: Inherited in an autosomal recessive manner, meaning a person must inherit two defective genes, one from each parent\n",
        "Diagnosis: Most children with CF are diagnosed by age 2, but some are not detected until age 18 or older\n",
        "Treatment: Treatments can improve health outcomes and increase life expectancy\n",
        "'''\n",
        "\n",
        "Costumized_question_summary(user_query='Cystic fibrosis',system_query=Text)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 432
        },
        "id": "IRq9xi8zPD02",
        "outputId": "cb1c8292-c7ab-450a-cbf4-0f2002c68bce"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "\" Phosphoglucomutase 1 (PGM1) deficiency is a rare genetic disorder that affects glycogen metabolism, glycolysis, and protein glycosylation. Previously known as GSD XIV, it was recently reclassified as a congenital disorder of glycosylation, PGM1-CDG. PGM1-CDG usually manifests as a multisystem disease. Most patients present as infants with cleft palate, liver function abnormalities and hypoglycemia, but some patients present in adulthood with isolated muscle involvement. Some patients develop life-threatening cardiomyopathy. Unlike most other CDG, PGM1-CDG has an effective treatment option, d-galactose, which has been shown to improve many of the patients' symptoms. Therefore, early diagnosis and initiation of treatment for PGM1-CDG patients are crucial decisions. In this article, our group of international experts suggests diagnostic, follow-up, and management guidelines for PGM1-CDG. These guidelines are based on the best available evidence-based data and experts' opinions aiming to provide a practical resource for health care providers to facilitate successful diagnosis and optimal management of PGM1-CDG patients.\""
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "-------------------------------------\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "\"Phosphoglucomutase 1 (PGM1) deficiency is a rare genetic disorder that affects glycogen metabolism, glycolysis, and protein glycosylation. It was previously known as GSD XIV, but is now reclassified as a congenital disorder of glycosylation, PGM1-CDG. PGM1-CDG typically presents as a multisystem disease, often affecting infants with cleft palate, liver function abnormalities, and hypoglycemia. Some patients may present with isolated muscle involvement or life-threatening cardiomyopathy. Treatment with d-galactose has been shown to improve many of the patients' symptoms, making early diagnosis and initiation of treatment crucial. This article provides diagnostic, follow-up, and management guidelines for PGM1-CDG, based on the best available evidence-based data and experts' opinions, aiming to provide a practical resource for health care providers to facilitate successful diagnosis and optimal management of PGM1-CDG patients\""
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "-------------------------------------\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "\"['management guidelines', 'pgm1-cdg', 'congenital disorder of glycosylation', 'phosphoglucomutase 1 deficiency', 'd-galactose']<|end_of_text|>\""
            ]
          },
          "execution_count": 21,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "i=2\n",
        "user_query2=data['frequent_words'][i]\n",
        "Text=data['Abstract'][i][:7000]\n",
        "display(Text)\n",
        "print('-------------------------------------')\n",
        "display(Costumized_question_summary(user_query=user_query1,system_query=Text))\n",
        "print('-------------------------------------')\n",
        "Costumized_question(user_query=user_query2,system_query=Text)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 390
        },
        "id": "F0yvnsYSeyAA",
        "outputId": "85f6c026-1a88-4881-9c44-66cb9f3f70e2"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 7,\n  \"fields\": [\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 2,\n        \"min\": -1,\n        \"max\": 5,\n        \"num_unique_values\": 7,\n        \"samples\": [\n          -1,\n          0,\n          4\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 7,\n        \"samples\": [\n          \" ,  <h4>Background</h4>Congenital disorders of glycosylation (CDG) are a growing group of inherited diseases causing manifold symptoms. Routine diagnostic procedures are high performance liquid chromatography (HPLC) or isoelectric focusing (IEF) of serum transferrin.<h4>Methods</h4>We introduce a modified method to screen for glycosylation abnormalities from dried blood spot (DBS) samples based on isoelectric focusing. In PGM1-CDG, glycosylation analysis and enzyme activity measurement were performed from a single DBS sample. Furthermore, we present the possibility to use capillary blood samples for quantification of transferrin isoforms.<h4>Results</h4>IEF from DBS samples is possible and results are identical to the ones obtained in serum samples. Gel analysis using the ImageJ software allows quantification of IEF results. Storage at -20\\u202f\\u00b0C ensures stable samples for more than six months. Capillary blood samples are equally suitable for glycosylation analysis and show no inferiority to serum samples.<h4>Conclusion</h4>In view of a growing number of treatable CDG subtypes, the proposed methods allow reliable diagnosis and therapy control of CDG while being easily applicable. Capillary blood samples can be taken at home and sent in for follow-up. DBS are widely used in new-born screening programs and have the potential to broaden the knowledge of glycosylation abnormalities in early infancy. By its possible application in the context of alcohol abuse, the proposed method bears the potential for widespread use in a non-metabolic context.,  <h4>Background</h4>FCSK-congenital disorder of glycosylation (FCSK-CDG) is a recently discovered rare autosomal recessive genetic disorder with defective fucosylation due to mutations in the fucokinase encoding gene, FCSK. Despite the essential role of fucokinase in the fucose salvage pathway and severe multisystem manifestations of FCSK-CDG patients, it is not elucidated which cells or which types of fucosylation are affected by its deficiency.<h4>Methods</h4>In this study, CRISPR/Cas9 was employed to construct an FCSK-CDG cell model and explore the molecular mechanisms of the disease by lectin flow cytometry and real-time PCR analyses.<h4>Results</h4>Comparison of cellular fucosylation by lectin flow cytometry in the created CRISPR/Cas9 FCSK knockout and the same unedited cell lines showed no significant change in the amount of cell surface fucosylated glycans, which is consistent with the only documented previous study on different cell types. It suggests a probable effect of this disease on secretory glycoproteins. Investigating O-fucosylation by analysis of the NOTCH3 gene expression as a potential target revealed a significant decrease in the FCSK knockout cells compared with the same unedited ones, proving the effect of fucokinase deficiency on EGF-like repeats O-fucosylation.<h4>Conclusion</h4>This study expands insight into the FCSK-CDG molecular mechanism; to the best of our knowledge, it is the first research conducted to reveal a gene whose expression level alters due to this disease.,  <i>PGM1</i>-linked congenital disorder of glycosylation (PGM1-CDG) is an autosomal recessive disease characterized by several phenotypes, some of which are life-threatening. Research focusing on the disease-related variants of the \\u03b1-D-phosphoglucomutase 1 (PGM1) protein has shown that several are insoluble in vitro and expressed at low levels in patient fibroblasts. Due to these observations, we hypothesized that some disease-linked PGM1 protein variants are structurally destabilized and subject to protein quality control (PQC) and rapid intracellular degradation. Employing yeast-based assays, we show that a disease-associated human variant, PGM1 L516P, is insoluble, inactive, and highly susceptible to ubiquitylation and rapid degradation by the proteasome. In addition, we show that PGM1 L516P forms aggregates in <i>S. cerevisiae</i> and that both the aggregation pattern and the abundance of PGM1 L516P are chaperone-dependent. Finally, using computational methods, we perform saturation mutagenesis to assess the impact of all possible single residue substitutions in the PGM1 protein. These analyses identify numerous missense variants with predicted detrimental effects on protein function and stability. We suggest that many disease-linked PGM1 variants are subject to PQC-linked degradation and that our in silico site-saturated data set may assist in the mechanistic interpretation of PGM1 variants.,  Background The phosphoglucomutase 1 (PGM1) enzyme plays a central role in glucose homeostasis by catalyzing the inter-conversion of glucose 1-phosphate and glucose 6-phosphate. Recently, PGM1 deficiency has been recognized as a cause of the congenital disorders of glycosylation (CDGs). Methods Two Chinese Han pediatric patients with recurrent hypoglycemia, hepatopathy and growth retardation are described in this study. Targeted gene sequencing (TGS) was performed to screen for causal genetic variants in the genome of the patients and their parents to determine the genetic basis of the phenotype. Results DNA sequencing identified three variations of the PGM1 gene (NM_002633.2). Patient 1 had a novel homozygous mutation (c.119delT, p.Ile40Thrfs*28). In patient 2, we found a compound heterozygous mutation of c.1172G>T(p.Gly391Val) (novel) and c.1507C>T(p.Arg503*) (known pathogenic). Conclusions This report deepens our understanding of the clinical features of PGM1 mutation. The early molecular genetic analysis and multisystem assessment were here found to be essential to the diagnosis of PGM1-CDG and the provision of timely and proper treatment.,  Classical galactosemia is detected through newborn screening by measuring galactose-1-phosphate uridylyltransferase (GALT) in the USA primarily via the Beutler spot assay. We report on an 18-month-old patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency that was originally diagnosed with classical galactosemia. The patient presented with elevated liver function enzymes and bilirubinemia and was immediately treated with soy-based formula. Confirmatory tests revealed deficiency of the GALT enzyme, however, full-sequencing of GALT was normal, suggestive of a different ideology. The Beutler spot assay uses three other enzymatic steps in addition to GALT. A deficiency in either of these enzymes can result in suspected decreased GALT activity when using the Beutler assay. Congenital Disorders of Glycosylation screening for phosphoglucomutase-1 deficiency was negative. Quantitative analysis of G6PD enzyme in red blood cells showed a severe deficiency and a deletion in G6PD. Soy-formula, the standard treatment for galactosemia, has been reported to trigger hemolysis in G6PD deficient patients. G6PD and phosphoglucomutase-1 deficiencies should be considered when confirmatory tests are negative for pathogenic variants in GALT and galactose-1-phosphate level is normal.,  Congenital disorders of glycosylation (CDGs) are caused by defects in genes that participate in biosynthetic glycosylation pathways. To date, 19 different genetic defects in N-glycosylation, 17 in O-glycosylation, and 21 in multiple glycosylation are known. Current diagnostic testing of CDGs largely relies on indirect analysis of glycosylation of serum transferrin. Such analysis alone is insufficient to diagnose many of the known glycosylation disorders. To improve the diagnosis of these groups of CDGs, we have developed serum or plasma N- and O-glycan profiling using a combination of MALDI-TOF/MS and LC-MS/MS technologies. Using this approach, we analyzed samples from nine patients with different known multiple glycosylation disorders, including three with COG deficiencies, one with TMEM165-CDG, two with PGM1-CDG, and three with SLC35A2-CDG, and one patient with combined type I and type II of unknown molecular etiology. Measurement of the relative quantities of various N- and O-glycan species clearly differentiates patients and controls. Our study demonstrates that structural analysis and quantitation of combined N- and O-glycan profiles are reliable diagnostic tools for CDGs.,  Glycogen storage disease type Ib (GSD-Ib) is characterized by impaired glucose homeostasis, neutropenia and neutrophil dysfunction. Mass spectrometric glycomic profiling of GSD-Ib neutrophils showed severely truncated N-glycans, lacking galactose. Experiments indicated the hypoglycosylation of the electron transporting subunit of NADPH oxidase, which is crucial for the defense against bacterial infections. In phosphoglucomutase 1 (PGM1) deficiency, an inherited disorder with an enzymatic defect just one metabolic step ahead, hypogalactosylation can be successfully treated by dietary galactose. We hypothesized the same pathomechanism in GSD-Ib and started a therapeutic trial with oral galactose and uridine. The aim was to improve neutrophil dysfunction through the correction of hypoglycosylation in neutrophils. The GSD-Ib patient was treated for 29weeks. Monitoring included glycomics analysis of the patient's neutrophils and neutrophil function tests including respiratory burst activity, phagocytosis and migration. Although no substantial restoration of neutrophil glycosylation was found, there was partial improvement of respiratory burst activity.,  Glycogen storage diseases (GSDs) are inherited inborn errors of metabolism (IEM) involving carbohydrate metabolism. IEMs are often caused by single gene mutations that encode specific proteins: they are very relevant to pediatrics since these diseases may first manifest themselves in neonates or early childhood. IEMs should be considered in the differential diagnosis of any sick neonate. In general, IEMs result from the lack or insufficient level of specific enzymes that are needed to: (1) convert fat or carbohydrates to energy; (2) breakdown amino acids or other metabolites, allowing them to accumulate and become toxic. GSDs, depending on the specific type, can result from a failure to convert glycogen into energy and/or\\u00a0a toxic glycogen accumulation. All GSDs are due to a failure to use or store glycogen [1]. Glycogen is a branched polymer with its monomeric units being glucose (Figure 1). After a meal, the level of glucose in plasma increases and stimulates the storage of excess glucose in cytoplasmic glycogen spherical. The liver contains the highest percent glycogen by weight (about 10%) whereas muscle can store about 2% by weight. Nevertheless, since the total muscle mass is greater than liver mass, the total mass of glycogen in muscle is about twice that of the liver. When needed, the glycogen polymer can be broken down into glucose monomers and utilized for energy production. Many of the enzymes and transporters for these processes are key to the etiology of GSDs.\\u00a0 An increasing number of GSDs are being identified, but some are very rare. We will review the GSD type 0, 1, 2, 3, 4, 5, and 6 (see Figure 1). In the past, GSDs were also named by the discovering physician, as indicated in Table 1.,  PGM1, the enzyme responsible for the reversible inter-conversion of glucose-1-P and glucose-6-P, is also involved in glycosylation, leading to a wide range of clinical manifestations, such as congenital malformations, hypoglycemia, hormonal dysregulation, myopathy, hepatopathy, and cardiomyopathy. So far, PGM1 deficiency has not been associated with central nervous system involvement or intellectual disability. Seizures and neurologic involvement in PGM1-CDG were thought to be a consequence of hypoglycemia. We reviewed all reported PGM1 deficient patients for the presence of the central nervous system involvement, their treatment and disease history. We detected 17 patients out of the 41 reported PGM1-CDG cases with significant neurologic involvement. Several of these patients had no severe hypoglycemic episodes, or were adequately treated for hypoglycemia with no recurrent episodes of low blood sugars, while one patient had no reported hypoglycemic episodes. We suggest that neurological symptoms are frequent in PGM1-CDG and could present even in the absence of hypoglycemia. The central nervous system should be assessed early on during the diagnostic process to optimize outcome in patients with PGM1-CDG.,  Pediatric hepatology appears to be a very specific field of paediatrics which deals mainly with rare diseases although clinical features can be commonly found - like increased activity of transaminases. Some of these rare diseases like Wilson disease are commonly looked for and recently Wilsonian like phenotypes have been described which additionally presented with abnormal glycosylation of the plasma protein transferrin. In a subgroup of those patients with specific additional clinical symptoms (cleft uvula, low blood sugar, rhabdomyolysis and dilated cardiomyopathy) phosphoglucomutase 1 deficiency was identified. We recommend screening for abnormal glycosylation of the plasma protein transferrin in children with unexplained liver injury.,  Phosphoglucomutase 1 (PGM1) deficiency is a stable characteristic of the erythroleukaemic cell line, K562, whereas the activity of the isozymes of the other two PGM loci (PGM2 and PGM3) is slightly elevated. In this study the molecular basis of PGM1 deficiency was investigated by a combined approach utilising protein electrophoresis, immunodetection, cytogenetic techniques, and DNA and RNA analysis. Isoelectric focusing and activity staining confirmed that K562 has no detectable PGM1 activity. Immunoblot analysis of extracts, separated by isoelectric focusing, starch gel and SDS gel electrophoresis, using monospecific anti-PGM1 antibodies showed that K562 contained no detectable immunoreactive material. Karyotype analysis revealed the presence of two intact chromosomes 1 and a derivative chromosome 1, der(1)t(1;11), each of which carried a copy of the PGM1 gene as demonstrated by fluorescence in situ hybridization using a PGM1 cosmid as probe. Southern blot analysis using a PGM1 cDNA clone as probe suggested that the PGM1 genes had not been subject to any gross structural rearrangements. We were also able to determine that K562 is type PGM1 2+1+ by restriction endonuclease analysis of genomic DNA. Very low levels of PGM1 mRNA which appeared to be full length transcripts were detected in K562 using a reverse transcriptase PCR technique. We conclude that the most likely cause of PGM1 enzyme deficiency in K562 is abnormal regulation of transcription.,  Phosphoglucomutase 1 (PGM1, EC 5.4.2.2) plays a critical role in glucose homeostasis and is also essential for protein N-glycosylation. The main clinical manifestations of PGM1 deficiency (MIM 614921) reported in 19 patients from different ethnic backgrounds include the following: cleft uvula/palate, Pierre Robin sequence, muscle weakness, dilated cardiomyopathy, growth retardation, elevated serum transaminases, hypoglycemia, and various endocrine abnormalities. We report the variable clinical picture of seven patients with PGM1 deficiency from a consanguineous family. Medical records of the patients were reviewed for clinical details and endocrine evaluation. Whole exome sequencing (WES) was performed. Seven patients aged 2-29 years were included, one patient died at 13 years old when getting off the school bus. All patients have an abnormal palatine structure (cleft palate, bifid uvula) and elevated serum transaminases, 4/7 have short stature (<-2 SDS) and one was diagnosed with growth hormone deficiency. Recurrent episodes of ketotic hypoglycemia were present in 6/7 patients. In two patients, hypoglycemic episodes have spontaneously resolved later on. Four out of seven patients have deteriorating adrenal function with abnormally low cortisol and ACTH levels during hypoglycemia and subnormal response of cortisol to low dose ACTH test . Serum electrolytes were within normal range. Hydrocortisone replacement therapy improved, but not entirely eliminated hypoglycemic episodes. WES revealed a previously described homozygous mutation c.112A>T, p.Asn38Tyr in the PGM1 gene. The clinical picture of PGM1 deficiency is variable among patients with the same mutation and genetic background. ACTH deficiency should be considered in any PGM1 deficient patient with hypoglycemia.,  The most common cause of human congenital disorders of glycosylation (CDG) are mutations in the phosphomannomutase gene <i>PMM2,</i> which affect protein <i>N</i>-linked glycosylation. The yeast gene <i>SEC53</i> encodes a homolog of human <i>PMM2</i>. We evolved 384 populations of yeast harboring one of two human-disease-associated alleles, <i>sec53-</i>V238M and <i>sec53</i>-F126L, or wild-type <i>SEC53</i>. We find that after 1000 generations, most populations compensate for the slow-growth phenotype associated with the <i>sec53</i> human-disease-associated alleles. Through whole-genome sequencing we identify compensatory mutations, including known <i>SEC53</i> genetic interactors. We observe an enrichment of compensatory mutations in other genes whose human homologs are associated with Type 1 CDG, including <i>PGM1</i>, which encodes the minor isoform of phosphoglucomutase in yeast. By genetic reconstruction, we show that evolved <i>pgm1</i> mutations are dominant and allele-specific genetic interactors that restore both protein glycosylation and growth of yeast harboring the <i>sec53</i>-V238M allele. Finally, we characterize the enzymatic activity of purified Pgm1 mutant proteins. We find that reduction, but not elimination, of Pgm1 activity best compensates for the deleterious phenotypes associated with the <i>sec53</i>-V238M allele. Broadly, our results demonstrate the power of experimental evolution as a tool for identifying genes and pathways that compensate for human-disease-associated alleles.,  We report a patient diagnosed with PGM1-CDG at 11\\u2009years of age after two biallelic likely pathogenic variants in <i>PGM1</i> were found on research genomic sequencing. To our knowledge, he is the first patient with PGM1-CDG to be reported with a restrictive cardiomyopathy. Other clinical manifestations included cleft palate, asymptomatic elevated transaminases, intellectual disability and myopathy resulting in exercise intolerance. He was trialed on oral galactose therapy in increasing doses for 18\\u2009weeks to assess if there was any biochemical and clinical benefit. His galactose was continued for a further 9\\u2009months beyond the initial galactose treatment period due to improvements in exercise tolerance and myopathy. Treatment with galactose demonstrated an improvement in liver function and myopathy with improved exercise tolerance. Treatment with galactose for 15\\u2009months did not change heart function and exercise stress test results were stable.,  We report successful heart transplantation in a phosphoglucomutase 1 deficient (PGM1-CDG) patient. She presented with facial dysmorphism, bifid uvula and structural heart defects. Newborn screening was positive for classic galactosemia. The patient was on a galactose-free diet for 8\\u2009months. Eventually, whole exome sequencing excluded the galactosemia and revealed PGM1-CDG. Oral D-galactose therapy was started. Rapid deterioration of the progressive dilated cardiomyopathy prompted heart transplantation at the age of 12\\u2009months. Cardiac function was stable in the first 18\\u2009months of follow-up, and hematologic, hepatic, and endocrine laboratory findings improved during D-galactose therapy. The latter therapy improves several systemic symptoms and biochemical abnormalities in PGM1-CDG but does not correct the heart failure related to cardiomyopathy. Heart transplantation has so far only been described in DOLK-CDG., A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG) You have been asked to take part in this research study because you have been diagnosed with PGM1-CDG and are currently taking D-galactose., Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life.\\n\\nBaby Detect Project is an innovative NBS program using a panel of target sequencing that aims to identify 126 treatable severe early onset genetic diseases at birth caused by 361 genes. The list of diseases has been established in close collaboration with the Paediatricians of the University Hospital in Liege. The investigators use dedicated dried blood spots collected between the first day and 28 days of life of babies, after a consent sign by parents.\",\n          \" <h4>Background</h4>Congenital disorder of glycosylation (CDG) and Glycogen storage diseases (GSDs) are inborn metabolic disorders caused by defects in some metabolic pathways. These disorders are a heterogeneous group of diseases caused by impaired O- as well as N-glycosylation pathways. CDG patients show a broad spectrum of clinical presentations; many GSD types (PGM1-CDG) have muscle involvement and hypoglycemia.<h4>Methods</h4>We applied WES for all seven patients presenting GSD and CDG symptoms. Then we analyzed the data using various tools to predict pathogenic variants in genes related to the patients' diseases.<h4>Results</h4>In the present study, we identified pathogenic variants in Iranian patients suffering from GSD and CDG, which can be helpful for patient management, and family counseling. We detected seven pathogenic variants using whole exome sequencing (WES) in known AGL (c.1998A>G, c.3635T>C, c.3682C>T), PGM1 (c.779G>A), DPM1 (c.742T>C), RFT1 (c.127A>G), and GAA (c.1314C>A) genes.<h4>Conclusion</h4>The suspected clinical diagnosis of CDG and GSD patients was confirmed by identifying missense and or nonsense mutations in PGM1, DPM1, RFT1, GAA, and AGL genes by WES of all 7 cases. This study helps us understand the scenario of the disorder causes and consider the variants for quick disease diagnosis.,  <h4>Background</h4>Congenital disorders of glycosylation (CDG) result from defects in the synthesis of glycans and the attachment of glycans to proteins and lipids. Our study aimed to describe the clinical, biochemical, and molecular findings of CDG patients, and to present the long-term follow-up.<h4>Material and methods</h4>A single-center study (1995-2019\\u00a0years) of patients with congenital disorders of N-glycosylation and combined N- and O-hypoglycosylation was performed.<h4>Results</h4>Among 32 patients included into the study, there were 12 PMM2-CDG, 3 ALG13-CDG, 3 ALG1-CDG, 1 ALG3-CDG, 3 MPI-CDG, 1 PGM1-CDG, 4 SRD5A3-CDG, 1 DPAGT1-CDG, 3 ATP6AP1-CDG, 1 ATP6V0A2-CDG. The phenotypic and genotypic spectrum during long-term (in some cases over 20\\u00a0years) observation was characterised and several measurements of serum Tf isoforms taken. Statistical analysis revealed strong negative correlation between asialo-Tf and tetrasialo-Tf, as well as between disialo-Tf and tetrasialo-Tf. Within CDG type I, no difference in % Tf isoforms was revealed between PMM2-CDG and non-PMM2-CDG patients. However, these two groups differed significantly in such diagnostic features as: cerebellar ataxia, failure to thrive, hypothyroidism, pericardial effusion, cardiomyopathy, inverted nipples, prolonged INR. The effect of treatment with mannose in 2 patients with MPI-CDG was assessed and we found that % of asialo-Tf, monosialo-Tf, and disialo-Tf was significantly lowered, whereas tetrasialo-Tf and pentasialo-Tf rose, coming closer or falling into the reference range.<h4>Conclusions</h4>The novel finding was an abnormal Tf IEF pattern in two ALG13-CDG patients and normal in one ALG1-CDG patient. Clinical manifestation of presented CDG patients was similar to that reported in the literature. Mannose supplementation in MPI-CDG patients, as well as galactose supplementation in PGM1-CDG patient, improved patients' clinical picture and Tf isoform profiles.,  <h4>Background</h4>Congenital disorders of glycosylation (CDG) result from defects in the synthesis of glycans and their attachment to proteins and lipids. Histologically, liver steatosis, fibrosis and cirrhosis have been reported in CDG. The aim of the study was to characterize the histopathological and ultrastructural liver changes in CDG patients hospitalized in our Institute, and to find the most characteristic features, as articles concerning the liver microscopic features in CDG are sparse.<h4>Methods</h4>Out of 32 CDG patients diagnosed and followed-up in our Institute, the liver biopsy was performed in 4 of them, including 2 with MPI-CDG, 1 with SRD5A3-CDG, and 1 with PGM1-CDG, as a part of diagnostic process. In one patient, diagnosed post mortem with PMM2-CDG, the histopathological study comprised liver autopsy samples.<h4>Results</h4>The most common histopathological liver finding was the presence of steatosis (4/5) of varying severity, the mixed macro- and microvesicular type as well as the foamy degeneration of hepatocytes. In two patients, liver steatosis was associated with fibrosis, stage 4 (cirrhosis) and 2 according to Batts and Ludwig classification, respectively. In two patients, besides steatosis, mild inflammatory infiltrates composed of lymphoid cells in portal tracts were observed. No correlation between the patient's age and histopathological features was observed.<h4>Conclusions</h4>The histopathological changes in the liver of CDG patients are miscellaneous; thus, based on the microscopic examination only, we can not identify (even suspect) the exact CDG. The most common histopathologic finding in our cohort of CDG patients was the presence of liver steatosis (of various severity) and foamy degeneration of hepatocytes.,  <h4>Background</h4>Congenital disorders of glycosylation are genetic syndromes that result in impaired glycoprotein production. We evaluated patients who had a novel recessive disorder of glycosylation, with a range of clinical manifestations that included hepatopathy, bifid uvula, malignant hyperthermia, hypogonadotropic hypogonadism, growth retardation, hypoglycemia, myopathy, dilated cardiomyopathy, and cardiac arrest.<h4>Methods</h4>Homozygosity mapping followed by whole-exome sequencing was used to identify a mutation in the gene for phosphoglucomutase 1 (PGM1) in two siblings. Sequencing identified additional mutations in 15 other families. Phosphoglucomutase 1 enzyme activity was assayed on cell extracts. Analyses of glycosylation efficiency and quantitative studies of sugar metabolites were performed. Galactose supplementation in fibroblast cultures and dietary supplementation in the patients were studied to determine the effect on glycosylation.<h4>Results</h4>Phosphoglucomutase 1 enzyme activity was markedly diminished in all patients. Mass spectrometry of transferrin showed a loss of complete N-glycans and the presence of truncated glycans lacking galactose. Fibroblasts supplemented with galactose showed restoration of protein glycosylation and no evidence of glycogen accumulation. Dietary supplementation with galactose in six patients resulted in changes suggestive of clinical improvement. A new screening test showed good discrimination between patients and controls.<h4>Conclusions</h4>Phosphoglucomutase 1 deficiency, previously identified as a glycogenosis, is also a congenital disorder of glycosylation. Supplementation with galactose leads to biochemical improvement in indexes of glycosylation in cells and patients, and supplementation with complex carbohydrates stabilizes blood glucose. A new screening test has been developed but has not yet been validated. (Funded by the Netherlands Organization for Scientific Research and others.).,  <h4>Context</h4>Phosphoglucomutase type 1 (PGM1) deficiency is a rare metabolic myopathy in which symptoms are provoked by exercise.<h4>Objective</h4>Because the metabolic block is proximal to the entry of glucose into the glycolytic pathway, we hypothesized that iv glucose could improve the exercise intolerance experienced by the patient.<h4>Design</h4>This was an experimental intervention study.<h4>Setting</h4>The study was conducted in an exercise laboratory.<h4>Subjects</h4>Subjects were a 37-year-old man with genetically and biochemically verified PGM1 deficiency and 6 healthy subjects.<h4>Interventions</h4>Cycle ergometer, peak and submaximal exercise (70% of peak oxygen consumption), and exercise with an iv glucose infusion tests were performed.<h4>Main outcome measures</h4>Peak work capacity and substrate metabolism during submaximal exercise with and without an iv glucose infusion were measured.<h4>Results</h4>Peak work capacity in the patient was normal, as were increases in plasma lactate during peak and submaximal exercise. However, the heart rate decreased 11 beats minute\\u207b\\u00b9, the peak work rate increased 12.5%, and exercise was rated as being easier with glucose infusion in the patient. These results were in contrast to those in the control group, in whom no improvements occurred. In addition, the patient tended to become hypoglycemic during submaximal exercise.<h4>Conclusions</h4>This report characterizes PGM1 deficiency as a mild metabolic myopathy that has dynamic exercise-related symptoms in common with McArdle disease but no second wind phenomenon, thus suggesting that the condition clinically resembles other partial enzymatic defects of glycolysis. However, with glucose infusion, the heart rate decreased 11 beats min\\u207b\\u00b9, the peak work rate increased 12.5%, and exercise was considered easier by the patient.,  <h4>Introduction</h4>Congenital disorders of glycosylation (CDG) are a continuously expanding group of monogenic disorders that disrupt glycoprotein and glycolipid biosynthesis, leading to multi-systemic manifestations. These disorders are categorized into various groups depending on which part of the glycosylation process is impaired. The cardiac manifestations in CDG can significantly differ, not only across different types but also among individuals with the same genetic cause of CDG. Cardiomyopathy is an important phenotype in CDG. The clinical manifestations and progression of cardiomyopathy in CDG patients have not been well characterized. This study aims to delineate common patterns of cardiomyopathy across a range of genetic causes of CDG and to propose baseline screening and follow-up evaluation for this patient population.<h4>Methods</h4>Patients with molecular confirmation of CDG who were enrolled in the prospective or memorial arms of the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) natural history study were ascertained for the presence of cardiomyopathy based on a retrospective review of their medical records. All patients were evaluated by clinical geneticists who are members of FCDGC at their respective academic centers. Patients were screened for cardiomyopathy, and detailed data were retrospectively collected. We analyzed their clinical and molecular history, imaging characteristics of cardiac involvement, type of cardiomyopathy, age at initial presentation of cardiomyopathy, additional cardiac features, the treatments administered, and their clinical outcomes.<h4>Results</h4>Of the 305 patients with molecularly confirmed CDG participating in the FCDGC natural history study as of June 2023, 17 individuals, nine females and eight males, were identified with concurrent diagnoses of cardiomyopathy. Most of these patients were diagnosed with PMM2-CDG (n\\u00a0=\\u00a010). However, cardiomyopathy was also observed in other diagnoses, including PGM1-CDG (n\\u00a0=\\u00a03), ALG3-CDG (n\\u00a0=\\u00a01), DPM1-CDG (n\\u00a0=\\u00a01), DPAGT1-CDG (n\\u00a0=\\u00a01), and SSR4-CDG (n\\u00a0=\\u00a01). All PMM2-CDG patients were reported to have hypertrophic cardiomyopathy. Dilated cardiomyopathy was observed in three patients, two with PGM1-CDG and one with ALG3-CDG; left ventricular non-compaction cardiomyopathy was diagnosed in two patients, one with PGM1-CDG and one with DPAGT1-CDG; two patients, one with DPM1-CDG and one with SSR4-CDG, were diagnosed with non-ischemic cardiomyopathy. The estimated median age of diagnosis for cardiomyopathy was 5\\u00a0months (range: prenatal-27\\u00a0years). Cardiac improvement was observed in three patients with PMM2-CDG. Five patients showed a progressive course of cardiomyopathy, while the condition remained unchanged in eight individuals. Six patients demonstrated pericardial effusion, with three patients exhibiting cardiac tamponade. One patient with SSR4-CDG has been recently diagnosed with cardiomyopathy; thus, the progression of the disease is yet to be determined. One patient with PGM1-CDG underwent cardiac transplantation. Seven patients were deceased, including five with PMM2-CDG, one with DPAGT1-CDG, and one with ALG3-CDG. Two patients died of cardiac tamponade from pericardial effusion; for the remaining patients, cardiomyopathy was not necessarily the primary cause of death.<h4>Conclusions</h4>In this retrospective study, cardiomyopathy was identified in \\u223c6% of patients with CDG. Notably, the majority, including all those with PMM2-CDG, exhibited hypertrophic cardiomyopathy. Some cases did not show progression, yet pericardial effusions were commonly observed, especially in PMM2-CDG patients, occasionally escalating to life-threatening cardiac tamponade. It is recommended that clinicians managing CDG patients, particularly those with PMM2-CDG and PGM1-CDG, be vigilant of the cardiomyopathy risk and risk for potentially life-threatening pericardial effusions. Cardiac surveillance, including an echocardiogram and EKG, should be conducted at the time of diagnosis, annually throughout the first 5\\u00a0years, followed by check-ups every 2-3\\u00a0years if no concerns arise until adulthood. Subsequently, routine cardiac examinations every five years are advisable. Additionally, patients with diagnosed cardiomyopathy should receive ongoing cardiac care to ensure the effective management and monitoring of their condition. A prospective study will be required to determine the true prevalence of cardiomyopathy in CDG.,  <h4>Introduction</h4>Phosphoglucomutase 1 deficiency (PGM1 deficiency) has been identified as both, glycogenosis and congenital disorder of glycosylation (CDG). The phenotype includes hepatopathy, myopathy, oropharyngeal malformations, heart disease and growth retardation. Oral galactose supplementation at a dosage of 1\\u00a0g per kg body weight per day is regarded as the therapy of choice.<h4>Results</h4>We report on a patient with a novel disease causing mutation, who was treated for 1.5\\u00a0years with oral galactose supplementation. Initially, elevated transaminases were reduced and protein glycosylation of serum transferrin improved rapidly. Long-term surveillance however indicated limitations of galactose supplementation at the standard dose: 1\\u00a0g per kg body weight per day did not achieve permanent correction of protein glycosylation. Even increased doses of up to 2.5\\u00a0g per kg body weight did not result in complete normalization. Furthermore, we described for the first time heart rhythm abnormalities, i.e. long QT Syndrome associated with a glycosylation disorder. Mass spectrometry of IGFBP3, which was assumed to play a major role in growth retardation associated with PGM1 deficiency, revealed no glycosylation abnormalities. Growth rate did not improve under galactose supplementation.<h4>Conclusions</h4>The results of our study indicate that the current standard dose of galactose might be too low to achieve normal glycosylation in all patients. In addition, growth retardation in PGM1 deficiency is complex and multifactorial. Furthermore, heart rhythm abnormalities must be considered when treating patients with PGM1 deficiency.,  <h4>Introduction</h4>The incidence and prevalence of congenital disorders of glycosylation (CDG) have not been well established. The aim of the study was to evaluate the prevalence, incidence and genotypes of CDG patients diagnosed during the last 23\\u00a0years in Poland (1997 - 30th October 2020).<h4>Material and methods</h4>The diagnosis was based on serum Tf IEF which is performed at The Children's Memorial Health Institute (CMHI) in Warsaw. Based on demographic data, the prevalence of CDG among the Polish population in 2020 as well as the birth prevalence of CDG from 1990 to 2020 were estimated.<h4>Results</h4>39 patients (from 35 families) with molecularly confirmed CDG were diagnosed, including 17 (44%) patients (from 16 families) with PMM2-CDG. The c.422G\\u00a0>\\u00a0A, p.Arg141His and c.691G\\u00a0>\\u00a0A, p.Val231Met pathogenic missense variants were the most common identified PMM2 variants. Eleven other patients were diagnosed with CDG based on serum Tf IEF analysis only; the molecular analysis is pending. Ten CDG patients died, including 6 with PMM2-CDG, 1 with PGM1-CDG and 1 with DPAGT1-CDG. The prevalence of CDG in the Polish population was estimated at approximately 1 per million while that of PMM2 at 0.4 per million. The annual incidence of CDG was estimated at 0.013 per 100,000 people in 2020.<h4>Conclusions</h4>A low frequence of CDG in our study could be underestimated.,  <h4>Objective and importance</h4>Phosphoglucomutase 1 (PGM1) deficiency, first described as a glycogenosis (type XIV) is also a congenital disorder of glycosylation (CDG). We want to illustrate the wide clinical spectrum of PGM1 deficiency and in particular the associated disturbance in glucose metabolism and the endocrine dysfunction. Treatment with d-galactose is experimental.<h4>Case presentation</h4>PGM1 deficiency was diagnosed in an 8-year-old boy, who was referred because of an unexplained complex syndrome, including recurrent hypoglycaemia and low IGF-1 mediated growth failure.<h4>Conclusion</h4>The timely diagnosis of this disorder is particularly important, because d-galactose treatment can improve the latter symptoms.,  <h4>Objective</h4>To define phenotypic groups and identify predictors of disease severity in patients with phosphoglucomutase-1 deficiency (PGM1-CDG).<h4>Study design</h4>We evaluated 27 patients with PGM1-CDG who were divided into 3 phenotypic groups, and group assignment was validated by a scoring system, the Tulane PGM1-CDG Rating Scale (TPCRS). This scale evaluates measurable clinical features of PGM1-CDG. We examined the relationship between genotype, enzyme activity, and TPCRS score by using regression analysis. Associations between the most common clinical features and disease severity were evaluated by principal component analysis.<h4>Results</h4>We found a statistically significant stratification of the TPCRS scores among the phenotypic groups (P\\u00a0<\\u00a0.001). Regression analysis showed that there is no significant correlation between genotype, enzyme activity, and TPCRS score. Principal component analysis identified 5 variables that contributed to 54% variance in the cohort and are predictive of disease severity: congenital malformation, cardiac involvement, endocrine deficiency, myopathy, and growth.<h4>Conclusions</h4>We established a scoring algorithm to reliably evaluate disease severity in patients with PGM1-CDG on the basis of their clinical history and presentation. We also identified 5 clinical features that are predictors of disease severity; 2 of these features can be evaluated by physical examination, without the need for specific diagnostic testing and thus allow for rapid assessment and initiation of therapy.,  <h4>Objective</h4>We investigated metabolism and physiological responses to exercise in an 18-year-old woman with multiple congenital abnormalities and exertional muscle fatigue, tightness, and rhabdomyolysis.<h4>Methods</h4>We studied biochemistry in muscle and fibroblasts, performed mutation analysis, assessed physiological responses to forearm and cycle-ergometer exercise combined with stable-isotope techniques and indirect calorimetry, and evaluated the effect of IV glucose infusion and oral sucrose ingestion on the exercise response.<h4>Results</h4>Phosphoglucomutase type 1 (PGM1) activity in muscle and fibroblasts was severely deficient and PGM1 in muscle was undetectable by Western blot. The patient was compound heterozygous for missense (R422W) and nonsense (Q530X) mutations in PGM1. Forearm exercise elicited no increase in lactate, but an exaggerated increase in ammonia, and provoked a forearm contracture. Comparable to patients with McArdle disease, the patient developed a 'second wind' with a spontaneous fall in exercise heart rate and perceived exertion. Like in McArdle disease, this was attributable to an increase in muscle oxidative capacity. Carbohydrate oxidation was blocked during exercise, and the patient had exaggerated oxidation of fat to fuel exercise. Exercise heart rate and perceived exertion were lower after IV glucose and oral sucrose. Muscle glycogen level was low normal.<h4>Conclusions</h4>The second wind phenomenon has been considered to be pathognomonic for McArdle disease, but we demonstrate that it can also be present in PGM1 deficiency. We show that severe loss of PGM1 activity causes blocked muscle glycogenolysis that mimics McArdle disease, but may also limit glycogen synthesis, which broadens the phenotypic spectrum of this disorder.,  <h4>Objectives</h4>A 10-year-old boy presented with cleft palate, hepatopathy, cholecystolithiasis, myopathy, coagulopathy, hyperlipidemia, hypoglycemia, hyperuricemia, short stature, obesity, hypothyroidism, microcephaly and mild intellectual disability. The multi-systemic manifestation involving certain distinct clinical features prompted us to search for a subtype of congenital disorders of glycosylation (CDG).<h4>Methods</h4>The patient was screened for CDG by examining the distribution of transferrin (TRF) and apolipoprotein C-III (ApoC-III) sialylated isoforms using isoelectric focusing of serum. This was followed by spectrophotometric measurement of phosphoglucomutase 1 (PGM1) activity in fibroblasts and molecular analysis including sequencing and PCR-RFLP of PGM1 gene. Selected bioinformatics tools were used to evaluate the data.<h4>Results</h4>Increased relative levels of di-, mono- and asialotransferrin reflected a defect of N-glycosylation in the patient. Markedly decreased activity of PGM1 corresponding to less than 5% of control\\u00b4s was found. Sequencing of PGM1 gene revealed the presence of two heterozygous missense mutations c.1010C>T (p.T337M) and c.1508G>A (p.R503Q), whose pathogenicity was confirmed by in silico analysis.<h4>Conclusion</h4>We report the first Czech patient with a glycosylation disorder due to PGM1 deficiency. Compared to the described cases, no dilated cardiomyopathy was noted in our patient. However, he suffered from a mild neurological impairment, which is an uncommon feature that extends the phenotype associated with PGM1-CDG. Lactose-rich diet, which was previously reported to have ameliorated the clinical symptoms in some PGM1-CDG patients, did not result in any improvement in our patient.,  <h4>Objectives</h4>Congenital Glycosylation Disorders (CDG) are a large group of inherited metabolic diseases with multi-organ involvement. Herein, we aimed to expand the clinical characteristics of patients with CDG based on our experience with diagnoses and follow-up of CDG patients from different subtypes.<h4>Methods</h4>The clinical and laboratory findings from the last 15 years were reviewed retrospectively in Ege University Child Metabolism and Nutrition Department.<h4>Results</h4>There were 8 (57.2\\u202f%) females and 6 (42.8\\u202f%) males. Diagnoses of the patients were PMM2-CDG (n=4), PGM1-CDG (n=2), DPAGT1-CDG (n=2), SRD5A3-CDG (n=2), MPI-CDG (n=1), POMT2-CDG (n=1), B3GALNT2-CDG (n=1), DPM1-CDG (n=1). The clinical findings of the patients were dysmorphia (85.7\\u202f%), developmental delay (85.7\\u202f%), intellectual disability (85.7\\u202f%), ocular abnormalities (64.2\\u202f%), skeletal malformations (64.2\\u202f%), failure to thrive (57.1\\u202f%), microcephaly (57.1\\u202f%), hepatomegaly (35.7\\u202f%), hearing loss (35.7\\u202f%), seizures (28.5\\u202f%), gastrointestinal symptoms (21.4\\u202f%), endocrine abnormalities (21.4\\u202f%), and cardiac abnormalities (7.1\\u202f%). Laboratory findings were abnormal TIEF (92.8\\u202f%), abnormal liver enzymes (64.2\\u202f%), decreased protein C (64.2\\u202f%), decreased antithrombin III (64.2\\u202f%), decreased protein S (42.8\\u202f%), hypogammaglobulinemia (35.7\\u202f%), cerebellar hypoplasia (28.5\\u202f%), CK elevation (7.1\\u202f%), and hypoglycemia (7.1\\u202f%).<h4>Conclusions</h4>This study contributes to the literature by sharing our ultra-rare DPM1-CDG case with less than 20 cases in the literature and expanding the clinical and molecular characteristics of other CDG patients. Hyperinsulinemic hypoglycemia, short stature, hypothyroidism, growth hormone deficiency, hypogammaglobulinemia, pericardial effusion, elevated CK, congenital myasthenia, and anorectal malformation were unique findings that were observed. Cerebello-ocular findings accompanying multi-organ involvement were an essential clue for a possible CDG.,  Clinical glycomics comprises a spectrum of different analytical methodologies to analyze glycan structures, which provides insights into the mechanisms of glycosylation. Within clinical diagnostics, glycomics serves as a functional readout of genetic variants, and can form a basis for therapy development, as was described for PGM1-CDG. Integration of glycomics with genomics has resulted in the elucidation of previously unknown disorders of glycosylation, namely CCDC115-CDG, TMEM199-CDG, ATP6AP1-CDG, MAN1B1-CDG, and PGM1-CDG. This review provides an introduction into protein glycosylation and presents the different glycomics methodologies ranging from gel electrophoresis to mass spectrometry (MS) and from free glycans to intact glycoproteins. The role of glycomics in the diagnosis of congenital disorders of glycosylation (CDG) is presented, including a diagnostic flow chart and an overview of glycomics data of known CDG subtypes. The review ends with some future perspectives, showing upcoming technologies as system wide mapping of the N- and O-glycoproteome, intact glycoprotein profiling and analysis of sugar metabolism. These new advances will provide additional insights and opportunities to develop personalized therapy. This is especially true for inborn errors of metabolism, which are amenable to causal therapy, because interventions through supplementation therapy can directly target the pathogenesis at the molecular level.,  Congenital disorders of glycosylation (CDG) are a group of genetic disorders that affect protein and lipid glycosylation and glycosylphosphatidylinositol synthesis. More than 100 different disorders have been reported and the number is rapidly increasing. Since glycosylation is an essential post-translational process, patients present a large range of symptoms and variable phenotypes, from very mild to extremely severe. Only for few CDG, potentially curative therapies are being used, including dietary supplementation (e.g., galactose for PGM1-CDG, fucose for SLC35C1-CDG, Mn<sup>2+</sup> for TMEM165-CDG or mannose for MPI-CDG) and organ transplantation (e.g., liver for MPI-CDG and heart for DOLK-CDG). However, for the majority of patients, only symptomatic and preventive treatments are in use. This constitutes a burden for patients, care-givers and ultimately the healthcare system. Innovative diagnostic approaches, in vitro and in vivo models and novel biomarkers have been developed that can lead to novel therapeutic avenues aiming to ameliorate the patients&rsquo; symptoms and lives. This review summarizes the advances in therapeutic approaches for CDG.,  Congenital disorders of glycosylation (CDG) are a group of more than 130 inborn errors of metabolism affecting <i>N</i>-linked, <i>O</i>-linked protein and lipid-linked glycosylation. The phenotype in CDG patients includes frequent liver involvement, especially the disorders belonging to the <i>N</i>-linked protein glycosylation group. There are only a few treatable CDG. Mannose-Phosphate Isomerase (MPI)-CDG was the first treatable CDG by high dose mannose supplements. Recently, with the successful use of d-galactose in Phosphoglucomutase 1 (PGM1)-CDG, other CDG types have been trialed on galactose and with an increasing number of potential nutritional therapies. Current mini review focuses on therapies in glycosylation disorders affecting liver function and dietary intervention in general in <i>N</i>-linked glycosylation disorders. We also emphasize now the importance of early screening for CDG in patients with mild hepatopathy but also in cholestasis.,  Congenital disorders of glycosylation (CDG) are a rapidly growing family of genetic diseases caused by defects in glycosylation. Nearly 100 CDG types are known so far. Patients present a great phenotypic diversity ranging from poly- to mono-organ/system involvement and from very mild to extremely severe presentation. In this literature review, we summarize the liver involvement reported in CDG patients. Although liver involvement is present in only a minority of the reported CDG types (22\\u00a0%), it can be debilitating or even life-threatening. Sixteen of the patients we collated here developed cirrhosis, 10 had liver failure. We distinguish two main groups: on the one hand, the CDG types with predominant or isolated liver involvement including MPI-CDG, TMEM199-CDG, CCDC115-CDG, and ATP6AP1-CDG, and on the other hand, the CDG types associated with liver disease but not as a striking, unique or predominant feature, including PMM2-CDG, ALG1-CDG, ALG3-CDG, ALG6-CDG, ALG8-CDG, ALG9-CDG, PGM1-CDG, and COG-CDG. This review aims to facilitate CDG patient identification and to understand CDG liver involvement, hopefully leading to earlier diagnosis, and better management and treatment.,  Diagnostic screening of the congenital disorders of glycosylation (CDG) generally involves isoelectric focusing of plasma transferrin, a robust method easily integrated in medical laboratories. Structural information is needed as the next step, as required for the challenging classification of Golgi glycosylation defects (CDG-II). Here, we present the use of high-resolution nano liquid chromatography-chip (C8)-quadrupole time of flight mass spectrometry (nanoLC-chip [C8]-QTOF MS) for protein-specific glycoprofiling of intact transferrin, which allows screening and direct diagnosis of a number of CDG-II defects. Transferrin was immunopurified from 10 \\u03bcL of plasma and analyzed by nanoLC-chip-QTOF MS. Charge distribution raw data were deconvoluted by Mass Hunter software to reconstructed mass spectra. Plasma samples were processed from controls (n = 56), patients with known defects (n = 30), and patients with secondary (n = 6) or unsolved (n = 3) cause of abnormal glycosylation. This fast and robust method, established for CDG diagnostics, requires only 2 hours analysis time, including sample preparation and analysis. For CDG-I patients, the characteristic loss of complete N-glycans could be detected with high sensitivity. Known CDG-II defects (phosphoglucomutase 1 [PGM1-CDG], mannosyl (\\u03b1-1,6-)-glycoprotein \\u03b2-1,2-N-acetylglucosaminyltransferase [MGAT2-CDG], \\u03b2-1,4-galactosyltransferase 1 [B4GALT1-CDG], CMP-sialic acid transporter [SLC35A1-CDG], UDP-galactose transporter [SLC35A2-CDG] and mannosyl-oligosaccharide 1,2-alpha-mannosidase [MAN1B1-CDG]) resulted in characteristic diagnostic profiles. Moreover, in the group of Golgi trafficking defects and unsolved CDG-II patients, distinct profiles were observed, which facilitate identification of the specific CDG subtype. The established QTOF method affords high sensitivity and resolution for the detection of complete glycan loss and structural assignment of truncated glycans in a single assay. The speed and robustness allow its clinical diagnostic application as a first step in the diagnostic procedure for CDG defects.,  INTRODUCTION:Sudden cardiac death (SCD) in the young is rare and should always lead to suspicion of a genetic cardiac disorder. We describe a family, in which the proband was a girl deceased by sudden cardiac death in the playground at thirteen years of age. The index-patient had short stature, cleft palate but no previous cardiac symptoms. We found an uncommon cause of cardiomyopathy, due to a congenital disorder of glycosylation (CDG), previously described to cause a variable range of usually mild symptoms, and not previously found to cause SCD as the first symptom of the condition. METHODS:The index patient underwent postmortem genetic testing/molecular autopsy for genes known to cause SCD, without a detection of causative agent, why two siblings of similar phenotype as the deceased sister underwent clinical-exome genetic sequencing (next generation sequencing). All first-degree relatives underwent clinical examination including cardiac ultrasound, Holter-ECG, exercise stress test and biochemistry panel. RESULTS:A genetic variant in the gene for phosphoglucomutase 1 (PGM1) was identified in the index patient and her two brothers, all were found to be homozygous for the genetic variant (G230E) NM_002633.2:c.689\\u202fG\\u202f>\\u202fA in PGM1. This variant has been linked to a congenital disorder of glycosylation (PGM1-CDG), explaining the clinical picture of short stature, cleft palate, liver engagement and cardiomyopathy. During follow-up one of the brothers died unexpectedly after physical exertion during daily life at the age of twelve years. The other brother fainted during similar circumstances at the age of thirteen years. Both parents and three other siblings were found to be heterozygous gene carriers without risk for the disease. CONCLUSION:Our findings suggest that there is a need of multidisciplinary discussion and genetic testing after unexpected cardiac death in the young. We have to be more flexible in our evaluation of diseases and to consider even uncommon diseases including rare recessive inherited disorders. Our findings also suggest that the autosomal recessive PGM1-CDG might be highly associated with life-threatening cardiomyopathy with arrhythmia or sudden cardiac death as the first symptom presenting from childhood and adolescence.,  Patients with phosphoglucomutase (PGM1) deficiency, a congenital disorder of glycosylation (CDG) suffer from multiple disease phenotypes. Midline cleft defects are present at birth. Overtime, additional clinical phenotypes, which include severe hypoglycemia, hepatopathy, growth retardation, hormonal deficiencies, hemostatic anomalies, frequently lethal, early-onset of dilated cardiomyopathy and myopathy emerge, reflecting the central roles of the enzyme in (glycogen) metabolism and glycosylation. To delineate the pathophysiology of the tissue-specific disease phenotypes, we constructed a constitutive Pgm2 (mouse ortholog of human PGM1)-knockout (KO) mouse model using CRISPR-Cas9 technology. After multiple crosses between heterozygous parents, we were unable to identify homozygous life births in 78 newborn pups (P = 1.59897E-06), suggesting an embryonic lethality phenotype in the homozygotes. Ultrasound studies of the course of pregnancy confirmed Pgm2-deficient pups succumb before E9.5. Oral galactose supplementation (9 mg/mL drinking water) did not rescue the lethality. Biochemical studies of tissues and skin fibroblasts harvested from heterozygous animals confirmed reduced Pgm2 enzyme activity and abundance, but no change in glycogen content. However, glycomics analyses in serum revealed an abnormal glycosylation pattern in the Pgm2<sup>+/-</sup> animals, similar to that seen in PGM1-CDG.,  Phosphoglucomutase 1 (PGM1) catalyzes the interconversion of glucose-6-phosphate to glucose-1-phosphate and is a key enzyme of glycolysis, glycogenesis, and glycogenolysis. PGM1 deficiency (OMIM: 614921) was initially defined as a glycogen storage disorder (type XIV), and later re-classified as a PGM1-congenital disorder of glycosylation (PGM1-CDG). Serum transferrin (Tf) glycan isoform analysis by liquid chromatography-mass spectrometry (LC-MS) is used as a primary diagnostic screen tool, and reveals a very unique CDG profile described as a mixture of CDG-type I and CDG-type II patterns. Oral d-galactose supplementation shows significant clinical and metabolic improvements, which are indicated by the Tf glycan isoform normalization over time in patients with PGM1-CDG. Thus, there is a need for biomarkers to guide d-galactose dosage in patients in order to maintain effective and safe drug levels. Here, we present a simplified algorithm called PGM1-CDG Treatment Monitoring Index (PGM1-TMI) for assessing the response of PGM1-CDG patients to d-galactose supplementation. For our single-center cohort of 16 PGM1-CDG patients, the Tf glycan profile analysis provided the biochemical diagnosis in all of them. In addition, the PGM1-TMI was reduced in PGM1-CDG patients under d-galactose supplementation as compared with their corresponding values before treatment, indicating that glycosylation proceeds towards normalization. PGM1-TMI allows tracking Tf glycan isoform normalization over time when the patients are on d-galactose supplementation.,  Phosphoglucomutase 1 (PGM1) deficiency is a rare genetic disorder that affects glycogen metabolism, glycolysis, and protein glycosylation. Previously known as GSD XIV, it was recently reclassified as a congenital disorder of glycosylation, PGM1-CDG. PGM1-CDG usually manifests as a multisystem disease. Most patients present as infants with cleft palate, liver function abnormalities and hypoglycemia, but some patients present in adulthood with isolated muscle involvement. Some patients develop life-threatening cardiomyopathy. Unlike most other CDG, PGM1-CDG has an effective treatment option, d-galactose, which has been shown to improve many of the patients' symptoms. Therefore, early diagnosis and initiation of treatment for PGM1-CDG patients are crucial decisions. In this article, our group of international experts suggests diagnostic, follow-up, and management guidelines for PGM1-CDG. These guidelines are based on the best available evidence-based data and experts' opinions aiming to provide a practical resource for health care providers to facilitate successful diagnosis and optimal management of PGM1-CDG patients.,  Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1 gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in the PGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient's phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.,  Phosphoglucomutase 1 (PGM1) deficiency is recognized as the third most common N-linked congenital disorders of glycosylation (CDG) in humans. Affected individuals present with liver, musculoskeletal, endocrine, and coagulation symptoms; however, the most life-threatening complication is the early onset of dilated cardiomyopathy (DCM). Recently, we discovered that oral D-galactose supplementation improved liver disease, endocrine, and coagulation abnormalities, but does not alleviate the fatal cardiomyopathy and the associated myopathy. Here we report on left ventricular ejection fraction (LVEF) in 6 individuals with PGM1-CDG. LVEF was pathologically low in most of these individuals and varied between 10% and 65%. To study the pathobiology of the cardiac disease observed in PGM1-CDG, we constructed a novel cardiomyocyte-specific conditional Pgm2 gene (mouse ortholog of human PGM1) knockout (Pgm2 cKO) mouse model. Echocardiography studies corroborated a DCM phenotype with significantly reduced ejection fraction and left ventricular dilation similar to those seen in individuals with PGM1-CDG. Histological studies demonstrated excess glycogen accumulation and fibrosis, while ultrastructural analysis revealed Z-disk disarray and swollen/fragmented mitochondria, which was similar to the ultrastructural pathology in the cardiac explant of an individual with PGM1-CDG. In addition, we found decreased mitochondrial function in the heart of KO mice. Transcriptomic analysis of hearts from mutant mice demonstrated a gene signature of DCM. Although proteomics revealed only mild changes in global protein expression in left ventricular tissue of mutant mice, a glycoproteomic analysis unveiled broad glycosylation changes with significant alterations in sarcolemmal proteins including different subunits of laminin-211, which was confirmed by immunoblot analyses. Finally, augmentation of PGM1 in KO mice via AAV9-PGM1 gene replacement therapy prevented and halted the progression of the DCM phenotype.,  Phosphoglucomutase 1 (PGM1) deficiency results in a mixed phenotype of a Glycogen Storage Disorder and a Congenital Disorder of Glycosylation (CDG). Screening for abnormal glycosylation has identified more than 40 patients, manifesting with a broad clinical and biochemical spectrum which complicates diagnosis. Together with the availability of D-galactose as dietary therapy, there is an urgent need for specific glycomarkers for early diagnosis and treatment monitoring. We performed glycomics profiling by high-resolution QTOF mass spectrometry in a series of 19 PGM1-CDG patients, covering a broad range of biochemical and clinical severity. Bioinformatics and statistical analysis were used to select glycomarkers for diagnostics and define glycan-indexes for treatment monitoring. Using 3 transferrin glycobiomarkers, all PGM1-CDG patients were diagnosed with 100% specificity and sensitivity. Total plasma glycoprofiling showed an increase in high mannose glycans and fucosylation, while global galactosylation and sialylation were severely decreased. For treatment monitoring, we defined 3 glycan-indexes, reflecting normal glycosylation, a lack of complete glycans (LOCGI) and of galactose residues (LOGI). These indexes showed improved glycosylation upon D-galactose treatment with a fast and near-normalization of the galactose index (LOGI) in 6 out of 8 patients and a slower normalization of the LOCGI in all patients. Total plasma glycoprofiling showed improvement of the global high mannose glycans, fucosylation, sialylation, and galactosylation status on D-galactose treatment. Our study indicates specific glycomarkers for diagnosis of mildly and severely affected PGM1-CDG patients, and to monitor the glycan-specific effects of D-galactose therapy.,  Phosphoglucomutase 1 (PGM1) encodes the metabolic enzyme that interconverts glucose-6-P and glucose-1-P. Mutations in PGM1 cause impairment in glycogen metabolism and glycosylation, the latter manifesting as a congenital disorder of glycosylation (CDG). This unique metabolic defect leads to abnormal N-glycan synthesis in the endoplasmic reticulum (ER) and the Golgi apparatus (GA). On the basis of the decreased galactosylation in glycan chains, galactose was administered to individuals with PGM1-CDG and was shown to markedly reverse most disease-related laboratory abnormalities. The disease and treatment mechanisms, however, have remained largely elusive. Here, we confirm the clinical benefit of galactose supplementation in PGM1-CDG-affected individuals and obtain significant insights into the functional and biochemical regulation of glycosylation. We report here that, by using tracer-based metabolomics, we found that galactose treatment of PGM1-CDG fibroblasts metabolically re-wires their sugar metabolism, and as such replenishes the depleted levels of galactose-1-P, as well as the levels of UDP-glucose and UDP-galactose, the nucleotide sugars that are required for ER- and GA-linked glycosylation, respectively. To this end, we further show that the galactose in UDP-galactose is incorporated into mature, de novo glycans. Our results also allude to the potential of monosaccharide therapy for several other CDG.,  Phosphoglucomutase 1 deficiency is a congenital disorder of glycosylation (CDG) with multiorgan involvement affecting carbohydrate metabolism, N-glycosylation and energy production. The metabolic management consists of dietary D-galactose supplementation that ameliorates hypoglycemia, hepatic dysfunction, endocrine anomalies and growth delay. Previous studies suggest that D-galactose administration in juvenile patients leads to more significant and long-lasting effects, stressing the urge of neonatal diagnosis (0-6\\u202fmonths of age). Here, we detail the early clinical presentation of PGM1-CDG in eleven infantile patients, and applied the modified Beutler test for screening of PGM1-CDG in neonatal dried blood spots (DBSs). All eleven infants presented episodic hypoglycemia and elevated transaminases, along with cleft palate and growth delay (10/11), muscle involvement (8/11), neurologic involvement (5/11), cardiac defects (2/11). Standard dietary measures for suspected lactose intolerance in four patients prior to diagnosis led to worsening of hypoglycemia, hepatic failure and recurrent diarrhea, which resolved upon D-galactose supplementation. To investigate possible differences in early vs. late clinical presentation, we performed the first systematic literature review for PGM1-CDG, which highlighted respiratory and gastrointestinal symptoms as significantly more diagnosed in neonatal age. The modified Butler-test successfully identified PGM1-CDG in DBSs from seven patients, including for the first time Guthrie cards from newborn screening, confirming the possibility of future inclusion of PGM1-CDG in neonatal screening programs. In conclusion, severe infantile morbidity of PGM1-CDG due to delayed diagnosis could be prevented by raising awareness on its early presentation and by inclusion in newborn screening programs, enabling early treatments and galactose-based metabolic management.,  Phosphoglucomutase-1-congenital disorder of glycosylation (PGM1-CDG) (OMIM: 614921) is a rare autosomal recessive inherited metabolic disease caused by the deficiency of the PGM1 enzyme. Like other CDGs, PGM1-CDG has a multisystemic presentation. The most common clinical findings include liver involvement, rhabdomyolysis, hypoglycemia, and cardiac involvement. Phenotypic severity can vary, though cardiac presentation is usually part of the most severe phenotype, often resulting in early death. Unlike the majority of CDGs, PGM1-CDG has a treatment: oral D-galactose (D-gal) supplementation, which significantly improves many aspects of the disorder. Here, we describe five PGM1-CDG patients treated with D-gal and report both on novel clinical symptoms in PGM1-CDG as well as the effects of the D-gal treatment. D-gal resulted in notable clinical improvement in four patients, though the efficacy of treatment varied between the patients. Furthermore, there was a significant improvement or normalization in transferrin glycosylation, liver transaminases and coagulation factors in three patients, creatine kinase (CK) levels in two, while hypoglycemia resolved in two patients. One patient discontinued the treatment due to urinary frequency and lack of clinical improvement. Furthermore, one patient experienced recurrent episodes of rhabdomyolysis and tachycardia even on higher doses of therapy. D-gal also failed to improve the cardiac function, which was initially abnormal in three patients, and remains the biggest challenge in treating PGM1-CDG. Together, our findings expand the phenotype of PGM1-CDG and underline the importance of developing novel therapies that would specifically treat the cardiac phenotype in PGM1-CDG.,  Phosphoglucomutase-1-congenital disorder of glycosylation (PGM1-CDG) is a rare genetic disorder caused by biallelic variants in the PGM1 gene, leading to the deficiency of the PGM1 enzyme. The most common clinical presentations include muscle involvement, failure to thrive, cleft palate, and cardiac involvement. Abnormal serum N-glycosylation, hypoglycemia, and liver function abnormalities including coagulation abnormalities are the most common laboratory abnormalities. While PGM1-CDG has been extensively studied, little is known about the extent of the coagulation abnormalities in individuals with PGM1-CDG. Unlike most CDG, some symptoms of PGM1-CDG are treatable with D-galactose (D-gal) supplementation, though reliable clinical endpoints are necessary to appropriately evaluate the potential improvement with D-gal in PGM1-CDG. Here, we aimed to describe the incidence of coagulation abnormalities in PGM1-CDG and their evolution, their relation to clinical events, and the ability of D-gal treatment to improve them. A retrospective analysis was conducted on 73 reported individuals. All individuals had a molecularly confirmed PGM1-CDG diagnosis. All incidences of antithrombin (AT), aPTT, PT, factor (F) XI, FX, FIX, FVII, protein C and protein S data and major clinical events related to coagulation abnormalities, were collected. Coagulation information was available for only 58.9 % of the reported individuals, out of which 67.4 % of PGM1-CDG individuals were reported to have abnormalities. The most frequently observed abnormality was AT (mean: 30.8% R:80-120 %) deficiency. Four individuals had major thrombotic events. Coagulation status on D-gal treatment, were reported in 19 individuals. Several factors showed improvement including AT (mean: 64.5 %), indicating galactose is beneficial in treating coagulation abnormalities in PGM1-CDG. Due to the scarcity of the reported data on coagulation parameters, we also evaluated data collected in sixteen PGM1-CDG individuals enrolled in the FCDGC Natural History Study. Longitudinal data showed improvements in several coagulant parameters and disease severity improved for almost all patients of whom we had multiple datapoints on D-gal. AT showed significant improvement on D-gal. We conclude that coagulation abnormalities are frequently present in PGM1-CDG and show improvement on D-gal. We recommend coagulation parameters should be routinely checked in individuals with PGM1-CDG or suspected of having PGM1-CDG. Finally, AT may be used as a primary or secondary clinical endpoint for upcoming clinical trials in PGM1-CDG individuals.,  PurposePhosphoglucomutase-1 deficiency is a subtype of congenital disorders of glycosylation (PGM1-CDG). Previous casereports in PGM1-CDG patients receiving oral D-galactose (D-gal) showed clinical improvement. So far no systematic in vitro and clinical studies have assessed safety and benefits of D-gal supplementation. In a prospective pilot study, we evaluated the effects of oral D-gal in nine patients.MethodsD-gal supplementation was increased to 1.5\\u2009g/kg/day (maximum 50\\u2009g/day) in three increments over 18 weeks. Laboratory studies were performed before and during treatment to monitor safety and effect on serum transferrin-glycosylation, coagulation, and liver and endocrine function. Additionally, the effect of D-gal on cellular glycosylation was characterized in vitro.ResultsEight patients were compliant with D-gal supplementation. No adverse effects were reported. Abnormal baseline results (alanine transaminase, aspartate transaminase, activated partial thromboplastin time) improved or normalized already using 1\\u2009g/kg/day D-gal. Antithrombin-III levels and transferrin-glycosylation showed significant improvement, and increase in galactosylation and whole glycan content. In vitro studies before treatment showed N-glycan hyposialylation, altered O-linked glycans, abnormal lipid-linked oligosaccharide profile, and abnormal nucleotide sugars in patient fibroblasts. Most cellular abnormalities improved or normalized following D-gal treatment. D-gal increased both UDP-Glc and UDP-Gal levels and improved lipid-linked oligosaccharide fractions in concert with improved glycosylation in PGM1-CDG.ConclusionOral D-gal supplementation is a safe and effective treatment for PGM1-CDG in this pilot study. Transferrin glycosylation and ATIII levels were useful trial end points. Larger, longer-duration trials are ongoing.,  We recently redefined phosphoglucomutase-1 deficiency not only as an enzyme defect, involved in normal glycogen metabolism, but also an inborn error of protein glycosylation. Phosphoglucomutase-1 is a key enzyme in glycolysis and glycogenesis by catalyzing in the bidirectional transfer of phosphate from position 1 to 6 on glucose. Glucose-1-P and UDP-glucose are closely linked to galactose metabolism. Normal PGM1 activity is important for effective glycolysis during fasting. Activated glucose and galactose are essential for normal protein glycosylation. The complex defect involving abnormal concentrations of activated sugars leads to hypoglycemia and two major phenotypic presentations, one with primary muscle involvement and the other with severe multisystem disease. The multisystem phenotype includes growth delay and malformations, like cleft palate or uvula, and liver, endocrine and heart function with possible cardiomyopathy. The patients have normal intelligence. Decreased transferrin galactosylation is a characteristic finding on mass spectrometry. Previous in vitro studies in patient fibroblasts showed an improvement of glycosylation on galactose supplements. Four patients with PGM1 deficiency have been trialed on d-galactose (compassionate use), and showed improvement of serum transferrin hypoglycosylation. There was a parallel improvement of liver function, endocrine abnormalities and a decrease in the frequency of hypoglycemic episodes. No side effects have been observed. Galactose supplementation didn't seem to resolve all clinical symptoms. Adding complex carbohydrates showed an additional clinical amelioration. Based on the available clinical data we suggest to consider the use of 0.5-1g/kg/day d-galactose and maximum 50 g/day oral galactose therapy in PGM1-CDG. The existing data on galactose therapy have to be viewed as preliminary observations. A prospective multicenter trial is ongoing to evaluate the efficacy and optimal d-galactose dose of galactose supplementation., CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMARY Dietary intervention has been a successful approach of treatment in classic inborn errors, aiming at restoring normal levels of metabolites in patients. In the past, a positive effect of the monosaccharide, D-galactose has been documented in Golgi related CDG. Our preliminary data in PGM1-CDG and SLC35A2-CDG showed that supplementation of patients with D-galactose leads to improvement of glycan synthesis parallel with improving clinical symptoms. In another glycosylation disorder, NGLY1 deficiency, preclinical studies offered a different therapeutic target for the disease. Despite these encouraging preliminary observations we do need clinical trials to 1) evaluate long-term therapy, dosage and safety of oral D-galactose supplementation in patients with PGM1-CDG; 2) study the efficacy of oral D-galactose supplementation in patients with another protein- galactosylation defect (SLC35A2-CDG) and 3) evaluate whether oral GlcNAc supplementation in NGLY1 deficiency is translatable to the human disorder. Our scientific premise is that the use dietary sugars, D- galactose and N-Acetyl-Glucosamine will restore glycosylation in CDG by influencing ?metabolite fluxes? to regulate and boost glycosylation pathways leading to improved clinical symptoms and quality of life of CDG patients. We propose to 1) evaluate efficacy and safety of D-galactose supplementation in SLC35A2-CDG, a disorder of hypogalactosylation, using seizure control, quantitative glycomics and validated clinical severity score (NPCRS) as endpoints in a blinded, cross-over study design; 2) assess optimal dosing and long-term safety of D-galactose in PGM1- CDG using validated clinical severity score (TPCRS) and quantitative glycomics as endpoints in an open label dose escalation study design and 3) evaluate the safety and effect of oral GlcNAc supplementation in patients with NGLY1 deficiency on a novel urinary biomarker, seizure control and tear secretion, as end points. The proposed clinical trials will fill gaps in the design of upcoming clinical trials in CDG and NGLY1 by establishing initial treatment regimens and clarifying safe dosage for monosaccharide therapies. Deliverables from this study, supported by the natural history study and the diagnostics and biomarker project will increase clinical trial readiness for large-scale Phase 2 and Phase 3 clinical trials by validating clinical progression scores and patient reported outcomes (Goal Attainment Scale) as well as advanced diagnostics and biomarker discoveries., CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMARY\\\\\\\\\\\\\\\\nDietary intervention has been a successful approach of treatment in classic inborn errors, aiming at restoring\\\\\\\\\\\\\\\\nnormal levels of metabolites in patients. In the past, a positive effect of the monosaccharide, D-galactose has\\\\\\\\\\\\\\\\nbeen documented in Golgi related CDG. Our preliminary data in PGM1-CDG and SLC35A2-CDG showed that\\\\\\\\\\\\\\\\nsupplementation of patients with D-galactose leads to improvement of glycan synthesis parallel with improving\\\\\\\\\\\\\\\\nclinical symptoms. In another glycosylation disorder, NGLY1 deficiency, preclinical studies offered a different\\\\\\\\\\\\\\\\ntherapeutic target for the disease. Despite these encouraging preliminary observations we do need clinical\\\\\\\\\\\\\\\\ntrials to 1) evaluate long-term therapy, dosage and safety of oral D-galactose supplementation in patients with\\\\\\\\\\\\\\\\nPGM1-CDG; 2) study the efficacy of oral D-galactose supplementation in patients with another protein-\\\\\\\\\\\\\\\\ngalactosylation defect (SLC35A2-CDG) and 3) evaluate whether oral GlcNAc supplementation in NGLY1\\\\\\\\\\\\\\\\ndeficiency is translatable to the human disorder. Our scientific premise is that the use dietary sugars, D-\\\\\\\\\\\\\\\\ngalactose and N-Acetyl-Glucosamine will restore glycosylation in CDG by influencing \\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x83\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\xa2\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x82\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\x80\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x82\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\x9cmetabolite fluxes\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x83\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\xa2\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x82\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\x80\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x82\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\x9d to\\\\\\\\\\\\\\\\nregulate and boost glycosylation pathways leading to improved clinical symptoms and quality of life of CDG\\\\\\\\\\\\\\\\npatients. We propose to 1) evaluate efficacy and safety of D-galactose supplementation in SLC35A2-CDG, a\\\\\\\\\\\\\\\\ndisorder of hypogalactosylation, using seizure control, quantitative glycomics and validated clinical severity\\\\\\\\\\\\\\\\nscore (NPCRS) as endpoints in a blinded, cross-over study design; 2) assess optimal dosing and long-term\\\\\\\\\\\\\\\\nsafety of D-galactose in PGM1- CDG using validated clinical severity score (TPCRS) and quantitative\\\\\\\\\\\\\\\\nglycomics as endpoints in an open label dose escalation study design and 3) evaluate the safety and effect of\\\\\\\\\\\\\\\\noral GlcNAc supplementation in patients with NGLY1 deficiency on a novel urinary biomarker, seizure control\\\\\\\\\\\\\\\\nand tear secretion, as end points. The proposed clinical trials will fill gaps in the design of upcoming clinical\\\\\\\\\\\\\\\\ntrials in CDG and NGLY1 by establishing initial treatment regimens and clarifying safe dosage for\\\\\\\\\\\\\\\\nmonosaccharide therapies. Deliverables from this study, supported by the natural history study and the\\\\\\\\\\\\\\\\ndiagnostics and biomarker project will increase clinical trial readiness for large-scale Phase 2 and Phase 3\\\\\\\\\\\\\\\\nclinical trials by validating clinical progression scores and patient reported outcomes (Goal Attainment Scale)\\\\\\\\\\\\\\\\nas well as advanced diagnostics and biomarker discoveries., DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/PROJECT SUMMARY Congenital disorders of glycosylation (CDG) have rapidly developed into one of the largest group of metabolic disorders, yet they are poorly described without natural histories, affective treatment, validated biomarkers correlating with disease severity and without comprehensive diagnostic tools. PMM2-CDG and congenital disorders of galactosylation (e.g. SLC35A2-CDG, PGM1-CDG) are the most common N-glycosylation disorders with emerging potential therapies. Congenital disorders of de-glycosylation is a recently discovered group of abnormal glycosylation with a potential noninvasive diagnostic biomarker in NGLY1 deficiency. Some long-known CDG types, like ALG13-CDG however still have no reliable, validated diagnostic methods. Our overall objective and overreaching aim is to develop and validate new biochemical diagnostic techniques and therapeutic biomarkers for future CDG clinical trials. We will overcome the shortcomings of current biochemical techniques and biomarkers in measuring therapeutic efficacy and diagnostics of specific CDG. To address the unmet need and accomplish our overall objective, we will 1) develop and validate biomarkers to monitor therapeutic efficacy in clinical trials for PMM2-CDG; 2) develop quantitative biomarkers to diagnose PGM1-CDG and monitor galactose therapy efficacy; 3) develop quantitative biomarkers to diagnose SLC35A2-CDG and monitor galactose therapy efficacy; 4) validate biomarker to diagnose and follow NGLY1 deficiency and monitor N-acetylglucosamine (GlcNAc) therapy response; 5) validate novel diagnostic biomarkers for ALG13-CDG; 6) qualify and admit new patients to the general CDG population. The impact of this aim on the CDG community is twofold. We will significantly improve diagnostics of patients with CDG, and through improved diagnostics and identification of biomarkers we will increase clinical trial readiness. Achieving these aims should enable us to correlate disease progression and disease severity (Project 1) and their response to therapy (Project 3) with quantifiable biochemical assays. Parallel measurements of the same biomaterial at the different laboratories will not only increase reliability, but will be integral to the validation process and facilitate the process of developing standard biochemical test for diagnosis of the disorders. Such improved diagnostics will be important to assess disease severity and through validation of biochemical outcome measures or biomarkers our efforts will support upcoming clinical trials in CDG. The multiple approaches using state-of-the- art technologies will provide data to assess the overall success of the project. Moreover, the biochemical validations may provide a framework for assessing other emerging or yet-to-be identified glycosylation disorders., DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/PROJECT SUMMARY\\\\\\\\\\\\\\\\nCongenital disorders of glycosylation (CDG) have rapidly developed into one of the largest group of metabolic\\\\\\\\\\\\\\\\ndisorders, yet they are poorly described without natural histories, affective treatment, validated biomarkers\\\\\\\\\\\\\\\\ncorrelating with disease severity and without comprehensive diagnostic tools. PMM2-CDG and congenital disorders\\\\\\\\\\\\\\\\nof galactosylation (e.g. SLC35A2-CDG, PGM1-CDG) are the most common N-glycosylation disorders with\\\\\\\\\\\\\\\\nemerging potential therapies. Congenital disorders of de-glycosylation is a recently discovered group of abnormal\\\\\\\\\\\\\\\\nglycosylation with a potential noninvasive diagnostic biomarker in NGLY1 deficiency. Some long-known CDG types,\\\\\\\\\\\\\\\\nlike ALG13-CDG however still have no reliable, validated diagnostic methods. Our overall objective and\\\\\\\\\\\\\\\\noverreaching aim is to develop and validate new biochemical diagnostic techniques and therapeutic biomarkers for\\\\\\\\\\\\\\\\nfuture CDG clinical trials. We will overcome the shortcomings of current biochemical techniques and biomarkers in\\\\\\\\\\\\\\\\nmeasuring therapeutic efficacy and diagnostics of specific CDG. To address the unmet need and accomplish our\\\\\\\\\\\\\\\\noverall objective, we will 1) develop and validate biomarkers to monitor therapeutic efficacy in clinical trials for\\\\\\\\\\\\\\\\nPMM2-CDG; 2) develop quantitative biomarkers to diagnose PGM1-CDG and monitor galactose therapy efficacy;\\\\\\\\\\\\\\\\n3) develop quantitative biomarkers to diagnose SLC35A2-CDG and monitor galactose therapy efficacy; 4) validate\\\\\\\\\\\\\\\\nbiomarker to diagnose and follow NGLY1 deficiency and monitor N-acetylglucosamine (GlcNAc) therapy response;\\\\\\\\\\\\\\\\n5) validate novel diagnostic biomarkers for ALG13-CDG; 6) qualify and admit new patients to the general CDG\\\\\\\\\\\\\\\\npopulation. The impact of this aim on the CDG community is twofold. We will significantly improve diagnostics of\\\\\\\\\\\\\\\\npatients with CDG, and through improved diagnostics and identification of biomarkers we will increase clinical trial\\\\\\\\\\\\\\\\nreadiness. Achieving these aims should enable us to correlate disease progression and disease severity (Project 1)\\\\\\\\\\\\\\\\nand their response to therapy (Project 3) with quantifiable biochemical assays. Parallel measurements of the same\\\\\\\\\\\\\\\\nbiomaterial at the different laboratories will not only increase reliability, but will be integral to the validation process\\\\\\\\\\\\\\\\nand facilitate the process of developing standard biochemical test for diagnosis of the disorders. Such improved\\\\\\\\\\\\\\\\ndiagnostics will be important to assess disease severity and through validation of biochemical outcome measures\\\\\\\\\\\\\\\\nor biomarkers our efforts will support upcoming clinical trials in CDG. The multiple approaches using state-of-the-\\\\\\\\\\\\\\\\nart technologies will provide data to assess the overall success of the project. Moreover, the biochemical validations\\\\\\\\\\\\\\\\nmay provide a framework for assessing other emerging or yet-to-be identified glycosylation disorders., Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy This study aims to characterize the pathophysiological mechanisms of 21 different metabolic myopathies. The study will focus on exercise capacity and the metabolic derangement during exercise.\",\n          \" Phosphoglucomutase 1 deficiency has recently been reported as a novel disease that belongs to two different classes of metabolic disorders, congenital disorders of glycosylation (CDG) and glycogen storage diseases.This paper focuses on previously reported siblings with short stature, hypothyroidism, increased transaminases, and, in one of them, dilated cardiomyopathy (DCM). An intronic point mutation in the PGM1-gene (c.1145-222 G>T) leads to a complex alternative splicing pattern and to almost complete absence of PGM1 activity.Exercise-induced muscle fatigue, chest pain, and rhabdomyolysis persisted into adulthood. Fainting occurred during the first minutes of strong exercise due to glucose depletion and serum heart troponin was increased. A second wind phenomenon with an improvement in exercise capacity after some minutes of training was observed. Regular aerobic training improved fitness and helped to avoid acute damage. DCM improved during therapy.Glycosylation deficiency was most prominent in childhood. Glycosylation improved with age and further improved with oral galactose supplementation even in adulthood. Optimal improvement of glycosylation-dependent phenotypes should be achieved by early and permanent galactose treatment.However, in case of mutations in ZASP, DCM can develop as a consequence of impaired binding of PGM1 to the heart-specific isoform of ZASP, independently of overall glycosylation efficiency. Thus, even if mutations in PGM1 impair the function of the ZASP-PGM1 complex, supplementation of galactose cannot be expected to restore that function. Therefore, knowledge of PGM1 deficiency in a patient should prompt surveillance of early signs of DCM and specific treatment if necessary.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 148,\n        \"min\": 10,\n        \"max\": 408,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          121,\n          408,\n          14\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"frequent_words\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"congenital disorders of glycosylation , galactose , phosphoglucomutase 1 , hypoglycemia , pgm1\\u2010cdg\",\n          \"congenital disorder of glycosylation , galactose , pgm1-cdg , cdg , phosphoglucomutase 1 deficiency\",\n          \"\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-f702aa3d-abd3-484d-ba90-353c65f4300f\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  &lt;h4&gt;Background&lt;/h4&gt;Congenital disorders of...</td>\n",
              "      <td>[AVTX-801, fucokinase, fcsk, crispr/cas9, cong...</td>\n",
              "      <td>121</td>\n",
              "      <td>congenital disorders of glycosylation , galact...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;h4&gt;Background&lt;/h4&gt;Congenital disorder of gly...</td>\n",
              "      <td>[Sugar, Address, Animal Model, Biochemical Gen...</td>\n",
              "      <td>408</td>\n",
              "      <td>congenital disorder of glycosylation , galacto...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>A 27 year-old Canadian man suffered from fluc...</td>\n",
              "      <td>[glycogen storage disease, whole exome sequenc...</td>\n",
              "      <td>15</td>\n",
              "      <td>congenital disorder of glycosylation , glycoge...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2</td>\n",
              "      <td>Human phosphoglucomutase 1 (PGM1) plays a cen...</td>\n",
              "      <td>[metabolic disease, enzyme mutation, kinetics,...</td>\n",
              "      <td>10</td>\n",
              "      <td>metabolic disease , enzyme mutation , kinetics...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>3</td>\n",
              "      <td>Metabolism not only produces energy necessary...</td>\n",
              "      <td>[glycosylation, induced pluripotent stem cells...</td>\n",
              "      <td>12</td>\n",
              "      <td>glycosylation , induced pluripotent stem cells...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>4</td>\n",
              "      <td>Phosphoglucomutase 1 deficiency has recently ...</td>\n",
              "      <td>[]</td>\n",
              "      <td>12</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>5</td>\n",
              "      <td>Biochemical analysis using biopsied muscle sp...</td>\n",
              "      <td>[]</td>\n",
              "      <td>14</td>\n",
              "      <td></td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-f702aa3d-abd3-484d-ba90-353c65f4300f')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-f702aa3d-abd3-484d-ba90-353c65f4300f button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-f702aa3d-abd3-484d-ba90-353c65f4300f');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-470270db-d791-4b0f-a498-f7a13f591dca\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-470270db-d791-4b0f-a498-f7a13f591dca')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-470270db-d791-4b0f-a498-f7a13f591dca button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_39ec5fc5-27d2-4170-9bd1-091c46d6b8be\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_39ec5fc5-27d2-4170-9bd1-091c46d6b8be button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  <h4>Background</h4>Congenital disorders of...   \n",
              "1          0   <h4>Background</h4>Congenital disorder of gly...   \n",
              "2          1   A 27 year-old Canadian man suffered from fluc...   \n",
              "3          2   Human phosphoglucomutase 1 (PGM1) plays a cen...   \n",
              "4          3   Metabolism not only produces energy necessary...   \n",
              "5          4   Phosphoglucomutase 1 deficiency has recently ...   \n",
              "6          5   Biochemical analysis using biopsied muscle sp...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [AVTX-801, fucokinase, fcsk, crispr/cas9, cong...   121   \n",
              "1  [Sugar, Address, Animal Model, Biochemical Gen...   408   \n",
              "2  [glycogen storage disease, whole exome sequenc...    15   \n",
              "3  [metabolic disease, enzyme mutation, kinetics,...    10   \n",
              "4  [glycosylation, induced pluripotent stem cells...    12   \n",
              "5                                                 []    12   \n",
              "6                                                 []    14   \n",
              "\n",
              "                                      frequent_words  \n",
              "0  congenital disorders of glycosylation , galact...  \n",
              "1  congenital disorder of glycosylation , galacto...  \n",
              "2  congenital disorder of glycosylation , glycoge...  \n",
              "3  metabolic disease , enzyme mutation , kinetics...  \n",
              "4  glycosylation , induced pluripotent stem cells...  \n",
              "5                                                     \n",
              "6                                                     "
            ]
          },
          "execution_count": 100,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "data"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "JgpdlYpugLDb",
        "outputId": "85f41c9d-9913-435d-da8f-b39ce2c9fb28"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "{'Mutation in the BMPER Gene and its Clinical Spectrum': 'The researchers have contributed to our understanding of the clinical spectrum of BMPER gene mutations. They have highlighted the importance of the regular assessment of respiratory failure for successful management of this condition. Their work has expanded our knowledge of the clinical manifestations associated with BMPER gene mutations, particularly in the context of respiratory failure, which is a common and potentially fatal symptom.',\n",
              " 'ISD and DSD as a Spectrum of Severity': 'The researchers have contributed to our understanding of ISD and DSD as a spectrum of severity. They have provided evidence that these disorders represent different manifestations of the same disease process, with ISD being the milder form. Their work has helped to refine our understanding of the clinical spectrum of BMPER-related skeletal disorders.',\n",
              " 'Biallelic BMPER Mutations in ISD': ''}"
            ]
          },
          "execution_count": 38,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "import re\n",
        "\n",
        "def organize_research_expertise(text):\n",
        "    text2=text.lower()\n",
        "    if    'expertise area' in text2:  text_split= text2.split('expertise area')\n",
        "    elif  'expertise_area' in text2:  text_split= text2.split('expertise_area')\n",
        "    else: text_split=text2\n",
        "    if len(text_split)==2:            text=text_split[-1]\n",
        "    text='text_adjustment '+text\n",
        "    expertise_entries = re.split(r'[\\s|n]\\d+[\\.-]', text.strip())[1:]\n",
        "    research_expertise = {}\n",
        "    for idx, entry in enumerate(expertise_entries, start=1):\n",
        "        entry = entry.strip()\n",
        "        split_point = entry.split(\":\")\n",
        "        try:\n",
        "           research_expertise[split_point[0].strip()]= split_point[1].strip().replace('<|end_of_text|>','')\n",
        "        except:\n",
        "           pass\n",
        "    return research_expertise\n",
        "organize_research_expertise(text)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "mXNDzK-g58Dy",
        "outputId": "c250d82d-c2b8-4a6b-d6ab-174f474525e3"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "{}"
            ]
          },
          "execution_count": 190,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "data['Llama_3_n'][i]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 294
        },
        "id": "-GZf0deMiEYw",
        "outputId": "40cfa9dd-c672-4292-be9e-fcc604132c80"
      },
      "outputs": [
        {
          "ename": "ValueError",
          "evalue": "Incompatible indexer with Series",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mValueError\u001b[0m                                Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-191-6e4e5ad47cb5>\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[0;32m----> 1\u001b[0;31m \u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mloc\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m'Llama_3_n'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mdata\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'Llama_3_n'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/pandas/core/indexing.py\u001b[0m in \u001b[0;36m__setitem__\u001b[0;34m(self, key, value)\u001b[0m\n\u001b[1;32m    909\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    910\u001b[0m         \u001b[0miloc\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m \u001b[0;32mif\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mname\u001b[0m \u001b[0;34m==\u001b[0m \u001b[0;34m\"iloc\"\u001b[0m \u001b[0;32melse\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mobj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0miloc\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 911\u001b[0;31m         \u001b[0miloc\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_setitem_with_indexer\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mindexer\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mvalue\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    912\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    913\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0m_validate_key\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mkey\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0maxis\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0mAxisInt\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/pandas/core/indexing.py\u001b[0m in \u001b[0;36m_setitem_with_indexer\u001b[0;34m(self, indexer, value, name)\u001b[0m\n\u001b[1;32m   1940\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mtake_split_path\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1941\u001b[0m             \u001b[0;31m# We have to operate column-wise\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1942\u001b[0;31m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_setitem_with_indexer_split_path\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mindexer\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mvalue\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1943\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1944\u001b[0m             \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_setitem_single_block\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mindexer\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mvalue\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mname\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/pandas/core/indexing.py\u001b[0m in \u001b[0;36m_setitem_with_indexer_split_path\u001b[0;34m(self, indexer, value, name)\u001b[0m\n\u001b[1;32m   1961\u001b[0m             \u001b[0;32mfrom\u001b[0m \u001b[0mpandas\u001b[0m \u001b[0;32mimport\u001b[0m \u001b[0mSeries\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1962\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1963\u001b[0;31m             \u001b[0mvalue\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_align_series\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mindexer\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mSeries\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mvalue\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1964\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1965\u001b[0m         \u001b[0;31m# Ensure we have something we can iterate over\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/pandas/core/indexing.py\u001b[0m in \u001b[0;36m_align_series\u001b[0;34m(self, indexer, ser, multiindex_indexer, using_cow)\u001b[0m\n\u001b[1;32m   2453\u001b[0m             \u001b[0;32mreturn\u001b[0m \u001b[0mser\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mreindex\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0max\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_values\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2454\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 2455\u001b[0;31m         \u001b[0;32mraise\u001b[0m \u001b[0mValueError\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m\"Incompatible indexer with Series\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   2456\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2457\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0m_align_frame\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mindexer\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mdf\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0mDataFrame\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;34m->\u001b[0m \u001b[0mDataFrame\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mValueError\u001b[0m: Incompatible indexer with Series"
          ]
        }
      ],
      "source": [
        "data.loc[i,'Llama_3_n']"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "adxoVJvePJ2f",
        "outputId": "7e94b2ff-6c06-46c1-d5c3-ed2688c46285"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/spacy/util.py:1740: UserWarning: [W111] Jupyter notebook detected: if using `prefer_gpu()` or `require_gpu()`, include it in the same cell right before `spacy.load()` to ensure that the model is loaded on the correct device. More information: http://spacy.io/usage/v3#jupyter-notebook-gpu\n",
            "  warnings.warn(Warnings.W111)\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n",
            " ,  <h4>Background</h4>Congenital disorders of glycosylation (CDG) are a growing group of inherited diseases causing manifold symptoms. Routine diagnostic procedures are high performance liquid chromatography (HPLC) or isoelectric focusing (IEF) of serum transferrin.<h4>Methods</h4>We introduce a modified method to screen for glycosylation abnormalities from dried blood spot (DBS) samples based on isoelectric focusing. In PGM1-CDG, glycosylation analysis and enzyme activity measurement were performed from a single DBS sample. Furthermore, we present the possibility to use capillary blood samples for quantification of transferrin isoforms.<h4>Results</h4>IEF from DBS samples is possible and results are identical to the ones obtained in serum samples. Gel analysis using the ImageJ software allows quantification of IEF results. Storage at -20 °C ensures stable samples for more than six months. Capillary blood samples are equally suitable for glycosylation analysis and show no inferiority to serum samples.<h4>Conclusion</h4>In view of a growing number of treatable CDG subtypes, the proposed methods allow reliable diagnosis and therapy control of CDG while being easily applicable. Capillary blood samples can be taken at home and sent in for follow-up. DBS are widely used in new-born screening programs and have the potential to broaden the knowledge of glycosylation abnormalities in early infancy. By its possible application in the context of alcohol abuse, the proposed method bears the potential for widespread use in a non-metabolic context.,  <h4>Background</h4>FCSK-congenital disorder of glycosylation (FCSK-CDG) is a recently discovered rare autosomal recessive genetic disorder with defective fucosylation due to mutations in the fucokinase encoding gene, FCSK. Despite the essential role of fucokinase in the fucose salvage pathway and severe multisystem manifestations of FCSK-CDG patients, it is not elucidated which cells or which types of fucosylation are affected by its deficiency.<h4>Methods</h4>In this study, CRISPR/Cas9 was employed to construct an FCSK-CDG cell model and explore the molecular mechanisms of the disease by lectin flow cytometry and real-time PCR analyses.<h4>Results</h4>Comparison of cellular fucosylation by lectin flow cytometry in the created CRISPR/Cas9 FCSK knockout and the same unedited cell lines showed no significant change in the amount of cell surface fucosylated glycans, which is consistent with the only documented previous study on different cell types. It suggests a probable effect of this disease on secretory glycoproteins. Investigating O-fucosylation by analysis of the NOTCH3 gene expression as a potential target revealed a significant decrease in the FCSK knockout cells compared with the same unedited ones, proving the effect of fucokinase deficiency on EGF-like repeats O-fucosylation.<h4>Conclusion</h4>This study expands insight into the FCSK-CDG molecular mechanism; to the best of our knowledge, it is the first research conducted to reveal a gene whose expression level alters due to this disease.,  <i>PGM1</i>-linked congenital disorder of glycosylation (PGM1-CDG) is an autosomal recessive disease characterized by several phenotypes, some of which are life-threatening. Research focusing on the disease-related variants of the α-D-phosphoglucomutase 1 (PGM1) protein has shown that several are insoluble in vitro and expressed at low levels in patient fibroblasts. Due to these observations, we hypothesized that some disease-linked PGM1 protein variants are structurally destabilized and subject to protein quality control (PQC) and rapid intracellular degradation. Employing yeast-based assays, we show that a disease-associated human variant, PGM1 L516P, is insoluble, inactive, and highly susceptible to ubiquitylation and rapid degradation by the proteasome. In addition, we show that PGM1 L516P forms aggregates in <i>S. cerevisiae</i> and that both the aggregation pattern and the abundance of PGM1 L516P are chaperone-dependent. Finally, using computational methods, we perform saturation mutagenesis to assess the impact of all possible single residue substitutions in the PGM1 protein. These analyses identify numerous missense variants with predicted detrimental effects on protein function and stability. We suggest that many disease-linked PGM1 variants are subject to PQC-linked degradation and that our in silico site-saturated data set may assist in the mechanistic interpretation of PGM1 variants.,  Background The phosphoglucomutase 1 (PGM1) enzyme plays a central role in glucose homeostasis by catalyzing the inter-conversion of glucose 1-phosphate and glucose 6-phosphate. Recently, PGM1 deficiency has been recognized as a cause of the congenital disorders of glycosylation (CDGs). Methods Two Chinese Han pediatric patients with recurrent hypoglycemia, hepatopathy and growth retardation are described in this study. Targeted gene sequencing (TGS) was performed to screen for causal genetic variants in the genome of the patients and their parents to determine the genetic basis of the phenotype. Results DNA sequencing identified three variations of the PGM1 gene (NM_002633.2). Patient 1 had a novel homozygous mutation (c.119delT, p.Ile40Thrfs*28). In patient 2, we found a compound heterozygous mutation of c.1172G>T(p.Gly391Val) (novel) and c.1507C>T(p.Arg503*) (known pathogenic). Conclusions This report deepens our understanding of the clinical features of PGM1 mutation. The early molecular genetic analysis and multisystem assessment were here found to be essential to the diagnosis of PGM1-CDG and the provision of timely and proper treatment.,  Classical galactosemia is detected through newborn screening by measuring galactose-1-phosphate uridylyltransferase (GALT) in the USA primarily via the Beutler spot assay. We report on an 18-month-old patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency that was originally diagnosed with classical galactosemia. The patient presented with elevated liver function enzymes and bilirubinemia and was immediately treated with soy-based formula. Confirmatory tests revealed deficiency of the GALT enzyme, however, full-sequencing of GALT was normal, suggestive of a different ideology. The Beutler spot assay uses three other enzymatic steps in addition to GALT. A deficiency in either of these enzymes can result in suspected decreased GALT activity when using the Beutler assay. Congenital Disorders of Glycosylation screening for phosphoglucomutase-1 deficiency was negative. Quantitative analysis of G6PD enzyme in red blood cells showed a severe deficiency and a deletion in G6PD. Soy-formula, the standard treatment for galactosemia, has been reported to trigger hemolysis in G6PD deficient patients. G6PD and phosphoglucomutase-1 deficiencies should be considered when confirmatory tests are negative for pathogenic variants in GALT and galactose-1-phosphate level is normal.,  Congenital disorders of glycosylation (CDGs) are caused by defects in genes that participate in biosynthetic glycosylation pathways. To date, 19 different genetic defects in N-glycosylation, 17 in O-glycosylation, and 21 in multiple glycosylation are known. Current diagnostic testing of CDGs largely relies on indirect analysis of glycosylation of serum transferrin. Such analysis alone is insufficient to diagnose many of the known glycosylation disorders. To improve the diagnosis of these groups of CDGs, we have developed serum or plasma N- and O-glycan profiling using a combination of MALDI-TOF/MS and LC-MS/MS technologies. Using this approach, we analyzed samples from nine patients with different known multiple glycosylation disorders, including three with COG deficiencies, one with TMEM165-CDG, two with PGM1-CDG, and three with SLC35A2-CDG, and one patient with combined type I and type II of unknown molecular etiology. Measurement of the relative quantities of various N- and O-glycan species clearly differentiates patients and controls. Our study demonstrates that structural analysis and quantitation of combined N- and O-glycan profiles are reliable diagnostic tools for CDGs.,  Glycogen storage disease type Ib (GSD-Ib) is characterized by impaired glucose homeostasis, neutropenia and neutrophil dysfunction. Mass spectrometric glycomic profiling of GSD-Ib neutrophils showed severely truncated N-glycans, lacking galactose. Experiments indicated the hypoglycosylation of the electron transporting subunit of NADPH oxidase, which is crucial for the defense against bacterial infections. In phosphoglucomutase 1 (PGM1) deficiency, an inherited disorder with an enzymatic defect just one metabolic step ahead, hypogalactosylation can be successfully treated by dietary galactose. We hypothesized the same pathomechanism in GSD-Ib and started a therapeutic trial with oral galactose and uridine. The aim was to improve neutrophil dysfunction through the correction of hypoglycosylation in neutrophils. The GSD-Ib patient was treated for 29weeks. Monitoring included glycomics analysis of the patient's neutrophils and neutrophil function tests including respiratory burst activity, phagocytosis and migration. Although no substantial restoration of neutrophil glycosylation was found, there was partial improvement of respiratory burst activity.,  Glycogen storage diseases (GSDs) are inherited inborn errors of metabolism (IEM) involving carbohydrate metabolism. IEMs are often caused by single gene mutations that encode specific proteins: they are very relevant to pediatrics since these diseases may first manifest themselves in neonates or early childhood. IEMs should be considered in the differential diagnosis of any sick neonate. In general, IEMs result from the lack or insufficient level of specific enzymes that are needed to: (1) convert fat or carbohydrates to energy; (2) breakdown amino acids or other metabolites, allowing them to accumulate and become toxic. GSDs, depending on the specific type, can result from a failure to convert glycogen into energy and/or a toxic glycogen accumulation. All GSDs are due to a failure to use or store glycogen [1]. Glycogen is a branched polymer with its monomeric units being glucose (Figure 1). After a meal, the level of glucose in plasma increases and stimulates the storage of excess glucose in cytoplasmic glycogen spherical. The liver contains the highest percent glycogen by weight (about 10%) whereas muscle can store about 2% by weight. Nevertheless, since the total muscle mass is greater than liver mass, the total mass of glycogen in muscle is about twice that of the liver. When needed, the glycogen polymer can be broken down into glucose monomers and utilized for energy production. Many of the enzymes and transporters for these processes are key to the etiology of GSDs.  An increasing number of GSDs are being identified, but some are very rare. We will review the GSD type 0, 1, 2, 3, 4, 5, and 6 (see Figure 1). In the past, GSDs were also named by the discovering physician, as indicated in Table 1.,  PGM1, the enzyme responsible for the reversible inter-conversion of glucose-1-P and glucose-6-P, is also involved in glycosylation, leading to a wide range of clinical manifestations, such as congenital malformations, hypoglycemia, hormonal dysregulation, myopathy, hepatopathy, and cardiomyopathy. So far, PGM1 deficiency has not been associated with central nervous system involvement or intellectual disability. Seizures and neurologic involvement in PGM1-CDG were thought to be a consequence of hypoglycemia. We reviewed all reported PGM1 deficient patients for the presence of the central nervous system involvement, their treatment and disease history. We detected 17 patients out of the 41 reported PGM1-CDG cases with significant neurologic involvement. Several of these patients had no severe hypoglycemic episodes, or were adequately treated for hypoglycemia with no recurrent episodes of low blood sugars, while one patient had no reported hypoglycemic episodes. We suggest that neurological symptoms are frequent in PGM1-CDG and could present even in the absence of hypoglycemia. The central nervous system should be assessed early on during the diagnostic process to optimize outcome in patients with PGM1-CDG.,  Pediatric hepatology appears to be a very specific field of paediatrics which deals mainly with rare diseases although clinical features can be commonly found - like increased activity of transaminases. Some of these rare diseases like Wilson disease are commonly looked for and recently Wilsonian like phenotypes have been described which additionally presented with abnormal glycosylation of the plasma protein transferrin. In a subgroup of those patients with specific additional clinical symptoms (cleft uvula, low blood sugar, rhabdomyolysis and dilated cardiomyopathy) phosphoglucomutase 1 deficiency was identified. We recommend screening for abnormal glycosylation of the plasma protein transferrin in children with unexplained liver injury.,  Phosphoglucomutase 1 (PGM1) deficiency is a stable characteristic of the erythroleukaemic cell line, K562, whereas the activity of the isozymes of the other two PGM loci (PGM2 and PGM3) is slightly elevated. In this study the molecular basis of PGM1 deficiency was investigated by a combined approach utilising protein electrophoresis, immunodetection, cytogenetic techniques, and DNA and RNA analysis. Isoelectric focusing and activity staining confirmed that K562 has no detectable PGM1 activity. Immunoblot analysis of extracts, separated by isoelectric focusing, starch gel and SDS gel electrophoresis, using monospecific anti-PGM1 antibodies showed that K562 contained no detectable immunoreactive material. Karyotype analysis revealed the presence of two intact chromosomes 1 and a derivative chromosome 1, der(1)t(1;11), each of which carried a copy of the PGM1 gene as demonstrated by fluorescence in situ hybridization using a PGM1 cosmid as probe. Southern blot analysis using a PGM1 cDNA clone as probe suggested that the PGM1 genes had not been subject to any gross structural rearrangements. We were also able to determine that K562 is type PGM1 2+1+ by restriction endonuclease analysis of genomic DNA. Very low levels of PGM1 mRNA which appeared to be full length transcripts were detected in K562 using a reverse transcriptase PCR technique. We conclude that the most likely cause of PGM1 enzyme deficiency in K562 is abnormal regulation of transcription.,  Phosphoglucomutase 1 (PGM1, EC 5.4.2.2) plays a critical role in glucose homeostasis and is also essential for protein N-glycosylation. The main clinical manifestations of PGM1 deficiency (MIM 614921) reported in 19 patients from different ethnic backgrounds include the following: cleft uvula/palate, Pierre Robin sequence, muscle weakness, dilated cardiomyopathy, growth retardation, elevated serum transaminases, hypoglycemia, and various endocrine abnormalities. We report the variable clinical picture of seven patients with PGM1 deficiency from a consanguineous family. Medical records of the patients were reviewed for clinical details and endocrine evaluation. Whole exome sequencing (WES) was performed. Seven patients aged 2-29 years were included, one patient died at 13 years old when getting off the school bus. All patients have an abnormal palatine structure (cleft palate, bifid uvula) and elevated serum transaminases, 4/7 have short stature (<-2 SDS) and one was diagnosed with growth hormone deficiency. Recurrent episodes of ketotic hypoglycemia were present in 6/7 patients. In two patients, hypoglycemic episodes have spontaneously resolved later on. Four out of seven patients have deteriorating adrenal function with abnormally low cortisol and ACTH levels during hypoglycemia and subnormal response of cortisol to low dose ACTH test . Serum electrolytes were within normal range. Hydrocortisone replacement therapy improved, but not entirely eliminated hypoglycemic episodes. WES revealed a previously described homozygous mutation c.112A>T, p.Asn38Tyr in the PGM1 gene. The clinical picture of PGM1 deficiency is variable among patients with the same mutation and genetic background. ACTH deficiency should be considered in any PGM1 deficient patient with hypoglycemia.,  The most common cause of human congenital disorders of glycosylation (CDG) are mutations in the phosphomannomutase gene <i>PMM2,</i> which affect protein <i>N</i>-linked glycosylation. The yeast gene <i>SEC53</i> encodes a homolog of human <i>PMM2</i>. We evolved 384 populations of yeast harboring one of two human-disease-associated alleles, <i>sec53-</i>V238M and <i>sec53</i>-F126L, or wild-type <i>SEC53</i>. We find that after 1000 generations, most populations compensate for the slow-growth phenotype associated with the <i>sec53</i> human-disease-associated alleles. Through whole-genome sequencing we identify compensatory mutations, including known <i>SEC53</i> genetic interactors. We observe an enrichment of compensatory mutations in other genes whose human homologs are associated with Type 1 CDG, including <i>PGM1</i>, which encodes the minor isoform of phosphoglucomutase in yeast. By genetic reconstruction, we show that evolved <i>pgm1</i> mutations are dominant and allele-specific genetic interactors that restore both protein glycosylation and growth of yeast harboring the <i>sec53</i>-V238M allele. Finally, we characterize the enzymatic activity of purified Pgm1 mutant proteins. We find that reduction, but not elimination, of Pgm1 activity best compensates for the deleterious phenotypes associated with the <i>sec53</i>-V238M allele. Broadly, our results demonstrate the power of experimental evolution as a tool for identifying genes and pathways that compensate for human-disease-associated alleles.,  We report a patient diagnosed with PGM1-CDG at 11 years of age after two biallelic likely pathogenic variants in <i>PGM1</i> were found on research genomic sequencing. To our knowledge, he is the first patient with PGM1-CDG to be reported with a restrictive cardiomyopathy. Other clinical manifestations included cleft palate, asymptomatic elevated transaminases, intellectual disability and myopathy resulting in exercise intolerance. He was trialed on oral galactose therapy in increasing doses for 18 weeks to assess if there was any biochemical and clinical benefit. His galactose was continued for a further 9 months beyond the initial galactose treatment period due to improvements in exercise tolerance and myopathy. Treatment with galactose demonstrated an improvement in liver function and myopathy with improved exercise tolerance. Treatment with galactose for 15 months did not change heart function and exercise stress test results were stable.,  We report successful heart transplantation in a phosphoglucomutase 1 deficient (PGM1-CDG) patient. She presented with facial dysmorphism, bifid uvula and structural heart defects. Newborn screening was positive for classic galactosemia. The patient was on a galactose-free diet for 8 months. Eventually, whole exome sequencing excluded the galactosemia and revealed PGM1-CDG. Oral D-galactose therapy was started. Rapid deterioration of the progressive dilated cardiomyopathy prompted heart transplantation at the age of 12 months. Cardiac function was stable in the first 18 months of follow-up, and hematologic, hepatic, and endocrine laboratory findings improved during D-galactose therapy. The latter therapy improves several systemic symptoms and biochemical abnormalities in PGM1-CDG but does not correct the heart failure related to cardiomyopathy. Heart transplantation has so far only been described in DOLK-CDG., A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG) You have been asked to take part in this research study because you have been diagnosed with PGM1-CDG and are currently taking D-galactose., Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life.\n",
            "\n",
            "Baby Detect Project is an innovative NBS program using a panel of target sequencing that aims to identify 126 treatable severe early onset genetic diseases at birth caused by 361 genes. The list of diseases has been established in close collaboration with the Paediatricians of the University Hospital in Liege. The investigators use dedicated dried blood spots collected between the first day and 28 days of life of babies, after a consent sign by parents.\n",
            "{'Screening for Glycosylation Abnormalities from Dried Blood Spot Samples': 'The researchers have developed a modified method to screen for glycosylation abnormalities from dried blood spot (DBS) samples. This method is based on isoelectric focusing and has been shown to be effective in identifying glycosylation abnormalities. Their work demonstrates that DBS samples are suitable for glycosylation analysis and that the results obtained from DBS samples are comparable to those obtained in serum samples. This method is particularly useful for CDG diagnosis as it allows for easy sample collection and storage. Furthermore, the proposed method has the potential for widespread use in a non-metabolic context, such as alcohol abuse screening.\\n\\n###', 'Capillary Blood Samples for Quantification of Transferrin Isoforms': \"The researchers have also shown that capillary blood samples are suitable for quantification of transferrin isoforms and that they show no inferiority to serum samples. This finding is significant as it allows for the collection of capillary blood samples at home, which can be sent in for follow-up testing. This method is particularly useful in the context of CDG diagnosis and therapy control as it allows for easy and non-invasive sample collection. Capillary blood samples are widely used in newborn screening programs, and the researchers' work has the potential to expand the knowledge of glycosylation abnormalities in early infancy.\\n\\n###\", 'Isoelectric Focusing from DBS Samples': 'The researchers have demonstrated that isoelectric focusing from DBS samples is possible and that the results are identical to those obtained in serum samples. They have also shown that gel analysis using the ImageJ software allows quantification of IEF results. This method is particularly useful for CDG diagnosis as it allows for easy sample collection and storage. Furthermore, the proposed method has the potential for widespread use in a non-metabolic context, such as alcohol abuse screening.\\n\\n###', 'Storage of DBS Samples': \"The researchers have shown that storage at -20°C ensures stable samples for more than six months. This finding is significant as it allows for long-term storage of DBS samples for follow-up testing. This method is particularly useful in the context of CDG diagnosis and therapy control as it allows for easy and non-invasive sample collection. Capillary blood samples are widely used in newborn screening programs, and the researchers' work has the potential to expand the knowledge of glycosylation abnormalities in early infancy.\\n\\n###\", 'Capillary Blood Samples for Glycosylation Analysis': \"The researchers have shown that capillary blood samples are suitable for glycosylation analysis and that they show no inferiority to serum samples. This finding is significant as it allows for the collection of capillary blood samples at home, which can be sent in for follow-up testing. This method is particularly useful in the context of CDG diagnosis and therapy control as it allows for easy and non-invasive sample collection. Capillary blood samples are widely used in newborn screening programs, and the researchers' work has the potential to expand the knowledge of glycosylation abnormalities in early infancy.\\n\\n###\", 'Capillary Blood Samples for Glycosylation Analysis and Therapy Control': \"The researchers have shown that capillary blood samples are suitable for glycosylation analysis and therapy control, and that they show no inferiority to serum samples. This finding is significant as it allows for the collection of capillary blood samples at home, which can be sent in for follow-up testing. This method is particularly useful in the context of CDG diagnosis and therapy control as it allows for easy and non-invasive sample collection. Capillary blood samples are widely used in newborn screening programs, and the researchers' work has the potential to expand the knowledge of glycosylation abnormalities in early infancy.\\n\\n### 30\", 'Capillary Blood Samples for Quantification of Transferrin Isoforms and Therapy Control': \"The researchers have also shown that capillary blood samples are suitable for quantification of transferrin isoforms and therapy control, and that they show no inferiority to serum samples. This finding is significant as it allows for the collection of capillary blood samples at home, which can be sent in for follow-up testing. This method is particularly useful in the context of CDG diagnosis and therapy control as it allows for easy and non-invasive sample collection. Capillary blood samples are widely used in newborn screening programs, and the researchers' work has the potential to expand the knowledge of glycosylation abnormalities in early infancy.\\n\\n###\"}\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "<ipython-input-178-4cb58338f99c>:56: FutureWarning: ChainedAssignmentError: behaviour will change in pandas 3.0!\n",
            "You are setting values through chained assignment. Currently this works in certain cases, but when using Copy-on-Write (which will become the default behaviour in pandas 3.0) this will never work to update the original DataFrame or Series, because the intermediate object on which we are setting values will behave as a copy.\n",
            "A typical example is when you are setting values in a column of a DataFrame, like:\n",
            "\n",
            "df[\"col\"][row_indexer] = value\n",
            "\n",
            "Use `df.loc[row_indexer, \"col\"] = values` instead, to perform the assignment in a single step and ensure this keeps updating the original `df`.\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "\n",
            "  data['Llama_3_n'][i] = dic\n",
            "<ipython-input-178-4cb58338f99c>:56: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  data['Llama_3_n'][i] = dic\n"
          ]
        }
      ],
      "source": [
        "from langchain.text_splitter import SpacyTextSplitter\n",
        "import spacy\n",
        "from transformers import AutoTokenizer\n",
        "\n",
        "# Load the language model\n",
        "nlp = spacy.load(\"en_core_web_sm\")\n",
        "\n",
        "# Adjust the max_length parameter if necessary\n",
        "nlp.max_length = 5000000  # Adjust based on your system's available memory\n",
        "\n",
        "# Initialize SpacyTextSplitter with chunk size and overlap\n",
        "splitter = SpacyTextSplitter(chunk_size=5000, chunk_overlap=200)\n",
        "\n",
        "# Initialize the tokenizer\n",
        "tokenizer1 = AutoTokenizer.from_pretrained(\"gpt2\")  # Replace with your tokenizer if using a different model\n",
        "data['Llama_3_n']=None\n",
        "data['Llama_3_n'] = data['Llama_3_n'].astype('object')\n",
        "# Processing text\n",
        "for i in data.index:\n",
        "  if i <1:\n",
        "    print(i)\n",
        "    text = data['Abstract'][i]\n",
        "    if not isinstance(text, str):\n",
        "        continue\n",
        "    n = 0\n",
        "\n",
        "    # Ensure the chunking works properly and limit iterations to avoid infinite loops\n",
        "    while len(tokenizer1.tokenize(text)) > 5000 and n < 10:\n",
        "        # Split text into chunks\n",
        "        chunks = splitter.split_text(text)\n",
        "        text = ''\n",
        "\n",
        "        # Process each chunk individually\n",
        "        for j, chunk in enumerate(chunks):\n",
        "          if j <10:\n",
        "            text += ' ' + Costumized_question_summary(user_query=disease, system_query=chunk)\n",
        "\n",
        "        n += 1\n",
        "\n",
        "    # Apply the custom function for the query\n",
        "    #if data['frequent_words'][i] == '':\n",
        "    user_query= disease\n",
        "    #else:    user_query = data['frequent_words'][i]\n",
        "    print(text)\n",
        "    eval=False\n",
        "    while eval==False:\n",
        "       res = Costumized_question(user_query=user_query, system_query=text)\n",
        "       dic=organize_research_expertise(res)\n",
        "       n,m=0,0\n",
        "       for i in dic:\n",
        "         if len(i) >2: n+=1\n",
        "         if i !='' and dic[i] != '': m+=1\n",
        "         if n>0 and m >=3:  eval=True\n",
        "\n",
        "    print(dic)\n",
        "    data['Llama_3_n'][i] = dic\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "fGgLITYNkuhq",
        "outputId": "e3da8d9e-0742-4015-93a9-31e7c1d83624"
      },
      "outputs": [
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "<ipython-input-165-de3327e54fa3>:2: FutureWarning: ChainedAssignmentError: behaviour will change in pandas 3.0!\n",
            "You are setting values through chained assignment. Currently this works in certain cases, but when using Copy-on-Write (which will become the default behaviour in pandas 3.0) this will never work to update the original DataFrame or Series, because the intermediate object on which we are setting values will behave as a copy.\n",
            "A typical example is when you are setting values in a column of a DataFrame, like:\n",
            "\n",
            "df[\"col\"][row_indexer] = value\n",
            "\n",
            "Use `df.loc[row_indexer, \"col\"] = values` instead, to perform the assignment in a single step and ensure this keeps updating the original `df`.\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "\n",
            "  data['Llama_3_n'][5] = text\n",
            "<ipython-input-165-de3327e54fa3>:2: SettingWithCopyWarning: \n",
            "A value is trying to be set on a copy of a slice from a DataFrame\n",
            "\n",
            "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n",
            "  data['Llama_3_n'][5] = text\n"
          ]
        }
      ],
      "source": [
        "text= {'PGM1 Deficiency and Congenital Disorders of Glycosylation': 'PGM1 deficiency is a recently recognized metabolic disorder that belongs to the group of congenital disorders of glycosylation (CDG). These disorders are characterized by a defect in the glycosylation process, which is essential for the proper functioning of many cellular processes. PGM1 deficiency is caused by mutations in the PGM1 gene, which encodes the enzyme phosphoglucomutase', 'Clinical Features of PGM1 Deficiency': 'The clinical features of PGM1 deficiency can vary depending on the severity of the mutation and the age of onset. Some of the most common clinical features include short stature, hypothyroidism, increased transaminases, and dilated cardiomyopathy (DCM). In one of the reported siblings, DCM was also present, which is a rare finding in CDG. \\n\\n###', 'Exercise-Induced Muscle Fatigue and Rhabdomyolysis': 'The siblings with PGM1 deficiency also experienced exercise-induced muscle fatigue, chest pain, and rhabdomyolysis, which persisted into adulthood. Rhabdomyolysis is a condition where muscle tissue is damaged, leading to the release of muscle fiber contents into the bloodstream, which can cause kidney damage. \\n\\n###', 'Second Wind Phenomenon': \"A second wind phenomenon was observed in the siblings, where their exercise capacity improved after some minutes of training. This may be due to the body's adaptation to the exercise and the increased energy production. \\n\\n###\", 'DCM and PGM1 Deficiency': 'The DCM in one of the siblings was attributed to the PGM1 deficiency, as the mutation in the PGM1 gene leads to a complex alternative splicing pattern and almost complete absence of PGM1 activity. PGM1 is involved in the glycosylation process, and its deficiency can lead to impaired binding of PGM1 to the heart-specific isoform of ZASP, which can cause DCM. \\n\\n###', 'Treatment': 'Glycosylation deficiency was most prominent in childhood, but it improved with age and further improved with oral galactose supplementation even in adulthood. This suggests that early and permanent galactose treatment can help improve the glycosylation-dependent phenotypes of PGM1 deficiency. However, in case of mutations in ZASP, DCM can develop as a consequence of impaired binding of PGM1 to the heart-specific isoform of ZASP, independently of overall glycosylation efficiency. Thus, even if mutations in PGM1 impair the function of the ZASP-PGM1 complex, supplementation of galactose cannot be expected to restore that function. Therefore, knowledge of PGM1 deficiency in a patient should prompt surveillance of early signs of DCM and specific treatment if necessary.'}\n",
        "data['Llama_3_n'][5] = text\n"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "2Xj-GaEmNtXz"
      },
      "source": [
        "# building nodes\n",
        "\n",
        "```\n",
        "# This is formatted as code\n",
        "```\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "vDOrK3KF0U3L"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "4o9Uc0V8zD6k",
        "outputId": "f9d137fc-e821-4850-d5fa-d1ea2fbe49fe"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "['PGM1', 'PGM1-CDG', 'Phosphoglucomutase deficiency', 'PGM1 deficiency', 'CDG']\n"
          ]
        }
      ],
      "source": [
        "def convert_to_list(text):\n",
        "    # Remove the surrounding square brackets and strip any leading/trailing whitespaces\n",
        "    text=text.replace('<|end_of_text|>','')\n",
        "    text = text.strip(\"[]\")\n",
        "    # Split by commas to get individual elements\n",
        "    words = text.split(',')\n",
        "    # Clean each word by stripping extra spaces and quotes\n",
        "    cleaned_words = [word.strip().strip(\"'\\\"\")  for word in words   if word.strip().strip(\"'\\\"\")  !='']\n",
        "    return cleaned_words\n",
        "\n",
        "\n",
        "# Example usage:\n",
        "input_text = \"['congenital disorders of glycosylation', 'galactose', 'congenital disorder of glycosylation', 'pgm1', ''\"\n",
        "input_text = \"['PGM1', 'PGM1-CDG', 'Phosphoglucomutase deficiency', 'PGM1 deficiency', 'CDG']<|end_of_text|>\"\n",
        "#input_text = \"['PGM1', 'PGM1-CDG', 'Phosphogluco\"\n",
        "\n",
        "\n",
        "result = convert_to_list(input_text)\n",
        "print(result)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 366
        },
        "id": "jP1t827nUMIn",
        "outputId": "381d0ad4-09ad-48fc-b437-ea9bc22c1dec"
      },
      "outputs": [
        {
          "ename": "NameError",
          "evalue": "name 'three_most_frequent_terms' is not defined",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mNameError\u001b[0m                                 Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-16-a2f8958b5379>\u001b[0m in \u001b[0;36m<cell line: 20>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     18\u001b[0m \u001b[0mdata\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mresult\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     19\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 20\u001b[0;31m \u001b[0mdata\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'frequent_words'\u001b[0m\u001b[0;34m]\u001b[0m  \u001b[0;34m=\u001b[0m \u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mapply\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;32mlambda\u001b[0m \u001b[0mx\u001b[0m\u001b[0;34m:\u001b[0m  \u001b[0mthree_most_frequent_terms\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mx\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'Terms'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m   \u001b[0;34m,\u001b[0m \u001b[0maxis\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     21\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mi\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mindex\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     22\u001b[0m     \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/core/frame.py\u001b[0m in \u001b[0;36mapply\u001b[0;34m(self, func, axis, raw, result_type, args, by_row, engine, engine_kwargs, **kwargs)\u001b[0m\n\u001b[1;32m  10372\u001b[0m             \u001b[0mkwargs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m  10373\u001b[0m         )\n\u001b[0;32m> 10374\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0mop\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mapply\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m__finalize__\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mmethod\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;34m\"apply\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m  10375\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m  10376\u001b[0m     def map(\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/core/apply.py\u001b[0m in \u001b[0;36mapply\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m    914\u001b[0m             \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mapply_raw\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mengine\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mengine\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mengine_kwargs\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mengine_kwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    915\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 916\u001b[0;31m         \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mapply_standard\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    917\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    918\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0magg\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/core/apply.py\u001b[0m in \u001b[0;36mapply_standard\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m   1061\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0mapply_standard\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1062\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mengine\u001b[0m \u001b[0;34m==\u001b[0m \u001b[0;34m\"python\"\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1063\u001b[0;31m             \u001b[0mresults\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mres_index\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mapply_series_generator\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1064\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1065\u001b[0m             \u001b[0mresults\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mres_index\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mapply_series_numba\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.10/dist-packages/pandas/core/apply.py\u001b[0m in \u001b[0;36mapply_series_generator\u001b[0;34m(self)\u001b[0m\n\u001b[1;32m   1079\u001b[0m             \u001b[0;32mfor\u001b[0m \u001b[0mi\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mv\u001b[0m \u001b[0;32min\u001b[0m \u001b[0menumerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mseries_gen\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1080\u001b[0m                 \u001b[0;31m# ignore SettingWithCopy here in case the user mutates\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1081\u001b[0;31m                 \u001b[0mresults\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m]\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mv\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m*\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1082\u001b[0m                 \u001b[0;32mif\u001b[0m \u001b[0misinstance\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mresults\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mABCSeries\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1083\u001b[0m                     \u001b[0;31m# If we have a view on v, we need to make a copy because\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m<ipython-input-16-a2f8958b5379>\u001b[0m in \u001b[0;36m<lambda>\u001b[0;34m(x)\u001b[0m\n\u001b[1;32m     18\u001b[0m \u001b[0mdata\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mresult\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     19\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 20\u001b[0;31m \u001b[0mdata\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'frequent_words'\u001b[0m\u001b[0;34m]\u001b[0m  \u001b[0;34m=\u001b[0m \u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mapply\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;32mlambda\u001b[0m \u001b[0mx\u001b[0m\u001b[0;34m:\u001b[0m  \u001b[0mthree_most_frequent_terms\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mx\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'Terms'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m   \u001b[0;34m,\u001b[0m \u001b[0maxis\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m1\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     21\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mi\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mdata\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mindex\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     22\u001b[0m     \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mi\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mNameError\u001b[0m: name 'three_most_frequent_terms' is not defined"
          ]
        }
      ],
      "source": [
        "A=['PGM1-CDG','Cerebral cavernous malformations 3',\"CLOVES syndrome\",\"STT3B-CDG\",\"Thoracolaryngopelvic dysplasia\",\"Actinic prurigo\",\"Non-syndromic polydactyly\",\"Genitopatellar syndrome\",\"Diaphanospondylodysostosis\"]\n",
        "B=['GARD0004329','GARD0018314',\"GARD0010939\",\"GARD0017603\",\"GARD0005184\", \"GARD0017510\",\"GARD0004410\",\"GARD0010994\",\"GARD0016674\"]\n",
        "#for n in range(len(A)):\n",
        "disease= A[0]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid=B[0] #'GARD0017510'\n",
        "\n",
        "\n",
        "concatenated_data= merge_community_detection_and_researchers_info(disease)\n",
        "# Assuming you have a DataFrame `clustering_2`\n",
        "clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', num_clusters=10, n_components=100)\n",
        "# Group by 'Community' and aggregate columns using sum_strings and sum_terms functions\n",
        "result = clustering_.groupby('Community').agg(\n",
        "    Abstract=('Abstract', sum_strings),\n",
        "    Terms=('Terms', sum_terms),\n",
        "    Size=('Community', 'size')  # Count of occurrences\n",
        ").reset_index()\n",
        "\n",
        "data=result\n",
        "\n",
        "data['frequent_words']  = data.apply(lambda x:  three_most_frequent_terms(x['Terms'])   , axis=1)\n",
        "\n",
        "# Processing text\n",
        "for i in data.index:\n",
        "    print(i)\n",
        "    text = data['Abstract'][i]\n",
        "    if not isinstance(text, str):\n",
        "        continue\n",
        "    n = 0\n",
        "\n",
        "    # Ensure the chunking works properly and limit iterations to avoid infinite loops\n",
        "    while len(tokenizer1.tokenize(text)) > 5000 and n < 10:\n",
        "        # Split text into chunks\n",
        "        chunks = splitter.split_text(text)\n",
        "        text = ''\n",
        "\n",
        "        # Process each chunk individually\n",
        "        for j, chunk in enumerate(chunks):\n",
        "          if j <10:\n",
        "            text += ' ' + Costumized_question_summary(user_query=disease, system_query=chunk)\n",
        "\n",
        "        n += 1\n",
        "\n",
        "    # Apply the custom function for the query\n",
        "    #if data['frequent_words'][i] == '':\n",
        "    user_query= disease\n",
        "    #else:    user_query = data['frequent_words'][i]\n",
        "    print(text)\n",
        "    eval=False\n",
        "    while eval==False:\n",
        "       res = Costumized_question(user_query=user_query, system_query=text[:5000])\n",
        "       dic=organize_research_expertise(res)\n",
        "       n,m=0,0\n",
        "       for i in dic:\n",
        "         if len(i) >2: n+=1\n",
        "         if i !='' and dic[i] != '': m+=1\n",
        "         if n>0 and m >=3:  eval=True\n",
        "\n",
        "    print(dic)\n",
        "    data['Llama_3_n'][i] = dic\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "ZVT4MLIAtD_R",
        "outputId": "08338c86-cd6a-4ba8-820c-9ba7cee17449"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "1\n",
            "1\n",
            "1\n",
            "1\n",
            "1\n"
          ]
        }
      ],
      "source": [
        "\n",
        "\n",
        "if data['Llama_3_n'][1]:  # If 'Key_trems' exists in properties\n",
        "            dic_expertise= data['Llama_3_n'][1]# Convert to list of expertise terms\n",
        "            for sentence in dic_expertise:\n",
        "              if (sentence!= '') and (sentence.lower() != disease.lower()) and (dic_expertise[sentence]!=''):\n",
        "                         print(1)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 390
        },
        "id": "l41UJByPxWQb",
        "outputId": "17d42d2a-6c15-4f72-e001-c22d27ddbd4d"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 7,\n  \"fields\": [\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 2,\n        \"min\": -1,\n        \"max\": 5,\n        \"num_unique_values\": 7,\n        \"samples\": [\n          -1,\n          0,\n          4\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 7,\n        \"samples\": [\n          \" ,  <h4>Background</h4>Congenital disorders of glycosylation (CDG) are a growing group of inherited diseases causing manifold symptoms. Routine diagnostic procedures are high performance liquid chromatography (HPLC) or isoelectric focusing (IEF) of serum transferrin.<h4>Methods</h4>We introduce a modified method to screen for glycosylation abnormalities from dried blood spot (DBS) samples based on isoelectric focusing. In PGM1-CDG, glycosylation analysis and enzyme activity measurement were performed from a single DBS sample. Furthermore, we present the possibility to use capillary blood samples for quantification of transferrin isoforms.<h4>Results</h4>IEF from DBS samples is possible and results are identical to the ones obtained in serum samples. Gel analysis using the ImageJ software allows quantification of IEF results. Storage at -20\\u202f\\u00b0C ensures stable samples for more than six months. Capillary blood samples are equally suitable for glycosylation analysis and show no inferiority to serum samples.<h4>Conclusion</h4>In view of a growing number of treatable CDG subtypes, the proposed methods allow reliable diagnosis and therapy control of CDG while being easily applicable. Capillary blood samples can be taken at home and sent in for follow-up. DBS are widely used in new-born screening programs and have the potential to broaden the knowledge of glycosylation abnormalities in early infancy. By its possible application in the context of alcohol abuse, the proposed method bears the potential for widespread use in a non-metabolic context.,  <h4>Background</h4>FCSK-congenital disorder of glycosylation (FCSK-CDG) is a recently discovered rare autosomal recessive genetic disorder with defective fucosylation due to mutations in the fucokinase encoding gene, FCSK. Despite the essential role of fucokinase in the fucose salvage pathway and severe multisystem manifestations of FCSK-CDG patients, it is not elucidated which cells or which types of fucosylation are affected by its deficiency.<h4>Methods</h4>In this study, CRISPR/Cas9 was employed to construct an FCSK-CDG cell model and explore the molecular mechanisms of the disease by lectin flow cytometry and real-time PCR analyses.<h4>Results</h4>Comparison of cellular fucosylation by lectin flow cytometry in the created CRISPR/Cas9 FCSK knockout and the same unedited cell lines showed no significant change in the amount of cell surface fucosylated glycans, which is consistent with the only documented previous study on different cell types. It suggests a probable effect of this disease on secretory glycoproteins. Investigating O-fucosylation by analysis of the NOTCH3 gene expression as a potential target revealed a significant decrease in the FCSK knockout cells compared with the same unedited ones, proving the effect of fucokinase deficiency on EGF-like repeats O-fucosylation.<h4>Conclusion</h4>This study expands insight into the FCSK-CDG molecular mechanism; to the best of our knowledge, it is the first research conducted to reveal a gene whose expression level alters due to this disease.,  <i>PGM1</i>-linked congenital disorder of glycosylation (PGM1-CDG) is an autosomal recessive disease characterized by several phenotypes, some of which are life-threatening. Research focusing on the disease-related variants of the \\u03b1-D-phosphoglucomutase 1 (PGM1) protein has shown that several are insoluble in vitro and expressed at low levels in patient fibroblasts. Due to these observations, we hypothesized that some disease-linked PGM1 protein variants are structurally destabilized and subject to protein quality control (PQC) and rapid intracellular degradation. Employing yeast-based assays, we show that a disease-associated human variant, PGM1 L516P, is insoluble, inactive, and highly susceptible to ubiquitylation and rapid degradation by the proteasome. In addition, we show that PGM1 L516P forms aggregates in <i>S. cerevisiae</i> and that both the aggregation pattern and the abundance of PGM1 L516P are chaperone-dependent. Finally, using computational methods, we perform saturation mutagenesis to assess the impact of all possible single residue substitutions in the PGM1 protein. These analyses identify numerous missense variants with predicted detrimental effects on protein function and stability. We suggest that many disease-linked PGM1 variants are subject to PQC-linked degradation and that our in silico site-saturated data set may assist in the mechanistic interpretation of PGM1 variants.,  Background The phosphoglucomutase 1 (PGM1) enzyme plays a central role in glucose homeostasis by catalyzing the inter-conversion of glucose 1-phosphate and glucose 6-phosphate. Recently, PGM1 deficiency has been recognized as a cause of the congenital disorders of glycosylation (CDGs). Methods Two Chinese Han pediatric patients with recurrent hypoglycemia, hepatopathy and growth retardation are described in this study. Targeted gene sequencing (TGS) was performed to screen for causal genetic variants in the genome of the patients and their parents to determine the genetic basis of the phenotype. Results DNA sequencing identified three variations of the PGM1 gene (NM_002633.2). Patient 1 had a novel homozygous mutation (c.119delT, p.Ile40Thrfs*28). In patient 2, we found a compound heterozygous mutation of c.1172G>T(p.Gly391Val) (novel) and c.1507C>T(p.Arg503*) (known pathogenic). Conclusions This report deepens our understanding of the clinical features of PGM1 mutation. The early molecular genetic analysis and multisystem assessment were here found to be essential to the diagnosis of PGM1-CDG and the provision of timely and proper treatment.,  Classical galactosemia is detected through newborn screening by measuring galactose-1-phosphate uridylyltransferase (GALT) in the USA primarily via the Beutler spot assay. We report on an 18-month-old patient with glucose-6-phosphate dehydrogenase (G6PD) deficiency that was originally diagnosed with classical galactosemia. The patient presented with elevated liver function enzymes and bilirubinemia and was immediately treated with soy-based formula. Confirmatory tests revealed deficiency of the GALT enzyme, however, full-sequencing of GALT was normal, suggestive of a different ideology. The Beutler spot assay uses three other enzymatic steps in addition to GALT. A deficiency in either of these enzymes can result in suspected decreased GALT activity when using the Beutler assay. Congenital Disorders of Glycosylation screening for phosphoglucomutase-1 deficiency was negative. Quantitative analysis of G6PD enzyme in red blood cells showed a severe deficiency and a deletion in G6PD. Soy-formula, the standard treatment for galactosemia, has been reported to trigger hemolysis in G6PD deficient patients. G6PD and phosphoglucomutase-1 deficiencies should be considered when confirmatory tests are negative for pathogenic variants in GALT and galactose-1-phosphate level is normal.,  Congenital disorders of glycosylation (CDGs) are caused by defects in genes that participate in biosynthetic glycosylation pathways. To date, 19 different genetic defects in N-glycosylation, 17 in O-glycosylation, and 21 in multiple glycosylation are known. Current diagnostic testing of CDGs largely relies on indirect analysis of glycosylation of serum transferrin. Such analysis alone is insufficient to diagnose many of the known glycosylation disorders. To improve the diagnosis of these groups of CDGs, we have developed serum or plasma N- and O-glycan profiling using a combination of MALDI-TOF/MS and LC-MS/MS technologies. Using this approach, we analyzed samples from nine patients with different known multiple glycosylation disorders, including three with COG deficiencies, one with TMEM165-CDG, two with PGM1-CDG, and three with SLC35A2-CDG, and one patient with combined type I and type II of unknown molecular etiology. Measurement of the relative quantities of various N- and O-glycan species clearly differentiates patients and controls. Our study demonstrates that structural analysis and quantitation of combined N- and O-glycan profiles are reliable diagnostic tools for CDGs.,  Glycogen storage disease type Ib (GSD-Ib) is characterized by impaired glucose homeostasis, neutropenia and neutrophil dysfunction. Mass spectrometric glycomic profiling of GSD-Ib neutrophils showed severely truncated N-glycans, lacking galactose. Experiments indicated the hypoglycosylation of the electron transporting subunit of NADPH oxidase, which is crucial for the defense against bacterial infections. In phosphoglucomutase 1 (PGM1) deficiency, an inherited disorder with an enzymatic defect just one metabolic step ahead, hypogalactosylation can be successfully treated by dietary galactose. We hypothesized the same pathomechanism in GSD-Ib and started a therapeutic trial with oral galactose and uridine. The aim was to improve neutrophil dysfunction through the correction of hypoglycosylation in neutrophils. The GSD-Ib patient was treated for 29weeks. Monitoring included glycomics analysis of the patient's neutrophils and neutrophil function tests including respiratory burst activity, phagocytosis and migration. Although no substantial restoration of neutrophil glycosylation was found, there was partial improvement of respiratory burst activity.,  Glycogen storage diseases (GSDs) are inherited inborn errors of metabolism (IEM) involving carbohydrate metabolism. IEMs are often caused by single gene mutations that encode specific proteins: they are very relevant to pediatrics since these diseases may first manifest themselves in neonates or early childhood. IEMs should be considered in the differential diagnosis of any sick neonate. In general, IEMs result from the lack or insufficient level of specific enzymes that are needed to: (1) convert fat or carbohydrates to energy; (2) breakdown amino acids or other metabolites, allowing them to accumulate and become toxic. GSDs, depending on the specific type, can result from a failure to convert glycogen into energy and/or\\u00a0a toxic glycogen accumulation. All GSDs are due to a failure to use or store glycogen [1]. Glycogen is a branched polymer with its monomeric units being glucose (Figure 1). After a meal, the level of glucose in plasma increases and stimulates the storage of excess glucose in cytoplasmic glycogen spherical. The liver contains the highest percent glycogen by weight (about 10%) whereas muscle can store about 2% by weight. Nevertheless, since the total muscle mass is greater than liver mass, the total mass of glycogen in muscle is about twice that of the liver. When needed, the glycogen polymer can be broken down into glucose monomers and utilized for energy production. Many of the enzymes and transporters for these processes are key to the etiology of GSDs.\\u00a0 An increasing number of GSDs are being identified, but some are very rare. We will review the GSD type 0, 1, 2, 3, 4, 5, and 6 (see Figure 1). In the past, GSDs were also named by the discovering physician, as indicated in Table 1.,  PGM1, the enzyme responsible for the reversible inter-conversion of glucose-1-P and glucose-6-P, is also involved in glycosylation, leading to a wide range of clinical manifestations, such as congenital malformations, hypoglycemia, hormonal dysregulation, myopathy, hepatopathy, and cardiomyopathy. So far, PGM1 deficiency has not been associated with central nervous system involvement or intellectual disability. Seizures and neurologic involvement in PGM1-CDG were thought to be a consequence of hypoglycemia. We reviewed all reported PGM1 deficient patients for the presence of the central nervous system involvement, their treatment and disease history. We detected 17 patients out of the 41 reported PGM1-CDG cases with significant neurologic involvement. Several of these patients had no severe hypoglycemic episodes, or were adequately treated for hypoglycemia with no recurrent episodes of low blood sugars, while one patient had no reported hypoglycemic episodes. We suggest that neurological symptoms are frequent in PGM1-CDG and could present even in the absence of hypoglycemia. The central nervous system should be assessed early on during the diagnostic process to optimize outcome in patients with PGM1-CDG.,  Pediatric hepatology appears to be a very specific field of paediatrics which deals mainly with rare diseases although clinical features can be commonly found - like increased activity of transaminases. Some of these rare diseases like Wilson disease are commonly looked for and recently Wilsonian like phenotypes have been described which additionally presented with abnormal glycosylation of the plasma protein transferrin. In a subgroup of those patients with specific additional clinical symptoms (cleft uvula, low blood sugar, rhabdomyolysis and dilated cardiomyopathy) phosphoglucomutase 1 deficiency was identified. We recommend screening for abnormal glycosylation of the plasma protein transferrin in children with unexplained liver injury.,  Phosphoglucomutase 1 (PGM1) deficiency is a stable characteristic of the erythroleukaemic cell line, K562, whereas the activity of the isozymes of the other two PGM loci (PGM2 and PGM3) is slightly elevated. In this study the molecular basis of PGM1 deficiency was investigated by a combined approach utilising protein electrophoresis, immunodetection, cytogenetic techniques, and DNA and RNA analysis. Isoelectric focusing and activity staining confirmed that K562 has no detectable PGM1 activity. Immunoblot analysis of extracts, separated by isoelectric focusing, starch gel and SDS gel electrophoresis, using monospecific anti-PGM1 antibodies showed that K562 contained no detectable immunoreactive material. Karyotype analysis revealed the presence of two intact chromosomes 1 and a derivative chromosome 1, der(1)t(1;11), each of which carried a copy of the PGM1 gene as demonstrated by fluorescence in situ hybridization using a PGM1 cosmid as probe. Southern blot analysis using a PGM1 cDNA clone as probe suggested that the PGM1 genes had not been subject to any gross structural rearrangements. We were also able to determine that K562 is type PGM1 2+1+ by restriction endonuclease analysis of genomic DNA. Very low levels of PGM1 mRNA which appeared to be full length transcripts were detected in K562 using a reverse transcriptase PCR technique. We conclude that the most likely cause of PGM1 enzyme deficiency in K562 is abnormal regulation of transcription.,  Phosphoglucomutase 1 (PGM1, EC 5.4.2.2) plays a critical role in glucose homeostasis and is also essential for protein N-glycosylation. The main clinical manifestations of PGM1 deficiency (MIM 614921) reported in 19 patients from different ethnic backgrounds include the following: cleft uvula/palate, Pierre Robin sequence, muscle weakness, dilated cardiomyopathy, growth retardation, elevated serum transaminases, hypoglycemia, and various endocrine abnormalities. We report the variable clinical picture of seven patients with PGM1 deficiency from a consanguineous family. Medical records of the patients were reviewed for clinical details and endocrine evaluation. Whole exome sequencing (WES) was performed. Seven patients aged 2-29 years were included, one patient died at 13 years old when getting off the school bus. All patients have an abnormal palatine structure (cleft palate, bifid uvula) and elevated serum transaminases, 4/7 have short stature (<-2 SDS) and one was diagnosed with growth hormone deficiency. Recurrent episodes of ketotic hypoglycemia were present in 6/7 patients. In two patients, hypoglycemic episodes have spontaneously resolved later on. Four out of seven patients have deteriorating adrenal function with abnormally low cortisol and ACTH levels during hypoglycemia and subnormal response of cortisol to low dose ACTH test . Serum electrolytes were within normal range. Hydrocortisone replacement therapy improved, but not entirely eliminated hypoglycemic episodes. WES revealed a previously described homozygous mutation c.112A>T, p.Asn38Tyr in the PGM1 gene. The clinical picture of PGM1 deficiency is variable among patients with the same mutation and genetic background. ACTH deficiency should be considered in any PGM1 deficient patient with hypoglycemia.,  The most common cause of human congenital disorders of glycosylation (CDG) are mutations in the phosphomannomutase gene <i>PMM2,</i> which affect protein <i>N</i>-linked glycosylation. The yeast gene <i>SEC53</i> encodes a homolog of human <i>PMM2</i>. We evolved 384 populations of yeast harboring one of two human-disease-associated alleles, <i>sec53-</i>V238M and <i>sec53</i>-F126L, or wild-type <i>SEC53</i>. We find that after 1000 generations, most populations compensate for the slow-growth phenotype associated with the <i>sec53</i> human-disease-associated alleles. Through whole-genome sequencing we identify compensatory mutations, including known <i>SEC53</i> genetic interactors. We observe an enrichment of compensatory mutations in other genes whose human homologs are associated with Type 1 CDG, including <i>PGM1</i>, which encodes the minor isoform of phosphoglucomutase in yeast. By genetic reconstruction, we show that evolved <i>pgm1</i> mutations are dominant and allele-specific genetic interactors that restore both protein glycosylation and growth of yeast harboring the <i>sec53</i>-V238M allele. Finally, we characterize the enzymatic activity of purified Pgm1 mutant proteins. We find that reduction, but not elimination, of Pgm1 activity best compensates for the deleterious phenotypes associated with the <i>sec53</i>-V238M allele. Broadly, our results demonstrate the power of experimental evolution as a tool for identifying genes and pathways that compensate for human-disease-associated alleles.,  We report a patient diagnosed with PGM1-CDG at 11\\u2009years of age after two biallelic likely pathogenic variants in <i>PGM1</i> were found on research genomic sequencing. To our knowledge, he is the first patient with PGM1-CDG to be reported with a restrictive cardiomyopathy. Other clinical manifestations included cleft palate, asymptomatic elevated transaminases, intellectual disability and myopathy resulting in exercise intolerance. He was trialed on oral galactose therapy in increasing doses for 18\\u2009weeks to assess if there was any biochemical and clinical benefit. His galactose was continued for a further 9\\u2009months beyond the initial galactose treatment period due to improvements in exercise tolerance and myopathy. Treatment with galactose demonstrated an improvement in liver function and myopathy with improved exercise tolerance. Treatment with galactose for 15\\u2009months did not change heart function and exercise stress test results were stable.,  We report successful heart transplantation in a phosphoglucomutase 1 deficient (PGM1-CDG) patient. She presented with facial dysmorphism, bifid uvula and structural heart defects. Newborn screening was positive for classic galactosemia. The patient was on a galactose-free diet for 8\\u2009months. Eventually, whole exome sequencing excluded the galactosemia and revealed PGM1-CDG. Oral D-galactose therapy was started. Rapid deterioration of the progressive dilated cardiomyopathy prompted heart transplantation at the age of 12\\u2009months. Cardiac function was stable in the first 18\\u2009months of follow-up, and hematologic, hepatic, and endocrine laboratory findings improved during D-galactose therapy. The latter therapy improves several systemic symptoms and biochemical abnormalities in PGM1-CDG but does not correct the heart failure related to cardiomyopathy. Heart transplantation has so far only been described in DOLK-CDG., A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Crossover, Trial Assessing the Efficacy, Safety, and Tolerability of AVTX-801 in Subjects With Phosphoglucomutase 1 Deficiency Related Congenital Disorders of Glycosylation (PGM1-CDG) You have been asked to take part in this research study because you have been diagnosed with PGM1-CDG and are currently taking D-galactose., Universal Genomic Newborn Screening in the Wallonia-Brussels Federation: Baby Detect Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple blood test, rare genetic conditions can be easily detected, and the early start of transformative treatment will help avoid severe disabilities and increase the quality of life.\\n\\nBaby Detect Project is an innovative NBS program using a panel of target sequencing that aims to identify 126 treatable severe early onset genetic diseases at birth caused by 361 genes. The list of diseases has been established in close collaboration with the Paediatricians of the University Hospital in Liege. The investigators use dedicated dried blood spots collected between the first day and 28 days of life of babies, after a consent sign by parents.\",\n          \" <h4>Background</h4>Congenital disorder of glycosylation (CDG) and Glycogen storage diseases (GSDs) are inborn metabolic disorders caused by defects in some metabolic pathways. These disorders are a heterogeneous group of diseases caused by impaired O- as well as N-glycosylation pathways. CDG patients show a broad spectrum of clinical presentations; many GSD types (PGM1-CDG) have muscle involvement and hypoglycemia.<h4>Methods</h4>We applied WES for all seven patients presenting GSD and CDG symptoms. Then we analyzed the data using various tools to predict pathogenic variants in genes related to the patients' diseases.<h4>Results</h4>In the present study, we identified pathogenic variants in Iranian patients suffering from GSD and CDG, which can be helpful for patient management, and family counseling. We detected seven pathogenic variants using whole exome sequencing (WES) in known AGL (c.1998A>G, c.3635T>C, c.3682C>T), PGM1 (c.779G>A), DPM1 (c.742T>C), RFT1 (c.127A>G), and GAA (c.1314C>A) genes.<h4>Conclusion</h4>The suspected clinical diagnosis of CDG and GSD patients was confirmed by identifying missense and or nonsense mutations in PGM1, DPM1, RFT1, GAA, and AGL genes by WES of all 7 cases. This study helps us understand the scenario of the disorder causes and consider the variants for quick disease diagnosis.,  <h4>Background</h4>Congenital disorders of glycosylation (CDG) result from defects in the synthesis of glycans and the attachment of glycans to proteins and lipids. Our study aimed to describe the clinical, biochemical, and molecular findings of CDG patients, and to present the long-term follow-up.<h4>Material and methods</h4>A single-center study (1995-2019\\u00a0years) of patients with congenital disorders of N-glycosylation and combined N- and O-hypoglycosylation was performed.<h4>Results</h4>Among 32 patients included into the study, there were 12 PMM2-CDG, 3 ALG13-CDG, 3 ALG1-CDG, 1 ALG3-CDG, 3 MPI-CDG, 1 PGM1-CDG, 4 SRD5A3-CDG, 1 DPAGT1-CDG, 3 ATP6AP1-CDG, 1 ATP6V0A2-CDG. The phenotypic and genotypic spectrum during long-term (in some cases over 20\\u00a0years) observation was characterised and several measurements of serum Tf isoforms taken. Statistical analysis revealed strong negative correlation between asialo-Tf and tetrasialo-Tf, as well as between disialo-Tf and tetrasialo-Tf. Within CDG type I, no difference in % Tf isoforms was revealed between PMM2-CDG and non-PMM2-CDG patients. However, these two groups differed significantly in such diagnostic features as: cerebellar ataxia, failure to thrive, hypothyroidism, pericardial effusion, cardiomyopathy, inverted nipples, prolonged INR. The effect of treatment with mannose in 2 patients with MPI-CDG was assessed and we found that % of asialo-Tf, monosialo-Tf, and disialo-Tf was significantly lowered, whereas tetrasialo-Tf and pentasialo-Tf rose, coming closer or falling into the reference range.<h4>Conclusions</h4>The novel finding was an abnormal Tf IEF pattern in two ALG13-CDG patients and normal in one ALG1-CDG patient. Clinical manifestation of presented CDG patients was similar to that reported in the literature. Mannose supplementation in MPI-CDG patients, as well as galactose supplementation in PGM1-CDG patient, improved patients' clinical picture and Tf isoform profiles.,  <h4>Background</h4>Congenital disorders of glycosylation (CDG) result from defects in the synthesis of glycans and their attachment to proteins and lipids. Histologically, liver steatosis, fibrosis and cirrhosis have been reported in CDG. The aim of the study was to characterize the histopathological and ultrastructural liver changes in CDG patients hospitalized in our Institute, and to find the most characteristic features, as articles concerning the liver microscopic features in CDG are sparse.<h4>Methods</h4>Out of 32 CDG patients diagnosed and followed-up in our Institute, the liver biopsy was performed in 4 of them, including 2 with MPI-CDG, 1 with SRD5A3-CDG, and 1 with PGM1-CDG, as a part of diagnostic process. In one patient, diagnosed post mortem with PMM2-CDG, the histopathological study comprised liver autopsy samples.<h4>Results</h4>The most common histopathological liver finding was the presence of steatosis (4/5) of varying severity, the mixed macro- and microvesicular type as well as the foamy degeneration of hepatocytes. In two patients, liver steatosis was associated with fibrosis, stage 4 (cirrhosis) and 2 according to Batts and Ludwig classification, respectively. In two patients, besides steatosis, mild inflammatory infiltrates composed of lymphoid cells in portal tracts were observed. No correlation between the patient's age and histopathological features was observed.<h4>Conclusions</h4>The histopathological changes in the liver of CDG patients are miscellaneous; thus, based on the microscopic examination only, we can not identify (even suspect) the exact CDG. The most common histopathologic finding in our cohort of CDG patients was the presence of liver steatosis (of various severity) and foamy degeneration of hepatocytes.,  <h4>Background</h4>Congenital disorders of glycosylation are genetic syndromes that result in impaired glycoprotein production. We evaluated patients who had a novel recessive disorder of glycosylation, with a range of clinical manifestations that included hepatopathy, bifid uvula, malignant hyperthermia, hypogonadotropic hypogonadism, growth retardation, hypoglycemia, myopathy, dilated cardiomyopathy, and cardiac arrest.<h4>Methods</h4>Homozygosity mapping followed by whole-exome sequencing was used to identify a mutation in the gene for phosphoglucomutase 1 (PGM1) in two siblings. Sequencing identified additional mutations in 15 other families. Phosphoglucomutase 1 enzyme activity was assayed on cell extracts. Analyses of glycosylation efficiency and quantitative studies of sugar metabolites were performed. Galactose supplementation in fibroblast cultures and dietary supplementation in the patients were studied to determine the effect on glycosylation.<h4>Results</h4>Phosphoglucomutase 1 enzyme activity was markedly diminished in all patients. Mass spectrometry of transferrin showed a loss of complete N-glycans and the presence of truncated glycans lacking galactose. Fibroblasts supplemented with galactose showed restoration of protein glycosylation and no evidence of glycogen accumulation. Dietary supplementation with galactose in six patients resulted in changes suggestive of clinical improvement. A new screening test showed good discrimination between patients and controls.<h4>Conclusions</h4>Phosphoglucomutase 1 deficiency, previously identified as a glycogenosis, is also a congenital disorder of glycosylation. Supplementation with galactose leads to biochemical improvement in indexes of glycosylation in cells and patients, and supplementation with complex carbohydrates stabilizes blood glucose. A new screening test has been developed but has not yet been validated. (Funded by the Netherlands Organization for Scientific Research and others.).,  <h4>Context</h4>Phosphoglucomutase type 1 (PGM1) deficiency is a rare metabolic myopathy in which symptoms are provoked by exercise.<h4>Objective</h4>Because the metabolic block is proximal to the entry of glucose into the glycolytic pathway, we hypothesized that iv glucose could improve the exercise intolerance experienced by the patient.<h4>Design</h4>This was an experimental intervention study.<h4>Setting</h4>The study was conducted in an exercise laboratory.<h4>Subjects</h4>Subjects were a 37-year-old man with genetically and biochemically verified PGM1 deficiency and 6 healthy subjects.<h4>Interventions</h4>Cycle ergometer, peak and submaximal exercise (70% of peak oxygen consumption), and exercise with an iv glucose infusion tests were performed.<h4>Main outcome measures</h4>Peak work capacity and substrate metabolism during submaximal exercise with and without an iv glucose infusion were measured.<h4>Results</h4>Peak work capacity in the patient was normal, as were increases in plasma lactate during peak and submaximal exercise. However, the heart rate decreased 11 beats minute\\u207b\\u00b9, the peak work rate increased 12.5%, and exercise was rated as being easier with glucose infusion in the patient. These results were in contrast to those in the control group, in whom no improvements occurred. In addition, the patient tended to become hypoglycemic during submaximal exercise.<h4>Conclusions</h4>This report characterizes PGM1 deficiency as a mild metabolic myopathy that has dynamic exercise-related symptoms in common with McArdle disease but no second wind phenomenon, thus suggesting that the condition clinically resembles other partial enzymatic defects of glycolysis. However, with glucose infusion, the heart rate decreased 11 beats min\\u207b\\u00b9, the peak work rate increased 12.5%, and exercise was considered easier by the patient.,  <h4>Introduction</h4>Congenital disorders of glycosylation (CDG) are a continuously expanding group of monogenic disorders that disrupt glycoprotein and glycolipid biosynthesis, leading to multi-systemic manifestations. These disorders are categorized into various groups depending on which part of the glycosylation process is impaired. The cardiac manifestations in CDG can significantly differ, not only across different types but also among individuals with the same genetic cause of CDG. Cardiomyopathy is an important phenotype in CDG. The clinical manifestations and progression of cardiomyopathy in CDG patients have not been well characterized. This study aims to delineate common patterns of cardiomyopathy across a range of genetic causes of CDG and to propose baseline screening and follow-up evaluation for this patient population.<h4>Methods</h4>Patients with molecular confirmation of CDG who were enrolled in the prospective or memorial arms of the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC) natural history study were ascertained for the presence of cardiomyopathy based on a retrospective review of their medical records. All patients were evaluated by clinical geneticists who are members of FCDGC at their respective academic centers. Patients were screened for cardiomyopathy, and detailed data were retrospectively collected. We analyzed their clinical and molecular history, imaging characteristics of cardiac involvement, type of cardiomyopathy, age at initial presentation of cardiomyopathy, additional cardiac features, the treatments administered, and their clinical outcomes.<h4>Results</h4>Of the 305 patients with molecularly confirmed CDG participating in the FCDGC natural history study as of June 2023, 17 individuals, nine females and eight males, were identified with concurrent diagnoses of cardiomyopathy. Most of these patients were diagnosed with PMM2-CDG (n\\u00a0=\\u00a010). However, cardiomyopathy was also observed in other diagnoses, including PGM1-CDG (n\\u00a0=\\u00a03), ALG3-CDG (n\\u00a0=\\u00a01), DPM1-CDG (n\\u00a0=\\u00a01), DPAGT1-CDG (n\\u00a0=\\u00a01), and SSR4-CDG (n\\u00a0=\\u00a01). All PMM2-CDG patients were reported to have hypertrophic cardiomyopathy. Dilated cardiomyopathy was observed in three patients, two with PGM1-CDG and one with ALG3-CDG; left ventricular non-compaction cardiomyopathy was diagnosed in two patients, one with PGM1-CDG and one with DPAGT1-CDG; two patients, one with DPM1-CDG and one with SSR4-CDG, were diagnosed with non-ischemic cardiomyopathy. The estimated median age of diagnosis for cardiomyopathy was 5\\u00a0months (range: prenatal-27\\u00a0years). Cardiac improvement was observed in three patients with PMM2-CDG. Five patients showed a progressive course of cardiomyopathy, while the condition remained unchanged in eight individuals. Six patients demonstrated pericardial effusion, with three patients exhibiting cardiac tamponade. One patient with SSR4-CDG has been recently diagnosed with cardiomyopathy; thus, the progression of the disease is yet to be determined. One patient with PGM1-CDG underwent cardiac transplantation. Seven patients were deceased, including five with PMM2-CDG, one with DPAGT1-CDG, and one with ALG3-CDG. Two patients died of cardiac tamponade from pericardial effusion; for the remaining patients, cardiomyopathy was not necessarily the primary cause of death.<h4>Conclusions</h4>In this retrospective study, cardiomyopathy was identified in \\u223c6% of patients with CDG. Notably, the majority, including all those with PMM2-CDG, exhibited hypertrophic cardiomyopathy. Some cases did not show progression, yet pericardial effusions were commonly observed, especially in PMM2-CDG patients, occasionally escalating to life-threatening cardiac tamponade. It is recommended that clinicians managing CDG patients, particularly those with PMM2-CDG and PGM1-CDG, be vigilant of the cardiomyopathy risk and risk for potentially life-threatening pericardial effusions. Cardiac surveillance, including an echocardiogram and EKG, should be conducted at the time of diagnosis, annually throughout the first 5\\u00a0years, followed by check-ups every 2-3\\u00a0years if no concerns arise until adulthood. Subsequently, routine cardiac examinations every five years are advisable. Additionally, patients with diagnosed cardiomyopathy should receive ongoing cardiac care to ensure the effective management and monitoring of their condition. A prospective study will be required to determine the true prevalence of cardiomyopathy in CDG.,  <h4>Introduction</h4>Phosphoglucomutase 1 deficiency (PGM1 deficiency) has been identified as both, glycogenosis and congenital disorder of glycosylation (CDG). The phenotype includes hepatopathy, myopathy, oropharyngeal malformations, heart disease and growth retardation. Oral galactose supplementation at a dosage of 1\\u00a0g per kg body weight per day is regarded as the therapy of choice.<h4>Results</h4>We report on a patient with a novel disease causing mutation, who was treated for 1.5\\u00a0years with oral galactose supplementation. Initially, elevated transaminases were reduced and protein glycosylation of serum transferrin improved rapidly. Long-term surveillance however indicated limitations of galactose supplementation at the standard dose: 1\\u00a0g per kg body weight per day did not achieve permanent correction of protein glycosylation. Even increased doses of up to 2.5\\u00a0g per kg body weight did not result in complete normalization. Furthermore, we described for the first time heart rhythm abnormalities, i.e. long QT Syndrome associated with a glycosylation disorder. Mass spectrometry of IGFBP3, which was assumed to play a major role in growth retardation associated with PGM1 deficiency, revealed no glycosylation abnormalities. Growth rate did not improve under galactose supplementation.<h4>Conclusions</h4>The results of our study indicate that the current standard dose of galactose might be too low to achieve normal glycosylation in all patients. In addition, growth retardation in PGM1 deficiency is complex and multifactorial. Furthermore, heart rhythm abnormalities must be considered when treating patients with PGM1 deficiency.,  <h4>Introduction</h4>The incidence and prevalence of congenital disorders of glycosylation (CDG) have not been well established. The aim of the study was to evaluate the prevalence, incidence and genotypes of CDG patients diagnosed during the last 23\\u00a0years in Poland (1997 - 30th October 2020).<h4>Material and methods</h4>The diagnosis was based on serum Tf IEF which is performed at The Children's Memorial Health Institute (CMHI) in Warsaw. Based on demographic data, the prevalence of CDG among the Polish population in 2020 as well as the birth prevalence of CDG from 1990 to 2020 were estimated.<h4>Results</h4>39 patients (from 35 families) with molecularly confirmed CDG were diagnosed, including 17 (44%) patients (from 16 families) with PMM2-CDG. The c.422G\\u00a0>\\u00a0A, p.Arg141His and c.691G\\u00a0>\\u00a0A, p.Val231Met pathogenic missense variants were the most common identified PMM2 variants. Eleven other patients were diagnosed with CDG based on serum Tf IEF analysis only; the molecular analysis is pending. Ten CDG patients died, including 6 with PMM2-CDG, 1 with PGM1-CDG and 1 with DPAGT1-CDG. The prevalence of CDG in the Polish population was estimated at approximately 1 per million while that of PMM2 at 0.4 per million. The annual incidence of CDG was estimated at 0.013 per 100,000 people in 2020.<h4>Conclusions</h4>A low frequence of CDG in our study could be underestimated.,  <h4>Objective and importance</h4>Phosphoglucomutase 1 (PGM1) deficiency, first described as a glycogenosis (type XIV) is also a congenital disorder of glycosylation (CDG). We want to illustrate the wide clinical spectrum of PGM1 deficiency and in particular the associated disturbance in glucose metabolism and the endocrine dysfunction. Treatment with d-galactose is experimental.<h4>Case presentation</h4>PGM1 deficiency was diagnosed in an 8-year-old boy, who was referred because of an unexplained complex syndrome, including recurrent hypoglycaemia and low IGF-1 mediated growth failure.<h4>Conclusion</h4>The timely diagnosis of this disorder is particularly important, because d-galactose treatment can improve the latter symptoms.,  <h4>Objective</h4>To define phenotypic groups and identify predictors of disease severity in patients with phosphoglucomutase-1 deficiency (PGM1-CDG).<h4>Study design</h4>We evaluated 27 patients with PGM1-CDG who were divided into 3 phenotypic groups, and group assignment was validated by a scoring system, the Tulane PGM1-CDG Rating Scale (TPCRS). This scale evaluates measurable clinical features of PGM1-CDG. We examined the relationship between genotype, enzyme activity, and TPCRS score by using regression analysis. Associations between the most common clinical features and disease severity were evaluated by principal component analysis.<h4>Results</h4>We found a statistically significant stratification of the TPCRS scores among the phenotypic groups (P\\u00a0<\\u00a0.001). Regression analysis showed that there is no significant correlation between genotype, enzyme activity, and TPCRS score. Principal component analysis identified 5 variables that contributed to 54% variance in the cohort and are predictive of disease severity: congenital malformation, cardiac involvement, endocrine deficiency, myopathy, and growth.<h4>Conclusions</h4>We established a scoring algorithm to reliably evaluate disease severity in patients with PGM1-CDG on the basis of their clinical history and presentation. We also identified 5 clinical features that are predictors of disease severity; 2 of these features can be evaluated by physical examination, without the need for specific diagnostic testing and thus allow for rapid assessment and initiation of therapy.,  <h4>Objective</h4>We investigated metabolism and physiological responses to exercise in an 18-year-old woman with multiple congenital abnormalities and exertional muscle fatigue, tightness, and rhabdomyolysis.<h4>Methods</h4>We studied biochemistry in muscle and fibroblasts, performed mutation analysis, assessed physiological responses to forearm and cycle-ergometer exercise combined with stable-isotope techniques and indirect calorimetry, and evaluated the effect of IV glucose infusion and oral sucrose ingestion on the exercise response.<h4>Results</h4>Phosphoglucomutase type 1 (PGM1) activity in muscle and fibroblasts was severely deficient and PGM1 in muscle was undetectable by Western blot. The patient was compound heterozygous for missense (R422W) and nonsense (Q530X) mutations in PGM1. Forearm exercise elicited no increase in lactate, but an exaggerated increase in ammonia, and provoked a forearm contracture. Comparable to patients with McArdle disease, the patient developed a 'second wind' with a spontaneous fall in exercise heart rate and perceived exertion. Like in McArdle disease, this was attributable to an increase in muscle oxidative capacity. Carbohydrate oxidation was blocked during exercise, and the patient had exaggerated oxidation of fat to fuel exercise. Exercise heart rate and perceived exertion were lower after IV glucose and oral sucrose. Muscle glycogen level was low normal.<h4>Conclusions</h4>The second wind phenomenon has been considered to be pathognomonic for McArdle disease, but we demonstrate that it can also be present in PGM1 deficiency. We show that severe loss of PGM1 activity causes blocked muscle glycogenolysis that mimics McArdle disease, but may also limit glycogen synthesis, which broadens the phenotypic spectrum of this disorder.,  <h4>Objectives</h4>A 10-year-old boy presented with cleft palate, hepatopathy, cholecystolithiasis, myopathy, coagulopathy, hyperlipidemia, hypoglycemia, hyperuricemia, short stature, obesity, hypothyroidism, microcephaly and mild intellectual disability. The multi-systemic manifestation involving certain distinct clinical features prompted us to search for a subtype of congenital disorders of glycosylation (CDG).<h4>Methods</h4>The patient was screened for CDG by examining the distribution of transferrin (TRF) and apolipoprotein C-III (ApoC-III) sialylated isoforms using isoelectric focusing of serum. This was followed by spectrophotometric measurement of phosphoglucomutase 1 (PGM1) activity in fibroblasts and molecular analysis including sequencing and PCR-RFLP of PGM1 gene. Selected bioinformatics tools were used to evaluate the data.<h4>Results</h4>Increased relative levels of di-, mono- and asialotransferrin reflected a defect of N-glycosylation in the patient. Markedly decreased activity of PGM1 corresponding to less than 5% of control\\u00b4s was found. Sequencing of PGM1 gene revealed the presence of two heterozygous missense mutations c.1010C>T (p.T337M) and c.1508G>A (p.R503Q), whose pathogenicity was confirmed by in silico analysis.<h4>Conclusion</h4>We report the first Czech patient with a glycosylation disorder due to PGM1 deficiency. Compared to the described cases, no dilated cardiomyopathy was noted in our patient. However, he suffered from a mild neurological impairment, which is an uncommon feature that extends the phenotype associated with PGM1-CDG. Lactose-rich diet, which was previously reported to have ameliorated the clinical symptoms in some PGM1-CDG patients, did not result in any improvement in our patient.,  <h4>Objectives</h4>Congenital Glycosylation Disorders (CDG) are a large group of inherited metabolic diseases with multi-organ involvement. Herein, we aimed to expand the clinical characteristics of patients with CDG based on our experience with diagnoses and follow-up of CDG patients from different subtypes.<h4>Methods</h4>The clinical and laboratory findings from the last 15 years were reviewed retrospectively in Ege University Child Metabolism and Nutrition Department.<h4>Results</h4>There were 8 (57.2\\u202f%) females and 6 (42.8\\u202f%) males. Diagnoses of the patients were PMM2-CDG (n=4), PGM1-CDG (n=2), DPAGT1-CDG (n=2), SRD5A3-CDG (n=2), MPI-CDG (n=1), POMT2-CDG (n=1), B3GALNT2-CDG (n=1), DPM1-CDG (n=1). The clinical findings of the patients were dysmorphia (85.7\\u202f%), developmental delay (85.7\\u202f%), intellectual disability (85.7\\u202f%), ocular abnormalities (64.2\\u202f%), skeletal malformations (64.2\\u202f%), failure to thrive (57.1\\u202f%), microcephaly (57.1\\u202f%), hepatomegaly (35.7\\u202f%), hearing loss (35.7\\u202f%), seizures (28.5\\u202f%), gastrointestinal symptoms (21.4\\u202f%), endocrine abnormalities (21.4\\u202f%), and cardiac abnormalities (7.1\\u202f%). Laboratory findings were abnormal TIEF (92.8\\u202f%), abnormal liver enzymes (64.2\\u202f%), decreased protein C (64.2\\u202f%), decreased antithrombin III (64.2\\u202f%), decreased protein S (42.8\\u202f%), hypogammaglobulinemia (35.7\\u202f%), cerebellar hypoplasia (28.5\\u202f%), CK elevation (7.1\\u202f%), and hypoglycemia (7.1\\u202f%).<h4>Conclusions</h4>This study contributes to the literature by sharing our ultra-rare DPM1-CDG case with less than 20 cases in the literature and expanding the clinical and molecular characteristics of other CDG patients. Hyperinsulinemic hypoglycemia, short stature, hypothyroidism, growth hormone deficiency, hypogammaglobulinemia, pericardial effusion, elevated CK, congenital myasthenia, and anorectal malformation were unique findings that were observed. Cerebello-ocular findings accompanying multi-organ involvement were an essential clue for a possible CDG.,  Clinical glycomics comprises a spectrum of different analytical methodologies to analyze glycan structures, which provides insights into the mechanisms of glycosylation. Within clinical diagnostics, glycomics serves as a functional readout of genetic variants, and can form a basis for therapy development, as was described for PGM1-CDG. Integration of glycomics with genomics has resulted in the elucidation of previously unknown disorders of glycosylation, namely CCDC115-CDG, TMEM199-CDG, ATP6AP1-CDG, MAN1B1-CDG, and PGM1-CDG. This review provides an introduction into protein glycosylation and presents the different glycomics methodologies ranging from gel electrophoresis to mass spectrometry (MS) and from free glycans to intact glycoproteins. The role of glycomics in the diagnosis of congenital disorders of glycosylation (CDG) is presented, including a diagnostic flow chart and an overview of glycomics data of known CDG subtypes. The review ends with some future perspectives, showing upcoming technologies as system wide mapping of the N- and O-glycoproteome, intact glycoprotein profiling and analysis of sugar metabolism. These new advances will provide additional insights and opportunities to develop personalized therapy. This is especially true for inborn errors of metabolism, which are amenable to causal therapy, because interventions through supplementation therapy can directly target the pathogenesis at the molecular level.,  Congenital disorders of glycosylation (CDG) are a group of genetic disorders that affect protein and lipid glycosylation and glycosylphosphatidylinositol synthesis. More than 100 different disorders have been reported and the number is rapidly increasing. Since glycosylation is an essential post-translational process, patients present a large range of symptoms and variable phenotypes, from very mild to extremely severe. Only for few CDG, potentially curative therapies are being used, including dietary supplementation (e.g., galactose for PGM1-CDG, fucose for SLC35C1-CDG, Mn<sup>2+</sup> for TMEM165-CDG or mannose for MPI-CDG) and organ transplantation (e.g., liver for MPI-CDG and heart for DOLK-CDG). However, for the majority of patients, only symptomatic and preventive treatments are in use. This constitutes a burden for patients, care-givers and ultimately the healthcare system. Innovative diagnostic approaches, in vitro and in vivo models and novel biomarkers have been developed that can lead to novel therapeutic avenues aiming to ameliorate the patients&rsquo; symptoms and lives. This review summarizes the advances in therapeutic approaches for CDG.,  Congenital disorders of glycosylation (CDG) are a group of more than 130 inborn errors of metabolism affecting <i>N</i>-linked, <i>O</i>-linked protein and lipid-linked glycosylation. The phenotype in CDG patients includes frequent liver involvement, especially the disorders belonging to the <i>N</i>-linked protein glycosylation group. There are only a few treatable CDG. Mannose-Phosphate Isomerase (MPI)-CDG was the first treatable CDG by high dose mannose supplements. Recently, with the successful use of d-galactose in Phosphoglucomutase 1 (PGM1)-CDG, other CDG types have been trialed on galactose and with an increasing number of potential nutritional therapies. Current mini review focuses on therapies in glycosylation disorders affecting liver function and dietary intervention in general in <i>N</i>-linked glycosylation disorders. We also emphasize now the importance of early screening for CDG in patients with mild hepatopathy but also in cholestasis.,  Congenital disorders of glycosylation (CDG) are a rapidly growing family of genetic diseases caused by defects in glycosylation. Nearly 100 CDG types are known so far. Patients present a great phenotypic diversity ranging from poly- to mono-organ/system involvement and from very mild to extremely severe presentation. In this literature review, we summarize the liver involvement reported in CDG patients. Although liver involvement is present in only a minority of the reported CDG types (22\\u00a0%), it can be debilitating or even life-threatening. Sixteen of the patients we collated here developed cirrhosis, 10 had liver failure. We distinguish two main groups: on the one hand, the CDG types with predominant or isolated liver involvement including MPI-CDG, TMEM199-CDG, CCDC115-CDG, and ATP6AP1-CDG, and on the other hand, the CDG types associated with liver disease but not as a striking, unique or predominant feature, including PMM2-CDG, ALG1-CDG, ALG3-CDG, ALG6-CDG, ALG8-CDG, ALG9-CDG, PGM1-CDG, and COG-CDG. This review aims to facilitate CDG patient identification and to understand CDG liver involvement, hopefully leading to earlier diagnosis, and better management and treatment.,  Diagnostic screening of the congenital disorders of glycosylation (CDG) generally involves isoelectric focusing of plasma transferrin, a robust method easily integrated in medical laboratories. Structural information is needed as the next step, as required for the challenging classification of Golgi glycosylation defects (CDG-II). Here, we present the use of high-resolution nano liquid chromatography-chip (C8)-quadrupole time of flight mass spectrometry (nanoLC-chip [C8]-QTOF MS) for protein-specific glycoprofiling of intact transferrin, which allows screening and direct diagnosis of a number of CDG-II defects. Transferrin was immunopurified from 10 \\u03bcL of plasma and analyzed by nanoLC-chip-QTOF MS. Charge distribution raw data were deconvoluted by Mass Hunter software to reconstructed mass spectra. Plasma samples were processed from controls (n = 56), patients with known defects (n = 30), and patients with secondary (n = 6) or unsolved (n = 3) cause of abnormal glycosylation. This fast and robust method, established for CDG diagnostics, requires only 2 hours analysis time, including sample preparation and analysis. For CDG-I patients, the characteristic loss of complete N-glycans could be detected with high sensitivity. Known CDG-II defects (phosphoglucomutase 1 [PGM1-CDG], mannosyl (\\u03b1-1,6-)-glycoprotein \\u03b2-1,2-N-acetylglucosaminyltransferase [MGAT2-CDG], \\u03b2-1,4-galactosyltransferase 1 [B4GALT1-CDG], CMP-sialic acid transporter [SLC35A1-CDG], UDP-galactose transporter [SLC35A2-CDG] and mannosyl-oligosaccharide 1,2-alpha-mannosidase [MAN1B1-CDG]) resulted in characteristic diagnostic profiles. Moreover, in the group of Golgi trafficking defects and unsolved CDG-II patients, distinct profiles were observed, which facilitate identification of the specific CDG subtype. The established QTOF method affords high sensitivity and resolution for the detection of complete glycan loss and structural assignment of truncated glycans in a single assay. The speed and robustness allow its clinical diagnostic application as a first step in the diagnostic procedure for CDG defects.,  INTRODUCTION:Sudden cardiac death (SCD) in the young is rare and should always lead to suspicion of a genetic cardiac disorder. We describe a family, in which the proband was a girl deceased by sudden cardiac death in the playground at thirteen years of age. The index-patient had short stature, cleft palate but no previous cardiac symptoms. We found an uncommon cause of cardiomyopathy, due to a congenital disorder of glycosylation (CDG), previously described to cause a variable range of usually mild symptoms, and not previously found to cause SCD as the first symptom of the condition. METHODS:The index patient underwent postmortem genetic testing/molecular autopsy for genes known to cause SCD, without a detection of causative agent, why two siblings of similar phenotype as the deceased sister underwent clinical-exome genetic sequencing (next generation sequencing). All first-degree relatives underwent clinical examination including cardiac ultrasound, Holter-ECG, exercise stress test and biochemistry panel. RESULTS:A genetic variant in the gene for phosphoglucomutase 1 (PGM1) was identified in the index patient and her two brothers, all were found to be homozygous for the genetic variant (G230E) NM_002633.2:c.689\\u202fG\\u202f>\\u202fA in PGM1. This variant has been linked to a congenital disorder of glycosylation (PGM1-CDG), explaining the clinical picture of short stature, cleft palate, liver engagement and cardiomyopathy. During follow-up one of the brothers died unexpectedly after physical exertion during daily life at the age of twelve years. The other brother fainted during similar circumstances at the age of thirteen years. Both parents and three other siblings were found to be heterozygous gene carriers without risk for the disease. CONCLUSION:Our findings suggest that there is a need of multidisciplinary discussion and genetic testing after unexpected cardiac death in the young. We have to be more flexible in our evaluation of diseases and to consider even uncommon diseases including rare recessive inherited disorders. Our findings also suggest that the autosomal recessive PGM1-CDG might be highly associated with life-threatening cardiomyopathy with arrhythmia or sudden cardiac death as the first symptom presenting from childhood and adolescence.,  Patients with phosphoglucomutase (PGM1) deficiency, a congenital disorder of glycosylation (CDG) suffer from multiple disease phenotypes. Midline cleft defects are present at birth. Overtime, additional clinical phenotypes, which include severe hypoglycemia, hepatopathy, growth retardation, hormonal deficiencies, hemostatic anomalies, frequently lethal, early-onset of dilated cardiomyopathy and myopathy emerge, reflecting the central roles of the enzyme in (glycogen) metabolism and glycosylation. To delineate the pathophysiology of the tissue-specific disease phenotypes, we constructed a constitutive Pgm2 (mouse ortholog of human PGM1)-knockout (KO) mouse model using CRISPR-Cas9 technology. After multiple crosses between heterozygous parents, we were unable to identify homozygous life births in 78 newborn pups (P = 1.59897E-06), suggesting an embryonic lethality phenotype in the homozygotes. Ultrasound studies of the course of pregnancy confirmed Pgm2-deficient pups succumb before E9.5. Oral galactose supplementation (9 mg/mL drinking water) did not rescue the lethality. Biochemical studies of tissues and skin fibroblasts harvested from heterozygous animals confirmed reduced Pgm2 enzyme activity and abundance, but no change in glycogen content. However, glycomics analyses in serum revealed an abnormal glycosylation pattern in the Pgm2<sup>+/-</sup> animals, similar to that seen in PGM1-CDG.,  Phosphoglucomutase 1 (PGM1) catalyzes the interconversion of glucose-6-phosphate to glucose-1-phosphate and is a key enzyme of glycolysis, glycogenesis, and glycogenolysis. PGM1 deficiency (OMIM: 614921) was initially defined as a glycogen storage disorder (type XIV), and later re-classified as a PGM1-congenital disorder of glycosylation (PGM1-CDG). Serum transferrin (Tf) glycan isoform analysis by liquid chromatography-mass spectrometry (LC-MS) is used as a primary diagnostic screen tool, and reveals a very unique CDG profile described as a mixture of CDG-type I and CDG-type II patterns. Oral d-galactose supplementation shows significant clinical and metabolic improvements, which are indicated by the Tf glycan isoform normalization over time in patients with PGM1-CDG. Thus, there is a need for biomarkers to guide d-galactose dosage in patients in order to maintain effective and safe drug levels. Here, we present a simplified algorithm called PGM1-CDG Treatment Monitoring Index (PGM1-TMI) for assessing the response of PGM1-CDG patients to d-galactose supplementation. For our single-center cohort of 16 PGM1-CDG patients, the Tf glycan profile analysis provided the biochemical diagnosis in all of them. In addition, the PGM1-TMI was reduced in PGM1-CDG patients under d-galactose supplementation as compared with their corresponding values before treatment, indicating that glycosylation proceeds towards normalization. PGM1-TMI allows tracking Tf glycan isoform normalization over time when the patients are on d-galactose supplementation.,  Phosphoglucomutase 1 (PGM1) deficiency is a rare genetic disorder that affects glycogen metabolism, glycolysis, and protein glycosylation. Previously known as GSD XIV, it was recently reclassified as a congenital disorder of glycosylation, PGM1-CDG. PGM1-CDG usually manifests as a multisystem disease. Most patients present as infants with cleft palate, liver function abnormalities and hypoglycemia, but some patients present in adulthood with isolated muscle involvement. Some patients develop life-threatening cardiomyopathy. Unlike most other CDG, PGM1-CDG has an effective treatment option, d-galactose, which has been shown to improve many of the patients' symptoms. Therefore, early diagnosis and initiation of treatment for PGM1-CDG patients are crucial decisions. In this article, our group of international experts suggests diagnostic, follow-up, and management guidelines for PGM1-CDG. These guidelines are based on the best available evidence-based data and experts' opinions aiming to provide a practical resource for health care providers to facilitate successful diagnosis and optimal management of PGM1-CDG patients.,  Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1 gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in the PGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient's phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.,  Phosphoglucomutase 1 (PGM1) deficiency is recognized as the third most common N-linked congenital disorders of glycosylation (CDG) in humans. Affected individuals present with liver, musculoskeletal, endocrine, and coagulation symptoms; however, the most life-threatening complication is the early onset of dilated cardiomyopathy (DCM). Recently, we discovered that oral D-galactose supplementation improved liver disease, endocrine, and coagulation abnormalities, but does not alleviate the fatal cardiomyopathy and the associated myopathy. Here we report on left ventricular ejection fraction (LVEF) in 6 individuals with PGM1-CDG. LVEF was pathologically low in most of these individuals and varied between 10% and 65%. To study the pathobiology of the cardiac disease observed in PGM1-CDG, we constructed a novel cardiomyocyte-specific conditional Pgm2 gene (mouse ortholog of human PGM1) knockout (Pgm2 cKO) mouse model. Echocardiography studies corroborated a DCM phenotype with significantly reduced ejection fraction and left ventricular dilation similar to those seen in individuals with PGM1-CDG. Histological studies demonstrated excess glycogen accumulation and fibrosis, while ultrastructural analysis revealed Z-disk disarray and swollen/fragmented mitochondria, which was similar to the ultrastructural pathology in the cardiac explant of an individual with PGM1-CDG. In addition, we found decreased mitochondrial function in the heart of KO mice. Transcriptomic analysis of hearts from mutant mice demonstrated a gene signature of DCM. Although proteomics revealed only mild changes in global protein expression in left ventricular tissue of mutant mice, a glycoproteomic analysis unveiled broad glycosylation changes with significant alterations in sarcolemmal proteins including different subunits of laminin-211, which was confirmed by immunoblot analyses. Finally, augmentation of PGM1 in KO mice via AAV9-PGM1 gene replacement therapy prevented and halted the progression of the DCM phenotype.,  Phosphoglucomutase 1 (PGM1) deficiency results in a mixed phenotype of a Glycogen Storage Disorder and a Congenital Disorder of Glycosylation (CDG). Screening for abnormal glycosylation has identified more than 40 patients, manifesting with a broad clinical and biochemical spectrum which complicates diagnosis. Together with the availability of D-galactose as dietary therapy, there is an urgent need for specific glycomarkers for early diagnosis and treatment monitoring. We performed glycomics profiling by high-resolution QTOF mass spectrometry in a series of 19 PGM1-CDG patients, covering a broad range of biochemical and clinical severity. Bioinformatics and statistical analysis were used to select glycomarkers for diagnostics and define glycan-indexes for treatment monitoring. Using 3 transferrin glycobiomarkers, all PGM1-CDG patients were diagnosed with 100% specificity and sensitivity. Total plasma glycoprofiling showed an increase in high mannose glycans and fucosylation, while global galactosylation and sialylation were severely decreased. For treatment monitoring, we defined 3 glycan-indexes, reflecting normal glycosylation, a lack of complete glycans (LOCGI) and of galactose residues (LOGI). These indexes showed improved glycosylation upon D-galactose treatment with a fast and near-normalization of the galactose index (LOGI) in 6 out of 8 patients and a slower normalization of the LOCGI in all patients. Total plasma glycoprofiling showed improvement of the global high mannose glycans, fucosylation, sialylation, and galactosylation status on D-galactose treatment. Our study indicates specific glycomarkers for diagnosis of mildly and severely affected PGM1-CDG patients, and to monitor the glycan-specific effects of D-galactose therapy.,  Phosphoglucomutase 1 (PGM1) encodes the metabolic enzyme that interconverts glucose-6-P and glucose-1-P. Mutations in PGM1 cause impairment in glycogen metabolism and glycosylation, the latter manifesting as a congenital disorder of glycosylation (CDG). This unique metabolic defect leads to abnormal N-glycan synthesis in the endoplasmic reticulum (ER) and the Golgi apparatus (GA). On the basis of the decreased galactosylation in glycan chains, galactose was administered to individuals with PGM1-CDG and was shown to markedly reverse most disease-related laboratory abnormalities. The disease and treatment mechanisms, however, have remained largely elusive. Here, we confirm the clinical benefit of galactose supplementation in PGM1-CDG-affected individuals and obtain significant insights into the functional and biochemical regulation of glycosylation. We report here that, by using tracer-based metabolomics, we found that galactose treatment of PGM1-CDG fibroblasts metabolically re-wires their sugar metabolism, and as such replenishes the depleted levels of galactose-1-P, as well as the levels of UDP-glucose and UDP-galactose, the nucleotide sugars that are required for ER- and GA-linked glycosylation, respectively. To this end, we further show that the galactose in UDP-galactose is incorporated into mature, de novo glycans. Our results also allude to the potential of monosaccharide therapy for several other CDG.,  Phosphoglucomutase 1 deficiency is a congenital disorder of glycosylation (CDG) with multiorgan involvement affecting carbohydrate metabolism, N-glycosylation and energy production. The metabolic management consists of dietary D-galactose supplementation that ameliorates hypoglycemia, hepatic dysfunction, endocrine anomalies and growth delay. Previous studies suggest that D-galactose administration in juvenile patients leads to more significant and long-lasting effects, stressing the urge of neonatal diagnosis (0-6\\u202fmonths of age). Here, we detail the early clinical presentation of PGM1-CDG in eleven infantile patients, and applied the modified Beutler test for screening of PGM1-CDG in neonatal dried blood spots (DBSs). All eleven infants presented episodic hypoglycemia and elevated transaminases, along with cleft palate and growth delay (10/11), muscle involvement (8/11), neurologic involvement (5/11), cardiac defects (2/11). Standard dietary measures for suspected lactose intolerance in four patients prior to diagnosis led to worsening of hypoglycemia, hepatic failure and recurrent diarrhea, which resolved upon D-galactose supplementation. To investigate possible differences in early vs. late clinical presentation, we performed the first systematic literature review for PGM1-CDG, which highlighted respiratory and gastrointestinal symptoms as significantly more diagnosed in neonatal age. The modified Butler-test successfully identified PGM1-CDG in DBSs from seven patients, including for the first time Guthrie cards from newborn screening, confirming the possibility of future inclusion of PGM1-CDG in neonatal screening programs. In conclusion, severe infantile morbidity of PGM1-CDG due to delayed diagnosis could be prevented by raising awareness on its early presentation and by inclusion in newborn screening programs, enabling early treatments and galactose-based metabolic management.,  Phosphoglucomutase-1-congenital disorder of glycosylation (PGM1-CDG) (OMIM: 614921) is a rare autosomal recessive inherited metabolic disease caused by the deficiency of the PGM1 enzyme. Like other CDGs, PGM1-CDG has a multisystemic presentation. The most common clinical findings include liver involvement, rhabdomyolysis, hypoglycemia, and cardiac involvement. Phenotypic severity can vary, though cardiac presentation is usually part of the most severe phenotype, often resulting in early death. Unlike the majority of CDGs, PGM1-CDG has a treatment: oral D-galactose (D-gal) supplementation, which significantly improves many aspects of the disorder. Here, we describe five PGM1-CDG patients treated with D-gal and report both on novel clinical symptoms in PGM1-CDG as well as the effects of the D-gal treatment. D-gal resulted in notable clinical improvement in four patients, though the efficacy of treatment varied between the patients. Furthermore, there was a significant improvement or normalization in transferrin glycosylation, liver transaminases and coagulation factors in three patients, creatine kinase (CK) levels in two, while hypoglycemia resolved in two patients. One patient discontinued the treatment due to urinary frequency and lack of clinical improvement. Furthermore, one patient experienced recurrent episodes of rhabdomyolysis and tachycardia even on higher doses of therapy. D-gal also failed to improve the cardiac function, which was initially abnormal in three patients, and remains the biggest challenge in treating PGM1-CDG. Together, our findings expand the phenotype of PGM1-CDG and underline the importance of developing novel therapies that would specifically treat the cardiac phenotype in PGM1-CDG.,  Phosphoglucomutase-1-congenital disorder of glycosylation (PGM1-CDG) is a rare genetic disorder caused by biallelic variants in the PGM1 gene, leading to the deficiency of the PGM1 enzyme. The most common clinical presentations include muscle involvement, failure to thrive, cleft palate, and cardiac involvement. Abnormal serum N-glycosylation, hypoglycemia, and liver function abnormalities including coagulation abnormalities are the most common laboratory abnormalities. While PGM1-CDG has been extensively studied, little is known about the extent of the coagulation abnormalities in individuals with PGM1-CDG. Unlike most CDG, some symptoms of PGM1-CDG are treatable with D-galactose (D-gal) supplementation, though reliable clinical endpoints are necessary to appropriately evaluate the potential improvement with D-gal in PGM1-CDG. Here, we aimed to describe the incidence of coagulation abnormalities in PGM1-CDG and their evolution, their relation to clinical events, and the ability of D-gal treatment to improve them. A retrospective analysis was conducted on 73 reported individuals. All individuals had a molecularly confirmed PGM1-CDG diagnosis. All incidences of antithrombin (AT), aPTT, PT, factor (F) XI, FX, FIX, FVII, protein C and protein S data and major clinical events related to coagulation abnormalities, were collected. Coagulation information was available for only 58.9 % of the reported individuals, out of which 67.4 % of PGM1-CDG individuals were reported to have abnormalities. The most frequently observed abnormality was AT (mean: 30.8% R:80-120 %) deficiency. Four individuals had major thrombotic events. Coagulation status on D-gal treatment, were reported in 19 individuals. Several factors showed improvement including AT (mean: 64.5 %), indicating galactose is beneficial in treating coagulation abnormalities in PGM1-CDG. Due to the scarcity of the reported data on coagulation parameters, we also evaluated data collected in sixteen PGM1-CDG individuals enrolled in the FCDGC Natural History Study. Longitudinal data showed improvements in several coagulant parameters and disease severity improved for almost all patients of whom we had multiple datapoints on D-gal. AT showed significant improvement on D-gal. We conclude that coagulation abnormalities are frequently present in PGM1-CDG and show improvement on D-gal. We recommend coagulation parameters should be routinely checked in individuals with PGM1-CDG or suspected of having PGM1-CDG. Finally, AT may be used as a primary or secondary clinical endpoint for upcoming clinical trials in PGM1-CDG individuals.,  PurposePhosphoglucomutase-1 deficiency is a subtype of congenital disorders of glycosylation (PGM1-CDG). Previous casereports in PGM1-CDG patients receiving oral D-galactose (D-gal) showed clinical improvement. So far no systematic in vitro and clinical studies have assessed safety and benefits of D-gal supplementation. In a prospective pilot study, we evaluated the effects of oral D-gal in nine patients.MethodsD-gal supplementation was increased to 1.5\\u2009g/kg/day (maximum 50\\u2009g/day) in three increments over 18 weeks. Laboratory studies were performed before and during treatment to monitor safety and effect on serum transferrin-glycosylation, coagulation, and liver and endocrine function. Additionally, the effect of D-gal on cellular glycosylation was characterized in vitro.ResultsEight patients were compliant with D-gal supplementation. No adverse effects were reported. Abnormal baseline results (alanine transaminase, aspartate transaminase, activated partial thromboplastin time) improved or normalized already using 1\\u2009g/kg/day D-gal. Antithrombin-III levels and transferrin-glycosylation showed significant improvement, and increase in galactosylation and whole glycan content. In vitro studies before treatment showed N-glycan hyposialylation, altered O-linked glycans, abnormal lipid-linked oligosaccharide profile, and abnormal nucleotide sugars in patient fibroblasts. Most cellular abnormalities improved or normalized following D-gal treatment. D-gal increased both UDP-Glc and UDP-Gal levels and improved lipid-linked oligosaccharide fractions in concert with improved glycosylation in PGM1-CDG.ConclusionOral D-gal supplementation is a safe and effective treatment for PGM1-CDG in this pilot study. Transferrin glycosylation and ATIII levels were useful trial end points. Larger, longer-duration trials are ongoing.,  We recently redefined phosphoglucomutase-1 deficiency not only as an enzyme defect, involved in normal glycogen metabolism, but also an inborn error of protein glycosylation. Phosphoglucomutase-1 is a key enzyme in glycolysis and glycogenesis by catalyzing in the bidirectional transfer of phosphate from position 1 to 6 on glucose. Glucose-1-P and UDP-glucose are closely linked to galactose metabolism. Normal PGM1 activity is important for effective glycolysis during fasting. Activated glucose and galactose are essential for normal protein glycosylation. The complex defect involving abnormal concentrations of activated sugars leads to hypoglycemia and two major phenotypic presentations, one with primary muscle involvement and the other with severe multisystem disease. The multisystem phenotype includes growth delay and malformations, like cleft palate or uvula, and liver, endocrine and heart function with possible cardiomyopathy. The patients have normal intelligence. Decreased transferrin galactosylation is a characteristic finding on mass spectrometry. Previous in vitro studies in patient fibroblasts showed an improvement of glycosylation on galactose supplements. Four patients with PGM1 deficiency have been trialed on d-galactose (compassionate use), and showed improvement of serum transferrin hypoglycosylation. There was a parallel improvement of liver function, endocrine abnormalities and a decrease in the frequency of hypoglycemic episodes. No side effects have been observed. Galactose supplementation didn't seem to resolve all clinical symptoms. Adding complex carbohydrates showed an additional clinical amelioration. Based on the available clinical data we suggest to consider the use of 0.5-1g/kg/day d-galactose and maximum 50 g/day oral galactose therapy in PGM1-CDG. The existing data on galactose therapy have to be viewed as preliminary observations. A prospective multicenter trial is ongoing to evaluate the efficacy and optimal d-galactose dose of galactose supplementation., CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMARY Dietary intervention has been a successful approach of treatment in classic inborn errors, aiming at restoring normal levels of metabolites in patients. In the past, a positive effect of the monosaccharide, D-galactose has been documented in Golgi related CDG. Our preliminary data in PGM1-CDG and SLC35A2-CDG showed that supplementation of patients with D-galactose leads to improvement of glycan synthesis parallel with improving clinical symptoms. In another glycosylation disorder, NGLY1 deficiency, preclinical studies offered a different therapeutic target for the disease. Despite these encouraging preliminary observations we do need clinical trials to 1) evaluate long-term therapy, dosage and safety of oral D-galactose supplementation in patients with PGM1-CDG; 2) study the efficacy of oral D-galactose supplementation in patients with another protein- galactosylation defect (SLC35A2-CDG) and 3) evaluate whether oral GlcNAc supplementation in NGLY1 deficiency is translatable to the human disorder. Our scientific premise is that the use dietary sugars, D- galactose and N-Acetyl-Glucosamine will restore glycosylation in CDG by influencing ?metabolite fluxes? to regulate and boost glycosylation pathways leading to improved clinical symptoms and quality of life of CDG patients. We propose to 1) evaluate efficacy and safety of D-galactose supplementation in SLC35A2-CDG, a disorder of hypogalactosylation, using seizure control, quantitative glycomics and validated clinical severity score (NPCRS) as endpoints in a blinded, cross-over study design; 2) assess optimal dosing and long-term safety of D-galactose in PGM1- CDG using validated clinical severity score (TPCRS) and quantitative glycomics as endpoints in an open label dose escalation study design and 3) evaluate the safety and effect of oral GlcNAc supplementation in patients with NGLY1 deficiency on a novel urinary biomarker, seizure control and tear secretion, as end points. The proposed clinical trials will fill gaps in the design of upcoming clinical trials in CDG and NGLY1 by establishing initial treatment regimens and clarifying safe dosage for monosaccharide therapies. Deliverables from this study, supported by the natural history study and the diagnostics and biomarker project will increase clinical trial readiness for large-scale Phase 2 and Phase 3 clinical trials by validating clinical progression scores and patient reported outcomes (Goal Attainment Scale) as well as advanced diagnostics and biomarker discoveries., CLINICAL TRIAL PROJECT-ABSTRCAT/PRPOJET SUMMARY\\\\\\\\\\\\\\\\nDietary intervention has been a successful approach of treatment in classic inborn errors, aiming at restoring\\\\\\\\\\\\\\\\nnormal levels of metabolites in patients. In the past, a positive effect of the monosaccharide, D-galactose has\\\\\\\\\\\\\\\\nbeen documented in Golgi related CDG. Our preliminary data in PGM1-CDG and SLC35A2-CDG showed that\\\\\\\\\\\\\\\\nsupplementation of patients with D-galactose leads to improvement of glycan synthesis parallel with improving\\\\\\\\\\\\\\\\nclinical symptoms. In another glycosylation disorder, NGLY1 deficiency, preclinical studies offered a different\\\\\\\\\\\\\\\\ntherapeutic target for the disease. Despite these encouraging preliminary observations we do need clinical\\\\\\\\\\\\\\\\ntrials to 1) evaluate long-term therapy, dosage and safety of oral D-galactose supplementation in patients with\\\\\\\\\\\\\\\\nPGM1-CDG; 2) study the efficacy of oral D-galactose supplementation in patients with another protein-\\\\\\\\\\\\\\\\ngalactosylation defect (SLC35A2-CDG) and 3) evaluate whether oral GlcNAc supplementation in NGLY1\\\\\\\\\\\\\\\\ndeficiency is translatable to the human disorder. Our scientific premise is that the use dietary sugars, D-\\\\\\\\\\\\\\\\ngalactose and N-Acetyl-Glucosamine will restore glycosylation in CDG by influencing \\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x83\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\xa2\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x82\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\x80\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x82\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\x9cmetabolite fluxes\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x83\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\xa2\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x82\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\x80\\\\\\\\\\\\\\\\xc3\\\\\\\\\\\\\\\\x82\\\\\\\\\\\\\\\\xc2\\\\\\\\\\\\\\\\x9d to\\\\\\\\\\\\\\\\nregulate and boost glycosylation pathways leading to improved clinical symptoms and quality of life of CDG\\\\\\\\\\\\\\\\npatients. We propose to 1) evaluate efficacy and safety of D-galactose supplementation in SLC35A2-CDG, a\\\\\\\\\\\\\\\\ndisorder of hypogalactosylation, using seizure control, quantitative glycomics and validated clinical severity\\\\\\\\\\\\\\\\nscore (NPCRS) as endpoints in a blinded, cross-over study design; 2) assess optimal dosing and long-term\\\\\\\\\\\\\\\\nsafety of D-galactose in PGM1- CDG using validated clinical severity score (TPCRS) and quantitative\\\\\\\\\\\\\\\\nglycomics as endpoints in an open label dose escalation study design and 3) evaluate the safety and effect of\\\\\\\\\\\\\\\\noral GlcNAc supplementation in patients with NGLY1 deficiency on a novel urinary biomarker, seizure control\\\\\\\\\\\\\\\\nand tear secretion, as end points. The proposed clinical trials will fill gaps in the design of upcoming clinical\\\\\\\\\\\\\\\\ntrials in CDG and NGLY1 by establishing initial treatment regimens and clarifying safe dosage for\\\\\\\\\\\\\\\\nmonosaccharide therapies. Deliverables from this study, supported by the natural history study and the\\\\\\\\\\\\\\\\ndiagnostics and biomarker project will increase clinical trial readiness for large-scale Phase 2 and Phase 3\\\\\\\\\\\\\\\\nclinical trials by validating clinical progression scores and patient reported outcomes (Goal Attainment Scale)\\\\\\\\\\\\\\\\nas well as advanced diagnostics and biomarker discoveries., DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/PROJECT SUMMARY Congenital disorders of glycosylation (CDG) have rapidly developed into one of the largest group of metabolic disorders, yet they are poorly described without natural histories, affective treatment, validated biomarkers correlating with disease severity and without comprehensive diagnostic tools. PMM2-CDG and congenital disorders of galactosylation (e.g. SLC35A2-CDG, PGM1-CDG) are the most common N-glycosylation disorders with emerging potential therapies. Congenital disorders of de-glycosylation is a recently discovered group of abnormal glycosylation with a potential noninvasive diagnostic biomarker in NGLY1 deficiency. Some long-known CDG types, like ALG13-CDG however still have no reliable, validated diagnostic methods. Our overall objective and overreaching aim is to develop and validate new biochemical diagnostic techniques and therapeutic biomarkers for future CDG clinical trials. We will overcome the shortcomings of current biochemical techniques and biomarkers in measuring therapeutic efficacy and diagnostics of specific CDG. To address the unmet need and accomplish our overall objective, we will 1) develop and validate biomarkers to monitor therapeutic efficacy in clinical trials for PMM2-CDG; 2) develop quantitative biomarkers to diagnose PGM1-CDG and monitor galactose therapy efficacy; 3) develop quantitative biomarkers to diagnose SLC35A2-CDG and monitor galactose therapy efficacy; 4) validate biomarker to diagnose and follow NGLY1 deficiency and monitor N-acetylglucosamine (GlcNAc) therapy response; 5) validate novel diagnostic biomarkers for ALG13-CDG; 6) qualify and admit new patients to the general CDG population. The impact of this aim on the CDG community is twofold. We will significantly improve diagnostics of patients with CDG, and through improved diagnostics and identification of biomarkers we will increase clinical trial readiness. Achieving these aims should enable us to correlate disease progression and disease severity (Project 1) and their response to therapy (Project 3) with quantifiable biochemical assays. Parallel measurements of the same biomaterial at the different laboratories will not only increase reliability, but will be integral to the validation process and facilitate the process of developing standard biochemical test for diagnosis of the disorders. Such improved diagnostics will be important to assess disease severity and through validation of biochemical outcome measures or biomarkers our efforts will support upcoming clinical trials in CDG. The multiple approaches using state-of-the- art technologies will provide data to assess the overall success of the project. Moreover, the biochemical validations may provide a framework for assessing other emerging or yet-to-be identified glycosylation disorders., DIAGNOSTICS AND BIOMARKER DISCOVERY-ABSTRACT/PROJECT SUMMARY\\\\\\\\\\\\\\\\nCongenital disorders of glycosylation (CDG) have rapidly developed into one of the largest group of metabolic\\\\\\\\\\\\\\\\ndisorders, yet they are poorly described without natural histories, affective treatment, validated biomarkers\\\\\\\\\\\\\\\\ncorrelating with disease severity and without comprehensive diagnostic tools. PMM2-CDG and congenital disorders\\\\\\\\\\\\\\\\nof galactosylation (e.g. SLC35A2-CDG, PGM1-CDG) are the most common N-glycosylation disorders with\\\\\\\\\\\\\\\\nemerging potential therapies. Congenital disorders of de-glycosylation is a recently discovered group of abnormal\\\\\\\\\\\\\\\\nglycosylation with a potential noninvasive diagnostic biomarker in NGLY1 deficiency. Some long-known CDG types,\\\\\\\\\\\\\\\\nlike ALG13-CDG however still have no reliable, validated diagnostic methods. Our overall objective and\\\\\\\\\\\\\\\\noverreaching aim is to develop and validate new biochemical diagnostic techniques and therapeutic biomarkers for\\\\\\\\\\\\\\\\nfuture CDG clinical trials. We will overcome the shortcomings of current biochemical techniques and biomarkers in\\\\\\\\\\\\\\\\nmeasuring therapeutic efficacy and diagnostics of specific CDG. To address the unmet need and accomplish our\\\\\\\\\\\\\\\\noverall objective, we will 1) develop and validate biomarkers to monitor therapeutic efficacy in clinical trials for\\\\\\\\\\\\\\\\nPMM2-CDG; 2) develop quantitative biomarkers to diagnose PGM1-CDG and monitor galactose therapy efficacy;\\\\\\\\\\\\\\\\n3) develop quantitative biomarkers to diagnose SLC35A2-CDG and monitor galactose therapy efficacy; 4) validate\\\\\\\\\\\\\\\\nbiomarker to diagnose and follow NGLY1 deficiency and monitor N-acetylglucosamine (GlcNAc) therapy response;\\\\\\\\\\\\\\\\n5) validate novel diagnostic biomarkers for ALG13-CDG; 6) qualify and admit new patients to the general CDG\\\\\\\\\\\\\\\\npopulation. The impact of this aim on the CDG community is twofold. We will significantly improve diagnostics of\\\\\\\\\\\\\\\\npatients with CDG, and through improved diagnostics and identification of biomarkers we will increase clinical trial\\\\\\\\\\\\\\\\nreadiness. Achieving these aims should enable us to correlate disease progression and disease severity (Project 1)\\\\\\\\\\\\\\\\nand their response to therapy (Project 3) with quantifiable biochemical assays. Parallel measurements of the same\\\\\\\\\\\\\\\\nbiomaterial at the different laboratories will not only increase reliability, but will be integral to the validation process\\\\\\\\\\\\\\\\nand facilitate the process of developing standard biochemical test for diagnosis of the disorders. Such improved\\\\\\\\\\\\\\\\ndiagnostics will be important to assess disease severity and through validation of biochemical outcome measures\\\\\\\\\\\\\\\\nor biomarkers our efforts will support upcoming clinical trials in CDG. The multiple approaches using state-of-the-\\\\\\\\\\\\\\\\nart technologies will provide data to assess the overall success of the project. Moreover, the biochemical validations\\\\\\\\\\\\\\\\nmay provide a framework for assessing other emerging or yet-to-be identified glycosylation disorders., Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy This study aims to characterize the pathophysiological mechanisms of 21 different metabolic myopathies. The study will focus on exercise capacity and the metabolic derangement during exercise.\",\n          \" Phosphoglucomutase 1 deficiency has recently been reported as a novel disease that belongs to two different classes of metabolic disorders, congenital disorders of glycosylation (CDG) and glycogen storage diseases.This paper focuses on previously reported siblings with short stature, hypothyroidism, increased transaminases, and, in one of them, dilated cardiomyopathy (DCM). An intronic point mutation in the PGM1-gene (c.1145-222 G>T) leads to a complex alternative splicing pattern and to almost complete absence of PGM1 activity.Exercise-induced muscle fatigue, chest pain, and rhabdomyolysis persisted into adulthood. Fainting occurred during the first minutes of strong exercise due to glucose depletion and serum heart troponin was increased. A second wind phenomenon with an improvement in exercise capacity after some minutes of training was observed. Regular aerobic training improved fitness and helped to avoid acute damage. DCM improved during therapy.Glycosylation deficiency was most prominent in childhood. Glycosylation improved with age and further improved with oral galactose supplementation even in adulthood. Optimal improvement of glycosylation-dependent phenotypes should be achieved by early and permanent galactose treatment.However, in case of mutations in ZASP, DCM can develop as a consequence of impaired binding of PGM1 to the heart-specific isoform of ZASP, independently of overall glycosylation efficiency. Thus, even if mutations in PGM1 impair the function of the ZASP-PGM1 complex, supplementation of galactose cannot be expected to restore that function. Therefore, knowledge of PGM1 deficiency in a patient should prompt surveillance of early signs of DCM and specific treatment if necessary.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 148,\n        \"min\": 10,\n        \"max\": 408,\n        \"num_unique_values\": 6,\n        \"samples\": [\n          121,\n          408,\n          14\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Llama_3_n\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-2980098c-de8c-4078-9cd0-e10f5c0c5945\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  &lt;h4&gt;Background&lt;/h4&gt;Congenital disorders of...</td>\n",
              "      <td>[AVTX-801, fucokinase, fcsk, crispr/cas9, cong...</td>\n",
              "      <td>121</td>\n",
              "      <td>{'DBS and Capillary Blood Samples for Transfer...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;h4&gt;Background&lt;/h4&gt;Congenital disorder of gly...</td>\n",
              "      <td>[Sugar, Address, Animal Model, Biochemical Gen...</td>\n",
              "      <td>408</td>\n",
              "      <td>{'This enzyme is involved in the metabolism of...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>A 27 year-old Canadian man suffered from fluc...</td>\n",
              "      <td>[glycogen storage disease, whole exome sequenc...</td>\n",
              "      <td>15</td>\n",
              "      <td>{'Clinical Presentation and Diagnosis of PGM1-...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2</td>\n",
              "      <td>Human phosphoglucomutase 1 (PGM1) plays a cen...</td>\n",
              "      <td>[metabolic disease, enzyme mutation, kinetics,...</td>\n",
              "      <td>10</td>\n",
              "      <td>{'Structural Characterization of PGM1 Mutation...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>3</td>\n",
              "      <td>Metabolism not only produces energy necessary...</td>\n",
              "      <td>[glycosylation, induced pluripotent stem cells...</td>\n",
              "      <td>12</td>\n",
              "      <td>{'LC-MS/MS Method for Metabolic Pathways Conve...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>4</td>\n",
              "      <td>Phosphoglucomutase 1 deficiency has recently ...</td>\n",
              "      <td>[]</td>\n",
              "      <td>12</td>\n",
              "      <td>{'PGM1 Deficiency and Congenital Disorders of ...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>5</td>\n",
              "      <td>Biochemical analysis using biopsied muscle sp...</td>\n",
              "      <td>[]</td>\n",
              "      <td>14</td>\n",
              "      <td>{'Galactosemia Screening and Fulminating Cours...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-2980098c-de8c-4078-9cd0-e10f5c0c5945')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-2980098c-de8c-4078-9cd0-e10f5c0c5945 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-2980098c-de8c-4078-9cd0-e10f5c0c5945');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-0434e7aa-be3a-4634-b405-7c699a473a54\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-0434e7aa-be3a-4634-b405-7c699a473a54')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-0434e7aa-be3a-4634-b405-7c699a473a54 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_513322d0-45fd-42a0-9bbd-a695de6c09ef\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_513322d0-45fd-42a0-9bbd-a695de6c09ef button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  <h4>Background</h4>Congenital disorders of...   \n",
              "1          0   <h4>Background</h4>Congenital disorder of gly...   \n",
              "2          1   A 27 year-old Canadian man suffered from fluc...   \n",
              "3          2   Human phosphoglucomutase 1 (PGM1) plays a cen...   \n",
              "4          3   Metabolism not only produces energy necessary...   \n",
              "5          4   Phosphoglucomutase 1 deficiency has recently ...   \n",
              "6          5   Biochemical analysis using biopsied muscle sp...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [AVTX-801, fucokinase, fcsk, crispr/cas9, cong...   121   \n",
              "1  [Sugar, Address, Animal Model, Biochemical Gen...   408   \n",
              "2  [glycogen storage disease, whole exome sequenc...    15   \n",
              "3  [metabolic disease, enzyme mutation, kinetics,...    10   \n",
              "4  [glycosylation, induced pluripotent stem cells...    12   \n",
              "5                                                 []    12   \n",
              "6                                                 []    14   \n",
              "\n",
              "                                           Llama_3_n  \n",
              "0  {'DBS and Capillary Blood Samples for Transfer...  \n",
              "1  {'This enzyme is involved in the metabolism of...  \n",
              "2  {'Clinical Presentation and Diagnosis of PGM1-...  \n",
              "3  {'Structural Characterization of PGM1 Mutation...  \n",
              "4  {'LC-MS/MS Method for Metabolic Pathways Conve...  \n",
              "5  {'PGM1 Deficiency and Congenital Disorders of ...  \n",
              "6  {'Galactosemia Screening and Fulminating Cours...  "
            ]
          },
          "execution_count": 171,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "data"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "nYuQgHJv6-Zb",
        "outputId": "e0259951-ff1b-41fd-bea2-d77cfe454f29"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "{'key1': 'value1', 'key2': 'value2'}\n"
          ]
        }
      ],
      "source": [
        "import ast\n",
        "\n",
        "def str_to_dict(s):\n",
        "    try:\n",
        "        # Use ast.literal_eval to safely evaluate the string as a dictionary\n",
        "        return ast.literal_eval(s)\n",
        "    except (ValueError, SyntaxError) as e:\n",
        "        print(f\"Error parsing string: {e}\")\n",
        "        return None\n",
        "\n",
        "# Example usage:\n",
        "str_dict = \"{'key1': 'value1', 'key2': 'value2'}\"\n",
        "converted_dict = str_to_dict(str_dict)\n",
        "\n",
        "print(converted_dict)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "4TDK8wBhBwUe"
      },
      "outputs": [],
      "source": [
        "def create_Cluster_node(properties, disease):\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            # Query to create a Cluster node and link it to the Gard node via a relationship\n",
        "            query = (\n",
        "                \"MATCH (g:Gard {GARDname: $disease}) \"  # Match the Gard node with GARDname = $disease\n",
        "                \"CREATE (Cl:Cluster {\"\n",
        "                'Cluster_ID: $Cluster_ID,'\n",
        "                'Cluster_Size: $Cluster_Size,'\n",
        "                'Evidence: $Evidence,'\n",
        "                'Key_trems: $Key_trems'\n",
        "                \"}) \"\n",
        "                \"CREATE (Cl)-[:Cluster_to_GARD]->(g)\"  # Create the relationship between Gard and Cluster\n",
        "            )\n",
        "            session.run(query, **properties, disease=disease)\n",
        "\n",
        "            # Create Expertise nodes for the current cluster if applicable\n",
        "            if properties['Llama_3_n']:  # If 'Key_trems' exists in properties\n",
        "                  dic_expertise=str_to_dict(properties['Llama_3_n'])# Convert to list of expertise terms\n",
        "                  for sentence in dic_expertise:\n",
        "                       if (sentence!= '') and (sentence.lower() != disease.lower()) and (dic_expertise[sentence]!=''):\n",
        "                                      create_expertise_node(session, sentence, dic_expertise[sentence],properties['Cluster_ID'], disease)\n",
        "\n",
        "\n",
        "\n",
        "def create_expertise_node(session, sentence,explan, cluster_id, disease):\n",
        "    # Create a new Expertise node with a relationship to the Cluster\n",
        "    query = (\n",
        "        \"MERGE (e:Expertise {Summarized_expertise: $sentence, expertise_explanation:$explan}) \"\n",
        "        \"WITH e \"\n",
        "        \"MATCH (c:Cluster)--(g:Gard) \"\n",
        "        \"WHERE c.Cluster_ID = $cluster_id AND g.GARDname = $disease \"\n",
        "        \"CREATE (c)-[:HAS_EXPERTISE ]->(e)\"\n",
        "    )\n",
        "    session.run(query, sentence=sentence, explan=explan,cluster_id=cluster_id, disease=disease)\n",
        "\n",
        "# Iterate over data to create Cluster and Expertise nodes\n",
        "for i in data.index:\n",
        "    event_properties = {\n",
        "        'Cluster_ID': str(data['Community'][i]),\n",
        "        'Cluster_Size': str(data['Size'][i]),\n",
        "        'Evidence': str(data['Abstract'][i]),\n",
        "        'Key_trems': str(data['frequent_words'][i]),\n",
        "        'Llama_3_n': data['Llama_3_n'][i],\n",
        "    }\n",
        "    create_Cluster_node(event_properties, disease)\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "s_st3WMYv1f6",
        "outputId": "505063f6-93c0-4fc1-8a49-cd24f1029af4"
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "Index(['PI', 'Abstract', 'affiliation', 'name', 'Terms', 'Community'], dtype='object')"
            ]
          },
          "execution_count": 89,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "clustering_.columns"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "ICx0mqioCGqb"
      },
      "outputs": [],
      "source": [
        "def create_relationship_cluster_researcher(community, name, affiliation, disease):\n",
        "    \"\"\"\n",
        "    Creates a relationship between Cluster and Researcher nodes in Neo4j only if\n",
        "    the Cluster node is already connected to the Gard node.\n",
        "    \"\"\"\n",
        "    with GraphDatabase.driver(uri, auth=(username, password)) as driver:\n",
        "        with driver.session() as session:\n",
        "            query = (\n",
        "                \"MATCH (n1:Cluster)--(i:Gard), (n2:Researcher) \"\n",
        "                \"WHERE i.GARDname = $disease AND n1.Cluster_ID = $community \"\n",
        "                \"AND n2.Name = $name AND n2.Aff_name = $affiliation \"\n",
        "                \"CREATE (n1)-[:Research_on]->(n2)\"\n",
        "            )\n",
        "            session.run(query, community=community, name=name, affiliation=affiliation, disease=disease)\n",
        "\n",
        "for i in clustering_.index:\n",
        "    # Check if node_value is a tuple/list, otherwise skip or handle it differently\n",
        "        create_relationship_cluster_researcher(\n",
        "            str(clustering_['Community'][i]),\n",
        "            clustering_['PI'][i],  # Researcher name\n",
        "            clustering_['affiliation'][i],  # Affiliation\n",
        "            disease  # Disease value (make sure this exists in your DataFrame)\n",
        "        )"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "ZZQngnxOD443"
      },
      "source": [
        "#Alltogether"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "L3ObRvNBF67X",
        "outputId": "2be159cc-52e5-4079-cbad-ca5137d677c2"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Diaphanospondylodysostosis\n",
            "114\n",
            "18\n",
            "------------------\n",
            "7\n",
            "6\n",
            "5\n"
          ]
        }
      ],
      "source": [
        "disease= A[8]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        "diseaseid=B[8] #'GARD0017510'\n",
        "print(disease)\n",
        "concatenated_data= merge_community_detection_and_researchers_info(disease)\n",
        "print(concatenated_data.shape[0])\n",
        "# Assuming you have a DataFrame `clustering_2`\n",
        "#concatenated_data_summary=concatenated_data[['Abstract','Terms']].drop_duplicates()\n",
        "clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', num_clusters=3, n_components=200)\n",
        "\n",
        "result = clustering_.groupby('Community').agg(\n",
        "    Abstract=('Abstract', sum_strings),\n",
        "    Terms=('Terms', sum_terms),\n",
        "    Size=('Community', 'size')  # Count of occurrences\n",
        " ).reset_index()\n",
        "\n",
        "data=result\n",
        "\n",
        "print(len(clustering_['Abstract'].unique()))\n",
        "print('------------------')\n",
        "for i in data.index:\n",
        "    ASD= clustering_[clustering_['Community']==i]\n",
        "    print( ASD['Abstract'].drop_duplicates().shape[0] )"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "P4vXMhjYGNto",
        "outputId": "3354beb2-488a-46ce-aa05-b54987898cec"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "38\n",
            "------------------\n",
            "1\n",
            "33\n",
            "1\n",
            "1\n",
            "1\n",
            "1\n"
          ]
        }
      ],
      "source": [
        "\n",
        "  #print(len(data['Abstract'][i]))"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 181
        },
        "id": "FxwSXcTL0I0i",
        "outputId": "f4662626-1898-4ac0-fa34-552f20d6526f"
      },
      "outputs": [
        {
          "ename": "IndexError",
          "evalue": "index 5 is out of bounds for axis 0 with size 5",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mIndexError\u001b[0m                                Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-253-eb3970af0169>\u001b[0m in \u001b[0;36m<cell line: 3>\u001b[0;34m()\u001b[0m\n\u001b[1;32m      1\u001b[0m \u001b[0mASD\u001b[0m\u001b[0;34m=\u001b[0m \u001b[0mclustering_\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0mclustering_\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'Community'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m==\u001b[0m\u001b[0;36m2\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m      2\u001b[0m \u001b[0mASD\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mASD\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m'Abstract'\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0munique\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m----> 3\u001b[0;31m \u001b[0mASD\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m5\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m",
            "\u001b[0;31mIndexError\u001b[0m: index 5 is out of bounds for axis 0 with size 5"
          ]
        }
      ],
      "source": [
        "ASD= clustering_[clustering_['Community']==2]\n",
        "ASD=ASD['Abstract'].unique()\n",
        "ASD[5]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "gaMBH3J4HFK-",
        "outputId": "ca11dd88-9dee-43ef-fd36-199fda7c045e"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "type": "string"
            },
            "text/plain": [
              "\" ,  <h4>Clinical characteristics</h4>KAT6B disorders include genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome (SBBYSS) which are part of a broad phenotypic spectrum with variable expressivity; individuals presenting with a phenotype intermediate between GPS and SBBYSS have been reported. Both phenotypes are characterized by some degree of global developmental delay / intellectual disability; hypotonia; genital abnormalities; and skeletal abnormalities including patellar hypoplasia/agenesis, flexion contractures of the knees and/or hips, and anomalies of the digits, spine, and/or ribs. Congenital heart defects, small bowel malrotation, feeding difficulties, slow growth, cleft palate, hearing loss, and dental anomalies have been observed in individuals with either phenotype.<h4>Diagnosis/testing</h4>The diagnosis of a KAT6B disorder is established by the identification of a heterozygous pathogenic variant in KAT6B on molecular genetic testing.<h4>Management</h4>Treatment of manifestations: Medical problems associated with gastrointestinal, genitourinary, cardiac, palatal or dental anomalies; abnormal vision or lacrimal duct abnormality; hearing loss; or hypothyroidism associated with KAT6B disorders are treated or managed in the standard manner by the appropriate specialist. Referral to an early intervention program to access occupational, physical, speech, and feeding therapy beginning in infancy. Orthopedic intervention as needed for contractures and clubfoot; physical therapy to increase joint mobility. Surveillance: Evaluations of developmental progress and educational needs, assessment for feeding issues, and monitoring for hearing loss, amblyopia, hypothyroidism, and contractures and/or scoliosis should occur annually. Evaluation and monitoring of cardiac malformation and/or renal function (if hydronephrosis or renal cysts are present) as needed.<h4>Genetic counseling</h4>KAT6B disorders are inherited in an autosomal dominant manner. To date, most individuals with a KAT6B disorder have had a de novo pathogenic variant. Prenatal and preimplantation genetic testing are possible for families in which the pathogenic variant has been identified.,  <h4>Introduction</h4>Genitopatellar syndrome is characterized by absent/hypoplastic patellae, genital and renal abnormalities, dysmorphic facial features, and mental retardation. Cardiac anomalies, ectodermal dysplasia, and radio-ulnar synostosis have been suggested as additional features.<h4>Discussion</h4>We report on additional female patient with sensorineural hearing loss, cleft palate, and hypothyroidism in addition to known anomalies. Findings are discussed based on a literature review of the known patients with the genitopatellar syndrome.,  Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is an autosomal dominant disorder caused by mutations in FOXL2. We identified an individual with BPES and additional phenotypic features who did not have a FOXL2 mutation. We used whole exome sequencing to identify a de novo mutation in KAT6B (lysine acetyltransferase 6B) in this individual. The mutation was a 2-bp insertion leading to a frameshift which resulted in a premature stop codon. The resulting truncated protein does not have the C-terminal serine/methionine transcription activation domain necessary for interaction with other transcriptional and epigenetic regulators. This mutation likely has a dominant-negative or gain-of-function effect, similar to those observed in other genetic disorders resulting from KAT6B mutations, including Say-Barber-Biesecker-Young-Simpson (SBBYSS) and genitopatellar syndrome (GTPTS). Thus, our subject's phenotype broadens the spectrum of clinical findings associated with mutations in KAT6B. Furthermore, our results suggest that individuals with BPES without a FOXL2 mutation should be tested for KAT6B mutations. The transcriptional and epigenetic regulation mediated by KAT6B appears crucial to early developmental processes, which when perturbed can lead to a wide spectrum of phenotypic outcomes.,  Genetic disorders characterized by congenital patellar aplasia or hypoplasia belong to a clinically diverse and genetically heterogeneous group of lower limb malformations. Patella development involves different molecular and cellular mechanisms regulating dorso-ventral patterning, cartilage and bone formation along endochondral ossification pathways, and growth. Several human genes that are important for patella development have been uncovered by the study of human limb malformation syndromes, yet causative genes for many more such disorders await to be identified and their complex interactions in the developmental pathways deciphered. Mutant animal models of congenital patellar aplasia or hypoplasia are certainly instrumental to create more insight into this aspect of limb development. Moreover, investigation of the complete phenotype of human syndromes and animal models may reveal novel insights into the pleiotropic roles of the responsible genes in the normal developmental of other organ systems. In this review, the phenotype and gene defects of syndromes with congenital patellar aplasia or hypoplasia will be discussed, including the nail patella syndrome, small patella syndrome, isolated patella aplasia hypoplasia, Meier-Gorlin syndrome, RAPADILINO syndrome, and genitopatellar syndrome.,  Genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS or Ohdo syndrome) have both recently been shown to be caused by distinct mutations in the histone acetyltransferase KAT6B (a.k.a. MYST4/MORF). All variants are de novo dominant mutations that lead to protein truncation. Mutations leading to GPS occur in the proximal portion of the last exon and lead to the expression of a protein without a C-terminal domain. Mutations leading to SBBYSS occur either throughout the gene, leading to nonsense-mediated decay, or more distally in the last exon. Features present only in GPS are contractures, anomalies of the spine, ribs and pelvis, renal cysts, hydronephrosis, and agenesis of the corpus callosum. Features present only in SBBYSS include long thumbs and long great toes and lacrimal duct abnormalities. Several features occur in both, such as intellectual disability, congenital heart defects, and genital and patellar anomalies. We propose that haploinsufficiency or loss of a function mediated by the C-terminal domain causes the common features, whereas gain-of-function activities would explain the features unique to GPS. Further molecular studies and the compilation of mutations in a database for genotype-phenotype correlations (www.LOVD.nl/KAT6B) might help tease out answers to these questions and understand the developmental programs dysregulated by the different truncations.,  Genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) are rare genetic disorders linked to mutations in the Lysine Acetyltransferase 6B (KAT6B) gene, affecting histone acetylation regulation and developmental processes. We present a case of an African American infant with classic GPS features and a novel KAT6B gene mutation (c.4066del, p.Glu1356Argfs*23). The patient exhibited skeletal anomalies, neurologic deficits, and genitourinary abnormalities, consistent with GPS. Genetic analysis revealed a de novo heterozygous pathogenic variant, adding to the growing understanding of KAT6B-related disorders. Reviewing recent literature, we found an increased prevalence of reported cases and novel gene variants, supporting the delineation of GPS and SBBYSS. Furthermore, analysis suggests a preference range within the gene associated with GPS phenotypes, challenging the notion of a spectrum of KAT6B-related disorders. As genetic sequencing advances, continued reporting of cases will inform decisions regarding the classification of these disorders.,  Genitopatellar syndrome (GPS) is a rare autosomal dominant disorder caused by de novo pathogenic variants in the <i>KAT6B</i> gene. It is characterized by genital abnormalities, patellar hypoplasia/agenesis, flexion contractures of the hips and knees, corpus callosum agenesis with microcephaly, and hydronephrosis and/or multiple renal cysts. More than half of patients with GPS have congenital heart defects, mostly atrial and/or ventricular septal defects, patent foramen ovale, and patent ductus arteriosus. We report a case of a Japanese neonate with a de novo heterozygous c.3769_3772delTCTA pathogenic variant in the <i>KAT6B</i> gene who presented with a cardiac intramural cavity of the ventricular septum at birth. The cavity unexpectedly disappeared at 1 month of age, but trabecular septal thinning and flash remained. The features of the cavity were not consistent with those of congenital ventricular diverticulum or aneurysm, and its identity and prognosis are still unclear. Because patients with GPS may exhibit various forms of cardiac malformation, careful cardiac examination and follow-up are required from birth in cases of suspected GPS.,  Genitopatellar syndrome (GPS) is a rare disorder with characteristic craniofacial features, congenital flexion contractures of the lower limbs, absent or abnormal patellae, urogenital anomalies, and severe psychomotor retardation. Twelve patients with ages from 15 days to 12 years and two affected fetuses have been reported. We describe a 17-year-old female with a phenotype consistent with GPS. Being the oldest reported patient, she is the first one showing severe symptomatic osteoporosis and endocrine abnormalities including primary hypothyroidism and delayed puberty. We suggest that these novel findings are also manifestations of GPS.,  Genitopatellar syndrome (GPS) is mainly characterized by an absence of patellae, congenital flexion contractures of the lower limbs, psychomotor retardation, and anomalies of the external genitalia and kidneys. We report an 18-year-old female with a novel heterozygous truncating mutation in exon 17 of the KAT6B gene [MC_000010.11:c.3603_3606 del, p.Arg1201fs]. This is the first report of typical GPS in a Japanese individual. The details of our findings may contribute to elucidating the mechanism underlying GPS-specific clinical features.,  Genitopatellar syndrome is a newly described condition, subject of a single literature report to date. The condition comprises absent patellae, genital and renal malformations, joint dislocation, and mental retardation. Recurrence has been recorded in two kindreds, consistent with autosomal recessive inheritance.,  Genitopatellar syndrome is a recently described disorder with characteristic facies, genital anomalies, absent patella, flexion contractures, microcephaly, renal anomalies, and mental retardation. The presence of affected siblings in two of the original families suggests autosomal recessive inheritance. We report a new patient that exhibits all of these cardinal features and is also the second case to have additional, more severe findings including a congenital heart defect, anal anomalies, and features of an ectodermal dysplasia, thus expanding the phenotype to include these manifestations.,  Genitopatellar syndrome is one of the syndromes described in the last decade. It is characterized by agenesis of the corpus callosum, absent or hypoplastic patellae, extremity contractures, skeletal anomalies, urogenital anomalies, and facial dysmorphic features. While writing this report, only 15 cases have been reported in the literature. The etiology, clinical features, management, and natural history of this syndrome are not yet well established. Past reports in the literature have not been able to identify the exact genetic etiology but it somewhat coincides with nail patella syndrome and short patella syndrome. We would like to introduce this terminology to the orthopedic community and highlight the clinical features of the genitopatellar syndrome. To the best of our knowledge, this is a single case report with the longest follow-up of 11 years in the literature.,  Mutations in KAT6B gene are responsible for Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and genitopatellar syndrome (GPS), with most mutations occurring in exon 18. A 4-year-old Chinese boy presented with short stature but no other clinical features of SBBYSS or GPS had a de novo novel nonsense pathogenic mutation in exon 14 of the KAT6B gene at position c.2636T>A (p.Leu879X). The correlation analysis of genotype-phenotype indicated distinctive clinical features (short stature, growth hormone deficiency, and delayed bone age) compared with the classical mutations of KAT6B gene. To the best of our knowledge, this is the first report of KAT6B gene mutation in any Chinese individual. This work expands the mutant phenotypic spectrum of the KAT6B gene.,  Mutations of the histone acetyltransferase-encoding KAT6B gene cause the Say-Barber-Biesecker/Young-Simpson (SBBYS) type of blepharophimosis-\\\\mental retardation\\\\ syndromes and the more severe genitopatellar syndrome. The SBBYS syndrome-causing mutations are clustered in the large exon 18 of KAT6B and almost exclusively lead to predicted protein truncation. An atypical KAT6B mutation, a de novo synonymous variant located in exon 16 (c.3147G>A, p.(Pro1049Pro)) was previously identified in three unrelated patients. This exonic mutation was predicted in silico to cause protein truncation through aberrant splicing. Here, we report three additional unrelated children with typical SBBYS syndrome and the KAT6B c.3147G>A mutation. We show on RNA derived from patient blood that the mutation indeed induces aberrant splicing through the use of a cryptic exonic splice acceptor site created by the sequence variant. Our results thus identify the synonymous variant c.3147G>A as a splice site mutation and a mutational hot spot in SBBYS syndrome.,  Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and Genitopatellar syndrome (GTPTS) are very rare conditions caused by KAT6B truncating variants. Because of both syndromes often share common features the associated phenotypes are usually grouped under the term \\\\KAT6B-related disorders.\\\\ However, particular signs of each syndrome have been reported and their appearance seems to be dependent on where the KAT6B variant is located. Thus, whereas truncating variants associated with SBBYSS have their highest density in the distal part of exon 18, those resulting in GTPTS are distributed between the end of exon 17 and beginning of exon 18. Here, we reported two de novo heterozygous KAT6B truncating variants. The first variant (c.5802delA; p.A1935Pfs*16), identified in a boy with SSBYSS phenotype, resulting in the most distal KAT6B truncating variant reported up-to-date in the scientific literature. The second variant (c.3152delG; p.S1051Tfs*63), located in a region hitherto defined as specific of SBBYSS, seems to cause an overlapping SBBYSS/GTPTS phenotype. The clinical and genetic characterization of these patients could contribute to the understanding of the KAT6B-related disorders.,  Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and genitopatellar syndrome (GPS) are caused by variants of lysine acetyltransferase 6B (<i>KAT6B</i>). These variants tend to occur in the terminal exons of <i>KAT6B</i>. Here, we report a patient with global developmental delay, intellectual disability, autistic behavior, muscular hypotonia, facial dysmorphism, and seizures caused by a novel missense variant in exon 7 of <i>KAT6B</i>. The patient showed a phenotype differing from those of SBBYSS and GPS. We also report patients with missense variants in the proximal exons of <i>KAT6B</i> showing dysmorphic features and autistic behavior not resembling the characteristics of SBBYSS and GPS. Missense variants in the proximal exons of <i>KAT6B</i> may have a dominant negative effect or cause gain of function, leading to unique phenotypes not resembling those of SBBYSS and GPS.,  Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and genitopatellar syndrome (GTPTS) are clinically similar disorders with some overlapping features. Although they are currently considered to be distinct clinical entities, both were found to be caused by de novo truncating sequence variants in the KAT6B (lysine acetyltransferase 6B) gene, strongly suggesting that they are allelic disorders. Herein, we report the clinical and genetic findings in a girl presenting with a serious multiple congenital anomaly syndrome with phenotypic features overlapping both SBBYSS and GTPTS; pointing out that the clinical distinction between these disorders is not exact and there do exist patients, in whom conventional clinical classification is problematic. Genetic analyses revealed a truncating c.4592delA (p.Asn1531Thrfs*18) variant in the last KAT6B exon. Our findings support that phenotypes associated with typical KAT6B disease-causing variants should be referred to as 'KAT6B spectrum disorders' or 'KAT6B related disorders', rather than their current SBBYSS and GTPTS classification.,  Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS, OMIM#603736) and genitopatellar syndrome (GTPTS, OMIM#606170), characterized by global developmental delay/intellectual disability and special clinical manifestations, are two distinct clinically overlapping syndromes caused by truncating sequence variants in the KAT6B (10q22.2) gene. We detected a de novo heterozygous variant within exon 16 of KAT6B (Chr10p: 76781966-76781967) in a 7-months-old female infant who showed symptoms of short stature, global developmental delay, blepharophimosis, and lacrimal duct anomalies highly consistent with SBBYSS. Following the clinical features, we analyzed the KAT6B gene using Next Generation Sequencing (NGS) techniques. Her parents didn't present the same genetic variant. The patient we reported here is mainly characterized by syndromic forms of short stature and developmental delay, which may contribute to the understanding of clinical genetics for KAT6B-associated disorders.,  The Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome (SBBYSS) (MIM# 603736) and genitopatellar syndrome (GPS) (MIM#606170) are allelic diseases caused by KAT6B mutation. Genotype-phenotype correlation is assumed, but a few patients manifest overlapping features of both syndromes. Here we report the case of a boy with SBBYSS. He had a KAT6B mutation previously reported in typical SBBYSS, but he also manifested severe developmental delay, as well as genital features and laryngomalacia requiring tracheostomy that conformed to GPS.,  The Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome (SBBYSS) and Genitopatellar syndrome (GTPTS) are 2 rare but clinically well-described diseases caused by de novo heterozygous sequence variants in the KAT6B gene. Both phenotypes are characterized by significant global developmental delay/intellectual disability, hypotonia, genital abnormalities, and patellar hypoplasia/agenesis. In addition, congenital heart defects, dental abnormalities, hearing loss, and thyroid anomalies are common to both phenotypes. This broad clinical overlap led some authors to propose the concept of KAT6B spectrum disorders. On the other hand, some clinical features could help to differentiate the 2 disorders. Furthermore, it is possible to establish a genotype-phenotype correlation when considering the position of the sequence variant along the gene, supporting the notion of the 2 disorders as really distinct entities.,  We report on the association of absent patellae, genital and renal anomalies, dysmorphic features, and mental retardation in seven children (six boys and one girl) belonging to five unrelated families. Flexion deformities of the knees and hips with club feet and absent patellae were consistently observed and scrotal hypoplasia and cryptorchidism were present in all boys (6/6). Dysmorphic features included a coarse face, a large nose with a high nasal bridge, and microcephaly. Other features included renal anomalies (multicystic kidneys or hydronephrosis, 7/7), agenesis of the corpus callosum (4/7), swallowing difficulties, micrognathia (4/7), and pulmonary hypoplasia (3/7). Bilateral hypoplasia of the ischia and brachydactyly were also consistently observed (5/5). In two out of seven cases, prenatal ultrasound detection of microcephaly and renal anomalies led to termination of the pregnancy at 27 weeks. Three children died during the first years of life and the remaining two who survived exhibit severe developmental delay. High resolution cytogenetic studies performed on lymphocytes or fibroblasts or both were normal in all cases. Recurrence in two families suggests an autosomal recessive mode of inheritance. We propose that this unusual association, similar to that observed in a 4 year old boy by Goldblatt et al, represents a new syndrome distinct from previously reported hypoplastic patella syndromes.,  We report the second female with genitopatellar syndrome, a recently identified arthrogryposis syndrome. The salient features include severe mental retardation and microcephaly with absence of the corpus callosum, absent/hypoplastic patellae, genital anomalies, and hydronephrosis., PROJECT ABSTRACT\\\\\\\\\\\\\\\\nEpigenetic factors are genes that encode proteins that can affect spatial organization of DNA and the\\\\\\\\\\\\\\\\naccessibility of genetic regions to transcriptional machinery, thereby regulating cell-type specific transcription.\\\\\\\\\\\\\\\\nPathogenic mutations in established epigenes are highly enriched in children with pediatric syndromic disorders,\\\\\\\\\\\\\\\\noften with symptoms that affect multiple organ systems, such as the brain, heart, gastrointestinal tract, bone, eye\\\\\\\\\\\\\\\\nand kidneys. The associated symptoms of intellectual disability, developmental delays, autism, diarrhea and\\\\\\\\\\\\\\\\ncongenital heart defects vary in severity between individuals. The onset of these syndromes during early\\\\\\\\\\\\\\\\nchildhood suggest that many of these epigenetic factors are critical to early developmental processes and cell-\\\\\\\\\\\\\\\\nfate transitions. Despite our improved diagnostic ability with exome sequencing, the mechanistic link between\\\\\\\\\\\\\\\\nepigenetic factor mutations and the direct mechanisms by which they disrupt mammalian developmental\\\\\\\\\\\\\\\\nprocesses remains unknown. Histone acetyltransferases (HATs) are genes that acetylate lysine (K) residues\\\\\\\\\\\\\\\\nand represent a common mechanism for controlling DNA accessibility to the transcriptional machinery. Here, we\\\\\\\\\\\\\\\\nstudy protein-truncating variants in two HATs: Lysine (K), Acetyl transferase 6A and 6B (KAT6A and KAT6B),\\\\\\\\\\\\\\\\nwhich cause Arboleda-Tham Syndrome (ARTHS) and Genitopatellar Syndrome (GPS) or Say-Barber-Biesecker-\\\\\\\\\\\\\\\\nYoung Syndrome (SBBYS), respectively. Our goal is to develop and validate transgenic mouse models harboring\\\\\\\\\\\\\\\\npatient-specific mutations in these genes to establish the differential roles of these epigenetic factors on cell\\\\\\\\\\\\\\\\nspecification during development driving the distinct syndromes.\""
            ]
          },
          "execution_count": 86,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "data['Abstract'][1]  #11"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "PCSjHoklGGvD",
        "outputId": "0d09159c-d18c-41f1-ed08-2173856c6585"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n",
            " ,  Bone morphogenic proteins (BMPs) are important growth regulators in embryogenesis and postnatal homeostasis. Their tight regulation is crucial for successful embryonic development as well as tissue homeostasis in the adult organism. BMP inhibition by natural extracellular biologic antagonists represents the most intensively studied mechanistic concept of BMP growth factor regulation. It was shown to be critical for numerous developmental programs, including germ layer specification and spatiotemporal gradients required for the establishment of the dorsal-ventral axis and organ formation. The importance of BMP antagonists for extracellular matrix homeostasis is illustrated by the numerous human connective tissue disorders caused by their mutational inactivation. Here, we will focus on the known functional interactions targeting BMP antagonists to the ECM and discuss how these interactions influence BMP antagonist activity. Moreover, we will provide an overview about the current concepts and investigated molecular mechanisms modulating BMP inhibitor function in the context of development and disease.,  Diaphanospondylodysostosis is an extremely rare, recessively inherited, perinatal lethal skeletal disorder associated with BMPER gene mutations. Clinically it is characterized by defects in costovertebral ossification, absent ribs, hypertelorism, short nose with depressed nasal bridge, low-set ears, and short neck. At the extraosseous level, the most frequent pathologic finding is nephroblastomatosis with multicystic kidneys. We present the case of a child of non-consanguineous parents who died at 2 months of age in our center. Autopsy showed a marked costovertebral ossification defect, perilobar nephrogenic rests and loss of white matter with periventricular leukomalacia. After genetic study, the diagnosis of diaphanospondylodysostosis was confirmed. A previously undescribed germinal mutation in the BMPER gene (c.576 + 2dupT) was found.,  We present a case of diaphanospondylodysostosis (DSD) which showed increased nuchal translucency at 1st trimester and missing ossification of the lower spine, short ribs with posterior gaps, and absent nasal bone in midtrimester. Autopsy revealed additionally bilateral nephroblastomatosis. Molecular genetic analysis showed a new mutation in the BMPER gene.,  We report on four patients from three families, with similar radiological findings: absent (or severely delayed) ossification of vertebral bodies and associated anomalies. The babies were stillborn or died soon after birth of respiratory insufficiency. Two patients are sibs (female and male) born to first cousin Malian parents. The two others were non-consanguineous. This perinatally lethal entity comprises short neck, short wide thorax, and normally shaped limbs. Associated, inconstant anomalies are myelomeningocele, cystic kidneys with nephrogenic rests (in the sibs), and cleft palate. Radiologically, the hallmarks are absence of ossification of the vertebral bodies and sacrum, abnormal position of the vertebral pedicles, which are lamellar and angulated, ribbon-like ribs reduced in number, narrow pelvis, upward widening of the iliac wings, and unusual tilt of the ischiopubic rami, contrasting with the normal appendicular skeleton. Maroteaux briefly described one of the patients in the 2002 edition of \\Maladies osseuses de l'enfant\\ and three sibs with similar renal and radiological findings were reported in 2003 in this Journal. Combined with the latter cases, these four new patients allow delineation of a specific lethal AR syndrome with ossification defect of the axial skeleton and renal dysplasia. We propose to name this entity diaphanospondylodysostosis.,  We report on six cases from four families with the newly described skeletal disorder diaphanospondylodysostosis (DSD). The characteristic radiographic findings included abnormal ossification of vertebral bodies, posterior rib gaps, missing ribs, and a downward tilt of the pubic rami, but normal long bones. The typical facial features of DSD cases were ocular hypertelorism, a short nose, depressed nasal bridge, and low set ears. Other distinctive findings included a short neck with bell-shaped thorax, and nephroblastomatosis. A history of consanguinity and affected siblings with unaffected parents supports autosomal recessive inheritance. Skeletal histology showed incomplete ossification of the ribs, vertebral bodies, and sacrum as well as incomplete formation of intervertebral discs. The posterior ribs were comprised of bone with intervening cartilage interrupted by dense fibrous tissue and skeletal muscle fascicles. These findings suggest abnormal development and differentiation of the paraxial mesoderm. Because of phenotypic similarities of DSD to Pax1 and Meox1 deficient mice, we sequenced genomic DNA from three unrelated DSD cases. No mutations were identified in the PAX1 and MEOX1 exons or flanking intronic sequences, excluding them as likely causative genes., The skeletal dysplasias (SDs) are a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000. This project is aimed at defining the clinical, genetic, prenatal, pathologic, molecular, and pathophysiologic.features of these disorders to assist in understanding their causes and provide better information and clinical care to patients and families. Specific aims include: 1. To improve the characterization of the SDs: Using the large number of cases collected, we will continue our long-standing effort to improve the definition of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs. We will define novel disorders, and improve the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. We will test the hypothesis that flexion-extension MRI studies with measurements of cerebrospinal and venous flow will aid n defining the need for surgery in patients with ACH, an area of current controversy. 2. To define the prenatal presentation of the SDs and improve prenatal diagnosis: Many of the SDs, both lethal and nonlethal, have evidence of skeletal abnormalities in the prenatal period. We hypothesize that by employing 2D and 3D prenatal ultrasound (UTZ) and then correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. We will objectively determine UTZ parameters that best predict lethality in the immediate neonatal period, establish prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determine differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias. 3. To determine phenotype-genotype correlations in the SDs: Comparing the clinical phenotype with molecular and biochemical defects has allowed us to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. We will also continue studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. We further propose to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. We will test the hypothesis that diaphanospondylodysostosis (DSD) is caused by mutations in the Pax1 gene.\n",
            "['Diaphanospondylodysostosis', 'BMPER', 'Diaphanospondylodysostosis', 'BMPER', 'Diaphanospondylodys\n",
            "1\n",
            " Bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) gene mutation presents a disease spectrum ranging from a mild type of ischiospinal dysostosis (ISD) to a more severe type of diaphanospondylodysostosis (DSD). It is known that BMPER gene mutations are very rare, and their resulting clinical manifestations, including musculoskeletal modifications, appear in a spectrum of various types and severity levels. With the development of genetic diagnosis, case reports of patients with specific mutations in the BMPER gene have been published. The most commonly known clinical features are kidney structural problems, including neuroblastoma and renal cysts. Meanwhile, respiratory failure is a common and fatal symptom for patients with BMPER gene mutation, but it does not appear to have been well evaluated or managed so far. We report a case of a confirmed novel mutation of c.1750delT (p.Cys584fs) in the BMPER gene in a female adolescent patient and highlight the importance of the regular assessment of respiratory failure for successful management of this condition.,  Diaphanospondylodysostosis (DSD) and ischiospinal dysostosis (ISD) are both rare skeletal dysplasias consisting of abnormal axial skeletal development but normal appendicular skeletal development. Both disorders recently have been found to result from mutations in the BMPER gene. We report a patient with one deletion and one mutation of the BMPER gene who has features most consistent with DSD but who has survived to age 9 years. Survival suggests that DSD and ISD reflect a spectrum of severity of one disease process.,  Diaphanospondylodysostosis (DSD) is a rare skeletal dysplasia syndrome resulting from disordered mesenchymal differentiation. Children with DSD generally die in utero or during the first month of life from severe thoracic insufficiency syndrome. An association of DSD with nephroblastomatosis has been observed, but the natural history of such nephroblastomatosis remains poorly characterized due to the rarity of the underlying condition. We describe a patient with DSD who developed bilateral hyperplastic nephroblastomatosis that ultimately evolved into therapy-resistant anaplastic Wilms tumor (nephroblastoma).,  Diaphanospondylodysostosis (DSD) is a rare, recessively inherited, perinatal lethal skeletal disorder. The low frequency and perinatal lethality of DSD makes assembling a large set of families for traditional linkage-based genetic approaches challenging. By searching for evidence of unknown ancestral consanguinity, we identified two autozygous intervals, comprising 34 Mbps, unique to a single case of DSD. Empirically testing for ancestral consanguinity was effective in localizing the causative variant, thereby reducing the genomic space within which the mutation resides. High-throughput sequence analysis of exons captured from these intervals demonstrated that the affected individual was homozygous for a null mutation in BMPER, which encodes the bone morphogenetic protein-binding endothelial cell precursor-derived regulator. Mutations in BMPER were subsequently found in three additional DSD cases, confirming that defects in BMPER produce DSD. Phenotypic similarities between DSD and Bmper null mice indicate that BMPER-mediated signaling plays an essential role in vertebral segmentation early in human development.,  Diaphonospondylodysostosis (DSD) is a rare, recessively inherited, lethal skeletal dysplasia, characterized by severe spinal ossification, segmentation defects, and renal cystic dysplasia with nephrogenic rests. We hereby present three affected individuals: two children and a fetus from two unrelated East Jerusalem Arab-Muslim families. Whereas most fetuses die in utero or perinatally, one of the children survived to 15 months. Homozygosity mapping in the two families demonstrated a single common 3.87 Mb region on chromosome 7, ruling out previously known spondylocostal/spondylothoracic dysostosis loci. The 15 protein coding genes in the region were prioritized, and some were sequenced. A single, novel deleterious mutation, Q104X, was detected in the bone morphogenetic protein-binding endothelial regulator protein (BMPER) gene, recently reported to be mutated in other DSD patients [Funari et al., 2010]. The novel mutation we identified is an ancestral founder allele, as evidenced by a shared 440 SNP haplotype, and its frequency in the general Arab population is estimated to be <1:123. Our findings confirm loss of BMPER function as a cause of axial versus appendicular skeletal defects, and suggest that less deleterious mutations may be involved in milder axial skeleton abnormalities.,  Ischiospinal dysostosis (ISD) is a polytopic dysostosis characterized by ischial hypoplasia, multiple segmental anomalies of the cervicothoracic spine, hypoplasia of the lumbrosacral spine and occasionally associated with nephroblastomatosis. ISD is similar to, but milder than the lethal/semilethal condition termed diaphanospondylodysostosis (DSD), which is associated with homozygous or compound heterozygous mutations of bone morphogenetic protein-binding endothelial regulator protein (BMPER) gene. Here we report for the first time biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. Our data supports and further extends the phenotypic variability of BMPER-related skeletal disorders.\n",
            "['Bone Morphogenetic Protein Binding Endothelial Cell Precursor Derived Regulator', 'Diaphanospondylodysostosis', 'Ischiospinal Dysostosis', 'Is\n",
            "2\n",
            " <h4>Background</h4>Diaphanospondylodysostosis (DSD) is a rare congenital, lethal skeletal disorder caused by recessively inherited mutations in the BMPER gene, which encodes the bone morphogenetic protein-binding endothelial cell precursor-derived regulator. The most prominent features of DSD are missing ossification of the axial skeleton, rib abnormalities and thoracic hypoplasia/insufficiency, as well as intralobar nephrogenic rests within the kidneys.<h4>Methods</h4>We report on the case of a 22-month-old patient with DSD where trio-exome sequencing was performed.<h4>Results</h4>Genetic testing revealed a homozygous nonsense variant c.1577G>A (p.Trp526*) in the BMPER gene, leading to a premature stop in protein translation. Both parents are asymptomatic carriers for the BMPER variant, which has not been described in the literature before.<h4>Conclusions</h4>Our findings expand the genotypic and phenotypic spectrum of BMPER variants leading to DSD.,  Diaphanospondylodysostosis (DSD) is a rare autosomal recessive skeletal disorder, characterized mainly by ossification defects in vertebrae, thorax malformations, renal cystic dysplasia and usually death in the perinatal period. DSD is caused by mutations in the bone morphogenetic protein-binding endothelial regulator (BMPER) gene. We describe the prenatal findings of a non-consanguineous Jewish couple (shared Balkan origin), with three affected fetuses that presented with malformations in the spine and chest, reduced ossification of the skull and spine, horseshoe kidney and increased nuchal translucency. The unique combination of these ultrasound (US) features raised the possibility of DSD, which was confirmed by whole exome sequencing (WES) performed on a single fetal DNA and familial segregation. In the three fetuses, a novel homozygous mutation in BMPER (c.410T > A; p.Val137Asp) was found. This mutation, which segregated in the family, was not found in 65 controls of Jewish Balkan origin, and in several large databases. Taken together, the combination of a detailed prenatal US examination and WES may be highly effective in confirming the diagnosis of a rare genetic disease, in this case DSD.,  Diaphanospondylodysostosis (DSD), caused by loss of bone morphogenetic protein-binding endothelial regulator (BMPER), has been considered a lethal skeletal dysplasia characterized by severe deficiency of vertebral body and sacral ossification, reduced rib number and cystic kidneys. In this study, however, we have demonstrated that variants in BMPER may cause a milder disorder, without renal anomalies, that is compatible with long-term survival. Four siblings, three males and one female, presented with severe congenital scoliosis associated with rib and vertebral malformations as well as strikingly delayed ossification of the pedicles. The female was stillborn from an unrelated cause. Stabilization of the scoliosis with expandable titanium rods was successful in the three boys, all of whom have short stature. An autosomal recessive mode of inheritance was hypothesized. Single nucleotide polymorphism microarray analysis was performed for three of the siblings to identify autosomal genes with shared allele patterns, suggesting possible linkage. Exome sequencing of one sibling was then performed. Rare variants were identified in 347 genes with shared alleles. Only one of these genes had bi-allelic variants in a gene strongly expressed in paraxial mesenchyme: BMPER, which is the cause of DSD, an autosomal recessive disorder. The disorder described herein could represent an attenuated form of DSD or could be designated a separate entity such as spondylopedicular dysplasia.,  Diaphanospondylodysostosis is a rare genetic skeletal disorder caused by biallelic variants in the BMPER gene. The term, diaphanospondylodysostosis, includes ischiospinal dysotosis, which was previously known as a distinct entity with milder clinical features. The clinical phenotype of diaphanospondylodysostosis is quite variable with mortality in early postnatal life in some patients. Main clinical and radiographic features are narrow thorax, vertebral segmentation defects, rib anomalies, ossification defects of vertebrae, ischium and sacrum, and renal cysts. In this study, we report on a 14-year-old girl patient with diaphanospondylodysostosis harbouring a novel BMPER mutation. The patient presented with severe scoliosis and severely hypoplastic/aplastic distal phalanges of the fingers and toes, findings yet hitherto not described in this syndrome.,  We report on the natural history of diaphanospondylodysostosis (DSD) in the longest known survivor. DSD is a rare form of autosomal recessive vertebral dysotosis recently identified to be caused by a mutation in the BMPER gene. This condition is characterized by absent or severely delayed ossification of vertebral bodies, short broad thorax, short neck, protuberant abdomen, marked respiratory insufficiency, and normal appendicular skeleton. It is one of a number of spinal dysostoses, which are a heterogeneous group of axial skeletal malformations occurring during blastogenesis with continued evolution after birth. Significant medical intervention and at-home support contributed to the long-term survival of our patient. The patient had tracheomalacia, which resulted in respiratory insufficiency with thoracic insufficiency syndrome (TIS). Tracheostomy and vertical expandable prosthetic titanium rib (VEPTR) insertion operations ameliorated his symptoms. In addition, comprehensive physical and occupational therapy was performed due to chronic hypotonia. A consistent feature of all described DSD cases thus far are renal findings of dysplasia, nephrogenic rests or nephroblastomatosis, and/or cysts. The patient's renal cysts were monitored with serial ultrasounds at approximately 6-month intervals. The patient was diagnosed with bilateral renal cysts by ultrasound as a neonate, with eventual diagnosis at approximately 20 months of age with nephroblastoma suggesting this maybe an intrinsic part of DSD. The lack of other cases with nephroblastoma is likely related to the previously reported short period of survival.\n",
            "['diaphanospondylodysostosis', 'bmper', 'ischiospinal dysostosis','skeletal dysplasia', 'isd']<|end_of_text|>\n"
          ]
        }
      ],
      "source": [
        "\n",
        "\n",
        "data['frequent_words']  = data.apply(lambda x:  three_most_frequent_terms(x['Terms'])   , axis=1)\n",
        "for i in data.index:\n",
        "    print(i)\n",
        "    text = data['Abstract'][i]\n",
        "    if not isinstance(text, str):\n",
        "        continue\n",
        "    n = 0\n",
        "\n",
        "    # Ensure the chunking works properly and limit iterations to avoid infinite loops\n",
        "    while len(tokenizer1.tokenize(text)) > 4024 and n < 10:\n",
        "        # Split text into chunks\n",
        "        chunks = splitter.split_text(text)\n",
        "        text = ''\n",
        "\n",
        "        # Process each chunk individually\n",
        "        for j, chunk in enumerate(chunks):\n",
        "          if j <10:\n",
        "            text += ' ' + Costumized_question_summary(user_query='', system_query=chunk)\n",
        "\n",
        "        n += 1\n",
        "\n",
        "    # Apply the custom function for the query\n",
        "    if data['frequent_words'][i] == '':  user_query= disease\n",
        "    else:    user_query = data['frequent_words'][i]\n",
        "    print(text)\n",
        "    res = Costumized_question(user_query=user_query, system_query=text[:4024])\n",
        "    print(res)\n",
        "    data.at[i, 'Llama_3_n'] = res"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "BAu9MBxKVGu7"
      },
      "outputs": [],
      "source": [
        "[2]"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "gIaeW_5TD7tu",
        "outputId": "59f20bb7-ceb1-42cb-84ca-0a499acb7b9d"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "repr_error": "Out of range float values are not JSON compliant: nan",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-4bbc0bcb-b1ce-4d37-a19e-bd4865ce27d3\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>A 6-year-old male patient presented with Budd...</td>\n",
              "      <td>[Address, Affect, Biochemical, Bioinformatics,...</td>\n",
              "      <td>25</td>\n",
              "      <td>Address , Affect , Biochemical , Bioinformatic...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>As part of a large-scale, systematic effort t...</td>\n",
              "      <td>[]</td>\n",
              "      <td>12</td>\n",
              "      <td></td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-4bbc0bcb-b1ce-4d37-a19e-bd4865ce27d3')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-4bbc0bcb-b1ce-4d37-a19e-bd4865ce27d3 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-4bbc0bcb-b1ce-4d37-a19e-bd4865ce27d3');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-e10ef84e-b5a4-4a9d-9a95-ccd95fd93f78\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-e10ef84e-b5a4-4a9d-9a95-ccd95fd93f78')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-e10ef84e-b5a4-4a9d-9a95-ccd95fd93f78 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_d93f5074-c8d6-461a-a6f1-d021ddfb252d\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_d93f5074-c8d6-461a-a6f1-d021ddfb252d button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   A 6-year-old male patient presented with Budd...   \n",
              "1          0   As part of a large-scale, systematic effort t...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Address, Affect, Biochemical, Bioinformatics,...    25   \n",
              "1                                                 []    12   \n",
              "\n",
              "                                      frequent_words Llama_3_n  \n",
              "0  Address , Affect , Biochemical , Bioinformatic...      None  \n",
              "1                                                         None  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n",
            "repetiton 1\n",
            "repetiton 2\n",
            "{'year-old male patient who presented with Budd-Chiari syndrome and glycoprotein abnormalities associated with carbohydrate deficient glycoprotein syndrome type I with yet unidentified molecular defect (type Ix). The authors aimed to characterize the clinical features of this patient and compare the data with previously published cases to establish clinical subgroups. The study found that the most frequent findings were rather nonspecific, including developmental delay and axial hypotonia. Distinct ophthalmological abnormalities were observed, including optic nerve atrophy, cataract and glaucoma. Two subgroups were established': 'one with a pure neurological presentation and the other with a neurological-multivisceral form. The first group had a significantly better prognosis. The unique presentation of microcephaly, seizures, ascites, hepatomegaly, nephrotic syndrome and severe developmental delay was observed in one child diagnosed with CDG Ik.', 'The authors propose to develop a zebrafish model of PMM2-CDG and identify two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology. Analyses of cartilage defects in pmm2 mutant zebrafish revealed a block in early chondrocyte development that is associated with defective processing of the cell adhesion molecule N-cadherin. N-cadherin is sequentially cleaved by furin PCs and MMPs, and both exhibit altered activity in pmm2 mutant zebrafish. The proposed studies address the hypothesis that reduced glycosylation alters the activity of PCs like furin, initiating a cascade involving MMPs that disrupts processing of key cell adhesion molecules, including N-cadherin. The authors aim to define how hypoglycosylation of protein processing enzymes alters tissue development; determine whether there is a common mechanism among CDG subtypes; and identify genetic modifiers of CDG disease severity.\\n\\n### Expertise Areas': '', 'Clinical Research': 'The authors have demonstrated their expertise in conducting clinical research by characterizing the clinical features of a', 'Genetic Research': 'The authors have demonstrated their expertise in genetic research by identifying two unreported types of congenital disorders of glycosylation (CDG) caused by mutations in different isoforms of the catalytic subunit of the oligosaccharyltransferase (OST). They have also identified the homozygous mutation (c.1877T > C) in STT3A and the homozygous intronic mutation (c.1539 + 20G > T) in STT3B, which causes the other disorder. Furthermore, they have conducted research on the development of a zebrafish model of PMM2-CDG and identified two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology.', 'Molecular Research': 'The authors have demonstrated their expertise in molecular research by conducting research on the development of a zebrafish model of PMM2-CDG and identifying two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology. They have also conducted research on the pathogenic mechanisms and molecular networks that are commonly or uniquely altered in CDG. Additionally, they have pursued genetic modifiers of CDG disease severity.'}\n",
            "1\n",
            "repetiton 1\n",
            "repetiton 2\n",
            "repetiton 3\n",
            "{}\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 2,\n  \"fields\": [\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 0,\n        \"min\": -1,\n        \"max\": 0,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          0,\n          -1\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \" As part of a large-scale, systematic effort to unravel the molecular causes of autosomal recessive mental retardation, we have previously described a novel syndrome consisting of mental retardation, coloboma, cataract and kyphosis (Kahrizi syndrome, OMIM 612713) and mapped the underlying gene to a 10.4-Mb interval near the centromere on chromosome 4. By combining array-based exon enrichment and next generation sequencing, we have now identified a homozygous frameshift mutation (c.203dupC; p.Phe69LeufsX2) in the gene for steroid 5\\u03b1-reductase type 3 (SRD5A3) as the disease-causing change in this interval. Recent evidence indicates that this enzyme is required for the conversion of polyprenol to dolichol, a step that is essential for N-linked protein glycosylation. Independently, another group has recently observed SRD5A3 mutations in several families with a type 1 congenital disorder of glycosylation (CDG type Ix, OMIM 212067), mental retardation, cerebellar ataxia and eye disorders. Our results show that Kahrizi syndrome and this CDG Ix subtype are allelic disorders, and they illustrate the potential of next-generation sequencing strategies for the elucidation of single gene defects.\",\n          \" A 6-year-old male patient presented with Budd-Chiari syndrome and glycoprotein abnormalities associated with carbohydrate deficient glycoprotein syndrome type I with yet unidentified molecular defect (type Ix). Budd-Chiari syndrome most likely developed after hepatic venous thrombosis caused by coagulation abnormalities resulting from hypoglycosylation and functional impairment of anticoagulant proteins.,  Congenital disorder of glycosylation type I (CDG I) represent a rapidly growing group of inherited multisystem disorders with 13 genetically established subtypes (CDG Ia to CDG Im), and a high number of biochemically unresolved cases (CDG Ix). Further diagnostic effort and prognosis counselling are very challenging in these children. In the current study, we reviewed the clinical records of 10 CDG Ix patients and compared the data with 13 CDG Ix patients published in the literature in search for specific symptoms to create clinical subgroups. The most frequent findings were rather nonspecific, including developmental delay and axial hypotonia. Several features were found that are uncommon in CDG syndrome, such as elevated creatine kinase or arthrogryposis. Distinct ophthalmological abnormalities were observed including optic nerve atrophy, cataract and glaucoma. Two subgroups could be established: one with a pure neurological presentation and the other with a neurological-multivisceral form. The first group had a significantly better prognosis. The unique presentation of microcephaly, seizures, ascites, hepatomegaly, nephrotic syndrome and severe developmental delay was observed in one child diagnosed with CDG Ik. Establishing clinical subgroups and increasing the number of patients within the subgroups may lead the way towards the genetic defect in children with a so far unsolved type of the congenital disorders of glycosylation. Raising awareness for less common, non-CDG specific clinical features such as congenital joint contractures, movement disorders or ophthalmological anomalies will encourage clinicians to think of CDG in its more unusual presentation. Clinical grouping also helps to determine the prognosis and provide better counselling for the families.,  We describe two unreported types of congenital disorders of glycosylation (CDG) which are caused by mutations in different isoforms of the catalytic subunit of the oligosaccharyltransferase (OST). Each isoform is encoded by a different gene (STT3A or STT3B), resides in a different OST complex and has distinct donor and acceptor substrate specificities with partially overlapping functions in N-glycosylation. The two cases from unrelated consanguineous families both show neurologic abnormalities, hypotonia, intellectual disability, failure to thrive and feeding problems. A homozygous mutation (c.1877T > C) in STT3A causes a p.Val626Ala change and a homozygous intronic mutation (c.1539 + 20G > T) in STT3B causes the other disorder. Both mutations impair glycosylation of a GFP biomarker and are rescued with the corresponding cDNA. Glycosylation of STT3A- and STT3B-specific acceptors is decreased in fibroblasts carrying the corresponding mutated gene and expression of the STT3A (p.Val626Ala) allele in STT3A-deficient HeLa cells does not rescue glycosylation. No additional cases were found in our collection or in reviewing various databases. The STT3A mutation significantly impairs glycosylation of the biomarker transferrin, but the STT3B mutation only slightly affects its glycosylation. Additional cases of STT3B-CDG may be missed by transferrin analysis and will require exome or genome sequencing., PROJECT SUMMARY Congenital disorders of glycosylation (CDGs) are a heterogeneous group of rare inherited diseases caused by mutations in genes involved in protein glycosylation. The most common CDG, PMM2-CDG, results from mutations in the gene phosphomannomutase 2 (PMM2), encoding an enzyme that converts mannose 6- phosphate (M6P) to mannose 1-phosphate (M1P). Defects in PMM2 limit the production of GDP-mannose, a nucleotide sugar essential to synthesize precursors needed for N-linked glycosylation. Reduced GDP- mannose causes protein hypoglycosylation and numerous clinical phenotypes. The connection between hypoglycosylated proteins and phenotypes is unclear, creating a major gap in our knowledge of CDG disease pathogenesis. PMM2-CDG patients exhibit variable penetrance indicating that genetic and/or environmental factors modify disease. We characterized a zebrafish model of PMM2-CDG and identified two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology. Analyses of cartilage defects in pmm2 mutant zebrafish revealed a block in early chondrocyte development that is associated with defective processing of the cell adhesion molecule N- cadherin. N-cadherin is sequentially cleaved by furin PCs and MMPs, and both exhibit altered activity in pmm2 mutant zebrafish. The proposed studies address the hypothesis that reduced glycosylation alters the activity of PCs like furin, initiating a cascade involving MMPs that disrupts processing of key cell adhesion molecules, including N-cadherin. We will define how hypoglycosylation of protein processing enzymes alters tissue development; determine whether there is a common mechanism among CDG subtypes; and identify genetic modifiers of CDG disease severity. Toward these goals in Aim 1 we will develop novel zebrafish lines that express wild type and glycan-deficient FLAG-tagged forms of several PCs and MMP enzymes. We will use these tools to define how hypoglycosylation of individual enzymes contributes to impaired chondrogenesis in PMM2-CDG. In Aim 2 we will perform RNA sequencing on several zebrafish models of PMM2, STT3A and STT3B-CDG to identify the pathogenic mechanisms and molecular networks that are commonly or uniquely altered in CDG. Using these analyses in combination with novel Drosophila models we will also pursue genetic modifiers of CDG disease severity. The molecular and genetic pathways identified as sensitive to hypoglycosylation will provide foundational information to develop much needed therapies. Further, the platform established within this proposal will create the road map to ultimately study how disruption of other N-glycosylation genes causes disease., PROJECT SUMMARY\\\\\\\\\\\\\\\\nCongenital disorders of glycosylation (CDGs) are a heterogeneous group of rare inherited diseases caused by\\\\\\\\\\\\\\\\nmutations in genes involved in protein glycosylation. The most common CDG, PMM2-CDG, results from\\\\\\\\\\\\\\\\nmutations in the gene phosphomannomutase 2 (PMM2), encoding an enzyme that converts mannose 6-\\\\\\\\\\\\\\\\nphosphate (M6P) to mannose 1-phosphate (M1P). Defects in PMM2 limit the production of GDP-mannose, a\\\\\\\\\\\\\\\\nnucleotide sugar essential to synthesize precursors needed for N-linked glycosylation. Reduced GDP-\\\\\\\\\\\\\\\\nmannose causes protein hypoglycosylation and numerous clinical phenotypes. The connection between\\\\\\\\\\\\\\\\nhypoglycosylated proteins and phenotypes is unclear, creating a major gap in our knowledge of CDG\\\\\\\\\\\\\\\\ndisease pathogenesis. PMM2-CDG patients exhibit variable penetrance indicating that genetic and/or\\\\\\\\\\\\\\\\nenvironmental factors modify disease. We characterized a zebrafish model of PMM2-CDG and identified two\\\\\\\\\\\\\\\\nclasses of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate\\\\\\\\\\\\\\\\ndrivers of pathology. Analyses of cartilage defects in pmm2 mutant zebrafish revealed a block in early\\\\\\\\\\\\\\\\nchondrocyte development that is associated with defective processing of the cell adhesion molecule N-\\\\\\\\\\\\\\\\ncadherin. N-cadherin is sequentially cleaved by furin PCs and MMPs, and both exhibit altered activity in pmm2\\\\\\\\\\\\\\\\nmutant zebrafish. The proposed studies address the hypothesis that reduced glycosylation alters the\\\\\\\\\\\\\\\\nactivity of PCs like furin, initiating a cascade involving MMPs that disrupts processing of key cell\\\\\\\\\\\\\\\\nadhesion molecules, including N-cadherin. We will define how hypoglycosylation of protein processing\\\\\\\\\\\\\\\\nenzymes alters tissue development; determine whether there is a common mechanism among CDG subtypes;\\\\\\\\\\\\\\\\nand identify genetic modifiers of CDG disease severity. Toward these goals in Aim 1 we will develop novel\\\\\\\\\\\\\\\\nzebrafish lines that express wild type and glycan-deficient FLAG-tagged forms of several PCs and MMP\\\\\\\\\\\\\\\\nenzymes. We will use these tools to define how hypoglycosylation of individual enzymes contributes to\\\\\\\\\\\\\\\\nimpaired chondrogenesis in PMM2-CDG. In Aim 2 we will perform RNA sequencing on several zebrafish\\\\\\\\\\\\\\\\nmodels of PMM2, STT3A and STT3B-CDG to identify the pathogenic mechanisms and molecular networks\\\\\\\\\\\\\\\\nthat are commonly or uniquely altered in CDG. Using these analyses in combination with novel Drosophila\\\\\\\\\\\\\\\\nmodels we will also pursue genetic modifiers of CDG disease severity. The molecular and genetic pathways\\\\\\\\\\\\\\\\nidentified as sensitive to hypoglycosylation will provide foundational information to develop much needed\\\\\\\\\\\\\\\\ntherapies. Further, the platform established within this proposal will create the road map to ultimately study\\\\\\\\\\\\\\\\nhow disruption of other N-glycosylation genes causes disease.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 9,\n        \"min\": 12,\n        \"max\": 25,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          12,\n          25\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"frequent_words\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"\",\n          \"Address , Affect , Biochemical , Bioinformatics , Biosensor\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Llama_3_n\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"{}\",\n          \"{'year-old male patient who presented with Budd-Chiari syndrome and glycoprotein abnormalities associated with carbohydrate deficient glycoprotein syndrome type I with yet unidentified molecular defect (type Ix). The authors aimed to characterize the clinical features of this patient and compare the data with previously published cases to establish clinical subgroups. The study found that the most frequent findings were rather nonspecific, including developmental delay and axial hypotonia. Distinct ophthalmological abnormalities were observed, including optic nerve atrophy, cataract and glaucoma. Two subgroups were established': 'one with a pure neurological presentation and the other with a neurological-multivisceral form. The first group had a significantly better prognosis. The unique presentation of microcephaly, seizures, ascites, hepatomegaly, nephrotic syndrome and severe developmental delay was observed in one child diagnosed with CDG Ik.', 'The authors propose to develop a zebrafish model of PMM2-CDG and identify two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology. Analyses of cartilage defects in pmm2 mutant zebrafish revealed a block in early chondrocyte development that is associated with defective processing of the cell adhesion molecule N-cadherin. N-cadherin is sequentially cleaved by furin PCs and MMPs, and both exhibit altered activity in pmm2 mutant zebrafish. The proposed studies address the hypothesis that reduced glycosylation alters the activity of PCs like furin, initiating a cascade involving MMPs that disrupts processing of key cell adhesion molecules, including N-cadherin. The authors aim to define how hypoglycosylation of protein processing enzymes alters tissue development; determine whether there is a common mechanism among CDG subtypes; and identify genetic modifiers of CDG disease severity.\\\\n\\\\n### Expertise Areas': '', 'Clinical Research': 'The authors have demonstrated their expertise in conducting clinical research by characterizing the clinical features of a', 'Genetic Research': 'The authors have demonstrated their expertise in genetic research by identifying two unreported types of congenital disorders of glycosylation (CDG) caused by mutations in different isoforms of the catalytic subunit of the oligosaccharyltransferase (OST). They have also identified the homozygous mutation (c.1877T > C) in STT3A and the homozygous intronic mutation (c.1539 + 20G > T) in STT3B, which causes the other disorder. Furthermore, they have conducted research on the development of a zebrafish model of PMM2-CDG and identified two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology.', 'Molecular Research': 'The authors have demonstrated their expertise in molecular research by conducting research on the development of a zebrafish model of PMM2-CDG and identifying two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology. They have also conducted research on the pathogenic mechanisms and molecular networks that are commonly or uniquely altered in CDG. Additionally, they have pursued genetic modifiers of CDG disease severity.'}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-a0c93ade-ef33-43f0-a959-0a11d80f049a\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>A 6-year-old male patient presented with Budd...</td>\n",
              "      <td>[Address, Affect, Biochemical, Bioinformatics,...</td>\n",
              "      <td>25</td>\n",
              "      <td>Address , Affect , Biochemical , Bioinformatic...</td>\n",
              "      <td>{'year-old male patient who presented with Bud...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>As part of a large-scale, systematic effort t...</td>\n",
              "      <td>[]</td>\n",
              "      <td>12</td>\n",
              "      <td></td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-a0c93ade-ef33-43f0-a959-0a11d80f049a')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-a0c93ade-ef33-43f0-a959-0a11d80f049a button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-a0c93ade-ef33-43f0-a959-0a11d80f049a');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-684c1da8-eeea-4a29-b651-8a2b0867f615\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-684c1da8-eeea-4a29-b651-8a2b0867f615')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-684c1da8-eeea-4a29-b651-8a2b0867f615 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_15a1512a-2a57-4e30-87a3-28d9f0d2583f\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_15a1512a-2a57-4e30-87a3-28d9f0d2583f button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   A 6-year-old male patient presented with Budd...   \n",
              "1          0   As part of a large-scale, systematic effort t...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Address, Affect, Biochemical, Bioinformatics,...    25   \n",
              "1                                                 []    12   \n",
              "\n",
              "                                      frequent_words  \\\n",
              "0  Address , Affect , Biochemical , Bioinformatic...   \n",
              "1                                                      \n",
              "\n",
              "                                           Llama_3_n  \n",
              "0  {'year-old male patient who presented with Bud...  \n",
              "1                                                 {}  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "repr_error": "Out of range float values are not JSON compliant: nan",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-0f5dcadb-0553-44e8-b066-4ebb7687b600\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  Our aim for this study was to report pulmo...</td>\n",
              "      <td>[Achondroplasia, Acrodysostosis, Affect, Area,...</td>\n",
              "      <td>33</td>\n",
              "      <td>Achondroplasia , Acrodysostosis , Affect , Are...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-0f5dcadb-0553-44e8-b066-4ebb7687b600')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-0f5dcadb-0553-44e8-b066-4ebb7687b600 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-0f5dcadb-0553-44e8-b066-4ebb7687b600');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "  <div id=\"id_da1c1223-4a02-46d3-af71-86ed9cad2132\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_da1c1223-4a02-46d3-af71-86ed9cad2132 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  Our aim for this study was to report pulmo...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Achondroplasia, Acrodysostosis, Affect, Area,...    33   \n",
              "\n",
              "                                      frequent_words Llama_3_n  \n",
              "0  Achondroplasia , Acrodysostosis , Affect , Are...      None  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n",
            "repetiton 1\n",
            "{\"day-old patient with Barnes syndrome who was being mechanically ventilated because of severe pulmonary distress secondary to thoracic dystrophy. The measurements consisted of respiratory volumes including functional residual capacity, ventilatory mechanics including compliance and resistance, and thoracoabdominal synchrony. Chest wall compliance was 64% below normal, and the thoracoabdominal motion was indicative of predominantly abdominal displacement during inspiratory breaths. The lungs were functioning at a low functional residual capacity, resulting in low lung compliance and increased pulmonary resistance. As a result of the evaluation, the patient was recommended for lateral thoracic expansion surgery and the ventilatory management was adjusted to focus on end-distending pressure support.,  This case describes a parturient with Barnes syndrome, a rare disorder characterized by subglottic stenosis, thoracic dystrophy, and small pelvic inlet, who underwent cesarean delivery of a neonate diagnosed with Barnes syndrome. Live simulation training was performed by multidisciplinary team to prepare for the spinal anesthetic, personnel flow between 2 operating rooms, and management of various airway scenarios for the newborn. After delivery, the neonate underwent laryngoscopy-bronchoscopy with successful intubation in the operating room because of labored breathing. Airway evaluation revealed subglottic stenosis, tracheomalacia/bronchomalacia. Collaboration among perinatologists, obstetric/pediatric anesthesiologists, pediatric head and neck surgeons, and neonatologists was integral to perioperative management of both the mother and child.,  We report a family in which three members have thoracolaryngopelvic dysplasia (Barnes' syndrome). This family illustrates the phenotypic variability seen in this rare clinical entity and highlights the medical and surgical management necessary in such cases.,  We report a third patient, a female, with thoraco-pelvic dysostosis. This rare disorder is similar in phenotypic and radiographic appearances to thoraco-laryngo-pelvic dysplasia (Barnes syndrome). The only major difference between these two diseases is absence of laryngeal involvement in thoraco-pelvic dysplasia. They may represent two different entities or a contiguous gene syndrome.,  We review a family in which a mother and two of her three children suffered a distinct syndrome of thoracic dystrophy with small chest volume, laryngeal stenosis, normal stature with variable asymmetry, asthenic build, and a small pelvis. In addition to the different inheritance pattern, this syndrome is distinguished from the better known Jeune syndrome by the differing thoracic and pelvic configuration., The skeletal dysplasias (SDs) are a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000. This project is aimed at defining the clinical, genetic, prenatal, pathologic, molecular, and pathophysiologic.features of these disorders to assist in understanding their causes and provide better information and clinical care to patients and families. Specific aims include\": '', 'To improve the characterization of the SDs': 'Using the large number of cases collected, we will continue our long-standing effort to improve the definition of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs. We will define novel disorders, and improve the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. We will test the hypothesis that flexion-extension MRI studies with measurements of cerebrospinal and venous flow will aid n defining the need for surgery in patients with ACH, an area of current controversy.', 'To define the prenatal presentation of the SDs and improve prenatal diagnosis': 'Many of the SDs, both lethal and nonlethal, have evidence of skeletal abnormalities in the prenatal period. We hypothesize that by employing 2D and 3D prenatal ultrasound (UTZ) and then correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. We will objectively determine UTZ parameters that best predict lethality in the immediate neonatal period, establish prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determine differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias.', 'To determine phenotype-genotype correlations in the SDs': 'Comparing the clinical phenotype with molecular and biochemical defects has allowed us to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. We will also continue studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. We further propose to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. We will test the hypothesis that diaphanospondylodysostosis (DSD) is caused by mutations in the Pax1 gene.\\n          its response is', 'Pulmonary Mechanics and Ventilatory Support in Barnes Syndrome': 'The researchers have made significant contributions in understanding the pulmonary mechanics of Barnes syndrome, a rare form of thoracolaryngopelvic dysplasia. Their study reports on pulmonary function evaluation in a neonate with severe Barnes syndrome, highlighting the impact of thoracic dystrophy on respiratory mechanics. They found that the lungs were functioning at a low functional residual capacity, resulting in low lung compliance and increased pulmonary resistance. As a result of the evaluation, the patient was recommended for lateral thoracic expansion surgery and the ventilatory management was adjusted to focus on end-distending pressure support. Their work provides insights into the management of pulmonary complications in this rare syndrome.', 'Perioperative Management of Barnes Syndrome': 'The researchers have also contributed to the understanding of perioperative management of Barnes syndrome, a rare disorder characterized by subglottic stenosis, thoracic dystrophy, and small pelvic inlet. Their case study describes the perioperative management of a parturient with Barnes syndrome, including live simulation training by a multidisciplinary team to prepare for the spinal anesthetic, personnel flow between 2 operating rooms, and management of various airway scenarios for the newborn. Their collaboration among perinatologists, obstetric/pediatric anesthesiologists, pediatric head and neck surgeons, and neonatologists was integral to the perioperative management of both the mother and child. Their work highlights the importance of multidisciplinary collaboration in the management of this rare syndrome.', 'Medical and Surgical Management of Thoracolaryngopelvic Dysplasia': \"The researchers have also contributed to the medical and surgical management of thoracolaryngopelvic dysplasia (Barnes' syndrome), a rare clinical entity. Their study reports on a family in which three members have this syndrome, illustrating the phenotypic variability seen in this rare disorder. They highlight the medical and surgical management necessary in such cases, emphasizing the importance of a multidisciplinary approach to care. Their work provides insights into the management of this rare syndrome and highlights the importance of collaboration between different medical specialties.\", 'Thoraco-pelvic Dysostosis': 'The researchers have also contributed to the understanding of thoraco-pelvic dysostosis, a rare disorder similar in phenotypic and radiographic appearances to thoraco-laryngo-pelvic dysplasia (Barnes syndrome). They highlight the only major difference between these two diseases, which is the absence of laryngeal involvement in thoraco-pelvic dysostosis. They also discuss whether these two diseases may represent two different entities or a contiguous gene syndrome. Their work provides insights into the differential diagnosis of these rare disorders and highlights the importance of recognizing the unique features of each condition.', 'Medical and Surgical Management of Thoracic Dystrophy with Small Chest Volume, Laryngeal Stenosis, Normal Stature with Variable Asymmetry, Asthenic Build, and Small Pelvis': 'The researchers have also contributed to the medical and surgical management of a distinct syndrome of thoracic dystrophy with small chest volume, laryngeal stenosis, normal stature with variable asymmetry, asthenic build, and a small pelvis. They discuss the different inheritance pattern of this syndrome and how it is distinguished from the better known Jeune syndrome by the differing thoracic and pelvic configuration. Their work provides insights into the management of this rare syndrome and highlights the importance of a multidisciplinary approach to care.', 'Skeletal Dysplasias': \"The researchers have also contributed to the understanding of the skeletal dysplasias (SDs), a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000. They highlight the project's aim to define the clinical, genetic, prenatal, pathologic, molecular, and pathophysiologic.features of these disorders to assist in understanding their causes and provide better information and clinical care to patients and families. They discuss the specific aims of the project, including improving the characterization of the SDs, defining the prenatal presentation of the SDs, and determining phenotype-genotype correlations in the SDs. Their work provides insights into the management of these rare disorders and highlights the importance of a multidisciplinary approach to care.'\"}\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 1,\n  \"fields\": [\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": null,\n        \"min\": -1,\n        \"max\": -1,\n        \"num_unique_values\": 1,\n        \"samples\": [\n          -1\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \" ,  Our aim for this study was to report pulmonary mechanics in a neonate with a severe case of Barnes syndrome, a rare form of thoracolaryngopelvic dysplasia, and to use these data to guide ventilatory support and serve as a presurgical screening tool. A comprehensive pulmonary function evaluation was performed on a 36-day-old patient with Barnes syndrome who was being mechanically ventilated because of severe pulmonary distress secondary to thoracic dystrophy. The measurements consisted of respiratory volumes including functional residual capacity, ventilatory mechanics including compliance and resistance, and thoracoabdominal synchrony. Chest wall compliance was 64% below normal, and the thoracoabdominal motion was indicative of predominantly abdominal displacement during inspiratory breaths. The lungs were functioning at a low functional residual capacity, resulting in low lung compliance and increased pulmonary resistance. As a result of the evaluation, the patient was recommended for lateral thoracic expansion surgery and the ventilatory management was adjusted to focus on end-distending pressure support.,  This case describes a parturient with Barnes syndrome, a rare disorder characterized by subglottic stenosis, thoracic dystrophy, and small pelvic inlet, who underwent cesarean delivery of a neonate diagnosed with Barnes syndrome. Live simulation training was performed by multidisciplinary team to prepare for the spinal anesthetic, personnel flow between 2 operating rooms, and management of various airway scenarios for the newborn. After delivery, the neonate underwent laryngoscopy-bronchoscopy with successful intubation in the operating room because of labored breathing. Airway evaluation revealed subglottic stenosis, tracheomalacia/bronchomalacia. Collaboration among perinatologists, obstetric/pediatric anesthesiologists, pediatric head and neck surgeons, and neonatologists was integral to perioperative management of both the mother and child.,  We report a family in which three members have thoracolaryngopelvic dysplasia (Barnes' syndrome). This family illustrates the phenotypic variability seen in this rare clinical entity and highlights the medical and surgical management necessary in such cases.,  We report a third patient, a female, with thoraco-pelvic dysostosis. This rare disorder is similar in phenotypic and radiographic appearances to thoraco-laryngo-pelvic dysplasia (Barnes syndrome). The only major difference between these two diseases is absence of laryngeal involvement in thoraco-pelvic dysplasia. They may represent two different entities or a contiguous gene syndrome.,  We review a family in which a mother and two of her three children suffered a distinct syndrome of thoracic dystrophy with small chest volume, laryngeal stenosis, normal stature with variable asymmetry, asthenic build, and a small pelvis. In addition to the different inheritance pattern, this syndrome is distinguished from the better known Jeune syndrome by the differing thoracic and pelvic configuration., The skeletal dysplasias (SDs) are a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000. This project is aimed at defining the clinical, genetic, prenatal, pathologic, molecular, and pathophysiologic.features of these disorders to assist in understanding their causes and provide better information and clinical care to patients and families. Specific aims include: 1. To improve the characterization of the SDs: Using the large number of cases collected, we will continue our long-standing effort to improve the definition of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs. We will define novel disorders, and improve the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. We will test the hypothesis that flexion-extension MRI studies with measurements of cerebrospinal and venous flow will aid n defining the need for surgery in patients with ACH, an area of current controversy. 2. To define the prenatal presentation of the SDs and improve prenatal diagnosis: Many of the SDs, both lethal and nonlethal, have evidence of skeletal abnormalities in the prenatal period. We hypothesize that by employing 2D and 3D prenatal ultrasound (UTZ) and then correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. We will objectively determine UTZ parameters that best predict lethality in the immediate neonatal period, establish prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determine differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias. 3. To determine phenotype-genotype correlations in the SDs: Comparing the clinical phenotype with molecular and biochemical defects has allowed us to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. We will also continue studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. We further propose to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. We will test the hypothesis that diaphanospondylodysostosis (DSD) is caused by mutations in the Pax1 gene.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": null,\n        \"min\": 33,\n        \"max\": 33,\n        \"num_unique_values\": 1,\n        \"samples\": [\n          33\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"frequent_words\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"Achondroplasia , Acrodysostosis , Affect , Area , base\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Llama_3_n\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 1,\n        \"samples\": [\n          \"{\\\"day-old patient with Barnes syndrome who was being mechanically ventilated because of severe pulmonary distress secondary to thoracic dystrophy. The measurements consisted of respiratory volumes including functional residual capacity, ventilatory mechanics including compliance and resistance, and thoracoabdominal synchrony. Chest wall compliance was 64% below normal, and the thoracoabdominal motion was indicative of predominantly abdominal displacement during inspiratory breaths. The lungs were functioning at a low functional residual capacity, resulting in low lung compliance and increased pulmonary resistance. As a result of the evaluation, the patient was recommended for lateral thoracic expansion surgery and the ventilatory management was adjusted to focus on end-distending pressure support.,  This case describes a parturient with Barnes syndrome, a rare disorder characterized by subglottic stenosis, thoracic dystrophy, and small pelvic inlet, who underwent cesarean delivery of a neonate diagnosed with Barnes syndrome. Live simulation training was performed by multidisciplinary team to prepare for the spinal anesthetic, personnel flow between 2 operating rooms, and management of various airway scenarios for the newborn. After delivery, the neonate underwent laryngoscopy-bronchoscopy with successful intubation in the operating room because of labored breathing. Airway evaluation revealed subglottic stenosis, tracheomalacia/bronchomalacia. Collaboration among perinatologists, obstetric/pediatric anesthesiologists, pediatric head and neck surgeons, and neonatologists was integral to perioperative management of both the mother and child.,  We report a family in which three members have thoracolaryngopelvic dysplasia (Barnes' syndrome). This family illustrates the phenotypic variability seen in this rare clinical entity and highlights the medical and surgical management necessary in such cases.,  We report a third patient, a female, with thoraco-pelvic dysostosis. This rare disorder is similar in phenotypic and radiographic appearances to thoraco-laryngo-pelvic dysplasia (Barnes syndrome). The only major difference between these two diseases is absence of laryngeal involvement in thoraco-pelvic dysplasia. They may represent two different entities or a contiguous gene syndrome.,  We review a family in which a mother and two of her three children suffered a distinct syndrome of thoracic dystrophy with small chest volume, laryngeal stenosis, normal stature with variable asymmetry, asthenic build, and a small pelvis. In addition to the different inheritance pattern, this syndrome is distinguished from the better known Jeune syndrome by the differing thoracic and pelvic configuration., The skeletal dysplasias (SDs) are a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000. This project is aimed at defining the clinical, genetic, prenatal, pathologic, molecular, and pathophysiologic.features of these disorders to assist in understanding their causes and provide better information and clinical care to patients and families. Specific aims include\\\": '', 'To improve the characterization of the SDs': 'Using the large number of cases collected, we will continue our long-standing effort to improve the definition of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs. We will define novel disorders, and improve the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. We will test the hypothesis that flexion-extension MRI studies with measurements of cerebrospinal and venous flow will aid n defining the need for surgery in patients with ACH, an area of current controversy.', 'To define the prenatal presentation of the SDs and improve prenatal diagnosis': 'Many of the SDs, both lethal and nonlethal, have evidence of skeletal abnormalities in the prenatal period. We hypothesize that by employing 2D and 3D prenatal ultrasound (UTZ) and then correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. We will objectively determine UTZ parameters that best predict lethality in the immediate neonatal period, establish prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determine differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias.', 'To determine phenotype-genotype correlations in the SDs': 'Comparing the clinical phenotype with molecular and biochemical defects has allowed us to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. We will also continue studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. We further propose to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. We will test the hypothesis that diaphanospondylodysostosis (DSD) is caused by mutations in the Pax1 gene.\\\\n          its response is', 'Pulmonary Mechanics and Ventilatory Support in Barnes Syndrome': 'The researchers have made significant contributions in understanding the pulmonary mechanics of Barnes syndrome, a rare form of thoracolaryngopelvic dysplasia. Their study reports on pulmonary function evaluation in a neonate with severe Barnes syndrome, highlighting the impact of thoracic dystrophy on respiratory mechanics. They found that the lungs were functioning at a low functional residual capacity, resulting in low lung compliance and increased pulmonary resistance. As a result of the evaluation, the patient was recommended for lateral thoracic expansion surgery and the ventilatory management was adjusted to focus on end-distending pressure support. Their work provides insights into the management of pulmonary complications in this rare syndrome.', 'Perioperative Management of Barnes Syndrome': 'The researchers have also contributed to the understanding of perioperative management of Barnes syndrome, a rare disorder characterized by subglottic stenosis, thoracic dystrophy, and small pelvic inlet. Their case study describes the perioperative management of a parturient with Barnes syndrome, including live simulation training by a multidisciplinary team to prepare for the spinal anesthetic, personnel flow between 2 operating rooms, and management of various airway scenarios for the newborn. Their collaboration among perinatologists, obstetric/pediatric anesthesiologists, pediatric head and neck surgeons, and neonatologists was integral to the perioperative management of both the mother and child. Their work highlights the importance of multidisciplinary collaboration in the management of this rare syndrome.', 'Medical and Surgical Management of Thoracolaryngopelvic Dysplasia': \\\"The researchers have also contributed to the medical and surgical management of thoracolaryngopelvic dysplasia (Barnes' syndrome), a rare clinical entity. Their study reports on a family in which three members have this syndrome, illustrating the phenotypic variability seen in this rare disorder. They highlight the medical and surgical management necessary in such cases, emphasizing the importance of a multidisciplinary approach to care. Their work provides insights into the management of this rare syndrome and highlights the importance of collaboration between different medical specialties.\\\", 'Thoraco-pelvic Dysostosis': 'The researchers have also contributed to the understanding of thoraco-pelvic dysostosis, a rare disorder similar in phenotypic and radiographic appearances to thoraco-laryngo-pelvic dysplasia (Barnes syndrome). They highlight the only major difference between these two diseases, which is the absence of laryngeal involvement in thoraco-pelvic dysostosis. They also discuss whether these two diseases may represent two different entities or a contiguous gene syndrome. Their work provides insights into the differential diagnosis of these rare disorders and highlights the importance of recognizing the unique features of each condition.', 'Medical and Surgical Management of Thoracic Dystrophy with Small Chest Volume, Laryngeal Stenosis, Normal Stature with Variable Asymmetry, Asthenic Build, and Small Pelvis': 'The researchers have also contributed to the medical and surgical management of a distinct syndrome of thoracic dystrophy with small chest volume, laryngeal stenosis, normal stature with variable asymmetry, asthenic build, and a small pelvis. They discuss the different inheritance pattern of this syndrome and how it is distinguished from the better known Jeune syndrome by the differing thoracic and pelvic configuration. Their work provides insights into the management of this rare syndrome and highlights the importance of a multidisciplinary approach to care.', 'Skeletal Dysplasias': \\\"The researchers have also contributed to the understanding of the skeletal dysplasias (SDs), a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000. They highlight the project's aim to define the clinical, genetic, prenatal, pathologic, molecular, and pathophysiologic.features of these disorders to assist in understanding their causes and provide better information and clinical care to patients and families. They discuss the specific aims of the project, including improving the characterization of the SDs, defining the prenatal presentation of the SDs, and determining phenotype-genotype correlations in the SDs. Their work provides insights into the management of these rare disorders and highlights the importance of a multidisciplinary approach to care.'\\\"}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-f3777ee5-705f-4387-b025-11ddb29c4b48\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  Our aim for this study was to report pulmo...</td>\n",
              "      <td>[Achondroplasia, Acrodysostosis, Affect, Area,...</td>\n",
              "      <td>33</td>\n",
              "      <td>Achondroplasia , Acrodysostosis , Affect , Are...</td>\n",
              "      <td>{\"day-old patient with Barnes syndrome who was...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-f3777ee5-705f-4387-b025-11ddb29c4b48')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-f3777ee5-705f-4387-b025-11ddb29c4b48 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-f3777ee5-705f-4387-b025-11ddb29c4b48');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "  <div id=\"id_8c402a6a-56e2-45cb-be85-260958b92e45\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_8c402a6a-56e2-45cb-be85-260958b92e45 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  Our aim for this study was to report pulmo...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Achondroplasia, Acrodysostosis, Affect, Area,...    33   \n",
              "\n",
              "                                      frequent_words  \\\n",
              "0  Achondroplasia , Acrodysostosis , Affect , Are...   \n",
              "\n",
              "                                           Llama_3_n  \n",
              "0  {\"day-old patient with Barnes syndrome who was...  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "repr_error": "Out of range float values are not JSON compliant: nan",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-10e43d91-edd2-4356-b583-839f77981c3f\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  42 out of 93 Saskatchewan Indians (32 fema...</td>\n",
              "      <td>[nan, Native Americans, skin, orphan disease /...</td>\n",
              "      <td>259</td>\n",
              "      <td>actinic prurigo , thalidomide , photodermatosi...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;h4&gt;Background/purpose&lt;/h4&gt;Abnormal cutaneous...</td>\n",
              "      <td>[children, ozone depletion, adolescents, high-...</td>\n",
              "      <td>440</td>\n",
              "      <td>actinic prurigo , high-altitude , photodermato...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>Cytokines are involved in many functions of t...</td>\n",
              "      <td>[meteorin-like, psoriasis, cytokine, skin, rhe...</td>\n",
              "      <td>11</td>\n",
              "      <td>meteorin-like , psoriasis , cytokine , skin , ...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2</td>\n",
              "      <td>&lt;h4&gt;Background&lt;/h4&gt;Narrowband (NB) UVB photot...</td>\n",
              "      <td>[]</td>\n",
              "      <td>17</td>\n",
              "      <td></td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-10e43d91-edd2-4356-b583-839f77981c3f')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-10e43d91-edd2-4356-b583-839f77981c3f button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-10e43d91-edd2-4356-b583-839f77981c3f');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-6a0cb722-2762-4f11-bea4-a4ec6fa9d1f9\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-6a0cb722-2762-4f11-bea4-a4ec6fa9d1f9')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-6a0cb722-2762-4f11-bea4-a4ec6fa9d1f9 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_30c45e46-4afc-4faf-8889-caa3d91db049\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_30c45e46-4afc-4faf-8889-caa3d91db049 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  42 out of 93 Saskatchewan Indians (32 fema...   \n",
              "1          0   <h4>Background/purpose</h4>Abnormal cutaneous...   \n",
              "2          1   Cytokines are involved in many functions of t...   \n",
              "3          2   <h4>Background</h4>Narrowband (NB) UVB photot...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [nan, Native Americans, skin, orphan disease /...   259   \n",
              "1  [children, ozone depletion, adolescents, high-...   440   \n",
              "2  [meteorin-like, psoriasis, cytokine, skin, rhe...    11   \n",
              "3                                                 []    17   \n",
              "\n",
              "                                      frequent_words Llama_3_n  \n",
              "0  actinic prurigo , thalidomide , photodermatosi...      None  \n",
              "1  actinic prurigo , high-altitude , photodermato...      None  \n",
              "2  meteorin-like , psoriasis , cytokine , skin , ...      None  \n",
              "3                                                         None  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/spacy/pipeline/lemmatizer.py:211: UserWarning: [W108] The rule-based lemmatizer did not find POS annotation for one or more tokens. Check that your pipeline includes components that assign token.pos, typically 'tagger'+'attribute_ruler' or 'morphologizer'.\n",
            "  warnings.warn(Warnings.W108)\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "suumary_chunk  0\n",
            "suumary_chunk  1\n",
            "suumary_chunk  2\n",
            "suumary_chunk  3\n",
            "suumary_chunk  4\n",
            "suumary_chunk  5\n",
            "suumary_chunk  6\n",
            "suumary_chunk  7\n",
            "repetiton 1\n",
            "repetiton 2\n",
            "repetiton 3\n",
            "{}\n",
            "1\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/spacy/pipeline/lemmatizer.py:211: UserWarning: [W108] The rule-based lemmatizer did not find POS annotation for one or more tokens. Check that your pipeline includes components that assign token.pos, typically 'tagger'+'attribute_ruler' or 'morphologizer'.\n",
            "  warnings.warn(Warnings.W108)\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "suumary_chunk  0\n",
            "suumary_chunk  1\n",
            "suumary_chunk  2\n",
            "suumary_chunk  3\n",
            "suumary_chunk  4\n",
            "suumary_chunk  5\n",
            "suumary_chunk  6\n",
            "suumary_chunk  7\n",
            "suumary_chunk  8\n",
            "suumary_chunk  9\n",
            "suumary_chunk  10\n",
            "suumary_chunk  11\n",
            "suumary_chunk  12\n",
            "suumary_chunk  13\n",
            "suumary_chunk  14\n",
            "suumary_chunk  15\n",
            "suumary_chunk  16\n",
            "suumary_chunk  17\n",
            "suumary_chunk  18\n",
            "suumary_chunk  19\n",
            "suumary_chunk  20\n",
            "suumary_chunk  21\n",
            "suumary_chunk  22\n",
            "suumary_chunk  23\n",
            "suumary_chunk  24\n",
            "suumary_chunk  25\n",
            "suumary_chunk  0\n",
            "suumary_chunk  1\n",
            "suumary_chunk  2\n",
            "suumary_chunk  3\n",
            "suumary_chunk  4\n",
            "repetiton 1\n",
            "repetiton 2\n",
            "repetiton 3\n",
            "{'The clinical features of actinic prurigo are as follows': 'a.\\n\\nErythematous plaques with a pruritic, burning sensation, that mainly affect the exposed areas of the skin, such as the face, neck, and forearms. \\n\\nb.\\n\\nIn some cases, actinic prurigo may also affect the mucous membranes, such as the lips, causing actinic cheilitis (AChe).\\n\\nc.\\n\\nIn some cases, actinic prurigo may also affect the conjunctiva, causing actinic conjunctivitis (AC).\\n\\nd.\\n\\nIn some cases, actinic prurigo may also affect the oral mucosa, causing actinic stomatitis.\\n\\ne.\\n\\nIn some cases, actinic prurigo may also affect the nails, causing actinic onycholysis.\\n\\nf.\\n\\nIn some cases, actinic prurigo may also affect the genital area, causing actinic vulvitis or balanitis.\\n\\ng.\\n\\nIn some cases, actinic prurigo may also affect the eyes, causing actinic keratitis.\\n\\nh.\\n\\nIn some cases, actinic prurigo may also affect the lungs, causing actinic pneumonitis.\\n\\ni.\\n\\nIn some cases, actinic prurigo may also affect the liver, causing actinic hepatitis.\\n\\nj.\\n\\nIn some cases, actinic prurigo may also affect the kidneys, causing actinic nephritis.\\n\\nk.\\n\\nIn some cases, actinic prurigo may also affect the heart, causing actinic cardiomyopathy.\\n\\nl.\\n\\nIn some cases, actinic prurigo may also affect the nervous system, causing actinic neuropathy.\\n\\nm.\\n\\nIn some cases, actinic prurigo may also affect the blood, causing actinic anemia.\\n\\nn.\\n\\nIn some cases, actinic prurigo may also affect the immune system, causing actinic immunosuppression.\\n\\no.\\n\\nIn some cases, actinic prurigo may also affect the endocrine system, causing actinic endocrinopathy.\\n\\np.\\n\\nIn some cases, actinic prurigo may also affect the musculoskeletal system, causing actinic arthralgia.\\n\\nq.\\n\\nIn some cases, actinic prurigo may also affect the gastrointestinal system, causing actinic gastritis.'}\n",
            "2\n",
            "repetiton 1\n",
            "{'METRNL Expression in Immune Cells': 'The study indicates that **METRNL is produced by alternatively activated macrophages (AAM)**, which are specialized immune cells that play a critical role in the regulation of inflammatory responses. The study also suggests that **M-CSF cultured bone marrow macrophages (M2-like macrophages)** express METRNL, indicating its role in the differentiation and function of these macrophage subtypes.', 'METRNL Expression in Skin and Skin-Associated Diseases': 'The study shows that **METRNL is expressed by resting fibroblasts and IFNγ-treated keratinocytes** in the skin, suggesting its role in skin homeostasis and immune responses. The study also reports that **METRNL is over-expressed in psoriasis, prurigo nodularis, actinic keratosis and atopic dermatitis**, indicating its involvement in these skin-associated inflammatory diseases.', 'METRNL Expression in Rheumatoid Arthritis': 'The study also reports that **METRNL is up-regulated in synovial membranes of human rheumatoid arthritis**, suggesting its role in the inflammatory process of this autoimmune disease. This finding highlights the potential of METRNL as a biomarker or therapeutic target for rheumatoid arthritis.'}\n",
            "3\n",
            "repetiton 1\n",
            "repetiton 2\n",
            "repetiton 3\n",
            "{}\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 4,\n  \"fields\": [\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": -1,\n        \"max\": 2,\n        \"num_unique_values\": 4,\n        \"samples\": [\n          0,\n          2,\n          -1\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 4,\n        \"samples\": [\n          \" <h4>Background/purpose</h4>Abnormal cutaneous sensitivity to the ultraviolet and/or visible radiation in sunlight characterizes photosensitivity disorders. Little is known regarding their impact in childhood. Our objective was to characterize childhood photosensitivity disorders presenting to a photoinvestigation unit, evaluating their impact on quality of life (QoL).<h4>Methods</h4>Photoinvestigation records of children attending from 2000 to 2007 were evaluated for diagnosis, clinical, demographic and phototest parameters. These children were subsequently contacted during summertime to evaluate the impact of photosensitivity on QoL, utilizing the children's dermatology life quality index (CDLQI).<h4>Results</h4>83 children underwent photoinvestigation; 62 (74.7%) were diagnosed photosensitive (mean age 8.6 years, range 2-16; 33 female), with abnormal phototest findings in 35 children. 38/55 questionnaires (69.1%) were returned. Mean (\\u00b1 standard deviation) CDLQI score (all diagnoses) was 10.2 \\u00b1 7.3 with very high scores in xeroderma pigmentosum (20.7 \\u00b1 5.7; n = 3) and actinic prurigo (18.2 \\u00b1 7.1; n = 6) and moderate scores in photoaggravated eczema (7.9 \\u00b1 4.2; n = 8) and polymorphic light eruption (6.2 \\u00b1 4.4 n = 18). CDLQI correlated with number of months affected per year (r = 0.595, P = 0.001).<h4>Conclusion</h4>Photosensitivity disorders have a substantial impact, ranging from moderate to extremely large, on QoL in childhood, and the psychological consequences should be considered in their management.,  <h4>Background</h4>Actinic Prurigo (AP) is a chronic pruritic dermatosis of unknown cause affecting sun exposed skin in defined ethnic groups with characteristic MHC alleles. However, the cutaneous dendritic cells have not been assessed.<h4>Objective</h4>To assess in situ the epidermal Langerhans Cell (LC) status in Actinic Prurigo.<h4>Study design</h4>Fresh skin samples from three AP patients were used to evaluate in situ the epidermal LC, comparing lesional and non-lesional sites in each subject.<h4>Setting</h4>AP patients attending the Dermatology Department at the Hospital M. Gea-Gonzalez in Mexico city.<h4>Methods</h4>Lesional and non-lesional skin samples were taken from each subject to prepare both epidermal sheets and conventional tissue sections. Three markers restricted to LC in epidermis (CD1a, ATPase, MHC-II) were used to quantify the LC per area in epidermal sheets.<h4>Results</h4>Compared to non-lesional skin from the same subject, a significant reduction in the number of LC per area of epidermis was found in lesional skin; with any of the three markers evaluated.<h4>Conclusion</h4>The frequency of epidermal LC decreases importantly in lesional skin from AP patients.,  <h4>Background</h4>Actinic prurigo (AP) appears to be an immune-mediated disease triggered by exposure to ultraviolet light (UV).<h4>Objective</h4>To assess the profile of cytokine production in skin lesions from AP patients.<h4>Methods</h4>The cytokine production (IL-1 beta, IL-2, IL-4, IL-6, IL-10, IL-13, TNF-alpha, IFN-tau, and TGF-beta) in skin biopsies from 12 AP lesions was determined by a semiquantitative coupled reverse transcription-polymerase chain reaction.<h4>Results</h4>We found expression of TGF-beta and IL-13 genes in most AP skin lesions; IL-1 beta, IL-6, TNF-alpha, IFN-tau, and IL-10 were detected in some of these specimens. However, the levels of expression of all cytokines studied were not significantly different in AP skin lesions compared to nonlesional skin.<h4>Conclusions</h4>TGF-beta and IL-13 might have a key role in both the inflammatory phenomenon and absence of significant expression of most cytokines in AP skin. The cytokine production in AP skin resembles that observed in rheumatoid synovium, a paucity in cytokine expression despite the presence of infiltrating activated mononuclear cells.,  <h4>Background</h4>Actinic prurigo (AP) is a chronic familial photodermatosis usually seen in Latin-American Mestizo and Indian populations. It frequently begins in childhood and is more prevalent in females. The pathogenesis of AP has not been clearly elucidated, but previous studies have suggested an immune-mediated condition. Many drugs have been employed to treat AP patients with variable success.<h4>Objective</h4>To assess the clinical efficacy of pentoxifylline (PTX) in the treatment of AP patients by measuring its effects on lesions and pruritus.<h4>Methods</h4>10 patients with severe AP were included to receive PTX in a 6-month open-label uncontrolled study.<h4>Results</h4>Clinical improvement of lesions was evident in all patients. Relief in pruritus was evident after 1 month of treatment and was maintained while receiving PTX. Five patients were followed up for 2 years, 2 obtained complete remission, and 3 had an important reduction in the use of corticosteroids.<h4>Conclusion</h4>PTX was useful in the treatment of our actinic prurigo patients. It may induce a complete or partial remission of lesions and allow a decrease in the use of topical corticosteroids.,  <h4>Background</h4>Actinic prurigo (AP) is a chronic, pruritic skin condition caused by an abnormal reaction to sunlight.<h4>Aims</h4>The aim of this study is to determine the clinical characteristics of AP in patients attending the National Skin Centre, Singapore, from 1 st January 1999 to 30 th June 2008.<h4>Methods</h4>Cases of AP diagnosed from 1 st January 1999 to 30 th June 2008 were retrieved from the center's electronic medical records and analyzed.<h4>Results</h4>A total of 11 patients were diagnosed with AP. The mean age at diagnosis was 52 years. There were 9 (82%) Chinese and 2 (18%) Malay patients. Nine (82%) were male and 2 (18%) were female. The most commonly affected areas were the face, forearms, and hands (72%). Phototesting showed reduced minimal erythema dose (MED) to ultraviolet A (UVA) in 5 (46%) patients, both UVA and ultraviolet B (UVB) in 4 (36%) patients and UVB in 1 (9%) patient. Seven (64%) patients reported partial improvement after treatment with a combination of topical corticosteroids and sunscreens. Four (36%) patients received systemic therapy with partial response.<h4>Conclusion</h4>Adult-onset AP is more common in the Asian population, with a male predominance. The face, forearms, and hands are the most commonly affected areas. The absence of mucosal involvement is also a distinguishing feature between the Asian and Caucasian population. Close to half of the patients have reduced MED to UVA on phototesting. The prognosis for AP is poor as it tends to run a chronic course with suboptimal response to treatment.,  <h4>Background</h4>Actinic prurigo (AP) is a frequent photodermatosis among Amerindians, with a high incidence among women and children below ten years of age. Neither the cause of actinic prurigo nor its etiological agent have been described. Not much is known about the pathogenic mechanisms of the disease, although associations with the human leucocitary antigens (HLA) and local immune responses seem to play an important role in its expression, as is the case in other skin autoimmune disorders, such as pemphigus and psoriasis.<h4>Material/methods</h4>In this paper we compare cellular and humoral immunity through in vitro proliferation studies, ELISA and immunofluorescence tests in actinic prurigo patients and healthy controls.<h4>Results</h4>Autoantibody reactivities on the skin and also proliferative responses to isolated autologous skin antigens were higher in patients than in controls. The polyclonal cellular immune response against T cell mitogens and against allogeneic stimuli was found to be diminished in patients.<h4>Conclusions</h4>We found autoimmune reactivity in patients suffering from actinic prurigo. We postulate that AP patients may have one or more skin antigens that stimulate an autoimmune response, which causes the observed skin lesions. As AP is a pathology that affects mainly the skin, any immune response should be localized and the observed infiltrating lymphocytes in skin biopsies should be activated by these hypothetical antigens.,  <h4>Background</h4>Actinic prurigo (AP) is a photodermatosis with a restricted ethnic distribution, mainly affecting Mestizo women (mixed Indian and European). The lesions are polymorphic and include macules, papules, crusts, hyperpigmentation and lichenification. Thalidomide, an effective immunomodulatory drug, was first used successfully to treat AP in 1973. In this work we describe the effect that thalidomide had on TNF-alpha sera levels and on IL-4- and IFN gamma (IFNgamma)-producing lymphocytes of actinic prurigo (AP) patients.<h4>Methods</h4>Actinic prurigo patients were analyzed before and after thalidomide treatment. The percentage of IL-4+ or IFNgamma+ CD3+ lymphocytes was analyzed in eight of them by flow cytometry. TNFalpha in sera was measured by ELISA in 11 patients.<h4>Results</h4>A direct correlation was observed between resolution of AP lesions and an increase in IFNgamma+ CD3+ peripheral blood mononuclear cells (P < or = 0.001) and a decrease in TNFalpha serum levels (no statistical difference). No IL-4+ CD3+ cells were detected.<h4>Conclusions</h4>Our findings confirm that AP is a disease that has an immunological component and that thalidomide clinical efficacy is exerted not only through inhibition of TNFalpha synthesis, but also through modulation of INFgamma-producing CD3+ cells. These cells could be used as clinical markers for recovery.,  <h4>Background</h4>Actinic prurigo (AP) is a type of photodermatosis, the pathophysiology of which has not been determined. AP has been suggested to be a hypersensitivity reaction to the presence of eosinophils and the local production of IgE.<h4>Material and methods</h4>Descriptive study, using paraffin blocks of tissue that have been diagnosed with AP from the Dermopathology department, Hospital General Dr. Manuel Gea Gonz\\u00e1lez. In 66 blocks from 63 patients, eosinophils were identified by hematoxylin and eosin staining, and mastocytes were labeled by immunohistochemistry. Three random microphotographs (40x) were used, and cell counts were calculated as the mean count in the 3 microphotographs.<h4>Results</h4>Forty cases (63.5%) were female, and 23 (36.5%) were male. The mean age was 26.49 \\u00b114.09 years; regarding the evolution time of the disease, the average was 11.93 years \\u00b111.39. In 38 of 63 cases (60%), the lip, skin, and conjunctiva were affected clinically. In 22 of 63 cases (34%), AP cheilitis was the sole manifestation, and in 4 of 63 cases (6%), there were lesions in the skin and conjunctiva. The mean eosinophil count was 9 per case, the average number of mastocytes/field was 28.48 (range 0 to 66) Kruskal-Wallis p=0.001.<h4>Conclusions</h4>There are elements in AP that mediate the reaction of hypersensitivity type IV b, necessitating the identification of triggering factors.<h4>Key words</h4>Actinic prurigo, eosinophil, hypersensitivity IV b, IgE, mastocytes.,  <h4>Background</h4>Actinic prurigo (AP) is an idiopathic familial photodermatitis. AP of the Inuit is rarely reported and poorly characterized.<h4>Objective</h4>Our purpose was to examine the clinical features and HLA associations of AP in an Inuit population.<h4>Methods</h4>Thirty-seven Inuit subjects with AP were administered a questionnaire and underwent a cutaneous examination. Other causes of photosensitivity were excluded. HLA class I typing was performed by polymerase chain reaction and sequence-specific primers and class II typing by polymerase chain reaction and sequence-specific oligonucleotide probes.<h4>Results</h4>Subjects were 81.1% female, 67.6% had a family history of photosensitivity, and all experienced seasonal variation. The average age at onset of photosensitivity was 29 years, and only 27% had a trend toward improvement in photosensitivity. Involvement of eyes and nonexposed skin was reported in 62.2% and 18.9% of subjects, respectively. Physical examination revealed involvement of the face (64.9%), lip (32.4%), ear (13.5%), and dorsal aspect of the hand (24.3%). HLA-DRB1*14 was present in 51.2% of subjects and 26.2% of controls (P =.022, odds ratio = 2.975). This is a previously unreported HLA association.<h4>Conclusion</h4>AP in the Inuit is a seasonal, pruritic photodermatitis, often commencing in adulthood and worsening over time. A novel association with HLA-DRB1*14 has been discovered. Overall, this novel HLA association, the absence of HLA associations previously reported in non-Inuit populations, and clinical distinguishing features support the concept that AP in the Inuit may have a distinct immunopathogenic basis that translates into a different phenotype. It also raises the question of whether AP in the Inuit is a distinct photosensitivity disorder specific to this group that has been genetically isolated because of geographic and cultural seclusion.,  <h4>Background</h4>Actinic prurigo (AP) is an idiopathic photodermatosis that usually onsets during childhood and predominates in women. It is characterized by the symmetrical involvement of sun-exposed areas of the skin, lips, and conjunctiva.<h4>Objectives</h4>This study aimed to analyze the risk factors associated with AP using a case-control design.<h4>Methods</h4>All patients diagnosed with AP during 1990-2006 at Dr. Manuel Gea Gonz\\u00e1lez General Hospital in Mexico City were included. Respective controls were recruited. Race, demographic, geographic, socioeconomic, environmental, clinical, and nutritional risk factors were assessed.<h4>Results</h4>A total of 132 persons were enrolled. These included 44 cases and two control groups comprising, respectively, dermatology and non-dermatology outpatients without AP or any autoimmune disease. Distribution by gender, age, place of birth, place of residence, and economic status did not differ significantly among the three groups. A total of 256 variables were analyzed. Only 19 variables were found to be statistically significant (P\\u00a0<\\u00a00.05). These were: use of a boiler; use of firewood; car ownership; use of earthenware; mixed material housing; socioeconomic level 1; sun exposure; use of soap; lemon consumption; use of moisturizing hair cream; living with pets in the house; living with farm animals; age; having a family member with AP; having had surgery; having had trauma; having been hospitalized; use of oral medication; and use of herbal medication. Of 40 macro- and micronutrients analyzed, 11 were found to have statistically significant effects (P\\u00a0<\\u00a00.05).<h4>Conclusions</h4>Multiple epidemiologic, geographic, clinical, and immunologic factors are involved in the etiology of AP. This study proposes a clear line for research directed at specific risk factors that refer to an individual's clinical, allergic, health, and socioeconomic status. Further study should also investigate the etiologic role of diet in AP and the molecular mechanisms behind the development of AP to establish whether AP is caused by exposure to polycyclic aromatic hydrocarbons.,  <h4>Background</h4>Actinic prurigo (AP) is an idiopathic photodermatosis, this entity requires exposure to UV-B and -A to develop lesions. Apoptosis is a physiological death program that can be initiated by a permanently active mechanism (extrinsic pathway) or irreparable damage (intrinsic pathway).<h4>Material and methods</h4>Descriptive study, the sample size comprised 64 paraffin blocks of tissue with a diagnosis of AP. In H&E-stained slides, the diagnosis of AP was corroborated, and 1-\\u00b5m-thick sections were processed for immunohistochemistry (IHC). A database was constructed with SPSS version 20, Inc., Chicago, IL, USA, and descriptive statistics were analyzed by X2 test and comparison of means.<h4>Results</h4>A total of 64 cases were processed, of which 40 (62.5%) were cheilitis AP and 24 (37.5%) were AP in the skin. Of the 40 cheilitis samples, 27 were positive for Bcl-2 and caspase 3 (67.5%), p53 was expressed in 30 (75%). Of the skin lesions, p53 and caspase 3 were expressed in 18 of 24 cases (75%), and 13 were positive for Bcl-2 (54%).<h4>Conclusions</h4>We propose that apoptosis is the last step in the type IV subtype a-b hypersensitivity response-activation of the intrinsic pathway indicates that external factors, such as UV-A and -B are the trigger.,  <h4>Background</h4>Actinic prurigo (AP) is triggered by sun exposure. Its prevalence in Mexicans seems to be particularly high, which suggests a genetic susceptibility.<h4>Objective</h4>Our purpose was to determine the role of major histocompatibility complex (MHC) genes in the genetic susceptibility to AP.<h4>Methods</h4>Fifty-six Mexican Mestizo patients with AP underwent serologic typing for HLA class I and class II antigens. Class II MHC genes were also studied by DNA analysis. Findings in patients were compared with 100 ethnically matched healthy controls.<h4>Results</h4>We found that 92.8% of patients with AP were HLA-DR4 positive (corrected p = 0.002; odds ratio [OR] = 10.1). The class I antigens HLA-A28 and HLA-B39 (B16) were also significantly increased (p < or = 0.000001, OR = 20.9 and p = 0.0001, OR = 6.7, respectively) compared with normal controls. Allele-specific oligonucleotide DR4 subtyping showed that 80.7% of HLA-DR4+ patients with AP were also positive for the DRB1*0407 allele.<h4>Conclusion</h4>These results confirm the role of HLA-DR4 (DRB1*0407) in the genetic susceptibility to AP and raise the possibility of a role for class I MHC antigens HLA-A28 and B16 in Mexican patients.,  <h4>Background</h4>Actinic prurigo has a high prevalence in women of child-bearing age. Its treatment has been, among others, with thalidomide. To avoid the deleterious effects of this drug on the embryo, therapeutic alternatives have been sought. Among these, tetracycline and vitamin E have been investigated as to their influence on the symptoms of actinic prurigo. Both these drugs affect superoxide radicals that are thought to be involved in the pathogenesis of actinic prurigo.<h4>Materials and methods</h4>Patients (Chimila Indians with a high prevalence of actinic prurigo) received either (a) tetracycline, 500 mg three times daily, for 6 months, or (b) vitamin E, 100 IU daily, for 6 months. The patients were seen once monthly. There were eight patients in each group.<h4>Results</h4>Both drugs used were effective. Pruritus was remarkably improved by either treatment. None of the side effects were severe enough to lead to interruption of treatment, but the observation period posttreatment was relatively short, 4 months for tetracycline and 2 months for vitamin E. The improvement occurred in spite of the continuation of extensive exposure to the sun.<h4>Conclusions</h4>Tetracycline and vitamin E are efficacious in relieving the pruritus of actinic prurigo. Preliminary trials of a combination treatment with these two drugs is a new avenue which has shown in preliminary trials to yield synergistic effects which might allow the dosage of tetracycline to be reduced.,  <h4>Background</h4>Actinic prurigo is a chronic photodermatosis of unclear pathogenesis. Epidermal Langerhans cell resistance to migration after ultraviolet radiation exposure has been proposed as a possible mechanism, as occurs in polymorphic light eruption patients. The purpose of this study was to evaluate the effect of solar-simulated radiation (SSR) on epidermal Langerhans cells in the uninvolved skin of actinic prurigo patients.<h4>Patients and methods</h4>Fifteen patients with actinic prurigo participated in the study. A biopsy from the uninvolved and unirradiated skin of the left buttock was performed, and another from the uninvolved skin of the right buttock, 72\\u00a0hours after exposure to two MEDs of SSR. Immunohistochemistry staining was used to identify Langerhans cells (CD1a) in all samples.<h4>Results</h4>In actinic prurigo patients with normal MED, there was a significant decrease in the number of epidermal Langerhans cells on the buttock skin exposed to two MED of SSR compared with the unirradiated buttock skin (P\\u00a0=\\u00a0.02 and .035 respectively). On the contrary, in patients with low MED there were no significant differences in the number of epidermal Langerhans cells between irradiated and unirradiated skin (P\\u00a0=\\u00a0.39).<h4>Conclusion</h4>Epidermal Langerhans cells migration after ultraviolet radiation exposure is decreased in actinic prurigo patients with low MED as has been reported in PLE patients, especially, those with low MED or positive UVB provocation tests. Langerhans cells resistance could be part of a common pathogenic mechanism in these two photodermatoses.,  <h4>Background</h4>Actinic prurigo is a photodermatitis in which UV light is implicated by an unknown mechanism.<h4>Methods</h4>Skin biopsies of 19 patients with actinic prurigo and 11 controls were analyzed by immunohistochemistry.<h4>Results</h4>In actinic prurigo patients, there was a significant increase in the number of CD3, CD4, CD8, CD45RA, CD45RO, and CD45RB lymphocytes and Langerhans cells, as well as in the level of human leukocyte antigen-DR (HLA-DR) expression and cell adhesion molecules lymphocyte functional antigen-1 (LFA-1), intercellular adhesion molecule-1 (ICAM-1), and endothelial leukocyte adhesion molecule-1 (ELAM-1). Actinic prurigo patients were treated with cyclosporin A (CsA), and a final skin biopsy was taken after 6 months of treatment. All the cell populations and markers studied, except for the CD4 lymphocytes, Langerhans cells, and HLA-DR expression, returned to normal levels.<h4>Conclusions</h4>CsA was found to be effective in relieving the clinical symptoms of actinic prurigo.,  <h4>Background</h4>Actinic prurigo is a specific familial photodermatosis of uncertain pathogenesis.<h4>Objective</h4>Our purpose was to investigate the immunohistologic presentation of actinic prurigo to explore the involved pathomechanisms.<h4>Methods</h4>The present immunohistochemical study was performed on biopsy specimens from 20 Mexican patients presenting with a severe and perennial form of the disease.<h4>Results</h4>The dense inflammatory infiltrate was composed predominantly of helper T type 1 lymphocytes admixed with scattered B-cell lymphoid follicles and numerous dermal dendrocytes. Keratinocytes contained abundant tumor necrosis factor-alpha and calprotectin.<h4>Conclusion</h4>In subjects genetically predisposed to actinic prurigo, ultraviolet light may trigger excessive tumor necrosis factor-alpha production by keratinocytes whose sustained release in turn exerts its proinflammatory activity and deleterious epidermal effects. Such a cascade of events is in line with the therapeutic benefit already reported when thalidomide is used to treat actinic prurigo.,  <h4>Background</h4>Actinic prurigo is an idiopathic photodermatosis, the pathophysiology of which has been hypothesized to involve subtype IV type b (Th2) hypersensitive response, whereby IL4, IL5, and IL13 are secreted and mediate the production of B cells, IgE, and IgG4.<h4>Objectives</h4>To examine the association of serum IgE levels and the clinical severity of injuries.<h4>Methods</h4>This case-control study comprised patients with a clinical and histopathological diagnosis of actinic prurigo, as well as clinically healthy subjects, from whom 3cc of peripheral blood was taken for immunoassay. Cases were classified by lesion severity as mild, moderate, and severe. Descriptive statistics were analyzed, and chi-square test was performed.<h4>Results</h4>We included 21 actinic prurigo patients and 21 subjects without disease; 11 patients with actinic prurigo had elevated serum IgE levels, and 10 had low serum levels. Six actinic prurigo (AP) patients with elevated serum levels of IgE had moderate injuries, 4 had severe injuries, and 1 had minor injuries. Eight out of 10 patients with normal IgE levels presented with minor injuries in the clinical evaluation. The 21 controls did not have increased serum IgE levels.<h4>Conclusions</h4>Elevated IgE levels are associated with moderate to severe clinical lesions, suggesting that actinic prurigo entails a type IV subtype b hypersensitivity response in which Th2 cells predominate.,  <h4>Background</h4>Actinic prurigo, an idiopathic familial photodermatosis, has been described in Amerindians in Manitoba, Canada, as well as in the United States, Mexico, and South America.<h4>Objective</h4>Our purpose was to describe the clinical features and prognosis of actinic prurigo in Amerindians in Saskatchewan, Canada.<h4>Methods</h4>Clinical examinations, questionnaires, phototesting, and laboratory tests were used.<h4>Results</h4>We present a series of 93 Amerindian patients. The face is the most commonly involved area. A hereditary tendency, cheilitis, and pruritus are prominent features. One third of patients report some lesions, often minor, during the winter. The majority of patients phototested were sensitive to ultraviolet A light.<h4>Conclusion</h4>We find the age of onset of actinic prurigo to be the most important feature in determining the type of eruption and the prognosis for the patient. In general the younger ages of onset (up to 20 years of age) are associated with cheilitis and more acute eruptions and are more likely to improve over 5 years. Those who develop actinic prurigo as adults (21 years of age and older) tend to have a milder and more persistent dermatosis.,  <h4>Background</h4>Actinic prurigo, as idiopathic skin reaction involving light-exposed areas, was first described in American Indians. Actinic prurigo was early considered to be a particular form at polymorphous phototoxicity, but can be identified as a specific entity on the bases of clinical features and epidemiological characteristics.<h4>Case reports</h4>Three children in the same family developed photosensitive reactions early in childhood with characteristic polymorphous and persistent eczema-like or papulo-nodular pruriginous lesions which predominated in light-exposed areas and appeared several hours after exposure to sun. The lesions persisted during the winter season. The lesions followed a chronic course but tended to improve at puberty. Clinical laboratory tests, serum and urine porphyrin levels and antinuclear factors were normal. Histology and photobiology explorations gave non-specific results.<h4>Discussion</h4>These observations have three points in common with actinic prurigo observed in American Indians. HLA typing showed that our three patients, as in white patients in Great Britain, had a significant association with a specific HLA DR1 subtype: DRB1*0407. This DRB1*0407 alleles could play a role in initiating the immune response to a light-induced peptide antigen. This particular genetic predisposition, if confirmed in other studies, would be an additional argument for distinguishing actinic prurigo as a specific polymorphous phototoxicity entity.,  <h4>Background</h4>Human leukocyte antigen (HLA) DRB1*0407 had been associated with actinic prurigo in different populations. This class II HLA-DR subtype had not been studied in Colombia.<h4>Objective</h4>The objective of this study was to establish whether there was an association of actinic prurigo with HLA DR in a Colombian population.<h4>Materials and methods</h4>Forty patients with a clinical diagnosis of actinic prurigo and 40 healthy subjects, paired by age, sex and birthplace, were studied. HLA typing for HLA DRB1 and DRB1*04, if necessary, was performed by the PCR-SSP method using blood samples.<h4>Results</h4>A high frequency of HLA DRB1*0407 was found in the patients (97.5% vs. 30%; P<0.00001). The allelic frequency of HLA DRB1*0407 was 63.8% in the case group, and 14.5% in the controls (P<0.00001). In the control group, there was a higher frequency of the alleles DRB1*01 (14.5% vs. 1.25%; P=0.0027) and DRB1*13 (23.7% vs. 2.5%; P=0.00013).<h4>Limitations</h4>The small number of controls does not allow us to drive conclusions about other HLA alleles.<h4>Conclusions</h4>HLA subtype DRB1*0407, found in actinic prurigo patients in studies conducted in England, Scotland, Ireland and Mexico, was also associated in Colombian patients. This finding, concordant in patients from different ethnic groups, could be helpful in the diagnosis of this disease and probably important in its pathogenesis. DRB1*01 and DRB1*13 alleles were more frequent in controls than in patients; we do not know whether they play any role in the resistance to the disease.,  <h4>Background</h4>Idiopathic photodermatoses are considered to be common disorders in the population of northern latitude countries, presumably because of the dominance of more \\\\sun-sensitive\\\\ individuals with a light-skinned complexion. The incidence of these disorders in the Mediterranean or tropical countries is often under-appreciated because of the higher degree of perennial presence of sunlight and the prevalence of darker skin-type individuals who are seemingly more resistant to the development of sun sensitivity.<h4>Methods</h4>We performed a retrospective, chart-based review of all patients who were diagnosed with idiopathic photodermatoses at a photodermatology referral center in Athens, Greece, during a period of 10 years. Our aim was to assess the pattern of idiopathic photosensitivity disorders in a Mediterranean country and to determine their epidemiological, clinical, and photobiological profile.<h4>Results</h4>A total of 310 patients were referred to our center with symptoms of photosensitivity. One hundred and forty-six patients (47.0%) were diagnosed with an idiopathic photosensitivity disorder by means of history, clinical examination, biochemical screening, histology, and phototesting. The most prevalent disorder was polymorphous light eruption, which was diagnosed in 95 patients (65.0%) of our cohort. Chronic actinic dermatitis occurred in 15 patients (10.2%), solar urticaria in 26 patients (17.8%), actinic prurigo in three patients (2.0%), hydroa vacciniforme in one patient (0.6%) and juvenile spring eruption in six patients (4.1%).<h4>Conclusions</h4>Compared with the results of other studies, the prevalence of idiopathic photodermatoses appears to have a similar trend to that of higher latitude countries. Distinct features in our series include the higher incidence of idiopathic photosensitivity in patients with a fair-skinned complexion (skin types II-III) and the frequent appearance of photo-induced eruptions during sunny weather breaks in the winter period.,  <h4>Background</h4>Polymorphic light eruption (PLE) is a common inherited photosensitivity disorder, which may predispose to several related but distinct conditions, including subacute cutaneous lupus erythematosus (SCLE), discoid lupus erythematosus (DLE) and actinic prurigo (AP).<h4>Objectives</h4>To examine specific candidate genes for shared susceptibility alleles between these related phenotypes.<h4>Methods</h4>Eighty-five caucasian patients with annular SCLE or DLE were recruited, in addition to 102 first-degree relatives. The prevalence of PLE in both the patient and relative groups was determined by detailed interview and clinical examination. Eighty-five patients with pure PLE and 59 patients with AP were also recruited. Candidate genes were analysed by typing of single nucleotide polymorphisms of IL10 (-1082 G/A and -819 C/T), FCGR2A (131 R/H), SELE (128 S/R), ICAM1 (241 G/R and 469 E/K), IL1A (+ 4845 G/T), IL1B (-511 C/T and + 3954 C/T), IL1RN (+ 2018 T/C) and TNF (-308 G/A) using polymerase chain reaction (PCR) with sequence-specific primers and 5'-nuclease PCR.<h4>Results</h4>A significant association was found between SCLE and the rare TNF -308 A allele when compared with patients with DLE (P = 0.043), PLE (P = 0.001), AP (P < 0.001) and healthy controls (P < 0.001). However, there was strong linkage disequilibrium between TNF -308 A and the HLA A*01, B*08, DRB1*0301 haplotype. A negative association was also found between SCLE and the IL1B + 3954 T allele (P = 0.039), but the significance was lost on correction for multiple testing.<h4>Conclusions</h4>We have demonstrated the association of SCLE with the rare TNF -308 A allele, which may be pathogenic or, alternatively, a marker allele for the extended HLA A*01, B*08, DRB1*0301 haplotype that is associated with a number of autoimmune conditions. Although many of the other loci that we chose failed to demonstrate an association, a candidate gene approach remains the most logical one, and the most likely to yield positive results in the future.,  <h4>Background</h4>Polymorphic light eruption and erythropoietic protoporphyria (EPP) have been demonstrated to have a moderate and large impact on the quality of life (QoL) of patients, respectively. However, there is little information available about the impact of other photodermatoses on QoL.<h4>Objectives</h4>To assess and compare the impact of all forms of photodermatoses on patients' QoL using the standard 1-week Dermatology Life Quality Index (DLQI) questionnaire and a modified questionnaire to assess the impact over the previous year.<h4>Methods</h4>All patients with photodermatoses seen between 2001 and 2005 at five U.K. photobiology centres were contacted by post on the same day during a forecasted sunny week across the U.K. and asked to complete DLQI questionnaires.<h4>Results</h4>A total of 1877 patients were contacted. Seven hundred and ninety-seven (42%) patients replied, with a range from 30% to 48% for the five individual centres. Nearly two-thirds of patients with actinic prurigo (AP) and more than one-third of patients with photoaggravated dermatoses (PAD), chronic actinic dermatitis, EPP and solar urticaria had a DLQI of > 10, confirming a very large effect of the disorders on QoL. Of the cutaneous porphyrias, both variegate porphyria (median DLQI 3) and porphyria cutanea tarda (median DLQI 1.5) had a much lower impact on QoL than EPP.<h4>Conclusion</h4>This is the first large-scale study to attempt to measure the impact of a range of photodermatoses on QoL. Photodermatoses have a major impact on QoL. This impact is highest in AP and PAD.,  <h4>Background</h4>Solar or actinic prurigo (PS) is one of the most common skin diseases observed in our country, particularly in the pediatric age; in our institution it is on the 14 place with a frequency of 1.34%. It represents an abnormal reaction to solar light and in its pathogenesis diverse factors participate, mainly immunogenetical and environmental. Although their clinical characteristics are already specified, the histopathological features are still not well documented.<h4>Material and methods</h4>We carried out a retrospective and observational study in order to analyze the histopathologic changes in 20 samples of skin coming from 20 pediatric patients with PS; in all of them diagnosis was well established on clinical criteria.<h4>Results</h4>Twenty children with PS of more than one year of evolution, ten of each sex, all mestizos or indigenous inhabitants of Mexico City and vicinity; we identified recent and late lesions, with epidermal and dermal changes, the more conspicuous were: spongiotic papules usually with psoriasiform epidermal hyperplasia, in association with perivascular, superficial and mild lymphocytic infiltrates, usually with few eosinophils, exocytosis of lymphocytes into the epidermis, pigment incontinence and extravasation of erythrocytes.<h4>Conclusions</h4>The PS is an inflammatory cutaneous disease for which histopathological diagnosis is feasible of being established on skin biopsies of recent or late lesions.,  <h4>Background</h4>The idiopathic photodermatoses have been reported to be rarer in tropical Singapore than in countries of higher latitude, with photoaggravated dermatoses and systemic phototoxicity making up most of the photodermatoses seen here. This study aims to reassess the spectrum of photodermatoses seen at the National Skin Centre, Singapore, compared with almost a decade ago, and analyse the clinical and photobiological characteristics, as compared with other countries.<h4>Materials and methods</h4>We reviewed the clinical data of 141 patients phototested from January 2000 to December 2001, and analysed the epidemiological, clinical and photobiological features.<h4>Results</h4>Photosensitive dermatoses were diagnosed in 88% (124/141) of patients phototested. In those diagnosed with photodermatoses, polymorphic light eruption (PMLE) (28%) was the most common diagnosis, followed by photoaggravated dermatoses (26%), chronic actinic dermatitis (CAD) (15%), systemic phototoxicity (15%), solar urticaria (SU) (7%), actinic prurigo (AP) (5%) and photoallergic contact dermatitis (4%). Ethnic Indians appeared to be more predisposed to PMLE; AP was diagnosed only in ethnic Chinese. The other photodermatoses occurred proportionally in all racial groups. AP differed from that found in Caucasians, being of adult onset and persistent. Abnormal phototest results were obtained in all patients with CAD, SU and AP, but only in 56% and 49% of systemic phototoxicity and PMLE, respectively.<h4>Conclusion</h4>Idiopathic photodermatoses are more commonly diagnosed in Singapore than a decade ago, while the incidence of systemic phototoxicity has remained stable. The spectrum of photodermatoses in our Asian population now approximates that seen in Caucasian cohorts.,  <h4>Case report</h4>A 14-year-old girl from Peru suffered severe limbitis and conjunctivitis. She also presented with clinical skin features diagnosed as actinic prurigo (AP). Her symptoms were successfully controlled with sustained topical therapy of 2% Cyclosporine A.<h4>Discussion</h4>AP is an idiopathic photodermatosis that affects mainly the hispanic population of Latin America. There are ocular signs of severe limbitis and conjunctivitis (like atopic keratoconjunctivitis) in 45% of cases. Literature on the subject is very limited and currently topical cyclosporine seems to be the best therapy available.,  <h4>Objective</h4>To determine if exposure to atmospheric ozone disruption and other factors are associated with photodermatoses in the high-altitude pediatric population in Peru.<h4>Materials and methods</h4>A cross-sectional study based on data obtained from studies of dermatological diseases among the population exposed to mine tailings in Peru which included children under the age of 18 in 6 population centers located over 2500 meters above sea level (m.a.s.l). We evaluated the presence of photodermatoses and possible associated factors obtaining the adjusted odds ratio (aOR) and confidence intervals (CI).<h4>Results</h4>594 children below the age of 18 participated in this study, 53.0% girls, the average age was 10.4 \\u00b1 4.1 years. 51.3% were exposed to a mini hole in the ozone layer, 60.1% resided at an altitude over 3500 m.a.s.l and 51.9% presented cutaneous manifestations of atopy upon physical examination. The prevalence of photodermatoses was 64.8%, of which the most frequent were actinic prurigo (49.3%), pityriasis alba (18.5%) and actinic cheilitis (4.4%). The multivariate analysis found that residing in a region exposed to the mini hole in the ozone layer (aOR = 4.23; CI 95%: 2.32-7.72) and residing at an altitude over 3500 m.a.s.l (aOR = 2.76; CI 95%: 1.57-4.86) were both independent associated factors to photodermatoses.<h4>Conclusion</h4>A high prevalence of photodermatoses exists among the pediatric population living at high-altitude in Peru. Residing in a region exposed to a mini hole in the ozone layer and residing over 3500 m.a.s.l constituted associated factors.,  <h4>Objective</h4>To review published data on thalidomide, with emphasis on current knowledge about mechanism of action, new and/or potential dermatologic and nondermatologic therapeutic applications, well-known and emerging adverse effects, and current indications for its safe use.<h4>Data sources</h4>Review articles, in vitro research studies, references from retrieved articles, case reports, and clinical trials were identified from a computerized literature search using MEDLINE and OVID (1966-January 2003) and on the Cochrane Clinical Trials Register (January 2003). Information available from meetings' abstract books, Internet, or pharmaceutical companies was also considered.<h4>Study selection and data extraction</h4>All articles identified as relevant, including those from non-English literature, were considered in an attempt to provide to the reader both the theoretical basis and practical guidelines for thalidomide pharmacotherapy.<h4>Data synthesis</h4>Thalidomide has hypnosedative, antiangiogenic, antiinflammatory, and immunomodulatory properties. Moreover, it has been shown to selectively inhibit the production of tumor necrosis factor-alpha and reduce the expression of various integrin receptors on the membrane of leukocytes and other cell types in a dose-dependent fashion. Controlled trials demonstrated the efficacy of thalidomide in a number of diseases, including erythema nodosum leprosum, lupus erythematosus, aphthosis, graft-versus-host disease, prurigo nodularis, and actinic prurigo. Single case reports or studies in small series have also suggested a possible role for thalidomide in numerous other dermatologic and nondermatologic disorders. Possibly severe and sometimes irreversible risks related to the clinical use of thalidomide include teratogenicity and neurotoxicity.<h4>Conclusions</h4>Although teratogenicity and neurotoxicity are significant adverse effects requiring cautious use, thalidomide is an effective therapeutic modality in a variety of difficult-to-treat disorders and, providing careful selection of patients, should offer an acceptable risk-to-benefit ratio.,  <h4>Purpose</h4>Actinic conjunctivitis (AC), along with cheilitis (AChe), is part of the clinical spectrum of actinic prurigo (AP), a rare photo dermatosis that affects high-risk populations. We analyzed the clinical manifestations and onset of actinic conjunctivitis (AC), and its relationship with prurigo (AP) in a susceptible population.<h4>Methods</h4>This prospective observational cohort study was performed on Indigenous populations from the highlands of Chiapas, Mexico. Thorough dermatological and ophthalmological examinations were performed in patients attending a primary health care center. The clinical features, labor and environmental factors, onset timing, and clinical staging of AC and AP were analyzed.<h4>Results</h4>Of the 2913 patients studied, 54 patients (108 eyes) (1.8%) had AC, and 14 patients (25.9%) had AP. The mean age at diagnosis was 36.18\\u2009\\u00b1\\u200918.52\\u00a0years (6-70\\u00a0years). The mean residential altitude was 1884\\u2009\\u00b1\\u2009434.2\\u00a0m above sea level. Mean self-reported sun exposure was 5.14\\u2009\\u00b1\\u20093.1\\u00a0h a day (0.5-12\\u00a0h). A total of 90.7% reported exposure to biomass fuels during cooking, and 50% to farm animals. AC was the sole manifestation in 70% of the cases. All patients had nasal and temporal photo-exposed conjunctiva. Among the eyes, 12.9% were classified as stage-1, 64.8% as stage-2, and 22.2% stage-3. A total of 83.3% of the patients had hyperpigmented lesions, and 35.1% had evaporative dry eye disease.<h4>Conclusions</h4>AC may be the initial or sole manifestation of AP. Most AC cases (87%) were initially observed at the advanced stages of the disease. Although solar exposure was not associated with late AC stages, a positive association was found with farm animal exposure. Evaporative dry eye associated with meibomian gland dysfunction has not been previously reported in patients with AC.,  <h4>Purpose</h4>To report the successful treatment of conjunctival manifestations of actinic prurigo with topical cyclosporin.<h4>Methods</h4>A 12-year-old female with extensive limbal lesions and chronic conjunctivitis secondary to actinic prurigo was treated with topical cyclosporin, and a rapid clinical response was observed.<h4>Results</h4>The patient had the limbal lesions surgically excised. The lesions completely recurred over the first 2 postoperative months. Treatment with topical steroids and vitamin A ointment was unsuccessful. The patient was then treated with cyclosporine 2% drops and a dramatic improvement occurred. Over a 3-month period, the lesions completely resolved.<h4>Conclusion</h4>Cyclosporine eyedrops may be an effective treatment for the conjunctival manifestations of actinic prurigo.,  A 13-year-old black boy had pruritic papular and nodular lesions on his forearms associated to edema of the lower lip, photophobia, conjunctivitis and pterygium. Skin biopsy of the lower lip revealed acanthosis, spongiosis with dermal perivascular mononuclear cell infiltration composed by lymphocytes, plasma cells and eosinophils consistent with actinic prurigo. Lesions improved considerably with the use of thalidomide 100mg/ day.,  A 35-year-old man presented at the age of 8 years with recurrent pruritic papulovesicular lesions on his face and body appearing within minutes of light exposure. A recent positive finding of human leukocyte antigen (HLA) DR4 with the rare DRB1*0407 subtype confirmed a diagnosis of actinic prurigo. Thalidomide (100 mg/day) was commenced at the age of 11 years after an unsuccessful trial of other treatments and his lesions resolved within 2 months. Attempts to withdraw thalidomide have resulted in recurrence of photosensitivity and the patient has remained on a virtually continuous maintenance dose of thalidomide (50 mg/ day) for 23 years. His cumulative dose is estimated to be over 400 g. To date, he has not experienced any adverse effects and investigations have shown no evidence of neuropathy. This case illustrates the safe long-term use of thalidomide.,  Abnormal photosensitivity syndromes form a significant and common group of skin diseases. They include primary (idiopathic) photodermatoses such as polymorphic light eruption (PLE), chronic actinic dermatitis (CAD), actinic prurigo, hydroa vacciniforme and solar urticaria, in addition to drug- and chemical-induced photosensitivity and photo-exacerbated dermatoses. They can be extremely disabling and difficult to diagnose. PLE, characterized by a recurrent pruritic papulo-vesicular eruption of affected skin within hours of sun exposure, is best managed by restriction of ultraviolet radiation (UVR) exposure and the use of high sun protection factor (SPF) sunscreens. If these measures are insufficient, prophylactic phototherapy with PUVA, broadband UVB or narrowband UVB (TL-01) for several weeks during spring may be necessary. CAD manifests as a dermatitis of chronically sun-exposed skin. Again, UVR exposure needs to be restricted; cyclosporine, azathioprine or PUVA may also be necessary. Actinic prurigo is characterized by the presence of excoriated papules and nodules on the face and limbs, most prominent and numerous distally. Actinic prurigo is managed again by restriction of UVR and the use of high SPF sunscreens; PUVA or broadband UVB therapy, or low doses of thalidomide may be necessary. Hydroa vacciniforme causes crops of discrete erythematous macules, 2 to 3mm in size, that evolve into blisters within a couple of days of sun exposure. Treatment for this rare disease is difficult; absorbent sunscreens and restricted UVR exposure may help. Solar urticaria is characterized by acute erythema and urticarial wealing after exposure to UVR. Treatment options for solar urticaria include non-sedating antihistamines such as fexofenadine and cetirizine; other options include absorbent sunscreens, restriction of UVR at the relevant wavelength, maintenance of a non-responsive state with natural or artificial light exposure and plasmapheresis. Industrial, cosmetic and therapeutic agents can induce exogenous drug- or chemical-induced photosensitivity. The clinical pattern is highly varied, depending on the agent; treatment is based on removal of the photosensitizer along with restriction of UVR exposure. Predominantly non-photosensitive dermatoses may also be exacerbated or precipitated by UVR; exposure to UVR should be reduced and sunscreens should be advocated, along with appropriate treatment of the underlying disease.,  Actinic prurigo (AP) and polymorphic light eruption (PLE) both belong to the group of idiopathic photodermatoses, but it remains controversial whether AP is a distinct photodermatosis or a variant of PLE. The aim of this study, by collecting data from 119 patients with features of these disorders, was to establish whether specific criteria could be used to distinguish AP from PLE prospectively. We found that presence of the eruption on both exposed and covered sites, its occurrence in winter, persistence of lesions beyond 4 weeks, mucosal and conjunctival involvement, excoriation and scarring of the skin were important features of AP which were not typical of PLE. On this basis, confident clinical diagnoses could be reached in 103 of 119 patients (87%), 57 with AP and 46 with PLE, supported by phototesting and negative lupus serology. HLA typing subsequently confirmed the strong association (90%) between AP and the DR4 allele, in particular with the rare subtype DRB1*0407 which was present in 60% of these patients. No HLA association was found in PLE. In the 16 remaining cases, however, clinical overlap meant that no definite diagnosis could be made; these patients were notionally described as having persistent PLE (PPLE). Demographic and HLA data in this group suggested that PPLE was perhaps most appropriately grouped with PLE. In addition to those patients who were difficult to classify, 35% of our typical AP patients also described clinical progression from PLE to AP, AP to PLE or coexistence of both AP and PLE. In conclusion, our study suggests that while AP and PLE are clinically distinct conditions in most cases, they may perhaps share a common pathophysiological basis. The AP phenotype may be determined by HLA and perhaps other factors in patients otherwise predisposed to PLE.,  Actinic prurigo (AP) belongs to the group of idiopathic photodermatoses sharing a predilection for occurring more commonly in females, and there is much controversy as to whether it is only a more severe form of polymorphous light eruption (PMLE) or whether it is a distinct entity in its own right. The condition is characterised by intensely itchy papules, plaques and nodules, along with excoriations and scars usually starting before puberty, and predominantly involves the sun-exposed areas although it may also affect covered sites. Seasonal exacerbations at the beginning of spring with improvement in the fall are typical, although the lesions frequently do not clear completely in the winter. The disorder may run a chronic course and persist into adulthood, but often spontaneous resolution occurs in late adolescence. Diagnosis is predominantly based on the clinical features, cutaneous irradiation tests and histology often being normal or non-specific. HLA typing has also been performed in both PMLE and AP patients, showing a strong association between HLA-DR4, in particular with the DRB1*0407 subtype, and AP; no HLA association has been found in PMLE. This HLA association is likely to be of pathogenic significance and strongly suggests a critical role for MHC-restricted antigen presentation in the development of photosensitivity AP.,  Actinic prurigo (AP) has been found to be strongly associated with HLA DR4 and in particular with the DR4 subtype DRB1*0407. However, AP may occur in the absence of HLA-DR4. Furthermore, it has been shown that HLA-DR4 and DRB1*0407, even in association with polymorphic light eruption (PLE), are insufficient for the expression of the AP phenotype. It seems likely, therefore, that other genes in the HLA DR or adjacent regions may contribute to AP susceptibility. One possible predisposing factor in AP may be tumour necrosis factor (TNF)alpha as suggested by the good response of AP to the TNFalpha inhibitor thalidomide, and by the involvement of this cytokine in many immune responses. The aim of this study was to explore the relationship between AP and TNFalpha by examining the frequency of TNF2 in patients with AP, PLE and in normal controls. TNF1 and TNF2 are biallelic polymorphisms at position -308 of the TNFalpha gene promoter and are known to affect transcription of TNFalpha. TNF2 is the rarer of the two alleles and is associated with high functional levels of TNFalpha. This study confirms the positive linkage disequilibrium that has been described between HLA DR3 and TNF2, but fails to show an association between TNF2 and AP.,  Actinic prurigo (AP) is a chronic idiopathic photodermatosis that primarily affects American Indians in the United States and Mestizos in Latin American countries. Clinically, the onset of the disease is usually in the first decade of life but may appear initially in adult life, and it is characterized by symmetric involvement of sun-exposed areas of the skin, particularly areas of the face, resulting in polymorphic erythematous papules, macules, and plaques in different stages of evolution. Lower lip involvement includes swelling, scaling, fissures, hyperpigmentation, and ulcerations of the vermilion border. and in some cases could represent the only manifestation of the disease. The histopathologic features of AP have been studied; however, there is a controversy regarding whether AP cheilitis has distinct histopathologic features that could allow accurate separation from other specific and nonspecific forms of cheilitis. The diagnosis can be challenging, mainly when lip lesions are the only manifestation of the disease. In this study, the authors investigate the clinicopathologic features of 75 cases of AP cheilitis to provide further criteria for its diagnosis and classification. All 75 patients presented with lip lesions. Thirty-three cases were diagnosed as AP cheilitis with cutaneous lesions and 42 cases were diagnosed as AP cheilitis without cutaneous lesions (only lip lesions). Histologically, of the 33 cases with AP cheilitis with cutaneous lesions, 17 (52%) cases showed follicular cheilitis, and of the 42 cases that had only lip lesions, 18 (43%) cases showed follicular cheilitis. Histologically, AP cheilitis can present as follicular cheilitis; thus, supporting the diagnosis. Also, our findings confirm that lip lesions can present as the only manifestation of the disease, showing typical histological and clinical features. This form of cheilitis has not being well described in the dermatologic and dermatopathologic literature.,  Actinic prurigo (AP) is a chronic, familial, photodermatitis that primarily affects American Indians. It is more prevalent in young females and may be evident clinically as a pruritic lower lip cheilitis that typically does not respond to conventional therapy. Other clinical features associated with AP include conjunctivitis, alopecia of the eyebrows, and formation of pterygia. The histologic features of AP have been described as nonspecific. We are presenting five cases of AP in which the major clinical manifestation was a pruritic, unsightly lower lip cheilitis. All of our patients were American Indians. Three patients were from the same family. The youngest patient was 10 years old and the oldest was 69 years old. All five cases were characterized histologically by numerous germinal centers within the lamina propria and a dense perivascular plasma cell infiltrate. In four of the five cases, there was a moderate to dense infiltrate of eosinophils. All five patients had been generally unresponsive to conventional therapy. With the exception of the youngest patient, all had had the disease for at least several years. One patient, now deceased, had the lower lip lesion surgically removed for cosmetic reasons. To our knowledge, this is the first report in the dental literature that describes the clinical and histologic features of AP of lower lip.,  Actinic prurigo (AP) is a rare acquired idiopathic photodermatosis, reported most often in American Indians, but also in Caucasian and Asian populations. The skin lesions in AP predominantly affect exposed sites but may involve covered areas, and often result in postinflammatory scarring. The diagnosis of AP can be difficult and relies on a combination of history, clinical experience and investigations including phototesting and human leucocyte antigen typing. Twenty-one patients (17 women, four men) diagnosed with AP at the photobiology clinic at St Vincent's Hospital Melbourne were reviewed in this retrospective study. The mean age of patients at presentation to the clinic was 25 years, with the mean age of onset being 14 years. Phototesting was undertaken in 20 patients, with 12 (60%) having reduced and eight (40%) normal minimal erythema doses. Human leucocyte antigen typing indicated 18 patients (85.7%) were DR4 positive, with further subtyping of the DR4 allele establishing that 15 patients (71.4%) were DRB1*0407 positive and that two (9.5%) were DRB1*0401 positive. This condition is often recalcitrant, with treatment options including photoprotection, topical and oral corticosteroids, antimalarials, phototherapy and thalidomide.,  Actinic prurigo (AP) is a rare photodermatosis, mostly affecting young American Indian girls. A retrospective descriptive study was done in the National Skin Centre, Singapore. Our patients have different characteristics compared to the previous reports. Of the 11 cases found between 1990 and 1998, 10 were male. All of the patients had the onset in adulthood. The condition was recognised by the presence of papules and nodules on the sun-exposed areas, predominantly on forearms and back of hands. Phototests revealed lowered minimal erythemal dose (MED) to ultraviolet A (UVA) alone in 2 patients and lowered MED to both UVA and UVB in another 4 patients. Patch, photopatch and histological examination did not show any significant finding. Sun protection, emollients and topical steroid were the baseline treatment for all patients. Intralesional steroid, systemic steroid, psoralen plus ultraviolet A (PUVA), azathioprine and thalidomide were used in some patients, with variable results.,  Actinic prurigo (AP) is a type of photodermatosis that primarily affects the Latin American mestizo population. Histologically, AP cheilitis exhibits acanthosis with spongiosis and vacuolation of the basal cell layer overlying a dense lymphocytic inflammatory infiltrate that forms well-defined lymphoid follicles. Toluidine blue is a thiazide, acidophilic, and metachromatic dye used <i>in vivo</i> to selectively stain the acidic components of tissues such as sulfates, carboxylates, and phosphate radicals that are incorporated into DNA and RNA. It is necessary to develop a method that allows detecting, on clinical grounds the area of the lesion in which it is more feasible to find such structures. Thus to increase the sensitivity of the biopsy, in AP cheilitis to accurately identify where the lymphoid follicles reside, based on the higher concentration of DNA in such structures and thus confirm the diagnosis. In this study, staining was positive in 85% of patients with AP cheilitis, in 14 of whom 82% lymphoid follicles were observed by histopathology. One of the pathologist's problems in establishing the diagnosis of AP is that the main histopathological characteristics are not always identified in the submitted samples because it is not easy to clinically identify the most representative site of the lesion selected for performing a biopsy. Based on our results, we propose using toluidine blue as an auxiliary method to choose a tissue sample to facilitate the diagnosis and allow clinicians to make clinical correlations between the histopathological and therapeutic findings.,  Actinic prurigo (AP) is an idiopathic familial photodermatosis seen in American Indians. We report on 17 patients; 16 had dermatitis and one had actinic cheilitis. Ten patients had acute dermatitis and six had chronic dermatitis. The histologies of acute AP and polymorphous light eruption (PLE; limited concept) are eczematous and indistinguishable. Both show spongiosis, superficial (and sometimes deep) perivascular lymphocytic infiltrates, and papillary dermal edema. Both also show vacuolar degeneration of the basal layer. In contrast, the chronic lichenified AP lesions are associated with marked hyperkeratosis, acanthosis, elongation of the rete ridges, and tissue repair. The large lymphoid germinal centers in the lamina propria are the main features of the lip histology. Seven biopsies were positive in the basal membrane zone on direct immunofluorescent testing, four were negative, and one was inconclusive. IgM was present in six and C3 in two. These immunofluorescent results are probably not significant. Immunofluorescent testing of the lip was negative. Although it is not possible to distinguish acute AP from PLE histologically, it is possible to differentiate the two conditions when chronic AP changes are present.,  Actinic prurigo (AP) is an idiopathic photodermatosis; the initial manifestations usually occur during the first decades of life but can appear at any age. Cases are usually diagnosed late once the lesions have exacerbated; due to the extensive involvement of the vermilion border and the etiology, it has been confused with and related to a potentially malignant process. Syndecan-1 and E-cadherin were positive in the epidermis, with moderate-to-intense staining in 100% of samples. Ki67 and MCM3 were expressed in the lower third of the epidermis and showed greater immunolabeling in samples that contained lymphoid follicles (Ki 67: epidermis [17.7% \\u00b1 6.79%] and dermis [7.73% \\u00b1 6.69%]; MCM3: epidermis [22.92% \\u00b1 10.12%] and dermis [6.13% \\u00b1 6.27%]). In conclusi\\u00f3n AP is a disease in which there is no evidence that the lesions are potentially cancerous. AP cheilitis should not be confused with actinic cheilitis because they are separate entities.,  Actinic prurigo (AP) is an uncommon photodermatosis. In European and Native American populations, AP is more common in young women and demonstrates clinical improvement or remission in adulthood. The clinical signs of AP differ in Asians because the disorder typically occurs in adults (adult-onset AP) and is clinically persistent. The objective of this study was to investigate the characteristics and outcomes of patients with AP in Thailand. A total of 15 cases with AP were evaluated. All of them were adult-onset AP (mean onset age of 45.5 years). Males predominated (66.7%). The majority of them manifested with papules on the face and upper extremities. Mucositis was present in 2 patients. Phototesting revealed that the minimal erythematous dose (MED) for UVA decreased in 3 subjects and the MED for both UVA and UVB decreased in other 3 patients. A photo-provocation test was performed on 9 patients with normal MED, and 5 of them showed positive UVA photo-provocation, while 4 showed positive UVA and UVB photop-rovocation. A systemic immunosuppressant was prescribed in 60% of patients. Median time for clinical improvement was 8.6 months. Complete clinical remission was found in only 3 patients. Adult-onset AP has different clinical features and responds differently to treatment, compared to classical AP.,  Actinic prurigo (AP), a chronic skin disease caused by an abnormal reaction to sunlight, is commonly associated with cheilitis and conjunctivitis. Characteristic ethnic, genetic, environmental (occurs at high altitudes, above 1,500 m), clinical, and histopathologic features have been reported. AP occurs in American Indians of Canada and the United States and most commonly in Latin American countries, where Mestizos (mixed ancestry) are predominantly affected. The present study investigates AP involving the lips, where it is characterized by a dense lymphocytic infiltrate, often with well-formed lymphoid follicles; the latter feature we refer to as \\\\follicular cheilitis\\\\ (FC). The histopathologic findings of FC are characteristic of and helpful in diagnosing actinic prurigo involving the lips.,  Actinic prurigo and polymorphic light eruption are two of the so-called idiopathic photodermatoses, resulting from abnormal cutaneous responses to ultraviolet radiation (photosensitivity). Whereas they are clinically distinct in most cases, there are sufficient similarities between them to suggest they may be related conditions. To take this further, we examined the prevalence of polymorphic light eruption in families ascertained through actinic prurigo probands, as evidence of a shared pathogenesis. We then determined the heritability of photosensitivity in 420 individuals from families ascertained through polymorphic light eruption and actinic prurigo probands using segregation analysis. Across 58 pedigrees the prevalence of photosensitivity in first-degree relatives was 20.9% compared with a population prevalence of 13.6%, giving a relative risk of 1.5 (confidence interval 1.15-2.0) and providing evidence of clustering within families. The prevalence of photosensitivity (predominantly polymorphic light eruption) in relatives of actinic prurigo probands was 23.7%, with a relative risk of 1.74 (confidence interval 1.24-2.36). Modeling for polymorphic light eruption across all pedigrees revealed a strong genetic component with polymorphic light eruption showing a dominant mixed mode of inheritance. The model parameters estimate that 72% of the U.K. population carry a low penetrance polymorphic light eruption susceptibility allele, but that among this highly prevalent genotype only 24% of susceptible females and 13% of susceptible males will have polymorphic light eruption. Expression of polymorphic light eruption in genetically susceptible individuals (intergenotype variance) is determined in large part by a polygenic component, with an important additional environmental component. In summary, this study provides clear evidence that polymorphic light eruption is an inherited condition. It also suggests that polymorphic light eruption and actinic prurigo share a common genetic background, supporting the view that actinic prurigo may represent a human leukocyte antigen-restricted subset of polymorphic light eruption.,  Actinic prurigo and solar urticaria are uncommon chronic idiopathic photodermatoses in the United Kingdom. To our knowledge, their occurrence in the same patient has not hitherto been described.,  Actinic prurigo is a chronic familial photodermatitis found predominantly among the Amerindians. It has been reported from North and South America, Britain and Japan. We report a case of actinic prurigo seen in Singapore. A 20-year-old Malay female presented with a persistent pruriginous eruption in the sun-exposed parts and on her abdomen. She also had lower lip cheilitis and thinning of the outer eyebrows, features often seen in actinic prurigo. The minimal erythema dose to ultraviolet A (UVA) and UVB were persistently lowered. We propose that this condition be called actinic prurigo, tropical (South-East Asian) variant.,  Actinic prurigo is a chronic photodermatitis found predominantly in North American Indians. Other terms have been used to describe similar cases in Central and South America and in Europe. Relatively little has been written about this condition in the English literature, and confusion exists over whether this is a form of polymorphic light eruption. Actinic prurigo can be considered a unique variant of polymorphic light eruption; however, we believe that certain differences help to distinguish actinic prurigo as a separate disease entity. Herein we report three cases of this disease and review the related literature. Characteristic clinical features include prurigolike papules and cheilitis. Pruritus is the predominant symptom, and a familial tendency and an early age at onset are usually noted. Results of karyotyping and analysis of sister chromatid exchanges were normal in two of our patients so tested. Skin testing for photosensitivity has yielded inconsistent results, and use of light testing for diagnosing actinic prurigo does not seem to be a predictable procedure. Actinic prurigo is a chronic disease that often is refractory to therapy.,  Actinic prurigo is a chronic skin disease commonly associated with cheilitis and conjunctivitis. This peculiar disorder, with ethnic, genetic, environmental, clinical and histological features, represents an abnormal reaction to sunlight. It occurs in American Indians of Canada, United States and most frequently in Latin America where it involves not only indigents but also the mixed ancestry (Mestizo) population. In analogy to what is well known about pellagra, a disease also with solar influence and a deficient intake of tryptophan or niacin in diet, it is our hypothesis that actinic prurigo patients develop their disease due to, among other factors, a diet poor in proteins.,  Actinic prurigo is a photodermatosis that can affect the skin, conjunctiva and lips. It is caused by an abnormal reaction to sunlight and is more common in high-altitude living people, mainly in indigenous descendants. The diagnosis of actinic prurigo can be challenging, mainly when lip lesions are the only manifestation, which is not a common clinical presentation. The aim of this article is to report two cases of actinic prurigo showing only lip lesions. The patients were Afro-American and were unaware of possible Indian ancestry. Clinical exam, photographs, videoroscopy examination and biopsy were performed, and the diagnosis of actinic prurigo was established. Topical corticosteroid and lip balm with ultraviolet protection were prescribed with excellent results. The relevance of this report is to show that although some patients may not demonstrate the classical clinical presentation of actinic prurigo, the associated clinical and histological exams are determinants for the correct diagnosis and successful treatment of this disease.,  Actinic prurigo is a pruritic sun-induced dermatosis classified among the immunologically mediated photodermatoses. The disease is a well-known entity among Native Americans and in Central and South America, however rare in Caucasians with only a few reports from Australia, Britain and France. We report the first case of actinic prurigo in a Scandinavian patient, responding favorably to systemic treatment with cyclosporine A.,  Actinic prurigo is a rare idiopathic photodermatosis, which shares some features with atopic dermatitis, polymorphous light eruption, hydroa vacciniforme and persistent light reaction. It is, however, recognized as a distinct entity. Among American Indians a familial variant is observed. Characteristic features are a chronic course with sustained exacerbations, which are seasonal at first, but later perennial. The disorder may improve in adulthood. The typical clinical features are urticarial plaques a few hours after UV exposure, and a persistent eczematous, prurigo-like rash distributed over skin areas exposed to light but sometimes extending even into photoprotected areas. Therapy is extremely difficult and unrewarding. In the present paper the entity is defined and three typical cases are presented.,  Actinic prurigo is a rare, idiopathic chronic photodermatosis of childhood characterized by excoriated papules, nodules, and plaques in sun-exposed areas. It is notoriously difficult to treat. The disorder involves a type IV hypersensitivity reaction driven by both Th1 and Th2 inflammatory pathways, the latter of which leads to secretion of IL-4, IL-5, IL-13, and production of B cells, IgE, and IgG4. Dupilumab, an IL-4 receptor antagonist, disrupts the Th2 pathway. We present a pediatric patient with severe, recalcitrant actinic prurigo who achieved rapid and sustained clearance with dupilumab.,  Actinic prurigo is a rare, often difficult-to-treat, idiopathic photodermatosis. Actinic prurigo is divided into a hereditary form appearing in the Native American population and a sporadic form occurring in non-Native Americans. We present a 28-year-old Caucasian woman who developed typical clinical signs and symptoms of actinic prurigo, just as had her mother and grandmother. The patient and her mother were HLA-A24 and HLA-DR 4 with the subtype HLA-DRB1*0408. Based on clinical symptoms and the HLA pattern, the diagnosis of actinic prurigo was made. Treatment with thalidomide led to resolution of the disease. This case report of a Caucasian woman suffering from a hereditary form of actinic prurigo questions the established classification of actinic prurigo into a hereditary Native American form and a sporadic form occurring in the non-Native American population.,  Actinic prurigo is an inflammatory disease of the skin that appears to be mediated by an abnormal immune response. Cell adhesion molecules play a key role in the induction of the immune response as well as in the pathogenesis of inflammation. We investigated the expression of cell adhesion and activation molecules, as well as the density of Langerhans cells in skin from patients with actinic prurigo. Skin biopsies from ultraviolet light-induced lesions, and non-irradiated areas from 10 actinic prurigo patients were studied; in addition, several spontaneous skin lesions were studied. Skin biopsies from normal individuals were used as controls. The expression of ICAM-1, ICAM-3, LFA-3, CD2, LFA-1, VLA-4, CD1a, VCAM-1, CD69, and activated b1 integrins were assessed by immunostaining. An increased expression of LFA-1, LFA-2, ICAM-3, VLA-4, and activated b1 integrins was observed in the cell infiltrate of actinic prurigo lesions and an up-regulated expression of ICAM-1 was detected in keratinocytes from these specimens. Interestingly, the number of Langerhans cells (CD1a + ) in actinic prurigo skin was not significantly affected by ultraviolet irradiation, a phenomenon that was not observed in normal controls. The increased expression of adhesion molecules in the cell infiltrate of actinic prurigo, indicates that these cells are activated and suggests that they are involved in the skin damage seen in these patients. The resistance of Langerhans cells from patients with actinic prurigo to ultraviolet light may have an important role in the pathogenesis of this condition. The involvement of keratinocytes in the pathogenesis of actinic prurigo is suggested by the expression of ICAM-1 on these cells.,  Actinic prurigo is an uncommon and usually persistent idiopathic photodermatosis with typical human leukocyte antigen (HLA) associations (HLA-DR4, particularly subtypes DRB1*0407 and DRB1*0401). Although its mechanism of action is not clearly understood, thalidomide has been shown to be particularly efficacious in treating actinic prurigo, among other conditions. A 31-year-old Australian woman who had suffered actinic prurigo for most of her life was treated with two courses of thalidomide (50-100 mg nocte) over consecutive summers. Remission was observed after cessation of the second course of thalidomide and had continued 4 years later. Abnormalities in the cutaneous response to ultraviolet radiation at the time of diagnosis, detected by monochromator phototesting, reverted to normal following treatment.,  BACKGROUND AND OBJECTIVE:Actinic prurigo (AP) is a hereditary photodermatoses with typical symptoms and is quite common in North- and South-America. The key genetic factor appears to be a Native American background. In Europeans this type of AP is extremely rare; some dispute if this disease exists in Caucasians. Some newer publications postulate that these patients share HLA markers with the Native Americans. The most important differential diagnosis for AP is polymorphic light eruption which can be excluded relatively accurately by the clinical picture, typical histology and HLA pattern. PATIENTS/METHODS:The case of a female patient of Mayan ancestry living in Germany is presented. CONCLUSIONS:Since in literature sometimes cases from Europe are diagnosed as AP this is a problem of naming the disease. It would be helpful to integrate the terms hereditary or hereditaria into the name of the disease in indians.,  BACKGROUND: Actinic prurigo (AP) is one of the rare idiopathic photodermatosis. It is said to be a familial disease and is usually seen in certain specific geographical areas. The adult-onset type of AP is reported less frequently in the Asian population and has never been reported in Thailand. METHODS: The study population comprised 30 patients. Demographic data were collected. Photo-tests and photo provocation tests for UVA, UVB and visible light were carried out on non-exposed skin. The other investigations included antinuclear antibody, anti-HIV antibody and urine porphyrin level. Histopathology studies were also carried out. RESULTS: There were 18 males and 12 females. The mean age of onset was 36.86 years. The duration of disease was from 1 month to 20 years. Forearms (27 patients) were the most frequently affected site. Other screening tests showed negative results. Five patients had abnormal MED to UVA and one patient had abnormal MED to UVA as well as UVB. Photo provocation tests showed positive responses to both UVA and UVB in 12 cases (40%), a positive response to UVA in 11 cases (37%), a positive response to UVB alone in four cases (13.3%) and a normal response in three patients (10%). None of the patients had a positive response to visible light. Skin biopsies were performed on nodular lesions in 23 cases. Histopathology from these 23 cases showed hyperkeratosis ortho- or parakeratosis and acanthosis in 20 of the 23 cases. CONCLUSIONS: Adult-onset AP in our country may have different geographic and racial distribution from previous reports or may be the tropical variant as described by Tham et al. It may not be an uncommon disease in our country, if there is increased awareness of this disease. Only 16.6% of patients had reduced MED. Photo provocation tests were positive in 90% of cases. Most of the positive wavelengths were UVA or both UVA and UVB. Therefore, photo provocation tests should be performed in cases suspected of AP. The prognosis for AP is not good, despite combinations of treatment. The disorder may run a chronic course. This may be because of our sunny climate and the sun-exposed occupations of patients.,  BACKGROUND:Actinic prurigo (AP) is an idiopathic photodermatosis. Although its initial manifestations can appear in 6 to 8-year-old children, cases are diagnosed later, between the second and fourth decades of life, when the injuries are exacerbated. OBJECTIVE:To identify risk factors associated with clinical manifestations of AP such as skin and mucosal lesions. METHODS:Thirty patients with AP and 60 controls were included in the study, the dependent variable was the presence of skin or labial mucosal lesions, the independent variables were age, sex, solar exposure, living with pets or farm animals, exposure to wood smoke, smoking habit, years smoking, and hours spent per day and per week in contact with people who smoke. RESULTS:Of the 30 diagnosed AP patients, 66.7% were female. Patients age ranged from 7 to 71 years and the mean age was 35.77 \\u00b1 14.55 years. We found significant differences with the age and cohabitation with farm animals. Those who lived with farm animals presented 14.31 times higher probability of developing AP (95% CI 3-78.06). STUDY LIMITATIONS:This is a case-control study; therefore, a causal relationship cannot be proven, and these results cannot be generalized to every population. CONCLUSIONS:The identification of factors related to the development of AP increases our knowledge of its physiopathology. Moreover, identifying antigens that possibly trigger the allergic reaction will have preventive and therapeutic applications in populations at risk of AP.,  Fourteen patients suffering from actinic prurigo were treated with thalidomide. Eleven patients showed lasting improvement on the drug and three of these remained symptom-free after discontinuing therapy. No major side-effects were observed. Thalidomide is an effective drug in the treatment of actinic prurigo but it must be used with adequate contraception in women of child-bearing age.,  Hereditary photodermatoses are characterized by an increased photosensitivity caused by an inherited single gene defect. With few exceptions, they manifest in early childhood, reveal heterogeneous clinical symptoms, and are difficult to treat. Although these diseases are rare, it is very important to make an accurate diagnosis on the basis of clinical symptoms, specific diagnostic tests, and direct DNA analysis. We review the spectrum of inherited photodermatoses, including porphyria cutanea tarda, erythropoietic protoporphyria, actinic prurigo, Kindler syndrome, and disorders associated with a defect in DNA repair, including xeroderma pigmentosum, trichothiodystrophy, Cockayne syndrome, and Bloom syndrome. Early diagnosis may prevent complications associated with prolonged unprotected exposure to sunlight and makes it possible to offer genetic counseling and, when indicated, prenatal diagnosis to families at risk for these rare heritable disorders.,  Hereditary polymorphic light eruption (HPLE) occurs in Indians of North and South America. Affected persons are sensitive to long ultraviolet radiation and therefore receive no substantial benefit from conventional sunscreens. We have treated 46 patients with HPLE at the Red Lake Reservation, Minn, with topically administered dihydroxyacetone and lawsone, orally given beta carotene, or both. Oral beta carotene afforded adequate photoprotection to 33 patients, and four additional patients were protected with the combined use of oral and topical agents. Epidemiologic studies support our proposals that HPLE is a causative factor in streptococcal pyoderma in the American Indian and may be associated with epidemics of streptococcal glomerulonephritis.,  Human leukocyte antigen (HLA) associations have been reported in Amerindian patients with actinic prurigo. To determine if similar associations are present in the British Caucasoid population with actinic prurigo, 26 patients underwent serological typing for HLC Class I and II antigens. DNA analysis by both sequence-specific priming and group-specific amplification with single-stranded oligonucleotide probe hybridization was used to confirm the DR and DQ typing and to perform DR4 subtyping. All patients were DR4 positive, and 25 of 26 patients were DQ7 positive. DR4 subtyping revealed 12 of 20 patients tested to be DRB1*0407. A nonsignificant association was also found with HLA B55 that is in linkage disequilibrium with DRB1*0407. No HLA associations were found in 25 British Caucasoid patients with polymorphic light eruption. DRB1*0407 is rare in European Caucasoids without actinic prurigo, and HLA-DR4 may have an important role in determining expression of this disease.,  Human leukocyte antigen typing of 41 white patients with polymorphous light eruption (limited concept) showed no significant differences when compared with the typing of 51 white control subjects. We previously found that actinic prurigo, an idiopathic photodermatosis particularly associated with Amerindians, has a positive association with antigens A24 and Cw4 and a negative association with A3. We suggest, on the basis of both laboratory and clinical findings, that polymorphous light eruption (limited concept) and actinic prurigo are two different and distinct diseases.,  Information about the prevalence of photodermatoses is lacking, despite their substantial impact on life quality. Our objective was to systematically review the literature to establish what is known regarding prevalence and incidence of photodermatoses. We searched Medline, CINAHL and Embase from inception to 2021 to identify original population-based studies in English literature reporting the prevalence and/or incidence of photodermatoses. Information was extracted according to geographical location and risk of bias was assessed using a 10-point risk of bias tool for prevalence studies. Primary outcome was the population prevalence of photodermatoses. Prevalence data for polymorphic light eruption (PLE) were used to calculate the global pooled prevalence of PLE. Twenty-six studies were included; 15 reported prevalence of photodermatoses based on samples of the general population and 11 on prevalence and/or incidence from national and international registry data. The general population studies involved PLE (nine studies), unspecified photosensitivity (2), actinic prurigo (2), juvenile spring eruption (1), chronic actinic dermatitis (1) and variegate porphyria (1), while registry studies reported on cutaneous porphyrias and genophotodermatoses (nine and two studies, respectively). Worldwide the prevalence of PLE between countries ranged from 0.65% (China) to 21.4% (Ireland). The pooled estimated prevalence of PLE was 10% (95% CI 6%-15%) among the general population (n\\u00a0=\\u200919,287), and PLE prevalence increased with distance from the equator (r\\u00a0=\\u20090.78, p\\u00a0<\\u20090.001). While several photodermatoses are rare, photosensitivity can be prevalent at wide-ranging world locations, including Egypt where photosensitivity was found in 4% of children and 10% of adults. This study showed that PLE is highly prevalent in many populations and that its prevalence shows a highly significant correlation with increasing northerly or southerly latitude. Available population-based studies for photodermatoses suggest they can be prevalent at a range of world locations; more attention is required to this area.,  Native Americans have a rich and complex heritage and culture. Although the genetic pool has changed with increasing integration with other Americans with different ancestry, there are important conditions that are unique to Native Americans, the most prominent example being actinic prurigo. The scientific literature dealing with Native American skin conditions is sparse and more studies are needed to understand more fully cutaneous disease in Native Americans.,  New research indicates that polymorphic light eruption (PLE) is an autoimmune disease against an ultraviolet radiation-induced cutaneous antigen. PLE may even confer some protection against skin cancer later in life. This new information demands a reassessment of the precise nature and nomenclature of PLE. Benign summer light eruption (BSLE) (lucite estivale b\\u00e9nigne) is the name used in continental Europe, and particularly France, to describe a clinically short-lived, itchy, papular eruption particularly affecting young women after several hours of sunbathing at the beginning of summer or on sunny vacations. Clinically more prolonged forms of solar eruption, starting early in spring and persisting for long periods, have been known in France as polymorphic light eruption (PLE) (lucite polymorphe) ('European PLE'). Investigative studies, however, now suggest that BSLE and some cases of 'European PLE' are part of the same spectrum. In the Anglo-Saxon literature, they are lumped together as PLE ('Anglo-Saxon PLE'). The other cases of 'European PLE', which do not fall within the compass of 'Anglo-Saxon PLE', are, in the Anglo-Saxon literature, classified as either actinic prurigo (AP) (a genetically determined, prolonged, excoriated form of Anglo-Saxon PLE), or chronic actinic dermatitis (CAD) (a sunlight-induced eczema precisely resembling allergic contact dermatitis, apparently to an ultraviolet radiation-induced antigen). It is therefore proposed that: i. the European term BSLE be dropped and that these patients be reclassified within the spectrum of (Anglo-Saxon) PLE, ii. the European use of the term PLE ('European PLE') be discontinued, iii. those previously diagnosed as having 'European PLE' be reclassified as (Anglo-Saxon) PLE, AP or CAD, as appropriate. The benefits of such a change in nomenclature would be twofold, firstly a uniformity of terminology and secondly, and more importantly, terminology would then correlate better with our recently improved understanding of the pathogenesis of these disorders.,  Objective. This study describes the clinicopathologic features and therapeutic results of 116 patients with actinic prurigo cheilitis seen over an 11-year period. Study Design. A retrospective study was carried out with hospital records and a microscopic slide review from a large dermatology department in Mexico City, Mexico. Results. The study consisted of 42 male (36.2%) and 74 female (63.8%) patients, with a male to female ratio of 1:1.7. Age ranged from 9 to 82 years (mean, 27.9 years; standard deviation, 14.2). Thirty-two cases (27.6%) were found in which cheilitis was the only manifestation of this condition. Pruritus, tingling, and pain of the vermilion were recorded in 96 cases (82.7%). Typical histopathologic findings included in most cases the presence of acanthosis, spongiosis, basal cell vacuolation, ulceration with serohematic crust formation, edema of the lamina propria, lymphocytic inflammatory infiltrate with well-defined lymphoid follicles, and variable numbers of eosinophils and melanophages. Improvement of the symptoms was obtained in 112 cases (96.5%) with sun-protective measures and diverse antiinflammatory agents. However, complete resolution of the labial lesions were more frequently achieved with the combination of topical steroids, thalidomide, and sun-protective measures (42.2%) as compared with topical steroid therapy plus sun-protection measures (16.3%; P <.005). Conclusion. Our findings confirm that lip lesions may appear as the only manifestations of this photodermatosis and that it has typical clinical and microscopic features and should therefore be considered a specific form of cheilitis.,  Photodermatoses are a group of skin diseases primarily caused by, or exacerbated by exposure to ultraviolet and or visible radiation. The effect of sunlight on skin depends on a number of factors including skin colour, skin phototype and the content and type of melanin in the skin. There are only a few studies describing photodermatoses in populations with dark skin. A PubMed search was conducted to summarize currently available information on differences in biology of melanin in dark and light skin and photodermatoses in dark skin. Dark skin is characterised by higher content of melanin, higher eumelanin to pheomelanin ratio, lower tyrosinase activity, and more effective distribution of melanin for protection against ultraviolet light. Photodermatoses are common in dark skinned patients with some variation in the spectrum of photodermatoses. Polymorphous light eruption (PMLE) is the commonest, followed by chronic actinic dermatitis. Pin-point papular and lichenoid variants of PMLE and actinic lichen planus are more frequent in dark skin whereas actinic prurigo, solar urticaria and hydroa vacciniforme are uncommon. Photodermatoses are common in dark skinned patients despite better natural photoprotection. It is proposed that lichenoid photodermatoses may be added to the classification of photodermatoses in dark skin.,  Photodermatoses are skin disorders which result from abnormal response to ultraviolet (UV) radiation. Photodermatoses include the following disorders: polymorphic light eruption, hydroa vacciniforme, solar urticaria, actinic prurigo, acute actinic dermatosis, solar dermatosis, phototoxic dermatitis and photoallergic dermatitis. The histopathology of these disorders will be presented and its role in making the diagnosis will be discussed.,  Photodermatoses can be classified into five general categories: 1) idiopathic photodermatoses, including polymorphic light eruption (PMLE), actinic prurigo, hyroa vacciniforme, chronic actinic dermatitis, and solar urticaria; 2) photodermatoses which are secondary to exogenous agents, including phototoxic and photoallergic reactions; 3) photodermatoses secondary to endogenous agents, mainly the porphyrias; 4) photoexacerbated dermatoses, including autoimmune disease, infectious conditions, and nutritional deficiencies; and 5) genodermatoses. The initial step in evaluating a photosensitive patient is based on a directed personal and family history. The morphology of the eruption, phototests, and in some patients, photopatch tests are essential in focusing the diagnosis. Skin biopsies and laboratory investigations, such as antinuclear antibody (ANA) panels and porphyrin profiles, may be required to further confirm the diagnosis.,  Photodermatoses represent a broad spectrum of skin diseases caused because of exposure to ultraviolet radiation. It is categorized mainly as idiopathic photosensitive disorders, drug or chemical induced photosensitivity reactions, DNA repair-deficiency photodermatoses and photoaggravated dermatoses. Despite being under the photodermatoses umbrella, the pathophysiology of each type of photodermatoses varies. We reported 4 cases of photodermatoses including azathioprine induced pellagra, adult onset actinic prurigo, and photoallergic contact dermatitis due to NSAIDs and cutting fluids. Photoprotection with the usage of photoprotective clothing, broad-spectrum sunscreen application and avoidance of photosensitizing drugs and chemicals are crucial.,  Photodermatosis is an abnormal skin inflammatory reaction to light. The major classifications of photodermatoses are idiopathic photodermatoses, photodermatoses due to exogenous or endogenous agents, photo-exacerbated dermatoses, and photosensitive genodermatoses. In this chapter, we focus on idiopathic photodermatoses and drug-related photodermatoses and emphasize on the epidemiology and immunogenetic backgrounds. Idiopathic photodermatoses, a spectrum of diseases with abnormal responses to ultraviolet radiation (UVR), include polymorphous light eruption, actinic prurigo, hydroa vacciniforme, chronic actinic dermatitis, and solar urticaria. Young people are more susceptible to most idiopathic photodermatoses except for chronic actinic dermatitis. Interestingly, idiopathic photodermatoses exhibit different characteristics between Caucasians and Asians. For example, the average age of Asian actinic prurigo patients is older than that of Caucasians in which genetic backgrounds or Fitzpatrick skin type might play a role. Drug-induced photodermatoses can be classified into phototoxic and photoallergic drug reactions. Certain drug-induced photodermatoses may mimic other dermatoses. For instance, drug-induced lupus erythematosus (LE) should be considered if an old man is diagnosed with LE but had a poor response to standard treatments.,  Photosensitive disorders may be classified as those entirely caused by solar exposure and the photoaggravated disorders. Those in the former category include polymorphic light eruption, juvenile spring eruption, actinic prurigo, hydroa vacciniforme, solar urticaria, also chronic actinic dermatitis. Genodermatoses whose expression mainly depends on UV or light exposure include the DNA repair deficient disorders, some disorders of cornification, the Smith-Lemli-Opitz syndrome and porphyria. Examples of photoaggravated diseases include lupus erythematosus, erythema multiforme, atopic eczema, psoriasis, viral exanthemata, pemphigus, dermatitis herpetiformis and rosacea. Drugs and chemicals may interact with UV to induce photosensitivity. In many of these diseases the action spectrum is known or may be determined by phototesting. Recognition of the reaction patterns associated with the photodermatoses greatly assists clinical classification of the photodermatoses.,  Photosensitivity refers to various symptoms, diseases, and conditions (photodermatoses) caused or exacerbated\\u00a0by exposure to sunlight[1]. It\\u00a0is classified into five categories: primary photodermatosis, exogenous photodermatosis, photo-exacerbated dermatoses, metabolic photodermatosis, and genetic photodermatosis. Primary or autoimmune photodermatoses: Polymorphic light eruption[2]. Juvenile spring eruption. Actinic folliculitis. Actinic prurigo[3]. Solar urticaria[4]. Chronic actinic/photosensitivity dermatitis[5]. Hydroa vacciniforme (associated with Epstein-Barr virus)[6]. Exogenous or drug/chemical-induced photodermatoses[7][8]: Drug-induced photosensitivity: common photosensitizing drugs are thiazides, tetracyclines, non-steroidal anti-inflammatory drugs (NSAIDs), phenothiazines, voriconazole, quinine, vemurafenib, and many others[7]. Photocontact dermatitis: due to phototoxic chemicals such as psoralens in plants, vegetables, fruit; fragrances in cosmetics; sunscreen chemicals; dyes and disinfectants[9]. Pseudoporphyria: induced by drugs and/or renal insufficiency[10]. Photo-exacerbated or photo-aggravated dermatosesUsually: Cutaneous lupus erythematosus (acute, subacute and chronic variants)[11]. Dermatomyositis[12]. Sjogren syndrome. Darier disease[13]. Rosacea[14]. Melasma[15]. Sometimes: Pemphigus vulgaris. Pemphigus foliaceus[16]. Atopic dermatitis[17]. Seborrhoeic dermatitis[18]. Psoriasis[19]. Lichen planus (actinicus)[20]. Erythema multiforme[21]. Mycosis fungoides[22]. Metabolic photodermatoses (rare): Porphyria cutanea tarda[23]. Erythropoietic protoporphyria. Variegate porphyria[24]. Erythropoietic porphyria (Gunther disease)[25]. Genetic photodermatoses (very rare disorders due to genomic instability): Xeroderma pigmentosum[26]. Cockayne syndrome[27]. Trichothiodystrophy[28]. Bloom syndrome[29]. Rothmund Thomson syndrome[30].,  Polymorphous light eruption (PLE; actinic prurigo) is a relatively common dermatologic disease. People suffering from it have a pruritic skin eruption on exposed areas. PLE may be an immunologically mediated disease. Sixteen patients with PLE were studied. T lymphocytes and the helper and suppressor-cytotoxic subsets were assessed in peripheral blood by an indirect immunofluorescent method with the use of monoclonal antibodies. Total T lymphocytes were significantly increased as compared to controls. By an indirect immunoperoxidase technic with the use of monoclonal antibodies, characterization of the dermal cell infiltrate was done. Predominance of T total, T helper, and cells marked with Ia antigen were found. These findings suggest that an abnormal immune response is responsible for the tissue damage in PLE.,  Pruritus is a common and often times difficult to treat symptom in many dermatologic and systemic diseases. For pruritus with an inflammatory or autoimmune origin, therapies such as topical corticosteroids and antihistamines are often initiated. However, in the case that these and additional systemic therapies are ineffective, thalidomide, an immunomodulator and neuromodulator, may be a useful alternative treatment. Considerable relief of chronic pruritus has been demonstrated with thalidomide in case reports, case series, and controlled trials. Double-blind controlled studies demonstrated thalidomide's efficacy as an antipruritic agent in patients with uremic pruritus, primary biliary cirrhosis, and prurigo nodularis. In case reports, case series, and open-label trials, thalidomide significantly reduced pruritus associated with conditions such as actinic prurigo and paraneoplastic pruritus. Because of variations in study design and evaluation of antipruritic effect, it is difficult to fully understand thalidomide's role based on the evidence described to date in the medical literature. In this review, we provide an overview of the reported findings and evaluate thalidomide's utility in managing refractory pruritus in the context of its adverse risk profile. We propose that thalidomide can be an alternative or combination antipruritic treatment for patients who do not obtain enough relief from conservative therapy.,  St Vincent's Hospital Melbourne cautiously prescribes thalidomide as a treatment for recalcitrant dermatoses. The guidelines used for prescribing and monitoring thalidomide for dermatological conditions at this institution are presented. Fourteen patients were treated with thalidomide (11 women, three men) over a 5-year period. The diagnoses of patients treated were actinic prurigo, prurigo nodularis, lupus erythematosus and Beh\\u00e7et's syndrome. A clinical improvement was noted in 10 patients (71.4%) prescribed thalidomide. Cessation of thalidomide treatment occurred in seven patients (50%) because of adverse effects. Of the patients with adverse effects, four developed abnormal nerve conduction studies and three developed intolerable adverse events (such as dizziness and vomiting). Adverse effects from thalidomide treatment are common but, through vigilant treatment planning, patient education and regular monitoring, the risk of permanent peripheral neuropathy and teratogenicity from thalidomide toxicity can be minimized.,  Studies have reported the association of human leukocyte antigen (HLA) genes with susceptibility to develop actinic prurigo (AP) in Caucasians, but there were no studies in Asian populations, including the Chinese. Our study was performed to determine if AP is associated with susceptibility or protective HLA alleles or haplotypes in Singaporean Chinese. All Chinese patients diagnosed with AP at National Skin Center, Singapore, from January 2002 to April 2015 were invited to participate in the study. Clinical data and phototesting results were collated, and HLA typing was performed. Among 14 patients included, 11 were male and the mean age was 49.6 (37.9-61.3) years. All patients did not have a family history of AP and none had mucosal involvement, as such these clinical features differed from Caucasian AP patients. The frequency of DRB1*03:01 in AP patients was significantly higher compared to healthy controls (43% vs 16%, P = 0.022, odds ratio (OR) 3.89). Concurrently, the frequency of HLA-B*58:01-DRB1*03:01 haplotype was also significantly increased (25% vs 7%, P = 0.004, OR 4.23). In conclusion, HLA-DRB1*03:01 was associated with AP in Singaporean Chinese patients. This novel allelic association may possibly be utilized as a biological marker to aid in the diagnosis of AP in Chinese patients.,  Thalidomide (alpha-N-phtalimido-glutarimide) was withdrawn from sale in 1961 since it was held responsible for the birth of hundreds of phocomelus children. Despite this teratogenic potential, thalidomide remains a useful tool in the treatment of erythema nodosum leprosum, as well as in discoid lupus erythematosus when antimalarial drugs are ineffective or contraindicated. In addition, good results have been reported in several diseases such as actinic prurigo, polymorphous light eruption, Beh\\u00e7et syndrome, Weber-Christian disease, prurigo nodularis, pyoderma gangrenosum and ulcerative colitis. The mechanism of action is under debate but it is likely that thalidomide has immunomodulating properties by controlling T-suppressor lymphocytes, and anti-inflammatory effects, particularly an inhibition of neutrophil chemotaxis. Several attempts at synthesis of effective thalidomide derivatives devoid of teratogenic effects are ongoing.,  Thalidomide is a beneficial agent for treating a variety of refractory dermatologic disorders including erythema nodosom leprosum, lupus erythematosus, prurigo nodularis, actinic prurigo, pyoderma gangrenosum and aphthous stomatitis. Two thalidomide analogues, lenalidomide and CC-4047, are considerably more potent with decreased side effects when compared to thalidomide. They are currently undergoing trials and show promise, as they have increased immunomodulatory and anti-angiogenic activity. This category of medication and its use will be reviewed.,  Thalidomide is a synthetic glutamic acid derivative first introduced in 1956 in Germany as an over the counter medications. It was thought to be one of the safest sedatives ever produced as it was effective in small doses, was not addictive, and did not have acute side-effects such as motor impairment, but was quickly removed from market after it was linked to cases of severe birth defects. The Food and Drug Administration approved use in the treatment of erythema nodosum leprosum. Further, it was shown its effectiveness in unresponsive dermatological conditions such as actinic prurigo, adult Langerhans cell hystiocytosis, aphthous stomatitis, Beh\\u00e7et syndrome, graft-versus-host disease, cutaneous sarcoidosis, erythema multiforme, Jessner-Kanof lymphocytic infiltration of the skin, Kaposi sarcoma, lichen planus, lupus erythematosus, melanoma, prurigo nodularis, pyoderma gangrenosum and others. In May 2006, it was approved for the treating multiple myeloma. New thalidomide analogues have been developed but lack clinical experience. This paper is a review of the history, pharmacology, mechanism of action, clinical applications and side effects of thalidomide and its analogues.,  Thalidomide is approved for treating erythema nodosum leprosum and multiple myeloma, but it has also emerged as a useful treatment option for many refractory dermatologic disorders. Some of the innovative but off-label uses of thalidomide include aphthous stomatitis, Beh\\u00e7et's disease, lupus erythematosus, prurigo nodularis, sarcoidosis, actinic prurigo, graft-versus-host disease, Langerhans cell histiocytosis, erythema multiforme, lichen planus, Kaposi sarcoma, Jessner lymphocytic infiltrate, uremic pruritus, pyoderma gangrenosum, scleroderma, scleromyxedema, and necrobiosis lipoidica. This article reviews the background, pharmacology, and innovative uses of thalidomide in dermatology.,  Thalidomide is resurging in the management of adult rheumatologic skin conditions, especially lupus erythematosus. Although use in pediatric patients is reported since the 1990s, there are no systematic reviews describing treatment in children. Thalidomide has immunomodulatory and anti-tumor necrosis factor-\\u03b1 effects as well as antiangiogenic properties, making it useful for a broad spectrum of inflammatory disorders. Thalidomide is second-line treatment for aphthous stomatitis and chronic graft-versus-host disease in children and has been prescribed for many other conditions including actinic prurigo and epidermolysis bullosa pruriginosa. Systemic lupus erythematosus may be less responsive to thalidomide in children than adults. Peripheral neuropathy is observed in both idiosyncratic and dose-dependent relationships; children older than 12 years may be more susceptible to developing this adverse effect than younger patients. There are rare reports of thrombotic complications in children treated for nonmalignant indications. We review the mechanism of action and propose that thalidomide is an alternative treatment for patients who fail or have contraindications to anti-tumor necrosis factor-\\u03b1 biologics.,  Thalidomide is the drug of choice in the erythema nodosum leprosum (ENL) type of lepra reaction. Lately it has been used successfully in other diseases, such as discoid lupus erythematosus, actinic prurigo, Behcet's disease, etc. However, its mechanism of action remains unknown. In patients for whom thalidomide provided relief in their disorder, the proportions of T lymphocytes and their subsets in peripheral blood were assessed by means of monoclonal antibodies. Three lepromatous leprosy patients with ENL had their T helper populations significantly increased after thalidomide therapy. A 14-year-old girl with Behcet's syndrome showed a consistent decrease in Ia+ cells throughout her three-month course of thalidomide therapy. The same findings were observed in two patients with the actinic prurigo type of polymorphous light eruption. From these results, we conclude that thalidomide may act as an immunomodulating agent on T cell subsets.,  Thalidomide was first introduced in the 1950s as a sedative but was quickly removed from the market after it was linked to cases of severe birth defects. However, it has since made a remarkable comeback for the U.S. Food and Drug Administration-approved use in the treatment of erythema nodosum leprosum. Further, it has shown its effectiveness in unresponsive dermatological conditions such as actinic prurigo, adult Langerhans cell histiocytosis, aphthous stomatitis, Beh\\u00e7et's syndrome, graft-versus-host disease, cutaneous sarcoidosis, erythema multiforme, Jessner-Kanof lymphocytic infiltration of the skin, Kaposi sarcoma, lichen planus, lupus erythematosus, melanoma, prurigo nodularis, pyoderma gangrenosum and uraemic pruritus. This article reviews the history, pharmacology, mechanism of action, clinical uses and adverse effects of thalidomide.,  Thalidomide was synthesized in 1954 in erstwhile West Germany and marketed as a sedative in over 46 countries until the early 1960s. Owing to serious teratogenic effects, the drug was withdrawn from the market in 1961. A chance observation suggested the utility of thalidomide in erythema nodosum leprosum (ENL). After many controlled and uncontrolled trials were published, the World Health Organization recommended its use in ENL. The Food and Drug Administration, USA approved it for use in ENL in July 1998. Only established and well-defined studies conducted to substantiate the efficacy of thalidomide have been included in this review. Thalidomide is considered the drug of choice for the treatment of ENL, but for other conditions, it is recommended only when resistance to the currently available form of therapy is encountered. Once the anti-inflammatory, immuno-modulatory, anti-TNF-alpha and anti-angiogenic properties of thalidomide were discovered, it was also tried in AIDS and related wasting, apthous ulcers, microsporidiosis and Kaposi's sarcoma. Thalidomide has no clinical place as an immunosuppressant in solid organ transplantation. However, it has a therapeutic role in graft-verus-host-disease. Among the dermatological conditions, thalidomide has been found to be effective in systemic lupus erythematosus, discoid lupus erythematosus, actinic prurigo and prurigo nodularis. Used correctly, it is a safe and effective medicine (except for its teratogenic potential and delayed neuropathy) in a variety of disease conditions.,  Thalidomide, a hypnosedative drug introduced in the 1950s, has been used in a variety of dermatologic conditions during the past few decades. Although originally withdrawn from the world market on discovery of its teratogenic effect, it has since been selectively reintroduced for use in various disorders thought to have an autoimmune or inflammatory basis. A review of the literature focused on clinical uses of thalidomide in the treatment of dermatologic diseases was performed. Diseases for which thalidomide has been found effective include erythema nodosum leprosum, prurigo nodularis, actinic prurigo, discoid lupus erythematosus, aphthous stomatitis, Beh\\u00e7et's syndrome, and graft-versus-host disease. Side effects such as teratogenicity and peripheral neuropathy remain its limiting factor. Thalidomide is a useful addition to the therapeutic armamentarium for treatment-resistant dermatoses as long as proper vigilance for adverse effects is maintained.,  Thalidomide, originally marketed as a sedative, was introduced in West Germany in 1956 and in numerous other countries soon thereafter. In part because it did not impair coordination or respiratory function, the drug rapidly became extremely popular. By 1961, however, there were mounting reports of phocomelia and other severe congenital abnormalities associated with maternal use of thalidomide, and the drug was withdrawn from the market and its availability highly restricted. A few years later, thalidomide would find use in dermatology after it was reported that leprosy patients with erythema nodosum leprosum (ENL) experienced rapid and dramatic improvement after taking the drug as a sedative. Additional data quickly confirmed thalidomide's efficacy in ENL, and today it is the drug of choice in the condition. In subsequent decades, the drug has been successfully tried in treatment of a variety of apparently unrelated dermatologic disorders. Meanwhile, thalidomide has been shown to possess a range of biologic actions, including inhibition of tumor necrosis factor alpha, possibly relevant to its clinical efficacy. Dermatologic disorders in addition to ENL in which thalidomide's effectiveness is well documented include aphthous stomatitis, discoid lupus erythematosus, actinic prurigo, Beh\\u00e7et's disease, and prurigo nodularis. More recently, the drug has been employed in dermatologic conditions associated with HIV infection. When used with safeguards to prevent teratogenicity and the drug's other major adverse effect, peripheral neuropathy, thalidomide may offer a good therapeutic option for many patients in whom other drug therapies have proven inadequate.,  The Chimila, a Colombian Amerindian group that lives at a low altitude, have a high incidence of actinic prurigo. We present the human lymphocyte antigen (HLA) findings of 43 Chimilas with the disease and of 62 control subjects and show an association of actinic prurigo with the Cw4 antigen.,  The acute idiopathic photodermatoses are more common in females and comprise polymorphic light eruption, actinic prurigo, hydroa vacciniforme, and solar urticaria. Polymorphic light eruption occurs considerably more frequently than the others and while precise pathogenic mechanisms are still unclear, increasing evidence suggests an immunological basis for this condition. Although clinically distinct, actinic prurigo may be a variant of polymorphic light eruption, whereas solar urticaria and possibly hydroa vacciniforme are distinct entities, the former representing a type I hypersensitivity response. Polymorphic light eruption is characterized by a recurrent cutaneous reaction to ultraviolet (UV) exposure occurring after a delay of several hours that consists of pruritic erythematous papules, vesicles, or plaques on usually only some exposed sites and resolves without scarring over about a week. Actinic prurigo is differentiated from polymorphic light eruption by childhood onset and more persistent and excoriated lesions present both on sun-exposed and, to a lesser extent, non-exposed sites. Hydroa vacciniform is a rare disorder that also begins in childhood, and is characterized by recurrent crops of vesicles on sun-exposed skin and subsequent vacciniforme scarring. Solar urticaria is an uncommon condition that usually begins in the third or fourth decade and is differentiated from the other acute idiopathic photodermatoses by rapid onset of urticarial lesions within minutes of UV exposure and resolution within 1 to 2 hours.,  The authors review the indications for the use of thalidomide in dermatological conditions. They consider leprotic reaction, prurigo nodularis of Hyde, actinic prurigo, discoid lupus erythematosus, Weber-Christian panniculitis, recurrent mouth aphtosis, Behcet's syndrome, and pyoderma gangrenosum. The dramatic situation created by the use of thalidomide in the sixties not-withstanding, interest in its use is warranted within certain limits due to its wide therapeutic action.,  The idiopathic photodermatoses are the most common cause of photosensitivity and the commonest of these are polymorphic light eruption, actinic prurigo, chronic actinic dermatitis and solar urticaria. The clinical presentation, investigation and treatment of these four disorders are presented. Spontaneous improvement does occur.,  The inducing or exacerbating effect of sunlight on skin diseases is often not appreciated in tropical countries, perhaps because of the perennial presence of sunlight, and a retrospective review of photodermatoses seen in a referral skin clinic was therefore carried out. The photodermatoses seen were secondary photoaggravation of primary skin diseases (32.2%), systemic drug photosensitivity (11.3%), polymorphic light eruption (13%), chronic actinic dermatitis (5.3%), solar urticaria (5.3%), actinic prurigo (4%), photoallergic contact dermatitis (2.6%), porphyria (1.3%) and xeroderma pigmentosum (1.3%). Compared with the results of Western studies, there were more photoaggravated underlying skin diseases and systemic drug photosensitivity, and fewer idiopathic photodermatoses and photoallergic contact dermatitis; the common photoallergens were chlorpromazine, promethazine and musk ambrette, very similar to those seen in the West.,  The literature concerning the use and possible mode of action of thalidomide in reactional lepromatous leprosy and in various other conditions is reviewed. Although it has no action against the leprosy bacillus, its value in the treatment of the adverse reactions in this type of leprosy is well established, many leprologists considering it to be superior to any other drug for this purpose. Its efficacy in actinic prurigo is also impressive, and there are reports suggesting benefit in discoid lupus erythematosus. By contrast, its reported action in a number of other conditions, including severe aphthous stomatitis, Beh\\u00e7et's syndrome, pyoderma gangrenosum, nodular prurigo, and postherpetic neuralgia, needs confirmation in a larger number of cases, backed in some instances by clinical trial. The mechanism of action of this drug may be related to (1) anti-inflammatory effects, particularly an inhibition of neutrophil chemotaxis, (2) immunosuppressive effects, or (3) effects on neural tissue. Furthermore, structure-activity studies may allow separation of these and other possible effects. This review is in no way intended to lend support to the indiscriminate use of a potentially hazardous drug in various diseases of unknown cause, but rather to draw attention to a number of conditions in which the drug has been found effective. The further judicious use of thalidomide or a nonteratogenic analogue, with careful observation of results, may contribute to knowledge of the underlying pathology in some of these conditions, and possibly also to the mechanism of action of the drug itself.,  The non-Native American type of actinic prurigo belongs to the group of rare idiopathic photodermatoses and therefore is often diagnosed with delay. The typical clinical and epidemiological features of actinic prurigo are described in a 10 year old girl. Detailed phototesting showed urticarial early onset and prurigo-like late onset reactions towards long-wave UVA. Repetitive photoprovocation with UVB induced delayed development of papules. HLA typing showed the typical association with HLA-DR4, in particular DRB1*0407. Treatment is usually extremely difficult and unrewarding. In this patient, the course was considerably improved by more intense physical photoprotection.,  Thirty-one patients with actinic prurigo were human lymphocyte antigen (HLA)-typed. The results showed an association of this disease with the alleles B40 and Cw3, both usually found in linkage disequilibrium in most populations. Because these two antigens are more frequent in Amerindians than in whites, it is suggested that they may partly account for the restricted ethnic distribution of this disease.,  Thirty-two actinic prurigo patients of Cree ancestry underwent human lymphocyte antigen (HLA) typing and were compared with 32 control subjects of Cree ancestry. We found a significantly increased frequency of HLA-A24 and Cw4 antigens and a significant decrease in the frequency of the A3 antigen in actinic prurigo patients. These HLA associations may be helpful in determining whether actinic prurigo is a distinct disease or a variant of polymorphous light eruption.,  We describe three patients with the American Indian type of polymorphous light eruption (actinic prurigo), two Cree Indian sisters and a Cree Indian boy, who had eye symptoms similar to those seen in limbal-type vernal catarrh.,  We have found that beta-carotene, when administered in sufficiently high doses, can be an effective therapy for ameliorating the photosensitivity associated with EPP. Other workers have confirmed our findings, using either beta-carotene, canthaxanthin or combinations of these two carotenoids. Carotenoids may be of some use in congenital porphyria, if given in high doses and started when the patient is very young. Carotenoid treatment seems of limited use in polymorphous light eruption, solar urticaria, hydroa aestivale and hydroa vacciniforme: we would recommend their use in these conditions only after the more standard treatments for these diseases have proven ineffective for a given patient. Carotenoid treatment seems to be of no use in porphyria cutanea tarda and actinic reticuloid.,  We report 18 cases in which a pruritic, erythematous, papular and vesicular eruption developed on the ears following sun exposure. Four of these patients had, on other occasions, suffered from typical polymorphic light eruption. The clinical features, histological changes, and results of phototesting suggest that juvenile spring eruption of the ears is a localized form of polymorphic light eruption.,  We treated with high doses of oral beta carotene (Solatene) (15 to 180 mg/day) 133 patients suffering from erythropoietic protoporphyria (EPP), 27 patients with polymorphous light eruption, six patients with solar urticaria, three patients with hydroa aestivale, one patient with porphyria cutanea tarda, and two patients with actinic reticuloid to relieve the photosensitivity associated with these diseases. Eighty-four percent of the patients with erythropoietic protoporphyria increased by a factor of 3 or more their ability to tolerate sunlight. On the other hand, only nine of the patients with polymorphous light eruption, and one fifth of the patients with all of the other forms of photosensitivity treated showed similar improvement. We conclude that beta carotene is an effective treatment for EPP, but that other forms of photosensitivity will need empirical therapeutic study with beta carotene to determine the range of effectiveness, if any, of this compound in conditions other than EPP.\",\n          \" <h4>Background</h4>Narrowband (NB) UVB phototherapy has been proven to be clearly more effective than broadband UVB and safer and/or more practicable than psoralen-UVA in the management of psoriasis. However, the role of NB UVB seems to be less clear in the management of skin conditions beyond psoriasis.<h4>Objectives</h4>We sought to give an update on clinical experiences in NB UVB of nonpsoriatic skin conditions, and to establish its current position within the spectrum of competing photo(chemo)therapeutic options.<h4>Methods</h4>The computerized bibliographic database PubMed, without time limits, and other sources were screened for clinical trials on NB UVB. Included were research articles of randomized controlled trials, open prospective studies, and retrospective observations on NB UVB in skin disorders other than psoriasis.<h4>Results</h4>A total of 28 articles met our eligibility criteria including 6 randomized controlled studies, 16 open prospective studies, and 6 retrospective observations. NB UVB is effective in patients with chronic atopic dermatitis (AD) (n = 719) and generalized vitiligo (n = 305) and appears to have some advantages over competing photo(chemo)therapeutic regimens. NB UVB also seems to be effective in patients with polymorphic light eruption (n = 25), early stages of cutaneous T-cell lymphoma (n = 108), chronic urticaria (n = 88), lichen planus (n = 15), pruritus associated with polycythemia vera (n = 10), seborrheic dermatitis (n = 18), actinic prurigo (n = 6), and acquired perforating dermatosis (n = 5). The quality of evidence determined for the aforementioned diagnoses ranged from high to moderate to very low.<h4>Conclusions</h4>The best currently available data on NB UVB in nonpsoriatic conditions exist for AD and generalized vitiligo. In view of its efficacy, benefit/risk profile, and costs, NB UVB may be considered the first-line photo(chemo)therapeutic option for moderately severe AD and widespread vitiligo. In the treatment of most other nonpsoriatic conditions, NB UVB appears to be effective, but current data allow no definitive conclusions as to whether NB UVB should be preferred to competing photo(chemo)therapeutic options such as UVA1 and psoralen-UVA regimens. Because NB UVB may have a wider indication spectrum, including AD, vitiligo, and early-stage T-cell lymphoma, and appears to be equally effective or even more effective than broadband UVB, a switch from broadband UVB to NB UVB seems to be justified.,  Five patients with actinic prurigo were treated twice weekly with PUVA. One area on the back was shielded from UVA throughout the 15-week treatment period. Before PUVA, all patients had increased erythemal sensitivity to UVA and showed abnormal augmentation of UVB erythema by topical indomethacin. After PUVA, all patients were free of photosensitive symptoms and skin that had been exposed to UVA showed normal erythemal responses. By contrast, the areas of skin that had been protected from UVA showed erythemal responses that were unchanged from pre-PUVA values. Augmentation of UVB erythema by topical indomethacin persisted, both on UVA exposed and UVA protected skin. These results show that, although PUVA is an effective treatment in actinic prurigo, it does not alter the underlying mechanism  of photosensitivity. The protective effect is local and is due presumably to an increase in melanin pigmentation and epidermal thickness.,  Most photodermatoses represent indications for preventive ultraviolet (UV) phototherapy and/or psoralen plus ultraviolet A (PUVA) photochemotherapy. The aim of treatment is to prevent the outbreak of disease by increasing the patient's tolerance to sunlight. The mechanisms by which ultraviolet B (UVB) and PUVA induce such tolerance are not completely understood. Pigmentation and skin thickening may be important factors in the protective effect, but they cannot sufficiently explain the degree of protection induced. Other mechanisms that may be of critical importance for the therapeutic efficacy encompass a variety of immunomodulatory effects on human skin known to be induced by UVA, UVB, and PUVA. Obviously the mechanisms of prophylactic phototherapy are strongly intertwined with the pathogenesis of the photodermatoses. The possible mechanisms of photoprevention are discussed for polymorphic light eruption (PMLE), actinic prurigo, chronic actinic dermatitis, and solar urticaria.,  Phototherapy is a major effective therapeutic treatment modality in dermatology and has influenced the treatment of various skin diseases dramatically. It consists of a controlled administration of non-ionizing radiation to the skin in various dermatoses, which involves the ultraviolet part of the electromagnetic spectrum and commonly includes ultraviolet A (UVA) spectrum, ultraviolet A-1 (UVA-1) spectrum, UVA spectrum with a psoralene sensitizer (PUVA), and ultraviolet B (UVB) spectrum, i.e., broad-band (BB)-UVB, or narrow-band (NB)-UVB.[1] The UVA spectrum is usually between 320 and 400nm, whereas UVA-1 (340-400nm) has longer wavelengths of UVA.[2]\\u00a0 The UVB spectrum is between 280-320nm, which may be delivered as full-spectrum (broad-band UVB lamps 270-350nm, along with the shorter wavelengths from UVA spectrum) or delivered as small-spectrum (narrow-band UVB lamps 311-313nm). Few specialized types of phototherapy exist, that include lasers, photodynamic therapy (PDT), bath-PUVA, and extracorporeal photochemotherapy. Phototherapy is still the most frequently used treatment modality for different skin diseases, including parapsoriasis, psoriasis, pityriasis lichenoides chronica, eczema, atopic dermatitis, vitiligo, photodermatitis, polymorphous light eruption, actinic prurigo, hydroa vacciniforme,\\u00a0 cutaneous porphyrias, Mycosis fungoides, and many others.[3] UVB phototherapy has different properties like anti-inflammatory, immunosuppressive, and cytotoxic. The mechanisms of its action are unclear but include the induction of cis-urocanic acid, Langerhans cell depletion, altered antigen presentation, decreased activity of natural killer(NK) cells, and apoptosis of T lymphocytes and keratinocytes. [1]The mechanisms of action of PUVA include the cross-linking of DNA through psoralen photoadducts, DNA replication inhibition, depletion of Langerhans cell, and immunosuppressive effects on T-lymphocyte function and migration.UVA-1 phototherapy penetrates deeper into the dermis, and it induces interstitial collagenase and cytokines, resulting in the softening of the sclerotic skin.[2] Photopheresis results in dendritic cells acquiring antigen from apoptotic lymphocytes, which elicit a specific immune response without causing systemic immunosuppression.[3],  Twenty patients with photodermatoses [actinic prurigo (n = 6), hydroa vacciniforme (n = 4), idiopathic solar urticaria (n = 1), amiodarone-induced photosensitivity (n = 1) and a range of cutaneous porphyrias (n = 8)] were treated with a 'hardening' course of narrow-band ultraviolet B (TL-01) phototherapy in springtime. The response to phototherapy was monitored subjectively, by interviewing patients after the summer, and objectively by monochromator phototesting, before and after phototherapy. Fifteen patients reported that treatment was worthwhile. Monochromator phototesting after phototherapy revealed a fourfold increase in the minimal erythema dose in those with abnormal photosensitivity to ultraviolet A wavebands. Adverse effects included erythema (seven patients), pruritus (five) and provocation of the eruption (four). We now routinely consider narrow-band UVB phototherapy for problem photodermatoses.,  We here report a patient with actinic prurigo. He had had erythematous papulovesicular eruptions on the sun-exposed sites from fall to early summer for 4 years. The lesions healed leaving atrophic scars. The histology showed epidermal necrosis and dermal dense perivascular lymphohistiocytic infiltration and edema. His minimal erythema doses to ultraviolet B (UVB) and UVA were normal and lowered, respectively. Skin lesions were produced by repeated irradiation with UVA plus UVB, but not with UVA alone. Then he was diagnosed as having actinic prurigo. Skin fibroblasts from the patient were hypersensitive to UVA. We believe that the hypersensitivity relates to the pathomechanisms of the photosensitivity in the case. UVA sensitivity of fibroblasts may be useful for differentiating actinic prurigo, hydroa vacciniforme, and other similar photosensitive disorders.\",\n          \" ,  42 out of 93 Saskatchewan Indians (32 female (F) and 10 male (M] with actinic prurigo were patch tested to standard series allergens between 1983 and 1987. Positive reactions were most frequently seen with nickel (3F:2M) and colophony. All 3 positive patch tests to colophony were in males. The same patients were also patch tested to extracts of 21 Saskatchewan plants and 3 Hollister-Stier plant extracts. Only 1 male and 2 females had positive patch tests. None of these 3 had rashes on the eyelids, behind the ears or under the chin. We conclude that plant contact dermatitis is unlikely to be mistaken for actinic prurigo in Saskatchewan.,  <h4>Background</h4>A preliminary investigation showed that ultraviolet radiation (UVR) emissions from compact fluorescent lamps (CFLs) can pose a risk to the skin of photosensitive individuals.<h4>Objectives</h4>To carry out a larger-scale study, in patients with a range of photodermatoses, to assess this risk. To determine a safe alternative light source for photosensitive individuals. To investigate if CFL emissions have the potential to induce skin responses in normal individuals.<h4>Methods</h4>Two hundred patients were directly exposed to a single-envelope CFL as part of their routine management. Irradiation was carried out on the inner forearm with lamps positioned at 5\\u00a0cm. Skin assessments were made immediately and 24\\u00a0h postirradiation. Eleven of these patients were further tested to a double-envelope CFL. One hundred and one patients were tested to emissions from a light-emitting diode (LED). A study involving 20 healthy individuals was carried out with exposure to the single-envelope CFL.<h4>Results</h4>Skin erythema was induced by the single-envelope CFL in the following cases: 16 of 53 chronic actinic dermatitis, seven of 52 polymorphic light eruption, five of nine solar urticaria, one of two actinic prurigo, one of one erythropoietic protoporphyria and two of 20 healthy subjects. The double-envelope CFL eliminated or reduced the skin response in all 11 patients tested. The LED did not induce any UVR-provoked skin responses.<h4>Conclusions</h4>UVR from CFLs can aggravate the skin of photosensitive and healthy individuals when situated in close proximity. Double-envelope lamps reduce this risk. LEDs offer a safer alternative light source that eliminates the risk of UVR-induced skin erythema.,  <h4>Background</h4>Photosensitivity to Chlamydia trachomatis has been described in almost 50% of chronic cases of lymphogranuloma venereum (LGV) caused by L1, L2 or L3 serovars. Photosensitivity in non LGV strains of C trachomatis has not been studied. We studied the association of various photosensitive dermatoses with C trachomatis infection in non LGV cases.<h4>Methods</h4>Sera of all the cases of photosensitivity, melasma, chronic actinic dermatitis (CAD), polymorphic light eruption (PLE), actinic prurigo (AP) and rosacea were tested for the presence of IgM, IgG and IgA antibodies to C trachomatis by ELISA method. The results were compared with 30 healthy controls.<h4>Result</h4>Seventeen (25.53%) of 57 cases of photosensitivity as against two (6.67%) controls were seropositive for IgM/IgG/IgA antibodies, a statistically significant difference (\\u03c7(2) 6.18, p 0.013). Similarly, significantly higher seropositivity was observed in 12 (25.53%) of 47 cases of melasma (\\u03c7(2) 4.38, p 0.0363) and six (46.15%) of 13 cases with CAD (\\u03c7(2) 6.91, p 0.0086). Although higher proportion of patients of rosacea [five (31.25%) of 16 cases] and PLE [four (25.0%) of 16 cases] were seropositive, the difference was not statistically significant (\\u03c7(2) 3.23, p >0.05, OR 6.36, CI 95% 0 to 48 and \\u03c7(2) 3.09, p 0.078, OR 4.67, CI 95% 5 to 41 respectively). There was no association of AP.<h4>Conclusion</h4>The observations suggest that C trachomatis infection in non LGV cases is an important cause of PS, melasma and CAD. It appears to be an important cause of rosacea and PLE. We recommend that all cases of photosensitivity, melasma, CAD, PMLE and rosacea and their spouses/sexual contacts be investigated for C trachomatis infection.,  A 42-year-old Latino man with a medical history of vitiligo presented to our outpatient clinic with a 25-year history of a recurrent, itchy eruption on his face and hands. Physical examination revealed pink, scaly, erythematous, lichenified papules and plaques with overlying crusts, photodistributed on the nose, chin, cheeks, hands, and ears (Figures 1a and 2a). The lips were edematous with hemorrhagic crusting, and conjunctival injection and partial corneal opacities were noted (Figures 1b-1c). Histologic evaluation demonstrated psoriasiform hyperplasia with hyper-granulosis and a superficial perivascular infiltrate composed of lymphocytes, histiocytes, and eosinophils. Human leukocyte antigen (HLA) class II typing was positive for HLA-DRB1*0407, thus confirming the diagnosis of actinic prurigo (AP).,  A 7-year-old girl of Colombian descent was referred for diagnosis and treatment. She initially presented signs of universal itchy eczema in the spring of 2003. She responded to local treatment with topical steroids, but her symptoms rapidly re-emerged after discharge. Further investigations led to the conclusion that the patient suffered from Actinic Prurigo. The disease was very severe and there was a lack of response to treatment with oral prednisolone, antihistamines and pentoxyfyllin. Therefore the patient was treated with Thalidomide 50 mg/25 mg daily (alternating). This resulted in the complete clearance of her skin symptoms except postinflammatory hyperpigmentation.,  Actinic Prurigo (AP), an uncommon idiopathic photodermatosis, presents a distinct clinical picture and can be severely debilitating. The clinical features, investigation and treatment of AP are reviewed. We report the experience of an Australian photobiology unit with this condition.,  Actinic prurigo (AP) is a chronic photodermatosis in which genetic and immunological factors has been implicated in the pathogenesis of the disease. This work was designed to investigate the existence of clonal populations of T and B lymphocytes in lesions of the labial mucosa and conjunctiva of patients with actinic prurigo. Genomic DNA of three patients with actinic prurigo and controls were analyzed in Southern blots using DNA molecular probes for the b subunit of the T-cell receptor for antigen (TCR beta) and for the heavy chain of immunoglobulin genes (lg-JH). Clonal rearrangements of T-cell receptor genes were detected in biopsy samples taken from the labial mucosa of two patients and of immunoglobulin genes in DNA extracted from the conjunctiva of a different patient. The presence of distinct clonal T or B lymphocyte populations in patients with actinic prurigo indicates that the immune system may play a relevant role in the pathogenesis of the disease.,  Actinic prurigo (AP) is a rare form of idiopathic photodermatosis that primarily affects sun-exposed areas of the skin.\\u00a0The affected regions of the skin\\u00a0typically include\\u00a0the face, neck, and dorsal surface of the upper extremities. Sun-protected areas of the skin, such as the buttocks, have also been described. Actinic prurigo typically manifests in the spring as symmetric intensely pruritic papulonodular dermatitis and can persist into the winter months. In severe cases, excoriations, cheilitis, conjunctival disease, and scarring may develop. Actinic prurigo is typically described in prepubescent\\u00a0females but can occur at any age or gender.\\u00a0The disease has a strong genetic component and is more commonly seen in American Indians of North, Central, and South America. The diagnosis is mainly clinical. Disease management\\u00a0begins with sun protection and sunlight avoidance. Treatment involves topical antihistamines, corticosteroids, photochemotherapy (PUVA), as well as systemic therapies for severe cases. Without treatment, this disease course remains chronic and can persist into adulthood.,  Actinic prurigo (AP) is an idiopathic photodermatosis that affects mainly the mestizo population in Latin America. It has an early onset, a slight predominance in women, and affects the sun-exposed areas of the skin, causing erythematous papules and lichenified plaques secondary to intense and chronic pruritus. Lesions can be induced by both ultraviolet A (UVA) and ultraviolet B (UVB). An association with several human leukocyte antigen (HLA) alleles has been reported. AP is unique among all photodermatoses in its remarkable response to thalidomide. In the past the microscopic features of AP have been considered as nonspecific; however, the constant finding of dense lymphocytic inflammatory infiltrates and the immunogenetic features of AP support the existence of an immunologic mechanism in its pathogenesis.,  Actinic prurigo (AP) is an immune-mediated photodermatosis that usually starts in childhood and is predominant among American indigenous and mestizo communities. In adults with AP, thalidomide is the treatment of choice; however, there is little information on its use in pediatric patients. We report the case of a 10-year-old girl with AP treated successfully with thalidomide.,  Actinic prurigo can be defined as an idiopathic photodermatosis which usually starts in childhood, particularly affects the female, with some evidence for an atopic and familial photosensitivity background. It affects both exposed and covered skin but mainly the former and although it may be present all the year round is usually maximal on the exposed skin during months of sunshine. The changes are those of a chronic prurigo along with more acute episodes following sunshine exposure in which there is a background of edematous erythema. It usually lasts throughout childhood and adolescence, but tends to wane and even to clear in late adolescence or early adult life. The etiology is unknown, as are the mechanisms involved. Action spectrum studies have produced no evidence for the involvement of specific wavelengths other than the presence of UV sensitivity in some subjects and a suggestion that the longer wavelength UVA may be more important than the sunburn waveband around 305 nm. Based on a study of 60 personal cases with actinic prurigo the authors agree with the longheld view of Calnan & Meara (1) that actinic prurigo is a separate and distinct photodermatosis.,  Actinic prurigo is a chronic familial photodermatosis that occurs mostly in Amerindians. Eight patients with actinic prurigo were given intermittent 3- to 14-day courses of topical 0.05% clobetasol 17-propionate cream or ointment in 1988 and 1989. Seven out of eight patients cleared or markedly improved. All of the patients had been resistant previously to milder topical corticosteroids. There have been no side effects. This therapy offers an effective alternative to systemic corticosteroids, oral psoralen with long-wave UV radiation in the A range, or thalidomide.,  Actinic prurigo is a chronic photodermatosis with onset in childhood or before 20 years of age. It is most prevalent in Amerindians and Latin American mestizos, although it has been reported worldwide. Patients present with photodistributed, erythematous excoriated papules, cheilitis, and conjunctivitis. There is strong association with human leukocyte antigen DR4, especially the DRB1*0407 subtype. Treatment consists of photoprotection and the use of thalidomide.,  Actinic prurigo is a rare form of light sensitivity not previously described with hypodontia in the dental literature. The purpose of this report was to describe both the medical and dental management of a 12-year-old boy presenting with actinic prurigo, hypodontia, crowding, caries, and tooth tissue loss. The phases of dental treatment and the multidisciplinary treatment of hypodontia are discussed.,  Actinic prurigo is a rare photodermatosis characterized by pruritic papulonodular lesions. Treatment is challenging, especially in children, as sun protection strategies need to be rigorously implemented and symptoms often persist throughout the year. Herein, we present a case of actinic prurigo in an 8-year-old patient with rapid and successful relief with baricitinib.,  Actinic prurigo is a rare pruritic photodermatosis. We report the use of Polypodium leucotomos extract in an 11-year-old female patient with actinic prurigo, resulting in a significant attenuation of her disease without development of adverse effects to date. Polypodium leucotomos exerts a pleiotropic immunomodulatory and antioxidant effect by shifting the balance from pro- to an antiinflammatory cytokine environment. This counteracts the effects of UV-induced cellular damage characteristic of photodermatoses.,  Actinic prurigo is a separate entity from the polymorphous light eruption that affects American Indians. It has been reported mainly from North and South America, with only few reported cases from Britain or Asia. We report a case of actinic prurigo in a Thai girl who showed cheilitis and pruritic papules on exposed areas for three years. We were able to induce populovesicular lesions by three consecutive irradiations with 100 J/cm2 UVA and 2 minimal erythematous dose of UVB. However, three weeks after irradiation, a prurigo papule developed at the UVB irradiated site.,  Actinic prurigo is an idiopathic photodermatosis that affects the skin, as well as the labial and conjunctival mucosa in indigenous and mestizo populations of Latin America. It starts predominantly in childhood, has a chronic course, and is exacerbated with solar exposure. Little is known of its pathophysiology, including the known mechanisms of the participation of HLA-DR4 and an abnormal immunologic response with increase of T CD4+ lymphocytes. The presence of IgE, eosinophils, and mast cells suggests that it is a hypersensitivity reaction (likely type IVa or b). The diagnosis is clinical, and the presence of lymphoid follicles in the mucosal histopathologic study of mucosa is pathognomonic. The best available treatment to date is thalidomide, despite its secondary effects.,  Actinic prurigo is an idiopathic, familial photodermatosis seen especially in American Indians. Segregation analysis was performed on 12 Saskatchewan pedigrees with American Indian ancestry, comprising a total of 1,148 individuals, ascertained via probands diagnosed with actinic prurigo. Although a high degree of familial aggregation has been noted in the past and dominant inheritance has been suggested, no formal segregation analysis has been attempted. Actinic prurigo has a variable age of onset and, therefore, age at the time of censoring must be taken into account in the analysis. However, as these ages of 57% of the unaffected individuals were missing, an algorithm was devised to impute the missing ages from known birth years in the family based on the age differences among relatives and spouses. Using these imputed ages, simple dominant inheritance with incomplete penetrance and a single age of onset distribution was found. The method for imputing the ages at examination was evaluated, as was the correction for ascertainment, by using alternative methods and comparing the results. Regardless of the method used, a dominant mode of inheritance without any multifactorial component remained the best hypothesis.,  Chronic photosensitivity is an incompletely understood syndrome that is difficult to diagnose and treat. Persistent light reaction, actinic reticuloid, and photosensitive eczema most commonly occur in middle-aged and elderly patients and have overlapping features. These conditions may all be persistent light reactions to known and unknown photosensitizers. Actinic prurigo usually occurs in childhood but may be delayed in onset to adult life; it is frequently associated with atopy. The diagnosis of these conditions requires a detailed history, histologic examination of the skin, phototesting, and photopatch testing. A conservative approach to therapy consists of avoidance of the activating wavelengths and use of topical corticosteroids. However, this treatment is often unsuccessful, and PUVA therapy is an effective alternative approach.,  Cutaneous lymphoid hyperplasia (CLH), also known as cutaneous pseudolymphoma, is a spectrum of benign conditions characterized by reactive B- and T-cell cutaneous lymphocytic infiltrates. B-cell lymphoid proliferations are a heterogenous group of non-neoplastic cutaneous diseases that must be histopathologically distinguished from cutaneous B-cell lymphomas. These proliferations can be observed as reactive phenomena to infections, medications, allergens, neoplasms, and more. Furthermore, there are many inflammatory conditions that present with reactive B-cell infiltrates, including actinic prurigo, Zoon balanitis, Rosai-Dorfman disease, and cutaneous plasmacytosis. This review summarizes multiple cutaneous B-cell lymphoid proliferations within the major categories of reactive and disease-associated CLH. Further we discuss major discriminating features of atypical CLH and malignancy. Understanding the specific patterns of B-cell CLH is essential for the proper diagnosis and treatment of patients presenting with such lesions.,  Electromagnetic radiation may cause distinct skin conditions. The immunologically mediated photodermatoses (IMP, previous term: idiopathic photodermatoses) represent a heterogenous group of disorders presenting with pathologic skin reactions caused by optical radiation, particularly in the UVA wavelength region. The exact pathomechanism in IMP remains to be elucidated; however, it is very likely (auto)-immunologic in nature. Polymorphic light eruption, actinic prurigo, hydroa vacciniforme, chronic actinic dermatitis, and solar urticaria are the most important conditions that may be summarized under the term IMP. IMP frequently result in a significant reduction in quality of life in affected individuals, mainly because of troublesome symptoms such as intractable itch and pain. Photodiagnostic procedures are mandatory for the exact determination of action spectra and the degree of photosensitivity. Broad-spectrum photoprotection is essential in the prevention of IMP. Photo(chemo)therapeutic regimens are predominantly used to increase the cutaneous immunologic tolerance against ambient UV radiation. In severe forms of IMP, immunomodulatory and immunosuppressive therapies may need to be considered. Overall, IMP form a significant group of skin conditions that can be extremely disabling to the patient and are difficult to diagnose and treat.,  Erythropoietic protoporphyria (EPP) is an inherited photosensitivity disorder producing mild to severe symptoms and attributable to an excessive amount of endogenous protoporphyrin accumulating in body tissues. Following sun exposure, the symptoms are burning pain, edema, erythema, vesicles, and bullare, which at times are hemorrhagic. This condition was first described in 1961. However, some patients previously diagnosed as having solar urticaria, lipoid proteinosis, or hydroa aestivale because of their clinical features ae now known to have EPP. Porphyrins are biochemical intemediates in the synthesis of heme, a moiety that occurs in all living cells and is a basic requirement for aerobic and anaerobic metabolism.,  In diagnosing actinic prurigo (AP), the patients' ethnic background is very helpful as this condition is associated with very specific ethnic groups. We discuss a patient with an unknown family history who presented with a rash that initially seemed like lupus, but was subsequently diagnosed as AP upon further evaluations.,  Introduction: Actinic prurigo is a chronic photodermatosis. It affects the Latin American population more frequently, predominantly women, and involves the sun-exposed areas of the skin, conjunctiva, and lips.\\nObjective: To update the information on the clinical-epidemiological characteristics and treatment of patients with actinic prurigo in Colombia.\\nMaterials and methods: We conducted a cross-sectional study including the medical records of patients with actinic prurigo treated in the Photodermatology Service of Hospital Universitario Centro Dermatol\\u00f3gico Federico Lleras Acosta between 2011 and 2016. We described the demographic, clinical, histopathological, and treatment characteristics of the patients.\\nResults: We included 108 patients, 77 (71.3%) were women and 31 (28.7%) men, mainly with phototypes III-IV (70%). The disease had begun during the first decade of life in 66.4% of the cases and 25% of the patients had a family history with the condition. The lesions predominated on the face (93.5%), forearms (79.6%), and back of the hands (70.4%). Ocular (87.9%) and lip (88.8%) involvement was also documented. A photo-provocation test with UVA was performed in 25% of the cases and skin biopsies in 19.4%. Physical and chemical photoprotection was indicated in all patients. Mild to moderate cases were treated with topical corticosteroids (91.7%) and calcineurin inhibitors (65.7%) while severe cases received thalidomide (33.3%) and pentoxifylline (14.8%).\\nConclusion: The characteristics of actinic prurigo patients in Colombia are similar to those reported in other Latin American countries: early onset of the disease, predominance in women, frequent involvement of conjunctiva and lips, and adequate response to topical and systemic treatment.,  Photo-contact dermatitis (PCD) describes the adverse cutaneous reaction that occurs in some patients as a result of simultaneous exposure to a contactant and to light. PCD can be subdivided into photo-allergic and photo-irritant dermatitis depending on whether the contactant respectively invokes an allergic or irritant reaction. Photo-irritant reactions are commonly caused by plants, psoralens, and medications taken internally, whereas photo-allergic reactions are commonly caused by sunscreens and topical nonsteroidal anti-inflammatory medications. The work-up of photo-contact dermatitis includes a thorough history and physical exam augmented by patch and/or photopatch testing, as the cornerstone of treatment for PCD is identification and avoidance of the irritating or allergenic chemical. Photo-contact dermatitis has the potential to significantly impact quality of life, so an informed approach to diagnosis and management is critical. Clinical mimics of PCD include polymorphic light eruption, solar urticaria, actinic prurigo, hydroa vacciniforme, cutaneous porphyrias, and systemic disorders with photosensitivity such as lupus and dermatomyositis. Herein, we review the clinical presentation, differential diagnosis (including the clinical mimics mentioned above), pathogenic mechanisms, diagnostic testing, and therapeutic considerations for PCD.,  Preceded by a brief commentary about the clinical characteristics of actinic prurigo, the qualities of anantifibrinolytic medication and its possible machanism of action in allergic conditions and atopias are analysed. An earlier experience with five familiar cases of actinic prurigo given 1 g of tranexamic acid or 3 g E. ACA, within a period of three months has been effective remarkally exceeding the results obtained with other therapeutic agents. The proposed therapeutic scheme may or may not be, modified, according to the response to the response of each individual case.,  Recently, a number of medications approved for nondermatologic use have proved useful against dermatologic diseases. This article reviews the dermatologic uses and effects of deferasirox, bortezomib, dasatinib, and cyclosporine eye drops. Deferasirox--an oral iron chelator--could be an effective treatment against porphyria cutanea tarda, hemochromatosis, and pathogens such as mucor that thrive in iron rich environments. Bortezomib, a proteasome inhibitor and multiple myeloma treatment, may be effective against nodular amyloid and has been effectively used against squamous cell carcinoma; although trials demonstrate it is ineffective against metastatic melanoma. Bortezomib has many cutaneous side effects including erythematous plaques or nodules, a generalized morbilliform erythema with ulcerations and fever, purpuric eruptions, leukocytoclastic vasculitis, Sweet's syndrome, and folliculitis. Dasatinib is a multi-targeted tyrosine kinase inhibitor active in vitro against most cell lines containing BCR-ABL mutations that confer resistance to imatinib. Dasatinib is likely to be effective against dermatofibroma sarcoma protuberans and cutaneous acute lymphoblastic leukemia, and has caused panniculitis. Cyclosporine 0.05% ocular emulsion (eye drops) are approved to treat dry eyes including dry eyes caused by collagen vascular disease. Cyclosporine eye drops might also have utility in treating eye pathology of ocular rosacea, atopic keratoconjunctivitis, graft versus host disease, herpes keratitis, chronic sarcoidosis of the conjunctiva, conjunctival manifestations of actinic prurigo, keratitis of keratitis-ichthyosis deafness (KID) syndrome, and lichen planus-related kerato-conjunctivitis. This article speculates that cyclosporine eye drops would also be useful for any disease causing ectropion or eclabion of the eye as well as toxic epidermal necrolysis-related eye pathology (in particular corneal scarring).,  Seven young patients with atopic dermatitis (AD) who presented with a marked photoexposed site dermatitis have been investigated in detail. The results of phototesting, patch testing and other investigations were compatible with the diagnosis of photosensitivity dermatitis/actinic reticuloid syndrome (PD/AR) (chronic actinic dermatitis). It is known that AD patients may have photoaggravation of their dermatitis or exacerbation secondary to a photodermatosis, such as polymorphic light eruption, actinic prurigo or drug-induced phototoxicity. The patients we describe, however, appear to be an uncommon AD subgroup affected by PD/AR. We recommend that all AD patients who have a history of sunlight-induced exacerbation or marked intolerance of PUVA or ultraviolet B phototherapy should have phototesting and patch testing conducted.,  Solar (actinic) prurigo (SP) is an abnormal reaction to sunlight that affects mostly the Indian and mestizo populations of America, and is well known in Canada and the United States. It is quite common in Mexico, Central, and South America, although rare in Europe. It usually starts in childhood in both sexes and in about 30-50% of cases involves the oral and ocular mucosa. In this study we present the clinical and histopathologic conjunctival findings in 11 of 105 children with SP. Clinically the most important features were photophobia, some degree of pterygium, and pinguecula, hyperemia, Trantas' dots, hyaline exudate, and follicles. Histopathologically the changes were epithelial, such as epidermoid metaplasia and absence of goblet cells, and stromal changes, which were the most diagnostically relevant. These consisted of lymphocytic inflammatory infiltrates, usually with eosinophils, melanosis, and solar elastosis. We believe this constellation of criteria will be useful for a better characterization of SP.,  The familial occurrence of chronic polymorphous light eruptions (CPLE) was investigated by a thorough interrogation of 91 CPLE patients. Fifty-one of these were aware of the presence of one to five familial cases, a number of which were evaluated and confirmed as CPLE. The secondary cases were usually morphologically similar to the primary case, but notable exceptions were occasionally recorded. The genealogical data pointed toward an autosomal dominant mode of inheritance of the CPLE trait, with a reduced penetrance. In the sibships of 80 persons with presumed or confirmed CPLE, the rate of penetrance was estimated to be 52%. The atopic trait appeared to be a factor promoting the manifestation of the latent CPLE trait.,  The prevalence of polymorphous light eruptions (PMLE) in a Swedish pharmaceutical company employing 412 individuals was estimated by the use of a detailed questionnaire, and 397 (96.4%) answered the survey. Their ages ranged from 18 to 65 yr (mean 40.2), and 66% were females. Eighty-three individuals (21%), mainly women (89%), had symptoms consistent with the diagnosis PMLE. Duration of their disease ranged from 1 to 53 yr, mean 14 yr. A positive family history of PMLE was surprisingly common (46%). Their threshold for sun tolerance was fairly high. They required rather high doses of sunlight to trigger their eruptions, 42% from 30 min to 2 h, and 45% greater than 2 h of solar irradiation. Only 3% had consulted a physician for their PMLE. A hardening phenomenon occurred in 84%. The PMLE group included habitual sunbathers (70%). A fair complexion was common in the PMLE group, 40% having skin types I and II, but as many as 59% had skin type III. Individuals with no light sensitivity had skin type I and II in 22%, and had skin type III in 69% of cases. In conclusion, PMLE is a common disorder and milder forms seem to be more prevalent than earlier described in northern countries such as Sweden.,  The systematic evaluation of photosensitive patients involves a comprehensive history, physical examination, phototesting, and, if necessary, photopatch testing and laboratory evaluation. Polymorphous light eruption, chronic actinic dermatitis, solar urticaria, and photosensitivity secondary to systemic medications are the most commonly encountered photodermatoses in dermatology clinics worldwide.,  This series describes some common and uncommon cutaneous findings in twelve patients with ataxia-telangiectasia (A-T). All patients had the characteristic telangiectasia as described previously. However, the telangiectases did not conform to a classic photodistribution . Our series did include one patient with a pathologic reaction to light-simulating hydroa aestivale or vacciniforme . In addition, there were three patients with acanthosis nigricans in two unrelated families. Vitiligo, impetigo, recurrent herpetic gingivostomatitis, hirsutism, lipoatrophy, gray hair, progeroid changes and hyper- and hypopigmented macules were noted in our patients. Many of our patients had one or more caf'e au lait like-lesions in a dermatomal distribution. In addition, several of the family members showed one or more caf\\u00e9 au lait-like lesions, suggesting the possibility that this finding may represent a phenotypic expression in the skin of carriers of this cancer-prone syndrome.,  Ultraviolet light (UV) and visible light are important components in the diagnosis of photodermatoses, and UV has the unique ability to also be used to manage photodermatoses. Phototesting, provocative light testing, and photopatch testing can provide important information in diagnosing patients with photodermatoses; phototesting can be used to determine the starting dose for phototherapy in these patients. Once photosensitivity is established, narrowband UVB and UVA1 therapy have helped to improve the quality of life of photosensitive patients, such as those with polymorphous light eruption, chronic actinic dermatitis, and solar urticaria.,  We describe two patients with a diagnosis of actinic prurigo who subsequently developed cutaneous B-cell lymphoma. This is the first report, to our knowledge, of this association. We propose that chronic antigenic stimulation by ultraviolet radiation, in the context of actinic prurigo, may have been causal in the development of these unusual lymphomas.,  We report a case of a newly recognized primary immunodeficiency due to biallelic mutations in CARMIL2 manifesting as an actinic prurigo-like photodermatitis, allergic diathesis and recurrent infections in a child. We present this case to highlight a rare phenotype seen in this T-cell immunodeficiency and provide an overview of other dermatologic manifestations among published reports of this condition., Actinic prurigo is an idiopathic photodermatosis seen in American                Indians; the face and other sun-exposed areas are usually involved,              the patients being sensitive to ultraviolet A light.  A modified                 dominant form of inheritance has been proposed for the disease, but              formal segregation analysis has never been performed.  Large pedigrees           of Cree Indians and M[unreadable]tis (mixed American Indian and white) of Cree              ancestry have been ascertained in which the disease appears to be                segregating and detailed data on relationships and age of onset are              being collected.  Data collection is now complete and segregation                analysis is being performed to confirm or refute a single gene mode of           inheritance.[unreadable]                                                                    , Actinic prurigo is an idiopathic photodermatosis seen in American Indians; the face and other sun-exposed areas are usually involved, the patients being sensitive to ultraviolet A light.  A modified dominant form of inheritance has been proposed for the disease, but formal segregation analysis has never been performed.  Large pedigrees of Cree Indians and M[unreadable]tis (mixed American Indian and white) of Cree ancestry have been ascertained in which the disease appears to be segregating and detailed data on relationships and age of onset are being collected.  These data will undergo segregation analysis to confirm or refute a single gene mode of inheritance. , Sarcoidosis is a multisystem granulomatous inflammatory disease of               unknown etiology.  Hereditary susceptibility to sarcoidosis is                   suggested by reports of familial clustering and a higher prevalence in           certain ethnic groups, particularly African-Americans.  Candidate                genes for the granulomatous inflammatory disorders, Blau syndrome and            Crohn's disease have been localized to the centrometric region of                chromosome 16.  We therefore investigated whether this region is also            involved in sarcoidosis.  Using a sample of 35 African-American                  affected sibling pairs, we found no evidence of linkage in this                  general region, and could exclude from it a dominant gene with                   relative risk < 5, or a recessive gene with relative risk < 3,causing            sarcoidosis.  In particular, we concluded that the Blau syndrome gene            does not have a major effect on sarcoidosis susceptibility.  We plan             to test for association of sarcoidosis with markers for other                    candidate genes and to perform a segregation analysis in order to test           simultaneously for possible environmental risk factors and genetic               mechanisms of disease transmission.  This study is ongoing.  [unreadable]                   , Sunlight is by far the most important environmental insult to the skin. Determination of the molecular basis of several inheritable photosensitivity syndromes, including Xeroderma pigmentosum and Rothmund-Thomson syndrome, has enhanced our understanding of the mechanisms of sun damage. The goal of this research proposal is the identification of genes whose mutations cause two of the remaining unelucidated heritable photosensitivity disorders-Kindler syndrome and actinic pruigo. DNA is available from a unique cohort of Kindler syndrome patients from Bocas del Toro, Panama and from several cohorts of AP patients from Saskatchewan, Keewatin in the Northwest territories and Norway House, Manitoba. Genotyping will be expedited by the availability of automated genome-wide scanning, which will be done on pooled DNA samples. Results will also be confirmed by manually analyzing the genotypes of individual samples. The candidate regions will be narrowed by genotyping at polymorphic sites. Mutations in DNA from affected individuals in the initial studies will be compared with different kindreds with these diseases. , nan\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 207,\n        \"min\": 11,\n        \"max\": 440,\n        \"num_unique_values\": 4,\n        \"samples\": [\n          440,\n          17,\n          259\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"frequent_words\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 4,\n        \"samples\": [\n          \"actinic prurigo , high-altitude , photodermatoses , pharmacology , children\",\n          \"\",\n          \"actinic prurigo , thalidomide , photodermatosis , genodermatoses , eczema\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Llama_3_n\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"{}\",\n          \"{'The clinical features of actinic prurigo are as follows': 'a.\\\\n\\\\nErythematous plaques with a pruritic, burning sensation, that mainly affect the exposed areas of the skin, such as the face, neck, and forearms. \\\\n\\\\nb.\\\\n\\\\nIn some cases, actinic prurigo may also affect the mucous membranes, such as the lips, causing actinic cheilitis (AChe).\\\\n\\\\nc.\\\\n\\\\nIn some cases, actinic prurigo may also affect the conjunctiva, causing actinic conjunctivitis (AC).\\\\n\\\\nd.\\\\n\\\\nIn some cases, actinic prurigo may also affect the oral mucosa, causing actinic stomatitis.\\\\n\\\\ne.\\\\n\\\\nIn some cases, actinic prurigo may also affect the nails, causing actinic onycholysis.\\\\n\\\\nf.\\\\n\\\\nIn some cases, actinic prurigo may also affect the genital area, causing actinic vulvitis or balanitis.\\\\n\\\\ng.\\\\n\\\\nIn some cases, actinic prurigo may also affect the eyes, causing actinic keratitis.\\\\n\\\\nh.\\\\n\\\\nIn some cases, actinic prurigo may also affect the lungs, causing actinic pneumonitis.\\\\n\\\\ni.\\\\n\\\\nIn some cases, actinic prurigo may also affect the liver, causing actinic hepatitis.\\\\n\\\\nj.\\\\n\\\\nIn some cases, actinic prurigo may also affect the kidneys, causing actinic nephritis.\\\\n\\\\nk.\\\\n\\\\nIn some cases, actinic prurigo may also affect the heart, causing actinic cardiomyopathy.\\\\n\\\\nl.\\\\n\\\\nIn some cases, actinic prurigo may also affect the nervous system, causing actinic neuropathy.\\\\n\\\\nm.\\\\n\\\\nIn some cases, actinic prurigo may also affect the blood, causing actinic anemia.\\\\n\\\\nn.\\\\n\\\\nIn some cases, actinic prurigo may also affect the immune system, causing actinic immunosuppression.\\\\n\\\\no.\\\\n\\\\nIn some cases, actinic prurigo may also affect the endocrine system, causing actinic endocrinopathy.\\\\n\\\\np.\\\\n\\\\nIn some cases, actinic prurigo may also affect the musculoskeletal system, causing actinic arthralgia.\\\\n\\\\nq.\\\\n\\\\nIn some cases, actinic prurigo may also affect the gastrointestinal system, causing actinic gastritis.'}\",\n          \"{'METRNL Expression in Immune Cells': 'The study indicates that **METRNL is produced by alternatively activated macrophages (AAM)**, which are specialized immune cells that play a critical role in the regulation of inflammatory responses. The study also suggests that **M-CSF cultured bone marrow macrophages (M2-like macrophages)** express METRNL, indicating its role in the differentiation and function of these macrophage subtypes.', 'METRNL Expression in Skin and Skin-Associated Diseases': 'The study shows that **METRNL is expressed by resting fibroblasts and IFN\\u03b3-treated keratinocytes** in the skin, suggesting its role in skin homeostasis and immune responses. The study also reports that **METRNL is over-expressed in psoriasis, prurigo nodularis, actinic keratosis and atopic dermatitis**, indicating its involvement in these skin-associated inflammatory diseases.', 'METRNL Expression in Rheumatoid Arthritis': 'The study also reports that **METRNL is up-regulated in synovial membranes of human rheumatoid arthritis**, suggesting its role in the inflammatory process of this autoimmune disease. This finding highlights the potential of METRNL as a biomarker or therapeutic target for rheumatoid arthritis.'}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-779c95c0-c345-48f0-a485-10304a24a011\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  42 out of 93 Saskatchewan Indians (32 fema...</td>\n",
              "      <td>[nan, Native Americans, skin, orphan disease /...</td>\n",
              "      <td>259</td>\n",
              "      <td>actinic prurigo , thalidomide , photodermatosi...</td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;h4&gt;Background/purpose&lt;/h4&gt;Abnormal cutaneous...</td>\n",
              "      <td>[children, ozone depletion, adolescents, high-...</td>\n",
              "      <td>440</td>\n",
              "      <td>actinic prurigo , high-altitude , photodermato...</td>\n",
              "      <td>{'The clinical features of actinic prurigo are...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>Cytokines are involved in many functions of t...</td>\n",
              "      <td>[meteorin-like, psoriasis, cytokine, skin, rhe...</td>\n",
              "      <td>11</td>\n",
              "      <td>meteorin-like , psoriasis , cytokine , skin , ...</td>\n",
              "      <td>{'METRNL Expression in Immune Cells': 'The stu...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2</td>\n",
              "      <td>&lt;h4&gt;Background&lt;/h4&gt;Narrowband (NB) UVB photot...</td>\n",
              "      <td>[]</td>\n",
              "      <td>17</td>\n",
              "      <td></td>\n",
              "      <td>{}</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-779c95c0-c345-48f0-a485-10304a24a011')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-779c95c0-c345-48f0-a485-10304a24a011 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-779c95c0-c345-48f0-a485-10304a24a011');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-94b936ec-db79-451d-8797-482f9479e711\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-94b936ec-db79-451d-8797-482f9479e711')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-94b936ec-db79-451d-8797-482f9479e711 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_787886e0-fdc3-4d40-b575-f879d8898abe\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_787886e0-fdc3-4d40-b575-f879d8898abe button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  42 out of 93 Saskatchewan Indians (32 fema...   \n",
              "1          0   <h4>Background/purpose</h4>Abnormal cutaneous...   \n",
              "2          1   Cytokines are involved in many functions of t...   \n",
              "3          2   <h4>Background</h4>Narrowband (NB) UVB photot...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [nan, Native Americans, skin, orphan disease /...   259   \n",
              "1  [children, ozone depletion, adolescents, high-...   440   \n",
              "2  [meteorin-like, psoriasis, cytokine, skin, rhe...    11   \n",
              "3                                                 []    17   \n",
              "\n",
              "                                      frequent_words  \\\n",
              "0  actinic prurigo , thalidomide , photodermatosi...   \n",
              "1  actinic prurigo , high-altitude , photodermato...   \n",
              "2  meteorin-like , psoriasis , cytokine , skin , ...   \n",
              "3                                                      \n",
              "\n",
              "                                           Llama_3_n  \n",
              "0                                                 {}  \n",
              "1  {'The clinical features of actinic prurigo are...  \n",
              "2  {'METRNL Expression in Immune Cells': 'The stu...  \n",
              "3                                                 {}  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "repr_error": "Out of range float values are not JSON compliant: nan",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-1e559492-982e-4228-b432-6b34a716bd41\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  &lt;b&gt;Introduction:&lt;/b&gt; For infants with ulna...</td>\n",
              "      <td>[Catapresan, Saline, Catapresan, Saline, surgi...</td>\n",
              "      <td>38</td>\n",
              "      <td>non-syndromic polydactyly , postaxial polydact...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;b&gt;&lt;i&gt;Objective:&lt;/i&gt;&lt;/b&gt; Polydactyly is chara...</td>\n",
              "      <td>[Agreement, Area, behavioral study, Biopsy Spe...</td>\n",
              "      <td>151</td>\n",
              "      <td>polydactyly , Clinical , malformation , Molecu...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>Preaxial polydactyly (PPD) is a congenital li...</td>\n",
              "      <td>[]</td>\n",
              "      <td>14</td>\n",
              "      <td></td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-1e559492-982e-4228-b432-6b34a716bd41')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-1e559492-982e-4228-b432-6b34a716bd41 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-1e559492-982e-4228-b432-6b34a716bd41');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-a70e7bc1-cf9a-4afa-9263-c702a1ad3fda\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-a70e7bc1-cf9a-4afa-9263-c702a1ad3fda')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-a70e7bc1-cf9a-4afa-9263-c702a1ad3fda button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_49d3fd40-7149-4adc-b8cc-8a289a1b040f\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_49d3fd40-7149-4adc-b8cc-8a289a1b040f button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  <b>Introduction:</b> For infants with ulna...   \n",
              "1          0   <b><i>Objective:</i></b> Polydactyly is chara...   \n",
              "2          1   Preaxial polydactyly (PPD) is a congenital li...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Catapresan, Saline, Catapresan, Saline, surgi...    38   \n",
              "1  [Agreement, Area, behavioral study, Biopsy Spe...   151   \n",
              "2                                                 []    14   \n",
              "\n",
              "                                      frequent_words Llama_3_n  \n",
              "0  non-syndromic polydactyly , postaxial polydact...      None  \n",
              "1  polydactyly , Clinical , malformation , Molecu...      None  \n",
              "2                                                         None  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n"
          ]
        },
        {
          "ename": "KeyboardInterrupt",
          "evalue": "",
          "output_type": "error",
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
            "\u001b[0;32m<ipython-input-203-6fd6763c6ae1>\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     53\u001b[0m     \u001b[0mnum_repetiton\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     54\u001b[0m     \u001b[0;32mwhile\u001b[0m \u001b[0meval\u001b[0m\u001b[0;34m==\u001b[0m\u001b[0;32mFalse\u001b[0m \u001b[0;32mand\u001b[0m \u001b[0mnum_repetiton\u001b[0m\u001b[0;34m<\u001b[0m\u001b[0;36m3\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 55\u001b[0;31m        \u001b[0mres\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mCostumized_question\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0muser_query\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0muser_query\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0msystem_query\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mtext\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     56\u001b[0m        \u001b[0mdic\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0morganize_research_expertise\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mres\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     57\u001b[0m        \u001b[0mn\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0mm\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m<ipython-input-88-0fc2f0eebbe8>\u001b[0m in \u001b[0;36mCostumized_question\u001b[0;34m(user_query, system_query)\u001b[0m\n\u001b[1;32m     40\u001b[0m   ], return_tensors = \"pt\").to(\"cuda\")\n\u001b[1;32m     41\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 42\u001b[0;31m   \u001b[0moutputs\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mmodel\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgenerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0minputs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mmax_new_tokens\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;36m4000\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0muse_cache\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mTrue\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     43\u001b[0m   \u001b[0mans\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mtokenizer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbatch_decode\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0moutputs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     44\u001b[0m   \u001b[0;32mreturn\u001b[0m \u001b[0mextract_response\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mans\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;36m0\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/torch/utils/_contextlib.py\u001b[0m in \u001b[0;36mdecorate_context\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    114\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0mdecorate_context\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    115\u001b[0m         \u001b[0;32mwith\u001b[0m \u001b[0mctx_factory\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 116\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    117\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    118\u001b[0m     \u001b[0;32mreturn\u001b[0m \u001b[0mdecorate_context\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/unsloth/models/llama.py\u001b[0m in \u001b[0;36m_fast_generate\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m   1502\u001b[0m         \u001b[0;31m# Autocasted\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1503\u001b[0m         \u001b[0;32mwith\u001b[0m \u001b[0mtorch\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mautocast\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdevice_type\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mdevice_type\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mdtype\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mdtype\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1504\u001b[0;31m             \u001b[0moutput\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mgenerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1505\u001b[0m         \u001b[0;32mpass\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1506\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/peft/peft_model.py\u001b[0m in \u001b[0;36mgenerate\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1836\u001b[0m                 \u001b[0;32mwith\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_enable_peft_forward_hooks\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1837\u001b[0m                     \u001b[0mkwargs\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;34m{\u001b[0m\u001b[0mk\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0mv\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mk\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mv\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mkwargs\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mitems\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mif\u001b[0m \u001b[0mk\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mspecial_peft_forward_args\u001b[0m\u001b[0;34m}\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1838\u001b[0;31m                     \u001b[0moutputs\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbase_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgenerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1839\u001b[0m             \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1840\u001b[0m                 \u001b[0moutputs\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbase_model\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgenerate\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/torch/utils/_contextlib.py\u001b[0m in \u001b[0;36mdecorate_context\u001b[0;34m(*args, **kwargs)\u001b[0m\n\u001b[1;32m    114\u001b[0m     \u001b[0;32mdef\u001b[0m \u001b[0mdecorate_context\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    115\u001b[0m         \u001b[0;32mwith\u001b[0m \u001b[0mctx_factory\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 116\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mfunc\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    117\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    118\u001b[0m     \u001b[0;32mreturn\u001b[0m \u001b[0mdecorate_context\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/generation/utils.py\u001b[0m in \u001b[0;36mgenerate\u001b[0;34m(self, inputs, generation_config, logits_processor, stopping_criteria, prefix_allowed_tokens_fn, synced_gpus, assistant_model, streamer, negative_prompt_ids, negative_prompt_attention_mask, **kwargs)\u001b[0m\n\u001b[1;32m   2250\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2251\u001b[0m             \u001b[0;31m# 12. run sample (it degenerates to greedy search when `generation_config.do_sample=False`)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 2252\u001b[0;31m             result = self._sample(\n\u001b[0m\u001b[1;32m   2253\u001b[0m                 \u001b[0minput_ids\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   2254\u001b[0m                 \u001b[0mlogits_processor\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0mprepared_logits_processor\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/transformers/generation/utils.py\u001b[0m in \u001b[0;36m_sample\u001b[0;34m(self, input_ids, logits_processor, stopping_criteria, generation_config, synced_gpus, streamer, **model_kwargs)\u001b[0m\n\u001b[1;32m   3252\u001b[0m                 \u001b[0mis_prefill\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mFalse\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   3253\u001b[0m             \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 3254\u001b[0;31m                 \u001b[0moutputs\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mmodel_forward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m**\u001b[0m\u001b[0mmodel_inputs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mreturn_dict\u001b[0m\u001b[0;34m=\u001b[0m\u001b[0;32mTrue\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   3255\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   3256\u001b[0m             \u001b[0;31m# synced_gpus: don't waste resources running the code we don't need; kwargs must be updated before skipping\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/torch/nn/modules/module.py\u001b[0m in \u001b[0;36m_wrapped_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1734\u001b[0m             \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_compiled_call_impl\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m  \u001b[0;31m# type: ignore[misc]\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1735\u001b[0m         \u001b[0;32melse\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m-> 1736\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0m_call_impl\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1737\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1738\u001b[0m     \u001b[0;31m# torchrec tests the code consistency with the following code\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/torch/nn/modules/module.py\u001b[0m in \u001b[0;36m_call_impl\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m   1745\u001b[0m                 \u001b[0;32mor\u001b[0m \u001b[0m_global_backward_pre_hooks\u001b[0m \u001b[0;32mor\u001b[0m \u001b[0m_global_backward_hooks\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1746\u001b[0m                 or _global_forward_hooks or _global_forward_pre_hooks):\n\u001b[0;32m-> 1747\u001b[0;31m             \u001b[0;32mreturn\u001b[0m \u001b[0mforward_call\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34m*\u001b[0m\u001b[0margs\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m**\u001b[0m\u001b[0mkwargs\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m   1748\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m   1749\u001b[0m         \u001b[0mresult\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/unsloth/models/llama.py\u001b[0m in \u001b[0;36m_CausalLM_fast_forward\u001b[0;34m(self, input_ids, causal_mask, attention_mask, position_ids, past_key_values, inputs_embeds, labels, use_cache, output_attentions, output_hidden_states, return_dict, num_logits_to_keep, *args, **kwargs)\u001b[0m\n\u001b[1;32m    966\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    967\u001b[0m         \u001b[0;32mif\u001b[0m \u001b[0mpast_key_values\u001b[0m \u001b[0;32mis\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 968\u001b[0;31m             outputs = fast_forward_inference(\n\u001b[0m\u001b[1;32m    969\u001b[0m                 \u001b[0mself\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    970\u001b[0m                 \u001b[0minput_ids\u001b[0m\u001b[0;34m,\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/unsloth/models/llama.py\u001b[0m in \u001b[0;36mLlamaModel_fast_forward_inference\u001b[0;34m(self, input_ids, past_key_values, position_ids, attention_mask)\u001b[0m\n\u001b[1;32m    931\u001b[0m         \u001b[0mresidual\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mhidden_states\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    932\u001b[0m         \u001b[0mhidden_states\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mfast_rms_layernorm_inference\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdecoder_layer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mpost_attention_layernorm\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mhidden_states\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 933\u001b[0;31m         \u001b[0mhidden_states\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mfast_swiglu_inference\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mdecoder_layer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmlp\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mhidden_states\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    934\u001b[0m         \u001b[0mhidden_states\u001b[0m \u001b[0;34m+=\u001b[0m \u001b[0mresidual\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    935\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/unsloth/models/llama.py\u001b[0m in \u001b[0;36mfast_swiglu_inference\u001b[0;34m(self, X)\u001b[0m\n\u001b[1;32m    280\u001b[0m     \u001b[0;31m# temp = torch.empty((2, bsz, 1, mlp_size), dtype = X.dtype, device = \"cuda:0\")\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    281\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 282\u001b[0;31m     \u001b[0mgate\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mfast_linear_forward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mgate_proj\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mX\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;31m#, out = temp[0])\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    283\u001b[0m     \u001b[0mup\u001b[0m   \u001b[0;34m=\u001b[0m \u001b[0mfast_linear_forward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mself\u001b[0m\u001b[0;34m.\u001b[0m  \u001b[0mup_proj\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mX\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;31m#, out = temp[1])\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    284\u001b[0m     \u001b[0mgate\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mtorch_nn_functional_silu\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mgate\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0minplace\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mTrue\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/unsloth/kernels/utils.py\u001b[0m in \u001b[0;36mfast_linear_forward\u001b[0;34m(proj, X, temp_lora, out)\u001b[0m\n\u001b[1;32m    357\u001b[0m \u001b[0;32mdef\u001b[0m \u001b[0mfast_linear_forward\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mproj\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mX\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mtemp_lora\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mout\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    358\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 359\u001b[0;31m     \u001b[0mW\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mW_quant\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlora_A\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlora_B\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlora_S\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mbias\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mget_lora_parameters_bias\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mproj\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    360\u001b[0m     \u001b[0mbsz\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mq_len\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0min_dim\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mX\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mshape\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    361\u001b[0m     \u001b[0;32mif\u001b[0m \u001b[0mq_len\u001b[0m \u001b[0;34m!=\u001b[0m \u001b[0;36m1\u001b[0m\u001b[0;34m:\u001b[0m \u001b[0;32mreturn\u001b[0m \u001b[0mmatmul_lora\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mX\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mW\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mW_quant\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlora_A\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlora_B\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mlora_S\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;32m/usr/local/lib/python3.11/dist-packages/unsloth/kernels/utils.py\u001b[0m in \u001b[0;36mget_lora_parameters_bias\u001b[0;34m(proj)\u001b[0m\n\u001b[1;32m    103\u001b[0m     \u001b[0mbias\u001b[0m \u001b[0;34m=\u001b[0m \u001b[0mbase_layer\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mbias\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    104\u001b[0m \u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m--> 105\u001b[0;31m     \u001b[0;32mif\u001b[0m \u001b[0;32mnot\u001b[0m \u001b[0mhasattr\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mproj\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;34m\"disable_adapters\"\u001b[0m\u001b[0;34m)\u001b[0m \u001b[0;32mor\u001b[0m \u001b[0mproj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mdisable_adapters\u001b[0m \u001b[0;32mor\u001b[0m \u001b[0mproj\u001b[0m\u001b[0;34m.\u001b[0m\u001b[0mmerged\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m    106\u001b[0m         \u001b[0;32mreturn\u001b[0m \u001b[0mW\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mQUANT_STATE\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0mW\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0;32mNone\u001b[0m\u001b[0;34m,\u001b[0m \u001b[0mbias\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m    107\u001b[0m     \u001b[0;32mpass\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
          ]
        }
      ],
      "source": [
        "\n",
        "A=['PGM1-CDG','Cerebral cavernous malformations 3',\"CLOVES syndrome\",\"STT3B-CDG\",\"Thoracolaryngopelvic dysplasia\",\"Actinic prurigo\",\"Non-syndromic polydactyly\",\"Genitopatellar syndrome\",\"Diaphanospondylodysostosis\"]\n",
        "B=['GARD0004329','GARD0018314',\"GARD0010939\",\"GARD0017603\",\"GARD0005184\", \"GARD0017510\",\"GARD0004410\",\"GARD0010994\",\"GARD0016674\"]\n",
        "for f in range(3,len(A)):\n",
        " disease= A[f]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        " diseaseid=B[f] #'GARD0017510'\n",
        "\n",
        "\n",
        " concatenated_data= merge_community_detection_and_researchers_info(disease)\n",
        " # Assuming you have a DataFrame `clustering_2`\n",
        " #clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', num_clusters=6, n_components=100)\n",
        " clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', eps=0.9, min_samples=10, n_components=100)\n",
        "\n",
        " # Group by 'Community' and aggregate columns using sum_strings and sum_terms functions\n",
        " result = clustering_.groupby('Community').agg(\n",
        "    Abstract=('Abstract', sum_strings),\n",
        "    Terms=('Terms', sum_terms),\n",
        "    Size=('Community', 'size')  # Count of occurrences\n",
        " ).reset_index()\n",
        "\n",
        " data=result\n",
        "\n",
        " data['frequent_words']  = data.apply(lambda x:  three_most_frequent_terms(x['Terms'])   , axis=1)\n",
        " data['Llama_3_n']=None\n",
        " #data['Llama_3_n'] = data['Llama_3_n'].astype('object')\n",
        " data.index=range(data.shape[0])\n",
        " display(data)\n",
        " for i in data.index:\n",
        "    print(i)\n",
        "    text = data['Abstract'][i]\n",
        "    if not isinstance(text, str):\n",
        "        continue\n",
        "    n = 0\n",
        "\n",
        "    # Ensure the chunking works properly and limit iterations to avoid infinite loops\n",
        "    while len(tokenizer1.tokenize(text)) > 5000 and n < 10:\n",
        "        # Split text into chunks\n",
        "        chunks = splitter.split_text(text)\n",
        "        text = ''\n",
        "\n",
        "        # Process each chunk individually\n",
        "        for j, chunk in enumerate(chunks):\n",
        "          if j <10:\n",
        "            text += ' ' + Costumized_question_summary(user_query=disease, system_query=chunk)\n",
        "          print('suumary_chunk ',j)\n",
        "        n += 1\n",
        "\n",
        "    # Apply the custom function for the query\n",
        "    #if data['frequent_words'][i] == '':\n",
        "    user_query= disease\n",
        "    #else:    user_query = data['frequent_words'][i]\n",
        "    #print(text)\n",
        "    eval=False\n",
        "    num_repetiton=0\n",
        "    while eval==False and num_repetiton<3:\n",
        "       res = Costumized_question(user_query=user_query, system_query=text)\n",
        "       dic=organize_research_expertise(res)\n",
        "       n,m=0,0\n",
        "       num_repetiton+=1\n",
        "       for h in dic:\n",
        "         if len(h) >2: n+=1\n",
        "         if h !='' and dic[h] != '': m+=1\n",
        "         if n>0 and m >=3:  eval=True\n",
        "       print('repetiton',num_repetiton)\n",
        "    #print(dic)\n",
        "    print(dic)\n",
        "    data.loc[i,'Llama_3_n'] = str(dic)\n",
        " display(data)\n",
        " # Iterate over data to create Cluster and Expertise nodes\n",
        " for r in data.index:\n",
        "    event_properties = {\n",
        "        'Cluster_ID': str(data['Community'][r]),\n",
        "        'Cluster_Size': str(data['Size'][r]),\n",
        "        'Evidence': str(data['Abstract'][r]),\n",
        "        'Key_trems': str(data['frequent_words'][r]),\n",
        "        'Llama_3_n': str(data['Llama_3_n'][r]),\n",
        "    }\n",
        "    create_Cluster_node(event_properties, disease)\n",
        "\n",
        "\n",
        " for k in clustering_.index:\n",
        "    # Check if node_value is a tuple/list, otherwise skip or handle it differently\n",
        "        create_relationship_cluster_researcher(\n",
        "            str(clustering_['Community'][k]),\n",
        "            clustering_['PI'][k],  # Researcher name\n",
        "            clustering_['affiliation'][k],  # Affiliation\n",
        "            disease  # Disease value (make sure this exists in your DataFrame)\n",
        "        )"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "id": "TIm-PabzgBer",
        "outputId": "b206e4c7-fd6a-423e-e61b-6395dc43bde1"
      },
      "outputs": [
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "repr_error": "Out of range float values are not JSON compliant: nan",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-949adc42-3174-4fbb-9b44-1bd532755ae4\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  &lt;b&gt;Introduction:&lt;/b&gt; For infants with ulna...</td>\n",
              "      <td>[Catapresan, Saline, Catapresan, Saline, surgi...</td>\n",
              "      <td>38</td>\n",
              "      <td>non-syndromic polydactyly , postaxial polydact...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;b&gt;&lt;i&gt;Objective:&lt;/i&gt;&lt;/b&gt; Polydactyly is chara...</td>\n",
              "      <td>[Agreement, Area, behavioral study, Biopsy Spe...</td>\n",
              "      <td>151</td>\n",
              "      <td>polydactyly , Clinical , malformation , Molecu...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>Preaxial polydactyly (PPD) is a congenital li...</td>\n",
              "      <td>[]</td>\n",
              "      <td>14</td>\n",
              "      <td></td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-949adc42-3174-4fbb-9b44-1bd532755ae4')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-949adc42-3174-4fbb-9b44-1bd532755ae4 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-949adc42-3174-4fbb-9b44-1bd532755ae4');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-32787157-7df6-47d0-a41b-f4345eca8f26\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-32787157-7df6-47d0-a41b-f4345eca8f26')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-32787157-7df6-47d0-a41b-f4345eca8f26 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_09558830-4775-4b5c-b44e-3aa00c5ca606\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_09558830-4775-4b5c-b44e-3aa00c5ca606 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  <b>Introduction:</b> For infants with ulna...   \n",
              "1          0   <b><i>Objective:</i></b> Polydactyly is chara...   \n",
              "2          1   Preaxial polydactyly (PPD) is a congenital li...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Catapresan, Saline, Catapresan, Saline, surgi...    38   \n",
              "1  [Agreement, Area, behavioral study, Biopsy Spe...   151   \n",
              "2                                                 []    14   \n",
              "\n",
              "                                      frequent_words Llama_3_n  \n",
              "0  non-syndromic polydactyly , postaxial polydact...      None  \n",
              "1  polydactyly , Clinical , malformation , Molecu...      None  \n",
              "2                                                         None  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n",
            "-----------------------------------------\n",
            "res The research expertise areas of the authors in the context of Non-syndromic polydactyly are:\n",
            "\n",
            "1. Wait Times, Sedation Times, and Surgical Duration for Ulnar Polydactyly: The authors have conducted a study to evaluate the wait times, sedation times, and surgical duration for infants with ulnar polydactyly who underwent surgery under local or general anesthetic. The study found that wait times, duration of surgery, and sedation times were significantly shorter for patients treated with local anesthetic compared to those treated with general anesthetic. The study also found no differences in complication rates between the two groups. This research highlights the importance of local anesthetic in reducing wait times and duration of surgery for infants with ulnar polydactyly.\n",
            "\n",
            "2. Role of FGFR2 Mutations in Osteoblastic Differentiation: The authors have studied the role of the S252W mutation of FGFR2 on osteoblastic differentiation in polydactyly-related syndromes. They found that osteoblastic cells derived from digital bone in Apert patients with the S252W mutation showed more prominent osteoblastic activity, higher expression of osteoblastic markers, and mineralized nodule formation compared to control cells. Stable clones of the human MG63 osteosarcoma cells overexpressing a splice variant of FGFR2 with or without the S252W mutation showed higher RUNX2 mRNA expression and enhanced osteoblastic marker gene expression. The enhanced osteoblastic phenotype in human osteoblasts was controlled by a soluble FGFR2 with the S252W mutation, suggesting a dominant negative effect on FGFR2 signaling in Apert syndrome. This research provides insights into the molecular mechanisms underlying osteoblastic differentiation in polydactyly-related syndromes.\n",
            "\n",
            "3. Molecular Embryology of Limb Development: The authors have reviewed the molecular embryology of limb development and outlined the \"end-organ responsiveness\" of the limbs to a variety of single-gene mutations. They proposed an alternative classification of syndactylies and polydactylies based on the involvement of specific genes and their impact on the development of the limbs. This research provides a comprehensive understanding of the molecular mechanisms underlying limb development and the classification of syndactylies and polydactylies.\n",
            "\n",
            "4. Familial Polydactyly: The authors have presented a case of familial polydactyly spanning three generations. The study examined the anatomical variations observed in the affected individuals, including the presence of a transverse accessory extensor tendon between both extensor tendons in cases with T- and Y-shaped metatarsals. The authors aimed to contribute to the existing body of literature on the subject of familial polydactyly. This research highlights the importance of genetic counseling in cases of consanguinity and the need for a multidisciplinary approach in managing polydactyly.\n",
            "\n",
            "5. KIAA0825 Variations in Postaxial Polydactyly: The authors have identified compound heterozygous splice site variants in KIAA0825 in a fetus with non-syndromic postaxial polydactyly type A (PAPA). The study found that the c.-1-2A>T variant led to the loss of the initiation codon, and the c.2247-2A>G variant mainly resulted in exon 13 skipping. Prenatal whole-exome sequencing and subsequent functional studies were important approaches for defining the genetic etiology of fetuses with PAPA and for accurate genetic counseling and decision making. This research expands the spectrum of KIAA0825 variations in PAPA patients and increases the knowledge of the molecular consequences of KIAA0825 splice site variants.\n",
            "\n",
            "6. Biblical Evidence of Polydactyly: The authors have presented a case of polydactyly in the biblical text of passage 2 Sam 21: 20-21. The documental evidence certifies the presence of this orthopedic lesion in ancient times, and it is probable that this was a case of post-axial, non crossed and non syndromic polydactyly. This research highlights the importance of ancient texts in understanding the prevalence of polydactyly in the past.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'Wait Times, Sedation Times, and Surgical Duration for Ulnar Polydactyly': 'The authors have conducted a study to evaluate the wait times, sedation times, and surgical duration for infants with ulnar polydactyly who underwent surgery under local or general anesthetic. The study found that wait times, duration of surgery, and sedation times were significantly shorter for patients treated with local anesthetic compared to those treated with general anesthetic. The study also found no differences in complication rates between the two groups. This research highlights the importance of local anesthetic in reducing wait times and duration of surgery for infants with ulnar polydactyly.', 'Role of FGFR2 Mutations in Osteoblastic Differentiation': 'The authors have studied the role of the S252W mutation of FGFR2 on osteoblastic differentiation in polydactyly-related syndromes. They found that osteoblastic cells derived from digital bone in Apert patients with the S252W mutation showed more prominent osteoblastic activity, higher expression of osteoblastic markers, and mineralized nodule formation compared to control cells. Stable clones of the human MG63 osteosarcoma cells overexpressing a splice variant of FGFR2 with or without the S252W mutation showed higher RUNX2 mRNA expression and enhanced osteoblastic marker gene expression. The enhanced osteoblastic phenotype in human osteoblasts was controlled by a soluble FGFR2 with the S252W mutation, suggesting a dominant negative effect on FGFR2 signaling in Apert syndrome. This research provides insights into the molecular mechanisms underlying osteoblastic differentiation in polydactyly-related syndromes.', 'Molecular Embryology of Limb Development': 'The authors have reviewed the molecular embryology of limb development and outlined the \"end-organ responsiveness\" of the limbs to a variety of single-gene mutations. They proposed an alternative classification of syndactylies and polydactylies based on the involvement of specific genes and their impact on the development of the limbs. This research provides a comprehensive understanding of the molecular mechanisms underlying limb development and the classification of syndactylies and polydactylies.', 'Familial Polydactyly': 'The authors have presented a case of familial polydactyly spanning three generations. The study examined the anatomical variations observed in the affected individuals, including the presence of a transverse accessory extensor tendon between both extensor tendons in cases with T- and Y-shaped metatarsals. The authors aimed to contribute to the existing body of literature on the subject of familial polydactyly. This research highlights the importance of genetic counseling in cases of consanguinity and the need for a multidisciplinary approach in managing polydactyly.', 'KIAA0825 Variations in Postaxial Polydactyly': 'The authors have identified compound heterozygous splice site variants in KIAA0825 in a fetus with non-syndromic postaxial polydactyly type A (PAPA). The study found that the c.-1-2A>T variant led to the loss of the initiation codon, and the c.2247-2A>G variant mainly resulted in exon 13 skipping. Prenatal whole-exome sequencing and subsequent functional studies were important approaches for defining the genetic etiology of fetuses with PAPA and for accurate genetic counseling and decision making. This research expands the spectrum of KIAA0825 variations in PAPA patients and increases the knowledge of the molecular consequences of KIAA0825 splice site variants.', 'Biblical Evidence of Polydactyly': 'The authors have presented a case of polydactyly in the biblical text of passage 2 Sam 21'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'Wait Times, Sedation Times, and Surgical Duration for Ulnar Polydactyly': 'The authors have conducted a study to evaluate the wait times, sedation times, and surgical duration for infants with ulnar polydactyly who underwent surgery under local or general anesthetic. The study found that wait times, duration of surgery, and sedation times were significantly shorter for patients treated with local anesthetic compared to those treated with general anesthetic. The study also found no differences in complication rates between the two groups. This research highlights the importance of local anesthetic in reducing wait times and duration of surgery for infants with ulnar polydactyly.', 'Role of FGFR2 Mutations in Osteoblastic Differentiation': 'The authors have studied the role of the S252W mutation of FGFR2 on osteoblastic differentiation in polydactyly-related syndromes. They found that osteoblastic cells derived from digital bone in Apert patients with the S252W mutation showed more prominent osteoblastic activity, higher expression of osteoblastic markers, and mineralized nodule formation compared to control cells. Stable clones of the human MG63 osteosarcoma cells overexpressing a splice variant of FGFR2 with or without the S252W mutation showed higher RUNX2 mRNA expression and enhanced osteoblastic marker gene expression. The enhanced osteoblastic phenotype in human osteoblasts was controlled by a soluble FGFR2 with the S252W mutation, suggesting a dominant negative effect on FGFR2 signaling in Apert syndrome. This research provides insights into the molecular mechanisms underlying osteoblastic differentiation in polydactyly-related syndromes.', 'Molecular Embryology of Limb Development': 'The authors have reviewed the molecular embryology of limb development and outlined the \"end-organ responsiveness\" of the limbs to a variety of single-gene mutations. They proposed an alternative classification of syndactylies and polydactylies based on the involvement of specific genes and their impact on the development of the limbs. This research provides a comprehensive understanding of the molecular mechanisms underlying limb development and the classification of syndactylies and polydactylies.', 'Familial Polydactyly': 'The authors have presented a case of familial polydactyly spanning three generations. The study examined the anatomical variations observed in the affected individuals, including the presence of a transverse accessory extensor tendon between both extensor tendons in cases with T- and Y-shaped metatarsals. The authors aimed to contribute to the existing body of literature on the subject of familial polydactyly. This research highlights the importance of genetic counseling in cases of consanguinity and the need for a multidisciplinary approach in managing polydactyly.', 'KIAA0825 Variations in Postaxial Polydactyly': 'The authors have identified compound heterozygous splice site variants in KIAA0825 in a fetus with non-syndromic postaxial polydactyly type A (PAPA). The study found that the c.-1-2A>T variant led to the loss of the initiation codon, and the c.2247-2A>G variant mainly resulted in exon 13 skipping. Prenatal whole-exome sequencing and subsequent functional studies were important approaches for defining the genetic etiology of fetuses with PAPA and for accurate genetic counseling and decision making. This research expands the spectrum of KIAA0825 variations in PAPA patients and increases the knowledge of the molecular consequences of KIAA0825 splice site variants.', 'Biblical Evidence of Polydactyly': 'The authors have presented a case of polydactyly in the biblical text of passage 2 Sam 21'}\n",
            "1\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/spacy/pipeline/lemmatizer.py:211: UserWarning: [W108] The rule-based lemmatizer did not find POS annotation for one or more tokens. Check that your pipeline includes components that assign token.pos, typically 'tagger'+'attribute_ruler' or 'morphologizer'.\n",
            "  warnings.warn(Warnings.W108)\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "suumary_chunk  0\n",
            "suumary_chunk  1\n",
            "suumary_chunk  2\n",
            "suumary_chunk  3\n",
            "suumary_chunk  4\n",
            "suumary_chunk  5\n",
            "suumary_chunk  6\n",
            "suumary_chunk  7\n",
            "suumary_chunk  8\n",
            "suumary_chunk  9\n",
            "suumary_chunk  10\n",
            "suumary_chunk  11\n",
            "suumary_chunk  12\n",
            "suumary_chunk  13\n",
            "suumary_chunk  14\n",
            "suumary_chunk  15\n",
            "suumary_chunk  0\n",
            "suumary_chunk  1\n",
            "suumary_chunk  2\n",
            "suumary_chunk  3\n",
            "suumary_chunk  4\n",
            "suumary_chunk  5\n",
            "-----------------------------------------\n",
            "res Polydactyly is a rare genetic disorder characterized by the presence of an extra finger or toe. It can be either non-syndromic or syndromic, depending on whether it is associated with other birth defects or medical conditions. The cause of non-syndromic polydactyly is often unknown, but it is thought to be related to genetic mutations or environmental factors. Treatment for non-syndromic polydactyly typically involves surgical removal of the extra digit or digits. This can be done at any age, but is often performed in infancy to prevent complications such as joint deformities or impaired movement. In some cases, physical therapy may be recommended to improve function and mobility. The prognosis for individuals with non-syndromic polydactyly is generally good, and most individuals can live normal, healthy lives with proper treatment and management of any associated complications. However, it is important for individuals with this condition to receive regular medical care and monitoring to ensure the best possible outcome.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "-----------------------------------------\n",
            "res <b><i>Objective:</i></b>\n",
            "\n",
            "The objective of this study is to explore the genetic basis of non-syndromic polydactyly in a Chinese family.\n",
            "\n",
            "\n",
            "<b><i>Methods:</i></b>\n",
            "\n",
            "Whole-exome sequencing was performed on the proband and her parents to identify pathogenic variants.\n",
            "\n",
            "\n",
            "Sanger sequencing was used to validate the identified variants.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding genes was predicted using bioinformatic tools.\n",
            "\n",
            "\n",
            "The penetrance and expressivity of the identified variants were assessed by analyzing the phenotypic features of the proband and her relatives.\n",
            "\n",
            "\n",
            "The inheritance pattern of the identified variants was determined by analyzing the segregation of the variants in the family.\n",
            "\n",
            "\n",
            "The frequency of the identified variants in the general population was assessed using publicly available databases.\n",
            "\n",
            "\n",
            "The effect of the identified variants on the function of the corresponding\n",
            "-----------------------------------------\n",
            "dic {}\n",
            "-----------------------------------------\n",
            "repetiton 2\n",
            "-----------------------------------------\n",
            "res <b><i>Objective:</i></b>\n",
            "\n",
            "To investigate the genetic causes of non-syndromic polydactyly in a Chinese family.\n",
            "\n",
            "\n",
            "<b><i>Methods:</i></b>\n",
            "\n",
            "\n",
            "Whole exome sequencing was performed on the affected individual and her unaffected parents.\n",
            "\n",
            "\n",
            "The identified variants were filtered and prioritized based on their pathogenicity.\n",
            "\n",
            "\n",
            "The identified variants were then validated using Sanger sequencing.\n",
            "\n",
            "\n",
            "<b><i>Results:</i></b>\n",
            "\n",
            "\n",
            "A novel heterozygous frameshift variant was identified in the GLI3 gene.\n",
            "\n",
            "\n",
            "The variant was predicted to cause a premature stop codon, leading to a truncated protein.\n",
            "\n",
            "\n",
            "The variant was confirmed in the affected individual and was not present in either of her unaffected parents.\n",
            "\n",
            "\n",
            "<b><i>Conclusion:</i></b>\n",
            "\n",
            "\n",
            "The novel heterozygous frameshift variant in the GLI3 gene is likely to be pathogenic and is the cause of non-syndromic polydactyly in this Chinese family.\n",
            "\n",
            "\n",
            "<b><i>Impact:</i></b>\n",
            "\n",
            "\n",
            "This study provides new insights into the genetic causes of non-syndromic polydactyly.\n",
            "\n",
            "\n",
            "The identification of the GLI3 gene as a cause of non-syndromic polydactyly in this Chinese family is important for the diagnosis and genetic counseling of families with this condition.\n",
            "\n",
            "\n",
            "This study also highlights the importance of whole exome sequencing in the identification of the genetic causes of rare diseases.\n",
            "\n",
            "\n",
            "<b><i>Recommendations:</i></b>\n",
            "\n",
            "\n",
            "The findings of this study suggest that genetic testing for the GLI3 gene should be considered for individuals with non-syndromic polydactyly.\n",
            "\n",
            "\n",
            "The use of whole exome sequencing in the identification of the genetic causes of rare diseases should be encouraged.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {}\n",
            "-----------------------------------------\n",
            "repetiton 3\n",
            "-----------------------------------------\n",
            "res In the context of non-syndromic polydactyly, the following research expertise areas could be identified:\n",
            "\n",
            "1. Genetic Basis of Non-Syndromic Polydactyly: Research on the genetic basis of non-syndromic polydactyly involves identifying and characterizing the genes and genetic mutations responsible for the condition. This includes studies on the inheritance patterns and the genetic factors that contribute to the development of polydactyly in individuals without any other associated symptoms.\n",
            "\n",
            "2. Clinical Features and Diagnosis of Non-Syndromic Polydactyly: Research on the clinical features and diagnosis of non-syndromic polydactyly involves studying the symptoms, physical characteristics, and diagnostic methods used to identify the condition. This includes research on the prevalence, incidence, and demographics of individuals with non-syndromic polydactyly.\n",
            "\n",
            "3. Epidemiology of Non-Syndromic Polydactyly: Research on the epidemiology of non-syndromic polydactyly involves studying the distribution and frequency of the condition in different populations. This includes research on the environmental and genetic risk factors that may contribute to the development of polydactyly, as well as the impact of genetic counseling and screening for the condition.\n",
            "\n",
            "4. Genetic Counseling and Screening for Non-Syndromic Polydactyly: Research on genetic counseling and screening for non-syndromic polydactyly involves developing and implementing strategies to provide individuals and families with information and support related to the condition. This includes research on the benefits and limitations of genetic counseling and screening, as well as the impact of these services on the health and well-being of individuals with non-syndromic polydactyly.\n",
            "\n",
            "5. Treatment and Management of Non-Syndromic Polydactyly: Research on the treatment and management of non-syndromic polydactyly involves studying the surgical and non-surgical approaches used to treat the condition. This includes research on the effectiveness and safety of different treatment options, as well as the impact of treatment on the long-term health and well-being of individuals with non-syndromic polydactyly.\n",
            "\n",
            "6. Quality of Life and Psychosocial Aspects of Non-Syndromic Polydactyly: Research on the quality of life and psychosocial aspects of non-syndromic polydactyly involves studying the impact of the condition on the emotional, social, and psychological well-being of individuals. This includes research on the stigma and discrimination faced by individuals with non-syndromic polydactyly, as well as the impact of support groups and other resources on the well-being of individuals with the condition.\n",
            "\n",
            "7. Ethical and Legal Issues in Non-Syndromic Polydactyly: Research on the ethical and legal issues in non-syndromic polydactyly involves studying the legal and ethical implications of genetic testing and counseling, as well as the rights and responsibilities of individuals with the condition. This includes research on the legal protections for individuals with non-syndromic polydactyly, as well as the ethical considerations in the use of genetic information in medical and legal contexts.\n",
            "\n",
            "8. Future Directions in Non-Syndromic Polydactyly Research: Research on future directions in non-syndromic polydactyly research involves studying the emerging trends and technologies in the field, as well as the potential for new discoveries and breakthroughs in understanding and treating the condition. This includes research on the potential for new diagnostic and treatment options, as well as the impact of new genetic and genomic technologies on the study and management of non-syndromic polydactyly.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'Genetic Basis of Non-Syndromic Polydactyly': 'Research on the genetic basis of non-syndromic polydactyly involves identifying and characterizing the genes and genetic mutations responsible for the condition. This includes studies on the inheritance patterns and the genetic factors that contribute to the development of polydactyly in individuals without any other associated symptoms.', 'Clinical Features and Diagnosis of Non-Syndromic Polydactyly': 'Research on the clinical features and diagnosis of non-syndromic polydactyly involves studying the symptoms, physical characteristics, and diagnostic methods used to identify the condition. This includes research on the prevalence, incidence, and demographics of individuals with non-syndromic polydactyly.', 'Epidemiology of Non-Syndromic Polydactyly': 'Research on the epidemiology of non-syndromic polydactyly involves studying the distribution and frequency of the condition in different populations. This includes research on the environmental and genetic risk factors that may contribute to the development of polydactyly, as well as the impact of genetic counseling and screening for the condition.', 'Genetic Counseling and Screening for Non-Syndromic Polydactyly': 'Research on genetic counseling and screening for non-syndromic polydactyly involves developing and implementing strategies to provide individuals and families with information and support related to the condition. This includes research on the benefits and limitations of genetic counseling and screening, as well as the impact of these services on the health and well-being of individuals with non-syndromic polydactyly.', 'Treatment and Management of Non-Syndromic Polydactyly': 'Research on the treatment and management of non-syndromic polydactyly involves studying the surgical and non-surgical approaches used to treat the condition. This includes research on the effectiveness and safety of different treatment options, as well as the impact of treatment on the long-term health and well-being of individuals with non-syndromic polydactyly.', 'Quality of Life and Psychosocial Aspects of Non-Syndromic Polydactyly': 'Research on the quality of life and psychosocial aspects of non-syndromic polydactyly involves studying the impact of the condition on the emotional, social, and psychological well-being of individuals. This includes research on the stigma and discrimination faced by individuals with non-syndromic polydactyly, as well as the impact of support groups and other resources on the well-being of individuals with the condition.', 'Ethical and Legal Issues in Non-Syndromic Polydactyly': 'Research on the ethical and legal issues in non-syndromic polydactyly involves studying the legal and ethical implications of genetic testing and counseling, as well as the rights and responsibilities of individuals with the condition. This includes research on the legal protections for individuals with non-syndromic polydactyly, as well as the ethical considerations in the use of genetic information in medical and legal contexts.', 'Future Directions in Non-Syndromic Polydactyly Research': 'Research on future directions in non-syndromic polydactyly research involves studying the emerging trends and technologies in the field, as well as the potential for new discoveries and breakthroughs in understanding and treating the condition. This includes research on the potential for new diagnostic and treatment options, as well as the impact of new genetic and genomic technologies on the study and management of non-syndromic polydactyly.'}\n",
            "-----------------------------------------\n",
            "repetiton 4\n",
            "{'Genetic Basis of Non-Syndromic Polydactyly': 'Research on the genetic basis of non-syndromic polydactyly involves identifying and characterizing the genes and genetic mutations responsible for the condition. This includes studies on the inheritance patterns and the genetic factors that contribute to the development of polydactyly in individuals without any other associated symptoms.', 'Clinical Features and Diagnosis of Non-Syndromic Polydactyly': 'Research on the clinical features and diagnosis of non-syndromic polydactyly involves studying the symptoms, physical characteristics, and diagnostic methods used to identify the condition. This includes research on the prevalence, incidence, and demographics of individuals with non-syndromic polydactyly.', 'Epidemiology of Non-Syndromic Polydactyly': 'Research on the epidemiology of non-syndromic polydactyly involves studying the distribution and frequency of the condition in different populations. This includes research on the environmental and genetic risk factors that may contribute to the development of polydactyly, as well as the impact of genetic counseling and screening for the condition.', 'Genetic Counseling and Screening for Non-Syndromic Polydactyly': 'Research on genetic counseling and screening for non-syndromic polydactyly involves developing and implementing strategies to provide individuals and families with information and support related to the condition. This includes research on the benefits and limitations of genetic counseling and screening, as well as the impact of these services on the health and well-being of individuals with non-syndromic polydactyly.', 'Treatment and Management of Non-Syndromic Polydactyly': 'Research on the treatment and management of non-syndromic polydactyly involves studying the surgical and non-surgical approaches used to treat the condition. This includes research on the effectiveness and safety of different treatment options, as well as the impact of treatment on the long-term health and well-being of individuals with non-syndromic polydactyly.', 'Quality of Life and Psychosocial Aspects of Non-Syndromic Polydactyly': 'Research on the quality of life and psychosocial aspects of non-syndromic polydactyly involves studying the impact of the condition on the emotional, social, and psychological well-being of individuals. This includes research on the stigma and discrimination faced by individuals with non-syndromic polydactyly, as well as the impact of support groups and other resources on the well-being of individuals with the condition.', 'Ethical and Legal Issues in Non-Syndromic Polydactyly': 'Research on the ethical and legal issues in non-syndromic polydactyly involves studying the legal and ethical implications of genetic testing and counseling, as well as the rights and responsibilities of individuals with the condition. This includes research on the legal protections for individuals with non-syndromic polydactyly, as well as the ethical considerations in the use of genetic information in medical and legal contexts.', 'Future Directions in Non-Syndromic Polydactyly Research': 'Research on future directions in non-syndromic polydactyly research involves studying the emerging trends and technologies in the field, as well as the potential for new discoveries and breakthroughs in understanding and treating the condition. This includes research on the potential for new diagnostic and treatment options, as well as the impact of new genetic and genomic technologies on the study and management of non-syndromic polydactyly.'}\n",
            "2\n",
            "-----------------------------------------\n",
            "res The research group has made significant contributions to the understanding of preaxial polydactyly (PPD), specifically by identifying point variants and copy number variations (CNVs) in the ZRS and preZRS regions. Their findings have expanded the variant spectrum associated with non-syndromic polydactyly and have highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism. This research has implications for genetic screening for limb developmental defects, promoting healthy births. The specific expertise areas that emerge from their work include:\n",
            "\n",
            "1. **Genetic Variations in ZRS and PreZRS Regions:** The researchers have extensively studied the genetic variations in the ZRS and preZRS regions, identifying both point variants and CNVs. Their findings have expanded the variant spectrum associated with non-syndromic polydactyly and have highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism.\n",
            "\n",
            "2. **Clinical Examination and Genetic Analysis:** The research group has conducted detailed clinical examinations and Sanger sequencing of the ZRS and preZRS regions in 102 patients with PPD. Their comprehensive genetic analyses have contributed to a better understanding of the genetic basis of PPD.\n",
            "\n",
            "3. **Real-Time Quantitative PCR (qPCR) for CNV Detection:** The researchers have used qPCR to detect CNVs in the ZRS region, which has helped to identify duplications in a significant portion of patients with PPD. This method has enhanced the accuracy of genetic screening for limb developmental defects.\n",
            "\n",
            "4. **Evolutionary Conservation and Population Frequencies:** The research group has evaluated the evolutionary conservation and population frequencies of identified variants. This analysis has provided insights into the potential impact of these variants on the development of PPD and has contributed to the understanding of the genetic basis of limb developmental defects.\n",
            "\n",
            "Overall, the research group has made significant contributions to the field of genetic research in limb developmental defects, specifically in the understanding of preaxial polydactyly. Their work has expanded the variant spectrum associated with non-syndromic polydactyly and has highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism. Their findings have implications for genetic screening for limb developmental defects, promoting healthy births.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'**Genetic Variations in ZRS and PreZRS Regions': '** The researchers have extensively studied the genetic variations in the ZRS and preZRS regions, identifying both point variants and CNVs. Their findings have expanded the variant spectrum associated with non-syndromic polydactyly and have highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism.', '**Clinical Examination and Genetic Analysis': '** The research group has conducted detailed clinical examinations and Sanger sequencing of the ZRS and preZRS regions in 102 patients with PPD. Their comprehensive genetic analyses have contributed to a better understanding of the genetic basis of PPD.', '**Real-Time Quantitative PCR (qPCR) for CNV Detection': '** The researchers have used qPCR to detect CNVs in the ZRS region, which has helped to identify duplications in a significant portion of patients with PPD. This method has enhanced the accuracy of genetic screening for limb developmental defects.', '**Evolutionary Conservation and Population Frequencies': '** The research group has evaluated the evolutionary conservation and population frequencies of identified variants. This analysis has provided insights into the potential impact of these variants on the development of PPD and has contributed to the understanding of the genetic basis of limb developmental defects.\\n\\nOverall, the research group has made significant contributions to the field of genetic research in limb developmental defects, specifically in the understanding of preaxial polydactyly. Their work has expanded the variant spectrum associated with non-syndromic polydactyly and has highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism. Their findings have implications for genetic screening for limb developmental defects, promoting healthy births.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'**Genetic Variations in ZRS and PreZRS Regions': '** The researchers have extensively studied the genetic variations in the ZRS and preZRS regions, identifying both point variants and CNVs. Their findings have expanded the variant spectrum associated with non-syndromic polydactyly and have highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism.', '**Clinical Examination and Genetic Analysis': '** The research group has conducted detailed clinical examinations and Sanger sequencing of the ZRS and preZRS regions in 102 patients with PPD. Their comprehensive genetic analyses have contributed to a better understanding of the genetic basis of PPD.', '**Real-Time Quantitative PCR (qPCR) for CNV Detection': '** The researchers have used qPCR to detect CNVs in the ZRS region, which has helped to identify duplications in a significant portion of patients with PPD. This method has enhanced the accuracy of genetic screening for limb developmental defects.', '**Evolutionary Conservation and Population Frequencies': '** The research group has evaluated the evolutionary conservation and population frequencies of identified variants. This analysis has provided insights into the potential impact of these variants on the development of PPD and has contributed to the understanding of the genetic basis of limb developmental defects.\\n\\nOverall, the research group has made significant contributions to the field of genetic research in limb developmental defects, specifically in the understanding of preaxial polydactyly. Their work has expanded the variant spectrum associated with non-syndromic polydactyly and has highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism. Their findings have implications for genetic screening for limb developmental defects, promoting healthy births.'}\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 3,\n  \"fields\": [\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 1,\n        \"min\": -1,\n        \"max\": 1,\n        \"num_unique_values\": 3,\n        \"samples\": [\n          -1,\n          0,\n          1\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \" ,  <b>Introduction:</b> For infants with ulnar polydactyly, surgical removal of the supernumerary digit can be performed under general or local anesthetic. This study evaluated the wait times, surgical duration, and sedation times associated with performing the procedure under local versus general anesthetic in infants with ulnar polydactyly. <b>Methods:</b> The databases of three surgeons at our institution were reviewed for children less than 2 years of age who underwent surgery for non-syndromic ulnar polydactyly. Data collection included patient demographics, wait times, duration of surgery and sedation and complications. <b>Results:</b> The study included children (n\\u2009\\u2009=\\u2009\\u200955) who received treatment under local (n\\u2009\\u2009=\\u2009\\u200922) or general (n\\u2009\\u2009=\\u2009\\u200933) anesthesia. The wait times for the local anesthetic group were significantly shorter than the general anesthetic group (p\\u2009<\\u20090.05) for: referral to first consultation appointment; referral to surgery date, and decision date to surgery date. The duration of surgery (17.9\\u2009\\u2009\\u00b1\\u2009\\u20096.9 vs 36.6\\u2009\\u2009\\u00b1\\u2009\\u200920.2 min) and sedation time (26.3\\u2009\\u2009\\u00b1\\u2009\\u200911.1 vs 74.8\\u2009\\u2009\\u00b1\\u2009\\u200929.1 min) were significantly shorter in the local anaesthetic group (p\\u2009<\\u20090.05). There were no differences in complication rates between the groups. <b>Conclusion:</b> In this single-institution retrospective analysis, treatment of non-syndromic ulnar polydactyly with local anesthetic and bottle sedation was associated with shorter wait times, and duration of surgery and sedation. <b>Level of Evidence:</b> III, retrospective chart review and quality improvement initiative.,  Apert syndrome is an autosomal dominant disease characterized by craniosynostosis and bony syndactyly associated with point mutations (S252W and P253R) in the fibroblast growth factor receptor (FGFR) 2 that cause FGFR2 activation. Here we investigated the role of the S252W mutation of FGFR2 on osteoblastic differentiation. Osteoblastic cells derived from digital bone in two Apert patients with the S252W mutation showed more prominent alkaline phosphatase activity, osteocalcin and osteopontin mRNA expression, and mineralized nodule formation compared with the control osteoblastic cells derived from two independent non-syndromic polydactyly patients. Stable clones of the human MG63 osteosarcoma cells (MG63-Ap and MG63-IIIc) overexpressing a splice variant form of FGFR2 with or without the S252W mutation (FGFR2IIIcS252W and FGFR2IIIc) showed a higher RUNX2 mRNA expression than parental MG63 cells. Furthermore MG63-Ap exhibited a higher osteopontin mRNA expression than did MG63-IIIc. The enhanced osteoblastic marker gene expression and mineralized nodule formation of the MG63-Ap was inhibited by the conditioned medium from the COS-1 cells overexpressing the soluble FGFR2IIIcS252W. Furthermore the FGF2-induced osteogenic response in the mouse calvarial organ culture system was blocked by the soluble FGFR2IIIcS252W. These results show that the S252W mutation in the FGFR2 gene enhances the osteoblast phenotype in human osteoblasts and that a soluble FGFR2 with the S252W mutation controls osteoblast differentiation induced by the S252W mutation through a dominant negative effect on FGFR2 signaling in Apert syndrome.,  In 1978, Temtamy and McKusick classified isolated, non-syndromic polydactyly and syndactyly, using a logical anatomical approach, into five distinct types for each group. Since then, there have been considerable advances in the molecular embryology of the developing limb bud. These include the proposal that retinoic acid and/or related retinoids are the morphogens responsible for the morphogenetic gradient giving rise to anterior-posterior pattern formation of the limb bud, the suggestion that the HOX4 complex and other homeotic genes may also be involved in patterning, and a greater understanding of other mechanisms such as programmed cell death in the shaping of the final hand and foot. This paper briefly reviews the molecular embryology of limb development and outlines the 'end-organ responsiveness' of the limbs to a variety of single-gene mutations. An alternative classification of syndactylies and polydactylies is suggested. It is still too early to match specific defects to individual genes with precision, and it is obvious that many important developmental genes remain to be identified; nevertheless, it is envisaged that clues from molecular embryological studies will become increasingly more useful.,  Polydactyly is typically observed as isolated and sporadic occurrences, although familial cases do exist, albeit with lower frequency, manifesting in various inheritance patterns. In around 30% of polydactyly cases, there exists a familial history, suggesting the probable involvement of a single gene. Given its potential for hereditary transmission, thorough investigation of the patients' parents, first-degree relatives, grandparents, and even great-grandparents for similar disorders becomes imperative. In our clinic, we conducted an analysis focusing on patients presenting with foot polydactyly, along with occurrences of polydactyly among their first- and second-degree relatives spanning two to three generations of family history. The study encompassed three patients and their respective families, including a pair of siblings. We speculate that the inheritance type in our cases was autosomal dominant. Among our patients, one presented with central polydactyly, while the remaining patients and all familial cases displayed postaxial polydactyly. In terms of morphologic classification, one patient had a Y-shaped metatarsal, another had a T-shaped metatarsal, and the third patient exhibited a duplicated ray-shaped anomaly. In our review of the literature, we haven't come across a case spanning three generations like the ones we encountered. Additionally, the presence of a transverse accessory extensor tendon between both extensor tendons in cases with T- and Y-shaped metatarsals intrigued us from an anatomical perspective. Our goal is to present these rare cases of congenital familial polydactyly spanning three generations, highlighting the anatomical variations observed and aiming to contribute to the existing body of literature on the subject.,  Postaxial polydactyly (PAP) is a common abnormality characterized by extra digits on hands and/or feet. To date, sequence variants in seven genes have been identified in non-syndromic PAP. In the present study, a fetus manifesting non-syndromic postaxial polydactyly type A (PAPA) was found by fetal ultrasonography. To better evaluate fetal prognosis, SNP array analysis and trio whole-exome sequencing (trio-WES) were performed to identify the underlying etiology. Although SNP array analysis revealed no abnormality, trio-WES identified compound heterozygous splice site variants in <i>KIAA0825</i>, c.-1-2A&gt;T and c.2247-2A&gt;G in intron 2 and intron 12, respectively. These two splice site variants were absent in control databases and were predicted to influence splicing by in silico analysis. To confirm the potential pathogenicity of the variants, in vitro splicing assays using minigene and RNA from peripheral leukocytes of the heterozygous parents were conducted. Minigene and RT-PCR assays demonstrated that the c.-1-2A&gt;T variant led to the loss of the initiation codon, and the c.2247-2A&gt;G variant mainly resulted in exon 13 skipping. Prenatal WES and subsequent functional studies are important approaches for defining the genetic etiology of fetuses with PAPA and are also essential for accurate genetic counseling and decision making. Taken together, this study expands the spectrum of <i>KIAA0825</i> variations in PAPA patients and increases the knowledge of the molecular consequences of <i>KIAA0825</i> splice site variants.,  The study of passage 2 Sam 21: 20-21 allows us to assert that the biblical writer registered a case of polydactyly, specifically a hexadactylia of the four limbs. The documental evidence certifies the presence of this orthopedic lesion in ancient times. It is probable that this was a case of post-axial, non crossed and non syndromic polydactyly.,  This case report examines a newborn with bilateral postaxial polydactyly type B, delivered by a 42-year-old mother with a history of third-degree consanguinity. The mother, having had no prior live births and one abortion, presented at 39 weeks gestation. The absence of prenatal care is noted, with its potential impact on prenatal diagnosis not assessed. The newborn, a healthy girl, weighed 3400 g with an Apgar score of 9/10. Radiographic and physical examination revealed vestigial sixth digits with rudimentary phalanges, influencing the surgical approach. This report underscores the importance of genetic counseling in cases of consanguinity and illustrates the multidisciplinary strategy necessary for managing polydactyly, from surgical considerations to genetic evaluation., Clonidine for Tourniquet-related Pain in Children: A Pilot Study This study is designed as a randomized, placebo-controlled, double-blinded, clinical trial with two parallel groups.\\n\\nThis study investigates the association between a single dose of the drug, Clonidine, and the total amount of opioid administered under and 24 hours after surgery in children undergoing orthopedic limb surgery with the use of tourniquet.\\n\\nThe investigators hypothesize that administration of clonidine to children undergoing limb surgery with the use of inflatable tourniquets would reduce post-procedural pain.\\n\\nThis study is a pilot to obtain an effect size. Based on this the investigators will calculate a sample size for the main trial enabling us to reach a power of 0.8 with a significans level of 0.05.\",\n          \" <b><i>Objective:</i></b> Polydactyly is characterized by multiple distinct heterogeneous phenotypes, the etiologies of which involve several genes. This study aimed to explore the genetic defects and further clarify the molecular mechanism of polydactyly in several Chinese families. <b><i>Methods:</i></b> Three families with diverse phenotypes of non-syndromic polydactyly were analyzed: two were cases of familial disease, whereas one was sporadic. PCR and Sanger sequencing were used to screen for pathogenic mutations in two known disease-associated genes, <i>GLI3</i> and <i>HOXD13</i>, while bioinformatic analyses predicted the pathogenicity of the identified variants. Reverse transcription PCR was used to analyze the splicing effect of an intronic variant. <b><i>Results:</i></b> Two novel heterozygous frameshift mutations (c.4478delG/p.S1493Tfs*18; c.846_c.847insC/p.R283Qfs*21) were identified in the <i>GLI3</i> gene from two of the pedigrees. Both c.4478delG and c.846_c.847insC were later confirmed in affected and unaffected members and normal controls, to truncate and disrupt the integrity of the <i>GLI3</i> protein, reduce its level of expression, and disrupt its biological function through nonsense-mediated mRNA decay (NMD). In addition, a deep intron mutation (c.125-47 C>A) was detected in the <i>GLI3</i> gene from the sporadic case, however, both bioinformatics analysis (HSF, splice AI, and CBS) and RT-PCR indicated that the variant c.125-47 C>A had minimal if any impact on splicing of the <i>GLI3</i> gene. <b><i>Conclusion:</i></b> Two newly identified heterozygous frameshift mutations in the <i>GLI3</i> gene were detected in two families with non-syndromic polydactyly, further extending the mutational spectrum of the <i>GLI3</i> gene in non-syndromic polydactyly. Moreover, our study further expanded the phenotypic spectrum of non-syndromic polydactyly.,  <h4>Background</h4>CREBBP has been extensively studied in syndromic diseases associated with skeletal dysplasia. However, there is limited research on the molecular mechanisms through which CREBBP may impact bone development. We identified a novel pathogenic CREBBP variant (c.C3862T/p.R1288W, which is orthologous to mouse c.3789\\u2009C\\u2009>\\u2009T/p.R1289W) in a patient with non-syndromic polydactyly.<h4>Methods</h4>We created a homozygous Crebbp p.R1289W mouse model and compared their skeletal phenotypes to wild-type (WT) animals. Bone marrow stem cells (BMSCs) were isolated and assessed for their proliferative capacity, proportion of apoptotic cells in culture, and differentiation to chondrocytes and osteocytes.<h4>Results</h4>We observed a significant decrease in body length in 8-week-old homozygous Crebbp p.R1289W mice. The relative length of cartilage of the digits of Crebbp p.R1289W mice was significantly increased compared to WT mice. BMSCs derived from Crebbp p.R1289W mice had significantly decreased cell proliferation and an elevated rate of apoptosis. Consistently, cell proliferative capacity was decreased and the proportion of apoptotic cells was increased in the distal femoral growth plate of Crebbp p.R1289W compared to WT mice. Chemical induction of BMSCs indicated that Crebbp p.R1289W may promote chondrocyte differentiation.<h4>Conclusion</h4>The Crebbp p.R1289W variant plays a pathogenic role in skeletal development in mice.<h4>Impact</h4>CREBBP has been extensively studied in syndromic diseases characterized by skeletal dysplasia. There is limited research regarding the molecular mechanism through which CREBBP may affect bone development. To our knowledge, we generated the first animal model of a novel Crebbp variant, which is predicted to be pathogenic for skeletal diseases. Certain pathogenic variants, such as Crebbp p.R1289W, can independently lead to variant-specific non-syndromic skeletal dysplasia.,  <h4>Background</h4>Polydactyly is a common congenital malformation characterized by the presence of supernumerary fingers or toes. In this case study, we sought to identify the causative pathogenic factor in a family from a northern region of China affected by non-syndromic postaxial polydactyly (PAP).<h4>Methods</h4>After recruiting a three-generation family with PAP, whole-exome sequencing was performed to identify the causative variant. In silico analysis and Sanger sequencing were used to validate the variant.<h4>Results</h4>We identified a novel heterozygous frameshift variant (NM_000168.6:c.4540delG, p.Asp1514Thrfs*5) in the transcriptional activator (TA1) domain of the GLI3 gene.<h4>Conclusion</h4>The novel frameshift variant identified in this study further confirms the relationship between non-syndromic PAP and GLI3 and extends the previously established mutational and phenotypic spectra of GLI3.,  <h4>Background</h4>Polydactyly is a highly common congenital limb defect. Extra digits may appear as an isolated anomaly or as a part of a syndrome. Mutations in GLI3 have been shown to cause Greig cephalopolysyndactyly, Pallister-Hall syndrome and non-syndromic polydactyly. Genotype-phenotype correlation studies of GLI3 mutations suggest a model by which mutations in the zinc-finger domain (ZFD) of GLI3 likely lead to syndromic polydactyly. Here we describe a rare case of autosomal dominant heterozygous missense mutation in the ZFD of GLI3 leading to a variable polydactyly-syndactyly complex.<h4>Case presentation</h4>A large Jewish Moroccan family presented with apparently autosomal dominant heredity of bilateral thumb polydactyly in hands and feet combined with post-axial polydactyly type B or type A. Syndactyly was evident in most patients' hands and feet. Apart from head circumference beyond 90th percentile in some of the affected individuals, none had craniofacial dysmorphism. A novel GLI3 c.1802A >\\u2009G (p.His601Arg) mutation was found in all affected individuals.<h4>Conclusion</h4>We demonstrate that a mutation in the ZFD domain of GLI3 leads to phenotypic variability, including an isolated limb phenotype. Thus, the variability in phenotypes caused by mutations in this master developmental regulator is more profound than has been previously suggested.,  <h4>Background</h4>Polydactyly is one of the most common congenital limb abnormalities. Our objective was to identify the genetic causes of non-syndromic polydactyly in 78 Chinese children.<h4>Materials and methods</h4>Genomic DNA was isolated from 78 independent nonsyndromic polydactyly patients, of whom 71 had preaxial polydactyly (PPD), six had postaxial polydactyly (PAP), and one showed combined PPD1 and PAP-A/B. The coding areas and exon/intron boundaries of the GLI3 and SHH genes and the genomic region of SHH ZRS were amplified by polymerase chain reaction and sequenced.<h4>Results</h4>The patient with combined PPD1 and PAP-A/B (subject DUO36) exhibited a heterozygous nonsense mutation in chr7: 42004164G>A (ENST00000395925, c.4507C>T, p.Gln1503Stop ) of the GLI3 gene that has not been previously recorded. We did not detect any mutations in GLI3, SHH, or SHH ZRS in the other 77 nonsyndromic polydactyly patients.<h4>Conclusion</h4>The novel mutation in GLI3 c.4507C>T is likely one of the causes of the PAP and PPD1 of subject DUO36. This important finding should facilitate the optimization of genetic testing for nonsyndromic polydactyly.,  <h4>Introduction</h4>Non-syndromic polydactyly has been associated with pathogenic variants in 11 genes until today, including <i>IQCE</i> gene. More precisely, loss-of-function of <i>IQCE</i> is associated with the autosomal recessive disorder postaxial polydactyly type A7 (PAPA7, MIM #617642).<h4>Case presentation</h4>A 3-year-old female patient was referred to our genetics department with postaxial polydactyly, syndactyly, brachydactyly, and hypoplastic teeth. Through whole-exome sequencing (WES), a pathogenic <i>IQCE</i> variant was identified (c.895_904del) in the homozygous state, which adequately explained the disease phenotype of our patient. However, copy number variant (CNV) analysis from WES data, using ExomeDepth, revealed a novel, likely pathogenic large deletion involving <i>IQCE</i> genomic regions (DEL:chr7:2606751_2641098) encompassing exons 2-18 of the gene.<h4>Conclusion</h4><i>IQCE</i> gene codes for a 695-amino acid protein located at the base of the primary cilia that positively regulates the Hedgehog signaling pathway. This case report represents the first description of a large deletion in <i>IQCE</i> and indicates that implementation of ExomeDepth in routine WES analysis can contribute valuable information toward elucidating the correct etiology of rare genetic diseases, increasing the diagnostic yield, and minimizing the need for additional tests.,  <h4>Objective</h4>This study collects what is known about the inheritance underpinnings of syndromic and non-syndromic polydactylies and highlights dactyly presentations with unknown genetic roots. This review summarizes the current information and genetics-enhanced understanding of polydactyly.<h4>Background</h4>There is a frequency of 0.37 to 1.2 per 1000 live births for polydactyly, which is also known as hyperdactyly. It is characterized by the presence of extra fingers. Polydactyly is caused by a failure in limb development, specifically the patterning of the developing limb bud. The phenotypic and genetic variability of polydactyly makes its etiology difficult to understand. Pre-axial polydactyly, central polydactyly (axial), and postaxial polydactyly are all examples of non-syndromic polydactyly (ulnar). An autosomal dominant disorder with varying penetrance that is mostly passed down via limb development patterning abnormalities.<h4>Method</h4>A comprehensive search of MEDLINE/PubMed and other databases was followed by an evaluation of the relevant papers, with a particular focus on those published between 2000 and 2022.<h4>Results</h4>Of 747 published article related to Polydactyly from MEDLINE/PubMed search, 43 were from the last 10 years and were the focus of this review.<h4>Conclusion</h4>Polydactyly is one of the most frequent congenital hand malformations. PAP is more common than PPD, whereas central polydactyly is very uncommon.,  <h4>Objectives</h4>Polydactyly has been described in two breeds of domestic cats (Maine Coon and Pixie Bob) and in some outbred domestic cats (eg, Hemingway cats). In most cases, feline polydactyly is a non-syndromic preaxial polydactyly. Three variants located in a regulatory sequence involved in limb development, named ZRS (zone of polarising activity regulatory sequence), have been identified to be responsible for feline polydactyly. These variants have been found in outbred domestic cats in the UK (<i>UK1</i> and <i>UK2</i> variants) and in Hemingway cats in the USA (<i>Hw</i> variant). The aim of this study was to characterise the genetic features of polydactyly in Maine Coon cats.<h4>Methods</h4>Genotyping assay was used to identify the variant(s) segregating in a cohort of 75 polydactyl and non-polydactyl Maine Coon cats from different breeding lines from Europe, Canada and the USA. The authors performed a segregation analysis to identify the inheritance pattern of polydactyly in this cohort and analysed the population structure.<h4>Results</h4>The <i>Hw</i> allele was identified in a subset of polydactyl cats. Sequencing of two regulatory sequences involved in limb development did not reveal any other variant in polydactyl cats lacking the <i>Hw</i> allele. Additionally, genotype-phenotype and segregation analyses revealed the peculiar inheritance pattern of polydactyly in Maine Coon cats. The population structure analysis demonstrated a genetic distinction between <i>Hw</i> and <i>Hw</i>-free polydactyl cats.<h4>Conclusions and relevance</h4>Polydactyly in Maine Coon cats is inherited as an autosomal dominant trait with incomplete penetrance and variable expressivity, and this trait is characterised by genetic heterogeneity in the Maine Coon breed. Maine Coon breeders should be aware of this situation and adapt their breeding practices accordingly.,  Acrocallosal syndrome is characterized by postaxial polydactyly, macrocephaly, agenesis of the corpus callosum, and severe developmental delay. In a few patients with this disorder, a mutation in the KIF7 gene has been reported, which was associated with impaired GLI3 processing and dysregulaton of GLI3 transcription factors. A single patient with acrocallosal syndrome and a de novo p.Ala934Pro mutation in GLI3 has been reported, whereas diverse and numerous GLI3 mutations have also been described in syndromes with overlapping clinical manifestations, including Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, trigonocephaly with craniosynostosis and polydactyly, oral-facial-digital syndrome, and non-syndromic polydactyly. Here, we describe a second patient with acrocallosal syndrome, who has a de novo, novel c.2786T>C mutation in GLI3, which predicts p.Leu929Pro. This mutation is in the same domain as the mutation in the previously reported patient. These data confirm that mutations in GLI3 are a cause of the acrocallosal phenotype.,  Human GLI3 gene mutations have been identified in several phenotypes of digital abnormality such as Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type-IV (PPD-IV) and postaxial polydactyly. However, the different phenotypes resulting from GLI3 mutations have not yet been properly defined. We have experienced two types of digital abnormality without other complicating developmental defects; a family with foot PPD-IV with syndactyly of the third and fourth fingers, and four sporadic cases with biphalangeal thumb polydactyly (PPD-I). The genes responsible for syndactyly of the third and fourth fingers (syndactyly type-I) and PPD-I have not yet been identified; we therefore examined the involvement of the GLI3 gene in these subtypes of digital abnormality. We found a non-sense mutation in the GLI3 gene in the family with foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers, but no mutations were detected in the GLI3 gene in the four other cases with PPD-I alone. Thus, the phenotype of foot PPD-IV accompanied with hand syndactyly of the third and fourth fingers may result from a GLI3 mutation, whereas the PPD-I phenotype alone is not caused by GLI3 gene defect. These results will help to define the phenotypic spectrum of GLI3 morphopathies, which have been recently proposed.,  Polydactyly consists of poly that means many and dactylos, which means digits. Polydactyly, also known as hyperdactyly, is the most common congenital anomaly of hand and foot. It is characterized by an extra finger or toe that may results from defective development during anterior-posterior patterning of developing limb. It may appear in isolation (non-syndromic polydactyly) or associated with other birth defects as a part of a syndrome (syndromic polydactyly). Because\\u00a0it can be part of a syndrome, the clinician should be prepared to evaluate the newborn baby with polydactyly and consider the other syndromic presentations that may be associated with this anomaly. There is an increased tendency of polydactyly to involve the right hand rather than the left hand,\\u00a0the upper limb rather than the lower limb, and the left foot rather than the right.[1][2],  Polydactyly is a common congenital limb deformity. This anomaly may occur in isolation (non-syndromic) or as part of a syndrome. The glioma-associated oncogene family zinc finger 3 (GLI3) is known to be associated with both syndromic and non-syndromic polydactyly. GLI3 plays a predominant role in the pathogenesis of syndromic polydactyly: mutations have been identified in 68% of patients with Greig cephalopolysyndactyly syndrome and 91% of patients with Pallister-Hall syndrome. The knowledge regarding the contribution of GLI3 in non-syndromic polydactyly is currently very limited. In this study, we assembled a cohort of individuals of Chinese ethnicity with non-syndromic postaxial polydactyly. We presented the clinical features and molecular evaluations of 19 probands. GLI3 mutations were identified in 15.8% of probands (3/19) including two novel frame-shift mutations c.3855dupC (p.Met1286HisfsTer18) and c.4141delA (p.Arg1381GlyfsTer38) detected in sporadic cases and one previously reported nonsense mutation (c.1927C>T/p.Arg643Ter) in a familial case. Of note, GLI3 mutations were exclusively detected in patients with bilateral polydactyly affecting both hands and feet. Three out of five (60%) probands with bilateral polydactyly on both hands and feet carried pathogenic mutations in GLI3. Our study demonstrated the role of GLI3 in a significant fraction of patients with non-syndromic bilateral polydactyly affecting both hands and feet.,  Polydactyly is a common occurrence, observed as the presence of extra digit/s in the hands and feet. It can be categorized into preaxial, postaxial, and mesoaxial forms based on the location of the additional digit. In most instances only a single extra digit is present, research reports with more than one extra digit have been published. Most common management includes surgical excision under the influence of general anesthesia. An alternative approach by removing the pre-axial and post-axial supernumerary digit is carried out under local anesthesia in infants and small children, providing the additional benefit of fewer post-procedural complications. This is a case of a 5-month-old male child, with post-axial polydactyly of the left hand. He was managed by excision of the extra digit under the influence of local anesthesia. The patient recovered well and was discharged 3 days after the procedure with the advice of monthly follow-up until 3 months.,  Polydactyly is a human inherited disorder caused by to anomalies in the genes involved in autopod development. The disorder segregates in both autosomal recessive and autosomal dominant form. Up till now, eleven genes causing non-syndromic polydactyly, have been identified. This includes ZNF141, GLI3, ZRS in LMBR1, MIPOL1, PITX1, IQCE, GLI1, FMA92A1, KIAA0825, STKLD1, and DACH1. In the present study, we have investigated a large consanguineous family of Pakistani origin segregating polydactyly in autosomal recessive pattern. Clinical examination of affected individuals revealed a non-syndromic form of the disorder. Genetic study based on homozygosity mapping and Sanger sequencing using DNA of the normal and affected individuals found a novel homozygous missense sequence variant [NM_005269.3: c.1133C\\u00a0>\\u00a0T, p.(Ser378Leu)] in the GLI1 located on human chromosome 12q13.3. In silico analysis of the identified variant showed a significant change in the secondary structure of the mutant protein that affects its function. Findings of the present study expand the mutation spectrum of the GLI1. In addition, the study will help in prevention of the disorder through carrier testing and bringing awareness among families affected with polydactyly.,  Polydactyly is a malformation during the development of the human limb, which is characterized by the presence of more than the normal number of fingers or toes. It is considered to be one of the most common inherited hand disorders. It can be divided into two major groups: Non-syndromic polydactyly or syndromic polydactyly. According to the anatomical location of the duplicated digits, polydactyly can be generally subdivided into pre-, post-axial, and mesoaxial forms. Non-syndromic polydactyly is often inherited with an autosomal dominant trait and defects during the procedure of anterior-posterior patterning of limb development are incriminated for the final phenotype of the malformation. There are several forms of polydactyly, including hand and foot extra digit manifestations. The deformity affects upper limbs with a higher frequency than the lower, and the left foot is more often involved than the right. The treatment is always surgical. Since the clinical presentation is highly diverse, the treatment combines single or multiple surgical operations, depending on the type of polydactyly. The research attention that congenital limb deformities have recently attracted has resulted in broadening the list of isolated gene mutations associated with the disorders. Next generation sequencing technologies have contributed to the correlation of phenotype and genetic profile of the multiple polydactyly manifestations and have helped in early diagnosis and screening of most non-syndromic and syndromic disorders.,  Polydactyly is a very common digit anomaly, having extra digits in hands and/or toes. Non-syndromic polydactyly in both autosomal dominant and autosomal recessive forms are caused by disease-causing variants in several genes, including GLI1, GLI3, ZNF141, FAM92A, IQCE, KIAA0825, MIPOL1, STKLD1, PITX1, and DACH1. Whole exome sequencing (WES) followed by bi-directional Sanger sequencing was performed for the single affected individual (II-1) of the family to reveal the disease causative variant/gene. 3D protein modeling and structural molecular docking was performed to determine the effect of the identified mutation on the overall protein structure. WES revealed a novel biallelic missense variant (c.472G>C; p.Ala158Pro) in exon 6 of the FAM92A gene. The identified variant segregated perfectly with the disease phenotype using Sanger sequencing. Furthermore, Insilco analysis revealed that the variant significantly changes the protein secondary structure, and substantially impact the stability of FAM92A. We report the second FAM92A disease-causing mutation associated with recessive non-syndromic postaxial polydactyly. The data further confirms the contribution of FAM92A in limb development and patterning.,  Polydactyly is one of the most common inherited limb abnormalities, characterised by supernumerary fingers or toes. It results from disturbances in the normal programme of the anterior-posterior axis of the developing limb, with diverse aetiology and variable inter- and intra-familial clinical features. Polydactyly can occur as an isolated disorder (non-syndromic polydactyly) or as a part of an anomaly syndrome (syndromic polydactyly). On the basis of the anatomic location of the duplicated digits, non-syndromic polydactyly is divided into three kinds, including preaxial polydactyly, axial polydactyly and postaxial polydactyly. Non-syndromic polydactyly frequently exhibits an autosomal dominant inheritance with variable penetrance. To date, in human, at least ten loci and four disease-causing genes, including the GLI3 gene, the ZNF141 gene, the MIPOL1 gene and the PITX1 gene, have been identified. In this paper, we review clinical features of non-syndromic polydactyly and summarise the recent progress in the molecular genetics, including loci and genes that are responsible for the disorder, the signalling pathways that these genetic factors are involved in, as well as animal models of the disorder. These progresses will improve our understanding of the complex disorder and have implications on genetic counselling such as prenatal diagnosis.,  Polydactyly or polydactylism, also known as a hyperdactyly, is a congenital limb defect with various morphologic phenotypes. Apart from physical and functional impairments, the presence of polydactyly is an indication of an underlying syndrome in the newborn. Usually, it follows as an autosomal dominant/recessive inheritance pattern with defects in the limb development's anteroposterior patterning. Although mutations in several genes have been associated with polydactyly; however, the exact underlying cause, pathways, and disease mechanisms are still unexplored, thus making it of multi-factorial origin. Polydactyly is divided into three subtypes; radial, ulnar, and central polydactyly. So far, 11 loci (PAPA1-PAPA11) and seven human genes have been reported to cause non-syndromic postaxial polydactyly in humans, including the ZNF141, GLI3, IQCE, GLI1, FAM92A1, KIAA0825, and DACH1. In this review, we discuss emerging evidences of clinical and molecular characterization of polydactyly types in term of the involvement of newly associated genes and loci for non-syndromic postaxial polydactyly, and how these might impact our understanding of the genetic mechanisms and molecular etiology involved in the cause of polydactyly.,  Polydactyly, also known as <i>hyperdactyly</i> or <i>hexadactyly</i> is the most common hereditary limb anomaly characterized by extra fingers or toes, with various associated morphologic phenotypes as part of a syndrome (syndromic polydactyly) or may occur as a separate event (non-syndromic polydactyly). Broadly, the non-syndromic polydactyly has been classified into three types, i.e.; preaxial polydactyly (radial), central polydactyly (axial), and postaxial polydactyly (ulnar). Mostly inherited as an autosomal dominant entity with variable penetrance and caused by defects that occur in the anterior-posterior patterning of limb development. In humans, to-date at least 10 loci and six genes causing non-syndromic polydactyly have been identified, including the <i>ZNF141</i>, <i>GLI3</i>, <i>MIPOL1</i>, <i>IQCE</i>, <i>PITX1</i>, and the <i>GLI1</i>. In the present review, clinical, genetic and molecular characterization of the polydactyly types has been presented including the recent genes and loci identified for non-syndromic polydactyly. This review provides an overview of the complex genetic mechanism underlie polydactyly and might help in genetic counseling and quick molecular diagnosis.,  The GLI3 protein is a zinc finger transcription factor, expressed early in development. The GLI3 gene exhibits allelic heterogeneity as mutations in this gene are associated with several developmental syndromic and non-syndromic polydactyly. The present study reports two cases: first, a familial case of Greig Cephalopolysyndactyly Syndrome (GCPS); the second is a sporadic case with both postaxial polydactyly (PAP) type A and B. Resequencing of GLI3 gene reveals a previously reported nonsense truncation mutation g.42007251G\\u2009>\\u2009A (p.R792X; rs121917714) in the GCPS family and a novel single nucleotide insertion g.42004239_42004240insA (p.E1478X) in the sporadic case of postaxial polydactyly (PAP). Both nonsense truncation mutations; p.R792X (GCPS) and p.E1478X (PAP) introduce a premature stop codon leading to loss of C-terminal domains., Genetic and Clinical Studies of Congenital Anomaly Syndromes We aim to delineate the range of severity, natural history, molecular etiology, and pathophysiology of Pallister-Hall syndrome (PHS), Greig cephalopolysyndactyly syndrome (GCPS), McKusick-Kaufman syndrome (MKS), Bardet-Biedl syndrome (BBS), Oro-facial digital syndromes (OFDs), and other overlapping phenotypes. These disorders comprise a syndrome community of overlapping manifestations and we hypothesize that this is a reflection of a common mechanistic pathway. This hypothesis be addressed by a combined clinical-molecular approach where we bring up to 50-100 patients with each disorder to the NIH clinical center for a comprehensive clinical evaluation with follow-up at a frequency appropriate to the disorder. Specimens will be collected and evaluated in the laboratory by linkage analysis, physical mapping, candidate gene characterization, mutation screening, and cell biologic studies of normal mutant proteins., Natural history studies  We operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome,  PIGA-related CNS dysplasia, Ogden syndrome, and Lenz microphthalmia syndrome. A recent focus has been to understand the relationship of Proteus syndrome to deep vein thrombosis and pulmonary embolism. To address this we have collaborated with Dr. Lozier of the NIH Clinical Center and are performing a systematic evaluation of both vascular and plasma mediators of coagulation in these patients.     Genotype-Phenotype studies  A key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on fibroadipose overgrowth disorders and are developing a cohort of 24 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable.     Therapeutic Studies  The identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We are working on two primary approaches - the first is an MRI volumetric approach in collaboration with Dr. Turkbey in NIH Clinical Center imaging. The second approach is a quantitative surface measurement technique with Dr. Darling of USUHS. We are pursuing collaborative agreements with pharmaceutical companies to repurpose oncology drugs for these trials.     Behavioral studies  We have also undertaken studies to explore the behavioral aspects of these disorders. Adaptation to these conditions is a key component of quality of life for patients. To that end, we have developed interview studies to evaluate self-perception and adaptation in patients with Bardet-Biedl syndrome. We have also developed a qualitative interview study for patients with these disorders who receive genomic testing results to gauge their interest and reactions to this testing, a key attribute that clinicians will need to consider when undertaking such analyses, whether clinical or research sequencing.     In addition, Dr. Biesecker is a co-founder and co-director of the Elements of Morphology dysmorphology standards working group. This group is working to standardize malformation descriptions to increase the utility of clinical descriptions and journal reports. The group is currently working on definitions for genital anomalies and an expanded set of limb morphology terms., Natural history studies We operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies and segmental overgrowth disorders. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that have studied in the past include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, a progeriod syndrome, and Lenz microphthalmia syndrome. Our current focus is on Proteus syndrome and related disorders.   Genotype-Phenotype studies A key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on fibroadipose overgrowth disorders and have developed a cohort of >100 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. We have published interim results on the first 32 such patients, the largest in the world.   Therapeutic Studies The identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We have established a productive collaborative agreement with a pharmaceutical companies to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have completed a phase 0 dose finding trial for this drug which has shown good safety and preliminary efficacy (NCT02594215).  We have also cofounded an international consortium to test therapeutic agents in PIK3CA related overgrowth disorders with the University of Cambridge and Lyon University. We are currently developing a phase 2 study for Proteus., Natural history studies We operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies and segmental overgrowth disorders. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that have studied in the past include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, a progeriod syndrome, and Lenz microphthalmia syndrome. Our current focus is on Proteus syndrome and related disorders.   Genotype-Phenotype studies A key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on fibroadipose overgrowth disorders and have developed a cohort of >100 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. We have published interim results on the first 32 such patients, the largest in the world. We have also expanded our efforts by collaborating with NCI and NIAID to support the COVIDcode study to identify genetic susceptibilities to severe COVID19 infection.  Therapeutic Studies The identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We have established a productive collaborative agreement with a pharmaceutical companies to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have completed a phase 0 dose finding trial for this drug which has shown good safety and preliminary efficacy (NCT02594215).  We have also completed an international collaborative trial to test therapeutic agents in PIK3CA related overgrowth disorders with the University of Cambridge and Lyon University. We have developed a phase 2 study for Proteus syndrome and are awaiting establishment of a CRADA from the Pharma partner., Natural history studies We operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies and segmental overgrowth disorders. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, a progeriod syndrome, and Lenz microphthalmia syndrome. A recent focus has been to understand the relationship of Proteus syndrome to deep vein thrombosis and pulmonary embolism, meningiomas, and gastrointestinal complications.   Genotype-Phenotype studies A key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on fibroadipose overgrowth disorders and are developing a cohort of >100 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. We have published interim results on the first 32 such patients, the largest in the world.   Therapeutic Studies The identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We are working on two primary approaches - the first is an MRI volumetric approach in collaboration with NIH Clinical Center imaging. The second approach is a quantitative surface measurement technique. We have established a productive collaborative agreement with a pharmaceutical companies to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have designed a phase 0 dose finding trial for this drug which has received preliminary IRB approval and we have been assigned an IND by the FDA. This trial has successfully launched and we have nearly completed the dose level 1 recruitment for this study (NCT02594215).  We have also cofounded an international consortium to test therapeutic agents in PIK3CA related overgrowth disorders with the University of Cambridge and Lyon University. This trial was launched in the summer of 2015 and has completed its recruitment and is under data analysis., Natural history studies We operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies and segmental overgrowth disorders. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, a progeriod syndrome, and Lenz microphthalmia syndrome. A recent focus has been to understand the relationship of Proteus syndrome to deep vein thrombosis and pulmonary embolism, meningiomas, and gastrointestinal complications.   Genotype-Phenotype studies A key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on fibroadipose overgrowth disorders and are developing a cohort of >100 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. We have published interim results on the first 32 such patients, the largest in the world.   Therapeutic Studies The identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We have established a productive collaborative agreement with a pharmaceutical companies to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have completed a phase 0 dose finding trial for this drug which has shown good safety and preliminary efficacy (NCT02594215).  We have also cofounded an international consortium to test therapeutic agents in PIK3CA related overgrowth disorders with the University of Cambridge and Lyon University. This trial was completed in the spring of 2018 and the paper has been accepted., Natural history studies We operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, a progeriod syndrome, and Lenz microphthalmia syndrome. A recent focus has been to understand the relationship of Proteus syndrome to deep vein thrombosis and pulmonary embolism. To address this we are performing a systematic evaluation of both vascular and plasma mediators of coagulation in these patients.   Genotype-Phenotype studies A key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on fibroadipose overgrowth disorders and are developing a cohort of >100 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. We have published interim results on the first 32 such patients, the largest in the world.   Therapeutic Studies The identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We are working on two primary approaches - the first is an MRI volumetric approach in collaboration with NIH Clinical Center imaging. The second approach is a quantitative surface measurement technique. We have established a productive collaborative agreement with a pharmaceutical companies to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have designed a phase 0 dose finding trial for this drug which has received preliminary IRB approval and we have been assigned an IND by the FDA. This trial has successfully launched and we have nearly completed the dose level 1 recruitment for this study (NCT02594215).  We have also cofounded an international consortium to test therapeutic agents in PIK3CA related overgrowth disorders with the University of Cambridge and Lyon University. This trial was launched in the summer of 2015 and has recruited 12 patients into the study.   Behavioral studies We have also developed a qualitative interview study for patients with these disorders who receive genomic testing results to gauge their interest and reactions to this testing, a key attribute that clinicians will need to consider when undertaking such analyses, whether clinical or research sequencing. We have launched a novel initiative to test a tablet-based interactive platform for informed consent for genomic research., Natural history studies We operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, a progeriod syndrome, and Lenz microphthalmia syndrome. A recent focus has been to understand the relationship of Proteus syndrome to deep vein thrombosis and pulmonary embolism. To address this we are performing a systematic evaluation of both vascular and plasma mediators of coagulation in these patients.   Genotype-Phenotype studies A key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on fibroadipose overgrowth disorders and are developing a cohort of >100 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. We have published interim results on the first 32 such patients, the largest in the world.   Therapeutic Studies The identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We are working on two primary approaches - the first is an MRI volumetric approach in collaboration with NIH Clinical Center imaging. The second approach is a quantitative surface measurement technique. We have established a productive collaborative agreement with a pharmaceutical companies to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have designed a phase 0 dose finding trial for this drug which has received preliminary IRB approval and we have been assigned an IND by the FDA. We have also cofounded an international consortium to test therapeutic agents in PIK3CA related overgrowth disorders with the University of Cambridge and Lyon University. This trial was launched in the summer of 2015   Behavioral studies We have also undertaken studies to explore the behavioral aspects of these disorders. Adaptation to these conditions is a key component of quality of life for patients. To that end, we have completed interview studies to evaluate self-perception and adaptation in patients with Bardet-Biedl syndrome. This manuscript is now ready for submission. We have also developed a qualitative interview study for patients with these disorders who receive genomic testing results to gauge their interest and reactions to this testing, a key attribute that clinicians will need to consider when undertaking such analyses, whether clinical or research sequencing. Transcripts from these interviews have been coded and analyzed and will be analyzed this fall.   In addition, Dr. Biesecker is a co-founder and co-director of the Elements of Morphology dysmorphology standards working group. This group is working to standardize malformation descriptions to increase the utility of clinical descriptions and journal reports. Our next project will be an expanded set of limb morphology terms to follow on our prior set of limb terms., Natural history studies We operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, an atypical Progeria syndrome, and Lenz microphthalmia syndrome. A recent focus has been to understand the relationship of Proteus syndrome to deep vein thrombosis and pulmonary embolism. To address this we are performing a systematic evaluation of both vascular and plasma mediators of coagulation in these patients.   Genotype-Phenotype studies A key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on fibroadipose overgrowth disorders and are developing a cohort of 50 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. We have published interim results on the first 32 such patients, the largest in the world.   Therapeutic Studies The identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We are working on two primary approaches - the first is an MRI volumetric approach in collaboration with NIH Clinical Center imaging. The second approach is a quantitative surface measurement technique. We have established a productive collaborative agreement with a pharmaceutical companies to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have designed a phase 0 dose finding trial for this drug which will be submitted for SRC and IRB review in the fall of 2014. We have also cofounded an international consortium to test therapeutic agents in PIK3CA related overgrowth disorders with the University of Cambridge and Lyon University. This group will be launching its first trial in early 2015.   Behavioral studies We have also undertaken studies to explore the behavioral aspects of these disorders. Adaptation to these conditions is a key component of quality of life for patients. To that end, we have completed interview studies to evaluate self-perception and adaptation in patients with Bardet-Biedl syndrome. This manuscript is now ready for submission. We have also developed a qualitative interview study for patients with these disorders who receive genomic testing results to gauge their interest and reactions to this testing, a key attribute that clinicians will need to consider when undertaking such analyses, whether clinical or research sequencing. Transcripts from these interviews have been coded and analyzed and will be analyzed this fall.   In addition, Dr. Biesecker is a co-founder and co-director of the Elements of Morphology dysmorphology standards working group. This group is working to standardize malformation descriptions to increase the utility of clinical descriptions and journal reports. The group has recently published definitions for genital anomalies and a set of general terms used in the field. Our next project will be an expanded set of limb morphology terms to follow on our prior set of limb terms., Natural history studies\\\\\\\\\\\\\\\\nWe operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies and segmental overgrowth disorders. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that have studied in the past include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, a progeriod syndrome, and Lenz microphthalmia syndrome. Our current focus is on Proteus syndrome and related disorders. \\\\\\\\\\\\\\\\n\\\\\\\\\\\\\\\\nGenotype-Phenotype studies\\\\\\\\\\\\\\\\nA key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on segmental overgrowth disorders, specifically, Proteus syndrome and have developed a cohort of >100 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. \\\\\\\\\\\\\\\\nWe have also expanded our efforts by collaborating with NCI and NIAID to support the COVIDcode study to identify genetic susceptibilities to severe COVID19 infection.\\\\\\\\\\\\\\\\n\\\\\\\\\\\\\\\\nTherapeutic Studies\\\\\\\\\\\\\\\\nThe identification of the molecular etiology for Proteus syndrome and fibroadipose overgrowth and CLOVES syndrome provide an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We have established a productive collaborative agreement with a pharmaceutical companies to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have completed a phase 0 dose finding trial for this drug which has shown good safety and preliminary efficacy (NCT02594215).  We have also completed an international collaborative trial to test therapeutic agents in PIK3CA related overgrowth disorders with the University of Cambridge and Lyon University. We have opened a phase 2 study for Proteus syndrome and have established a CRADA from the Pharma partner., Natural history studies\\\\\\\\\\\\\\\\nWe operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies and segmental overgrowth disorders. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that have studied in the past include non-syndromic polydactyly, Proteus syndrome, fibroadipose overgrowth syndrome, a progeriod syndrome, and Lenz microphthalmia syndrome. Our current focus is on Proteus syndrome and related disorders. \\\\\\\\\\\\\\\\n\\\\\\\\\\\\\\\\nGenotype-Phenotype studies\\\\\\\\\\\\\\\\nA key objective of genetic research is to understand not only what genes are associated with what phenotypes, but to understand in detail how specific variants are correlated with specific manifestations and the severity and complications of these disorders. These studies take a great deal of time and effort to attract sufficient patients. We are currently focusing on segmental overgrowth disorders, specifically, Proteus syndrome and have developed a cohort of >100 patients with detailed clinical analysis coupled to mutation detection from biopsied specimens. The challenge here is greater than it is for germline (inherited) disorders because in addition to gene, variant, and genetic background, one must take into account the mosaicism level in the patient, which is clearly an important variable. \\\\\\\\\\\\\\\\n\\\\\\\\\\\\\\\\nTherapeutic Studies\\\\\\\\\\\\\\\\nThe identification of the molecular etiology for Proteus syndrome provided an exciting new opportunity to develop therapeutic approaches to these devastating disorders. We have undertaken efforts to develop data for valid therapeutic endpoints for therapy of overgrowth disorders. We have established a productive collaborative agreement with Merck, Inc to repurpose an oncology drug for these trials. We have performed significant in vitro work (see companion Z01 on molecular studies) and have completed a phase 0 dose finding trial for this drug which has shown good safety and preliminary efficacy (NCT02594215). We have opened a phase 2 study for Proteus syndrome under a CRADA from the Pharma partner and have nearly completed enrollment in that study., The laboratory uses a translational research approach to study human malformations. In the clinical arena, we operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include Pallister-Hall, Greig cephalopolysyndactyly, McKusick Kaufman, non-syndromic polydactyly, Proteus, Bardet-Biedl, Lenz microphthalmia, and Oculofaciocardiodental syndromes.  We use the tools of modern molecular biology to determine the molecular pathogenesis of these disorders. These include positional cloning, microarray expression and microarray CGH analysis, cell and tissue culture studies to assess cell biologic functions and abnormalities of gene products, and the creation and analysis of animal models of human genetic disease (mouse and zebrafish).  Using these techniques we have elucidated the etiology of Pallister-Hall, McKusick-Kaufman, Lenz microphthalmia and Oculofaciocardiodental syndromes. In addition, we have demonstrated the functional defect of Pallister-Hall syndrome by comparing the function of the causative gene in that disorder (GLI3) to its Drosophila homologue (cubitus interruptus) and correlating those functions with mutations in over 150 patients. In so doing, we have determined that the mechanism of Pallister Hall syndrome is distinct from that of Greig cephalopolysyndactyly syndrome. We have also clinically redefined the Proteus syndrome, a disorder of mosaic overgrowth with tumor susceptibility. We did this through evaluating a series of 35 patients and an exhaustive survey of all cases reported in the literature. This allowed us to establish new clinical diagnostic criteria for this disorder and delineate two novel disease entities, the hemihyperplasia-multiple lipomatosis syndrome and CLOVE syndrome. In our studies of Lenz microphthalmia syndrome we determined that this disorder is actually an amalgamation of two distinct X-linked diseases and that one form of Lenz is allelic to Oculofaciocardiodental syndrome and that both of these diseases are caused by mutations in the BCOR gene.  Finally, we are using animal models to study two disorders, Amish microcephaly syndrome, which we determined to be caused by mutations in the DNC gene, and a phenocopy of Greig cephalopolysyndactyly syndrome. For Amish microcephaly, we have created a mouse knockout model of that disease using transgenic technology and are studying the pathophysiology of that disorder using genetic and biochemical analysis. We are also performing a positional cloning analysis of the Greig cephalopolysyndactyly phenotype in the mouse using a sporadic mutant identified at a large breeding facility. This disorder has now been mapped to a 500 KB interval and candidate genes are being sequenced., The laboratory uses a translational research approach to study human malformations. In the clinical arena, we operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include Pallister-Hall, Greig cephalopolysyndactyly, McKusick Kaufman, non-syndromic polydactyly, Proteus, Bardet-Biedl, Lenz microphthalmia, and Oculofaciocardiodental syndromes.  We use the tools of modern molecular biology to determine the molecular pathogenesis of these disorders. These include positional cloning, microarray expression and microarray CGH analysis, cell and tissue culture studies to assess cell biologic functions and abnormalities of gene products, and the creation and analysis of animal models of human genetic disease (mouse and zebrafish).  Using these techniques we have elucidated the etiology of TARP syndrome (Talipes, Atrial septal defect, Right superior vena cava, and cleft Palate), Pallister-Hall, McKusick-Kaufman, Lenz microphthalmia and Oculofaciocardiodental syndromes. In addition, we have demonstrated the functional defect of Pallister-Hall syndrome by comparing the function of the causative gene in that disorder (GLI3) to its Drosophila homologue (cubitus interruptus) and correlating those functions with mutations in over 150 patients. In so doing, we have determined that the mechanism of Pallister Hall syndrome is distinct from that of Greig cephalopolysyndactyly syndrome. We have also clinically redefined the Proteus syndrome, a disorder of mosaic overgrowth with tumor susceptibility. We did this through evaluating a series of 35 patients and an exhaustive survey of all cases reported in the literature. This allowed us to establish new clinical diagnostic criteria for this disorder and delineate two novel disease entities, the hemihyperplasia-multiple lipomatosis syndrome and CLOVE syndrome. In our studies of Lenz microphthalmia syndrome we determined that this disorder is actually an amalgamation of two distinct X-linked diseases and that one form of Lenz is allelic to Oculofaciocardiodental syndrome and that both of these diseases are caused by mutations in the BCOR gene.  We have also performed a positional cloning analysis of the Greig cephalopolysyndactyly phenotype in the mouse using a sporadic mutant identified at a large breeding facility. This disorder has now been postiionally cloned and the causative gene discovered., The laboratory uses a translational research approach to study human malformations. In the clinical arena, we operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include Pallister-Hall, Greig cephalopolysyndactyly, McKusick Kaufman, non-syndromic polydactyly, Proteus, Bardet-Biedl, Lenz microphthalmia, and Oculofaciocardiodental syndromes. [unreadable] We use the tools of modern molecular biology to determine the molecular pathogenesis of these disorders. These include positional cloning, microarray expression and microarray CGH analysis, cell and tissue culture studies to assess cell biologic functions and abnormalities of gene products, and the creation and analysis of animal models of human genetic disease (mouse and zebrafish). [unreadable] Using these techniques we have elucidated the etiology of Pallister-Hall, McKusick-Kaufman, Lenz microphthalmia and Oculofaciocardiodental syndromes. In addition, we have demonstrated the functional defect of Pallister-Hall syndrome by comparing the function of the causative gene in that disorder (GLI3) to its Drosophila homologue (cubitus interruptus) and correlating those functions with mutations in over 150 patients. In so doing, we have determined that the mechanism of Pallister Hall syndrome is distinct from that of Greig cephalopolysyndactyly syndrome. We have also clinically redefined the Proteus syndrome, a disorder of mosaic overgrowth with tumor susceptibility. We did this through evaluating a series of 35 patients and an exhaustive survey of all cases reported in the literature. This allowed us to establish new clinical diagnostic criteria for this disorder and delineate a novel disease entity, the hemihyperplasia-multiple lipomatosis syndrome. In our studies of Lenz microphthalmia syndrome we determined that this disorder is actually an amalgamation of two distinct X-linked diseases and that one form of Lenz is allelic to Oculofaciocardiodental syndrome and that both of these diseases are caused by mutations in the BCOR gene. [unreadable] Finally, we are using animal models to study two disorders, Amish microcephaly syndrome, which we determined to be caused by mutations in the DNC gene, and a phenocopy of Greig cephalopolysyndactyly syndrome. For Amish microcephaly, we have created a mouse knockout model of that disease using transgenic technology and are studying the pathophysiology of that disorder using genetic and biochemical analysis. We are also performing a positional cloning analysis of the Greig cephalopolysyndactyly phenotype in the mouse using a sporadic mutant identified at a large breeding facility. This disorder has now been mapped to a 500 KB interval and candidate genes are being sequenced., The laboratory uses a translational research approach to study human malformations. In the clinical arena, we operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include non-syndromic polydactyly, Proteus syndrome, non-Proteus asymmetric overgrowth syndrome, Bardet-Biedl syndrome, PIGA-related CNS dysplasia, Ogden syndrome, and Lenz microphthalmia syndrome.   We use the tools of modern molecular biology to determine the molecular pathogenesis of these disorders. These include high throughput sequencing, positional cloning, microarray expression and microarray CGH analysis, cell and tissue culture studies to assess cell biologic functions and abnormalities of gene products, and the creation and analysis of animal models of human genetic disease (mouse and zebrafish).   Using these techniques in the past year we have elucidated the etiology of PIGA-related CNS dysplasia, TARP syndrome (Talipes, Atrial septal defect, Right superior vena cava, and cleft Palate), Pallister-Hall, McKusick-Kaufman, two forms of Lenz microphthalmia, Oculofaciocardiodental syndromes, combined malonic and methylmalonic acidemia, Proteus syndrome, and PIK3CA-related non-Proteus overgrowth.  In addition, Dr. Biesecker is a co-founder and co-director of the Elements of Morphology dysmorphology standards working group. This group is working to standardize malformation descriptions to increase the utility of clinical descriptions and journal reports. The group is currently working on definitions for genital anomalies and an expanded set of limb morphology terms., The laboratory uses a translational research approach to study human malformations. In the clinical arena, we operate several clinical research protocols to assess the range of severity, spectrum of malformations, and natural history of pleiotropic developmental anomalies. We use clinical evaluations that include history and physical examination, imaging studies including radiography, ultrasound, and tomography, as well as EEG, pulmonary function testing, etc. to characterize functional and structural anomalies. In selected cases we also perform surgical treatments if they offer clinical benefit and can advance our understanding of the disease under study. Some of the disorders that we are currently studying include non-syndromic polydactyly, Proteus, Bardet-Biedl, and Lenz microphthalmia.  We use the tools of modern molecular biology to determine the molecular pathogenesis of these disorders. These include high throughput sequencing, positional cloning, microarray expression and microarray CGH analysis, cell and tissue culture studies to assess cell biologic functions and abnormalities of gene products, and the creation and analysis of animal models of human genetic disease (mouse and zebrafish).  Using these techniques we have elucidated the etiology of TARP syndrome (Talipes, Atrial septal defect, Right superior vena cava, and cleft Palate), Pallister-Hall, McKusick-Kaufman, Lenz microphthalmia, Oculofaciocardiodental syndromes, combined malonic and methylmalonic acidemia, and Proteus syndrome.\",\n          \" Preaxial polydactyly (PPD) is a congenital limb malformation, previously reported to be caused primarily by variants in the ZRS and upstream preZRS regions. This study investigated genetic variations associated with PPD, focusing on point variants and copy number variations (CNVs) in the ZRS and preZRS regions. Comprehensive genetic analyses were conducted on 102 patients with PPD, including detailed clinical examinations and Sanger sequencing of the ZRS and preZRS regions. Additionally, real-time quantitative PCR (qPCR) was used to detect CNVs in the ZRS region. The evolutionary conservation and population frequencies of identified variants were also evaluated. Six point variants were identified, among which four are likely pathogenic novel variants: 93G\\u2009>\\u2009T (g.156584477G\\u2009>\\u2009T), 106G\\u2009>\\u2009A (g.156584464G\\u2009>\\u2009A), 278G\\u2009>\\u2009A (g.156584292G\\u2009>\\u2009A), and 409A\\u2009>\\u2009C (g.156585378A\\u2009>\\u2009C). Additionally, qPCR analysis revealed that 66.67% of patients exhibited ZRS duplications. Notably, these duplications were also present in cases with newly identified potential pathogenic point variants. These findings suggest the possible interaction of point variants in ZRS and preZRS through a common pathogenic mechanism, leading jointly to PPD. The findings expand the variant spectrum associated with non-syndromic polydactyly and highlight that, despite different classifications, anterior polydactyly caused by variants in ZRS and nearby regions may share common pathogenic mechanisms. The incorporation of various variant types in genetic screening can effectively enhance the rate of pathogenic variant detection and contribute to the cost-effectiveness of genetic testing for limb developmental defects, thereby promoting healthy births.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 73,\n        \"min\": 14,\n        \"max\": 151,\n        \"num_unique_values\": 3,\n        \"samples\": [\n          38,\n          151,\n          14\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"frequent_words\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"non-syndromic polydactyly , postaxial polydactyly , autosomal dominant inheritance , congenital limb anomalies , polydactyly\",\n          \"polydactyly , Clinical , malformation , Molecular , Clinical Research Protocols\",\n          \"\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Llama_3_n\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 3,\n        \"samples\": [\n          \"{'Wait Times, Sedation Times, and Surgical Duration for Ulnar Polydactyly': 'The authors have conducted a study to evaluate the wait times, sedation times, and surgical duration for infants with ulnar polydactyly who underwent surgery under local or general anesthetic. The study found that wait times, duration of surgery, and sedation times were significantly shorter for patients treated with local anesthetic compared to those treated with general anesthetic. The study also found no differences in complication rates between the two groups. This research highlights the importance of local anesthetic in reducing wait times and duration of surgery for infants with ulnar polydactyly.', 'Role of FGFR2 Mutations in Osteoblastic Differentiation': 'The authors have studied the role of the S252W mutation of FGFR2 on osteoblastic differentiation in polydactyly-related syndromes. They found that osteoblastic cells derived from digital bone in Apert patients with the S252W mutation showed more prominent osteoblastic activity, higher expression of osteoblastic markers, and mineralized nodule formation compared to control cells. Stable clones of the human MG63 osteosarcoma cells overexpressing a splice variant of FGFR2 with or without the S252W mutation showed higher RUNX2 mRNA expression and enhanced osteoblastic marker gene expression. The enhanced osteoblastic phenotype in human osteoblasts was controlled by a soluble FGFR2 with the S252W mutation, suggesting a dominant negative effect on FGFR2 signaling in Apert syndrome. This research provides insights into the molecular mechanisms underlying osteoblastic differentiation in polydactyly-related syndromes.', 'Molecular Embryology of Limb Development': 'The authors have reviewed the molecular embryology of limb development and outlined the \\\"end-organ responsiveness\\\" of the limbs to a variety of single-gene mutations. They proposed an alternative classification of syndactylies and polydactylies based on the involvement of specific genes and their impact on the development of the limbs. This research provides a comprehensive understanding of the molecular mechanisms underlying limb development and the classification of syndactylies and polydactylies.', 'Familial Polydactyly': 'The authors have presented a case of familial polydactyly spanning three generations. The study examined the anatomical variations observed in the affected individuals, including the presence of a transverse accessory extensor tendon between both extensor tendons in cases with T- and Y-shaped metatarsals. The authors aimed to contribute to the existing body of literature on the subject of familial polydactyly. This research highlights the importance of genetic counseling in cases of consanguinity and the need for a multidisciplinary approach in managing polydactyly.', 'KIAA0825 Variations in Postaxial Polydactyly': 'The authors have identified compound heterozygous splice site variants in KIAA0825 in a fetus with non-syndromic postaxial polydactyly type A (PAPA). The study found that the c.-1-2A>T variant led to the loss of the initiation codon, and the c.2247-2A>G variant mainly resulted in exon 13 skipping. Prenatal whole-exome sequencing and subsequent functional studies were important approaches for defining the genetic etiology of fetuses with PAPA and for accurate genetic counseling and decision making. This research expands the spectrum of KIAA0825 variations in PAPA patients and increases the knowledge of the molecular consequences of KIAA0825 splice site variants.', 'Biblical Evidence of Polydactyly': 'The authors have presented a case of polydactyly in the biblical text of passage 2 Sam 21'}\",\n          \"{'Genetic Basis of Non-Syndromic Polydactyly': 'Research on the genetic basis of non-syndromic polydactyly involves identifying and characterizing the genes and genetic mutations responsible for the condition. This includes studies on the inheritance patterns and the genetic factors that contribute to the development of polydactyly in individuals without any other associated symptoms.', 'Clinical Features and Diagnosis of Non-Syndromic Polydactyly': 'Research on the clinical features and diagnosis of non-syndromic polydactyly involves studying the symptoms, physical characteristics, and diagnostic methods used to identify the condition. This includes research on the prevalence, incidence, and demographics of individuals with non-syndromic polydactyly.', 'Epidemiology of Non-Syndromic Polydactyly': 'Research on the epidemiology of non-syndromic polydactyly involves studying the distribution and frequency of the condition in different populations. This includes research on the environmental and genetic risk factors that may contribute to the development of polydactyly, as well as the impact of genetic counseling and screening for the condition.', 'Genetic Counseling and Screening for Non-Syndromic Polydactyly': 'Research on genetic counseling and screening for non-syndromic polydactyly involves developing and implementing strategies to provide individuals and families with information and support related to the condition. This includes research on the benefits and limitations of genetic counseling and screening, as well as the impact of these services on the health and well-being of individuals with non-syndromic polydactyly.', 'Treatment and Management of Non-Syndromic Polydactyly': 'Research on the treatment and management of non-syndromic polydactyly involves studying the surgical and non-surgical approaches used to treat the condition. This includes research on the effectiveness and safety of different treatment options, as well as the impact of treatment on the long-term health and well-being of individuals with non-syndromic polydactyly.', 'Quality of Life and Psychosocial Aspects of Non-Syndromic Polydactyly': 'Research on the quality of life and psychosocial aspects of non-syndromic polydactyly involves studying the impact of the condition on the emotional, social, and psychological well-being of individuals. This includes research on the stigma and discrimination faced by individuals with non-syndromic polydactyly, as well as the impact of support groups and other resources on the well-being of individuals with the condition.', 'Ethical and Legal Issues in Non-Syndromic Polydactyly': 'Research on the ethical and legal issues in non-syndromic polydactyly involves studying the legal and ethical implications of genetic testing and counseling, as well as the rights and responsibilities of individuals with the condition. This includes research on the legal protections for individuals with non-syndromic polydactyly, as well as the ethical considerations in the use of genetic information in medical and legal contexts.', 'Future Directions in Non-Syndromic Polydactyly Research': 'Research on future directions in non-syndromic polydactyly research involves studying the emerging trends and technologies in the field, as well as the potential for new discoveries and breakthroughs in understanding and treating the condition. This includes research on the potential for new diagnostic and treatment options, as well as the impact of new genetic and genomic technologies on the study and management of non-syndromic polydactyly.'}\",\n          \"{'**Genetic Variations in ZRS and PreZRS Regions': '** The researchers have extensively studied the genetic variations in the ZRS and preZRS regions, identifying both point variants and CNVs. Their findings have expanded the variant spectrum associated with non-syndromic polydactyly and have highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism.', '**Clinical Examination and Genetic Analysis': '** The research group has conducted detailed clinical examinations and Sanger sequencing of the ZRS and preZRS regions in 102 patients with PPD. Their comprehensive genetic analyses have contributed to a better understanding of the genetic basis of PPD.', '**Real-Time Quantitative PCR (qPCR) for CNV Detection': '** The researchers have used qPCR to detect CNVs in the ZRS region, which has helped to identify duplications in a significant portion of patients with PPD. This method has enhanced the accuracy of genetic screening for limb developmental defects.', '**Evolutionary Conservation and Population Frequencies': '** The research group has evaluated the evolutionary conservation and population frequencies of identified variants. This analysis has provided insights into the potential impact of these variants on the development of PPD and has contributed to the understanding of the genetic basis of limb developmental defects.\\\\n\\\\nOverall, the research group has made significant contributions to the field of genetic research in limb developmental defects, specifically in the understanding of preaxial polydactyly. Their work has expanded the variant spectrum associated with non-syndromic polydactyly and has highlighted the potential interaction of point variants in ZRS and preZRS through a common pathogenic mechanism. Their findings have implications for genetic screening for limb developmental defects, promoting healthy births.'}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-e4f67016-e0e7-459b-94dd-cb5022040178\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  &lt;b&gt;Introduction:&lt;/b&gt; For infants with ulna...</td>\n",
              "      <td>[Catapresan, Saline, Catapresan, Saline, surgi...</td>\n",
              "      <td>38</td>\n",
              "      <td>non-syndromic polydactyly , postaxial polydact...</td>\n",
              "      <td>{'Wait Times, Sedation Times, and Surgical Dur...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;b&gt;&lt;i&gt;Objective:&lt;/i&gt;&lt;/b&gt; Polydactyly is chara...</td>\n",
              "      <td>[Agreement, Area, behavioral study, Biopsy Spe...</td>\n",
              "      <td>151</td>\n",
              "      <td>polydactyly , Clinical , malformation , Molecu...</td>\n",
              "      <td>{'Genetic Basis of Non-Syndromic Polydactyly':...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>Preaxial polydactyly (PPD) is a congenital li...</td>\n",
              "      <td>[]</td>\n",
              "      <td>14</td>\n",
              "      <td></td>\n",
              "      <td>{'**Genetic Variations in ZRS and PreZRS Regio...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-e4f67016-e0e7-459b-94dd-cb5022040178')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-e4f67016-e0e7-459b-94dd-cb5022040178 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-e4f67016-e0e7-459b-94dd-cb5022040178');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-675b1ef2-989f-4d54-bf73-e7a774cbc397\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-675b1ef2-989f-4d54-bf73-e7a774cbc397')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-675b1ef2-989f-4d54-bf73-e7a774cbc397 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_38863bb7-a6ad-4a33-98f8-52529df80f3f\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_38863bb7-a6ad-4a33-98f8-52529df80f3f button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  <b>Introduction:</b> For infants with ulna...   \n",
              "1          0   <b><i>Objective:</i></b> Polydactyly is chara...   \n",
              "2          1   Preaxial polydactyly (PPD) is a congenital li...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Catapresan, Saline, Catapresan, Saline, surgi...    38   \n",
              "1  [Agreement, Area, behavioral study, Biopsy Spe...   151   \n",
              "2                                                 []    14   \n",
              "\n",
              "                                      frequent_words  \\\n",
              "0  non-syndromic polydactyly , postaxial polydact...   \n",
              "1  polydactyly , Clinical , malformation , Molecu...   \n",
              "2                                                      \n",
              "\n",
              "                                           Llama_3_n  \n",
              "0  {'Wait Times, Sedation Times, and Surgical Dur...  \n",
              "1  {'Genetic Basis of Non-Syndromic Polydactyly':...  \n",
              "2  {'**Genetic Variations in ZRS and PreZRS Regio...  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "repr_error": "Out of range float values are not JSON compliant: nan",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-4d42cf38-01af-4a03-bf3e-ed5f31c82dad\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  Genetic disorders characterized by congeni...</td>\n",
              "      <td>[Acetylation, Acetyltransferase, adult stem ce...</td>\n",
              "      <td>49</td>\n",
              "      <td>Acetylation , Acetyltransferase , adult stem c...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;h4&gt;Background&lt;/h4&gt;Say-Barber-Biesecker-Young...</td>\n",
              "      <td>[sbbyss, genitourinary complications, say-barb...</td>\n",
              "      <td>400</td>\n",
              "      <td>genitopatellar syndrome , kat6b , sbbyss , say...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-4d42cf38-01af-4a03-bf3e-ed5f31c82dad')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-4d42cf38-01af-4a03-bf3e-ed5f31c82dad button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-4d42cf38-01af-4a03-bf3e-ed5f31c82dad');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-0b05f628-19e8-494c-b6ba-cfef64b1d17c\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-0b05f628-19e8-494c-b6ba-cfef64b1d17c')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-0b05f628-19e8-494c-b6ba-cfef64b1d17c button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_057099c4-5ab2-4236-9aa2-2dc7407395c8\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_057099c4-5ab2-4236-9aa2-2dc7407395c8 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  Genetic disorders characterized by congeni...   \n",
              "1          0   <h4>Background</h4>Say-Barber-Biesecker-Young...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Acetylation, Acetyltransferase, adult stem ce...    49   \n",
              "1  [sbbyss, genitourinary complications, say-barb...   400   \n",
              "\n",
              "                                      frequent_words Llama_3_n  \n",
              "0  Acetylation , Acetyltransferase , adult stem c...      None  \n",
              "1  genitopatellar syndrome , kat6b , sbbyss , say...      None  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n",
            "-----------------------------------------\n",
            "res The following are the three key detailed research expertise areas that emerge from the work of authors in the context of Genitopatellar syndrome:\n",
            "\n",
            "1. **Genetic basis of Genitopatellar syndrome**: The authors have conducted extensive research on the genetic basis of Genitopatellar syndrome. They have identified the causative gene, which is the histone acetyltransferase gene, and have characterized the specific mutations that lead to the syndrome. This research has provided valuable insights into the genetic underpinnings of this rare condition and has opened up new avenues for targeted therapies.\n",
            "\n",
            "2. **Developmental mechanisms of Genitopatellar syndrome**: The authors have also focused on the developmental mechanisms of Genitopatellar syndrome. They have studied the impact of the causative gene mutations on the early developmental processes, such as cell differentiation, proliferation, and migration, and have identified the specific pathways that are affected. This research has provided a deeper understanding of the pathogenesis of this condition and has helped in the development of targeted interventions.\n",
            "\n",
            "3. **Animal models for Genitopatellar syndrome**: The authors have established animal models for Genitopatellar syndrome, using genetically engineered mice with the causative gene mutations. These models have allowed them to study the phenotypic manifestations of the syndrome in a controlled environment and to investigate the mechanisms by which the mutations affect the development of the affected organs. This research has contributed to our understanding of the disease process and has facilitated the development of new therapeutic strategies.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'**Genetic basis of Genitopatellar syndrome**': 'The authors have conducted extensive research on the genetic basis of Genitopatellar syndrome. They have identified the causative gene, which is the histone acetyltransferase gene, and have characterized the specific mutations that lead to the syndrome. This research has provided valuable insights into the genetic underpinnings of this rare condition and has opened up new avenues for targeted therapies.', '**Developmental mechanisms of Genitopatellar syndrome**': 'The authors have also focused on the developmental mechanisms of Genitopatellar syndrome. They have studied the impact of the causative gene mutations on the early developmental processes, such as cell differentiation, proliferation, and migration, and have identified the specific pathways that are affected. This research has provided a deeper understanding of the pathogenesis of this condition and has helped in the development of targeted interventions.', '**Animal models for Genitopatellar syndrome**': 'The authors have established animal models for Genitopatellar syndrome, using genetically engineered mice with the causative gene mutations. These models have allowed them to study the phenotypic manifestations of the syndrome in a controlled environment and to investigate the mechanisms by which the mutations affect the development of the affected organs. This research has contributed to our understanding of the disease process and has facilitated the development of new therapeutic strategies.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'**Genetic basis of Genitopatellar syndrome**': 'The authors have conducted extensive research on the genetic basis of Genitopatellar syndrome. They have identified the causative gene, which is the histone acetyltransferase gene, and have characterized the specific mutations that lead to the syndrome. This research has provided valuable insights into the genetic underpinnings of this rare condition and has opened up new avenues for targeted therapies.', '**Developmental mechanisms of Genitopatellar syndrome**': 'The authors have also focused on the developmental mechanisms of Genitopatellar syndrome. They have studied the impact of the causative gene mutations on the early developmental processes, such as cell differentiation, proliferation, and migration, and have identified the specific pathways that are affected. This research has provided a deeper understanding of the pathogenesis of this condition and has helped in the development of targeted interventions.', '**Animal models for Genitopatellar syndrome**': 'The authors have established animal models for Genitopatellar syndrome, using genetically engineered mice with the causative gene mutations. These models have allowed them to study the phenotypic manifestations of the syndrome in a controlled environment and to investigate the mechanisms by which the mutations affect the development of the affected organs. This research has contributed to our understanding of the disease process and has facilitated the development of new therapeutic strategies.'}\n",
            "1\n"
          ]
        },
        {
          "name": "stderr",
          "output_type": "stream",
          "text": [
            "/usr/local/lib/python3.11/dist-packages/spacy/pipeline/lemmatizer.py:211: UserWarning: [W108] The rule-based lemmatizer did not find POS annotation for one or more tokens. Check that your pipeline includes components that assign token.pos, typically 'tagger'+'attribute_ruler' or 'morphologizer'.\n",
            "  warnings.warn(Warnings.W108)\n"
          ]
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "suumary_chunk  0\n",
            "suumary_chunk  1\n",
            "suumary_chunk  2\n",
            "suumary_chunk  3\n",
            "suumary_chunk  4\n",
            "suumary_chunk  5\n",
            "suumary_chunk  6\n",
            "suumary_chunk  7\n",
            "-----------------------------------------\n",
            "res The expertise areas of the researchers in the context of Genitopatellar syndrome are:\n",
            "\n",
            "1. **Genetic basis of Genitopatellar syndrome**: The researchers have identified the KAT6B gene as the gene responsible for Genitopatellar syndrome. They have conducted genetic analyses to identify the specific mutations in the KAT6B gene that cause the syndrome.\n",
            "\n",
            "2. **Clinical manifestations of Genitopatellar syndrome**: The researchers have conducted clinical studies to identify and characterize the various features of Genitopatellar syndrome, including the absence or underdevelopment of the patella, genital and urinary abnormalities, intellectual disability, hypotonia, and facial dysmorphism.\n",
            "\n",
            "3. **Treatment and management of Genitopatellar syndrome**: The researchers have conducted studies to evaluate the various treatment options for individuals with Genitopatellar syndrome, including physical therapy, surgical intervention, and medication.\n",
            "\n",
            "4. **Genitopatellar syndrome and associated conditions**: The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other conditions, such as cardiac anomalies and ectodermal dysplasia.\n",
            "\n",
            "5. **Genitopatellar syndrome and radio-ulnar synostosis**: The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and radio-ulnar synostosis, which is the fusion of the bones in the forearm.\n",
            "\n",
            "6. **Genitopatellar syndrome and other digital abnormalities**: The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other digital abnormalities, such as preaxial and postaxial polydactyly.\n",
            "\n",
            "7. **Genitopatellar syndrome and intellectual disability**: The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and intellectual disability, including the evaluation of the severity and impact of intellectual disability in individuals with Genitopatellar syndrome.\n",
            "\n",
            "8. **Genitopatellar syndrome and hypotonia**: The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and hypotonia, including the evaluation of the severity and impact of hypotonia in individuals with Genitopatellar syndrome.\n",
            "\n",
            "9. **Genitopatellar syndrome and facial dysmorphism**: The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and facial dysmorphism, including the evaluation of the severity and impact of facial dysmorphism in individuals with Genitopatellar syndrome.\n",
            "\n",
            "10. **Genitopatellar syndrome and other associated features**: The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other associated features, such as cardiac anomalies, ectodermal dysplasia, and radio-ulnar synostosis.\n",
            "\n",
            "11. **Genitopatellar syndrome and its impact on quality of life**: The researchers have conducted studies to evaluate the impact of Genitopatellar syndrome on the quality of life of individuals with the syndrome, including the evaluation of the impact of the various features of the syndrome on the quality of life.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'**Genetic basis of Genitopatellar syndrome**': 'The researchers have identified the KAT6B gene as the gene responsible for Genitopatellar syndrome. They have conducted genetic analyses to identify the specific mutations in the KAT6B gene that cause the syndrome.', '**Clinical manifestations of Genitopatellar syndrome**': 'The researchers have conducted clinical studies to identify and characterize the various features of Genitopatellar syndrome, including the absence or underdevelopment of the patella, genital and urinary abnormalities, intellectual disability, hypotonia, and facial dysmorphism.', '**Treatment and management of Genitopatellar syndrome**': 'The researchers have conducted studies to evaluate the various treatment options for individuals with Genitopatellar syndrome, including physical therapy, surgical intervention, and medication.', '**Genitopatellar syndrome and associated conditions**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other conditions, such as cardiac anomalies and ectodermal dysplasia.', '**Genitopatellar syndrome and radio-ulnar synostosis**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and radio-ulnar synostosis, which is the fusion of the bones in the forearm.', '**Genitopatellar syndrome and other digital abnormalities**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other digital abnormalities, such as preaxial and postaxial polydactyly.', '**Genitopatellar syndrome and intellectual disability**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and intellectual disability, including the evaluation of the severity and impact of intellectual disability in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and hypotonia**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and hypotonia, including the evaluation of the severity and impact of hypotonia in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and facial dysmorphism**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and facial dysmorphism, including the evaluation of the severity and impact of facial dysmorphism in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and other associated features**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other associated features, such as cardiac anomalies, ectodermal dysplasia, and radio-ulnar synostosis.', '**Genitopatellar syndrome and its impact on quality of life**': 'The researchers have conducted studies to evaluate the impact of Genitopatellar syndrome on the quality of life of individuals with the syndrome, including the evaluation of the impact of the various features of the syndrome on the quality of life.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'**Genetic basis of Genitopatellar syndrome**': 'The researchers have identified the KAT6B gene as the gene responsible for Genitopatellar syndrome. They have conducted genetic analyses to identify the specific mutations in the KAT6B gene that cause the syndrome.', '**Clinical manifestations of Genitopatellar syndrome**': 'The researchers have conducted clinical studies to identify and characterize the various features of Genitopatellar syndrome, including the absence or underdevelopment of the patella, genital and urinary abnormalities, intellectual disability, hypotonia, and facial dysmorphism.', '**Treatment and management of Genitopatellar syndrome**': 'The researchers have conducted studies to evaluate the various treatment options for individuals with Genitopatellar syndrome, including physical therapy, surgical intervention, and medication.', '**Genitopatellar syndrome and associated conditions**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other conditions, such as cardiac anomalies and ectodermal dysplasia.', '**Genitopatellar syndrome and radio-ulnar synostosis**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and radio-ulnar synostosis, which is the fusion of the bones in the forearm.', '**Genitopatellar syndrome and other digital abnormalities**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other digital abnormalities, such as preaxial and postaxial polydactyly.', '**Genitopatellar syndrome and intellectual disability**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and intellectual disability, including the evaluation of the severity and impact of intellectual disability in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and hypotonia**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and hypotonia, including the evaluation of the severity and impact of hypotonia in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and facial dysmorphism**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and facial dysmorphism, including the evaluation of the severity and impact of facial dysmorphism in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and other associated features**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other associated features, such as cardiac anomalies, ectodermal dysplasia, and radio-ulnar synostosis.', '**Genitopatellar syndrome and its impact on quality of life**': 'The researchers have conducted studies to evaluate the impact of Genitopatellar syndrome on the quality of life of individuals with the syndrome, including the evaluation of the impact of the various features of the syndrome on the quality of life.'}\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 2,\n  \"fields\": [\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 0,\n        \"min\": -1,\n        \"max\": 0,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          0,\n          -1\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \" <h4>Background</h4>Say-Barber-Biesecker-Young-Simpson (SBBYSS) variant of Ohdo syndrome is a rare, autosomal dominant and clinically heterogenous disorder, caused by pathogenic variants in the KAT6B gene located on chromosome 10q22.2. KAT6B encodes a highly conserved histone acetyltransferase belonging to the MYST family. Currently, diseases caused by pathogenic variants in KAT6B (KAT6B-related disorders) comprise two allelic entities: SBBYSS variant of Ohdo syndrome and genitopatellar syndrome (GPS). Increase in the number of cases with overlapping GPS/SBBYSS phenotype which makes it necessary to redefine this group of phenotypes as KAT6B-related disorders or KAT6B spectrum disorders. Individuals with SBBYSS usually present with facial abnormalities, hypotonia, joint laxity, feeding problems, and long thumbs/great toes. This syndrome also typically involves skeletal problems including patellar hypoplasia/agenesis.<h4>Methods</h4>Here we report six SBBYS syndrome patients with the same dysmorphic features but a different course of the disease. One known and five novel KATB6 pathogenic variants were identified by molecular diagnostics using Next Generation Sequencing (NGS).<h4>Results</h4>We present a detailed phenotypic analysis of six individuals with KAT6B-related disorders, in whom a heterozygous pathogenic variant in KAT6B gene was found. In all of our patients facial dysmorphism as well as developmental and speech delay were present. Additionally, all but one patients presented with hypotonia, ocular abnormalities and long thumbs. Most of our probands showed blepharophimosis and skeletal (mainly knee) defects. Contrary to previously reported severe patellar defects (hypoplasia/agenesis) anomalies presented by our patients were less severe (dysplasia, habitual dislocation, subluxation) referring to KAT6B-related disorders.<h4>Conclusion</h4>While most of the anomalies found in our patients comply with SBBYSS criteria, phenotypic differences in our probands support a broader spectrum of the disease phenotype. To establish the range of this spectrum, a detailed analysis of clinical variability among patients with SBBYSS requires further investigation.,  <h4>Clinical characteristics</h4>KAT6B disorders include genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome (SBBYSS) which are part of a broad phenotypic spectrum with variable expressivity; individuals presenting with a phenotype intermediate between GPS and SBBYSS have been reported. Both phenotypes are characterized by some degree of global developmental delay / intellectual disability; hypotonia; genital abnormalities; and skeletal abnormalities including patellar hypoplasia/agenesis, flexion contractures of the knees and/or hips, and anomalies of the digits, spine, and/or ribs. Congenital heart defects, small bowel malrotation, feeding difficulties, slow growth, cleft palate, hearing loss, and dental anomalies have been observed in individuals with either phenotype.<h4>Diagnosis/testing</h4>The diagnosis of a KAT6B disorder is established by the identification of a heterozygous pathogenic variant in KAT6B on molecular genetic testing.<h4>Management</h4>Treatment of manifestations: Medical problems associated with gastrointestinal, genitourinary, cardiac, palatal or dental anomalies; abnormal vision or lacrimal duct abnormality; hearing loss; or hypothyroidism associated with KAT6B disorders are treated or managed in the standard manner by the appropriate specialist. Referral to an early intervention program to access occupational, physical, speech, and feeding therapy beginning in infancy. Orthopedic intervention as needed for contractures and clubfoot; physical therapy to increase joint mobility. Surveillance: Evaluations of developmental progress and educational needs, assessment for feeding issues, and monitoring for hearing loss, amblyopia, hypothyroidism, and contractures and/or scoliosis should occur annually. Evaluation and monitoring of cardiac malformation and/or renal function (if hydronephrosis or renal cysts are present) as needed.<h4>Genetic counseling</h4>KAT6B disorders are inherited in an autosomal dominant manner. To date, most individuals with a KAT6B disorder have had a de novo pathogenic variant. Prenatal and preimplantation genetic testing are possible for families in which the pathogenic variant has been identified.,  <h4>Introduction</h4>Genitopatellar syndrome is characterized by absent/hypoplastic patellae, genital and renal abnormalities, dysmorphic facial features, and mental retardation. Cardiac anomalies, ectodermal dysplasia, and radio-ulnar synostosis have been suggested as additional features.<h4>Discussion</h4>We report on additional female patient with sensorineural hearing loss, cleft palate, and hypothyroidism in addition to known anomalies. Findings are discussed based on a literature review of the known patients with the genitopatellar syndrome.,  <h4>Purpose</h4>Genitopatellar syndrome and Say-Barber-Biesecker-Young-Simpson syndrome are caused by variants in the KAT6B gene and are part of a broad clinical spectrum called KAT6B disorders, whose variable expressivity is increasingly being recognized.<h4>Methods</h4>We herein present the phenotypes of 32 previously unreported individuals with a molecularly confirmed diagnosis of a KAT6B disorder, report 24 new pathogenic KAT6B variants, and review phenotypic information available on all published individuals with this condition. We also suggest a classification of clinical subtypes within the KAT6B disorder spectrum.<h4>Results</h4>We demonstrate that cerebral anomalies, optic nerve hypoplasia, neurobehavioral difficulties, and distal limb anomalies other than long thumbs and great toes, such as polydactyly, are more frequently observed than initially reported. Intestinal malrotation and its serious consequences can be present in affected individuals. Additionally, we identified four children with Pierre Robin sequence, four individuals who had increased nuchal translucency/cystic hygroma prenatally, and two fetuses with severe renal anomalies leading to renal failure. We also report an individual in which a pathogenic variant was inherited from a mildly affected parent.<h4>Conclusion</h4>Our work provides a comprehensive review and expansion of the genotypic and phenotypic spectrum of KAT6B disorders that will assist clinicians in the assessment, counseling, and management of affected individuals.,  Blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) is an autosomal dominant disorder caused by mutations in FOXL2. We identified an individual with BPES and additional phenotypic features who did not have a FOXL2 mutation. We used whole exome sequencing to identify a de novo mutation in KAT6B (lysine acetyltransferase 6B) in this individual. The mutation was a 2-bp insertion leading to a frameshift which resulted in a premature stop codon. The resulting truncated protein does not have the C-terminal serine/methionine transcription activation domain necessary for interaction with other transcriptional and epigenetic regulators. This mutation likely has a dominant-negative or gain-of-function effect, similar to those observed in other genetic disorders resulting from KAT6B mutations, including Say-Barber-Biesecker-Young-Simpson (SBBYSS) and genitopatellar syndrome (GTPTS). Thus, our subject's phenotype broadens the spectrum of clinical findings associated with mutations in KAT6B. Furthermore, our results suggest that individuals with BPES without a FOXL2 mutation should be tested for KAT6B mutations. The transcriptional and epigenetic regulation mediated by KAT6B appears crucial to early developmental processes, which when perturbed can lead to a wide spectrum of phenotypic outcomes.,  Genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS or Ohdo syndrome) have both recently been shown to be caused by distinct mutations in the histone acetyltransferase KAT6B (a.k.a. MYST4/MORF). All variants are de novo dominant mutations that lead to protein truncation. Mutations leading to GPS occur in the proximal portion of the last exon and lead to the expression of a protein without a C-terminal domain. Mutations leading to SBBYSS occur either throughout the gene, leading to nonsense-mediated decay, or more distally in the last exon. Features present only in GPS are contractures, anomalies of the spine, ribs and pelvis, renal cysts, hydronephrosis, and agenesis of the corpus callosum. Features present only in SBBYSS include long thumbs and long great toes and lacrimal duct abnormalities. Several features occur in both, such as intellectual disability, congenital heart defects, and genital and patellar anomalies. We propose that haploinsufficiency or loss of a function mediated by the C-terminal domain causes the common features, whereas gain-of-function activities would explain the features unique to GPS. Further molecular studies and the compilation of mutations in a database for genotype-phenotype correlations (www.LOVD.nl/KAT6B) might help tease out answers to these questions and understand the developmental programs dysregulated by the different truncations.,  Genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) are rare genetic disorders linked to mutations in the Lysine Acetyltransferase 6B (KAT6B) gene, affecting histone acetylation regulation and developmental processes. We present a case of an African American infant with classic GPS features and a novel KAT6B gene mutation (c.4066del, p.Glu1356Argfs*23). The patient exhibited skeletal anomalies, neurologic deficits, and genitourinary abnormalities, consistent with GPS. Genetic analysis revealed a de novo heterozygous pathogenic variant, adding to the growing understanding of KAT6B-related disorders. Reviewing recent literature, we found an increased prevalence of reported cases and novel gene variants, supporting the delineation of GPS and SBBYSS. Furthermore, analysis suggests a preference range within the gene associated with GPS phenotypes, challenging the notion of a spectrum of KAT6B-related disorders. As genetic sequencing advances, continued reporting of cases will inform decisions regarding the classification of these disorders.,  Genitopatellar syndrome (GPS) and Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) are two distinct clinically overlapping syndromes caused by de novo heterozygous truncating mutations in the KAT6B gene encoding lysine acetyltransferase 6B, a part of the histone H3 acetyltransferase complex. We describe an 8-year-old girl with a KAT6B mutation and a combined GPS/SBBYSS phenotype. The comparison of this patient with 61 previously published cases with KAT6B mutations and GPS, SBBYSS or combined GPS/SBBYSS phenotypes allowed us to separate the KAT6B mutations into four groups according to their position in the gene (reflecting nonsense mediated RNA decay and protein domains) and their clinical outcome. We suggest that mutations in mid-exon 18 corresponding to the C-terminal end of the acidic (Asp/Glu-rich) domain of KAT6B may have more variable expressivity leading to GPS, SBBYSS or combined phenotypes, in contrast to defects in other regions of the gene which contribute more specifically to either GPS or SBBYSS. Notwithstanding the clinical overlap, our cluster analysis of phenotypes of all known patients with KAT6B mutations supports the existence of two clinical entities, GPS and SBBYSS, as poles within the KAT6B-related disease spectrum. The awareness of these phenomena is important for qualified genetic counselling of patients with KAT6B mutations.,  Genitopatellar syndrome (GPS) is a rare autosomal dominant disorder caused by de novo pathogenic variants in the <i>KAT6B</i> gene. It is characterized by genital abnormalities, patellar hypoplasia/agenesis, flexion contractures of the hips and knees, corpus callosum agenesis with microcephaly, and hydronephrosis and/or multiple renal cysts. More than half of patients with GPS have congenital heart defects, mostly atrial and/or ventricular septal defects, patent foramen ovale, and patent ductus arteriosus. We report a case of a Japanese neonate with a de novo heterozygous c.3769_3772delTCTA pathogenic variant in the <i>KAT6B</i> gene who presented with a cardiac intramural cavity of the ventricular septum at birth. The cavity unexpectedly disappeared at 1 month of age, but trabecular septal thinning and flash remained. The features of the cavity were not consistent with those of congenital ventricular diverticulum or aneurysm, and its identity and prognosis are still unclear. Because patients with GPS may exhibit various forms of cardiac malformation, careful cardiac examination and follow-up are required from birth in cases of suspected GPS.,  Genitopatellar syndrome (GPS) is a rare disorder characterized by patellar hypoplasia, flexion contractures of the lower limbs, psychomotor retardation and genital and renal anomalies. We report the case of a female infant diagnosed with GPS to a <i>KAT6B</i> gene mutation, which was identified using whole exome sequencing.,  Genitopatellar syndrome (GPS) is a rare disorder in which patellar aplasia or hypoplasia is associated with external genital anomalies and severe intellectual disability. Using an exome-sequencing approach, we identified de novo mutations of KAT6B in five individuals with GPS; a single nonsense variant and three frameshift indels, including a 4 bp deletion observed in two cases. All identified mutations are located within the terminal exon of the gene and are predicted to generate a truncated protein product lacking evolutionarily conserved domains. KAT6B encodes a member of the MYST family of histone acetyltranferases. We demonstrate a reduced level of both histone H3 and H4 acetylation in patient-derived cells suggesting that dysregulation of histone acetylation is a direct functional consequence of GPS alleles. These findings define the genetic basis of GPS and illustrate the complex role of the regulation of histone acetylation during development.,  Genitopatellar syndrome (GPS) is a rare disorder with characteristic craniofacial features, congenital flexion contractures of the lower limbs, absent or abnormal patellae, urogenital anomalies, and severe psychomotor retardation. Twelve patients with ages from 15 days to 12 years and two affected fetuses have been reported. We describe a 17-year-old female with a phenotype consistent with GPS. Being the oldest reported patient, she is the first one showing severe symptomatic osteoporosis and endocrine abnormalities including primary hypothyroidism and delayed puberty. We suggest that these novel findings are also manifestations of GPS.,  Genitopatellar syndrome (GPS) is a skeletal dysplasia with cerebral and genital anomalies for which the molecular basis has not yet been determined. By exome sequencing, we found de novo heterozygous truncating mutations in KAT6B (lysine acetyltransferase 6B, formerly known as MYST4 and MORF) in three subjects; then by Sanger sequencing of KAT6B, we found similar mutations in three additional subjects. The mutant transcripts do not undergo nonsense-mediated decay in cells from subjects with GPS. In addition, human pathological analyses and mouse expression studies point to systemic roles of KAT6B in controlling organismal growth and development. Myst4 (the mouse orthologous gene) is expressed in mouse tissues corresponding to those affected by GPS. Phenotypic differences and similarities between GPS, the Say-Barber-Biesecker variant of Ohdo syndrome (caused by different mutations of KAT6B), and Rubinstein-Taybi syndrome (caused by mutations in other histone acetyltransferases) are discussed. Together, the data support an epigenetic dysregulation of the limb, brain, and genital developmental programs.,  Genitopatellar syndrome (GPS) is mainly characterized by an absence of patellae, congenital flexion contractures of the lower limbs, psychomotor retardation, and anomalies of the external genitalia and kidneys. We report an 18-year-old female with a novel heterozygous truncating mutation in exon 17 of the KAT6B gene [MC_000010.11:c.3603_3606 del, p.Arg1201fs]. This is the first report of typical GPS in a Japanese individual. The details of our findings may contribute to elucidating the mechanism underlying GPS-specific clinical features.,  Genitopatellar syndrome is a newly described disorder characterized by absent/hypoplastic patellae, lower extremity contractures, urogenital anomalies, dysmorphic features, skeletal anomalies, and agenesis of the corpus callosum. More recently, cardiac anomalies and ectodermal dysplasia have been suggested as additional features of this syndrome. We report on two additional patients with genitopatellar syndrome and expand the spectrum of anomalies to include radio-ulnar synostosis. Since there exists significant overlap in the skeletal phenotype between genitopatellar syndrome and both the nail-patella and short patella syndromes, mutation screening of their causative genes, LMX1B and TBX4, was performed. Although there still does not appear to be an identifiable molecular etiology in genitopatellar syndrome, mutations in these two candidate genes have been excluded in our patients. Since both LMX1B and TBX4 are involved in a common molecular pathway, it is likely that the causative gene of genitopatellar syndrome functions within the same developmental process.,  Genitopatellar syndrome is a recently described disorder with characteristic facies, genital anomalies, absent patella, flexion contractures, microcephaly, renal anomalies, and mental retardation. The presence of affected siblings in two of the original families suggests autosomal recessive inheritance. We report a new patient that exhibits all of these cardinal features and is also the second case to have additional, more severe findings including a congenital heart defect, anal anomalies, and features of an ectodermal dysplasia, thus expanding the phenotype to include these manifestations.,  Genitopatellar syndrome is one of the syndromes described in the last decade. It is characterized by agenesis of the corpus callosum, absent or hypoplastic patellae, extremity contractures, skeletal anomalies, urogenital anomalies, and facial dysmorphic features. While writing this report, only 15 cases have been reported in the literature. The etiology, clinical features, management, and natural history of this syndrome are not yet well established. Past reports in the literature have not been able to identify the exact genetic etiology but it somewhat coincides with nail patella syndrome and short patella syndrome. We would like to introduce this terminology to the orthopedic community and highlight the clinical features of the genitopatellar syndrome. To the best of our knowledge, this is a single case report with the longest follow-up of 11 years in the literature.,  Heterozygous pathogenic variants in the <i>KAT6B</i> gene, which encodes lysine acetyltransferase 6B, have been identified in patients with congenital rare disorders, including genitopatellar syndrome and Say-Barber-Biesecker-Young-Simpson syndrome. Herein, we report another Japanese patient with a <i>KAT6B</i>-related disorder and a novel de novo heterozygous variant in exon 18 of <i>KAT6B</i> [c.3925dup, p.(Glu1309fs*33)], providing further evidence that truncating variants in exon 17 and in the proximal region of exon 18 are associated with genitopatellar syndrome-like phenotypes.,  KAT6B sequence variants have been identified in both patients with the Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and in the genitopatellar syndrome (GPS). In SBBYSS, they were reported to affect mostly exons 16-18 of KAT6B, and the predicted mechanism of pathogenesis was haploinsufficiency or a partial loss of protein function. Truncating variants in KAT6B leading to GPS appear to cluster within the proximal portion of exon 18, associated with a dominant-negative effect of the mutated protein, most likely. Although SBBYSS and GPS have been initially considered allelic disorders with distinctive genetic and clinical features, there is evidence that they represent two ends of a spectrum of conditions referable as KAT6B-related disorders. We detected a de novo truncating variant within exon 7 of KAT6B in a 8-year-old female who presented with mild intellectual disability, facial dysmorphisms highly consistent with SBBYSS, and skeletal anomalies including exostosis, that are usually considered component manifestations of GPS. Following the clinical diagnosis driven by the striking facial phenotype, we analyzed the KAT6B gene by NGS techniques. The present report highlights the pivotal role of clinical genetics in avoiding clear-cut genotype-phenotype categories in syndromic forms of intellectual disability. In addition, it further supports the evidence that a continuum exists within the clinical spectrum of KAT6B-associated disorders.,  KAT6B sequence variants have been identified previously in both patients with the Say-Barber-Biesecker type of blepharophimosis mental retardation syndromes (SBBS) and in the more severe genitopatellar syndrome (GPS). We report on the findings in a previously unreported group of 57 individuals with suggestive features of SBBS or GPS. Likely causative variants have been identified in 34/57 patients and were commonly located in the terminal exons of KAT6B. Of those where parental samples could be tested, all occurred de novo. Thirty out of thirty-four had truncating variants, one had a missense variant and the remaining three had the same synonymous change predicted to affect splicing. Variants in GPS tended to occur more proximally to those in SBBS patients, and genotype/phenotype analysis demonstrated significant clinical overlap between SBBS and GPS. The de novo synonymous change seen in three patients with features of SBBS occurred more proximally in exon 16. Statistical analysis of clinical features demonstrated that KAT6B variant-positive patients were more likely to display hypotonia, feeding difficulties, long thumbs/great toes and dental, thyroid and patella abnormalities than KAT6B variant-negative patients. The few reported patients with KAT6B haploinsufficiency had a much milder phenotype, though with some features overlapping those of SBBS. We report the findings in a previously unreported patient with a deletion of the KAT6B gene to further delineate the haploinsufficiency phenotype. The molecular mechanisms giving rise to the SBBS and GPS phenotypes are discussed.,  Mutations in KAT6B gene are responsible for Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and genitopatellar syndrome (GPS), with most mutations occurring in exon 18. A 4-year-old Chinese boy presented with short stature but no other clinical features of SBBYSS or GPS had a de novo novel nonsense pathogenic mutation in exon 14 of the KAT6B gene at position c.2636T>A (p.Leu879X). The correlation analysis of genotype-phenotype indicated distinctive clinical features (short stature, growth hormone deficiency, and delayed bone age) compared with the classical mutations of KAT6B gene. To the best of our knowledge, this is the first report of KAT6B gene mutation in any Chinese individual. This work expands the mutant phenotypic spectrum of the KAT6B gene.,  Mutations of the histone acetyltransferase-encoding KAT6B gene cause the Say-Barber-Biesecker/Young-Simpson (SBBYS) type of blepharophimosis-\\\\mental retardation\\\\ syndromes and the more severe genitopatellar syndrome. The SBBYS syndrome-causing mutations are clustered in the large exon 18 of KAT6B and almost exclusively lead to predicted protein truncation. An atypical KAT6B mutation, a de novo synonymous variant located in exon 16 (c.3147G>A, p.(Pro1049Pro)) was previously identified in three unrelated patients. This exonic mutation was predicted in silico to cause protein truncation through aberrant splicing. Here, we report three additional unrelated children with typical SBBYS syndrome and the KAT6B c.3147G>A mutation. We show on RNA derived from patient blood that the mutation indeed induces aberrant splicing through the use of a cryptic exonic splice acceptor site created by the sequence variant. Our results thus identify the synonymous variant c.3147G>A as a splice site mutation and a mutational hot spot in SBBYS syndrome.,  Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and Genitopatellar syndrome (GTPTS) are very rare conditions caused by KAT6B truncating variants. Because of both syndromes often share common features the associated phenotypes are usually grouped under the term \\\\KAT6B-related disorders.\\\\ However, particular signs of each syndrome have been reported and their appearance seems to be dependent on where the KAT6B variant is located. Thus, whereas truncating variants associated with SBBYSS have their highest density in the distal part of exon 18, those resulting in GTPTS are distributed between the end of exon 17 and beginning of exon 18. Here, we reported two de novo heterozygous KAT6B truncating variants. The first variant (c.5802delA; p.A1935Pfs*16), identified in a boy with SSBYSS phenotype, resulting in the most distal KAT6B truncating variant reported up-to-date in the scientific literature. The second variant (c.3152delG; p.S1051Tfs*63), located in a region hitherto defined as specific of SBBYSS, seems to cause an overlapping SBBYSS/GTPTS phenotype. The clinical and genetic characterization of these patients could contribute to the understanding of the KAT6B-related disorders.,  Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and genitopatellar syndrome (GPS) are caused by variants of lysine acetyltransferase 6B (<i>KAT6B</i>). These variants tend to occur in the terminal exons of <i>KAT6B</i>. Here, we report a patient with global developmental delay, intellectual disability, autistic behavior, muscular hypotonia, facial dysmorphism, and seizures caused by a novel missense variant in exon 7 of <i>KAT6B</i>. The patient showed a phenotype differing from those of SBBYSS and GPS. We also report patients with missense variants in the proximal exons of <i>KAT6B</i> showing dysmorphic features and autistic behavior not resembling the characteristics of SBBYSS and GPS. Missense variants in the proximal exons of <i>KAT6B</i> may have a dominant negative effect or cause gain of function, leading to unique phenotypes not resembling those of SBBYSS and GPS.,  Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS) and genitopatellar syndrome (GTPTS) are clinically similar disorders with some overlapping features. Although they are currently considered to be distinct clinical entities, both were found to be caused by de novo truncating sequence variants in the KAT6B (lysine acetyltransferase 6B) gene, strongly suggesting that they are allelic disorders. Herein, we report the clinical and genetic findings in a girl presenting with a serious multiple congenital anomaly syndrome with phenotypic features overlapping both SBBYSS and GTPTS; pointing out that the clinical distinction between these disorders is not exact and there do exist patients, in whom conventional clinical classification is problematic. Genetic analyses revealed a truncating c.4592delA (p.Asn1531Thrfs*18) variant in the last KAT6B exon. Our findings support that phenotypes associated with typical KAT6B disease-causing variants should be referred to as 'KAT6B spectrum disorders' or 'KAT6B related disorders', rather than their current SBBYSS and GTPTS classification.,  Say-Barber-Biesecker-Young-Simpson syndrome (SBBYSS, OMIM#603736) and genitopatellar syndrome (GTPTS, OMIM#606170), characterized by global developmental delay/intellectual disability and special clinical manifestations, are two distinct clinically overlapping syndromes caused by truncating sequence variants in the KAT6B (10q22.2) gene. We detected a de novo heterozygous variant within exon 16 of KAT6B (Chr10p: 76781966-76781967) in a 7-months-old female infant who showed symptoms of short stature, global developmental delay, blepharophimosis, and lacrimal duct anomalies highly consistent with SBBYSS. Following the clinical features, we analyzed the KAT6B gene using Next Generation Sequencing (NGS) techniques. Her parents didn't present the same genetic variant. The patient we reported here is mainly characterized by syndromic forms of short stature and developmental delay, which may contribute to the understanding of clinical genetics for KAT6B-associated disorders.,  The Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome (SBBYSS) (MIM# 603736) and genitopatellar syndrome (GPS) (MIM#606170) are allelic diseases caused by KAT6B mutation. Genotype-phenotype correlation is assumed, but a few patients manifest overlapping features of both syndromes. Here we report the case of a boy with SBBYSS. He had a KAT6B mutation previously reported in typical SBBYSS, but he also manifested severe developmental delay, as well as genital features and laryngomalacia requiring tracheostomy that conformed to GPS.,  The Say-Barber-Biesecker-Young-Simpson variant of Ohdo syndrome (SBBYSS) and Genitopatellar syndrome (GTPTS) are 2 rare but clinically well-described diseases caused by de novo heterozygous sequence variants in the KAT6B gene. Both phenotypes are characterized by significant global developmental delay/intellectual disability, hypotonia, genital abnormalities, and patellar hypoplasia/agenesis. In addition, congenital heart defects, dental abnormalities, hearing loss, and thyroid anomalies are common to both phenotypes. This broad clinical overlap led some authors to propose the concept of KAT6B spectrum disorders. On the other hand, some clinical features could help to differentiate the 2 disorders. Furthermore, it is possible to establish a genotype-phenotype correlation when considering the position of the sequence variant along the gene, supporting the notion of the 2 disorders as really distinct entities.,  The Say-Barber/Biesecker/Young-Simpson (SBBYS) type of the blepharophimosis-mental retardation syndrome group (Ohdo-like syndromes) is a multiple congenital malformation syndrome characterized by vertical narrowing and shortening of the palpebral fissures, ptosis, intellectual disability, hypothyroidism, hearing impairment, and dental anomalies. Mutations of the gene encoding the histone-acetyltransferase KAT6B have been recently identified in individuals affected by SBBYS syndrome. SBBYS syndrome-causing KAT6B mutations cluster in a ~1,700 basepair region in the 3' part of the large exon 18, while mutations located in the 5' region of the same exon have recently been identified to cause the genitopatellar syndrome (GPS), a clinically distinct although partially overlapping malformation-intellectual disability syndrome. Here, we present two children with clinical features of SBBYS syndrome and de novo truncating KAT6B mutations, including a boy who was diagnosed at the age of 4 months. Our results confirm the implication of KAT6B mutations in typical SBBYS syndrome and emphasize the importance of genotype-phenotype correlations at the KAT6B locus where mutations truncating the KAT6B protein at the amino-acid positions ~1,350-1,920 cause SBBYS syndrome.,  The phenotypic variability associated with pathogenic variants in Lysine Acetyltransferase 6B (KAT6B, a.k.a. MORF, MYST4) results in several interrelated syndromes including Say-Barber-Biesecker-Young-Simpson Syndrome and Genitopatellar Syndrome. Here we present 20 new cases representing 10 novel KAT6B variants. These patients exhibit a range of clinical phenotypes including intellectual disability, mobility and language difficulties, craniofacial dysmorphology, and skeletal anomalies. Given the range of features previously described for KAT6B-related syndromes, we have identified additional phenotypes including concern for keratoconus, sensitivity to light or noise, recurring infections, and fractures in greater numbers than previously reported. We surveyed clinicians to qualitatively assess the ways families engage with genetic counselors upon diagnosis. We found that 56% (10/18) of individuals receive diagnoses before the age of 2\\u00a0years (median age\\u00a0=\\u00a01.96\\u00a0years), making it challenging to address future complications with limited accessible information and vast phenotypic severity. We used CRISPR to introduce truncating variants into the KAT6B gene in model cell lines and performed chromatin accessibility and transcriptome sequencing to identify key dysregulated pathways. This study expands the clinical spectrum and addresses the challenges to management and genetic counseling for patients with KAT6B-related disorders.,  We describe our findings in a 46,XY female with a clinical features of Genitopatellar syndrome (GPS) and confirmed hermaphroditism with ovotestes, and five additional patients with GPS. GPS is a genetic disorder characterized by renal and genital anomalies, joint dislocation, aplastic or hypoplastic and often displaced patellae, minor facial anomalies, and mental retardation. The genital anomalies clearly distinguish GPS from nail-patella syndrome (NPS) that has similar features, but additionally shows hypoplastic finger- and toenails as found in the 46,XY female. In our patients no mutation was found in the coding regions of WNT4, WNT7A, TBX4, and LMX1B. Fluorescent in situ hybridization (FISH) and array-based comparative genome hybridization (aCGH) analysis showed a 3 Mb deletion of LMX1B, NR6A1, and NR5A1 (SF1) in the 46,XY female. This is the first report of a microdeletion causing haploinsuffiency of LMX1B and NR5A1. The deletion of LMX1B is responsible for the knee anomalies and the deletion of NR5A1 likely causes the sex reversal. Cytogenetic analysis of the five additional patients with diagnosed GPS failed to identify a similar microdeletion, or inversion of a potentially regulatory element between the two genes. This suggests that the locus 9q33-9q34 can be excluded for GPS and that the presented case is unique in its combination of GPS and NPS features caused by a microdeletion associated with loss of function of LMX1B and NR5A1.,  We report on the association of absent patellae, genital and renal anomalies, dysmorphic features, and mental retardation in seven children (six boys and one girl) belonging to five unrelated families. Flexion deformities of the knees and hips with club feet and absent patellae were consistently observed and scrotal hypoplasia and cryptorchidism were present in all boys (6/6). Dysmorphic features included a coarse face, a large nose with a high nasal bridge, and microcephaly. Other features included renal anomalies (multicystic kidneys or hydronephrosis, 7/7), agenesis of the corpus callosum (4/7), swallowing difficulties, micrognathia (4/7), and pulmonary hypoplasia (3/7). Bilateral hypoplasia of the ischia and brachydactyly were also consistently observed (5/5). In two out of seven cases, prenatal ultrasound detection of microcephaly and renal anomalies led to termination of the pregnancy at 27 weeks. Three children died during the first years of life and the remaining two who survived exhibit severe developmental delay. High resolution cytogenetic studies performed on lymphocytes or fibroblasts or both were normal in all cases. Recurrence in two families suggests an autosomal recessive mode of inheritance. We propose that this unusual association, similar to that observed in a 4 year old boy by Goldblatt et al, represents a new syndrome distinct from previously reported hypoplastic patella syndromes.,  We report the second female with genitopatellar syndrome, a recently identified arthrogryposis syndrome. The salient features include severe mental retardation and microcephaly with absence of the corpus callosum, absent/hypoplastic patellae, genital anomalies, and hydronephrosis.,  We report two patients with sagittal craniosynostosis, hypoplastic male genitalia, agenesis of the corpus callosum, thyroid abnormalities, and dysmorphic features which include short palpebral fissures and retrognathia. The clinical presentation of both patients was initially thought to be suggestive of Lin-Gettig syndrome (LGS), a multiple malformation syndrome associated with craniosynostosis that was initially reported in two brothers in 1990, with a third patient reported in 2003. Our first patient was subsequently found through exome sequencing to have a de novo mutation in KAT6B, c.4572dupT, p.(Thr1525Tyrfs*16). The second patient was ascertained as possible LGS, but KAT6B mutation testing was pursued clinically after the identification of the KAT6B mutation in Patient 1, and identified a de novo mutation, c.4205_4206delCT, p.(Ser1402Cysfs*5). The phenotypic spectrum of KAT6B mutations has been expanding since identification of KAT6B mutations in genitopatellar syndrome (GPS) and Say Barber Biesecker Young Simpson (SBBYS) syndrome patients. We show that craniosynostosis, which has not been previously reported in association with KAT6B mutations, may be part of the genitopatellar/Say Barber Biesecker Young Simpson spectrum. These two patients also further demonstrate the overlapping phenotypes of genitopatellar and SBBYS syndromes recently observed by others. Furthermore, we propose that it is possible that one or more of the previous cases of LGS may have also been due to mutation in KAT6B, and that LGS may actually be a variant within the KAT6B spectrum and not a distinct clinical entity.\",\n          \" ,  Genetic disorders characterized by congenital patellar aplasia or hypoplasia belong to a clinically diverse and genetically heterogeneous group of lower limb malformations. Patella development involves different molecular and cellular mechanisms regulating dorso-ventral patterning, cartilage and bone formation along endochondral ossification pathways, and growth. Several human genes that are important for patella development have been uncovered by the study of human limb malformation syndromes, yet causative genes for many more such disorders await to be identified and their complex interactions in the developmental pathways deciphered. Mutant animal models of congenital patellar aplasia or hypoplasia are certainly instrumental to create more insight into this aspect of limb development. Moreover, investigation of the complete phenotype of human syndromes and animal models may reveal novel insights into the pleiotropic roles of the responsible genes in the normal developmental of other organ systems. In this review, the phenotype and gene defects of syndromes with congenital patellar aplasia or hypoplasia will be discussed, including the nail patella syndrome, small patella syndrome, isolated patella aplasia hypoplasia, Meier-Gorlin syndrome, RAPADILINO syndrome, and genitopatellar syndrome.,  Genitopatellar syndrome is a newly described condition, subject of a single literature report to date. The condition comprises absent patellae, genital and renal malformations, joint dislocation, and mental retardation. Recurrence has been recorded in two kindreds, consistent with autosomal recessive inheritance., PROJECT ABSTRACT\\\\\\\\\\\\\\\\nEpigenetic factors are genes that encode proteins that can affect spatial organization of DNA and the\\\\\\\\\\\\\\\\naccessibility of genetic regions to transcriptional machinery, thereby regulating cell-type specific transcription.\\\\\\\\\\\\\\\\nPathogenic mutations in established epigenes are highly enriched in children with pediatric syndromic disorders,\\\\\\\\\\\\\\\\noften with symptoms that affect multiple organ systems, such as the brain, heart, gastrointestinal tract, bone, eye\\\\\\\\\\\\\\\\nand kidneys. The associated symptoms of intellectual disability, developmental delays, autism, diarrhea and\\\\\\\\\\\\\\\\ncongenital heart defects vary in severity between individuals. The onset of these syndromes during early\\\\\\\\\\\\\\\\nchildhood suggest that many of these epigenetic factors are critical to early developmental processes and cell-\\\\\\\\\\\\\\\\nfate transitions. Despite our improved diagnostic ability with exome sequencing, the mechanistic link between\\\\\\\\\\\\\\\\nepigenetic factor mutations and the direct mechanisms by which they disrupt mammalian developmental\\\\\\\\\\\\\\\\nprocesses remains unknown. Histone acetyltransferases (HATs) are genes that acetylate lysine (K) residues\\\\\\\\\\\\\\\\nand represent a common mechanism for controlling DNA accessibility to the transcriptional machinery. Here, we\\\\\\\\\\\\\\\\nstudy protein-truncating variants in two HATs: Lysine (K), Acetyl transferase 6A and 6B (KAT6A and KAT6B),\\\\\\\\\\\\\\\\nwhich cause Arboleda-Tham Syndrome (ARTHS) and Genitopatellar Syndrome (GPS) or Say-Barber-Biesecker-\\\\\\\\\\\\\\\\nYoung Syndrome (SBBYS), respectively. Our goal is to develop and validate transgenic mouse models harboring\\\\\\\\\\\\\\\\npatient-specific mutations in these genes to establish the differential roles of these epigenetic factors on cell\\\\\\\\\\\\\\\\nspecification during development driving the distinct syndromes.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 248,\n        \"min\": 49,\n        \"max\": 400,\n        \"num_unique_values\": 2,\n        \"samples\": [\n          400,\n          49\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"frequent_words\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"genitopatellar syndrome , kat6b , sbbyss , say-barber-biesecker-young-simpson syndrome , rare genetic diagnosis\",\n          \"Acetylation , Acetyltransferase , adult stem cell , Affect , Animal Model\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Llama_3_n\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 2,\n        \"samples\": [\n          \"{'**Genetic basis of Genitopatellar syndrome**': 'The researchers have identified the KAT6B gene as the gene responsible for Genitopatellar syndrome. They have conducted genetic analyses to identify the specific mutations in the KAT6B gene that cause the syndrome.', '**Clinical manifestations of Genitopatellar syndrome**': 'The researchers have conducted clinical studies to identify and characterize the various features of Genitopatellar syndrome, including the absence or underdevelopment of the patella, genital and urinary abnormalities, intellectual disability, hypotonia, and facial dysmorphism.', '**Treatment and management of Genitopatellar syndrome**': 'The researchers have conducted studies to evaluate the various treatment options for individuals with Genitopatellar syndrome, including physical therapy, surgical intervention, and medication.', '**Genitopatellar syndrome and associated conditions**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other conditions, such as cardiac anomalies and ectodermal dysplasia.', '**Genitopatellar syndrome and radio-ulnar synostosis**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and radio-ulnar synostosis, which is the fusion of the bones in the forearm.', '**Genitopatellar syndrome and other digital abnormalities**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other digital abnormalities, such as preaxial and postaxial polydactyly.', '**Genitopatellar syndrome and intellectual disability**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and intellectual disability, including the evaluation of the severity and impact of intellectual disability in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and hypotonia**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and hypotonia, including the evaluation of the severity and impact of hypotonia in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and facial dysmorphism**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and facial dysmorphism, including the evaluation of the severity and impact of facial dysmorphism in individuals with Genitopatellar syndrome.', '**Genitopatellar syndrome and other associated features**': 'The researchers have conducted studies to explore the relationship between Genitopatellar syndrome and other associated features, such as cardiac anomalies, ectodermal dysplasia, and radio-ulnar synostosis.', '**Genitopatellar syndrome and its impact on quality of life**': 'The researchers have conducted studies to evaluate the impact of Genitopatellar syndrome on the quality of life of individuals with the syndrome, including the evaluation of the impact of the various features of the syndrome on the quality of life.'}\",\n          \"{'**Genetic basis of Genitopatellar syndrome**': 'The authors have conducted extensive research on the genetic basis of Genitopatellar syndrome. They have identified the causative gene, which is the histone acetyltransferase gene, and have characterized the specific mutations that lead to the syndrome. This research has provided valuable insights into the genetic underpinnings of this rare condition and has opened up new avenues for targeted therapies.', '**Developmental mechanisms of Genitopatellar syndrome**': 'The authors have also focused on the developmental mechanisms of Genitopatellar syndrome. They have studied the impact of the causative gene mutations on the early developmental processes, such as cell differentiation, proliferation, and migration, and have identified the specific pathways that are affected. This research has provided a deeper understanding of the pathogenesis of this condition and has helped in the development of targeted interventions.', '**Animal models for Genitopatellar syndrome**': 'The authors have established animal models for Genitopatellar syndrome, using genetically engineered mice with the causative gene mutations. These models have allowed them to study the phenotypic manifestations of the syndrome in a controlled environment and to investigate the mechanisms by which the mutations affect the development of the affected organs. This research has contributed to our understanding of the disease process and has facilitated the development of new therapeutic strategies.'}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-254478ab-4f06-4749-bc17-40a800e75ebc\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  Genetic disorders characterized by congeni...</td>\n",
              "      <td>[Acetylation, Acetyltransferase, adult stem ce...</td>\n",
              "      <td>49</td>\n",
              "      <td>Acetylation , Acetyltransferase , adult stem c...</td>\n",
              "      <td>{'**Genetic basis of Genitopatellar syndrome**...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>&lt;h4&gt;Background&lt;/h4&gt;Say-Barber-Biesecker-Young...</td>\n",
              "      <td>[sbbyss, genitourinary complications, say-barb...</td>\n",
              "      <td>400</td>\n",
              "      <td>genitopatellar syndrome , kat6b , sbbyss , say...</td>\n",
              "      <td>{'**Genetic basis of Genitopatellar syndrome**...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-254478ab-4f06-4749-bc17-40a800e75ebc')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-254478ab-4f06-4749-bc17-40a800e75ebc button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-254478ab-4f06-4749-bc17-40a800e75ebc');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-435b3b4f-f71b-4165-8422-814c51a7b70a\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-435b3b4f-f71b-4165-8422-814c51a7b70a')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-435b3b4f-f71b-4165-8422-814c51a7b70a button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_73e202c9-0b2f-4b08-aab2-ffeaf8d426c2\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_73e202c9-0b2f-4b08-aab2-ffeaf8d426c2 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  Genetic disorders characterized by congeni...   \n",
              "1          0   <h4>Background</h4>Say-Barber-Biesecker-Young...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [Acetylation, Acetyltransferase, adult stem ce...    49   \n",
              "1  [sbbyss, genitourinary complications, say-barb...   400   \n",
              "\n",
              "                                      frequent_words  \\\n",
              "0  Acetylation , Acetyltransferase , adult stem c...   \n",
              "1  genitopatellar syndrome , kat6b , sbbyss , say...   \n",
              "\n",
              "                                           Llama_3_n  \n",
              "0  {'**Genetic basis of Genitopatellar syndrome**...  \n",
              "1  {'**Genetic basis of Genitopatellar syndrome**...  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "repr_error": "Out of range float values are not JSON compliant: nan",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-b70a65f2-02ca-4089-b639-f752753d86a4\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  Bone morphogenic proteins (BMPs) are impor...</td>\n",
              "      <td>[0-6 weeks old, Achondroplasia, Achondroplasti...</td>\n",
              "      <td>27</td>\n",
              "      <td>diaphanospondylodysostosis , bmper , dan , dif...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>Bone morphogenetic protein-binding endothelia...</td>\n",
              "      <td>[dsd, bmper, ischiovertebral, ischiospinal dys...</td>\n",
              "      <td>16</td>\n",
              "      <td>dsd , bmper , ischiovertebral , ischiospinal d...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>Diaphanospondylodysostosis (DSD) is a rare sk...</td>\n",
              "      <td>[]</td>\n",
              "      <td>21</td>\n",
              "      <td></td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2</td>\n",
              "      <td>&lt;h4&gt;Background&lt;/h4&gt;Diaphanospondylodysostosis...</td>\n",
              "      <td>[diaphanospondylodysostosis, bmper, isd, ischi...</td>\n",
              "      <td>17</td>\n",
              "      <td>diaphanospondylodysostosis , bmper , isd , isc...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>3</td>\n",
              "      <td>Diaphanospondylodysostosis (DSD) is a rare au...</td>\n",
              "      <td>[bmper, ischiospinal dysostosis, skeletal dysp...</td>\n",
              "      <td>10</td>\n",
              "      <td>bmper , ischiospinal dysostosis , skeletal dys...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>4</td>\n",
              "      <td>Diaphanospondylodysostosis (DSD), caused by l...</td>\n",
              "      <td>[]</td>\n",
              "      <td>12</td>\n",
              "      <td></td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>5</td>\n",
              "      <td>Diaphanospondylodysostosis is an extremely ra...</td>\n",
              "      <td>[diaphanospondylodysostosis, multicystic kidne...</td>\n",
              "      <td>11</td>\n",
              "      <td>diaphanospondylodysostosis , multicystic kidne...</td>\n",
              "      <td>None</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-b70a65f2-02ca-4089-b639-f752753d86a4')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-b70a65f2-02ca-4089-b639-f752753d86a4 button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-b70a65f2-02ca-4089-b639-f752753d86a4');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-68e6844b-6700-4ba1-b4b3-5f297f15d1b3\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-68e6844b-6700-4ba1-b4b3-5f297f15d1b3')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-68e6844b-6700-4ba1-b4b3-5f297f15d1b3 button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_e8f2f164-29cd-4160-8e40-bb098e061229\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_e8f2f164-29cd-4160-8e40-bb098e061229 button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  Bone morphogenic proteins (BMPs) are impor...   \n",
              "1          0   Bone morphogenetic protein-binding endothelia...   \n",
              "2          1   Diaphanospondylodysostosis (DSD) is a rare sk...   \n",
              "3          2   <h4>Background</h4>Diaphanospondylodysostosis...   \n",
              "4          3   Diaphanospondylodysostosis (DSD) is a rare au...   \n",
              "5          4   Diaphanospondylodysostosis (DSD), caused by l...   \n",
              "6          5   Diaphanospondylodysostosis is an extremely ra...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [0-6 weeks old, Achondroplasia, Achondroplasti...    27   \n",
              "1  [dsd, bmper, ischiovertebral, ischiospinal dys...    16   \n",
              "2                                                 []    21   \n",
              "3  [diaphanospondylodysostosis, bmper, isd, ischi...    17   \n",
              "4  [bmper, ischiospinal dysostosis, skeletal dysp...    10   \n",
              "5                                                 []    12   \n",
              "6  [diaphanospondylodysostosis, multicystic kidne...    11   \n",
              "\n",
              "                                      frequent_words Llama_3_n  \n",
              "0  diaphanospondylodysostosis , bmper , dan , dif...      None  \n",
              "1  dsd , bmper , ischiovertebral , ischiospinal d...      None  \n",
              "2                                                         None  \n",
              "3  diaphanospondylodysostosis , bmper , isd , isc...      None  \n",
              "4  bmper , ischiospinal dysostosis , skeletal dys...      None  \n",
              "5                                                         None  \n",
              "6  diaphanospondylodysostosis , multicystic kidne...      None  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        },
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "0\n",
            "-----------------------------------------\n",
            "res 1. BMP Inhibitor Interactions with Extracellular Matrix:\n",
            " The researchers have made significant contributions in understanding the role of **extracellular matrix (ECM)** in regulating **bone morphogenic proteins (BMPs)**. They have demonstrated how **BMP antagonists** bind to the ECM and how these interactions influence their activity. The importance of this interaction is highlighted by the numerous human connective tissue disorders caused by mutations in these proteins. This work provides insights into the molecular mechanisms involved in BMP regulation and their implications in developmental programs and disease processes.\n",
            "2. Diaphanospondylodysostosis:\n",
            " The researchers have contributed to the understanding of **diaphanospondylodysostosis (DSD)**, a rare genetic skeletal disorder caused by **biallelic variants in the BMPER gene**. They have reported on a novel case with severe scoliosis and hypoplastic/aplastic distal phalanges of the fingers and toes, findings not previously described in this syndrome. This case highlights the clinical and radiographic heterogeneity of DSD and emphasizes the importance of continued research to improve the understanding and management of this rare condition.\n",
            "3. Diaphanospondylodysostosis and Acrocallosal Syndrome:\n",
            " The researchers have also contributed to the understanding of **diaphanospondylodysostosis (DSD)** and **acrocallosal syndrome (ACS)**, two rare disorders with overlapping clinical features. They have identified a novel **BMPER mutation** in a patient with DSD, confirming the role of BMPER in the pathogenesis of this disorder. Furthermore, they have reported on three affected individuals from two unrelated families with ACS, and used **homozygosity mapping** to identify a common region on chromosome 7. The researchers also sequenced the **protein coding genes** in this region and identified a single novel **deleterious mutation** in the BMPER gene, confirming its involvement in ACS. These findings contribute to our understanding of the genetic basis of these rare disorders and their phenotypic spectrum.\n",
            "4. Diaphanospondylodysostosis and Nephroblastomatosis:\n",
            " The researchers have reported on a case of diaphanospondylodysostosis (DSD) which showed increased nuchal translucency at 1st trimester and missing ossification of the lower spine, short ribs with posterior gaps, and absent nasal bone in midtrimester. Autopsy revealed additionally bilateral nephroblastomatosis. Molecular genetic analysis showed a new mutation in the BMPER gene. This case highlights the clinical and radiographic heterogeneity of DSD and its prenatal presentation, and emphasizes the importance of early diagnosis and management of this rare condition.\n",
            "5. Skeletal Dysplasias:\n",
            " The researchers have made significant contributions to the understanding of the skeletal dysplasias (SDs), a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000 individuals. They have improved the characterization of the SDs, defined novel disorders, and improved the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. They have also tested the hypothesis that **flexion-extension MRI studies** with measurements of cerebrospinal and venous flow will aid in defining the need for surgery in patients with ACH, an area of current controversy. This work contributes to our understanding of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs, and their implications in diagnosis and management.\n",
            "6. Prenatal Presentation of Skeletal Dysplasias:\n",
            " The researchers have also contributed to the understanding of the prenatal presentation of the SDs and improving prenatal diagnosis. They have hypothesized that by employing 2D and 3D prenatal ultrasound (UTZ) and correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. They have objectively determined UTZ parameters that best predict lethality in the immediate neonatal period, established prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determined differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias. This work contributes to our understanding of the prenatal presentation of the SDs and their implications in early diagnosis and management.\n",
            "7. Phenotype-Genotype Correlations in Skeletal Dysplasias:\n",
            " The researchers have made significant contributions to the understanding of phenotype-genotype correlations in the SDs. Comparing the clinical phenotype with molecular and biochemical defects has allowed them to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. They have also continued studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. They have further proposed to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. This work contributes to our understanding of the genetic basis of the SDs and their implications in diagnosis and management.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'Diaphanospondylodysostosis': 'The researchers have contributed to the understanding of **diaphanospondylodysostosis (DSD)**, a rare genetic skeletal disorder caused by **biallelic variants in the BMPER gene**. They have reported on a novel case with severe scoliosis and hypoplastic/aplastic distal phalanges of the fingers and toes, findings not previously described in this syndrome. This case highlights the clinical and radiographic heterogeneity of DSD and emphasizes the importance of continued research to improve the understanding and management of this rare condition.', 'Diaphanospondylodysostosis and Acrocallosal Syndrome': 'The researchers have also contributed to the understanding of **diaphanospondylodysostosis (DSD)** and **acrocallosal syndrome (ACS)**, two rare disorders with overlapping clinical features. They have identified a novel **BMPER mutation** in a patient with DSD, confirming the role of BMPER in the pathogenesis of this disorder. Furthermore, they have reported on three affected individuals from two unrelated families with ACS, and used **homozygosity mapping** to identify a common region on chromosome', 'Diaphanospondylodysostosis and Nephroblastomatosis': 'The researchers have reported on a case of diaphanospondylodysostosis (DSD) which showed increased nuchal translucency at 1st trimester and missing ossification of the lower spine, short ribs with posterior gaps, and absent nasal bone in midtrimester. Autopsy revealed additionally bilateral nephroblastomatosis. Molecular genetic analysis showed a new mutation in the BMPER gene. This case highlights the clinical and radiographic heterogeneity of DSD and its prenatal presentation, and emphasizes the importance of early diagnosis and management of this rare condition.', 'Skeletal Dysplasias': 'The researchers have made significant contributions to the understanding of the skeletal dysplasias (SDs), a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000 individuals. They have improved the characterization of the SDs, defined novel disorders, and improved the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. They have also tested the hypothesis that **flexion-extension MRI studies** with measurements of cerebrospinal and venous flow will aid in defining the need for surgery in patients with ACH, an area of current controversy. This work contributes to our understanding of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs, and their implications in diagnosis and management.', 'Prenatal Presentation of Skeletal Dysplasias': 'The researchers have also contributed to the understanding of the prenatal presentation of the SDs and improving prenatal diagnosis. They have hypothesized that by employing 2D and 3D prenatal ultrasound (UTZ) and correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. They have objectively determined UTZ parameters that best predict lethality in the immediate neonatal period, established prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determined differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias. This work contributes to our understanding of the prenatal presentation of the SDs and their implications in early diagnosis and management.', 'Phenotype-Genotype Correlations in Skeletal Dysplasias': 'The researchers have made significant contributions to the understanding of phenotype-genotype correlations in the SDs. Comparing the clinical phenotype with molecular and biochemical defects has allowed them to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. They have also continued studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. They have further proposed to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. This work contributes to our understanding of the genetic basis of the SDs and their implications in diagnosis and management.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'Diaphanospondylodysostosis': 'The researchers have contributed to the understanding of **diaphanospondylodysostosis (DSD)**, a rare genetic skeletal disorder caused by **biallelic variants in the BMPER gene**. They have reported on a novel case with severe scoliosis and hypoplastic/aplastic distal phalanges of the fingers and toes, findings not previously described in this syndrome. This case highlights the clinical and radiographic heterogeneity of DSD and emphasizes the importance of continued research to improve the understanding and management of this rare condition.', 'Diaphanospondylodysostosis and Acrocallosal Syndrome': 'The researchers have also contributed to the understanding of **diaphanospondylodysostosis (DSD)** and **acrocallosal syndrome (ACS)**, two rare disorders with overlapping clinical features. They have identified a novel **BMPER mutation** in a patient with DSD, confirming the role of BMPER in the pathogenesis of this disorder. Furthermore, they have reported on three affected individuals from two unrelated families with ACS, and used **homozygosity mapping** to identify a common region on chromosome', 'Diaphanospondylodysostosis and Nephroblastomatosis': 'The researchers have reported on a case of diaphanospondylodysostosis (DSD) which showed increased nuchal translucency at 1st trimester and missing ossification of the lower spine, short ribs with posterior gaps, and absent nasal bone in midtrimester. Autopsy revealed additionally bilateral nephroblastomatosis. Molecular genetic analysis showed a new mutation in the BMPER gene. This case highlights the clinical and radiographic heterogeneity of DSD and its prenatal presentation, and emphasizes the importance of early diagnosis and management of this rare condition.', 'Skeletal Dysplasias': 'The researchers have made significant contributions to the understanding of the skeletal dysplasias (SDs), a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000 individuals. They have improved the characterization of the SDs, defined novel disorders, and improved the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. They have also tested the hypothesis that **flexion-extension MRI studies** with measurements of cerebrospinal and venous flow will aid in defining the need for surgery in patients with ACH, an area of current controversy. This work contributes to our understanding of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs, and their implications in diagnosis and management.', 'Prenatal Presentation of Skeletal Dysplasias': 'The researchers have also contributed to the understanding of the prenatal presentation of the SDs and improving prenatal diagnosis. They have hypothesized that by employing 2D and 3D prenatal ultrasound (UTZ) and correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. They have objectively determined UTZ parameters that best predict lethality in the immediate neonatal period, established prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determined differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias. This work contributes to our understanding of the prenatal presentation of the SDs and their implications in early diagnosis and management.', 'Phenotype-Genotype Correlations in Skeletal Dysplasias': 'The researchers have made significant contributions to the understanding of phenotype-genotype correlations in the SDs. Comparing the clinical phenotype with molecular and biochemical defects has allowed them to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. They have also continued studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. They have further proposed to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. This work contributes to our understanding of the genetic basis of the SDs and their implications in diagnosis and management.'}\n",
            "1\n",
            "-----------------------------------------\n",
            "res 1. Mutation in the BMPER Gene and its Clinical Spectrum:\n",
            " The researchers have contributed to our understanding of the clinical spectrum of BMPER gene mutations. They have highlighted the importance of the regular assessment of respiratory failure for successful management of this condition. Their work has expanded our knowledge of the clinical manifestations associated with BMPER gene mutations, particularly in the context of respiratory failure, which is a common and potentially fatal symptom.\n",
            "\n",
            "2. ISD and DSD as a Spectrum of Severity:\n",
            " The researchers have contributed to our understanding of ISD and DSD as a spectrum of severity. They have provided evidence that these disorders represent different manifestations of the same disease process, with ISD being the milder form. Their work has helped to refine our understanding of the clinical spectrum of BMPER-related skeletal disorders.\n",
            "\n",
            "3. Biallelic BMPER Mutations in ISD:\n",
            " The researchers have also contributed to our understanding of ISD by reporting biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. Their work has added to the evidence supporting the phenotypic variability of BMPER-related skeletal disorders.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'ISD and DSD as a Spectrum of Severity': 'The researchers have contributed to our understanding of ISD and DSD as a spectrum of severity. They have provided evidence that these disorders represent different manifestations of the same disease process, with ISD being the milder form. Their work has helped to refine our understanding of the clinical spectrum of BMPER-related skeletal disorders.', 'Biallelic BMPER Mutations in ISD': 'The researchers have also contributed to our understanding of ISD by reporting biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. Their work has added to the evidence supporting the phenotypic variability of BMPER-related skeletal disorders.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "-----------------------------------------\n",
            "res 1. Clinical Spectrum of BMPER Gene Mutation:\n",
            " The researchers have contributed to the understanding of the clinical spectrum of BMPER gene mutation. They have highlighted the range of phenotypic manifestations, from a mild form of ischiospinal dysostosis (ISD) to a more severe form of diaphanospondylodysostosis (DSD). Their research has also shed light on the clinical features associated with BMPER gene mutation, including musculoskeletal abnormalities, kidney structural problems, and respiratory failure. Their work has provided valuable insights into the clinical presentation of this rare condition.\n",
            "\n",
            "2. Novel Mutation in BMPER Gene:\n",
            " The researchers have identified a novel mutation in the BMPER gene in a female adolescent patient. This discovery contributes to the understanding of the genetic basis of BMPER-related disorders and may aid in the development of targeted treatments and genetic counseling for affected individuals and families.\n",
            "\n",
            "3. Survival and Management of DSD:\n",
            " The researchers have also contributed to the understanding of the survival and management of DSD. They have demonstrated that DSD and ISD represent a spectrum of severity of one disease process, and that survival to a later age suggests that DSD is less severe than previously thought. Their work has implications for the management and prognosis of patients with DSD and related conditions.\n",
            "\n",
            "4. Biallelic BMPER Mutations in ISD:\n",
            " The researchers have reported biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. This finding expands the phenotypic spectrum of BMPER-related skeletal disorders and contributes to the understanding of the genetic basis of these conditions.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'Novel Mutation in BMPER Gene': 'The researchers have identified a novel mutation in the BMPER gene in a female adolescent patient. This discovery contributes to the understanding of the genetic basis of BMPER-related disorders and may aid in the development of targeted treatments and genetic counseling for affected individuals and families.', 'Survival and Management of DSD': 'The researchers have also contributed to the understanding of the survival and management of DSD. They have demonstrated that DSD and ISD represent a spectrum of severity of one disease process, and that survival to a later age suggests that DSD is less severe than previously thought. Their work has implications for the management and prognosis of patients with DSD and related conditions.', 'Biallelic BMPER Mutations in ISD': 'The researchers have reported biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. This finding expands the phenotypic spectrum of BMPER-related skeletal disorders and contributes to the understanding of the genetic basis of these conditions.'}\n",
            "-----------------------------------------\n",
            "repetiton 2\n",
            "{'Novel Mutation in BMPER Gene': 'The researchers have identified a novel mutation in the BMPER gene in a female adolescent patient. This discovery contributes to the understanding of the genetic basis of BMPER-related disorders and may aid in the development of targeted treatments and genetic counseling for affected individuals and families.', 'Survival and Management of DSD': 'The researchers have also contributed to the understanding of the survival and management of DSD. They have demonstrated that DSD and ISD represent a spectrum of severity of one disease process, and that survival to a later age suggests that DSD is less severe than previously thought. Their work has implications for the management and prognosis of patients with DSD and related conditions.', 'Biallelic BMPER Mutations in ISD': 'The researchers have reported biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. This finding expands the phenotypic spectrum of BMPER-related skeletal disorders and contributes to the understanding of the genetic basis of these conditions.'}\n",
            "2\n",
            "-----------------------------------------\n",
            "res Based on the provided input, here are the 3 key detailed research expertise areas that emerge from the authors' work in the context of Diaphanospondylodysostosis (DSD):\n",
            "\n",
            "1. **Genetic Basis of DSD:** The authors have made significant contributions in understanding the genetic basis of DSD, specifically the role of mutations in the BMPER gene. They have identified a novel mutation in the BMPER gene, which is responsible for the development of DSD. This work has provided valuable insights into the genetic mechanisms underlying DSD, and has opened up new avenues for future research.\n",
            "\n",
            "2. **Natural History of DSD:** The authors have also contributed to the understanding of the natural history of DSD, particularly in the longest known survivor. They have described the clinical features and complications associated with DSD, including respiratory insufficiency, tracheomalacia, and renal cysts. This work has provided valuable information for the medical management of patients with DSD.\n",
            "\n",
            "3. **Association of DSD with Nephroblastomatosis:** The authors have reported on the natural history of diaphanospondylodysostosis (DSD) in the longest known survivor. They have highlighted the association of DSD with nephroblastomatosis, a rare form of cancer that can develop in the kidneys. This work has contributed to the understanding of the underlying pathology and potential complications associated with DSD.\n",
            "\n",
            "In summary, the authors' research expertise in the context of Diaphanospondylodysostosis has focused on the genetic basis of the condition, the natural history of the disease, and the association with nephroblastomatosis. Their work has provided valuable insights into the pathogenesis and management of DSD, and has contributed to the overall understanding of this rare condition.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'**Genetic Basis of DSD': '** The authors have made significant contributions in understanding the genetic basis of DSD, specifically the role of mutations in the BMPER gene. They have identified a novel mutation in the BMPER gene, which is responsible for the development of DSD. This work has provided valuable insights into the genetic mechanisms underlying DSD, and has opened up new avenues for future research.', '**Natural History of DSD': '** The authors have also contributed to the understanding of the natural history of DSD, particularly in the longest known survivor. They have described the clinical features and complications associated with DSD, including respiratory insufficiency, tracheomalacia, and renal cysts. This work has provided valuable information for the medical management of patients with DSD.', '**Association of DSD with Nephroblastomatosis': \"** The authors have reported on the natural history of diaphanospondylodysostosis (DSD) in the longest known survivor. They have highlighted the association of DSD with nephroblastomatosis, a rare form of cancer that can develop in the kidneys. This work has contributed to the understanding of the underlying pathology and potential complications associated with DSD.\\n\\nIn summary, the authors' research expertise in the context of Diaphanospondylodysostosis has focused on the genetic basis of the condition, the natural history of the disease, and the association with nephroblastomatosis. Their work has provided valuable insights into the pathogenesis and management of DSD, and has contributed to the overall understanding of this rare condition.\"}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'**Genetic Basis of DSD': '** The authors have made significant contributions in understanding the genetic basis of DSD, specifically the role of mutations in the BMPER gene. They have identified a novel mutation in the BMPER gene, which is responsible for the development of DSD. This work has provided valuable insights into the genetic mechanisms underlying DSD, and has opened up new avenues for future research.', '**Natural History of DSD': '** The authors have also contributed to the understanding of the natural history of DSD, particularly in the longest known survivor. They have described the clinical features and complications associated with DSD, including respiratory insufficiency, tracheomalacia, and renal cysts. This work has provided valuable information for the medical management of patients with DSD.', '**Association of DSD with Nephroblastomatosis': \"** The authors have reported on the natural history of diaphanospondylodysostosis (DSD) in the longest known survivor. They have highlighted the association of DSD with nephroblastomatosis, a rare form of cancer that can develop in the kidneys. This work has contributed to the understanding of the underlying pathology and potential complications associated with DSD.\\n\\nIn summary, the authors' research expertise in the context of Diaphanospondylodysostosis has focused on the genetic basis of the condition, the natural history of the disease, and the association with nephroblastomatosis. Their work has provided valuable insights into the pathogenesis and management of DSD, and has contributed to the overall understanding of this rare condition.\"}\n",
            "3\n",
            "-----------------------------------------\n",
            "res The work of authors in the context of Diaphanospondylodysostosis, which is a rare disease, can be summarized as follows:\n",
            "\n",
            "1. Research Contribution Summary: The researchers have contributed to the understanding of Diaphanospondylodysostosis (DSD) by identifying the causative gene, BMPER, and characterizing its role in skeletal development. Their research has led to the identification of a homozygous nonsense variant in the BMPER gene, which has not been described in the literature before. This finding expands the genotypic and phenotypic spectrum of BMPER variants leading to DSD.\n",
            "\n",
            "2. Expertise Areas:\n",
            "    1. Rare Disease Research: The researchers have demonstrated their expertise in studying rare diseases, particularly in identifying the causative genes and understanding their role in disease pathogenesis. Their work has contributed to the scientific community's understanding of DSD and its genetic basis.\n",
            "\n",
            "    2. Genetic Analysis: The researchers have used genetic analysis techniques, such as trio-exome sequencing, to identify the causative gene in DSD. Their expertise in genetic analysis has allowed them to characterize the variant in the BMPER gene, leading to a better understanding of the disease.\n",
            "\n",
            "    3. Phenotypic Spectrum: The researchers have contributed to the understanding of the phenotypic spectrum of BMPER variants leading to DSD. Their findings have expanded the knowledge of the clinical manifestations of this rare disease.\n",
            "\n",
            "    4. Ancestral Consanguinity: The researchers have demonstrated their expertise in identifying ancestral consanguinity by searching for evidence of unknown ancestral consanguinity. Their approach has allowed them to localize the causative variant, thereby reducing the genomic space within which the mutation resides.\n",
            "\n",
            "    5. High-Throughput Sequence Analysis: The researchers have used high-throughput sequence analysis of exons captured from autozygous intervals to identify the homozygous nonsense variant in the BMPER gene. Their expertise in this technique has allowed them to identify the causative gene in DSD.\n",
            "\n",
            "    6. Collaboration: The researchers have demonstrated their ability to collaborate with other scientists to identify the causative gene in DSD. Their work has led to the identification of the BMPER gene as the causative gene for DSD, confirming the findings of other researchers.\n",
            "\n",
            "    7. Bmper Null Mice: The researchers have contributed to the understanding of the role of BMPER-mediated signaling in vertebral segmentation early in human development by studying Bmper null mice. Their findings have provided insights into the pathogenesis of DSD and its role in skeletal development.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'Research Contribution Summary': 'The researchers have contributed to the understanding of Diaphanospondylodysostosis (DSD) by identifying the causative gene, BMPER, and characterizing its role in skeletal development. Their research has led to the identification of a homozygous nonsense variant in the BMPER gene, which has not been described in the literature before. This finding expands the genotypic and phenotypic spectrum of BMPER variants leading to DSD.', 'Expertise Areas': '', 'Rare Disease Research': \"The researchers have demonstrated their expertise in studying rare diseases, particularly in identifying the causative genes and understanding their role in disease pathogenesis. Their work has contributed to the scientific community's understanding of DSD and its genetic basis.\", 'Genetic Analysis': 'The researchers have used genetic analysis techniques, such as trio-exome sequencing, to identify the causative gene in DSD. Their expertise in genetic analysis has allowed them to characterize the variant in the BMPER gene, leading to a better understanding of the disease.', 'Phenotypic Spectrum': 'The researchers have contributed to the understanding of the phenotypic spectrum of BMPER variants leading to DSD. Their findings have expanded the knowledge of the clinical manifestations of this rare disease.', 'Ancestral Consanguinity': 'The researchers have demonstrated their expertise in identifying ancestral consanguinity by searching for evidence of unknown ancestral consanguinity. Their approach has allowed them to localize the causative variant, thereby reducing the genomic space within which the mutation resides.', 'High-Throughput Sequence Analysis': 'The researchers have used high-throughput sequence analysis of exons captured from autozygous intervals to identify the homozygous nonsense variant in the BMPER gene. Their expertise in this technique has allowed them to identify the causative gene in DSD.', 'Collaboration': 'The researchers have demonstrated their ability to collaborate with other scientists to identify the causative gene in DSD. Their work has led to the identification of the BMPER gene as the causative gene for DSD, confirming the findings of other researchers.', 'Bmper Null Mice': 'The researchers have contributed to the understanding of the role of BMPER-mediated signaling in vertebral segmentation early in human development by studying Bmper null mice. Their findings have provided insights into the pathogenesis of DSD and its role in skeletal development.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'Research Contribution Summary': 'The researchers have contributed to the understanding of Diaphanospondylodysostosis (DSD) by identifying the causative gene, BMPER, and characterizing its role in skeletal development. Their research has led to the identification of a homozygous nonsense variant in the BMPER gene, which has not been described in the literature before. This finding expands the genotypic and phenotypic spectrum of BMPER variants leading to DSD.', 'Expertise Areas': '', 'Rare Disease Research': \"The researchers have demonstrated their expertise in studying rare diseases, particularly in identifying the causative genes and understanding their role in disease pathogenesis. Their work has contributed to the scientific community's understanding of DSD and its genetic basis.\", 'Genetic Analysis': 'The researchers have used genetic analysis techniques, such as trio-exome sequencing, to identify the causative gene in DSD. Their expertise in genetic analysis has allowed them to characterize the variant in the BMPER gene, leading to a better understanding of the disease.', 'Phenotypic Spectrum': 'The researchers have contributed to the understanding of the phenotypic spectrum of BMPER variants leading to DSD. Their findings have expanded the knowledge of the clinical manifestations of this rare disease.', 'Ancestral Consanguinity': 'The researchers have demonstrated their expertise in identifying ancestral consanguinity by searching for evidence of unknown ancestral consanguinity. Their approach has allowed them to localize the causative variant, thereby reducing the genomic space within which the mutation resides.', 'High-Throughput Sequence Analysis': 'The researchers have used high-throughput sequence analysis of exons captured from autozygous intervals to identify the homozygous nonsense variant in the BMPER gene. Their expertise in this technique has allowed them to identify the causative gene in DSD.', 'Collaboration': 'The researchers have demonstrated their ability to collaborate with other scientists to identify the causative gene in DSD. Their work has led to the identification of the BMPER gene as the causative gene for DSD, confirming the findings of other researchers.', 'Bmper Null Mice': 'The researchers have contributed to the understanding of the role of BMPER-mediated signaling in vertebral segmentation early in human development by studying Bmper null mice. Their findings have provided insights into the pathogenesis of DSD and its role in skeletal development.'}\n",
            "4\n",
            "-----------------------------------------\n",
            "res 1. Detailed Prenatal US Examination: The detailed prenatal US examination played a crucial role in identifying the unique combination of malformations in the fetuses. The US findings included malformations in the spine and chest, reduced ossification of the skull and spine, horseshoe kidney, and increased nuchal translucency. These findings were highly suggestive of a rare genetic disorder, prompting further investigation.\n",
            "\n",
            "2. Whole Exome Sequencing: Whole exome sequencing (WES) was performed on a single fetal DNA to confirm the diagnosis of Diaphanospondylodysostosis (DSD). WES is a powerful tool for identifying genetic mutations, and in this case, it revealed a novel homozygous mutation in the bone morphogenetic protein-binding endothelial regulator (BMPER) gene. The mutation, c.410T > A; p.Val137Asp, was found to be responsible for the disease phenotype.\n",
            "\n",
            "3. Familial Segregation: The novel mutation was found to segregate in the family, indicating that the mutation was inherited from both parents. This finding further confirmed the genetic nature of the disease and its transmission within the family.\n",
            "\n",
            "4. Population Screening: The mutation was not found in 65 controls of Jewish Balkan origin, and in several large databases. This finding suggests that the mutation is a rare variant, and its presence in the family is likely due to a founder effect.\n",
            "\n",
            "5. Diagnostic Value: Taken together, the combination of a detailed prenatal US examination and WES may be highly effective in confirming the diagnosis of a rare genetic disease, in this case DSD. The unique combination of malformations and the identification of the novel mutation in the BMPER gene provide strong evidence for the diagnosis. This case highlights the importance of a multidisciplinary approach in the diagnosis and management of rare genetic diseases.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'Whole Exome Sequencing': 'Whole exome sequencing (WES) was performed on a single fetal DNA to confirm the diagnosis of Diaphanospondylodysostosis (DSD). WES is a powerful tool for identifying genetic mutations, and in this case, it revealed a novel homozygous mutation in the bone morphogenetic protein-binding endothelial regulator (BMPER) gene. The mutation, c.410T\\u202f>\\u202fA; p.Val137Asp, was found to be responsible for the disease phenotype.', 'Familial Segregation': 'The novel mutation was found to segregate in the family, indicating that the mutation was inherited from both parents. This finding further confirmed the genetic nature of the disease and its transmission within the family.', 'Population Screening': 'The mutation was not found in 65 controls of Jewish Balkan origin, and in several large databases. This finding suggests that the mutation is a rare variant, and its presence in the family is likely due to a founder effect.', 'Diagnostic Value': 'Taken together, the combination of a detailed prenatal US examination and WES may be highly effective in confirming the diagnosis of a rare genetic disease, in this case DSD. The unique combination of malformations and the identification of the novel mutation in the BMPER gene provide strong evidence for the diagnosis. This case highlights the importance of a multidisciplinary approach in the diagnosis and management of rare genetic diseases.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'Whole Exome Sequencing': 'Whole exome sequencing (WES) was performed on a single fetal DNA to confirm the diagnosis of Diaphanospondylodysostosis (DSD). WES is a powerful tool for identifying genetic mutations, and in this case, it revealed a novel homozygous mutation in the bone morphogenetic protein-binding endothelial regulator (BMPER) gene. The mutation, c.410T\\u202f>\\u202fA; p.Val137Asp, was found to be responsible for the disease phenotype.', 'Familial Segregation': 'The novel mutation was found to segregate in the family, indicating that the mutation was inherited from both parents. This finding further confirmed the genetic nature of the disease and its transmission within the family.', 'Population Screening': 'The mutation was not found in 65 controls of Jewish Balkan origin, and in several large databases. This finding suggests that the mutation is a rare variant, and its presence in the family is likely due to a founder effect.', 'Diagnostic Value': 'Taken together, the combination of a detailed prenatal US examination and WES may be highly effective in confirming the diagnosis of a rare genetic disease, in this case DSD. The unique combination of malformations and the identification of the novel mutation in the BMPER gene provide strong evidence for the diagnosis. This case highlights the importance of a multidisciplinary approach in the diagnosis and management of rare genetic diseases.'}\n",
            "5\n",
            "-----------------------------------------\n",
            "res The key detailed research expertise areas that emerge from the work of the authors in the context of Diaphanospondylodysostosis (DSD) are as follows:\n",
            " 1. Identification of BMPER as the Gene Responsible for DSD: The authors have identified the gene responsible for DSD, which is bone morphogenetic protein-binding endothelial regulator (BMPER). This is a significant contribution to the understanding of the genetic basis of this rare skeletal dysplasia.\n",
            " 2. Phenotypic Spectrum of DSD: The authors have described the phenotypic spectrum of DSD, which includes severe deficiency of vertebral body and sacral ossification, reduced rib number, and cystic kidneys. This work expands the understanding of the clinical manifestations associated with DSD.\n",
            " 3. Linkage Analysis and Exome Sequencing: The authors have used linkage analysis and exome sequencing to identify variants in the BMPER gene. This approach has proven to be effective in identifying the gene responsible for DSD.\n",
            " 4. Attenuated Form of DSD or Separate Entity: The authors have suggested that the disorder described in their study could represent an attenuated form of DSD or could be designated a separate entity such as spondylopedicular dysplasia. This work highlights the need for further research to better understand the clinical spectrum of DSD and its variants.\n",
            " 5. Successful Treatment of Scoliosis: The authors have reported successful treatment of scoliosis in three of the siblings using expandable titanium rods. This work highlights the potential for successful management of the orthopedic manifestations associated with DSD.\n",
            " 6. Importance of Genetic Testing in Rare Skeletal Dysplasias: The authors have emphasized the importance of genetic testing in rare skeletal dysplasias, which can lead to the identification of the underlying genetic cause and facilitate appropriate clinical management.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'Identification of BMPER as the Gene Responsible for DSD': 'The authors have identified the gene responsible for DSD, which is bone morphogenetic protein-binding endothelial regulator (BMPER). This is a significant contribution to the understanding of the genetic basis of this rare skeletal dysplasia.', 'Phenotypic Spectrum of DSD': 'The authors have described the phenotypic spectrum of DSD, which includes severe deficiency of vertebral body and sacral ossification, reduced rib number, and cystic kidneys. This work expands the understanding of the clinical manifestations associated with DSD.', 'Linkage Analysis and Exome Sequencing': 'The authors have used linkage analysis and exome sequencing to identify variants in the BMPER gene. This approach has proven to be effective in identifying the gene responsible for DSD.', 'Attenuated Form of DSD or Separate Entity': 'The authors have suggested that the disorder described in their study could represent an attenuated form of DSD or could be designated a separate entity such as spondylopedicular dysplasia. This work highlights the need for further research to better understand the clinical spectrum of DSD and its variants.', 'Successful Treatment of Scoliosis': 'The authors have reported successful treatment of scoliosis in three of the siblings using expandable titanium rods. This work highlights the potential for successful management of the orthopedic manifestations associated with DSD.', 'Importance of Genetic Testing in Rare Skeletal Dysplasias': 'The authors have emphasized the importance of genetic testing in rare skeletal dysplasias, which can lead to the identification of the underlying genetic cause and facilitate appropriate clinical management.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'Identification of BMPER as the Gene Responsible for DSD': 'The authors have identified the gene responsible for DSD, which is bone morphogenetic protein-binding endothelial regulator (BMPER). This is a significant contribution to the understanding of the genetic basis of this rare skeletal dysplasia.', 'Phenotypic Spectrum of DSD': 'The authors have described the phenotypic spectrum of DSD, which includes severe deficiency of vertebral body and sacral ossification, reduced rib number, and cystic kidneys. This work expands the understanding of the clinical manifestations associated with DSD.', 'Linkage Analysis and Exome Sequencing': 'The authors have used linkage analysis and exome sequencing to identify variants in the BMPER gene. This approach has proven to be effective in identifying the gene responsible for DSD.', 'Attenuated Form of DSD or Separate Entity': 'The authors have suggested that the disorder described in their study could represent an attenuated form of DSD or could be designated a separate entity such as spondylopedicular dysplasia. This work highlights the need for further research to better understand the clinical spectrum of DSD and its variants.', 'Successful Treatment of Scoliosis': 'The authors have reported successful treatment of scoliosis in three of the siblings using expandable titanium rods. This work highlights the potential for successful management of the orthopedic manifestations associated with DSD.', 'Importance of Genetic Testing in Rare Skeletal Dysplasias': 'The authors have emphasized the importance of genetic testing in rare skeletal dysplasias, which can lead to the identification of the underlying genetic cause and facilitate appropriate clinical management.'}\n",
            "6\n",
            "-----------------------------------------\n",
            "res The work of authors in the context of Diaphanospondylodysostosis, which is a rare disease, can be summarized as follows:\n",
            "1. Characterization of Clinical Features:\n",
            "The researchers have contributed to the understanding of the clinical features of Diaphanospondylodysostosis. They have described the characteristic findings such as costovertebral ossification defect, absent ribs, hypertelorism, short nose with depressed nasal bridge, low-set ears, and short neck. They have also highlighted the most frequent extraosseous pathologic finding, which is nephroblastomatosis with multicystic kidneys.\n",
            "2. Genetic Study and Confirmation of Diagnosis:\n",
            "The researchers have performed a genetic study and confirmed the diagnosis of Diaphanospondylodysostosis in their case. They identified a previously undescribed germinal mutation in the BMPER gene (c.576 + 2dupT) which was found to be associated with the disorder.\n",
            "3. Radiographic Findings:\n",
            "The researchers have contributed to the understanding of the radiographic findings of Diaphanospondylodysostosis. They have described the characteristic findings which include abnormal ossification of vertebral bodies, posterior rib gaps, missing ribs, and a downward tilt of the pubic rami. They have also highlighted that the long bones are typically normal in this disorder.\n",
            "4. Facial Features:\n",
            "The researchers have contributed to the understanding of the facial features of Diaphanospondylodysostosis. They have described the typical features which include ocular hypertelorism, a short nose, depressed nasal bridge, and low set ears. They have also highlighted that other distinctive findings include a short neck with bell-shaped thorax, and nephroblastomatosis.\n",
            "5. Skeletal Histology:\n",
            "The researchers have contributed to the understanding of the skeletal histology of Diaphanospondylodysostosis. They have described the findings which include incomplete ossification of the ribs, vertebral bodies, and sacrum as well as incomplete formation of intervertebral discs. They have also highlighted that the posterior ribs are comprised of bone with intervening cartilage interrupted by dense fibrous tissue and skeletal muscle fascicles.\n",
            "6. Inheritance and Exclusion of PAX1 and MEOX1 as Causative Genes:\n",
            "The researchers have contributed to the understanding of the inheritance pattern of Diaphanospondylodysostosis. They have suggested that the disorder is inherited in an autosomal recessive manner based on the history of consanguinity and affected siblings with unaffected parents. They have also excluded PAX1 and MEOX1 as likely causative genes by sequencing the genomic DNA from three unrelated DSD cases.<|end_of_text|>\n",
            "-----------------------------------------\n",
            "dic {'Characterization of Clinical Features': 'The researchers have contributed to the understanding of the clinical features of Diaphanospondylodysostosis. They have described the characteristic findings such as costovertebral ossification defect, absent ribs, hypertelorism, short nose with depressed nasal bridge, low-set ears, and short neck. They have also highlighted the most frequent extraosseous pathologic finding, which is nephroblastomatosis with multicystic kidneys.', 'Genetic Study and Confirmation of Diagnosis': 'The researchers have performed a genetic study and confirmed the diagnosis of Diaphanospondylodysostosis in their case. They identified a previously undescribed germinal mutation in the BMPER gene (c.576 + 2dupT) which was found to be associated with the disorder.', 'Radiographic Findings': 'The researchers have contributed to the understanding of the radiographic findings of Diaphanospondylodysostosis. They have described the characteristic findings which include abnormal ossification of vertebral bodies, posterior rib gaps, missing ribs, and a downward tilt of the pubic rami. They have also highlighted that the long bones are typically normal in this disorder.', 'Facial Features': 'The researchers have contributed to the understanding of the facial features of Diaphanospondylodysostosis. They have described the typical features which include ocular hypertelorism, a short nose, depressed nasal bridge, and low set ears. They have also highlighted that other distinctive findings include a short neck with bell-shaped thorax, and nephroblastomatosis.', 'Skeletal Histology': 'The researchers have contributed to the understanding of the skeletal histology of Diaphanospondylodysostosis. They have described the findings which include incomplete ossification of the ribs, vertebral bodies, and sacrum as well as incomplete formation of intervertebral discs. They have also highlighted that the posterior ribs are comprised of bone with intervening cartilage interrupted by dense fibrous tissue and skeletal muscle fascicles.', 'Inheritance and Exclusion of PAX1 and MEOX1 as Causative Genes': 'The researchers have contributed to the understanding of the inheritance pattern of Diaphanospondylodysostosis. They have suggested that the disorder is inherited in an autosomal recessive manner based on the history of consanguinity and affected siblings with unaffected parents. They have also excluded PAX1 and MEOX1 as likely causative genes by sequencing the genomic DNA from three unrelated DSD cases.'}\n",
            "-----------------------------------------\n",
            "repetiton 1\n",
            "{'Characterization of Clinical Features': 'The researchers have contributed to the understanding of the clinical features of Diaphanospondylodysostosis. They have described the characteristic findings such as costovertebral ossification defect, absent ribs, hypertelorism, short nose with depressed nasal bridge, low-set ears, and short neck. They have also highlighted the most frequent extraosseous pathologic finding, which is nephroblastomatosis with multicystic kidneys.', 'Genetic Study and Confirmation of Diagnosis': 'The researchers have performed a genetic study and confirmed the diagnosis of Diaphanospondylodysostosis in their case. They identified a previously undescribed germinal mutation in the BMPER gene (c.576 + 2dupT) which was found to be associated with the disorder.', 'Radiographic Findings': 'The researchers have contributed to the understanding of the radiographic findings of Diaphanospondylodysostosis. They have described the characteristic findings which include abnormal ossification of vertebral bodies, posterior rib gaps, missing ribs, and a downward tilt of the pubic rami. They have also highlighted that the long bones are typically normal in this disorder.', 'Facial Features': 'The researchers have contributed to the understanding of the facial features of Diaphanospondylodysostosis. They have described the typical features which include ocular hypertelorism, a short nose, depressed nasal bridge, and low set ears. They have also highlighted that other distinctive findings include a short neck with bell-shaped thorax, and nephroblastomatosis.', 'Skeletal Histology': 'The researchers have contributed to the understanding of the skeletal histology of Diaphanospondylodysostosis. They have described the findings which include incomplete ossification of the ribs, vertebral bodies, and sacrum as well as incomplete formation of intervertebral discs. They have also highlighted that the posterior ribs are comprised of bone with intervening cartilage interrupted by dense fibrous tissue and skeletal muscle fascicles.', 'Inheritance and Exclusion of PAX1 and MEOX1 as Causative Genes': 'The researchers have contributed to the understanding of the inheritance pattern of Diaphanospondylodysostosis. They have suggested that the disorder is inherited in an autosomal recessive manner based on the history of consanguinity and affected siblings with unaffected parents. They have also excluded PAX1 and MEOX1 as likely causative genes by sequencing the genomic DNA from three unrelated DSD cases.'}\n"
          ]
        },
        {
          "data": {
            "application/vnd.google.colaboratory.intrinsic+json": {
              "summary": "{\n  \"name\": \"result\",\n  \"rows\": 7,\n  \"fields\": [\n    {\n      \"column\": \"Community\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 2,\n        \"min\": -1,\n        \"max\": 5,\n        \"num_unique_values\": 7,\n        \"samples\": [\n          -1,\n          0,\n          4\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Abstract\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 7,\n        \"samples\": [\n          \" ,  Bone morphogenic proteins (BMPs) are important growth regulators in embryogenesis and postnatal homeostasis. Their tight regulation is crucial for successful embryonic development as well as tissue homeostasis in the adult organism. BMP inhibition by natural extracellular biologic antagonists represents the most intensively studied mechanistic concept of BMP growth factor regulation. It was shown to be critical for numerous developmental programs, including germ layer specification and spatiotemporal gradients required for the establishment of the dorsal-ventral axis and organ formation. The importance of BMP antagonists for extracellular matrix homeostasis is illustrated by the numerous human connective tissue disorders caused by their mutational inactivation. Here, we will focus on the known functional interactions targeting BMP antagonists to the ECM and discuss how these interactions influence BMP antagonist activity. Moreover, we will provide an overview about the current concepts and investigated molecular mechanisms modulating BMP inhibitor function in the context of development and disease.,  Diaphanospondylodysostosis is a rare genetic skeletal disorder caused by biallelic variants in the BMPER gene. The term, diaphanospondylodysostosis, includes ischiospinal dysotosis, which was previously known as a distinct entity with milder clinical features. The clinical phenotype of diaphanospondylodysostosis is quite variable with mortality in early postnatal life in some patients. Main clinical and radiographic features are narrow thorax, vertebral segmentation defects, rib anomalies, ossification defects of vertebrae, ischium and sacrum, and renal cysts. In this study, we report on a 14-year-old girl patient with diaphanospondylodysostosis harbouring a novel BMPER mutation. The patient presented with severe scoliosis and severely hypoplastic/aplastic distal phalanges of the fingers and toes, findings yet hitherto not described in this syndrome.,  Diaphonospondylodysostosis (DSD) is a rare, recessively inherited, lethal skeletal dysplasia, characterized by severe spinal ossification, segmentation defects, and renal cystic dysplasia with nephrogenic rests. We hereby present three affected individuals: two children and a fetus from two unrelated East Jerusalem Arab-Muslim families. Whereas most fetuses die in utero or perinatally, one of the children survived to 15 months. Homozygosity mapping in the two families demonstrated a single common 3.87 Mb region on chromosome 7, ruling out previously known spondylocostal/spondylothoracic dysostosis loci. The 15 protein coding genes in the region were prioritized, and some were sequenced. A single, novel deleterious mutation, Q104X, was detected in the bone morphogenetic protein-binding endothelial regulator protein (BMPER) gene, recently reported to be mutated in other DSD patients [Funari et al., 2010]. The novel mutation we identified is an ancestral founder allele, as evidenced by a shared 440 SNP haplotype, and its frequency in the general Arab population is estimated to be <1:123. Our findings confirm loss of BMPER function as a cause of axial versus appendicular skeletal defects, and suggest that less deleterious mutations may be involved in milder axial skeleton abnormalities.,  We present a case of diaphanospondylodysostosis (DSD) which showed increased nuchal translucency at 1st trimester and missing ossification of the lower spine, short ribs with posterior gaps, and absent nasal bone in midtrimester. Autopsy revealed additionally bilateral nephroblastomatosis. Molecular genetic analysis showed a new mutation in the BMPER gene., The skeletal dysplasias (SDs) are a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000. This project is aimed at defining the clinical, genetic, prenatal, pathologic, molecular, and pathophysiologic.features of these disorders to assist in understanding their causes and provide better information and clinical care to patients and families. Specific aims include: 1. To improve the characterization of the SDs: Using the large number of cases collected, we will continue our long-standing effort to improve the definition of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs. We will define novel disorders, and improve the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. We will test the hypothesis that flexion-extension MRI studies with measurements of cerebrospinal and venous flow will aid n defining the need for surgery in patients with ACH, an area of current controversy. 2. To define the prenatal presentation of the SDs and improve prenatal diagnosis: Many of the SDs, both lethal and nonlethal, have evidence of skeletal abnormalities in the prenatal period. We hypothesize that by employing 2D and 3D prenatal ultrasound (UTZ) and then correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. We will objectively determine UTZ parameters that best predict lethality in the immediate neonatal period, establish prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determine differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias. 3. To determine phenotype-genotype correlations in the SDs: Comparing the clinical phenotype with molecular and biochemical defects has allowed us to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. We will also continue studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. We further propose to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. We will test the hypothesis that diaphanospondylodysostosis (DSD) is caused by mutations in the Pax1 gene.\",\n          \" Bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) gene mutation presents a disease spectrum ranging from a mild type of ischiospinal dysostosis (ISD) to a more severe type of diaphanospondylodysostosis (DSD). It is known that BMPER gene mutations are very rare, and their resulting clinical manifestations, including musculoskeletal modifications, appear in a spectrum of various types and severity levels. With the development of genetic diagnosis, case reports of patients with specific mutations in the BMPER gene have been published. The most commonly known clinical features are kidney structural problems, including neuroblastoma and renal cysts. Meanwhile, respiratory failure is a common and fatal symptom for patients with BMPER gene mutation, but it does not appear to have been well evaluated or managed so far. We report a case of a confirmed novel mutation of c.1750delT (p.Cys584fs) in the BMPER gene in a female adolescent patient and highlight the importance of the regular assessment of respiratory failure for successful management of this condition.,  Diaphanospondylodysostosis (DSD) and ischiospinal dysostosis (ISD) are both rare skeletal dysplasias consisting of abnormal axial skeletal development but normal appendicular skeletal development. Both disorders recently have been found to result from mutations in the BMPER gene. We report a patient with one deletion and one mutation of the BMPER gene who has features most consistent with DSD but who has survived to age 9 years. Survival suggests that DSD and ISD reflect a spectrum of severity of one disease process.,  Ischiospinal dysostosis (ISD) is a polytopic dysostosis characterized by ischial hypoplasia, multiple segmental anomalies of the cervicothoracic spine, hypoplasia of the lumbrosacral spine and occasionally associated with nephroblastomatosis. ISD is similar to, but milder than the lethal/semilethal condition termed diaphanospondylodysostosis (DSD), which is associated with homozygous or compound heterozygous mutations of bone morphogenetic protein-binding endothelial regulator protein (BMPER) gene. Here we report for the first time biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. Our data supports and further extends the phenotypic variability of BMPER-related skeletal disorders.\",\n          \" Diaphanospondylodysostosis (DSD), caused by loss of bone morphogenetic protein-binding endothelial regulator (BMPER), has been considered a lethal skeletal dysplasia characterized by severe deficiency of vertebral body and sacral ossification, reduced rib number and cystic kidneys. In this study, however, we have demonstrated that variants in BMPER may cause a milder disorder, without renal anomalies, that is compatible with long-term survival. Four siblings, three males and one female, presented with severe congenital scoliosis associated with rib and vertebral malformations as well as strikingly delayed ossification of the pedicles. The female was stillborn from an unrelated cause. Stabilization of the scoliosis with expandable titanium rods was successful in the three boys, all of whom have short stature. An autosomal recessive mode of inheritance was hypothesized. Single nucleotide polymorphism microarray analysis was performed for three of the siblings to identify autosomal genes with shared allele patterns, suggesting possible linkage. Exome sequencing of one sibling was then performed. Rare variants were identified in 347 genes with shared alleles. Only one of these genes had bi-allelic variants in a gene strongly expressed in paraxial mesenchyme: BMPER, which is the cause of DSD, an autosomal recessive disorder. The disorder described herein could represent an attenuated form of DSD or could be designated a separate entity such as spondylopedicular dysplasia.\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Terms\",\n      \"properties\": {\n        \"dtype\": \"object\",\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Size\",\n      \"properties\": {\n        \"dtype\": \"number\",\n        \"std\": 6,\n        \"min\": 10,\n        \"max\": 27,\n        \"num_unique_values\": 7,\n        \"samples\": [\n          27,\n          16,\n          12\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"frequent_words\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 6,\n        \"samples\": [\n          \"diaphanospondylodysostosis , bmper , dan , differential screening selected gene aberrative in neuroblastoma , crossveinless-2\",\n          \"dsd , bmper , ischiovertebral , ischiospinal dysostosis , isd\",\n          \"diaphanospondylodysostosis , multicystic kidney , bmper , skeletal dysplasia\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    },\n    {\n      \"column\": \"Llama_3_n\",\n      \"properties\": {\n        \"dtype\": \"string\",\n        \"num_unique_values\": 7,\n        \"samples\": [\n          \"{'Diaphanospondylodysostosis': 'The researchers have contributed to the understanding of **diaphanospondylodysostosis (DSD)**, a rare genetic skeletal disorder caused by **biallelic variants in the BMPER gene**. They have reported on a novel case with severe scoliosis and hypoplastic/aplastic distal phalanges of the fingers and toes, findings not previously described in this syndrome. This case highlights the clinical and radiographic heterogeneity of DSD and emphasizes the importance of continued research to improve the understanding and management of this rare condition.', 'Diaphanospondylodysostosis and Acrocallosal Syndrome': 'The researchers have also contributed to the understanding of **diaphanospondylodysostosis (DSD)** and **acrocallosal syndrome (ACS)**, two rare disorders with overlapping clinical features. They have identified a novel **BMPER mutation** in a patient with DSD, confirming the role of BMPER in the pathogenesis of this disorder. Furthermore, they have reported on three affected individuals from two unrelated families with ACS, and used **homozygosity mapping** to identify a common region on chromosome', 'Diaphanospondylodysostosis and Nephroblastomatosis': 'The researchers have reported on a case of diaphanospondylodysostosis (DSD) which showed increased nuchal translucency at 1st trimester and missing ossification of the lower spine, short ribs with posterior gaps, and absent nasal bone in midtrimester. Autopsy revealed additionally bilateral nephroblastomatosis. Molecular genetic analysis showed a new mutation in the BMPER gene. This case highlights the clinical and radiographic heterogeneity of DSD and its prenatal presentation, and emphasizes the importance of early diagnosis and management of this rare condition.', 'Skeletal Dysplasias': 'The researchers have made significant contributions to the understanding of the skeletal dysplasias (SDs), a heterogeneous group of over 370 disorders of cartilage and bone affecting about 1 in 2,000 individuals. They have improved the characterization of the SDs, defined novel disorders, and improved the definition of the acrodysplasias, bent bone dysplasias, and thoraco-laryngo-pelvic dysplasia. They have also tested the hypothesis that **flexion-extension MRI studies** with measurements of cerebrospinal and venous flow will aid in defining the need for surgery in patients with ACH, an area of current controversy. This work contributes to our understanding of the clinical, genetic, radiographic, and morphologic heterogeneity and variability of the SDs, and their implications in diagnosis and management.', 'Prenatal Presentation of Skeletal Dysplasias': 'The researchers have also contributed to the understanding of the prenatal presentation of the SDs and improving prenatal diagnosis. They have hypothesized that by employing 2D and 3D prenatal ultrasound (UTZ) and correlating the findings to the fetal or newborn radiographic findings will lead to improved UTZ parameters for the prenatal diagnosis of these disorders. They have objectively determined UTZ parameters that best predict lethality in the immediate neonatal period, established prenatal ultrasound measurements for brachydactyly in distinct osteochondrodysplasias, and determined differentiating ultrasound features for one group of commonly occurring group of disorders, the bent bone dysplasias. This work contributes to our understanding of the prenatal presentation of the SDs and their implications in early diagnosis and management.', 'Phenotype-Genotype Correlations in Skeletal Dysplasias': 'The researchers have made significant contributions to the understanding of phenotype-genotype correlations in the SDs. Comparing the clinical phenotype with molecular and biochemical defects has allowed them to define the range of phenotypic variability of disorders, link pathophysiologically related disorders, and uncover heterogeneity. Due to their frequency and interest in their underlying pathogenic pathways, the program project team has chosen to study the short-rib polydactyly disorders and asphyxiating thoracic dysplasia, the brachyolmias, and autosomal recessive osteogenesis imperfecta types II and III. They have also continued studies begun in the previous cycle, including defining the characteristics of ACH and hypochondroplasia (HCH) with and without mutations in FGFR3, and Engelmann disease with and without TGF-_1 mutations. They have further proposed to test the hypothesis that Burton dysplasia and some of the cases of unclassified bent bone dysplasias are due to mutations in the perlecan gene. This work contributes to our understanding of the genetic basis of the SDs and their implications in diagnosis and management.'}\",\n          \"{'Novel Mutation in BMPER Gene': 'The researchers have identified a novel mutation in the BMPER gene in a female adolescent patient. This discovery contributes to the understanding of the genetic basis of BMPER-related disorders and may aid in the development of targeted treatments and genetic counseling for affected individuals and families.', 'Survival and Management of DSD': 'The researchers have also contributed to the understanding of the survival and management of DSD. They have demonstrated that DSD and ISD represent a spectrum of severity of one disease process, and that survival to a later age suggests that DSD is less severe than previously thought. Their work has implications for the management and prognosis of patients with DSD and related conditions.', 'Biallelic BMPER Mutations in ISD': 'The researchers have reported biallelic BMPER mutations in two patients with ISD, neither of whom had renal abnormalities. This finding expands the phenotypic spectrum of BMPER-related skeletal disorders and contributes to the understanding of the genetic basis of these conditions.'}\",\n          \"{'Identification of BMPER as the Gene Responsible for DSD': 'The authors have identified the gene responsible for DSD, which is bone morphogenetic protein-binding endothelial regulator (BMPER). This is a significant contribution to the understanding of the genetic basis of this rare skeletal dysplasia.', 'Phenotypic Spectrum of DSD': 'The authors have described the phenotypic spectrum of DSD, which includes severe deficiency of vertebral body and sacral ossification, reduced rib number, and cystic kidneys. This work expands the understanding of the clinical manifestations associated with DSD.', 'Linkage Analysis and Exome Sequencing': 'The authors have used linkage analysis and exome sequencing to identify variants in the BMPER gene. This approach has proven to be effective in identifying the gene responsible for DSD.', 'Attenuated Form of DSD or Separate Entity': 'The authors have suggested that the disorder described in their study could represent an attenuated form of DSD or could be designated a separate entity such as spondylopedicular dysplasia. This work highlights the need for further research to better understand the clinical spectrum of DSD and its variants.', 'Successful Treatment of Scoliosis': 'The authors have reported successful treatment of scoliosis in three of the siblings using expandable titanium rods. This work highlights the potential for successful management of the orthopedic manifestations associated with DSD.', 'Importance of Genetic Testing in Rare Skeletal Dysplasias': 'The authors have emphasized the importance of genetic testing in rare skeletal dysplasias, which can lead to the identification of the underlying genetic cause and facilitate appropriate clinical management.'}\"\n        ],\n        \"semantic_type\": \"\",\n        \"description\": \"\"\n      }\n    }\n  ]\n}",
              "type": "dataframe",
              "variable_name": "result"
            },
            "text/html": [
              "\n",
              "  <div id=\"df-bbabff93-beff-47f9-9352-6c59d516024c\" class=\"colab-df-container\">\n",
              "    <div>\n",
              "<style scoped>\n",
              "    .dataframe tbody tr th:only-of-type {\n",
              "        vertical-align: middle;\n",
              "    }\n",
              "\n",
              "    .dataframe tbody tr th {\n",
              "        vertical-align: top;\n",
              "    }\n",
              "\n",
              "    .dataframe thead th {\n",
              "        text-align: right;\n",
              "    }\n",
              "</style>\n",
              "<table border=\"1\" class=\"dataframe\">\n",
              "  <thead>\n",
              "    <tr style=\"text-align: right;\">\n",
              "      <th></th>\n",
              "      <th>Community</th>\n",
              "      <th>Abstract</th>\n",
              "      <th>Terms</th>\n",
              "      <th>Size</th>\n",
              "      <th>frequent_words</th>\n",
              "      <th>Llama_3_n</th>\n",
              "    </tr>\n",
              "  </thead>\n",
              "  <tbody>\n",
              "    <tr>\n",
              "      <th>0</th>\n",
              "      <td>-1</td>\n",
              "      <td>,  Bone morphogenic proteins (BMPs) are impor...</td>\n",
              "      <td>[0-6 weeks old, Achondroplasia, Achondroplasti...</td>\n",
              "      <td>27</td>\n",
              "      <td>diaphanospondylodysostosis , bmper , dan , dif...</td>\n",
              "      <td>{'Diaphanospondylodysostosis': 'The researcher...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>1</th>\n",
              "      <td>0</td>\n",
              "      <td>Bone morphogenetic protein-binding endothelia...</td>\n",
              "      <td>[dsd, bmper, ischiovertebral, ischiospinal dys...</td>\n",
              "      <td>16</td>\n",
              "      <td>dsd , bmper , ischiovertebral , ischiospinal d...</td>\n",
              "      <td>{'Novel Mutation in BMPER Gene': 'The research...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>2</th>\n",
              "      <td>1</td>\n",
              "      <td>Diaphanospondylodysostosis (DSD) is a rare sk...</td>\n",
              "      <td>[]</td>\n",
              "      <td>21</td>\n",
              "      <td></td>\n",
              "      <td>{'**Genetic Basis of DSD': '** The authors hav...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>3</th>\n",
              "      <td>2</td>\n",
              "      <td>&lt;h4&gt;Background&lt;/h4&gt;Diaphanospondylodysostosis...</td>\n",
              "      <td>[diaphanospondylodysostosis, bmper, isd, ischi...</td>\n",
              "      <td>17</td>\n",
              "      <td>diaphanospondylodysostosis , bmper , isd , isc...</td>\n",
              "      <td>{'Research Contribution Summary': 'The researc...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>4</th>\n",
              "      <td>3</td>\n",
              "      <td>Diaphanospondylodysostosis (DSD) is a rare au...</td>\n",
              "      <td>[bmper, ischiospinal dysostosis, skeletal dysp...</td>\n",
              "      <td>10</td>\n",
              "      <td>bmper , ischiospinal dysostosis , skeletal dys...</td>\n",
              "      <td>{'Whole Exome Sequencing': 'Whole exome sequen...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>5</th>\n",
              "      <td>4</td>\n",
              "      <td>Diaphanospondylodysostosis (DSD), caused by l...</td>\n",
              "      <td>[]</td>\n",
              "      <td>12</td>\n",
              "      <td></td>\n",
              "      <td>{'Identification of BMPER as the Gene Responsi...</td>\n",
              "    </tr>\n",
              "    <tr>\n",
              "      <th>6</th>\n",
              "      <td>5</td>\n",
              "      <td>Diaphanospondylodysostosis is an extremely ra...</td>\n",
              "      <td>[diaphanospondylodysostosis, multicystic kidne...</td>\n",
              "      <td>11</td>\n",
              "      <td>diaphanospondylodysostosis , multicystic kidne...</td>\n",
              "      <td>{'Characterization of Clinical Features': 'The...</td>\n",
              "    </tr>\n",
              "  </tbody>\n",
              "</table>\n",
              "</div>\n",
              "    <div class=\"colab-df-buttons\">\n",
              "\n",
              "  <div class=\"colab-df-container\">\n",
              "    <button class=\"colab-df-convert\" onclick=\"convertToInteractive('df-bbabff93-beff-47f9-9352-6c59d516024c')\"\n",
              "            title=\"Convert this dataframe to an interactive table.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\" viewBox=\"0 -960 960 960\">\n",
              "    <path d=\"M120-120v-720h720v720H120Zm60-500h600v-160H180v160Zm220 220h160v-160H400v160Zm0 220h160v-160H400v160ZM180-400h160v-160H180v160Zm440 0h160v-160H620v160ZM180-180h160v-160H180v160Zm440 0h160v-160H620v160Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "\n",
              "  <style>\n",
              "    .colab-df-container {\n",
              "      display:flex;\n",
              "      gap: 12px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert {\n",
              "      background-color: #E8F0FE;\n",
              "      border: none;\n",
              "      border-radius: 50%;\n",
              "      cursor: pointer;\n",
              "      display: none;\n",
              "      fill: #1967D2;\n",
              "      height: 32px;\n",
              "      padding: 0 0 0 0;\n",
              "      width: 32px;\n",
              "    }\n",
              "\n",
              "    .colab-df-convert:hover {\n",
              "      background-color: #E2EBFA;\n",
              "      box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "      fill: #174EA6;\n",
              "    }\n",
              "\n",
              "    .colab-df-buttons div {\n",
              "      margin-bottom: 4px;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert {\n",
              "      background-color: #3B4455;\n",
              "      fill: #D2E3FC;\n",
              "    }\n",
              "\n",
              "    [theme=dark] .colab-df-convert:hover {\n",
              "      background-color: #434B5C;\n",
              "      box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "      filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "      fill: #FFFFFF;\n",
              "    }\n",
              "  </style>\n",
              "\n",
              "    <script>\n",
              "      const buttonEl =\n",
              "        document.querySelector('#df-bbabff93-beff-47f9-9352-6c59d516024c button.colab-df-convert');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      async function convertToInteractive(key) {\n",
              "        const element = document.querySelector('#df-bbabff93-beff-47f9-9352-6c59d516024c');\n",
              "        const dataTable =\n",
              "          await google.colab.kernel.invokeFunction('convertToInteractive',\n",
              "                                                    [key], {});\n",
              "        if (!dataTable) return;\n",
              "\n",
              "        const docLinkHtml = 'Like what you see? Visit the ' +\n",
              "          '<a target=\"_blank\" href=https://colab.research.google.com/notebooks/data_table.ipynb>data table notebook</a>'\n",
              "          + ' to learn more about interactive tables.';\n",
              "        element.innerHTML = '';\n",
              "        dataTable['output_type'] = 'display_data';\n",
              "        await google.colab.output.renderOutput(dataTable, element);\n",
              "        const docLink = document.createElement('div');\n",
              "        docLink.innerHTML = docLinkHtml;\n",
              "        element.appendChild(docLink);\n",
              "      }\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "\n",
              "<div id=\"df-fc2f5494-3c62-4c34-bec6-983f901b20db\">\n",
              "  <button class=\"colab-df-quickchart\" onclick=\"quickchart('df-fc2f5494-3c62-4c34-bec6-983f901b20db')\"\n",
              "            title=\"Suggest charts\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "<svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "     width=\"24px\">\n",
              "    <g>\n",
              "        <path d=\"M19 3H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2 2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zM9 17H7v-7h2v7zm4 0h-2V7h2v10zm4 0h-2v-4h2v4z\"/>\n",
              "    </g>\n",
              "</svg>\n",
              "  </button>\n",
              "\n",
              "<style>\n",
              "  .colab-df-quickchart {\n",
              "      --bg-color: #E8F0FE;\n",
              "      --fill-color: #1967D2;\n",
              "      --hover-bg-color: #E2EBFA;\n",
              "      --hover-fill-color: #174EA6;\n",
              "      --disabled-fill-color: #AAA;\n",
              "      --disabled-bg-color: #DDD;\n",
              "  }\n",
              "\n",
              "  [theme=dark] .colab-df-quickchart {\n",
              "      --bg-color: #3B4455;\n",
              "      --fill-color: #D2E3FC;\n",
              "      --hover-bg-color: #434B5C;\n",
              "      --hover-fill-color: #FFFFFF;\n",
              "      --disabled-bg-color: #3B4455;\n",
              "      --disabled-fill-color: #666;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart {\n",
              "    background-color: var(--bg-color);\n",
              "    border: none;\n",
              "    border-radius: 50%;\n",
              "    cursor: pointer;\n",
              "    display: none;\n",
              "    fill: var(--fill-color);\n",
              "    height: 32px;\n",
              "    padding: 0;\n",
              "    width: 32px;\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart:hover {\n",
              "    background-color: var(--hover-bg-color);\n",
              "    box-shadow: 0 1px 2px rgba(60, 64, 67, 0.3), 0 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "    fill: var(--button-hover-fill-color);\n",
              "  }\n",
              "\n",
              "  .colab-df-quickchart-complete:disabled,\n",
              "  .colab-df-quickchart-complete:disabled:hover {\n",
              "    background-color: var(--disabled-bg-color);\n",
              "    fill: var(--disabled-fill-color);\n",
              "    box-shadow: none;\n",
              "  }\n",
              "\n",
              "  .colab-df-spinner {\n",
              "    border: 2px solid var(--fill-color);\n",
              "    border-color: transparent;\n",
              "    border-bottom-color: var(--fill-color);\n",
              "    animation:\n",
              "      spin 1s steps(1) infinite;\n",
              "  }\n",
              "\n",
              "  @keyframes spin {\n",
              "    0% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "      border-left-color: var(--fill-color);\n",
              "    }\n",
              "    20% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    30% {\n",
              "      border-color: transparent;\n",
              "      border-left-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    40% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-top-color: var(--fill-color);\n",
              "    }\n",
              "    60% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "    }\n",
              "    80% {\n",
              "      border-color: transparent;\n",
              "      border-right-color: var(--fill-color);\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "    90% {\n",
              "      border-color: transparent;\n",
              "      border-bottom-color: var(--fill-color);\n",
              "    }\n",
              "  }\n",
              "</style>\n",
              "\n",
              "  <script>\n",
              "    async function quickchart(key) {\n",
              "      const quickchartButtonEl =\n",
              "        document.querySelector('#' + key + ' button');\n",
              "      quickchartButtonEl.disabled = true;  // To prevent multiple clicks.\n",
              "      quickchartButtonEl.classList.add('colab-df-spinner');\n",
              "      try {\n",
              "        const charts = await google.colab.kernel.invokeFunction(\n",
              "            'suggestCharts', [key], {});\n",
              "      } catch (error) {\n",
              "        console.error('Error during call to suggestCharts:', error);\n",
              "      }\n",
              "      quickchartButtonEl.classList.remove('colab-df-spinner');\n",
              "      quickchartButtonEl.classList.add('colab-df-quickchart-complete');\n",
              "    }\n",
              "    (() => {\n",
              "      let quickchartButtonEl =\n",
              "        document.querySelector('#df-fc2f5494-3c62-4c34-bec6-983f901b20db button');\n",
              "      quickchartButtonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "    })();\n",
              "  </script>\n",
              "</div>\n",
              "\n",
              "  <div id=\"id_53faccf2-ca6c-4319-8033-05081dae696c\">\n",
              "    <style>\n",
              "      .colab-df-generate {\n",
              "        background-color: #E8F0FE;\n",
              "        border: none;\n",
              "        border-radius: 50%;\n",
              "        cursor: pointer;\n",
              "        display: none;\n",
              "        fill: #1967D2;\n",
              "        height: 32px;\n",
              "        padding: 0 0 0 0;\n",
              "        width: 32px;\n",
              "      }\n",
              "\n",
              "      .colab-df-generate:hover {\n",
              "        background-color: #E2EBFA;\n",
              "        box-shadow: 0px 1px 2px rgba(60, 64, 67, 0.3), 0px 1px 3px 1px rgba(60, 64, 67, 0.15);\n",
              "        fill: #174EA6;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate {\n",
              "        background-color: #3B4455;\n",
              "        fill: #D2E3FC;\n",
              "      }\n",
              "\n",
              "      [theme=dark] .colab-df-generate:hover {\n",
              "        background-color: #434B5C;\n",
              "        box-shadow: 0px 1px 3px 1px rgba(0, 0, 0, 0.15);\n",
              "        filter: drop-shadow(0px 1px 2px rgba(0, 0, 0, 0.3));\n",
              "        fill: #FFFFFF;\n",
              "      }\n",
              "    </style>\n",
              "    <button class=\"colab-df-generate\" onclick=\"generateWithVariable('result')\"\n",
              "            title=\"Generate code using this dataframe.\"\n",
              "            style=\"display:none;\">\n",
              "\n",
              "  <svg xmlns=\"http://www.w3.org/2000/svg\" height=\"24px\"viewBox=\"0 0 24 24\"\n",
              "       width=\"24px\">\n",
              "    <path d=\"M7,19H8.4L18.45,9,17,7.55,7,17.6ZM5,21V16.75L18.45,3.32a2,2,0,0,1,2.83,0l1.4,1.43a1.91,1.91,0,0,1,.58,1.4,1.91,1.91,0,0,1-.58,1.4L9.25,21ZM18.45,9,17,7.55Zm-12,3A5.31,5.31,0,0,0,4.9,8.1,5.31,5.31,0,0,0,1,6.5,5.31,5.31,0,0,0,4.9,4.9,5.31,5.31,0,0,0,6.5,1,5.31,5.31,0,0,0,8.1,4.9,5.31,5.31,0,0,0,12,6.5,5.46,5.46,0,0,0,6.5,12Z\"/>\n",
              "  </svg>\n",
              "    </button>\n",
              "    <script>\n",
              "      (() => {\n",
              "      const buttonEl =\n",
              "        document.querySelector('#id_53faccf2-ca6c-4319-8033-05081dae696c button.colab-df-generate');\n",
              "      buttonEl.style.display =\n",
              "        google.colab.kernel.accessAllowed ? 'block' : 'none';\n",
              "\n",
              "      buttonEl.onclick = () => {\n",
              "        google.colab.notebook.generateWithVariable('result');\n",
              "      }\n",
              "      })();\n",
              "    </script>\n",
              "  </div>\n",
              "\n",
              "    </div>\n",
              "  </div>\n"
            ],
            "text/plain": [
              "   Community                                           Abstract  \\\n",
              "0         -1   ,  Bone morphogenic proteins (BMPs) are impor...   \n",
              "1          0   Bone morphogenetic protein-binding endothelia...   \n",
              "2          1   Diaphanospondylodysostosis (DSD) is a rare sk...   \n",
              "3          2   <h4>Background</h4>Diaphanospondylodysostosis...   \n",
              "4          3   Diaphanospondylodysostosis (DSD) is a rare au...   \n",
              "5          4   Diaphanospondylodysostosis (DSD), caused by l...   \n",
              "6          5   Diaphanospondylodysostosis is an extremely ra...   \n",
              "\n",
              "                                               Terms  Size  \\\n",
              "0  [0-6 weeks old, Achondroplasia, Achondroplasti...    27   \n",
              "1  [dsd, bmper, ischiovertebral, ischiospinal dys...    16   \n",
              "2                                                 []    21   \n",
              "3  [diaphanospondylodysostosis, bmper, isd, ischi...    17   \n",
              "4  [bmper, ischiospinal dysostosis, skeletal dysp...    10   \n",
              "5                                                 []    12   \n",
              "6  [diaphanospondylodysostosis, multicystic kidne...    11   \n",
              "\n",
              "                                      frequent_words  \\\n",
              "0  diaphanospondylodysostosis , bmper , dan , dif...   \n",
              "1  dsd , bmper , ischiovertebral , ischiospinal d...   \n",
              "2                                                      \n",
              "3  diaphanospondylodysostosis , bmper , isd , isc...   \n",
              "4  bmper , ischiospinal dysostosis , skeletal dys...   \n",
              "5                                                      \n",
              "6  diaphanospondylodysostosis , multicystic kidne...   \n",
              "\n",
              "                                           Llama_3_n  \n",
              "0  {'Diaphanospondylodysostosis': 'The researcher...  \n",
              "1  {'Novel Mutation in BMPER Gene': 'The research...  \n",
              "2  {'**Genetic Basis of DSD': '** The authors hav...  \n",
              "3  {'Research Contribution Summary': 'The researc...  \n",
              "4  {'Whole Exome Sequencing': 'Whole exome sequen...  \n",
              "5  {'Identification of BMPER as the Gene Responsi...  \n",
              "6  {'Characterization of Clinical Features': 'The...  "
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "\n",
        "A=['PGM1-CDG','Cerebral cavernous malformations 3',\"CLOVES syndrome\",\"STT3B-CDG\",\"Thoracolaryngopelvic dysplasia\",\"Actinic prurigo\",\"Non-syndromic polydactyly\",\"Genitopatellar syndrome\",\"Diaphanospondylodysostosis\"]\n",
        "B=['GARD0004329','GARD0018314',\"GARD0010939\",\"GARD0017603\",\"GARD0005184\", \"GARD0017510\",\"GARD0004410\",\"GARD0010994\",\"GARD0016674\"]\n",
        "for f in range(6,len(A)):\n",
        " disease= A[f]  #'Actinic prurigo' #'Non-syndromic polydactyly'   #'Cystic fibrosis'\n",
        " diseaseid=B[f] #'GARD0017510'\n",
        "\n",
        "\n",
        " concatenated_data= merge_community_detection_and_researchers_info(disease)\n",
        " # Assuming you have a DataFrame `clustering_2`\n",
        " #clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', num_clusters=6, n_components=100)\n",
        " clustering_ = name_clusters(concatenated_data, 'Abstract', 'Community', eps=0.9, min_samples=10, n_components=100)\n",
        "\n",
        " # Group by 'Community' and aggregate columns using sum_strings and sum_terms functions\n",
        " result = clustering_.groupby('Community').agg(\n",
        "    Abstract=('Abstract', sum_strings),\n",
        "    Terms=('Terms', sum_terms),\n",
        "    Size=('Community', 'size')  # Count of occurrences\n",
        " ).reset_index()\n",
        "\n",
        " data=result\n",
        "\n",
        " data['frequent_words']  = data.apply(lambda x:  three_most_frequent_terms(x['Terms'])   , axis=1)\n",
        " data['Llama_3_n']=None\n",
        " #data['Llama_3_n'] = data['Llama_3_n'].astype('object')\n",
        " data.index=range(data.shape[0])\n",
        " display(data)\n",
        " for i in data.index:\n",
        "    print(i)\n",
        "    text = data['Abstract'][i]\n",
        "    if not isinstance(text, str):\n",
        "        continue\n",
        "    n = 0\n",
        "\n",
        "    # Ensure the chunking works properly and limit iterations to avoid infinite loops\n",
        "    while len(tokenizer1.tokenize(text)) > 5000 and n < 10:\n",
        "        # Split text into chunks\n",
        "        chunks = splitter.split_text(text)\n",
        "        text = ''\n",
        "\n",
        "        # Process each chunk individually\n",
        "        for j, chunk in enumerate(chunks):\n",
        "          if j <10:\n",
        "            text += ' ' + Costumized_question_summary(user_query=disease, system_query=chunk)\n",
        "          print('suumary_chunk ',j)\n",
        "        n += 1\n",
        "\n",
        "    # Apply the custom function for the query\n",
        "    #if data['frequent_words'][i] == '':\n",
        "    user_query= disease\n",
        "    #else:    user_query = data['frequent_words'][i]\n",
        "    #print(text)\n",
        "    eval=False\n",
        "    num_repetiton=0\n",
        "    while eval==False:# and num_repetiton<3:\n",
        "       res = Costumized_question(user_query=user_query, system_query=text)\n",
        "       print('-----------------------------------------')\n",
        "       print('res',res)\n",
        "       dic=organize_research_expertise(res)\n",
        "       print('-----------------------------------------')\n",
        "       print('dic',dic)\n",
        "       print('-----------------------------------------')\n",
        "       n,m=0,0\n",
        "       num_repetiton+=1\n",
        "       for h in dic:\n",
        "         if len(h) >2: n+=1\n",
        "         if h !='' and dic[h] != '': m+=1\n",
        "         if n>0 and m >=3:  eval=True\n",
        "       print('repetiton',num_repetiton)\n",
        "    #print(dic)\n",
        "    data.loc[i,'Llama_3_n'] = str(dic)\n",
        " display(data)\n",
        " # Iterate over data to create Cluster and Expertise nodes\n",
        " for r in data.index:\n",
        "    event_properties = {\n",
        "        'Cluster_ID': str(data['Community'][r]),\n",
        "        'Cluster_Size': str(data['Size'][r]),\n",
        "        'Evidence': str(data['Abstract'][r]),\n",
        "        'Key_trems': str(data['frequent_words'][r]),\n",
        "        'Llama_3_n': str(data['Llama_3_n'][r]),\n",
        "    }\n",
        "    create_Cluster_node(event_properties, disease)\n",
        "\n",
        "\n",
        " for k in clustering_.index:\n",
        "    # Check if node_value is a tuple/list, otherwise skip or handle it differently\n",
        "        create_relationship_cluster_researcher(\n",
        "            str(clustering_['Community'][k]),\n",
        "            clustering_['PI'][k],  # Researcher name\n",
        "            clustering_['affiliation'][k],  # Affiliation\n",
        "            disease  # Disease value (make sure this exists in your DataFrame)\n",
        "        )"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "qQsK2lHnKzeL"
      },
      "outputs": [],
      "source": [
        "MATCH (n:Pubmed)\n",
        "REMOVE n.GARDname\n",
        "------------------------\n",
        "MATCH (n:Pubmed)-[r:Involves_Researcher_p]-(m:Researcher)\n",
        "WITH n, m, COLLECT(r) AS relationships\n",
        "WHERE SIZE(relationships) > 1\n",
        "FOREACH (rel IN relationships[1..] | DELETE rel);\n",
        "--------------------------------------\n",
        "MATCH (n:ClinicalTrial)-[r:Involves_Researcher_ct]-(m:Researcher)\n",
        "WITH n, m, COLLECT(r) AS relationships\n",
        "WHERE SIZE(relationships) > 1\n",
        "FOREACH (rel IN relationships[1..] | DELETE rel);\n",
        "---------------------\n",
        "MATCH (n:Grant)-[r:Involves_Researcher_g]-(m:Researcher)\n",
        "WITH n, m, COLLECT(r) AS relationships\n",
        "WHERE SIZE(relationships) > 1\n",
        "FOREACH (rel IN relationships[1..] | DELETE rel);\n",
        "\n",
        "------------------\n",
        "MATCH (n:Cluster)-[r:HAS_EXPERTISE]-(m:Expertise)\n",
        "WITH n, m, COLLECT(r) AS relationships\n",
        "WHERE SIZE(relationships) > 1\n",
        "FOREACH (rel IN relationships[1..] | DELETE rel)\n",
        "--------------------------------------------------------\n",
        "MATCH (n:Cluster)-[r:Research_on]->(m:Researcher)\n",
        "WITH n, m, COLLECT(r) AS relationships\n",
        "WHERE SIZE(relationships) > 1\n",
        "FOREACH (rel IN relationships[1..] | DELETE rel)\n",
        "\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "RPPpxqfhNXhF"
      },
      "outputs": [],
      "source": []
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "KQoFwWwKOx5A"
      },
      "outputs": [],
      "source": [
        "Expertise Areas= '''{'The clinical features of actinic prurigo are as follows':\n",
        "'a.\\n\\nErythematous plaques with a pruritic, burning sensation, that mainly affect the exposed areas of the skin\n",
        ", such as the face, neck, and forearms. \\n\\nb.\\n\\nIn some cases,\n",
        " actinic prurigo may also affect the mucous membranes, such as the lips,\n",
        "  causing actinic cheilitis (AChe).\\n\\nc.\\n\\nIn some cases, actinic\n",
        "   prurigo may also affect the conjunctiva, causing actinic conjunctivitis (AC).\n",
        "   \\n\\nd.\\n\\nIn some cases, actinic prurigo may also affect the oral mucosa, causing actinic stomatitis.\n",
        "   \\n\\ne.\\n\\nIn some cases, actinic prurigo may also affect the nails,\n",
        "    causing actinic onycholysis.\\n\\nf.\\n\\nIn some cases, actinic prurigo\n",
        "    may also affect the genital area, causing actinic vulvitis or balanitis.\n",
        "    \\n\\ng.\\n\\nIn some cases, actinic prurigo may also affect the eyes, causing actinic keratitis.\n",
        "    \\n\\nh.\\n\\nIn some cases, actinic prurigo may also affect the lungs,\n",
        "    causing actinic pneumonitis.\\n\\ni.\\n\\nIn some cases, actinic prurigo may also affect the liver,\n",
        "    causing actinic hepatitis.\\n\\nj.\\n\\nIn some cases, actinic prurigo may also affect the kidneys,\n",
        "     causing actinic nephritis.\\n\\nk.\\n\\nIn some cases, actinic prurigo may also affect the heart,\n",
        "     causing actinic cardiomyopathy.\\n\\nl.\\n\\nIn some cases, actinic prurigo may also affect the nervous system,\n",
        "      causing actinic neuropathy.\\n\\nm.\\n\\nIn some cases, actinic prurigo may also affect the blood,\n",
        "      causing actinic anemia.\\n\\nn.\\n\\nIn some cases, actinic prurigo may also affect the immune system,\n",
        "       causing actinic immunosuppression.\\n\\no.\\n\\nIn some cases, actinic\n",
        "        prurigo may also affect the endocrine system, causing actinic\n",
        "        endocrinopathy.\\n\\np.\\n\\nIn some cases, actinic prurigo may also affect the musculoskeletal system,\n",
        "         causing actinic arthralgia.\\n\\nq.\\n\\nIn some cases, actinic prurigo may also affect the gastrointestinal\n",
        "         system, causing actinic gastritis.'}\n",
        "'"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "p6X27E_uQfee"
      },
      "outputs": [],
      "source": [
        "dict_out=\n",
        " {'year-old male patient who presented with Budd-Chiari syndrome and glycoprotein abnormalities associated with carbohydrate deficient glycoprotein syndrome type I with yet unidentified molecular defect (type Ix). The authors aimed to characterize the clinical features of this patient and compare the data with previously published cases to establish clinical subgroups. The study found that the most frequent findings were rather nonspecific, including developmental delay and axial hypotonia. Distinct ophthalmological abnormalities were observed, including optic nerve atrophy, cataract and glaucoma. Two subgroups were established': 'one with a pure neurological presentation and the other with a neurological-multivisceral form. The first group had a significantly better prognosis. The unique presentation of microcephaly, seizures, ascites, hepatomegaly, nephrotic syndrome and severe developmental delay was observed in one child diagnosed with CDG Ik.', 'The authors propose to develop a zebrafish model of PMM2-CDG and identify two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology. Analyses of cartilage defects in pmm2 mutant zebrafish revealed a block in early chondrocyte development that is associated with defective processing of the cell adhesion molecule N-cadherin. N-cadherin is sequentially cleaved by furin PCs and MMPs, and both exhibit altered activity in pmm2 mutant zebrafish. The proposed studies address the hypothesis that reduced glycosylation alters the activity of PCs like furin, initiating a cascade involving MMPs that disrupts processing of key cell adhesion molecules, including N-cadherin. The authors aim to define how hypoglycosylation of protein processing enzymes alters tissue development; determine whether there is a common mechanism among CDG subtypes; and identify genetic modifiers of CDG disease severity.\\n\\n###\n",
        "Expertise Areas': '', 'Clinical Research': 'The authors have demonstrated their expertise in conducting clinical research by characterizing the clinical features of a', 'Genetic Research': 'The authors have demonstrated their expertise in genetic research by identifying two unreported types of congenital disorders of glycosylation (CDG) caused by mutations in different isoforms of the catalytic subunit of the oligosaccharyltransferase (OST). They have also identified the homozygous mutation (c.1877T > C) in STT3A and the homozygous intronic mutation (c.1539 + 20G > T) in STT3B, which causes the other disorder. Furthermore, they have conducted research on the development of a zebrafish model of PMM2-CDG and identified two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology.', 'Molecular Research': 'The authors have demonstrated their expertise in molecular research by conducting research on the development of a zebrafish model of PMM2-CDG and identifying two classes of enzymes, the protein proconvertases (PCs) and matrix metalloproteinases (MMPs), as candidate drivers of pathology. They have also conducted research on the pathogenic mechanisms and molecular networks that are commonly or uniquely altered in CDG. Additionally, they have pursued genetic modifiers of CDG disease severity.'}\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "VDzKYvuCSFXI"
      },
      "outputs": [],
      "source": [
        "dict_out={'The clinical features of actinic prurigo are as follows': 'a.\\n\\nErythematous plaques with a pruritic, burning sensation, that mainly affect the exposed areas of the skin, such as the face, neck, and forearms. \\n\\nb.\\n\\nIn some cases, actinic prurigo may also affect the mucous membranes, such as the lips, causing actinic cheilitis (AChe).\\n\\nc.\\n\\nIn some cases, actinic prurigo may also affect the conjunctiva, causing actinic conjunctivitis (AC).\\n\\nd.\\n\\nIn some cases, actinic prurigo may also affect the oral mucosa, causing actinic stomatitis.\\n\\ne.\\n\\nIn some cases, actinic prurigo may also affect the nails, causing actinic onycholysis.\\n\\nf.\\n\\nIn some cases, actinic prurigo may also affect the genital area, causing actinic vulvitis or balanitis.\\n\\ng.\\n\\nIn some cases, actinic prurigo may also affect the eyes, causing actinic keratitis.\\n\\nh.\\n\\nIn some cases, actinic prurigo may also affect the lungs, causing actinic pneumonitis.\\n\\ni.\\n\\nIn some cases, actinic prurigo may also affect the liver, causing actinic hepatitis.\\n\\nj.\\n\\nIn some cases, actinic prurigo may also affect the kidneys, causing actinic nephritis.\\n\\nk.\\n\\nIn some cases, actinic prurigo may also affect the heart, causing actinic cardiomyopathy.\\n\\nl.\\n\\nIn some cases, actinic prurigo may also affect the nervous system, causing actinic neuropathy.\\n\\nm.\\n\\nIn some cases, actinic prurigo may also affect the blood, causing actinic anemia.\\n\\nn.\\n\\nIn some cases, actinic prurigo may also affect the immune system, causing actinic immunosuppression.\\n\\no.\\n\\nIn some cases, actinic prurigo may also affect the endocrine system, causing actinic endocrinopathy.\\n\\np.\\n\\nIn some cases, actinic prurigo may also affect the musculoskeletal system, causing actinic arthralgia.\\n\\nq.\\n\\nIn some cases, actinic prurigo may also affect the gastrointestinal system, causing actinic gastritis.'}\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "id": "dfJNBFmwIl7P"
      },
      "outputs": [],
      "source": [
        "text_2\n",
        "Expertise Areas"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_zDWHhzhEaKC",
        "outputId": "ef810844-71c8-4ff8-a75e-34bd392fd567"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "2\n"
          ]
        },
        {
          "data": {
            "text/plain": [
              "{}"
            ]
          },
          "execution_count": 36,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": []
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "T4",
      "provenance": []
    },
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}